GO and KEGG pathway analysis
ERM
2024-06-07
Last updated: 2024-06-07
Checks: 7 0
Knit directory: ATAC_learning/
This reproducible R Markdown analysis was created with workflowr (version 1.7.1). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.
Great! Since the R Markdown file has been committed to the Git repository, you know the exact version of the code that produced these results.
Great job! The global environment was empty. Objects defined in the global environment can affect the analysis in your R Markdown file in unknown ways. For reproduciblity it’s best to always run the code in an empty environment.
The command set.seed(20231016) was run prior to running
the code in the R Markdown file. Setting a seed ensures that any results
that rely on randomness, e.g. subsampling or permutations, are
reproducible.
Great job! Recording the operating system, R version, and package versions is critical for reproducibility.
Nice! There were no cached chunks for this analysis, so you can be confident that you successfully produced the results during this run.
Great job! Using relative paths to the files within your workflowr project makes it easier to run your code on other machines.
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
The results in this page were generated with repository version b5e8a1e. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.
Note that you need to be careful to ensure that all relevant files for
the analysis have been committed to Git prior to generating the results
(you can use wflow_publish or
wflow_git_commit). workflowr only checks the R Markdown
file, but you know if there are other scripts or data files that it
depends on. Below is the status of the Git repository when the results
were generated:
Ignored files:
Ignored: .RData
Ignored: .Rhistory
Ignored: .Rproj.user/
Ignored: analysis/figure/
Ignored: data/ARR_SNP_table.csv
Ignored: data/All_merged_peaks.tsv
Ignored: data/CAD_gwas_dataframe.RDS
Ignored: data/Collapsed_expressed_NG_peak_table.csv
Ignored: data/DEG_toplist_sep_n45.RDS
Ignored: data/FRiP_first_run.txt
Ignored: data/Frip_1_reads.csv
Ignored: data/Frip_2_reads.csv
Ignored: data/Frip_3_reads.csv
Ignored: data/Frip_4_reads.csv
Ignored: data/Frip_5_reads.csv
Ignored: data/Frip_6_reads.csv
Ignored: data/GO_KEGG_analysis/
Ignored: data/HF_SNP_table.csv
Ignored: data/Ind1_75DA24h_dedup_peaks.csv
Ignored: data/Ind1_TSS_peaks.RDS
Ignored: data/Ind1_firstfragment_files.txt
Ignored: data/Ind1_fragment_files.txt
Ignored: data/Ind1_peaks_list.RDS
Ignored: data/Ind1_summary.txt
Ignored: data/Ind2_TSS_peaks.RDS
Ignored: data/Ind2_fragment_files.txt
Ignored: data/Ind2_peaks_list.RDS
Ignored: data/Ind2_summary.txt
Ignored: data/Ind3_TSS_peaks.RDS
Ignored: data/Ind3_fragment_files.txt
Ignored: data/Ind3_peaks_list.RDS
Ignored: data/Ind3_summary.txt
Ignored: data/Ind4_79B24h_dedup_peaks.csv
Ignored: data/Ind4_TSS_peaks.RDS
Ignored: data/Ind4_V24h_fraglength.txt
Ignored: data/Ind4_fragment_files.txt
Ignored: data/Ind4_fragment_filesN.txt
Ignored: data/Ind4_peaks_list.RDS
Ignored: data/Ind4_summary.txt
Ignored: data/Ind5_TSS_peaks.RDS
Ignored: data/Ind5_fragment_files.txt
Ignored: data/Ind5_fragment_filesN.txt
Ignored: data/Ind5_peaks_list.RDS
Ignored: data/Ind5_summary.txt
Ignored: data/Ind6_TSS_peaks.RDS
Ignored: data/Ind6_fragment_files.txt
Ignored: data/Ind6_peaks_list.RDS
Ignored: data/Ind6_summary.txt
Ignored: data/Knowles_4.RDS
Ignored: data/Knowles_5.RDS
Ignored: data/Knowles_6.RDS
Ignored: data/MI_gwas.RDS
Ignored: data/SNP_supp_schneider.RDS
Ignored: data/all_TSSE_scores.RDS
Ignored: data/aln_run1_results.txt
Ignored: data/anno_ind1_DA24h.RDS
Ignored: data/anno_ind4_V24h.RDS
Ignored: data/background_n45_he_peaks.RDS
Ignored: data/cardiac_muscle_FRIP.csv
Ignored: data/cardiomyocyte_FRIP.csv
Ignored: data/col_ng_peak.csv
Ignored: data/cormotif_full_4_run.RDS
Ignored: data/cormotif_full_4_run_he.RDS
Ignored: data/cormotif_full_6_run.RDS
Ignored: data/cormotif_full_6_run_he.RDS
Ignored: data/cormotif_probability_45_list.csv
Ignored: data/cormotif_probability_45_list_he.csv
Ignored: data/cormotif_probability_all_6_list.csv
Ignored: data/cormotif_probability_all_6_list_he.csv
Ignored: data/embryo_heart_FRIP.csv
Ignored: data/enhancer_list_ENCFF126UHK.bed
Ignored: data/enhancerdata/
Ignored: data/filt_Peaks_efit2.RDS
Ignored: data/filt_Peaks_efit2_bl.RDS
Ignored: data/filt_Peaks_efit2_n45.RDS
Ignored: data/first_Peaksummarycounts.csv
Ignored: data/first_run_frag_counts.txt
Ignored: data/full_bedfiles/
Ignored: data/gene_ref.csv
Ignored: data/gwas_1_dataframe.RDS
Ignored: data/gwas_2_dataframe.RDS
Ignored: data/gwas_3_dataframe.RDS
Ignored: data/gwas_4_dataframe.RDS
Ignored: data/gwas_5_dataframe.RDS
Ignored: data/high_conf_peak_counts.csv
Ignored: data/high_conf_peak_counts.txt
Ignored: data/high_conf_peaks_bl_counts.txt
Ignored: data/high_conf_peaks_counts.txt
Ignored: data/hits_files/
Ignored: data/ind1_DA24hpeaks.RDS
Ignored: data/ind1_TSSE.RDS
Ignored: data/ind2_TSSE.RDS
Ignored: data/ind3_TSSE.RDS
Ignored: data/ind4_TSSE.RDS
Ignored: data/ind4_V24hpeaks.RDS
Ignored: data/ind5_TSSE.RDS
Ignored: data/ind6_TSSE.RDS
Ignored: data/initial_complete_stats_run1.txt
Ignored: data/left_ventricle_FRIP.csv
Ignored: data/mergedPeads.gff
Ignored: data/mergedPeaks.gff
Ignored: data/motif_list_full
Ignored: data/motif_list_n45
Ignored: data/motif_list_n45.RDS
Ignored: data/multiqc_fastqc_run1.txt
Ignored: data/multiqc_fastqc_run2.txt
Ignored: data/multiqc_genestat_run1.txt
Ignored: data/multiqc_genestat_run2.txt
Ignored: data/my_hc_filt_counts.RDS
Ignored: data/my_hc_filt_counts_n45.RDS
Ignored: data/n45_bedfiles/
Ignored: data/n45_files
Ignored: data/other_papers/
Ignored: data/peakAnnoList_1.RDS
Ignored: data/peakAnnoList_2.RDS
Ignored: data/peakAnnoList_24_full.RDS
Ignored: data/peakAnnoList_24_n45.RDS
Ignored: data/peakAnnoList_3.RDS
Ignored: data/peakAnnoList_3_full.RDS
Ignored: data/peakAnnoList_3_n45.RDS
Ignored: data/peakAnnoList_4.RDS
Ignored: data/peakAnnoList_5.RDS
Ignored: data/peakAnnoList_6.RDS
Ignored: data/peakAnnoList_full_motif.RDS
Ignored: data/peakAnnoList_n45_motif.RDS
Ignored: data/siglist_full.RDS
Ignored: data/siglist_n45.RDS
Ignored: data/test.list.RDS
Ignored: data/testnames.txt
Ignored: data/toplist_6.RDS
Ignored: data/toplist_full.RDS
Ignored: data/toplist_full_DAR_6.RDS
Ignored: data/toplist_n45.RDS
Ignored: data/trimmed_seq_length.csv
Ignored: data/unclassified_full_set_peaks.RDS
Ignored: data/unclassified_n45_set_peaks.RDS
Ignored: data/xstreme/
Ignored: trimmed_Ind1_75DA24h_S7.nodup.splited.bam/
Untracked files:
Untracked: EAR_2_plot.pdf
Untracked: ESR_1_plot.pdf
Untracked: Firstcorr plotATAC.pdf
Untracked: IND1_2_3_6_corrplot.pdf
Untracked: LR_3_plot.pdf
Untracked: NR_1_plot.pdf
Untracked: analysis/my_hc_filt_counts.csv
Untracked: analysis/nucleosome_explore.Rmd
Untracked: code/IGV_snapshot_code.R
Untracked: code/LongDARlist.R
Untracked: code/TSSE.R
Untracked: code/just_for_Fun.R
Untracked: code/toplist_assembly.R
Untracked: lcpm_filtered_corplot.pdf
Untracked: log2cpmfragcount.pdf
Untracked: output/cormotif_probability_45_list.csv
Untracked: output/cormotif_probability_all_6_list.csv
Untracked: splited/
Untracked: trimmed_Ind1_75DA24h_S7.nodup.fragment.size.distribution.pdf
Untracked: trimmed_Ind1_75DA3h_S1.nodup.fragment.size.distribution.pdf
Unstaged changes:
Modified: analysis/CorMotif_data_n45.Rmd
Modified: analysis/Fastqc_results.Rmd
Modified: analysis/Jaspar_motif.Rmd
Modified: analysis/Peak_calling.Rmd
Modified: analysis/Smaller_set_DAR.Rmd
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
These are the previous versions of the repository in which changes were
made to the R Markdown (analysis/GO_KEGG_analysis.Rmd) and
HTML (docs/GO_KEGG_analysis.html) files. If you’ve
configured a remote Git repository (see ?wflow_git_remote),
click on the hyperlinks in the table below to view the files as they
were in that past version.
| File | Version | Author | Date | Message |
|---|---|---|---|---|
| Rmd | b5e8a1e | reneeisnowhere | 2024-06-07 | updates and new analysis |
| html | 021ca5f | reneeisnowhere | 2024-06-07 | Build site. |
| Rmd | 95e0415 | reneeisnowhere | 2024-06-07 | updates, i think |
| html | eea0976 | reneeisnowhere | 2024-06-03 | Build site. |
| Rmd | 0672654 | reneeisnowhere | 2024-06-03 | updates to gene lists |
| html | 897af23 | reneeisnowhere | 2024-05-28 | Build site. |
| Rmd | 5c6ef83 | reneeisnowhere | 2024-05-28 | updates to KEGG/GO 20kb lists |
| html | d1a3829 | reneeisnowhere | 2024-05-17 | Build site. |
| Rmd | 9fb4f9a | reneeisnowhere | 2024-05-17 | adding in updates from Neargenes and enhncers |
| html | 2d991d7 | reneeisnowhere | 2024-05-03 | Build site. |
| Rmd | f57f2ee | reneeisnowhere | 2024-05-03 | first update |
library(tidyverse)
# library(ggsignif)
# library(cowplot)
# library(ggpubr)
# library(sjmisc)
library(kableExtra)
library(broom)
# library(biomaRt)
library(RColorBrewer)
library(gprofiler2)
# library(qvalue)
library(ChIPseeker)
library("TxDb.Hsapiens.UCSC.hg38.knownGene")
library("org.Hs.eg.db")
# library(ATACseqQC)
library(rtracklayer)
library(edgeR)
library(ggfortify)
library(limma)
library(readr)
library(BiocGenerics)
library(gridExtra)
library(VennDiagram)
library(scales)
library(ggVennDiagram)
# library(Cormotif)
library(BiocParallel)
library(ggpubr)
# library(devtools)
# # install_github('davetang/bedr')
# library(bedr)
library(biomaRt)
# library(clusterProfiler)data loading
peakAnnoList_n45_motif <- readRDS("data/peakAnnoList_n45_motif.RDS")
# list2env(peakAnnoList_n45_motif, envir = .GlobalEnv)
fills <- c("#C77CFF","#F8766D","#7CAE00", "#00BFC4" )
EAR_df <- as.data.frame(peakAnnoList_n45_motif$EAR_n45_gr)
EAR_df_gr <- GRanges(EAR_df)
ESR_df <- as.data.frame(peakAnnoList_n45_motif$ESR_n45_gr)
ESR_df_gr <- GRanges(ESR_df)
LR_df <- as.data.frame(peakAnnoList_n45_motif$LR_n45_gr)
LR_df_gr <- GRanges(LR_df)
NR_df <- as.data.frame(peakAnnoList_n45_motif$NR_n45_gr)
NR_df_gr <- GRanges(NR_df)
toplist_ATAC <- readRDS("data/toplist_n45.RDS")
DOX24h_peaks_hypo_list <- toplist_ATAC %>%
dplyr::filter(trt=="DOX" & time=="24 hours" & logFC<0)
DOX24h_peaks_hyper_list <- toplist_ATAC %>%
dplyr::filter(trt=="DOX" & time=="24 hours" & logFC>0)
exp_neargene_table <- read_delim("data/n45_bedfiles/exp_neargene_table.tsv",
delim = "\t", escape_double = FALSE,
trim_ws = TRUE)
background_genes <- read.csv("data/other_papers/backgroundRNAlist.csv", row.names = 1)
# col_ng_peak <- exp_neargene_table %>%
# group_by(chr, start, end, peakid) %>%
# summarise(NCBI_gene = paste(unique(ENTREZID),collapse=","),
# ensembl_ID= paste(unique(ensembl_id),collapse = ","),
# SYMBOL= paste(unique(SYMBOL),collapse = ",") ,
# dist_to_NG =min(dist_to_NG))
#
EAR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% EAR_df$id) %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::select(ENTREZID) %>%
distinct()
ESR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% ESR_df$id) %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::select(ENTREZID) %>%
distinct()
LR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% LR_df$id) %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::select(ENTREZID) %>%
distinct()
NR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% NR_df$id) %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::select(ENTREZID) %>%
distinct()
# background_genes <- exp_neargene_table %>%
# dplyr::select(ENTREZID) %>%
# distinct()
EAR_resgenes <- readRDS("data/GO_KEGG_analysis/EAR_resgenes.RDS")
ESR_resgenes <- readRDS("data/GO_KEGG_analysis/ESR_resgenes.RDS")
LR_resgenes <- readRDS("data/GO_KEGG_analysis/LR_resgenes.RDS")
NR_resgenes <- readRDS("data/GO_KEGG_analysis/NR_resgenes.RDS")
EAR_hyper_resgenes <- readRDS("data/GO_KEGG_analysis/EAR_hyper_resgenes.RDS")
EAR_hypo_resgenes <- readRDS("data/GO_KEGG_analysis/EAR_hypo_resgenes.RDS")
ESR_hyper_resgenes <- readRDS("data/GO_KEGG_analysis/ESR_hyper_resgenes.RDS")
ESR_hypo_resgenes <- readRDS("data/GO_KEGG_analysis/ESR_hypo_resgenes.RDS")
LR_hyper_resgenes <- readRDS("data/GO_KEGG_analysis/LR_hyper_resgenes.RDS")
LR_hypo_resgenes <- readRDS("data/GO_KEGG_analysis/LR_hypo_resgenes.RDS")
NR_hyper_resgenes <- readRDS("data/GO_KEGG_analysis/NR_hyper_resgenes.RDS")
NR_hypo_resgenes <- readRDS("data/GO_KEGG_analysis/NR_hypo_resgenes.RDS")
EAR_enh_peaks_20k <- readRDS("data/enhancerdata/EAR_enh_peaks_20k.RDS")
ESR_enh_peaks_20k <- readRDS("data/enhancerdata/ESR_enh_peaks_20k.RDS")
LR_enh_peaks_20k <- readRDS("data/enhancerdata/LR_enh_peaks_20k.RDS")
NR_enh_peaks_20k <- readRDS("data/enhancerdata/NR_enh_peaks_20k.RDS")
EAR_resgenes_20k <- readRDS("data/GO_KEGG_analysis/EAR_resgenes_20k.RDS")
EAR_resgenes_20k_enh <- readRDS("data/GO_KEGG_analysis/EAR_resgenes_20k_enh.RDS")
ESR_resgenes_20k <- readRDS("data/GO_KEGG_analysis/ESR_resgenes_20k.RDS")
ESR_resgenes_20k_enh <- readRDS("data/GO_KEGG_analysis/ESR_resgenes_20k_enh.RDS")
LR_resgenes_20k <- readRDS("data/GO_KEGG_analysis/LR_resgenes_20k.RDS")
LR_resgenes_20k_enh <- readRDS("data/GO_KEGG_analysis/LR_resgenes_20k_enh.RDS")
NR_resgenes_20k <- readRDS("data/GO_KEGG_analysis/NR_resgenes_20k.RDS")
NR_resgenes_20k_enh <- readRDS("data/GO_KEGG_analysis/NR_resgenes_20k_enh.RDS")
### intersection of peaks files
S13Table <- read.csv( "data/other_papers/S13Table_Matthews2024.csv",row.names = 1)
##14021
EAR_RNA <- S13Table %>%
dplyr::filter(MOTIF=="EAR") %>%
dplyr::select(ENTREZID) %>%
mutate(ENTREZID= as.character(ENTREZID))
ESR_RNA <- S13Table %>%
dplyr::filter(MOTIF=="ESR")%>%
dplyr::select(ENTREZID)%>%
mutate(ENTREZID= as.character(ENTREZID))
LR_RNA <- S13Table %>%
dplyr::filter(MOTIF=="LR")%>%
dplyr::select(ENTREZID)%>%
mutate(ENTREZID=as.character(ENTREZID))
NR_RNA <- S13Table %>%
dplyr::filter(MOTIF=="NR")%>%
dplyr::select(ENTREZID)%>%
mutate(ENTREZID= as.character(ENTREZID))
Resp_RNA <- EAR_RNA %>%
rbind(.,ESR_RNA) %>%
rbind(., LR_RNA) %>%
distinct(ENTREZID)
int_EAR_n_RNAresp <- intersect(EAR_NG_list$ENTREZID, Resp_RNA$ENTREZID)
int_ESR_n_RNAresp <- intersect(ESR_NG_list$ENTREZID, Resp_RNA$ENTREZID)
int_LR_n_RNAresp <- intersect(LR_NG_list$ENTREZID, Resp_RNA$ENTREZID)
int_NR_n_RNAresp <- intersect(NR_NG_list$ENTREZID, Resp_RNA$ENTREZID)
EAR_int_resgenes <- readRDS("data/GO_KEGG_analysis/EAR_int_resgenes.RDS")
ESR_int_resgenes <- readRDS("data/GO_KEGG_analysis/ESR_int_resgenes.RDS")
LR_int_resgenes <- readRDS("data/GO_KEGG_analysis/LR_int_resgenes.RDS")EAR response genes
# EAR_resgenes <- gost(query = EAR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(EAR_resgenes,"data/GO_KEGG_analysis/EAR_resgenes.RDS")
# EARnom <- gostplot(EAR_resgenes, capped = FALSE, interactive = TRUE)
# EARnom
EARnomtable <- EAR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
EARnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in EAR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 700 | 1951 | 1.00e-22 |
| GO:BP | GO:0048856 | anatomical structure development | 1307 | 4130 | 1.05e-20 |
| GO:BP | GO:0032502 | developmental process | 1397 | 4475 | 3.46e-20 |
| GO:BP | GO:0050789 | regulation of biological process | 2316 | 8037 | 4.82e-19 |
| GO:BP | GO:0032501 | multicellular organismal process | 1481 | 4830 | 2.13e-18 |
| GO:BP | GO:0007275 | multicellular organism development | 1086 | 3383 | 2.22e-18 |
| GO:BP | GO:0065007 | biological regulation | 2368 | 8275 | 5.07e-18 |
| GO:BP | GO:0048731 | system development | 948 | 2903 | 7.37e-18 |
| GO:BP | GO:0048869 | cellular developmental process | 972 | 2988 | 7.37e-18 |
| GO:BP | GO:0030154 | cell differentiation | 971 | 2987 | 8.69e-18 |
| GO:BP | GO:0050793 | regulation of developmental process | 629 | 1801 | 1.56e-17 |
| GO:BP | GO:0050794 | regulation of cellular process | 2207 | 7651 | 1.56e-17 |
| GO:BP | GO:0023052 | signaling | 1286 | 4180 | 1.48e-15 |
| GO:BP | GO:0007154 | cell communication | 1304 | 4248 | 1.60e-15 |
| GO:BP | GO:0007165 | signal transduction | 1187 | 3846 | 2.60e-14 |
| GO:BP | GO:0072359 | circulatory system development | 340 | 896 | 5.96e-14 |
| GO:BP | GO:0022008 | neurogenesis | 469 | 1327 | 2.04e-13 |
| GO:BP | GO:0048699 | generation of neurons | 414 | 1145 | 2.21e-13 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 680 | 2052 | 2.72e-13 |
| GO:BP | GO:0050896 | response to stimulus | 1681 | 5732 | 4.74e-13 |
| GO:BP | GO:0051716 | cellular response to stimulus | 1468 | 4933 | 8.85e-13 |
| GO:BP | GO:0048468 | cell development | 658 | 1999 | 4.15e-12 |
| GO:BP | GO:0016477 | cell migration | 387 | 1078 | 6.39e-12 |
| GO:BP | GO:0030182 | neuron differentiation | 387 | 1080 | 8.42e-12 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1360 | 4561 | 1.23e-11 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1219 | 4037 | 1.28e-11 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1153 | 3804 | 3.19e-11 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1257 | 4198 | 6.45e-11 |
| GO:BP | GO:0048513 | animal organ development | 687 | 2130 | 8.28e-11 |
| GO:BP | GO:0048870 | cell motility | 415 | 1190 | 8.28e-11 |
| GO:BP | GO:0007399 | nervous system development | 621 | 1903 | 1.41e-10 |
| GO:BP | GO:0009987 | cellular process | 3085 | 11450 | 1.91e-10 |
| GO:BP | GO:0008150 | biological_process | 3221 | 12051 | 3.84e-10 |
| GO:BP | GO:2000145 | regulation of cell motility | 277 | 745 | 3.89e-10 |
| GO:BP | GO:0035556 | intracellular signal transduction | 668 | 2079 | 3.89e-10 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 474 | 1403 | 3.89e-10 |
| GO:BP | GO:0030334 | regulation of cell migration | 266 | 710 | 4.10e-10 |
| GO:BP | GO:0048666 | neuron development | 322 | 894 | 5.18e-10 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 642 | 1992 | 5.84e-10 |
| GO:BP | GO:0030029 | actin filament-based process | 255 | 677 | 5.84e-10 |
| GO:BP | GO:0040012 | regulation of locomotion | 282 | 766 | 7.83e-10 |
| GO:BP | GO:0031175 | neuron projection development | 289 | 794 | 1.83e-09 |
| GO:BP | GO:0010646 | regulation of cell communication | 809 | 2601 | 1.98e-09 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 158 | 380 | 1.98e-09 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 209 | 540 | 3.16e-09 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 213 | 553 | 3.33e-09 |
| GO:BP | GO:0040011 | locomotion | 307 | 858 | 3.53e-09 |
| GO:BP | GO:0000902 | cell morphogenesis | 278 | 764 | 4.29e-09 |
| GO:BP | GO:0034330 | cell junction organization | 224 | 591 | 5.61e-09 |
| GO:BP | GO:0023051 | regulation of signaling | 804 | 2597 | 6.27e-09 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 243 | 653 | 6.47e-09 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 260 | 710 | 8.76e-09 |
| GO:BP | GO:0007507 | heart development | 199 | 515 | 9.98e-09 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 337 | 967 | 1.19e-08 |
| GO:BP | GO:0007155 | cell adhesion | 347 | 1004 | 1.87e-08 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 308 | 876 | 2.71e-08 |
| GO:BP | GO:0003008 | system process | 403 | 1201 | 4.24e-08 |
| GO:BP | GO:0009966 | regulation of signal transduction | 717 | 2307 | 4.42e-08 |
| GO:BP | GO:0009888 | tissue development | 467 | 1425 | 5.83e-08 |
| GO:BP | GO:0065008 | regulation of biological quality | 641 | 2039 | 6.23e-08 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 368 | 1088 | 9.07e-08 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 381 | 1134 | 1.09e-07 |
| GO:BP | GO:0009790 | embryo development | 301 | 864 | 1.23e-07 |
| GO:BP | GO:0035239 | tube morphogenesis | 241 | 668 | 1.92e-07 |
| GO:BP | GO:0007423 | sensory organ development | 157 | 399 | 2.08e-07 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 343 | 1011 | 2.35e-07 |
| GO:BP | GO:0016043 | cellular component organization | 1474 | 5139 | 2.52e-07 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1525 | 5340 | 3.88e-07 |
| GO:BP | GO:0035295 | tube development | 287 | 827 | 4.51e-07 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 218 | 601 | 6.69e-07 |
| GO:BP | GO:0001568 | blood vessel development | 201 | 546 | 6.99e-07 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 403 | 1227 | 7.03e-07 |
| GO:BP | GO:0030030 | cell projection organization | 413 | 1262 | 7.18e-07 |
| GO:BP | GO:0070848 | response to growth factor | 210 | 576 | 7.59e-07 |
| GO:BP | GO:0001944 | vasculature development | 209 | 573 | 7.82e-07 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 203 | 554 | 8.42e-07 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 224 | 625 | 1.19e-06 |
| GO:BP | GO:0048589 | developmental growth | 194 | 527 | 1.19e-06 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 409 | 1256 | 1.57e-06 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 91 | 208 | 1.61e-06 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 591 | 1900 | 1.69e-06 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 189 | 515 | 2.31e-06 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 174 | 467 | 2.48e-06 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 193 | 530 | 3.14e-06 |
| GO:BP | GO:0016358 | dendrite development | 86 | 196 | 3.21e-06 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 259 | 749 | 3.24e-06 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 194 | 534 | 3.42e-06 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 863 | 2902 | 4.72e-06 |
| GO:BP | GO:0001525 | angiogenesis | 150 | 397 | 8.04e-06 |
| GO:BP | GO:0048880 | sensory system development | 111 | 275 | 8.34e-06 |
| GO:BP | GO:0001654 | eye development | 110 | 272 | 8.38e-06 |
| GO:BP | GO:0001501 | skeletal system development | 141 | 369 | 8.73e-06 |
| GO:BP | GO:0014706 | striated muscle tissue development | 92 | 218 | 9.35e-06 |
| GO:BP | GO:0150063 | visual system development | 110 | 273 | 1.02e-05 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 158 | 425 | 1.14e-05 |
| GO:BP | GO:0008360 | regulation of cell shape | 56 | 115 | 1.14e-05 |
| GO:BP | GO:0042221 | response to chemical | 732 | 2436 | 1.16e-05 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 302 | 909 | 1.61e-05 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 436 | 1376 | 1.61e-05 |
| GO:BP | GO:0043010 | camera-type eye development | 97 | 236 | 1.80e-05 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 87 | 206 | 1.83e-05 |
| GO:BP | GO:0061061 | muscle structure development | 198 | 559 | 1.83e-05 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 218 | 626 | 1.95e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 694 | 2311 | 2.91e-05 |
| GO:BP | GO:0040007 | growth | 250 | 739 | 3.77e-05 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 272 | 815 | 4.20e-05 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 160 | 440 | 4.31e-05 |
| GO:BP | GO:0060537 | muscle tissue development | 133 | 353 | 4.38e-05 |
| GO:BP | GO:0007417 | central nervous system development | 252 | 748 | 4.76e-05 |
| GO:BP | GO:0044057 | regulation of system process | 147 | 399 | 5.13e-05 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 168 | 468 | 5.57e-05 |
| GO:BP | GO:0006468 | protein phosphorylation | 327 | 1008 | 5.65e-05 |
| GO:BP | GO:0007267 | cell-cell signaling | 369 | 1156 | 6.34e-05 |
| GO:BP | GO:0030900 | forebrain development | 113 | 292 | 6.56e-05 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 162 | 450 | 6.98e-05 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 150 | 411 | 7.11e-05 |
| GO:BP | GO:0001764 | neuron migration | 62 | 138 | 7.42e-05 |
| GO:BP | GO:0007010 | cytoskeleton organization | 386 | 1218 | 7.49e-05 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 225 | 662 | 8.79e-05 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 106 | 272 | 9.27e-05 |
| GO:BP | GO:0034329 | cell junction assembly | 130 | 349 | 1.07e-04 |
| GO:BP | GO:0060322 | head development | 201 | 583 | 1.10e-04 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 153 | 425 | 1.32e-04 |
| GO:BP | GO:0060284 | regulation of cell development | 207 | 605 | 1.37e-04 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 167 | 472 | 1.49e-04 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 119 | 316 | 1.54e-04 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 155 | 433 | 1.60e-04 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 560 | 1852 | 1.80e-04 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 95 | 242 | 2.13e-04 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 364 | 1154 | 2.38e-04 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 50 | 108 | 2.60e-04 |
| GO:BP | GO:0007015 | actin filament organization | 138 | 381 | 2.74e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 99 | 256 | 2.79e-04 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 115 | 307 | 2.88e-04 |
| GO:BP | GO:0003007 | heart morphogenesis | 88 | 222 | 2.96e-04 |
| GO:BP | GO:0023056 | positive regulation of signaling | 402 | 1292 | 3.04e-04 |
| GO:BP | GO:0007420 | brain development | 185 | 539 | 3.57e-04 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 400 | 1288 | 3.90e-04 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 114 | 306 | 4.12e-04 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 56 | 127 | 4.20e-04 |
| GO:BP | GO:0051960 | regulation of nervous system development | 130 | 358 | 4.22e-04 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 748 | 2555 | 4.54e-04 |
| GO:BP | GO:0050808 | synapse organization | 135 | 375 | 4.62e-04 |
| GO:BP | GO:0099536 | synaptic signaling | 178 | 518 | 4.74e-04 |
| GO:BP | GO:0051179 | localization | 1129 | 3978 | 4.76e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 183 | 535 | 4.78e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 34 | 66 | 4.90e-04 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 349 | 1111 | 5.13e-04 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 184 | 540 | 5.77e-04 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 111 | 299 | 6.07e-04 |
| GO:BP | GO:0050773 | regulation of dendrite development | 40 | 83 | 6.40e-04 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 129 | 358 | 6.59e-04 |
| GO:BP | GO:0051049 | regulation of transport | 363 | 1164 | 6.67e-04 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 65 | 156 | 7.12e-04 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 225 | 683 | 8.09e-04 |
| GO:BP | GO:0032879 | regulation of localization | 462 | 1521 | 8.12e-04 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 52 | 118 | 8.15e-04 |
| GO:BP | GO:0051641 | cellular localization | 809 | 2793 | 8.41e-04 |
| GO:BP | GO:0003013 | circulatory system process | 155 | 446 | 8.48e-04 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 58 | 136 | 8.77e-04 |
| GO:BP | GO:0016310 | phosphorylation | 375 | 1211 | 9.05e-04 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 103 | 276 | 9.05e-04 |
| GO:BP | GO:0048588 | developmental cell growth | 77 | 194 | 9.13e-04 |
| GO:BP | GO:0048638 | regulation of developmental growth | 97 | 257 | 9.25e-04 |
| GO:BP | GO:0021795 | cerebral cortex cell migration | 22 | 37 | 9.70e-04 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 77 | 195 | 1.11e-03 |
| GO:BP | GO:0060021 | roof of mouth development | 35 | 71 | 1.11e-03 |
| GO:BP | GO:0030048 | actin filament-based movement | 49 | 111 | 1.27e-03 |
| GO:BP | GO:0007409 | axonogenesis | 129 | 363 | 1.27e-03 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 69 | 171 | 1.27e-03 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 345 | 1109 | 1.27e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 25 | 45 | 1.28e-03 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 803 | 2780 | 1.29e-03 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 65 | 159 | 1.31e-03 |
| GO:BP | GO:0051216 | cartilage development | 63 | 153 | 1.33e-03 |
| GO:BP | GO:0048511 | rhythmic process | 88 | 231 | 1.41e-03 |
| GO:BP | GO:0060429 | epithelium development | 267 | 836 | 1.49e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 49 | 112 | 1.60e-03 |
| GO:BP | GO:1990089 | response to nerve growth factor | 24 | 43 | 1.61e-03 |
| GO:BP | GO:1990090 | cellular response to nerve growth factor stimulus | 24 | 43 | 1.61e-03 |
| GO:BP | GO:0010033 | response to organic substance | 545 | 1835 | 1.71e-03 |
| GO:BP | GO:0061564 | axon development | 140 | 402 | 1.71e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 344 | 1111 | 1.87e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 433 | 1430 | 1.87e-03 |
| GO:BP | GO:0090132 | epithelium migration | 94 | 252 | 1.88e-03 |
| GO:BP | GO:0010631 | epithelial cell migration | 94 | 252 | 1.88e-03 |
| GO:BP | GO:0051234 | establishment of localization | 979 | 3447 | 1.98e-03 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 169 | 501 | 1.99e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 200 | 607 | 2.00e-03 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 141 | 407 | 2.04e-03 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 190 | 573 | 2.04e-03 |
| GO:BP | GO:0042692 | muscle cell differentiation | 119 | 334 | 2.04e-03 |
| GO:BP | GO:0048729 | tissue morphogenesis | 162 | 478 | 2.12e-03 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 121 | 342 | 2.49e-03 |
| GO:BP | GO:0016049 | cell growth | 142 | 412 | 2.50e-03 |
| GO:BP | GO:0071310 | cellular response to organic substance | 415 | 1370 | 2.50e-03 |
| GO:BP | GO:0035265 | organ growth | 55 | 132 | 2.58e-03 |
| GO:BP | GO:0050877 | nervous system process | 207 | 634 | 2.61e-03 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 167 | 497 | 2.62e-03 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 167 | 497 | 2.62e-03 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 121 | 343 | 2.78e-03 |
| GO:BP | GO:0007623 | circadian rhythm | 64 | 160 | 2.87e-03 |
| GO:BP | GO:0048568 | embryonic organ development | 113 | 317 | 2.92e-03 |
| GO:BP | GO:0006897 | endocytosis | 174 | 522 | 2.95e-03 |
| GO:BP | GO:0061448 | connective tissue development | 82 | 217 | 3.14e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 56 | 136 | 3.14e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 113 | 318 | 3.33e-03 |
| GO:BP | GO:0090130 | tissue migration | 94 | 256 | 3.36e-03 |
| GO:BP | GO:0031032 | actomyosin structure organization | 73 | 189 | 3.39e-03 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 122 | 348 | 3.39e-03 |
| GO:BP | GO:0050807 | regulation of synapse organization | 72 | 186 | 3.44e-03 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 72 | 186 | 3.44e-03 |
| GO:BP | GO:0006810 | transport | 903 | 3176 | 3.48e-03 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 241 | 756 | 3.49e-03 |
| GO:BP | GO:0043583 | ear development | 62 | 155 | 3.49e-03 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 41 | 92 | 3.50e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 395 | 1304 | 3.51e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 394 | 1301 | 3.65e-03 |
| GO:BP | GO:2001222 | regulation of neuron migration | 22 | 40 | 3.84e-03 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 73 | 190 | 3.91e-03 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 205 | 632 | 3.91e-03 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 137 | 400 | 4.14e-03 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 40 | 90 | 4.43e-03 |
| GO:BP | GO:1990138 | neuron projection extension | 59 | 147 | 4.43e-03 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 160 | 479 | 4.67e-03 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 43 | 99 | 4.69e-03 |
| GO:BP | GO:0046328 | regulation of JNK cascade | 47 | 111 | 4.85e-03 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 62 | 157 | 5.10e-03 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 373 | 1231 | 5.22e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 31 | 65 | 5.31e-03 |
| GO:BP | GO:0021885 | forebrain cell migration | 24 | 46 | 5.34e-03 |
| GO:BP | GO:0001503 | ossification | 113 | 322 | 5.35e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 712 | 2474 | 5.38e-03 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 238 | 751 | 5.38e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 83 | 224 | 5.43e-03 |
| GO:BP | GO:0021537 | telencephalon development | 78 | 208 | 5.45e-03 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 86 | 234 | 5.66e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 706 | 2453 | 5.66e-03 |
| GO:BP | GO:0042592 | homeostatic process | 365 | 1204 | 5.67e-03 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 28 | 57 | 5.67e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 46 | 109 | 5.91e-03 |
| GO:BP | GO:0065009 | regulation of molecular function | 416 | 1389 | 5.94e-03 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 69 | 180 | 5.95e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 83 | 225 | 6.22e-03 |
| GO:BP | GO:0140352 | export from cell | 201 | 624 | 6.39e-03 |
| GO:BP | GO:0021543 | pallium development | 58 | 146 | 6.41e-03 |
| GO:BP | GO:0007610 | behavior | 149 | 445 | 6.41e-03 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 77 | 206 | 6.45e-03 |
| GO:BP | GO:0022029 | telencephalon cell migration | 23 | 44 | 6.59e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 55 | 137 | 6.69e-03 |
| GO:BP | GO:0046834 | lipid phosphorylation | 9 | 11 | 6.88e-03 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 42 | 98 | 7.23e-03 |
| GO:BP | GO:0099643 | signal release from synapse | 45 | 107 | 7.25e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 32 | 69 | 7.25e-03 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 45 | 107 | 7.25e-03 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 17 | 29 | 7.53e-03 |
| GO:BP | GO:0060419 | heart growth | 33 | 72 | 7.57e-03 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 65 | 169 | 7.68e-03 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 112 | 322 | 7.68e-03 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 598 | 2061 | 7.87e-03 |
| GO:BP | GO:0003012 | muscle system process | 117 | 339 | 7.88e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 648 | 2246 | 7.88e-03 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 153 | 461 | 7.91e-03 |
| GO:BP | GO:0030001 | metal ion transport | 180 | 554 | 7.94e-03 |
| GO:BP | GO:0048839 | inner ear development | 54 | 135 | 8.05e-03 |
| GO:BP | GO:0010720 | positive regulation of cell development | 113 | 326 | 8.11e-03 |
| GO:BP | GO:0021801 | cerebral cortex radial glia-guided migration | 14 | 22 | 8.11e-03 |
| GO:BP | GO:0022030 | telencephalon glial cell migration | 14 | 22 | 8.11e-03 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 296 | 963 | 8.13e-03 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 22 | 42 | 8.13e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 52 | 129 | 8.16e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 59 | 151 | 8.68e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 471 | 1597 | 8.70e-03 |
| GO:BP | GO:0001508 | action potential | 45 | 108 | 8.70e-03 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 26 | 53 | 8.77e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 31 | 67 | 8.86e-03 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 70 | 186 | 8.92e-03 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 317 | 1040 | 9.10e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 55 | 139 | 9.33e-03 |
| GO:BP | GO:0098657 | import into cell | 210 | 661 | 9.58e-03 |
| GO:BP | GO:0007517 | muscle organ development | 99 | 281 | 9.64e-03 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 67 | 177 | 9.72e-03 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 35 | 79 | 1.01e-02 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 21 | 40 | 1.03e-02 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 37 | 85 | 1.05e-02 |
| GO:BP | GO:0097485 | neuron projection guidance | 69 | 184 | 1.06e-02 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 39 | 91 | 1.06e-02 |
| GO:BP | GO:0007411 | axon guidance | 69 | 184 | 1.06e-02 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 39 | 91 | 1.06e-02 |
| GO:BP | GO:1903522 | regulation of blood circulation | 74 | 200 | 1.06e-02 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 187 | 582 | 1.06e-02 |
| GO:BP | GO:0048617 | embryonic foregut morphogenesis | 6 | 6 | 1.06e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 19 | 35 | 1.10e-02 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 200 | 628 | 1.10e-02 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 67 | 178 | 1.12e-02 |
| GO:BP | GO:0006811 | monoatomic ion transport | 240 | 769 | 1.12e-02 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 17 | 30 | 1.14e-02 |
| GO:BP | GO:0040008 | regulation of growth | 161 | 493 | 1.15e-02 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 284 | 926 | 1.16e-02 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 93 | 263 | 1.18e-02 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 495 | 1692 | 1.20e-02 |
| GO:BP | GO:0008015 | blood circulation | 126 | 374 | 1.24e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 45 | 110 | 1.29e-02 |
| GO:BP | GO:0048878 | chemical homeostasis | 222 | 708 | 1.36e-02 |
| GO:BP | GO:0007611 | learning or memory | 75 | 205 | 1.36e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 24 | 49 | 1.40e-02 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 52 | 132 | 1.40e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 615 | 2138 | 1.41e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 51 | 129 | 1.42e-02 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 30 | 66 | 1.44e-02 |
| GO:BP | GO:0003170 | heart valve development | 30 | 66 | 1.44e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 49 | 123 | 1.47e-02 |
| GO:BP | GO:0008104 | protein localization | 612 | 2128 | 1.47e-02 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 469 | 1601 | 1.49e-02 |
| GO:BP | GO:0002363 | alpha-beta T cell lineage commitment | 10 | 14 | 1.50e-02 |
| GO:BP | GO:0007612 | learning | 47 | 117 | 1.51e-02 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 47 | 117 | 1.51e-02 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 32 | 72 | 1.51e-02 |
| GO:BP | GO:0031399 | regulation of protein modification process | 292 | 959 | 1.51e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 33 | 75 | 1.54e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 42 | 102 | 1.59e-02 |
| GO:BP | GO:0060996 | dendritic spine development | 36 | 84 | 1.59e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 22 | 44 | 1.59e-02 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 139 | 421 | 1.59e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 38 | 90 | 1.59e-02 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 38 | 90 | 1.59e-02 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 64 | 171 | 1.62e-02 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 169 | 525 | 1.62e-02 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 157 | 484 | 1.72e-02 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 157 | 484 | 1.72e-02 |
| GO:BP | GO:0050709 | negative regulation of protein secretion | 23 | 47 | 1.73e-02 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 71 | 194 | 1.73e-02 |
| GO:BP | GO:0035025 | positive regulation of Rho protein signal transduction | 15 | 26 | 1.76e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 177 | 554 | 1.78e-02 |
| GO:BP | GO:0030198 | extracellular matrix organization | 84 | 237 | 1.84e-02 |
| GO:BP | GO:0007254 | JNK cascade | 53 | 137 | 1.89e-02 |
| GO:BP | GO:0048675 | axon extension | 43 | 106 | 1.90e-02 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 42 | 103 | 1.93e-02 |
| GO:BP | GO:0045995 | regulation of embryonic development | 34 | 79 | 1.96e-02 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 35 | 82 | 1.97e-02 |
| GO:BP | GO:0030516 | regulation of axon extension | 35 | 82 | 1.97e-02 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 38 | 91 | 1.97e-02 |
| GO:BP | GO:0050890 | cognition | 82 | 231 | 1.97e-02 |
| GO:BP | GO:0002360 | T cell lineage commitment | 12 | 19 | 2.01e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 144 | 441 | 2.01e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 74 | 205 | 2.03e-02 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 66 | 179 | 2.03e-02 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 84 | 238 | 2.05e-02 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 26 | 56 | 2.05e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 342 | 1145 | 2.05e-02 |
| GO:BP | GO:0043062 | extracellular structure organization | 84 | 238 | 2.05e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 48 | 122 | 2.06e-02 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 127 | 383 | 2.06e-02 |
| GO:BP | GO:0045444 | fat cell differentiation | 69 | 189 | 2.08e-02 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 80 | 225 | 2.08e-02 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 16 | 29 | 2.12e-02 |
| GO:BP | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 16 | 29 | 2.12e-02 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 92 | 265 | 2.13e-02 |
| GO:BP | GO:0046339 | diacylglycerol metabolic process | 14 | 24 | 2.15e-02 |
| GO:BP | GO:0051591 | response to cAMP | 28 | 62 | 2.17e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 44 | 110 | 2.20e-02 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 71 | 196 | 2.21e-02 |
| GO:BP | GO:0042391 | regulation of membrane potential | 102 | 299 | 2.22e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 43 | 107 | 2.22e-02 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 256 | 837 | 2.22e-02 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 78 | 219 | 2.22e-02 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 62 | 167 | 2.23e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 51 | 132 | 2.24e-02 |
| GO:BP | GO:0003407 | neural retina development | 23 | 48 | 2.25e-02 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 41 | 101 | 2.26e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 131 | 398 | 2.26e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 598 | 2088 | 2.26e-02 |
| GO:BP | GO:0006812 | monoatomic cation transport | 204 | 653 | 2.31e-02 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 163 | 509 | 2.31e-02 |
| GO:BP | GO:0032940 | secretion by cell | 183 | 579 | 2.31e-02 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 95 | 276 | 2.31e-02 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 11 | 17 | 2.32e-02 |
| GO:BP | GO:0030097 | hemopoiesis | 207 | 664 | 2.37e-02 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 97 | 283 | 2.38e-02 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 53 | 139 | 2.48e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 173 | 545 | 2.50e-02 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 45 | 114 | 2.53e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 56 | 149 | 2.68e-02 |
| GO:BP | GO:0009725 | response to hormone | 198 | 634 | 2.71e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 79 | 224 | 2.71e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 41 | 102 | 2.72e-02 |
| GO:BP | GO:0021987 | cerebral cortex development | 41 | 102 | 2.72e-02 |
| GO:BP | GO:0051050 | positive regulation of transport | 190 | 606 | 2.75e-02 |
| GO:BP | GO:0044872 | lipoprotein localization | 10 | 15 | 2.79e-02 |
| GO:BP | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 10 | 15 | 2.79e-02 |
| GO:BP | GO:0060065 | uterus development | 10 | 15 | 2.79e-02 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 22 | 46 | 2.83e-02 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 34 | 81 | 2.88e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 34 | 81 | 2.88e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 32 | 75 | 2.88e-02 |
| GO:BP | GO:0008283 | cell population proliferation | 406 | 1386 | 2.92e-02 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 46 | 118 | 2.92e-02 |
| GO:BP | GO:0055001 | muscle cell development | 62 | 169 | 2.92e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 62 | 169 | 2.92e-02 |
| GO:BP | GO:0036211 | protein modification process | 686 | 2423 | 2.95e-02 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 128 | 391 | 2.96e-02 |
| GO:BP | GO:0061038 | uterus morphogenesis | 5 | 5 | 2.96e-02 |
| GO:BP | GO:0003186 | tricuspid valve morphogenesis | 5 | 5 | 2.96e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 45 | 115 | 2.96e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 79 | 225 | 2.96e-02 |
| GO:BP | GO:0051046 | regulation of secretion | 135 | 415 | 2.96e-02 |
| GO:BP | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 5 | 5 | 2.96e-02 |
| GO:BP | GO:1905274 | regulation of modification of postsynaptic actin cytoskeleton | 5 | 5 | 2.96e-02 |
| GO:BP | GO:0044319 | wound healing, spreading of cells | 16 | 30 | 3.02e-02 |
| GO:BP | GO:0090505 | epiboly involved in wound healing | 16 | 30 | 3.02e-02 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 503 | 1744 | 3.02e-02 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 545 | 1900 | 3.11e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 74 | 209 | 3.16e-02 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 110 | 330 | 3.16e-02 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 25 | 55 | 3.17e-02 |
| GO:BP | GO:0032486 | Rap protein signal transduction | 9 | 13 | 3.17e-02 |
| GO:BP | GO:0045176 | apical protein localization | 9 | 13 | 3.17e-02 |
| GO:BP | GO:0043368 | positive T cell selection | 12 | 20 | 3.17e-02 |
| GO:BP | GO:0006836 | neurotransmitter transport | 54 | 144 | 3.17e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 70 | 196 | 3.19e-02 |
| GO:BP | GO:0048048 | embryonic eye morphogenesis | 14 | 25 | 3.19e-02 |
| GO:BP | GO:0007605 | sensory perception of sound | 40 | 100 | 3.19e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 58 | 157 | 3.22e-02 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 376 | 1279 | 3.22e-02 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 88 | 256 | 3.25e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 499 | 1732 | 3.36e-02 |
| GO:BP | GO:0060323 | head morphogenesis | 17 | 33 | 3.38e-02 |
| GO:BP | GO:0001570 | vasculogenesis | 29 | 67 | 3.38e-02 |
| GO:BP | GO:0097061 | dendritic spine organization | 29 | 67 | 3.38e-02 |
| GO:BP | GO:0007389 | pattern specification process | 103 | 307 | 3.38e-02 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 68 | 190 | 3.40e-02 |
| GO:BP | GO:0014896 | muscle hypertrophy | 32 | 76 | 3.42e-02 |
| GO:BP | GO:0046903 | secretion | 203 | 656 | 3.45e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 80 | 230 | 3.53e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 62 | 171 | 3.72e-02 |
| GO:BP | GO:0045216 | cell-cell junction organization | 58 | 158 | 3.72e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 48 | 126 | 3.74e-02 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 488 | 1694 | 3.74e-02 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 48 | 126 | 3.74e-02 |
| GO:BP | GO:0097484 | dendrite extension | 15 | 28 | 3.74e-02 |
| GO:BP | GO:0032924 | activin receptor signaling pathway | 18 | 36 | 3.74e-02 |
| GO:BP | GO:0060325 | face morphogenesis | 15 | 28 | 3.74e-02 |
| GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 15 | 28 | 3.74e-02 |
| GO:BP | GO:0007440 | foregut morphogenesis | 6 | 7 | 3.80e-02 |
| GO:BP | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration | 6 | 7 | 3.80e-02 |
| GO:BP | GO:0006915 | apoptotic process | 424 | 1459 | 3.86e-02 |
| GO:BP | GO:0032233 | positive regulation of actin filament bundle assembly | 24 | 53 | 3.90e-02 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 38 | 95 | 3.91e-02 |
| GO:BP | GO:0043149 | stress fiber assembly | 38 | 95 | 3.91e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 46 | 120 | 3.91e-02 |
| GO:BP | GO:1904353 | regulation of telomere capping | 13 | 23 | 3.96e-02 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 101 | 302 | 3.97e-02 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 93 | 275 | 4.02e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 19 | 39 | 4.02e-02 |
| GO:BP | GO:0014902 | myotube differentiation | 36 | 89 | 4.02e-02 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 26 | 59 | 4.05e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 54 | 146 | 4.16e-02 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 31 | 74 | 4.18e-02 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 31 | 74 | 4.18e-02 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 30 | 71 | 4.18e-02 |
| GO:BP | GO:0008219 | cell death | 437 | 1509 | 4.19e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 333 | 1128 | 4.19e-02 |
| GO:BP | GO:0090504 | epiboly | 16 | 31 | 4.21e-02 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 53 | 143 | 4.26e-02 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 324 | 1096 | 4.37e-02 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 41 | 105 | 4.37e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 103 | 310 | 4.41e-02 |
| GO:BP | GO:0043009 | chordate embryonic development | 166 | 529 | 4.42e-02 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 40 | 102 | 4.46e-02 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 144 | 452 | 4.47e-02 |
| GO:BP | GO:0010171 | body morphogenesis | 21 | 45 | 4.47e-02 |
| GO:BP | GO:0060324 | face development | 21 | 45 | 4.47e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 46 | 121 | 4.49e-02 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 46 | 121 | 4.49e-02 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 558 | 1959 | 4.52e-02 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 562 | 1974 | 4.54e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 55 | 150 | 4.55e-02 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 55 | 150 | 4.55e-02 |
| GO:BP | GO:0045058 | T cell selection | 14 | 26 | 4.63e-02 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 14 | 26 | 4.63e-02 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 75 | 216 | 4.63e-02 |
| GO:BP | GO:0007398 | ectoderm development | 10 | 16 | 4.64e-02 |
| GO:BP | GO:0032535 | regulation of cellular component size | 103 | 311 | 4.79e-02 |
| GO:BP | GO:0061337 | cardiac conduction | 35 | 87 | 4.84e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 12 | 21 | 4.89e-02 |
| GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 24 | 54 | 4.89e-02 |
| GO:BP | GO:0002027 | regulation of heart rate | 34 | 84 | 4.89e-02 |
| GO:BP | GO:0022607 | cellular component assembly | 697 | 2481 | 5.00e-02 |
| GO:BP | GO:0003015 | heart process | 73 | 210 | 5.00e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 18 | 37 | 5.00e-02 |
EARnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in EAR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04510 | Focal adhesion | 79 | 177 | 1.33e-05 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 73 | 164 | 2.47e-05 |
| KEGG | KEGG:04520 | Adherens junction | 42 | 86 | 4.14e-04 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 68 | 170 | 2.82e-03 |
| KEGG | KEGG:04360 | Axon guidance | 65 | 162 | 2.98e-03 |
| KEGG | KEGG:04713 | Circadian entrainment | 33 | 69 | 3.25e-03 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 58 | 142 | 3.25e-03 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 43 | 99 | 4.34e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 34 | 74 | 5.36e-03 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 31 | 69 | 1.52e-02 |
| KEGG | KEGG:05200 | Pathways in cancer | 135 | 408 | 1.65e-02 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 46 | 115 | 1.66e-02 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 35 | 82 | 1.69e-02 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 44 | 110 | 1.73e-02 |
| KEGG | KEGG:04530 | Tight junction | 53 | 138 | 1.73e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 30 | 69 | 2.27e-02 |
| KEGG | KEGG:04720 | Long-term potentiation | 25 | 55 | 2.54e-02 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 44 | 113 | 2.76e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 37 | 92 | 3.09e-02 |
| KEGG | KEGG:04730 | Long-term depression | 20 | 42 | 3.10e-02 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 48 | 127 | 3.10e-02 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 55 | 151 | 3.83e-02 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 26 | 61 | 3.96e-02 |
| KEGG | KEGG:04911 | Insulin secretion | 27 | 64 | 3.96e-02 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 22 | 49 | 3.96e-02 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 83 | 246 | 3.96e-02 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 63 | 179 | 3.96e-02 |
| KEGG | KEGG:04014 | Ras signaling pathway | 61 | 172 | 3.96e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 49 | 134 | 4.10e-02 |
| KEGG | KEGG:04742 | Taste transduction | 12 | 22 | 4.10e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 12 | 22 | 4.10e-02 |
| KEGG | KEGG:04725 | Cholinergic synapse | 33 | 83 | 4.10e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 47 | 128 | 4.19e-02 |
| KEGG | KEGG:05135 | Yersinia infection | 42 | 112 | 4.19e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 34 | 87 | 4.36e-02 |
EARnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(aes(fill="#F8766D"))+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
ESR response genes
# ESR_resgenes <- gost(query = ESR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(ESR_resgenes,"data/GO_KEGG_analysis/ESR_resgenes.RDS")
# ESRnom <- gostplot(ESR_resgenes, capped = FALSE, interactive = TRUE)
# ESRnom
ESRnomtable <- ESR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
ESRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in ESR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 2259 | 4830 | 6.45e-54 |
| GO:BP | GO:0048856 | anatomical structure development | 1964 | 4130 | 2.22e-50 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1034 | 1951 | 4.52e-46 |
| GO:BP | GO:0007154 | cell communication | 1992 | 4248 | 8.11e-46 |
| GO:BP | GO:0023052 | signaling | 1962 | 4180 | 2.92e-45 |
| GO:BP | GO:0007275 | multicellular organism development | 1633 | 3383 | 4.24e-44 |
| GO:BP | GO:0032502 | developmental process | 2072 | 4475 | 1.64e-43 |
| GO:BP | GO:0048731 | system development | 1424 | 2903 | 1.23e-41 |
| GO:BP | GO:0050896 | response to stimulus | 2549 | 5732 | 3.18e-40 |
| GO:BP | GO:0007165 | signal transduction | 1794 | 3846 | 1.01e-37 |
| GO:BP | GO:0051716 | cellular response to stimulus | 2225 | 4933 | 1.74e-37 |
| GO:BP | GO:0030154 | cell differentiation | 1438 | 2987 | 1.38e-36 |
| GO:BP | GO:0048869 | cellular developmental process | 1438 | 2988 | 1.61e-36 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1024 | 2052 | 2.62e-31 |
| GO:BP | GO:0048468 | cell development | 998 | 1999 | 1.81e-30 |
| GO:BP | GO:0009888 | tissue development | 746 | 1425 | 1.35e-29 |
| GO:BP | GO:0007399 | nervous system development | 953 | 1903 | 1.67e-29 |
| GO:BP | GO:0048513 | animal organ development | 1049 | 2130 | 2.25e-29 |
| GO:BP | GO:0007155 | cell adhesion | 553 | 1004 | 2.78e-28 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 943 | 1900 | 2.28e-27 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 491 | 876 | 3.32e-27 |
| GO:BP | GO:0010646 | regulation of cell communication | 1236 | 2601 | 3.87e-27 |
| GO:BP | GO:0050793 | regulation of developmental process | 899 | 1801 | 5.32e-27 |
| GO:BP | GO:0023051 | regulation of signaling | 1231 | 2597 | 1.88e-26 |
| GO:BP | GO:0050789 | regulation of biological process | 3343 | 8037 | 1.88e-26 |
| GO:BP | GO:0003008 | system process | 633 | 1201 | 9.66e-26 |
| GO:BP | GO:0048870 | cell motility | 625 | 1190 | 7.53e-25 |
| GO:BP | GO:0022008 | neurogenesis | 684 | 1327 | 1.73e-24 |
| GO:BP | GO:0065007 | biological regulation | 3418 | 8275 | 2.42e-24 |
| GO:BP | GO:0016477 | cell migration | 571 | 1078 | 1.16e-23 |
| GO:BP | GO:0050794 | regulation of cellular process | 3179 | 7651 | 6.29e-23 |
| GO:BP | GO:0035239 | tube morphogenesis | 381 | 668 | 1.19e-22 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 360 | 625 | 2.31e-22 |
| GO:BP | GO:0030029 | actin filament-based process | 384 | 677 | 3.02e-22 |
| GO:BP | GO:0035295 | tube development | 452 | 827 | 6.74e-22 |
| GO:BP | GO:0048699 | generation of neurons | 594 | 1145 | 7.79e-22 |
| GO:BP | GO:0072359 | circulatory system development | 483 | 896 | 7.79e-22 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 416 | 749 | 7.82e-22 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 704 | 1403 | 3.11e-21 |
| GO:BP | GO:0000902 | cell morphogenesis | 421 | 764 | 3.12e-21 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1986 | 4561 | 1.12e-20 |
| GO:BP | GO:0030182 | neuron differentiation | 560 | 1080 | 1.99e-20 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 392 | 710 | 7.19e-20 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1838 | 4198 | 8.13e-20 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 365 | 653 | 1.22e-19 |
| GO:BP | GO:0034330 | cell junction organization | 336 | 591 | 1.38e-19 |
| GO:BP | GO:0031175 | neuron projection development | 428 | 794 | 3.38e-19 |
| GO:BP | GO:0007267 | cell-cell signaling | 588 | 1156 | 4.46e-19 |
| GO:BP | GO:0044057 | regulation of system process | 243 | 399 | 4.52e-19 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 568 | 1111 | 5.28e-19 |
| GO:BP | GO:0048666 | neuron development | 472 | 894 | 5.74e-19 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1073 | 2307 | 5.74e-19 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 618 | 1227 | 6.64e-19 |
| GO:BP | GO:0048729 | tissue morphogenesis | 280 | 478 | 1.15e-18 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 337 | 601 | 2.12e-18 |
| GO:BP | GO:0030030 | cell projection organization | 631 | 1262 | 2.12e-18 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 521 | 1011 | 3.12e-18 |
| GO:BP | GO:0001944 | vasculature development | 323 | 573 | 4.51e-18 |
| GO:BP | GO:0001568 | blood vessel development | 310 | 546 | 6.16e-18 |
| GO:BP | GO:0035556 | intracellular signal transduction | 971 | 2079 | 1.66e-17 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 303 | 534 | 1.84e-17 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 301 | 530 | 2.02e-17 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1306 | 2902 | 2.22e-17 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 551 | 1088 | 2.51e-17 |
| GO:BP | GO:0040011 | locomotion | 449 | 858 | 4.25e-17 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 497 | 967 | 4.62e-17 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 270 | 467 | 5.86e-17 |
| GO:BP | GO:0065008 | regulation of biological quality | 951 | 2039 | 6.69e-17 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 929 | 1992 | 2.02e-16 |
| GO:BP | GO:2000145 | regulation of cell motility | 396 | 745 | 2.09e-16 |
| GO:BP | GO:0030334 | regulation of cell migration | 380 | 710 | 2.45e-16 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 619 | 1256 | 2.71e-16 |
| GO:BP | GO:0003013 | circulatory system process | 258 | 446 | 3.12e-16 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 289 | 515 | 9.19e-16 |
| GO:BP | GO:0040012 | regulation of locomotion | 403 | 766 | 9.47e-16 |
| GO:BP | GO:0060485 | mesenchyme development | 164 | 256 | 1.16e-15 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 563 | 1134 | 1.72e-15 |
| GO:BP | GO:0007010 | cytoskeleton organization | 599 | 1218 | 1.76e-15 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1743 | 4037 | 2.87e-15 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 267 | 472 | 4.07e-15 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 265 | 468 | 4.46e-15 |
| GO:BP | GO:0060429 | epithelium development | 430 | 836 | 1.07e-14 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 297 | 540 | 1.21e-14 |
| GO:BP | GO:0042221 | response to chemical | 1100 | 2436 | 1.35e-14 |
| GO:BP | GO:0008015 | blood circulation | 219 | 374 | 1.68e-14 |
| GO:BP | GO:0051049 | regulation of transport | 571 | 1164 | 2.00e-14 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 302 | 553 | 2.31e-14 |
| GO:BP | GO:0009790 | embryo development | 440 | 864 | 3.87e-14 |
| GO:BP | GO:0003012 | muscle system process | 201 | 339 | 4.79e-14 |
| GO:BP | GO:0030001 | metal ion transport | 301 | 554 | 6.34e-14 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1641 | 3804 | 7.16e-14 |
| GO:BP | GO:0098657 | import into cell | 349 | 661 | 7.65e-14 |
| GO:BP | GO:0070848 | response to growth factor | 310 | 576 | 1.22e-13 |
| GO:BP | GO:0098609 | cell-cell adhesion | 324 | 607 | 1.22e-13 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 300 | 554 | 1.22e-13 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 293 | 540 | 1.88e-13 |
| GO:BP | GO:0001525 | angiogenesis | 226 | 397 | 3.89e-13 |
| GO:BP | GO:0034329 | cell junction assembly | 203 | 349 | 5.08e-13 |
| GO:BP | GO:0061061 | muscle structure development | 300 | 559 | 5.63e-13 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 245 | 440 | 8.48e-13 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 217 | 380 | 8.54e-13 |
| GO:BP | GO:0016043 | cellular component organization | 2151 | 5139 | 1.10e-12 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 329 | 626 | 1.13e-12 |
| GO:BP | GO:0006810 | transport | 1383 | 3176 | 1.39e-12 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 137 | 216 | 1.44e-12 |
| GO:BP | GO:0048589 | developmental growth | 284 | 527 | 1.48e-12 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 221 | 391 | 2.04e-12 |
| GO:BP | GO:0009987 | cellular process | 4477 | 11450 | 2.26e-12 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 133 | 209 | 2.31e-12 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 613 | 1288 | 2.61e-12 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 164 | 272 | 2.68e-12 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 74 | 98 | 2.80e-12 |
| GO:BP | GO:0051960 | regulation of nervous system development | 205 | 358 | 2.95e-12 |
| GO:BP | GO:0023056 | positive regulation of signaling | 614 | 1292 | 3.43e-12 |
| GO:BP | GO:0008150 | biological_process | 4682 | 12051 | 3.92e-12 |
| GO:BP | GO:0006816 | calcium ion transport | 163 | 271 | 4.16e-12 |
| GO:BP | GO:0007507 | heart development | 276 | 515 | 7.76e-12 |
| GO:BP | GO:0006936 | muscle contraction | 160 | 267 | 1.10e-11 |
| GO:BP | GO:0006468 | protein phosphorylation | 491 | 1008 | 1.17e-11 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 226 | 407 | 1.20e-11 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 112 | 171 | 1.35e-11 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 69 | 91 | 1.35e-11 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 203 | 358 | 1.37e-11 |
| GO:BP | GO:0007423 | sensory organ development | 222 | 399 | 1.46e-11 |
| GO:BP | GO:0032879 | regulation of localization | 706 | 1521 | 1.46e-11 |
| GO:BP | GO:0007409 | axonogenesis | 205 | 363 | 1.76e-11 |
| GO:BP | GO:0051179 | localization | 1689 | 3978 | 2.27e-11 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 406 | 815 | 3.09e-11 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 380 | 756 | 3.78e-11 |
| GO:BP | GO:0061564 | axon development | 221 | 402 | 8.19e-11 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 231 | 425 | 1.19e-10 |
| GO:BP | GO:0140352 | export from cell | 320 | 624 | 1.28e-10 |
| GO:BP | GO:0023057 | negative regulation of signaling | 529 | 1111 | 1.53e-10 |
| GO:BP | GO:0016310 | phosphorylation | 571 | 1211 | 1.55e-10 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 181 | 318 | 1.70e-10 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 224 | 411 | 1.76e-10 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 234 | 433 | 1.79e-10 |
| GO:BP | GO:0014706 | striated muscle tissue development | 133 | 218 | 1.82e-10 |
| GO:BP | GO:0006897 | endocytosis | 274 | 522 | 1.91e-10 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 192 | 342 | 1.95e-10 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 230 | 425 | 2.20e-10 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 288 | 554 | 2.20e-10 |
| GO:BP | GO:0008283 | cell population proliferation | 643 | 1386 | 2.20e-10 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 527 | 1109 | 2.37e-10 |
| GO:BP | GO:0048568 | embryonic organ development | 180 | 317 | 2.43e-10 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 192 | 343 | 2.68e-10 |
| GO:BP | GO:0051234 | establishment of localization | 1471 | 3447 | 3.10e-10 |
| GO:BP | GO:0099536 | synaptic signaling | 271 | 518 | 3.85e-10 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 637 | 1376 | 4.42e-10 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 263 | 501 | 4.91e-10 |
| GO:BP | GO:1903522 | regulation of blood circulation | 123 | 200 | 5.14e-10 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 544 | 1154 | 5.19e-10 |
| GO:BP | GO:0010720 | positive regulation of cell development | 183 | 326 | 5.95e-10 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 106 | 167 | 9.09e-10 |
| GO:BP | GO:0048041 | focal adhesion assembly | 60 | 80 | 9.40e-10 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 265 | 508 | 9.55e-10 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 260 | 497 | 1.00e-09 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 260 | 497 | 1.00e-09 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 830 | 1852 | 1.00e-09 |
| GO:BP | GO:0009605 | response to external stimulus | 753 | 1664 | 1.11e-09 |
| GO:BP | GO:0060047 | heart contraction | 122 | 200 | 1.29e-09 |
| GO:BP | GO:0060284 | regulation of cell development | 307 | 605 | 1.52e-09 |
| GO:BP | GO:0046903 | secretion | 329 | 656 | 1.76e-09 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 593 | 1279 | 1.79e-09 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 158 | 276 | 1.94e-09 |
| GO:BP | GO:0042692 | muscle cell differentiation | 185 | 334 | 2.01e-09 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 172 | 306 | 2.01e-09 |
| GO:BP | GO:0050877 | nervous system process | 319 | 634 | 2.14e-09 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 537 | 1146 | 2.19e-09 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 271 | 525 | 2.25e-09 |
| GO:BP | GO:0003007 | heart morphogenesis | 132 | 222 | 2.33e-09 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 437 | 909 | 2.33e-09 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 340 | 683 | 2.45e-09 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 316 | 628 | 2.55e-09 |
| GO:BP | GO:0006811 | monoatomic ion transport | 377 | 769 | 2.55e-09 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 492 | 1040 | 2.66e-09 |
| GO:BP | GO:0003015 | heart process | 126 | 210 | 2.70e-09 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 148 | 256 | 2.82e-09 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 124 | 206 | 2.82e-09 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 147 | 254 | 2.92e-09 |
| GO:BP | GO:0060537 | muscle tissue development | 193 | 353 | 3.18e-09 |
| GO:BP | GO:0007411 | axon guidance | 113 | 184 | 3.45e-09 |
| GO:BP | GO:0097485 | neuron projection guidance | 113 | 184 | 3.45e-09 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 263 | 509 | 3.59e-09 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 83 | 125 | 4.48e-09 |
| GO:BP | GO:0007015 | actin filament organization | 205 | 381 | 5.31e-09 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 278 | 545 | 5.97e-09 |
| GO:BP | GO:0003205 | cardiac chamber development | 96 | 151 | 6.05e-09 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 123 | 206 | 6.76e-09 |
| GO:BP | GO:0009611 | response to wounding | 214 | 402 | 7.29e-09 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 151 | 265 | 7.40e-09 |
| GO:BP | GO:0010033 | response to organic substance | 816 | 1835 | 9.11e-09 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1105 | 2555 | 9.44e-09 |
| GO:BP | GO:0043009 | chordate embryonic development | 270 | 529 | 9.98e-09 |
| GO:BP | GO:0006812 | monoatomic cation transport | 324 | 653 | 1.05e-08 |
| GO:BP | GO:0055085 | transmembrane transport | 467 | 989 | 1.11e-08 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 110 | 181 | 1.42e-08 |
| GO:BP | GO:0090257 | regulation of muscle system process | 110 | 181 | 1.42e-08 |
| GO:BP | GO:0007417 | central nervous system development | 364 | 748 | 1.59e-08 |
| GO:BP | GO:0032940 | secretion by cell | 291 | 579 | 1.60e-08 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 327 | 662 | 1.61e-08 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 2188 | 5340 | 1.65e-08 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 74 | 110 | 1.74e-08 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1192 | 2780 | 1.74e-08 |
| GO:BP | GO:0071310 | cellular response to organic substance | 624 | 1370 | 1.80e-08 |
| GO:BP | GO:0006915 | apoptotic process | 660 | 1459 | 2.19e-08 |
| GO:BP | GO:0008016 | regulation of heart contraction | 104 | 170 | 2.44e-08 |
| GO:BP | GO:0040007 | growth | 359 | 739 | 2.65e-08 |
| GO:BP | GO:0042391 | regulation of membrane potential | 165 | 299 | 2.75e-08 |
| GO:BP | GO:0007610 | behavior | 231 | 445 | 2.75e-08 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 195 | 365 | 2.99e-08 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 108 | 179 | 3.51e-08 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 166 | 302 | 3.59e-08 |
| GO:BP | GO:0060322 | head development | 291 | 583 | 3.82e-08 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 138 | 242 | 3.85e-08 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 118 | 200 | 3.98e-08 |
| GO:BP | GO:0050808 | synapse organization | 199 | 375 | 4.08e-08 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 136 | 238 | 4.16e-08 |
| GO:BP | GO:0043062 | extracellular structure organization | 136 | 238 | 4.16e-08 |
| GO:BP | GO:0001775 | cell activation | 326 | 665 | 4.65e-08 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 715 | 1601 | 5.66e-08 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 129 | 224 | 5.66e-08 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 77 | 118 | 6.20e-08 |
| GO:BP | GO:0030198 | extracellular matrix organization | 135 | 237 | 6.24e-08 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 237 | 462 | 6.39e-08 |
| GO:BP | GO:0001654 | eye development | 151 | 272 | 7.95e-08 |
| GO:BP | GO:0048638 | regulation of developmental growth | 144 | 257 | 8.14e-08 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 119 | 204 | 8.40e-08 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 167 | 307 | 8.42e-08 |
| GO:BP | GO:0065009 | regulation of molecular function | 627 | 1389 | 8.93e-08 |
| GO:BP | GO:0008219 | cell death | 676 | 1509 | 9.04e-08 |
| GO:BP | GO:0007420 | brain development | 270 | 539 | 9.48e-08 |
| GO:BP | GO:0030048 | actin filament-based movement | 73 | 111 | 9.50e-08 |
| GO:BP | GO:0048588 | developmental cell growth | 114 | 194 | 9.90e-08 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 97 | 159 | 1.02e-07 |
| GO:BP | GO:0048880 | sensory system development | 152 | 275 | 1.02e-07 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 346 | 716 | 1.05e-07 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 310 | 632 | 1.05e-07 |
| GO:BP | GO:0150063 | visual system development | 151 | 273 | 1.06e-07 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 89 | 143 | 1.11e-07 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 397 | 837 | 1.19e-07 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 107 | 180 | 1.22e-07 |
| GO:BP | GO:0023061 | signal release | 179 | 335 | 1.31e-07 |
| GO:BP | GO:0012501 | programmed cell death | 673 | 1505 | 1.35e-07 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 47 | 63 | 1.37e-07 |
| GO:BP | GO:0031032 | actomyosin structure organization | 111 | 189 | 1.60e-07 |
| GO:BP | GO:0030900 | forebrain development | 159 | 292 | 1.74e-07 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 44 | 58 | 1.78e-07 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 44 | 58 | 1.78e-07 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1061 | 2474 | 1.95e-07 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 162 | 299 | 1.97e-07 |
| GO:BP | GO:0033002 | muscle cell proliferation | 95 | 157 | 2.55e-07 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 172 | 322 | 2.66e-07 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 72 | 111 | 2.76e-07 |
| GO:BP | GO:0003231 | cardiac ventricle development | 74 | 115 | 2.87e-07 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 523 | 1145 | 2.96e-07 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 81 | 129 | 3.00e-07 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 216 | 421 | 3.00e-07 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 127 | 225 | 3.58e-07 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 126 | 223 | 3.75e-07 |
| GO:BP | GO:0042060 | wound healing | 165 | 308 | 4.00e-07 |
| GO:BP | GO:0090130 | tissue migration | 141 | 256 | 4.74e-07 |
| GO:BP | GO:1901698 | response to nitrogen compound | 367 | 774 | 4.76e-07 |
| GO:BP | GO:0035265 | organ growth | 82 | 132 | 4.85e-07 |
| GO:BP | GO:0001501 | skeletal system development | 192 | 369 | 5.10e-07 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 119 | 209 | 5.19e-07 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 64 | 97 | 6.79e-07 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 112 | 195 | 7.13e-07 |
| GO:BP | GO:0001823 | mesonephros development | 54 | 78 | 7.13e-07 |
| GO:BP | GO:0043010 | camera-type eye development | 131 | 236 | 8.09e-07 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 161 | 302 | 9.08e-07 |
| GO:BP | GO:0051050 | positive regulation of transport | 294 | 606 | 9.62e-07 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 59 | 88 | 9.91e-07 |
| GO:BP | GO:0072001 | renal system development | 139 | 254 | 9.91e-07 |
| GO:BP | GO:0010631 | epithelial cell migration | 138 | 252 | 1.04e-06 |
| GO:BP | GO:0090132 | epithelium migration | 138 | 252 | 1.04e-06 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 61 | 92 | 1.07e-06 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 167 | 316 | 1.08e-06 |
| GO:BP | GO:1905314 | semi-lunar valve development | 33 | 41 | 1.13e-06 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 241 | 484 | 1.15e-06 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 241 | 484 | 1.15e-06 |
| GO:BP | GO:0055001 | muscle cell development | 99 | 169 | 1.17e-06 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 355 | 751 | 1.18e-06 |
| GO:BP | GO:0042592 | homeostatic process | 543 | 1204 | 1.22e-06 |
| GO:BP | GO:0003279 | cardiac septum development | 66 | 102 | 1.22e-06 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 53 | 77 | 1.24e-06 |
| GO:BP | GO:0072164 | mesonephric tubule development | 53 | 77 | 1.24e-06 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 250 | 506 | 1.48e-06 |
| GO:BP | GO:0006941 | striated muscle contraction | 91 | 153 | 1.51e-06 |
| GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 38 | 50 | 1.66e-06 |
| GO:BP | GO:0051046 | regulation of secretion | 210 | 415 | 1.80e-06 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 60 | 91 | 1.81e-06 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 206 | 406 | 1.83e-06 |
| GO:BP | GO:0061448 | connective tissue development | 121 | 217 | 1.83e-06 |
| GO:BP | GO:0060419 | heart growth | 50 | 72 | 1.89e-06 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 226 | 452 | 1.93e-06 |
| GO:BP | GO:0071772 | response to BMP | 77 | 125 | 2.02e-06 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 77 | 125 | 2.02e-06 |
| GO:BP | GO:0072073 | kidney epithelium development | 72 | 115 | 2.10e-06 |
| GO:BP | GO:0016358 | dendrite development | 111 | 196 | 2.10e-06 |
| GO:BP | GO:0001657 | ureteric bud development | 52 | 76 | 2.18e-06 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 110 | 194 | 2.19e-06 |
| GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 53 | 78 | 2.32e-06 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 986 | 2311 | 2.38e-06 |
| GO:BP | GO:0048878 | chemical homeostasis | 335 | 708 | 2.43e-06 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 47 | 67 | 2.80e-06 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 41 | 56 | 2.80e-06 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 47 | 67 | 2.80e-06 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 95 | 163 | 2.86e-06 |
| GO:BP | GO:0045321 | leukocyte activation | 273 | 563 | 2.88e-06 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 318 | 669 | 2.99e-06 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 59 | 90 | 2.99e-06 |
| GO:BP | GO:0045165 | cell fate commitment | 93 | 159 | 3.05e-06 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 77 | 126 | 3.12e-06 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 61 | 94 | 3.13e-06 |
| GO:BP | GO:0048844 | artery morphogenesis | 42 | 58 | 3.19e-06 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 91 | 155 | 3.25e-06 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 121 | 219 | 3.37e-06 |
| GO:BP | GO:0042330 | taxis | 142 | 265 | 3.45e-06 |
| GO:BP | GO:0006935 | chemotaxis | 142 | 265 | 3.45e-06 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 44 | 62 | 4.08e-06 |
| GO:BP | GO:0061572 | actin filament bundle organization | 83 | 139 | 4.18e-06 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 53 | 79 | 4.19e-06 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 82 | 137 | 4.28e-06 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 862 | 2006 | 4.47e-06 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 45 | 64 | 4.49e-06 |
| GO:BP | GO:0045216 | cell-cell junction organization | 92 | 158 | 4.59e-06 |
| GO:BP | GO:0060840 | artery development | 56 | 85 | 4.71e-06 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 91 | 156 | 4.74e-06 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 107 | 190 | 4.89e-06 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 74 | 121 | 5.04e-06 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 40 | 55 | 5.09e-06 |
| GO:BP | GO:0072006 | nephron development | 73 | 119 | 5.10e-06 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 870 | 2028 | 5.32e-06 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 206 | 411 | 5.32e-06 |
| GO:BP | GO:0050807 | regulation of synapse organization | 105 | 186 | 5.32e-06 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 87 | 148 | 5.40e-06 |
| GO:BP | GO:0001822 | kidney development | 133 | 247 | 5.71e-06 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 85 | 144 | 5.76e-06 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 848 | 1974 | 5.92e-06 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 131 | 243 | 6.40e-06 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 140 | 263 | 6.68e-06 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 396 | 861 | 7.19e-06 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 43 | 61 | 7.23e-06 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 227 | 461 | 7.38e-06 |
| GO:BP | GO:0051216 | cartilage development | 89 | 153 | 7.38e-06 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 33 | 43 | 7.38e-06 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 384 | 833 | 8.13e-06 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 222 | 450 | 8.29e-06 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 212 | 427 | 8.43e-06 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 59 | 92 | 8.44e-06 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 817 | 1900 | 8.44e-06 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 45 | 65 | 8.54e-06 |
| GO:BP | GO:0031399 | regulation of protein modification process | 436 | 959 | 8.54e-06 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 275 | 574 | 8.67e-06 |
| GO:BP | GO:0021915 | neural tube development | 82 | 139 | 9.32e-06 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 82 | 139 | 9.32e-06 |
| GO:BP | GO:0003281 | ventricular septum development | 47 | 69 | 9.82e-06 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 209 | 421 | 1.01e-05 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 234 | 479 | 1.03e-05 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 122 | 225 | 1.05e-05 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 97 | 171 | 1.07e-05 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 274 | 573 | 1.10e-05 |
| GO:BP | GO:0002521 | leukocyte differentiation | 197 | 394 | 1.14e-05 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 87 | 150 | 1.14e-05 |
| GO:BP | GO:1901342 | regulation of vasculature development | 114 | 208 | 1.20e-05 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 114 | 208 | 1.20e-05 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 839 | 1959 | 1.20e-05 |
| GO:BP | GO:0030509 | BMP signaling pathway | 71 | 117 | 1.24e-05 |
| GO:BP | GO:0051235 | maintenance of location | 138 | 261 | 1.26e-05 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 112 | 204 | 1.33e-05 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 43 | 62 | 1.38e-05 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 91 | 159 | 1.38e-05 |
| GO:BP | GO:0032409 | regulation of transporter activity | 91 | 159 | 1.38e-05 |
| GO:BP | GO:0072132 | mesenchyme morphogenesis | 37 | 51 | 1.48e-05 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 78 | 132 | 1.56e-05 |
| GO:BP | GO:0003170 | heart valve development | 45 | 66 | 1.60e-05 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 108 | 196 | 1.65e-05 |
| GO:BP | GO:0003176 | aortic valve development | 29 | 37 | 1.71e-05 |
| GO:BP | GO:1990138 | neuron projection extension | 85 | 147 | 1.78e-05 |
| GO:BP | GO:0006939 | smooth muscle contraction | 47 | 70 | 1.78e-05 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 387 | 846 | 1.80e-05 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 48 | 72 | 1.86e-05 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 144 | 276 | 1.92e-05 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 105 | 190 | 1.92e-05 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 435 | 963 | 1.96e-05 |
| GO:BP | GO:0060976 | coronary vasculature development | 34 | 46 | 2.04e-05 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 52 | 80 | 2.11e-05 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 332 | 715 | 2.15e-05 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 386 | 845 | 2.17e-05 |
| GO:BP | GO:0006949 | syncytium formation | 30 | 39 | 2.17e-05 |
| GO:BP | GO:0007517 | muscle organ development | 146 | 281 | 2.17e-05 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 61 | 98 | 2.21e-05 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 95 | 169 | 2.27e-05 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 212 | 433 | 2.75e-05 |
| GO:BP | GO:0099173 | postsynapse organization | 91 | 161 | 2.78e-05 |
| GO:BP | GO:0048771 | tissue remodeling | 71 | 119 | 2.87e-05 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 543 | 1231 | 2.99e-05 |
| GO:BP | GO:0048863 | stem cell differentiation | 108 | 198 | 3.03e-05 |
| GO:BP | GO:0030100 | regulation of endocytosis | 113 | 209 | 3.08e-05 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 190 | 383 | 3.30e-05 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 143 | 276 | 3.37e-05 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 93 | 166 | 3.54e-05 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 61 | 99 | 3.54e-05 |
| GO:BP | GO:0015833 | peptide transport | 105 | 192 | 3.56e-05 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 53 | 83 | 3.61e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 55 | 87 | 3.64e-05 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 283 | 602 | 3.93e-05 |
| GO:BP | GO:0002790 | peptide secretion | 97 | 175 | 3.99e-05 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 82 | 143 | 4.15e-05 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 41 | 60 | 4.30e-05 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 70 | 118 | 4.44e-05 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 188 | 380 | 4.57e-05 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 138 | 266 | 4.57e-05 |
| GO:BP | GO:0046879 | hormone secretion | 115 | 215 | 4.87e-05 |
| GO:BP | GO:0048839 | inner ear development | 78 | 135 | 4.89e-05 |
| GO:BP | GO:0007389 | pattern specification process | 156 | 307 | 4.90e-05 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 193 | 392 | 4.98e-05 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 65 | 108 | 5.06e-05 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 26 | 33 | 5.10e-05 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 75 | 129 | 5.49e-05 |
| GO:BP | GO:0009914 | hormone transport | 117 | 220 | 5.69e-05 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 74 | 127 | 5.69e-05 |
| GO:BP | GO:0006836 | neurotransmitter transport | 82 | 144 | 5.88e-05 |
| GO:BP | GO:0006813 | potassium ion transport | 82 | 144 | 5.88e-05 |
| GO:BP | GO:1901890 | positive regulation of cell junction assembly | 52 | 82 | 5.88e-05 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 187 | 379 | 5.88e-05 |
| GO:BP | GO:0002027 | regulation of heart rate | 53 | 84 | 5.88e-05 |
| GO:BP | GO:0061035 | regulation of cartilage development | 37 | 53 | 6.00e-05 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 196 | 400 | 6.05e-05 |
| GO:BP | GO:0050919 | negative chemotaxis | 31 | 42 | 6.05e-05 |
| GO:BP | GO:0043583 | ear development | 87 | 155 | 6.50e-05 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 424 | 946 | 6.70e-05 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 32 | 44 | 7.05e-05 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 485 | 1096 | 7.14e-05 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 67 | 113 | 7.16e-05 |
| GO:BP | GO:0000165 | MAPK cascade | 253 | 535 | 7.64e-05 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 125 | 239 | 7.73e-05 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 28 | 37 | 8.10e-05 |
| GO:BP | GO:0140253 | cell-cell fusion | 28 | 37 | 8.10e-05 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 74 | 128 | 8.19e-05 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 364 | 802 | 8.61e-05 |
| GO:BP | GO:0002376 | immune system process | 652 | 1512 | 8.84e-05 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 47 | 73 | 9.34e-05 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 47 | 73 | 9.34e-05 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 497 | 1128 | 9.40e-05 |
| GO:BP | GO:0048864 | stem cell development | 48 | 75 | 9.42e-05 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 195 | 400 | 9.44e-05 |
| GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 53 | 85 | 9.45e-05 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 50 | 79 | 9.47e-05 |
| GO:BP | GO:0031644 | regulation of nervous system process | 50 | 79 | 9.47e-05 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 159 | 317 | 9.66e-05 |
| GO:BP | GO:0003177 | pulmonary valve development | 19 | 22 | 9.76e-05 |
| GO:BP | GO:0031667 | response to nutrient levels | 181 | 368 | 1.03e-04 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 36 | 52 | 1.06e-04 |
| GO:BP | GO:0045927 | positive regulation of growth | 106 | 198 | 1.06e-04 |
| GO:BP | GO:0007369 | gastrulation | 83 | 148 | 1.09e-04 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 105 | 196 | 1.12e-04 |
| GO:BP | GO:0051641 | cellular localization | 1157 | 2793 | 1.12e-04 |
| GO:BP | GO:0048168 | regulation of neuronal synaptic plasticity | 30 | 41 | 1.12e-04 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 118 | 225 | 1.16e-04 |
| GO:BP | GO:0007611 | learning or memory | 109 | 205 | 1.16e-04 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 17 | 19 | 1.17e-04 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 122 | 234 | 1.17e-04 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 38 | 56 | 1.20e-04 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 242 | 512 | 1.23e-04 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 61 | 102 | 1.25e-04 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 70 | 121 | 1.37e-04 |
| GO:BP | GO:0072028 | nephron morphogenesis | 41 | 62 | 1.37e-04 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 42 | 64 | 1.42e-04 |
| GO:BP | GO:0021537 | telencephalon development | 110 | 208 | 1.44e-04 |
| GO:BP | GO:0008544 | epidermis development | 114 | 217 | 1.47e-04 |
| GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 134 | 262 | 1.48e-04 |
| GO:BP | GO:0009306 | protein secretion | 134 | 262 | 1.48e-04 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 100 | 186 | 1.48e-04 |
| GO:BP | GO:0014032 | neural crest cell development | 45 | 70 | 1.49e-04 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 47 | 74 | 1.50e-04 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 47 | 74 | 1.50e-04 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 47 | 74 | 1.50e-04 |
| GO:BP | GO:0016049 | cell growth | 199 | 412 | 1.50e-04 |
| GO:BP | GO:0014896 | muscle hypertrophy | 48 | 76 | 1.50e-04 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 47 | 74 | 1.50e-04 |
| GO:BP | GO:0042471 | ear morphogenesis | 48 | 76 | 1.50e-04 |
| GO:BP | GO:0003272 | endocardial cushion formation | 20 | 24 | 1.52e-04 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 216 | 452 | 1.53e-04 |
| GO:BP | GO:0030072 | peptide hormone secretion | 93 | 171 | 1.61e-04 |
| GO:BP | GO:0001755 | neural crest cell migration | 34 | 49 | 1.69e-04 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 34 | 49 | 1.69e-04 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 63 | 107 | 1.73e-04 |
| GO:BP | GO:0099643 | signal release from synapse | 63 | 107 | 1.73e-04 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 62 | 105 | 1.79e-04 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 184 | 378 | 1.80e-04 |
| GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 35 | 51 | 1.81e-04 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 35 | 51 | 1.81e-04 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 35 | 51 | 1.81e-04 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 96 | 178 | 1.81e-04 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 61 | 103 | 1.83e-04 |
| GO:BP | GO:0042886 | amide transport | 114 | 218 | 1.85e-04 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 24 | 31 | 1.89e-04 |
| GO:BP | GO:0022612 | gland morphogenesis | 60 | 101 | 1.89e-04 |
| GO:BP | GO:0048645 | animal organ formation | 36 | 53 | 1.91e-04 |
| GO:BP | GO:0050708 | regulation of protein secretion | 99 | 185 | 2.01e-04 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 29 | 40 | 2.01e-04 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 88 | 161 | 2.09e-04 |
| GO:BP | GO:0031099 | regeneration | 82 | 148 | 2.11e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 67 | 116 | 2.15e-04 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 55 | 91 | 2.15e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 67 | 116 | 2.15e-04 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 39 | 59 | 2.17e-04 |
| GO:BP | GO:0014902 | myotube differentiation | 54 | 89 | 2.19e-04 |
| GO:BP | GO:0035148 | tube formation | 74 | 131 | 2.24e-04 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 30 | 42 | 2.25e-04 |
| GO:BP | GO:0014888 | striated muscle adaptation | 30 | 42 | 2.25e-04 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 52 | 85 | 2.26e-04 |
| GO:BP | GO:0048736 | appendage development | 80 | 144 | 2.31e-04 |
| GO:BP | GO:0060173 | limb development | 80 | 144 | 2.31e-04 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 46 | 73 | 2.38e-04 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 47 | 75 | 2.38e-04 |
| GO:BP | GO:0060993 | kidney morphogenesis | 46 | 73 | 2.38e-04 |
| GO:BP | GO:0040008 | regulation of growth | 232 | 493 | 2.53e-04 |
| GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 181 | 373 | 2.56e-04 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 142 | 283 | 2.65e-04 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 32 | 46 | 2.71e-04 |
| GO:BP | GO:0003002 | regionalization | 138 | 274 | 2.74e-04 |
| GO:BP | GO:0006814 | sodium ion transport | 82 | 149 | 2.85e-04 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 22 | 28 | 2.86e-04 |
| GO:BP | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 22 | 28 | 2.86e-04 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 102 | 193 | 2.87e-04 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 130 | 256 | 2.87e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 303 | 664 | 2.89e-04 |
| GO:BP | GO:0048732 | gland development | 160 | 325 | 2.96e-04 |
| GO:BP | GO:0060348 | bone development | 86 | 158 | 3.10e-04 |
| GO:BP | GO:0007613 | memory | 56 | 94 | 3.12e-04 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 56 | 94 | 3.12e-04 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 91 | 169 | 3.12e-04 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 54 | 90 | 3.30e-04 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 79 | 143 | 3.31e-04 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 64 | 111 | 3.45e-04 |
| GO:BP | GO:0046649 | lymphocyte activation | 224 | 476 | 3.45e-04 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 51 | 84 | 3.54e-04 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 50 | 82 | 3.61e-04 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 147 | 296 | 3.62e-04 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 77 | 139 | 3.67e-04 |
| GO:BP | GO:0072088 | nephron epithelium morphogenesis | 39 | 60 | 3.70e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 40 | 62 | 3.76e-04 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 118 | 230 | 3.77e-04 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 44 | 70 | 3.82e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 42 | 66 | 3.82e-04 |
| GO:BP | GO:0055002 | striated muscle cell development | 44 | 70 | 3.82e-04 |
| GO:BP | GO:0035296 | regulation of tube diameter | 61 | 105 | 3.83e-04 |
| GO:BP | GO:0097746 | blood vessel diameter maintenance | 61 | 105 | 3.83e-04 |
| GO:BP | GO:0035150 | regulation of tube size | 61 | 105 | 3.83e-04 |
| GO:BP | GO:0006954 | inflammatory response | 216 | 458 | 3.98e-04 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 120 | 235 | 4.19e-04 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 20 | 25 | 4.26e-04 |
| GO:BP | GO:0001704 | formation of primary germ layer | 58 | 99 | 4.29e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 612 | 1430 | 4.38e-04 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 319 | 706 | 4.38e-04 |
| GO:BP | GO:0098739 | import across plasma membrane | 73 | 131 | 4.45e-04 |
| GO:BP | GO:0030073 | insulin secretion | 79 | 144 | 4.45e-04 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 98 | 186 | 4.67e-04 |
| GO:BP | GO:0050890 | cognition | 118 | 231 | 4.73e-04 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 560 | 1301 | 4.77e-04 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 71 | 127 | 4.92e-04 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 561 | 1304 | 5.01e-04 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 63 | 110 | 5.08e-04 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 290 | 637 | 5.15e-04 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 52 | 87 | 5.18e-04 |
| GO:BP | GO:1901653 | cellular response to peptide | 141 | 284 | 5.19e-04 |
| GO:BP | GO:0060675 | ureteric bud morphogenesis | 33 | 49 | 5.26e-04 |
| GO:BP | GO:0140115 | export across plasma membrane | 33 | 49 | 5.26e-04 |
| GO:BP | GO:0060977 | coronary vasculature morphogenesis | 15 | 17 | 5.34e-04 |
| GO:BP | GO:0019725 | cellular homeostasis | 272 | 594 | 5.43e-04 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 75 | 136 | 5.48e-04 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 61 | 106 | 5.49e-04 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 21 | 27 | 5.50e-04 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 115 | 225 | 5.64e-04 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 146 | 296 | 5.65e-04 |
| GO:BP | GO:0060541 | respiratory system development | 90 | 169 | 5.65e-04 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 26 | 36 | 5.76e-04 |
| GO:BP | GO:0050865 | regulation of cell activation | 176 | 366 | 5.80e-04 |
| GO:BP | GO:2001257 | regulation of cation channel activity | 45 | 73 | 5.95e-04 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 106 | 205 | 6.07e-04 |
| GO:BP | GO:0060079 | excitatory postsynaptic potential | 43 | 69 | 6.07e-04 |
| GO:BP | GO:0030239 | myofibril assembly | 42 | 67 | 6.10e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 40 | 63 | 6.10e-04 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 66 | 117 | 6.12e-04 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 18 | 22 | 6.12e-04 |
| GO:BP | GO:0007612 | learning | 66 | 117 | 6.12e-04 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 138 | 278 | 6.12e-04 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 18 | 22 | 6.12e-04 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 78 | 143 | 6.22e-04 |
| GO:BP | GO:0009725 | response to hormone | 288 | 634 | 6.42e-04 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 168 | 348 | 6.55e-04 |
| GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 22 | 29 | 6.71e-04 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 22 | 29 | 6.71e-04 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 22 | 29 | 6.71e-04 |
| GO:BP | GO:0007215 | glutamate receptor signaling pathway | 22 | 29 | 6.71e-04 |
| GO:BP | GO:1902414 | protein localization to cell junction | 55 | 94 | 6.81e-04 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 217 | 464 | 6.86e-04 |
| GO:BP | GO:0002791 | regulation of peptide secretion | 76 | 139 | 6.90e-04 |
| GO:BP | GO:0010817 | regulation of hormone levels | 164 | 339 | 6.93e-04 |
| GO:BP | GO:0070482 | response to oxygen levels | 139 | 281 | 7.01e-04 |
| GO:BP | GO:0043500 | muscle adaptation | 54 | 92 | 7.02e-04 |
| GO:BP | GO:0072009 | nephron epithelium development | 52 | 88 | 7.54e-04 |
| GO:BP | GO:1904064 | positive regulation of cation transmembrane transport | 52 | 88 | 7.54e-04 |
| GO:BP | GO:0072175 | epithelial tube formation | 68 | 122 | 7.64e-04 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 68 | 122 | 7.64e-04 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 68 | 122 | 7.64e-04 |
| GO:BP | GO:0003158 | endothelium development | 61 | 107 | 7.64e-04 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 68 | 122 | 7.64e-04 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 93 | 177 | 7.87e-04 |
| GO:BP | GO:0051651 | maintenance of location in cell | 93 | 177 | 7.87e-04 |
| GO:BP | GO:0098815 | modulation of excitatory postsynaptic potential | 30 | 44 | 7.96e-04 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 67 | 120 | 8.02e-04 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0032878 | regulation of establishment or maintenance of cell polarity | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0014887 | cardiac muscle adaptation | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 59 | 103 | 8.25e-04 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 136 | 275 | 8.32e-04 |
| GO:BP | GO:0003197 | endocardial cushion development | 31 | 46 | 8.32e-04 |
| GO:BP | GO:0061326 | renal tubule development | 47 | 78 | 8.57e-04 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 77 | 142 | 8.64e-04 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 77 | 142 | 8.64e-04 |
| GO:BP | GO:0030031 | cell projection assembly | 223 | 480 | 8.68e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 157 | 324 | 8.70e-04 |
| GO:BP | GO:0050900 | leukocyte migration | 107 | 209 | 8.87e-04 |
| GO:BP | GO:0060420 | regulation of heart growth | 33 | 50 | 8.93e-04 |
| GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 33 | 50 | 8.93e-04 |
| GO:BP | GO:0006950 | response to stress | 1114 | 2715 | 9.07e-04 |
| GO:BP | GO:0001707 | mesoderm formation | 35 | 54 | 9.37e-04 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 36 | 56 | 9.47e-04 |
| GO:BP | GO:0048332 | mesoderm morphogenesis | 36 | 56 | 9.47e-04 |
| GO:BP | GO:0007492 | endoderm development | 41 | 66 | 9.47e-04 |
| GO:BP | GO:0140238 | presynaptic endocytosis | 40 | 64 | 9.52e-04 |
| GO:BP | GO:0072078 | nephron tubule morphogenesis | 37 | 58 | 9.52e-04 |
| GO:BP | GO:0061333 | renal tubule morphogenesis | 39 | 62 | 9.54e-04 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 55 | 95 | 9.61e-04 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 105 | 205 | 9.96e-04 |
| GO:BP | GO:0002064 | epithelial cell development | 84 | 158 | 1.01e-03 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 25 | 35 | 1.01e-03 |
| GO:BP | GO:0019933 | cAMP-mediated signaling | 25 | 35 | 1.01e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 74 | 136 | 1.01e-03 |
| GO:BP | GO:0001701 | in utero embryonic development | 166 | 346 | 1.02e-03 |
| GO:BP | GO:0014020 | primary neural tube formation | 53 | 91 | 1.03e-03 |
| GO:BP | GO:0007498 | mesoderm development | 53 | 91 | 1.03e-03 |
| GO:BP | GO:0030010 | establishment of cell polarity | 73 | 134 | 1.06e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 206 | 441 | 1.08e-03 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 159 | 330 | 1.09e-03 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 26 | 37 | 1.10e-03 |
| GO:BP | GO:0046883 | regulation of hormone secretion | 91 | 174 | 1.12e-03 |
| GO:BP | GO:0030323 | respiratory tube development | 82 | 154 | 1.12e-03 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 66 | 119 | 1.13e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 130 | 263 | 1.19e-03 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 98 | 190 | 1.20e-03 |
| GO:BP | GO:0090087 | regulation of peptide transport | 76 | 141 | 1.20e-03 |
| GO:BP | GO:0003171 | atrioventricular valve development | 21 | 28 | 1.24e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 64 | 115 | 1.26e-03 |
| GO:BP | GO:0030324 | lung development | 80 | 150 | 1.26e-03 |
| GO:BP | GO:0036211 | protein modification process | 998 | 2423 | 1.26e-03 |
| GO:BP | GO:0055123 | digestive system development | 56 | 98 | 1.31e-03 |
| GO:BP | GO:0010721 | negative regulation of cell development | 100 | 195 | 1.34e-03 |
| GO:BP | GO:0014812 | muscle cell migration | 45 | 75 | 1.34e-03 |
| GO:BP | GO:0090276 | regulation of peptide hormone secretion | 74 | 137 | 1.34e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 45 | 75 | 1.34e-03 |
| GO:BP | GO:0001841 | neural tube formation | 55 | 96 | 1.37e-03 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 217 | 469 | 1.40e-03 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 30 | 45 | 1.40e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 30 | 45 | 1.40e-03 |
| GO:BP | GO:0007520 | myoblast fusion | 22 | 30 | 1.44e-03 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 307 | 687 | 1.44e-03 |
| GO:BP | GO:0001570 | vasculogenesis | 41 | 67 | 1.46e-03 |
| GO:BP | GO:0050817 | coagulation | 82 | 155 | 1.46e-03 |
| GO:BP | GO:0097061 | dendritic spine organization | 41 | 67 | 1.46e-03 |
| GO:BP | GO:0048488 | synaptic vesicle endocytosis | 39 | 63 | 1.50e-03 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 39 | 63 | 1.50e-03 |
| GO:BP | GO:0042063 | gliogenesis | 126 | 255 | 1.50e-03 |
| GO:BP | GO:0045859 | regulation of protein kinase activity | 165 | 346 | 1.51e-03 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 38 | 61 | 1.51e-03 |
| GO:BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 34 | 53 | 1.52e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 35 | 55 | 1.52e-03 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 35 | 55 | 1.52e-03 |
| GO:BP | GO:0048565 | digestive tract development | 52 | 90 | 1.53e-03 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 52 | 90 | 1.53e-03 |
| GO:BP | GO:0046777 | protein autophosphorylation | 81 | 153 | 1.53e-03 |
| GO:BP | GO:0032535 | regulation of cellular component size | 150 | 311 | 1.55e-03 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 18 | 23 | 1.56e-03 |
| GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 23 | 32 | 1.61e-03 |
| GO:BP | GO:0042110 | T cell activation | 155 | 323 | 1.63e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 137 | 281 | 1.65e-03 |
| GO:BP | GO:0031214 | biomineral tissue development | 64 | 116 | 1.69e-03 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 64 | 116 | 1.69e-03 |
| GO:BP | GO:0010954 | positive regulation of protein processing | 15 | 18 | 1.71e-03 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 57 | 101 | 1.74e-03 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 57 | 101 | 1.74e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 709 | 1692 | 1.74e-03 |
| GO:BP | GO:0001764 | neuron migration | 74 | 138 | 1.75e-03 |
| GO:BP | GO:0007009 | plasma membrane organization | 63 | 114 | 1.77e-03 |
| GO:BP | GO:0003230 | cardiac atrium development | 24 | 34 | 1.77e-03 |
| GO:BP | GO:0007599 | hemostasis | 82 | 156 | 1.87e-03 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 82 | 156 | 1.87e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 62 | 112 | 1.87e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 112 | 224 | 1.91e-03 |
| GO:BP | GO:0106027 | neuron projection organization | 45 | 76 | 1.98e-03 |
| GO:BP | GO:0043149 | stress fiber assembly | 54 | 95 | 1.99e-03 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 54 | 95 | 1.99e-03 |
| GO:BP | GO:1901652 | response to peptide | 179 | 381 | 2.03e-03 |
| GO:BP | GO:0072080 | nephron tubule development | 44 | 74 | 2.03e-03 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 76 | 143 | 2.05e-03 |
| GO:BP | GO:0001508 | action potential | 60 | 108 | 2.07e-03 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 43 | 72 | 2.09e-03 |
| GO:BP | GO:0046620 | regulation of organ growth | 43 | 72 | 2.09e-03 |
| GO:BP | GO:0007596 | blood coagulation | 80 | 152 | 2.10e-03 |
| GO:BP | GO:0031503 | protein-containing complex localization | 88 | 170 | 2.15e-03 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 65 | 119 | 2.15e-03 |
| GO:BP | GO:0050796 | regulation of insulin secretion | 65 | 119 | 2.15e-03 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 52 | 91 | 2.16e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 52 | 91 | 2.16e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 52 | 91 | 2.16e-03 |
| GO:BP | GO:0051047 | positive regulation of secretion | 106 | 211 | 2.22e-03 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 51 | 89 | 2.26e-03 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 20 | 27 | 2.26e-03 |
| GO:BP | GO:1902656 | calcium ion import into cytosol | 20 | 27 | 2.26e-03 |
| GO:BP | GO:0043217 | myelin maintenance | 13 | 15 | 2.31e-03 |
| GO:BP | GO:0034332 | adherens junction organization | 29 | 44 | 2.31e-03 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 30 | 46 | 2.37e-03 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 37 | 60 | 2.37e-03 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 36 | 58 | 2.40e-03 |
| GO:BP | GO:0031102 | neuron projection regeneration | 32 | 50 | 2.43e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 68 | 126 | 2.43e-03 |
| GO:BP | GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 34 | 54 | 2.43e-03 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 33 | 52 | 2.43e-03 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 34 | 54 | 2.43e-03 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 49 | 85 | 2.44e-03 |
| GO:BP | GO:0010001 | glial cell differentiation | 97 | 191 | 2.47e-03 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 56 | 100 | 2.49e-03 |
| GO:BP | GO:0008217 | regulation of blood pressure | 62 | 113 | 2.50e-03 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 62 | 113 | 2.50e-03 |
| GO:BP | GO:0032906 | transforming growth factor beta2 production | 9 | 9 | 2.52e-03 |
| GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 9 | 9 | 2.52e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 48 | 83 | 2.52e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 48 | 83 | 2.52e-03 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 129 | 265 | 2.62e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 1005 | 2453 | 2.62e-03 |
| GO:BP | GO:0007416 | synapse assembly | 80 | 153 | 2.67e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 60 | 109 | 2.78e-03 |
| GO:BP | GO:0003222 | ventricular trabecula myocardium morphogenesis | 11 | 12 | 2.78e-03 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 11 | 12 | 2.78e-03 |
| GO:BP | GO:0097581 | lamellipodium organization | 45 | 77 | 2.85e-03 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 22 | 31 | 2.85e-03 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 295 | 664 | 2.90e-03 |
| GO:BP | GO:0051249 | regulation of lymphocyte activation | 142 | 296 | 2.93e-03 |
| GO:BP | GO:0001666 | response to hypoxia | 121 | 247 | 2.93e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 69 | 129 | 3.01e-03 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 57 | 103 | 3.27e-03 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 261 | 582 | 3.27e-03 |
| GO:BP | GO:0001892 | embryonic placenta development | 41 | 69 | 3.27e-03 |
| GO:BP | GO:0030316 | osteoclast differentiation | 41 | 69 | 3.27e-03 |
| GO:BP | GO:0060606 | tube closure | 50 | 88 | 3.32e-03 |
| GO:BP | GO:0048846 | axon extension involved in axon guidance | 24 | 35 | 3.32e-03 |
| GO:BP | GO:0008038 | neuron recognition | 24 | 35 | 3.32e-03 |
| GO:BP | GO:1902284 | neuron projection extension involved in neuron projection guidance | 24 | 35 | 3.32e-03 |
| GO:BP | GO:0001890 | placenta development | 62 | 114 | 3.37e-03 |
| GO:BP | GO:0021700 | developmental maturation | 109 | 220 | 3.40e-03 |
| GO:BP | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 14 | 17 | 3.44e-03 |
| GO:BP | GO:0051590 | positive regulation of neurotransmitter transport | 14 | 17 | 3.44e-03 |
| GO:BP | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 14 | 17 | 3.44e-03 |
| GO:BP | GO:0038084 | vascular endothelial growth factor signaling pathway | 25 | 37 | 3.49e-03 |
| GO:BP | GO:0071870 | cellular response to catecholamine stimulus | 25 | 37 | 3.49e-03 |
| GO:BP | GO:0071868 | cellular response to monoamine stimulus | 25 | 37 | 3.49e-03 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 38 | 63 | 3.53e-03 |
| GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 38 | 63 | 3.53e-03 |
| GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 18 | 24 | 3.58e-03 |
| GO:BP | GO:0060996 | dendritic spine development | 48 | 84 | 3.59e-03 |
| GO:BP | GO:0071869 | response to catecholamine | 26 | 39 | 3.61e-03 |
| GO:BP | GO:0071867 | response to monoamine | 26 | 39 | 3.61e-03 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 26 | 39 | 3.61e-03 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 36 | 59 | 3.68e-03 |
| GO:BP | GO:0050795 | regulation of behavior | 27 | 41 | 3.72e-03 |
| GO:BP | GO:0051592 | response to calcium ion | 60 | 110 | 3.72e-03 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 35 | 57 | 3.73e-03 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 54 | 97 | 3.73e-03 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 65 | 121 | 3.73e-03 |
| GO:BP | GO:0044344 | cellular response to fibroblast growth factor stimulus | 47 | 82 | 3.73e-03 |
| GO:BP | GO:0010038 | response to metal ion | 126 | 260 | 3.73e-03 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 47 | 82 | 3.73e-03 |
| GO:BP | GO:0019229 | regulation of vasoconstriction | 28 | 43 | 3.77e-03 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 107 | 216 | 3.77e-03 |
| GO:BP | GO:0001658 | branching involved in ureteric bud morphogenesis | 28 | 43 | 3.77e-03 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 28 | 43 | 3.77e-03 |
| GO:BP | GO:0097120 | receptor localization to synapse | 33 | 53 | 3.80e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 400 | 926 | 3.80e-03 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 33 | 53 | 3.80e-03 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 32 | 51 | 3.83e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 59 | 108 | 3.88e-03 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 125 | 258 | 3.93e-03 |
| GO:BP | GO:0010876 | lipid localization | 148 | 312 | 3.93e-03 |
| GO:BP | GO:0033993 | response to lipid | 268 | 601 | 4.00e-03 |
| GO:BP | GO:0098703 | calcium ion import across plasma membrane | 19 | 26 | 4.06e-03 |
| GO:BP | GO:0003209 | cardiac atrium morphogenesis | 19 | 26 | 4.06e-03 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 19 | 26 | 4.06e-03 |
| GO:BP | GO:0043542 | endothelial cell migration | 92 | 182 | 4.07e-03 |
| GO:BP | GO:0010595 | positive regulation of endothelial cell migration | 52 | 93 | 4.07e-03 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 52 | 93 | 4.07e-03 |
| GO:BP | GO:0048675 | axon extension | 58 | 106 | 4.07e-03 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 147 | 310 | 4.15e-03 |
| GO:BP | GO:0097306 | cellular response to alcohol | 44 | 76 | 4.16e-03 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 51 | 91 | 4.28e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 51 | 91 | 4.28e-03 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 57 | 104 | 4.29e-03 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 43 | 74 | 4.33e-03 |
| GO:BP | GO:1903319 | positive regulation of protein maturation | 15 | 19 | 4.50e-03 |
| GO:BP | GO:0051588 | regulation of neurotransmitter transport | 42 | 72 | 4.51e-03 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 20 | 28 | 4.53e-03 |
| GO:BP | GO:0048713 | regulation of oligodendrocyte differentiation | 20 | 28 | 4.53e-03 |
| GO:BP | GO:0006869 | lipid transport | 131 | 273 | 4.64e-03 |
| GO:BP | GO:0006887 | exocytosis | 122 | 252 | 4.69e-03 |
| GO:BP | GO:0001843 | neural tube closure | 49 | 87 | 4.72e-03 |
| GO:BP | GO:0007605 | sensory perception of sound | 55 | 100 | 4.78e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 40 | 68 | 4.84e-03 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 40 | 68 | 4.84e-03 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 186 | 404 | 4.91e-03 |
| GO:BP | GO:0060914 | heart formation | 21 | 30 | 4.95e-03 |
| GO:BP | GO:0048512 | circadian behavior | 21 | 30 | 4.95e-03 |
| GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 69 | 131 | 4.99e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 39 | 66 | 5.00e-03 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 64 | 120 | 5.13e-03 |
| GO:BP | GO:0030217 | T cell differentiation | 95 | 190 | 5.17e-03 |
| GO:BP | GO:0007622 | rhythmic behavior | 22 | 32 | 5.31e-03 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 182 | 395 | 5.34e-03 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 91 | 181 | 5.35e-03 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 46 | 81 | 5.43e-03 |
| GO:BP | GO:0014074 | response to purine-containing compound | 58 | 107 | 5.45e-03 |
| GO:BP | GO:0051899 | membrane depolarization | 36 | 60 | 5.49e-03 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 35 | 58 | 5.65e-03 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 45 | 79 | 5.68e-03 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0032924 | activin receptor signaling pathway | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0032674 | regulation of interleukin-5 production | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0060896 | neural plate pattern specification | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0003190 | atrioventricular valve formation | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0060982 | coronary artery morphogenesis | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0003418 | growth plate cartilage chondrocyte differentiation | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0032634 | interleukin-5 production | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 33 | 54 | 5.85e-03 |
| GO:BP | GO:0051480 | regulation of cytosolic calcium ion concentration | 25 | 38 | 5.94e-03 |
| GO:BP | GO:0021670 | lateral ventricle development | 10 | 11 | 5.98e-03 |
| GO:BP | GO:0051923 | sulfation | 10 | 11 | 5.98e-03 |
| GO:BP | GO:0045055 | regulated exocytosis | 78 | 152 | 6.01e-03 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 99 | 200 | 6.02e-03 |
| GO:BP | GO:0045685 | regulation of glial cell differentiation | 31 | 50 | 6.02e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 30 | 48 | 6.09e-03 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 28 | 44 | 6.10e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 29 | 46 | 6.10e-03 |
| GO:BP | GO:0050922 | negative regulation of chemotaxis | 28 | 44 | 6.10e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 50 | 90 | 6.10e-03 |
| GO:BP | GO:0048145 | regulation of fibroblast proliferation | 43 | 75 | 6.10e-03 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 95 | 191 | 6.27e-03 |
| GO:BP | GO:0036465 | synaptic vesicle recycling | 42 | 73 | 6.38e-03 |
| GO:BP | GO:0060037 | pharyngeal system development | 17 | 23 | 6.45e-03 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 104 | 212 | 6.55e-03 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 104 | 212 | 6.55e-03 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 107 | 219 | 6.59e-03 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 41 | 71 | 6.65e-03 |
| GO:BP | GO:0051051 | negative regulation of transport | 144 | 306 | 6.70e-03 |
| GO:BP | GO:0021846 | cell proliferation in forebrain | 13 | 16 | 6.70e-03 |
| GO:BP | GO:0071774 | response to fibroblast growth factor | 48 | 86 | 6.74e-03 |
| GO:BP | GO:0043549 | regulation of kinase activity | 172 | 373 | 6.94e-03 |
| GO:BP | GO:0022607 | cellular component assembly | 1009 | 2481 | 7.15e-03 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 86 | 171 | 7.18e-03 |
| GO:BP | GO:0045124 | regulation of bone resorption | 18 | 25 | 7.30e-03 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 18 | 25 | 7.30e-03 |
| GO:BP | GO:0043393 | regulation of protein binding | 62 | 117 | 7.43e-03 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 62 | 117 | 7.43e-03 |
| GO:BP | GO:1904018 | positive regulation of vasculature development | 62 | 117 | 7.43e-03 |
| GO:BP | GO:0008366 | axon ensheathment | 66 | 126 | 7.60e-03 |
| GO:BP | GO:0007272 | ensheathment of neurons | 66 | 126 | 7.60e-03 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 85 | 169 | 7.62e-03 |
| GO:BP | GO:0000082 | G1/S transition of mitotic cell cycle | 95 | 192 | 7.67e-03 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 45 | 80 | 7.84e-03 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 119 | 248 | 7.87e-03 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 61 | 115 | 7.87e-03 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 141 | 300 | 7.98e-03 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 19 | 27 | 7.98e-03 |
| GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 19 | 27 | 7.98e-03 |
| GO:BP | GO:0032941 | secretion by tissue | 19 | 27 | 7.98e-03 |
| GO:BP | GO:0046849 | bone remodeling | 36 | 61 | 8.02e-03 |
| GO:BP | GO:0042552 | myelination | 65 | 124 | 8.03e-03 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 35 | 59 | 8.31e-03 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 112 | 232 | 8.43e-03 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 55 | 102 | 8.44e-03 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 20 | 29 | 8.57e-03 |
| GO:BP | GO:0070570 | regulation of neuron projection regeneration | 20 | 29 | 8.57e-03 |
| GO:BP | GO:0008361 | regulation of cell size | 83 | 165 | 8.59e-03 |
| GO:BP | GO:0038094 | Fc-gamma receptor signaling pathway | 14 | 18 | 8.61e-03 |
| GO:BP | GO:0060445 | branching involved in salivary gland morphogenesis | 14 | 18 | 8.61e-03 |
| GO:BP | GO:0001708 | cell fate specification | 33 | 55 | 8.79e-03 |
| GO:BP | GO:0032835 | glomerulus development | 33 | 55 | 8.79e-03 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 33 | 55 | 8.79e-03 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 21 | 31 | 8.98e-03 |
| GO:BP | GO:0048841 | regulation of axon extension involved in axon guidance | 21 | 31 | 8.98e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 662 | 1597 | 8.98e-03 |
| GO:BP | GO:0051928 | positive regulation of calcium ion transport | 42 | 74 | 8.98e-03 |
| GO:BP | GO:0097106 | postsynaptic density organization | 21 | 31 | 8.98e-03 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 32 | 53 | 9.00e-03 |
| GO:BP | GO:0060326 | cell chemotaxis | 82 | 163 | 9.08e-03 |
| GO:BP | GO:0072089 | stem cell proliferation | 48 | 87 | 9.16e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 122 | 256 | 9.16e-03 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 31 | 51 | 9.21e-03 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 141 | 301 | 9.21e-03 |
| GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 22 | 33 | 9.31e-03 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 41 | 72 | 9.32e-03 |
| GO:BP | GO:1903532 | positive regulation of secretion by cell | 98 | 200 | 9.32e-03 |
| GO:BP | GO:0031623 | receptor internalization | 53 | 98 | 9.32e-03 |
| GO:BP | GO:0010232 | vascular transport | 41 | 72 | 9.32e-03 |
| GO:BP | GO:0060997 | dendritic spine morphogenesis | 30 | 49 | 9.36e-03 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 23 | 35 | 9.52e-03 |
| GO:BP | GO:1905330 | regulation of morphogenesis of an epithelium | 29 | 47 | 9.52e-03 |
| GO:BP | GO:0009880 | embryonic pattern specification | 29 | 47 | 9.52e-03 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 70 | 136 | 9.57e-03 |
| GO:BP | GO:0001956 | positive regulation of neurotransmitter secretion | 11 | 13 | 9.60e-03 |
| GO:BP | GO:0072578 | neurotransmitter-gated ion channel clustering | 11 | 13 | 9.60e-03 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 24 | 37 | 9.65e-03 |
| GO:BP | GO:0045214 | sarcomere organization | 27 | 43 | 9.71e-03 |
| GO:BP | GO:0030517 | negative regulation of axon extension | 26 | 41 | 9.75e-03 |
| GO:BP | GO:0006996 | organelle organization | 1208 | 3001 | 9.82e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 351 | 815 | 9.88e-03 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 100 | 205 | 9.88e-03 |
| GO:BP | GO:0042476 | odontogenesis | 46 | 83 | 1.01e-02 |
| GO:BP | GO:0035418 | protein localization to synapse | 39 | 68 | 1.01e-02 |
| GO:BP | GO:0061024 | membrane organization | 292 | 669 | 1.01e-02 |
| GO:BP | GO:2000114 | regulation of establishment of cell polarity | 15 | 20 | 1.01e-02 |
| GO:BP | GO:1990806 | ligand-gated ion channel signaling pathway | 15 | 20 | 1.01e-02 |
| GO:BP | GO:0031281 | positive regulation of cyclase activity | 15 | 20 | 1.01e-02 |
| GO:BP | GO:0030534 | adult behavior | 51 | 94 | 1.03e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 83 | 166 | 1.04e-02 |
| GO:BP | GO:0071900 | regulation of protein serine/threonine kinase activity | 99 | 203 | 1.05e-02 |
| GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 38 | 66 | 1.05e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 68 | 132 | 1.07e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 431 | 1016 | 1.08e-02 |
| GO:BP | GO:0010565 | regulation of cellular ketone metabolic process | 55 | 103 | 1.09e-02 |
| GO:BP | GO:0030168 | platelet activation | 50 | 92 | 1.09e-02 |
| GO:BP | GO:0032414 | positive regulation of ion transmembrane transporter activity | 37 | 64 | 1.10e-02 |
| GO:BP | GO:0051640 | organelle localization | 238 | 537 | 1.10e-02 |
| GO:BP | GO:0003014 | renal system process | 44 | 79 | 1.11e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 36 | 62 | 1.15e-02 |
| GO:BP | GO:0048499 | synaptic vesicle membrane organization | 16 | 22 | 1.16e-02 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 914 | 2246 | 1.17e-02 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 43 | 77 | 1.17e-02 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 35 | 60 | 1.19e-02 |
| GO:BP | GO:0097529 | myeloid leukocyte migration | 62 | 119 | 1.21e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 42 | 75 | 1.23e-02 |
| GO:BP | GO:0048709 | oligodendrocyte differentiation | 42 | 75 | 1.23e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 42 | 75 | 1.23e-02 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 270 | 617 | 1.28e-02 |
| GO:BP | GO:0030431 | sleep | 9 | 10 | 1.28e-02 |
| GO:BP | GO:0045761 | regulation of adenylate cyclase activity | 17 | 24 | 1.28e-02 |
| GO:BP | GO:0046847 | filopodium assembly | 33 | 56 | 1.28e-02 |
| GO:BP | GO:0002063 | chondrocyte development | 17 | 24 | 1.28e-02 |
| GO:BP | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 9 | 10 | 1.28e-02 |
| GO:BP | GO:0022410 | circadian sleep/wake cycle process | 9 | 10 | 1.28e-02 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 17 | 24 | 1.28e-02 |
| GO:BP | GO:0045906 | negative regulation of vasoconstriction | 9 | 10 | 1.28e-02 |
| GO:BP | GO:0007584 | response to nutrient | 61 | 117 | 1.28e-02 |
| GO:BP | GO:0035270 | endocrine system development | 47 | 86 | 1.28e-02 |
| GO:BP | GO:0007600 | sensory perception | 124 | 263 | 1.30e-02 |
| GO:BP | GO:0070571 | negative regulation of neuron projection regeneration | 12 | 15 | 1.30e-02 |
| GO:BP | GO:1902932 | positive regulation of alcohol biosynthetic process | 12 | 15 | 1.30e-02 |
| GO:BP | GO:0090103 | cochlea morphogenesis | 12 | 15 | 1.30e-02 |
| GO:BP | GO:0071396 | cellular response to lipid | 184 | 407 | 1.32e-02 |
| GO:BP | GO:0051098 | regulation of binding | 101 | 209 | 1.33e-02 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 152 | 330 | 1.35e-02 |
| GO:BP | GO:0008104 | protein localization | 867 | 2128 | 1.35e-02 |
| GO:BP | GO:0010761 | fibroblast migration | 31 | 52 | 1.36e-02 |
| GO:BP | GO:0035904 | aorta development | 31 | 52 | 1.36e-02 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 18 | 26 | 1.37e-02 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 251 | 571 | 1.37e-02 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 18 | 26 | 1.37e-02 |
| GO:BP | GO:0048668 | collateral sprouting | 18 | 26 | 1.37e-02 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 18 | 26 | 1.37e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 314 | 727 | 1.40e-02 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 39 | 69 | 1.41e-02 |
| GO:BP | GO:0051223 | regulation of protein transport | 156 | 340 | 1.42e-02 |
| GO:BP | GO:0030516 | regulation of axon extension | 45 | 82 | 1.42e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 29 | 48 | 1.44e-02 |
| GO:BP | GO:0051649 | establishment of localization in cell | 684 | 1661 | 1.46e-02 |
| GO:BP | GO:0042100 | B cell proliferation | 28 | 46 | 1.47e-02 |
| GO:BP | GO:0098661 | inorganic anion transmembrane transport | 38 | 67 | 1.47e-02 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 38 | 67 | 1.47e-02 |
| GO:BP | GO:1904036 | negative regulation of epithelial cell apoptotic process | 28 | 46 | 1.47e-02 |
| GO:BP | GO:0050714 | positive regulation of protein secretion | 54 | 102 | 1.49e-02 |
| GO:BP | GO:0052652 | cyclic purine nucleotide metabolic process | 20 | 30 | 1.49e-02 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 20 | 30 | 1.49e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 27 | 44 | 1.50e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 27 | 44 | 1.50e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 27 | 44 | 1.50e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 27 | 44 | 1.50e-02 |
| GO:BP | GO:0051606 | detection of stimulus | 58 | 111 | 1.52e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 870 | 2138 | 1.52e-02 |
| GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 21 | 32 | 1.52e-02 |
| GO:BP | GO:0045453 | bone resorption | 26 | 42 | 1.52e-02 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 840 | 2061 | 1.52e-02 |
| GO:BP | GO:0060391 | positive regulation of SMAD protein signal transduction | 21 | 32 | 1.52e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 21 | 32 | 1.52e-02 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 21 | 32 | 1.52e-02 |
| GO:BP | GO:0006909 | phagocytosis | 73 | 145 | 1.52e-02 |
| GO:BP | GO:0051703 | biological process involved in intraspecies interaction between organisms | 22 | 34 | 1.53e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 25 | 40 | 1.53e-02 |
| GO:BP | GO:1903351 | cellular response to dopamine | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0003161 | cardiac conduction system development | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0090102 | cochlea development | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0035176 | social behavior | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0060711 | labyrinthine layer development | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0010656 | negative regulation of muscle cell apoptotic process | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 24 | 38 | 1.53e-02 |
| GO:BP | GO:0050863 | regulation of T cell activation | 104 | 217 | 1.54e-02 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 53 | 100 | 1.56e-02 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 48 | 89 | 1.58e-02 |
| GO:BP | GO:0061323 | cell proliferation involved in heart morphogenesis | 13 | 17 | 1.58e-02 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 48 | 89 | 1.58e-02 |
| GO:BP | GO:0032814 | regulation of natural killer cell activation | 13 | 17 | 1.58e-02 |
| GO:BP | GO:2000136 | regulation of cell proliferation involved in heart morphogenesis | 13 | 17 | 1.58e-02 |
| GO:BP | GO:0072673 | lamellipodium morphogenesis | 13 | 17 | 1.58e-02 |
| GO:BP | GO:0048678 | response to axon injury | 36 | 63 | 1.58e-02 |
| GO:BP | GO:0002682 | regulation of immune system process | 397 | 936 | 1.60e-02 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 476 | 1135 | 1.63e-02 |
| GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 42 | 76 | 1.63e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 114 | 241 | 1.65e-02 |
| GO:BP | GO:0003073 | regulation of systemic arterial blood pressure | 35 | 61 | 1.66e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 56 | 107 | 1.68e-02 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 78 | 157 | 1.68e-02 |
| GO:BP | GO:0070509 | calcium ion import | 34 | 59 | 1.73e-02 |
| GO:BP | GO:0043954 | cellular component maintenance | 34 | 59 | 1.73e-02 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 243 | 554 | 1.78e-02 |
| GO:BP | GO:0010256 | endomembrane system organization | 221 | 500 | 1.79e-02 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 59 | 114 | 1.80e-02 |
| GO:BP | GO:0042310 | vasoconstriction | 33 | 57 | 1.81e-02 |
| GO:BP | GO:0042116 | macrophage activation | 33 | 57 | 1.81e-02 |
| GO:BP | GO:0070168 | negative regulation of biomineral tissue development | 14 | 19 | 1.83e-02 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0019934 | cGMP-mediated signaling | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0098884 | postsynaptic neurotransmitter receptor internalization | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0010878 | cholesterol storage | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0042092 | type 2 immune response | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0048169 | regulation of long-term neuronal synaptic plasticity | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0140239 | postsynaptic endocytosis | 14 | 19 | 1.83e-02 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 436 | 1036 | 1.86e-02 |
| GO:BP | GO:0071871 | response to epinephrine | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0045651 | positive regulation of macrophage differentiation | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0036302 | atrioventricular canal development | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 39 | 70 | 1.90e-02 |
| GO:BP | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0002263 | cell activation involved in immune response | 79 | 160 | 1.92e-02 |
| GO:BP | GO:0032868 | response to insulin | 100 | 209 | 1.94e-02 |
| GO:BP | GO:0052548 | regulation of endopeptidase activity | 82 | 167 | 1.94e-02 |
| GO:BP | GO:0048144 | fibroblast proliferation | 49 | 92 | 1.95e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 44 | 81 | 1.96e-02 |
| GO:BP | GO:0072523 | purine-containing compound catabolic process | 65 | 128 | 1.96e-02 |
| GO:BP | GO:0043588 | skin development | 88 | 181 | 1.96e-02 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 65 | 128 | 1.96e-02 |
| GO:BP | GO:0009166 | nucleotide catabolic process | 72 | 144 | 1.96e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 432 | 1027 | 2.00e-02 |
| GO:BP | GO:0022414 | reproductive process | 397 | 939 | 2.01e-02 |
| GO:BP | GO:0099637 | neurotransmitter receptor transport | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0099590 | neurotransmitter receptor internalization | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0098810 | neurotransmitter reuptake | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0035024 | negative regulation of Rho protein signal transduction | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0015698 | inorganic anion transport | 48 | 90 | 2.05e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 96 | 200 | 2.06e-02 |
| GO:BP | GO:0006955 | immune response | 394 | 932 | 2.09e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 123 | 264 | 2.10e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 123 | 264 | 2.10e-02 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 67 | 133 | 2.16e-02 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 47 | 88 | 2.18e-02 |
| GO:BP | GO:0002021 | response to dietary excess | 16 | 23 | 2.18e-02 |
| GO:BP | GO:0060343 | trabecula formation | 16 | 23 | 2.18e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 16 | 23 | 2.18e-02 |
| GO:BP | GO:0010469 | regulation of signaling receptor activity | 36 | 64 | 2.19e-02 |
| GO:BP | GO:0001503 | ossification | 147 | 322 | 2.25e-02 |
| GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 26 | 43 | 2.28e-02 |
| GO:BP | GO:0031103 | axon regeneration | 26 | 43 | 2.28e-02 |
| GO:BP | GO:0051965 | positive regulation of synapse assembly | 26 | 43 | 2.28e-02 |
| GO:BP | GO:0048146 | positive regulation of fibroblast proliferation | 26 | 43 | 2.28e-02 |
| GO:BP | GO:0010664 | negative regulation of striated muscle cell apoptotic process | 17 | 25 | 2.29e-02 |
| GO:BP | GO:0060074 | synapse maturation | 17 | 25 | 2.29e-02 |
| GO:BP | GO:0032292 | peripheral nervous system axon ensheathment | 17 | 25 | 2.29e-02 |
| GO:BP | GO:0022011 | myelination in peripheral nervous system | 17 | 25 | 2.29e-02 |
| GO:BP | GO:0002793 | positive regulation of peptide secretion | 41 | 75 | 2.30e-02 |
| GO:BP | GO:0030705 | cytoskeleton-dependent intracellular transport | 94 | 196 | 2.31e-02 |
| GO:BP | GO:0031334 | positive regulation of protein-containing complex assembly | 79 | 161 | 2.31e-02 |
| GO:BP | GO:0045103 | intermediate filament-based process | 25 | 41 | 2.33e-02 |
| GO:BP | GO:0001649 | osteoblast differentiation | 88 | 182 | 2.33e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 62 | 122 | 2.34e-02 |
| GO:BP | GO:0010092 | specification of animal organ identity | 18 | 27 | 2.36e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 18 | 27 | 2.36e-02 |
| GO:BP | GO:1990573 | potassium ion import across plasma membrane | 18 | 27 | 2.36e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 24 | 39 | 2.36e-02 |
| GO:BP | GO:0042311 | vasodilation | 24 | 39 | 2.36e-02 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 18 | 27 | 2.36e-02 |
| GO:BP | GO:2001259 | positive regulation of cation channel activity | 24 | 39 | 2.36e-02 |
| GO:BP | GO:0050905 | neuromuscular process | 58 | 113 | 2.37e-02 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 54 | 104 | 2.38e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 72 | 145 | 2.38e-02 |
| GO:BP | GO:0033173 | calcineurin-NFAT signaling cascade | 23 | 37 | 2.40e-02 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 23 | 37 | 2.40e-02 |
| GO:BP | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 19 | 29 | 2.40e-02 |
| GO:BP | GO:0021591 | ventricular system development | 19 | 29 | 2.40e-02 |
| GO:BP | GO:0048483 | autonomic nervous system development | 19 | 29 | 2.40e-02 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 19 | 29 | 2.40e-02 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 19 | 29 | 2.40e-02 |
| GO:BP | GO:0009187 | cyclic nucleotide metabolic process | 20 | 31 | 2.41e-02 |
| GO:BP | GO:2000648 | positive regulation of stem cell proliferation | 21 | 33 | 2.41e-02 |
| GO:BP | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0034405 | response to fluid shear stress | 20 | 31 | 2.41e-02 |
| GO:BP | GO:0046321 | positive regulation of fatty acid oxidation | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0046579 | positive regulation of Ras protein signal transduction | 11 | 14 | 2.41e-02 |
| GO:BP | GO:1903350 | response to dopamine | 22 | 35 | 2.41e-02 |
| GO:BP | GO:0010885 | regulation of cholesterol storage | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0030888 | regulation of B cell proliferation | 22 | 35 | 2.41e-02 |
| GO:BP | GO:0010763 | positive regulation of fibroblast migration | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0007616 | long-term memory | 21 | 33 | 2.41e-02 |
| GO:BP | GO:0038166 | angiotensin-activated signaling pathway | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0071711 | basement membrane organization | 22 | 35 | 2.41e-02 |
| GO:BP | GO:0009261 | ribonucleotide catabolic process | 61 | 120 | 2.43e-02 |
| GO:BP | GO:1905952 | regulation of lipid localization | 57 | 111 | 2.48e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 53 | 102 | 2.49e-02 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 235 | 538 | 2.49e-02 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 98 | 206 | 2.50e-02 |
| GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 39 | 71 | 2.50e-02 |
| GO:BP | GO:0043412 | macromolecule modification | 1057 | 2631 | 2.51e-02 |
| GO:BP | GO:1903034 | regulation of response to wounding | 64 | 127 | 2.52e-02 |
| GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 74 | 150 | 2.52e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 74 | 150 | 2.52e-02 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 127 | 275 | 2.52e-02 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 83 | 171 | 2.57e-02 |
| GO:BP | GO:0042113 | B cell activation | 83 | 171 | 2.57e-02 |
| GO:BP | GO:0046942 | carboxylic acid transport | 103 | 218 | 2.57e-02 |
| GO:BP | GO:1904063 | negative regulation of cation transmembrane transport | 32 | 56 | 2.57e-02 |
| GO:BP | GO:0050802 | circadian sleep/wake cycle, sleep | 8 | 9 | 2.57e-02 |
| GO:BP | GO:0071361 | cellular response to ethanol | 8 | 9 | 2.57e-02 |
| GO:BP | GO:0061626 | pharyngeal arch artery morphogenesis | 8 | 9 | 2.57e-02 |
| GO:BP | GO:0003162 | atrioventricular node development | 8 | 9 | 2.57e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 158 | 350 | 2.60e-02 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 38 | 69 | 2.62e-02 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 38 | 69 | 2.62e-02 |
| GO:BP | GO:0042594 | response to starvation | 88 | 183 | 2.71e-02 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 47 | 89 | 2.76e-02 |
| GO:BP | GO:0043534 | blood vessel endothelial cell migration | 51 | 98 | 2.80e-02 |
| GO:BP | GO:0034097 | response to cytokine | 268 | 621 | 2.81e-02 |
| GO:BP | GO:0071621 | granulocyte chemotaxis | 30 | 52 | 2.82e-02 |
| GO:BP | GO:0003188 | heart valve formation | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 62 | 123 | 2.84e-02 |
| GO:BP | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0014047 | glutamate secretion | 12 | 16 | 2.84e-02 |
| GO:BP | GO:1900242 | regulation of synaptic vesicle endocytosis | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0097091 | synaptic vesicle clustering | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0046128 | purine ribonucleoside metabolic process | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0045762 | positive regulation of adenylate cyclase activity | 12 | 16 | 2.84e-02 |
| GO:BP | GO:1903540 | establishment of protein localization to postsynaptic membrane | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0001759 | organ induction | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0048339 | paraxial mesoderm development | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0006817 | phosphate ion transport | 12 | 16 | 2.84e-02 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 78 | 160 | 2.87e-02 |
| GO:BP | GO:0030902 | hindbrain development | 58 | 114 | 2.89e-02 |
| GO:BP | GO:0030595 | leukocyte chemotaxis | 58 | 114 | 2.89e-02 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 46 | 87 | 2.90e-02 |
| GO:BP | GO:0032754 | positive regulation of interleukin-5 production | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0060897 | neural plate regionalization | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0031223 | auditory behavior | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0003175 | tricuspid valve development | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0014031 | mesenchymal cell development | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0060710 | chorio-allantoic fusion | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0050861 | positive regulation of B cell receptor signaling pathway | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0099545 | trans-synaptic signaling by trans-synaptic complex | 6 | 6 | 2.92e-02 |
| GO:BP | GO:1903903 | regulation of establishment of T cell polarity | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 355 | 839 | 2.92e-02 |
| GO:BP | GO:0023041 | neuronal signal transduction | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0003415 | chondrocyte hypertrophy | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0072173 | metanephric tubule morphogenesis | 6 | 6 | 2.92e-02 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 68 | 137 | 2.93e-02 |
| GO:BP | GO:0015849 | organic acid transport | 103 | 219 | 2.96e-02 |
| GO:BP | GO:0070613 | regulation of protein processing | 28 | 48 | 3.00e-02 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 86 | 179 | 3.00e-02 |
| GO:BP | GO:0003407 | neural retina development | 28 | 48 | 3.00e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 845 | 2088 | 3.00e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 108 | 231 | 3.01e-02 |
| GO:BP | GO:0006835 | dicarboxylic acid transport | 35 | 63 | 3.03e-02 |
| GO:BP | GO:0090277 | positive regulation of peptide hormone secretion | 40 | 74 | 3.11e-02 |
| GO:BP | GO:0000003 | reproduction | 398 | 948 | 3.12e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 27 | 46 | 3.12e-02 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 27 | 46 | 3.12e-02 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0010996 | response to auditory stimulus | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0060706 | cell differentiation involved in embryonic placenta development | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0060402 | calcium ion transport into cytosol | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0055093 | response to hyperoxia | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0060392 | negative regulation of SMAD protein signal transduction | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0042593 | glucose homeostasis | 85 | 177 | 3.18e-02 |
| GO:BP | GO:1901292 | nucleoside phosphate catabolic process | 73 | 149 | 3.18e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 56 | 110 | 3.23e-02 |
| GO:BP | GO:0051489 | regulation of filopodium assembly | 26 | 44 | 3.23e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 63 | 126 | 3.23e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 39 | 72 | 3.27e-02 |
| GO:BP | GO:0032024 | positive regulation of insulin secretion | 33 | 59 | 3.35e-02 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 59 | 117 | 3.35e-02 |
| GO:BP | GO:0030032 | lamellipodium assembly | 33 | 59 | 3.35e-02 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 711 | 1746 | 3.38e-02 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 72 | 147 | 3.38e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 143 | 316 | 3.40e-02 |
| GO:BP | GO:0003156 | regulation of animal organ formation | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0032526 | response to retinoic acid | 43 | 81 | 3.40e-02 |
| GO:BP | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0062009 | secondary palate development | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0042278 | purine nucleoside metabolic process | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0051349 | positive regulation of lyase activity | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0010460 | positive regulation of heart rate | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0098781 | ncRNA transcription | 62 | 124 | 3.42e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 24 | 40 | 3.42e-02 |
| GO:BP | GO:0048013 | ephrin receptor signaling pathway | 24 | 40 | 3.42e-02 |
| GO:BP | GO:0045104 | intermediate filament cytoskeleton organization | 24 | 40 | 3.42e-02 |
| GO:BP | GO:0030858 | positive regulation of epithelial cell differentiation | 24 | 40 | 3.42e-02 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 271 | 631 | 3.42e-02 |
| GO:BP | GO:0022405 | hair cycle process | 38 | 70 | 3.43e-02 |
| GO:BP | GO:0034109 | homotypic cell-cell adhesion | 38 | 70 | 3.43e-02 |
| GO:BP | GO:0022404 | molting cycle process | 38 | 70 | 3.43e-02 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 710 | 1744 | 3.44e-02 |
| GO:BP | GO:0046660 | female sex differentiation | 47 | 90 | 3.44e-02 |
| GO:BP | GO:0046434 | organophosphate catabolic process | 89 | 187 | 3.48e-02 |
| GO:BP | GO:0050848 | regulation of calcium-mediated signaling | 32 | 57 | 3.48e-02 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 123 | 268 | 3.49e-02 |
| GO:BP | GO:0006940 | regulation of smooth muscle contraction | 23 | 38 | 3.51e-02 |
| GO:BP | GO:0009154 | purine ribonucleotide catabolic process | 58 | 115 | 3.51e-02 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 23 | 38 | 3.51e-02 |
| GO:BP | GO:0097720 | calcineurin-mediated signaling | 23 | 38 | 3.51e-02 |
| GO:BP | GO:0031400 | negative regulation of protein modification process | 156 | 348 | 3.56e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 705 | 1732 | 3.56e-02 |
| GO:BP | GO:0031641 | regulation of myelination | 22 | 36 | 3.56e-02 |
| GO:BP | GO:0030852 | regulation of granulocyte differentiation | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0042633 | hair cycle | 42 | 79 | 3.56e-02 |
| GO:BP | GO:0042303 | molting cycle | 42 | 79 | 3.56e-02 |
| GO:BP | GO:0042451 | purine nucleoside biosynthetic process | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0043666 | regulation of phosphoprotein phosphatase activity | 22 | 36 | 3.56e-02 |
| GO:BP | GO:0042455 | ribonucleoside biosynthetic process | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0035435 | phosphate ion transmembrane transport | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0035272 | exocrine system development | 22 | 36 | 3.56e-02 |
| GO:BP | GO:0046635 | positive regulation of alpha-beta T cell activation | 22 | 36 | 3.56e-02 |
| GO:BP | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 15 | 22 | 3.56e-02 |
| GO:BP | GO:0060033 | anatomical structure regression | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0042745 | circadian sleep/wake cycle | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0032717 | negative regulation of interleukin-8 production | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0046129 | purine ribonucleoside biosynthetic process | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0001942 | hair follicle development | 37 | 68 | 3.57e-02 |
| GO:BP | GO:0019217 | regulation of fatty acid metabolic process | 37 | 68 | 3.57e-02 |
| GO:BP | GO:0035640 | exploration behavior | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0071402 | cellular response to lipoprotein particle stimulus | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0098868 | bone growth | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0055078 | sodium ion homeostasis | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0002792 | negative regulation of peptide secretion | 21 | 34 | 3.63e-02 |
| GO:BP | GO:1901889 | negative regulation of cell junction assembly | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0106056 | regulation of calcineurin-mediated signaling | 20 | 32 | 3.67e-02 |
| GO:BP | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 20 | 32 | 3.67e-02 |
| GO:BP | GO:1902930 | regulation of alcohol biosynthetic process | 20 | 32 | 3.67e-02 |
| GO:BP | GO:0001659 | temperature homeostasis | 67 | 136 | 3.67e-02 |
| GO:BP | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 20 | 32 | 3.67e-02 |
| GO:BP | GO:0033500 | carbohydrate homeostasis | 85 | 178 | 3.67e-02 |
| GO:BP | GO:0071825 | protein-lipid complex organization | 20 | 32 | 3.67e-02 |
| GO:BP | GO:0048679 | regulation of axon regeneration | 17 | 26 | 3.68e-02 |
| GO:BP | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 17 | 26 | 3.68e-02 |
| GO:BP | GO:0048843 | negative regulation of axon extension involved in axon guidance | 17 | 26 | 3.68e-02 |
| GO:BP | GO:1902742 | apoptotic process involved in development | 19 | 30 | 3.69e-02 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 19 | 30 | 3.69e-02 |
| GO:BP | GO:0051339 | regulation of lyase activity | 19 | 30 | 3.69e-02 |
| GO:BP | GO:1904861 | excitatory synapse assembly | 18 | 28 | 3.69e-02 |
| GO:BP | GO:0007212 | dopamine receptor signaling pathway | 18 | 28 | 3.69e-02 |
| GO:BP | GO:0050850 | positive regulation of calcium-mediated signaling | 18 | 28 | 3.69e-02 |
| GO:BP | GO:0002366 | leukocyte activation involved in immune response | 76 | 157 | 3.70e-02 |
| GO:BP | GO:0032092 | positive regulation of protein binding | 30 | 53 | 3.75e-02 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 30 | 53 | 3.75e-02 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 121 | 264 | 3.80e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 100 | 214 | 3.95e-02 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 29 | 51 | 3.95e-02 |
| GO:BP | GO:1903317 | regulation of protein maturation | 29 | 51 | 3.95e-02 |
| GO:BP | GO:0140029 | exocytic process | 35 | 64 | 3.95e-02 |
| GO:BP | GO:0001656 | metanephros development | 35 | 64 | 3.95e-02 |
| GO:BP | GO:0071702 | organic substance transport | 738 | 1819 | 3.96e-02 |
| GO:BP | GO:0046888 | negative regulation of hormone secretion | 28 | 49 | 4.15e-02 |
| GO:BP | GO:0044843 | cell cycle G1/S phase transition | 99 | 212 | 4.20e-02 |
| GO:BP | GO:0007589 | body fluid secretion | 34 | 62 | 4.20e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 71 | 146 | 4.20e-02 |
| GO:BP | GO:0006470 | protein dephosphorylation | 88 | 186 | 4.26e-02 |
| GO:BP | GO:0015850 | organic hydroxy compound transport | 88 | 186 | 4.26e-02 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 58 | 116 | 4.26e-02 |
| GO:BP | GO:0032368 | regulation of lipid transport | 47 | 91 | 4.31e-02 |
| GO:BP | GO:0002252 | immune effector process | 145 | 323 | 4.31e-02 |
| GO:BP | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 27 | 47 | 4.33e-02 |
| GO:BP | GO:0002275 | myeloid cell activation involved in immune response | 27 | 47 | 4.33e-02 |
| GO:BP | GO:0061458 | reproductive system development | 101 | 217 | 4.33e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 27 | 47 | 4.33e-02 |
| GO:BP | GO:0001816 | cytokine production | 211 | 485 | 4.34e-02 |
| GO:BP | GO:0006195 | purine nucleotide catabolic process | 61 | 123 | 4.34e-02 |
| GO:BP | GO:0060347 | heart trabecula formation | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0060841 | venous blood vessel development | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0003159 | morphogenesis of an endothelium | 10 | 13 | 4.35e-02 |
| GO:BP | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0048681 | negative regulation of axon regeneration | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0048368 | lateral mesoderm development | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0061154 | endothelial tube morphogenesis | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0051547 | regulation of keratinocyte migration | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0045780 | positive regulation of bone resorption | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 54 | 107 | 4.37e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 67 | 137 | 4.40e-02 |
| GO:BP | GO:0060021 | roof of mouth development | 38 | 71 | 4.40e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 318 | 752 | 4.41e-02 |
| GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 26 | 45 | 4.49e-02 |
| GO:BP | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 57 | 114 | 4.49e-02 |
| GO:BP | GO:0045123 | cellular extravasation | 26 | 45 | 4.49e-02 |
| GO:BP | GO:0015711 | organic anion transport | 125 | 275 | 4.53e-02 |
| GO:BP | GO:0019216 | regulation of lipid metabolic process | 105 | 227 | 4.59e-02 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 32 | 58 | 4.64e-02 |
| GO:BP | GO:0046634 | regulation of alpha-beta T cell activation | 32 | 58 | 4.64e-02 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 63 | 128 | 4.65e-02 |
| GO:BP | GO:1903035 | negative regulation of response to wounding | 37 | 69 | 4.67e-02 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 37 | 69 | 4.67e-02 |
| GO:BP | GO:0031638 | zymogen activation | 25 | 43 | 4.69e-02 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 688 | 1694 | 4.69e-02 |
| GO:BP | GO:0001817 | regulation of cytokine production | 209 | 481 | 4.71e-02 |
| GO:BP | GO:0051048 | negative regulation of secretion | 56 | 112 | 4.78e-02 |
| GO:BP | GO:0045931 | positive regulation of mitotic cell cycle | 56 | 112 | 4.78e-02 |
| GO:BP | GO:0010035 | response to inorganic substance | 174 | 395 | 4.85e-02 |
| GO:BP | GO:0070227 | lymphocyte apoptotic process | 31 | 56 | 4.89e-02 |
| GO:BP | GO:0010827 | regulation of glucose transmembrane transport | 31 | 56 | 4.89e-02 |
| GO:BP | GO:0015800 | acidic amino acid transport | 24 | 41 | 4.89e-02 |
| GO:BP | GO:0010950 | positive regulation of endopeptidase activity | 52 | 103 | 4.95e-02 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 68 | 140 | 4.96e-02 |
| GO:BP | GO:0003417 | growth plate cartilage development | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0002828 | regulation of type 2 immune response | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0051546 | keratinocyte migration | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0072170 | metanephric tubule development | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0009267 | cellular response to starvation | 74 | 154 | 4.96e-02 |
| GO:BP | GO:0016082 | synaptic vesicle priming | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0060413 | atrial septum morphogenesis | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0060142 | regulation of syncytium formation by plasma membrane fusion | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0034616 | response to laminar fluid shear stress | 11 | 15 | 4.96e-02 |
ESRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in ESR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04020 | Calcium signaling pathway | 107 | 164 | 1.79e-10 |
| KEGG | KEGG:05200 | Pathways in cancer | 223 | 408 | 1.79e-10 |
| KEGG | KEGG:04510 | Focal adhesion | 113 | 177 | 1.79e-10 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 106 | 164 | 1.92e-10 |
| KEGG | KEGG:04360 | Axon guidance | 104 | 162 | 4.61e-10 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 98 | 151 | 6.04e-10 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 57 | 77 | 4.85e-09 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 105 | 170 | 6.84e-09 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 84 | 132 | 5.09e-08 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 54 | 75 | 5.87e-08 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 74 | 115 | 1.73e-07 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 58 | 84 | 1.73e-07 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 80 | 127 | 1.73e-07 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 62 | 94 | 6.46e-07 |
| KEGG | KEGG:04911 | Insulin secretion | 46 | 64 | 6.93e-07 |
| KEGG | KEGG:04924 | Renin secretion | 38 | 50 | 8.73e-07 |
| KEGG | KEGG:04611 | Platelet activation | 59 | 89 | 8.73e-07 |
| KEGG | KEGG:04713 | Circadian entrainment | 48 | 69 | 1.54e-06 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 53 | 79 | 2.08e-06 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 49 | 72 | 2.86e-06 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 137 | 256 | 2.86e-06 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 101 | 179 | 4.20e-06 |
| KEGG | KEGG:04934 | Cushing syndrome | 73 | 121 | 5.55e-06 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 83 | 142 | 5.71e-06 |
| KEGG | KEGG:04725 | Cholinergic synapse | 54 | 83 | 5.71e-06 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 68 | 112 | 8.77e-06 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 35 | 48 | 1.01e-05 |
| KEGG | KEGG:04014 | Ras signaling pathway | 96 | 172 | 1.19e-05 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 46 | 69 | 1.19e-05 |
| KEGG | KEGG:04971 | Gastric acid secretion | 37 | 52 | 1.19e-05 |
| KEGG | KEGG:04520 | Adherens junction | 54 | 86 | 2.37e-05 |
| KEGG | KEGG:04970 | Salivary secretion | 38 | 55 | 2.56e-05 |
| KEGG | KEGG:00000 | KEGG root term | 2317 | 5802 | 3.51e-05 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 30 | 41 | 4.30e-05 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 65 | 110 | 4.30e-05 |
| KEGG | KEGG:04972 | Pancreatic secretion | 39 | 58 | 4.78e-05 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 76 | 134 | 5.63e-05 |
| KEGG | KEGG:04726 | Serotonergic synapse | 41 | 63 | 8.95e-05 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 49 | 79 | 8.95e-05 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 44 | 69 | 8.95e-05 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 60 | 102 | 1.03e-04 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 82 | 149 | 1.04e-04 |
| KEGG | KEGG:05032 | Morphine addiction | 37 | 56 | 1.29e-04 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 125 | 246 | 1.41e-04 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 61 | 106 | 2.05e-04 |
| KEGG | KEGG:04929 | GnRH secretion | 35 | 53 | 2.05e-04 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 60 | 104 | 2.05e-04 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 39 | 61 | 2.16e-04 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 57 | 98 | 2.24e-04 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 49 | 82 | 2.95e-04 |
| KEGG | KEGG:04148 | Efferocytosis | 69 | 125 | 3.58e-04 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 52 | 89 | 3.92e-04 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 28 | 41 | 4.66e-04 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 55 | 96 | 4.95e-04 |
| KEGG | KEGG:04530 | Tight junction | 74 | 138 | 6.48e-04 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 77 | 145 | 7.12e-04 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 132 | 271 | 7.97e-04 |
| KEGG | KEGG:04730 | Long-term depression | 28 | 42 | 7.97e-04 |
| KEGG | KEGG:05226 | Gastric cancer | 64 | 117 | 7.97e-04 |
| KEGG | KEGG:04976 | Bile secretion | 28 | 42 | 7.97e-04 |
| KEGG | KEGG:05146 | Amoebiasis | 39 | 64 | 7.97e-04 |
| KEGG | KEGG:04916 | Melanogenesis | 45 | 77 | 1.01e-03 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 44 | 75 | 1.03e-03 |
| KEGG | KEGG:05224 | Breast cancer | 63 | 117 | 1.51e-03 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 44 | 76 | 1.51e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 43 | 74 | 1.53e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 51 | 91 | 1.53e-03 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 56 | 102 | 1.56e-03 |
| KEGG | KEGG:05131 | Shigellosis | 104 | 210 | 1.56e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 89 | 176 | 1.68e-03 |
| KEGG | KEGG:04814 | Motor proteins | 77 | 149 | 1.74e-03 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 65 | 123 | 2.18e-03 |
| KEGG | KEGG:04540 | Gap junction | 42 | 73 | 2.21e-03 |
| KEGG | KEGG:05214 | Glioma | 39 | 67 | 2.49e-03 |
| KEGG | KEGG:04740 | Olfactory transduction | 18 | 25 | 2.49e-03 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 19 | 27 | 2.73e-03 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 44 | 78 | 2.78e-03 |
| KEGG | KEGG:04720 | Long-term potentiation | 33 | 55 | 2.98e-03 |
| KEGG | KEGG:05031 | Amphetamine addiction | 30 | 49 | 3.15e-03 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 30 | 49 | 3.15e-03 |
| KEGG | KEGG:01522 | Endocrine resistance | 47 | 85 | 3.15e-03 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 23 | 35 | 3.15e-03 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 51 | 94 | 3.42e-03 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 50 | 92 | 3.58e-03 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 37 | 64 | 3.58e-03 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 46 | 84 | 4.49e-03 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 41 | 74 | 6.00e-03 |
| KEGG | KEGG:04727 | GABAergic synapse | 32 | 55 | 6.55e-03 |
| KEGG | KEGG:05135 | Yersinia infection | 58 | 112 | 6.59e-03 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 30 | 51 | 6.99e-03 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 55 | 106 | 7.91e-03 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 35 | 62 | 7.99e-03 |
| KEGG | KEGG:04931 | Insulin resistance | 50 | 95 | 8.20e-03 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 45 | 84 | 8.37e-03 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 41 | 76 | 1.07e-02 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 61 | 121 | 1.08e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 64 | 128 | 1.10e-02 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 70 | 142 | 1.13e-02 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 51 | 99 | 1.26e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 15 | 22 | 1.29e-02 |
| KEGG | KEGG:00052 | Galactose metabolism | 15 | 22 | 1.29e-02 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 57 | 113 | 1.34e-02 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 53 | 104 | 1.37e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 44 | 84 | 1.47e-02 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 28 | 49 | 1.50e-02 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 57 | 114 | 1.65e-02 |
| KEGG | KEGG:05218 | Melanoma | 32 | 58 | 1.69e-02 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 66 | 135 | 1.69e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 35 | 65 | 1.91e-02 |
| KEGG | KEGG:05030 | Cocaine addiction | 21 | 35 | 1.98e-02 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 19 | 31 | 2.09e-02 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 16 | 25 | 2.18e-02 |
| KEGG | KEGG:05212 | Pancreatic cancer | 39 | 75 | 2.53e-02 |
| KEGG | KEGG:05142 | Chagas disease | 39 | 75 | 2.53e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 46 | 91 | 2.60e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 44 | 87 | 2.97e-02 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 35 | 67 | 3.24e-02 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 35 | 67 | 3.24e-02 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 17 | 28 | 3.38e-02 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 16 | 26 | 3.46e-02 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 29 | 54 | 3.55e-02 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 27 | 50 | 4.04e-02 |
| KEGG | KEGG:05219 | Bladder cancer | 21 | 37 | 4.13e-02 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 68 | 145 | 4.19e-02 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 38 | 75 | 4.25e-02 |
ESRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(fill="#7CAE00")+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
LR response genes
# LR_resgenes <- gost(query = LR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(LR_resgenes,"data/GO_KEGG_analysis/LR_resgenes.RDS")
# LRnom <- gostplot(LR_resgenes, capped = FALSE, interactive = TRUE)
# LRnom
LRnomtable <- LR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
LRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 3247 | 4830 | 2.72e-50 |
| GO:BP | GO:0048856 | anatomical structure development | 2795 | 4130 | 3.32e-44 |
| GO:BP | GO:0007275 | multicellular organism development | 2324 | 3383 | 1.10e-41 |
| GO:BP | GO:0007154 | cell communication | 2854 | 4248 | 2.21e-41 |
| GO:BP | GO:0032502 | developmental process | 2991 | 4475 | 2.69e-41 |
| GO:BP | GO:0048731 | system development | 2022 | 2903 | 2.69e-41 |
| GO:BP | GO:0023052 | signaling | 2810 | 4180 | 4.92e-41 |
| GO:BP | GO:0050896 | response to stimulus | 3737 | 5732 | 1.83e-39 |
| GO:BP | GO:0007165 | signal transduction | 2587 | 3846 | 8.24e-37 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1401 | 1951 | 1.04e-36 |
| GO:BP | GO:0051716 | cellular response to stimulus | 3243 | 4933 | 3.56e-36 |
| GO:BP | GO:0048869 | cellular developmental process | 2041 | 2988 | 4.80e-33 |
| GO:BP | GO:0030154 | cell differentiation | 2040 | 2987 | 5.44e-33 |
| GO:BP | GO:0050789 | regulation of biological process | 5035 | 8037 | 6.02e-30 |
| GO:BP | GO:0065007 | biological regulation | 5159 | 8275 | 1.19e-27 |
| GO:BP | GO:0007399 | nervous system development | 1335 | 1903 | 4.38e-27 |
| GO:BP | GO:0010646 | regulation of cell communication | 1772 | 2601 | 1.05e-26 |
| GO:BP | GO:0022008 | neurogenesis | 963 | 1327 | 1.58e-26 |
| GO:BP | GO:0050794 | regulation of cellular process | 4791 | 7651 | 2.47e-26 |
| GO:BP | GO:0008150 | biological_process | 7248 | 12051 | 7.45e-26 |
| GO:BP | GO:0023051 | regulation of signaling | 1765 | 2597 | 8.50e-26 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1327 | 1900 | 1.13e-25 |
| GO:BP | GO:0048513 | animal organ development | 1472 | 2130 | 1.24e-25 |
| GO:BP | GO:0050793 | regulation of developmental process | 1263 | 1801 | 2.04e-25 |
| GO:BP | GO:0048518 | positive regulation of biological process | 2959 | 4561 | 6.87e-25 |
| GO:BP | GO:0048468 | cell development | 1386 | 1999 | 7.34e-25 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1416 | 2052 | 4.52e-24 |
| GO:BP | GO:0048699 | generation of neurons | 834 | 1145 | 1.56e-23 |
| GO:BP | GO:0009987 | cellular process | 6915 | 11450 | 2.06e-23 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1940 | 2902 | 4.41e-23 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 2728 | 4198 | 8.22e-23 |
| GO:BP | GO:0003008 | system process | 864 | 1201 | 1.06e-21 |
| GO:BP | GO:0030182 | neuron differentiation | 785 | 1080 | 1.32e-21 |
| GO:BP | GO:0007155 | cell adhesion | 732 | 1004 | 1.36e-20 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1557 | 2307 | 3.65e-20 |
| GO:BP | GO:0031175 | neuron projection development | 592 | 794 | 4.78e-20 |
| GO:BP | GO:0048666 | neuron development | 656 | 894 | 2.05e-19 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 872 | 1227 | 2.34e-19 |
| GO:BP | GO:0030030 | cell projection organization | 894 | 1262 | 3.07e-19 |
| GO:BP | GO:0072359 | circulatory system development | 656 | 896 | 4.85e-19 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 475 | 625 | 1.27e-18 |
| GO:BP | GO:0000902 | cell morphogenesis | 567 | 764 | 2.10e-18 |
| GO:BP | GO:0048870 | cell motility | 843 | 1190 | 4.90e-18 |
| GO:BP | GO:0009888 | tissue development | 993 | 1425 | 5.07e-18 |
| GO:BP | GO:0016477 | cell migration | 770 | 1078 | 8.01e-18 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 551 | 749 | 1.73e-16 |
| GO:BP | GO:0007267 | cell-cell signaling | 815 | 1156 | 1.73e-16 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 691 | 967 | 7.07e-16 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 406 | 534 | 8.10e-16 |
| GO:BP | GO:0001568 | blood vessel development | 414 | 546 | 8.39e-16 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 969 | 1403 | 9.24e-16 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 631 | 876 | 1.25e-15 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 392 | 515 | 2.10e-15 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 402 | 530 | 2.22e-15 |
| GO:BP | GO:0065008 | regulation of biological quality | 1364 | 2039 | 3.52e-15 |
| GO:BP | GO:0001944 | vasculature development | 430 | 573 | 4.05e-15 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 520 | 710 | 6.50e-15 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 794 | 1134 | 7.14e-15 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 764 | 1088 | 9.83e-15 |
| GO:BP | GO:0040012 | regulation of locomotion | 556 | 766 | 9.85e-15 |
| GO:BP | GO:0040011 | locomotion | 615 | 858 | 1.68e-14 |
| GO:BP | GO:2000145 | regulation of cell motility | 541 | 745 | 2.26e-14 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 357 | 468 | 3.04e-14 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1383 | 2079 | 3.38e-14 |
| GO:BP | GO:0006810 | transport | 2054 | 3176 | 3.74e-14 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 868 | 1256 | 4.25e-14 |
| GO:BP | GO:0051179 | localization | 2537 | 3978 | 4.99e-14 |
| GO:BP | GO:0035295 | tube development | 593 | 827 | 5.01e-14 |
| GO:BP | GO:0016043 | cellular component organization | 3229 | 5139 | 6.49e-14 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 403 | 540 | 1.63e-13 |
| GO:BP | GO:0030334 | regulation of cell migration | 515 | 710 | 1.63e-13 |
| GO:BP | GO:0044057 | regulation of system process | 308 | 399 | 1.99e-13 |
| GO:BP | GO:0032879 | regulation of localization | 1031 | 1521 | 2.48e-13 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 708 | 1011 | 3.40e-13 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1323 | 1992 | 3.58e-13 |
| GO:BP | GO:0003013 | circulatory system process | 339 | 446 | 3.75e-13 |
| GO:BP | GO:0042221 | response to chemical | 1596 | 2436 | 3.75e-13 |
| GO:BP | GO:0035239 | tube morphogenesis | 486 | 668 | 4.12e-13 |
| GO:BP | GO:0048519 | negative regulation of biological process | 2565 | 4037 | 4.25e-13 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 294 | 380 | 4.77e-13 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 770 | 1111 | 7.74e-13 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 409 | 553 | 1.01e-12 |
| GO:BP | GO:0098657 | import into cell | 480 | 661 | 1.01e-12 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 2422 | 3804 | 1.05e-12 |
| GO:BP | GO:0030029 | actin filament-based process | 490 | 677 | 1.33e-12 |
| GO:BP | GO:0051234 | establishment of localization | 2205 | 3447 | 1.97e-12 |
| GO:BP | GO:0034330 | cell junction organization | 433 | 591 | 2.05e-12 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 473 | 653 | 3.09e-12 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 454 | 626 | 7.53e-12 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 349 | 467 | 8.41e-12 |
| GO:BP | GO:0051049 | regulation of transport | 798 | 1164 | 1.11e-11 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 875 | 1288 | 1.80e-11 |
| GO:BP | GO:0023056 | positive regulation of signaling | 877 | 1292 | 2.20e-11 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 351 | 472 | 2.20e-11 |
| GO:BP | GO:0007409 | axonogenesis | 278 | 363 | 2.20e-11 |
| GO:BP | GO:0006897 | endocytosis | 384 | 522 | 2.31e-11 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1225 | 1852 | 2.52e-11 |
| GO:BP | GO:0061564 | axon development | 304 | 402 | 2.65e-11 |
| GO:BP | GO:0048589 | developmental growth | 386 | 527 | 5.57e-11 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 474 | 662 | 6.06e-11 |
| GO:BP | GO:0098609 | cell-cell adhesion | 437 | 607 | 1.33e-10 |
| GO:BP | GO:0030001 | metal ion transport | 402 | 554 | 1.73e-10 |
| GO:BP | GO:0008015 | blood circulation | 282 | 374 | 3.46e-10 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 1062 | 1601 | 4.72e-10 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 340 | 462 | 4.93e-10 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 3312 | 5340 | 7.52e-10 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 782 | 1154 | 8.47e-10 |
| GO:BP | GO:0007507 | heart development | 374 | 515 | 8.49e-10 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 430 | 601 | 8.54e-10 |
| GO:BP | GO:0007010 | cytoskeleton organization | 822 | 1218 | 8.65e-10 |
| GO:BP | GO:0071310 | cellular response to organic substance | 916 | 1370 | 1.23e-09 |
| GO:BP | GO:0016310 | phosphorylation | 816 | 1211 | 1.70e-09 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 388 | 540 | 3.61e-09 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 624 | 909 | 4.28e-09 |
| GO:BP | GO:0061061 | muscle structure development | 400 | 559 | 4.38e-09 |
| GO:BP | GO:0006468 | protein phosphorylation | 686 | 1008 | 5.25e-09 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 312 | 425 | 5.66e-09 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 317 | 433 | 6.77e-09 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 347 | 479 | 7.51e-09 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 302 | 411 | 9.49e-09 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 824 | 1231 | 1.02e-08 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 770 | 1145 | 1.15e-08 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 499 | 716 | 1.28e-08 |
| GO:BP | GO:0001525 | angiogenesis | 292 | 397 | 1.58e-08 |
| GO:BP | GO:0070848 | response to growth factor | 408 | 576 | 2.40e-08 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1769 | 2780 | 2.61e-08 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 197 | 256 | 2.78e-08 |
| GO:BP | GO:0010033 | response to organic substance | 1193 | 1835 | 4.01e-08 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 910 | 1376 | 4.62e-08 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 81 | 92 | 4.92e-08 |
| GO:BP | GO:1903522 | regulation of blood circulation | 158 | 200 | 5.06e-08 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 361 | 506 | 6.35e-08 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 392 | 554 | 6.35e-08 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 392 | 554 | 6.35e-08 |
| GO:BP | GO:0014706 | striated muscle tissue development | 170 | 218 | 7.11e-08 |
| GO:BP | GO:0051960 | regulation of nervous system development | 264 | 358 | 7.12e-08 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 308 | 425 | 7.31e-08 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 254 | 343 | 7.38e-08 |
| GO:BP | GO:0006811 | monoatomic ion transport | 529 | 769 | 7.40e-08 |
| GO:BP | GO:0009790 | embryo development | 589 | 864 | 7.56e-08 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 439 | 628 | 8.09e-08 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 569 | 833 | 9.06e-08 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1308 | 2028 | 9.06e-08 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 253 | 342 | 9.06e-08 |
| GO:BP | GO:0140352 | export from cell | 436 | 624 | 9.94e-08 |
| GO:BP | GO:0003015 | heart process | 164 | 210 | 1.07e-07 |
| GO:BP | GO:0060047 | heart contraction | 157 | 200 | 1.21e-07 |
| GO:BP | GO:1901698 | response to nitrogen compound | 531 | 774 | 1.22e-07 |
| GO:BP | GO:0007423 | sensory organ development | 290 | 399 | 1.27e-07 |
| GO:BP | GO:0006812 | monoatomic cation transport | 454 | 653 | 1.27e-07 |
| GO:BP | GO:0060429 | epithelium development | 570 | 836 | 1.29e-07 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 473 | 683 | 1.33e-07 |
| GO:BP | GO:1901652 | response to peptide | 278 | 381 | 1.42e-07 |
| GO:BP | GO:0099536 | synaptic signaling | 367 | 518 | 1.54e-07 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 356 | 501 | 1.54e-07 |
| GO:BP | GO:0003012 | muscle system process | 250 | 339 | 1.74e-07 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1292 | 2006 | 1.81e-07 |
| GO:BP | GO:0007417 | central nervous system development | 513 | 748 | 2.36e-07 |
| GO:BP | GO:0042391 | regulation of membrane potential | 223 | 299 | 2.41e-07 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1624 | 2555 | 2.45e-07 |
| GO:BP | GO:0090257 | regulation of muscle system process | 143 | 181 | 2.71e-07 |
| GO:BP | GO:0051641 | cellular localization | 1767 | 2793 | 2.84e-07 |
| GO:BP | GO:0001501 | skeletal system development | 269 | 369 | 2.84e-07 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 360 | 509 | 2.86e-07 |
| GO:BP | GO:0046903 | secretion | 454 | 656 | 3.04e-07 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 352 | 497 | 3.26e-07 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 352 | 497 | 3.26e-07 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 227 | 306 | 3.72e-07 |
| GO:BP | GO:0008016 | regulation of heart contraction | 135 | 170 | 3.83e-07 |
| GO:BP | GO:0031032 | actomyosin structure organization | 148 | 189 | 4.24e-07 |
| GO:BP | GO:0061448 | connective tissue development | 167 | 217 | 4.69e-07 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 204 | 272 | 4.79e-07 |
| GO:BP | GO:0034329 | cell junction assembly | 255 | 349 | 4.80e-07 |
| GO:BP | GO:0001503 | ossification | 237 | 322 | 5.52e-07 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 369 | 525 | 5.55e-07 |
| GO:BP | GO:0006816 | calcium ion transport | 203 | 271 | 6.06e-07 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 274 | 379 | 7.27e-07 |
| GO:BP | GO:0009725 | response to hormone | 438 | 634 | 7.65e-07 |
| GO:BP | GO:0048729 | tissue morphogenesis | 338 | 478 | 8.26e-07 |
| GO:BP | GO:0040007 | growth | 504 | 739 | 9.63e-07 |
| GO:BP | GO:1901653 | cellular response to peptide | 211 | 284 | 9.71e-07 |
| GO:BP | GO:0048638 | regulation of developmental growth | 193 | 257 | 9.71e-07 |
| GO:BP | GO:0042592 | homeostatic process | 794 | 1204 | 1.05e-06 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 274 | 380 | 1.06e-06 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 287 | 400 | 1.08e-06 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1470 | 2311 | 1.18e-06 |
| GO:BP | GO:0032940 | secretion by cell | 402 | 579 | 1.18e-06 |
| GO:BP | GO:0050877 | nervous system process | 437 | 634 | 1.18e-06 |
| GO:BP | GO:0051216 | cartilage development | 122 | 153 | 1.19e-06 |
| GO:BP | GO:0043434 | response to peptide hormone | 237 | 324 | 1.27e-06 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 165 | 216 | 1.33e-06 |
| GO:BP | GO:0048771 | tissue remodeling | 98 | 119 | 1.36e-06 |
| GO:BP | GO:0060284 | regulation of cell development | 418 | 605 | 1.52e-06 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 259 | 358 | 1.52e-06 |
| GO:BP | GO:0010720 | positive regulation of cell development | 238 | 326 | 1.53e-06 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 839 | 1279 | 1.57e-06 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 158 | 206 | 1.58e-06 |
| GO:BP | GO:0035265 | organ growth | 107 | 132 | 1.63e-06 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 312 | 440 | 1.74e-06 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 564 | 837 | 1.76e-06 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 513 | 756 | 1.84e-06 |
| GO:BP | GO:0048880 | sensory system development | 204 | 275 | 1.84e-06 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 204 | 275 | 1.84e-06 |
| GO:BP | GO:0043010 | camera-type eye development | 178 | 236 | 1.84e-06 |
| GO:BP | GO:0001654 | eye development | 202 | 272 | 1.85e-06 |
| GO:BP | GO:0072001 | renal system development | 190 | 254 | 1.87e-06 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 397 | 573 | 1.94e-06 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 225 | 307 | 2.03e-06 |
| GO:BP | GO:0030900 | forebrain development | 215 | 292 | 2.17e-06 |
| GO:BP | GO:0007015 | actin filament organization | 273 | 381 | 2.61e-06 |
| GO:BP | GO:0150063 | visual system development | 202 | 273 | 2.93e-06 |
| GO:BP | GO:0009605 | response to external stimulus | 1073 | 1664 | 2.96e-06 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 641 | 963 | 3.25e-06 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 230 | 316 | 3.68e-06 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 179 | 239 | 3.85e-06 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 548 | 815 | 4.09e-06 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 318 | 452 | 4.23e-06 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 82 | 98 | 4.23e-06 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 231 | 318 | 4.42e-06 |
| GO:BP | GO:0065009 | regulation of molecular function | 903 | 1389 | 4.72e-06 |
| GO:BP | GO:0036211 | protein modification process | 1531 | 2423 | 5.53e-06 |
| GO:BP | GO:0023057 | negative regulation of signaling | 731 | 1111 | 6.01e-06 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 288 | 407 | 7.29e-06 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 297 | 421 | 7.36e-06 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 137 | 178 | 8.08e-06 |
| GO:BP | GO:0097485 | neuron projection guidance | 141 | 184 | 8.51e-06 |
| GO:BP | GO:0007411 | axon guidance | 141 | 184 | 8.51e-06 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 337 | 484 | 8.97e-06 |
| GO:BP | GO:0060322 | head development | 400 | 583 | 8.97e-06 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 337 | 484 | 8.97e-06 |
| GO:BP | GO:0001822 | kidney development | 183 | 247 | 9.72e-06 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 132 | 171 | 9.74e-06 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 177 | 238 | 9.77e-06 |
| GO:BP | GO:0043062 | extracellular structure organization | 177 | 238 | 9.77e-06 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 101 | 126 | 9.98e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1559 | 2474 | 1.01e-05 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 728 | 1109 | 1.04e-05 |
| GO:BP | GO:0045216 | cell-cell junction organization | 123 | 158 | 1.07e-05 |
| GO:BP | GO:0030198 | extracellular matrix organization | 176 | 237 | 1.23e-05 |
| GO:BP | GO:0060537 | muscle tissue development | 252 | 353 | 1.27e-05 |
| GO:BP | GO:0003205 | cardiac chamber development | 118 | 151 | 1.29e-05 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 86 | 105 | 1.30e-05 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 76 | 91 | 1.35e-05 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 286 | 406 | 1.43e-05 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 393 | 574 | 1.54e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 73 | 87 | 1.57e-05 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 684 | 1040 | 1.59e-05 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 130 | 169 | 1.61e-05 |
| GO:BP | GO:0030048 | actin filament-based movement | 90 | 111 | 1.64e-05 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 303 | 433 | 1.68e-05 |
| GO:BP | GO:0055085 | transmembrane transport | 652 | 989 | 1.82e-05 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 390 | 571 | 2.49e-05 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 167 | 225 | 2.50e-05 |
| GO:BP | GO:0003007 | heart morphogenesis | 165 | 222 | 2.50e-05 |
| GO:BP | GO:0008283 | cell population proliferation | 895 | 1386 | 2.70e-05 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 170 | 230 | 3.11e-05 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 187 | 256 | 3.45e-05 |
| GO:BP | GO:0090130 | tissue migration | 187 | 256 | 3.45e-05 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 78 | 95 | 3.63e-05 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 217 | 302 | 3.64e-05 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 561 | 846 | 3.99e-05 |
| GO:BP | GO:0016358 | dendrite development | 147 | 196 | 4.07e-05 |
| GO:BP | GO:0030010 | establishment of cell polarity | 105 | 134 | 4.25e-05 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 120 | 156 | 4.30e-05 |
| GO:BP | GO:0090132 | epithelium migration | 184 | 252 | 4.30e-05 |
| GO:BP | GO:0010631 | epithelial cell migration | 184 | 252 | 4.30e-05 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 287 | 411 | 4.32e-05 |
| GO:BP | GO:0032409 | regulation of transporter activity | 122 | 159 | 4.37e-05 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 560 | 845 | 4.45e-05 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 111 | 143 | 4.83e-05 |
| GO:BP | GO:0033036 | macromolecule localization | 1539 | 2453 | 4.90e-05 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 152 | 204 | 5.07e-05 |
| GO:BP | GO:0007420 | brain development | 368 | 539 | 5.15e-05 |
| GO:BP | GO:0042692 | muscle cell differentiation | 237 | 334 | 5.45e-05 |
| GO:BP | GO:0007610 | behavior | 308 | 445 | 6.05e-05 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 108 | 139 | 6.06e-05 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 229 | 322 | 6.19e-05 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 30 | 31 | 6.29e-05 |
| GO:BP | GO:0030100 | regulation of endocytosis | 155 | 209 | 6.29e-05 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 311 | 450 | 6.51e-05 |
| GO:BP | GO:0001775 | cell activation | 446 | 665 | 8.42e-05 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 115 | 150 | 9.13e-05 |
| GO:BP | GO:0045165 | cell fate commitment | 121 | 159 | 9.75e-05 |
| GO:BP | GO:0060341 | regulation of cellular localization | 539 | 815 | 9.96e-05 |
| GO:BP | GO:0031399 | regulation of protein modification process | 628 | 959 | 1.04e-04 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 106 | 137 | 1.05e-04 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 1076 | 1692 | 1.06e-04 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 95 | 121 | 1.10e-04 |
| GO:BP | GO:0050808 | synapse organization | 262 | 375 | 1.11e-04 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 72 | 88 | 1.13e-04 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 164 | 224 | 1.16e-04 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 220 | 310 | 1.21e-04 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 272 | 391 | 1.24e-04 |
| GO:BP | GO:0009611 | response to wounding | 279 | 402 | 1.25e-04 |
| GO:BP | GO:0006936 | muscle contraction | 192 | 267 | 1.27e-04 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 126 | 167 | 1.27e-04 |
| GO:BP | GO:0048588 | developmental cell growth | 144 | 194 | 1.28e-04 |
| GO:BP | GO:0001649 | osteoblast differentiation | 136 | 182 | 1.29e-04 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 134 | 179 | 1.29e-04 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 105 | 136 | 1.34e-04 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 424 | 632 | 1.35e-04 |
| GO:BP | GO:0061572 | actin filament bundle organization | 107 | 139 | 1.37e-04 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 498 | 751 | 1.46e-04 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 113 | 148 | 1.48e-04 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 87 | 110 | 1.57e-04 |
| GO:BP | GO:0048041 | focal adhesion assembly | 66 | 80 | 1.59e-04 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 183 | 254 | 1.70e-04 |
| GO:BP | GO:0051050 | positive regulation of transport | 407 | 606 | 1.76e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 91 | 116 | 1.76e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 91 | 116 | 1.76e-04 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 158 | 216 | 1.80e-04 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1343 | 2138 | 1.80e-04 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 97 | 125 | 2.04e-04 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 128 | 171 | 2.04e-04 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 469 | 706 | 2.04e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 362 | 535 | 2.06e-04 |
| GO:BP | GO:0008104 | protein localization | 1336 | 2128 | 2.21e-04 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 72 | 89 | 2.30e-04 |
| GO:BP | GO:0003231 | cardiac ventricle development | 90 | 115 | 2.32e-04 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 147 | 200 | 2.40e-04 |
| GO:BP | GO:0046849 | bone remodeling | 52 | 61 | 2.45e-04 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 474 | 715 | 2.49e-04 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 74 | 92 | 2.52e-04 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 62 | 75 | 2.61e-04 |
| GO:BP | GO:0032535 | regulation of cellular component size | 219 | 311 | 2.76e-04 |
| GO:BP | GO:0021537 | telencephalon development | 152 | 208 | 2.84e-04 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 265 | 383 | 2.89e-04 |
| GO:BP | GO:0031099 | regeneration | 112 | 148 | 3.17e-04 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 211 | 299 | 3.18e-04 |
| GO:BP | GO:0051046 | regulation of secretion | 285 | 415 | 3.39e-04 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 73 | 91 | 3.42e-04 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 196 | 276 | 3.43e-04 |
| GO:BP | GO:0060485 | mesenchyme development | 183 | 256 | 3.50e-04 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 390 | 582 | 3.59e-04 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 61 | 74 | 3.59e-04 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 253 | 365 | 3.66e-04 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 143 | 195 | 3.73e-04 |
| GO:BP | GO:0001764 | neuron migration | 105 | 138 | 3.86e-04 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 738 | 1146 | 3.91e-04 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 70 | 87 | 4.18e-04 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 152 | 209 | 4.24e-04 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 58 | 70 | 4.26e-04 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 58 | 70 | 4.26e-04 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 150 | 206 | 4.29e-04 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 72 | 90 | 4.54e-04 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 142 | 194 | 4.61e-04 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 212 | 302 | 5.04e-04 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 108 | 143 | 5.05e-04 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 277 | 404 | 5.18e-04 |
| GO:BP | GO:0048592 | eye morphogenesis | 87 | 112 | 5.18e-04 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 313 | 461 | 5.22e-04 |
| GO:BP | GO:0042330 | taxis | 188 | 265 | 5.41e-04 |
| GO:BP | GO:0006935 | chemotaxis | 188 | 265 | 5.41e-04 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 443 | 669 | 5.42e-04 |
| GO:BP | GO:0032880 | regulation of protein localization | 479 | 727 | 5.42e-04 |
| GO:BP | GO:0043412 | macromolecule modification | 1633 | 2631 | 5.46e-04 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 162 | 225 | 5.46e-04 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 143 | 196 | 5.49e-04 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 143 | 196 | 5.49e-04 |
| GO:BP | GO:0014896 | muscle hypertrophy | 62 | 76 | 5.49e-04 |
| GO:BP | GO:0003279 | cardiac septum development | 80 | 102 | 5.81e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 52 | 62 | 5.81e-04 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 182 | 256 | 5.84e-04 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 44 | 51 | 6.03e-04 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 32 | 35 | 6.52e-04 |
| GO:BP | GO:0043149 | stress fiber assembly | 75 | 95 | 6.87e-04 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 75 | 95 | 6.87e-04 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 90 | 117 | 7.10e-04 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 613 | 946 | 7.33e-04 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 132 | 180 | 7.40e-04 |
| GO:BP | GO:0050900 | leukocyte migration | 151 | 209 | 7.50e-04 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 98 | 129 | 7.69e-04 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 186 | 263 | 7.69e-04 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 270 | 395 | 8.82e-04 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 58 | 71 | 9.15e-04 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 131 | 179 | 9.22e-04 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 150 | 208 | 9.22e-04 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 194 | 276 | 9.35e-04 |
| GO:BP | GO:0033043 | regulation of organelle organization | 655 | 1016 | 9.35e-04 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 273 | 400 | 9.35e-04 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 48 | 57 | 9.44e-04 |
| GO:BP | GO:0006950 | response to stress | 1680 | 2715 | 9.44e-04 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 40 | 46 | 9.45e-04 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 76 | 97 | 9.51e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 438 | 664 | 9.82e-04 |
| GO:BP | GO:0060348 | bone development | 117 | 158 | 9.86e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 269 | 394 | 1.01e-03 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 140 | 193 | 1.02e-03 |
| GO:BP | GO:0006996 | organelle organization | 1850 | 3001 | 1.05e-03 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 71 | 90 | 1.13e-03 |
| GO:BP | GO:0002376 | immune system process | 956 | 1512 | 1.13e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 399 | 602 | 1.15e-03 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 198 | 283 | 1.17e-03 |
| GO:BP | GO:0042063 | gliogenesis | 180 | 255 | 1.17e-03 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 124 | 169 | 1.17e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 116 | 157 | 1.23e-03 |
| GO:BP | GO:0006909 | phagocytosis | 108 | 145 | 1.26e-03 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 106 | 142 | 1.26e-03 |
| GO:BP | GO:0031667 | response to nutrient levels | 252 | 368 | 1.26e-03 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 102 | 136 | 1.26e-03 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 27 | 29 | 1.27e-03 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 52 | 63 | 1.28e-03 |
| GO:BP | GO:0050807 | regulation of synapse organization | 135 | 186 | 1.28e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 52 | 63 | 1.28e-03 |
| GO:BP | GO:0033993 | response to lipid | 398 | 601 | 1.28e-03 |
| GO:BP | GO:0006835 | dicarboxylic acid transport | 52 | 63 | 1.28e-03 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 150 | 209 | 1.29e-03 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 129 | 177 | 1.36e-03 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 159 | 223 | 1.36e-03 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 83 | 108 | 1.41e-03 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 23 | 24 | 1.44e-03 |
| GO:BP | GO:0098868 | bone growth | 23 | 24 | 1.44e-03 |
| GO:BP | GO:0002063 | chondrocyte development | 23 | 24 | 1.44e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 54 | 66 | 1.45e-03 |
| GO:BP | GO:0010876 | lipid localization | 216 | 312 | 1.47e-03 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 117 | 159 | 1.48e-03 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 49 | 59 | 1.51e-03 |
| GO:BP | GO:1990138 | neuron projection extension | 109 | 147 | 1.53e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 95 | 126 | 1.54e-03 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 171 | 242 | 1.56e-03 |
| GO:BP | GO:0010817 | regulation of hormone levels | 233 | 339 | 1.58e-03 |
| GO:BP | GO:0048568 | embryonic organ development | 219 | 317 | 1.59e-03 |
| GO:BP | GO:0007517 | muscle organ development | 196 | 281 | 1.60e-03 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 41 | 48 | 1.69e-03 |
| GO:BP | GO:0051235 | maintenance of location | 183 | 261 | 1.75e-03 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 58 | 72 | 1.76e-03 |
| GO:BP | GO:0010232 | vascular transport | 58 | 72 | 1.76e-03 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 304 | 452 | 1.76e-03 |
| GO:BP | GO:0060419 | heart growth | 58 | 72 | 1.76e-03 |
| GO:BP | GO:0046620 | regulation of organ growth | 58 | 72 | 1.76e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 46 | 55 | 1.76e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 297 | 441 | 1.81e-03 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 84 | 110 | 1.82e-03 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 26 | 28 | 1.86e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 159 | 224 | 1.86e-03 |
| GO:BP | GO:0016266 | O-glycan processing | 26 | 28 | 1.86e-03 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 106 | 143 | 1.89e-03 |
| GO:BP | GO:0010743 | regulation of macrophage derived foam cell differentiation | 18 | 18 | 1.89e-03 |
| GO:BP | GO:0023061 | signal release | 230 | 335 | 1.89e-03 |
| GO:BP | GO:0060349 | bone morphogenesis | 60 | 75 | 1.89e-03 |
| GO:BP | GO:0043588 | skin development | 131 | 181 | 1.89e-03 |
| GO:BP | GO:0048864 | stem cell development | 60 | 75 | 1.89e-03 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 102 | 137 | 1.90e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 53 | 65 | 1.91e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 71 | 91 | 1.92e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 71 | 91 | 1.92e-03 |
| GO:BP | GO:0006915 | apoptotic process | 921 | 1459 | 1.95e-03 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 48 | 58 | 2.01e-03 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 48 | 58 | 2.01e-03 |
| GO:BP | GO:0055001 | muscle cell development | 123 | 169 | 2.04e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1231 | 1974 | 2.14e-03 |
| GO:BP | GO:0003416 | endochondral bone growth | 22 | 23 | 2.16e-03 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 64 | 81 | 2.16e-03 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 79 | 103 | 2.19e-03 |
| GO:BP | GO:0071396 | cellular response to lipid | 275 | 407 | 2.25e-03 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 165 | 234 | 2.31e-03 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 40 | 47 | 2.31e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1186 | 1900 | 2.34e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 87 | 115 | 2.34e-03 |
| GO:BP | GO:0001659 | temperature homeostasis | 101 | 136 | 2.35e-03 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 89 | 118 | 2.35e-03 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 91 | 121 | 2.35e-03 |
| GO:BP | GO:0051051 | negative regulation of transport | 211 | 306 | 2.36e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1221 | 1959 | 2.53e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 159 | 225 | 2.54e-03 |
| GO:BP | GO:1901342 | regulation of vasculature development | 148 | 208 | 2.55e-03 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 226 | 330 | 2.62e-03 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 155 | 219 | 2.71e-03 |
| GO:BP | GO:0006629 | lipid metabolic process | 629 | 981 | 2.72e-03 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 54 | 67 | 2.83e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 54 | 67 | 2.83e-03 |
| GO:BP | GO:0060173 | limb development | 106 | 144 | 2.84e-03 |
| GO:BP | GO:0048736 | appendage development | 106 | 144 | 2.84e-03 |
| GO:BP | GO:0010638 | positive regulation of organelle organization | 290 | 432 | 2.87e-03 |
| GO:BP | GO:0001508 | action potential | 82 | 108 | 2.88e-03 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 84 | 111 | 2.91e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 98 | 132 | 2.93e-03 |
| GO:BP | GO:0008366 | axon ensheathment | 94 | 126 | 2.94e-03 |
| GO:BP | GO:0048469 | cell maturation | 88 | 117 | 2.94e-03 |
| GO:BP | GO:0007272 | ensheathment of neurons | 94 | 126 | 2.94e-03 |
| GO:BP | GO:0008038 | neuron recognition | 31 | 35 | 2.96e-03 |
| GO:BP | GO:0040008 | regulation of growth | 328 | 493 | 2.96e-03 |
| GO:BP | GO:0071711 | basement membrane organization | 31 | 35 | 2.96e-03 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 136 | 190 | 2.99e-03 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 145 | 204 | 3.12e-03 |
| GO:BP | GO:0051653 | spindle localization | 44 | 53 | 3.24e-03 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 130 | 181 | 3.25e-03 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 130 | 181 | 3.25e-03 |
| GO:BP | GO:0006814 | sodium ion transport | 109 | 149 | 3.38e-03 |
| GO:BP | GO:0048678 | response to axon injury | 51 | 63 | 3.42e-03 |
| GO:BP | GO:0055123 | digestive system development | 75 | 98 | 3.46e-03 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 191 | 276 | 3.46e-03 |
| GO:BP | GO:0071702 | organic substance transport | 1135 | 1819 | 3.46e-03 |
| GO:BP | GO:0032868 | response to insulin | 148 | 209 | 3.51e-03 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 217 | 317 | 3.52e-03 |
| GO:BP | GO:0006869 | lipid transport | 189 | 273 | 3.58e-03 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 95 | 128 | 3.65e-03 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 120 | 166 | 3.65e-03 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 46 | 56 | 3.68e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 53 | 66 | 3.71e-03 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 192 | 278 | 3.89e-03 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 264 | 392 | 3.93e-03 |
| GO:BP | GO:0060840 | artery development | 66 | 85 | 3.99e-03 |
| GO:BP | GO:0001894 | tissue homeostasis | 125 | 174 | 4.13e-03 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 68 | 88 | 4.13e-03 |
| GO:BP | GO:0060249 | anatomical structure homeostasis | 125 | 174 | 4.13e-03 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 312 | 469 | 4.16e-03 |
| GO:BP | GO:0046683 | response to organophosphorus | 72 | 94 | 4.35e-03 |
| GO:BP | GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation | 27 | 30 | 4.37e-03 |
| GO:BP | GO:0008219 | cell death | 947 | 1509 | 4.37e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 359 | 545 | 4.52e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 59 | 75 | 4.56e-03 |
| GO:BP | GO:0021954 | central nervous system neuron development | 50 | 62 | 4.56e-03 |
| GO:BP | GO:0042552 | myelination | 92 | 124 | 4.56e-03 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 88 | 118 | 4.60e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 349 | 529 | 4.60e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 203 | 296 | 4.65e-03 |
| GO:BP | GO:0006887 | exocytosis | 175 | 252 | 4.65e-03 |
| GO:BP | GO:0021846 | cell proliferation in forebrain | 16 | 16 | 4.67e-03 |
| GO:BP | GO:0012501 | programmed cell death | 944 | 1505 | 4.86e-03 |
| GO:BP | GO:0019725 | cellular homeostasis | 389 | 594 | 4.96e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 63 | 81 | 4.96e-03 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 135 | 190 | 5.04e-03 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 65 | 84 | 5.14e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 40 | 48 | 5.23e-03 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 183 | 265 | 5.29e-03 |
| GO:BP | GO:0050921 | positive regulation of chemotaxis | 67 | 87 | 5.29e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 459 | 708 | 5.32e-03 |
| GO:BP | GO:0071695 | anatomical structure maturation | 118 | 164 | 5.37e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 69 | 90 | 5.40e-03 |
| GO:BP | GO:0030031 | cell projection assembly | 318 | 480 | 5.44e-03 |
| GO:BP | GO:0010721 | negative regulation of cell development | 138 | 195 | 5.67e-03 |
| GO:BP | GO:0007584 | response to nutrient | 87 | 117 | 5.71e-03 |
| GO:BP | GO:0021987 | cerebral cortex development | 77 | 102 | 5.71e-03 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 87 | 117 | 5.71e-03 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 77 | 102 | 5.71e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 81 | 108 | 5.74e-03 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 42 | 51 | 5.99e-03 |
| GO:BP | GO:0050890 | cognition | 161 | 231 | 6.02e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 369 | 563 | 6.31e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 64 | 83 | 6.66e-03 |
| GO:BP | GO:0030278 | regulation of ossification | 66 | 86 | 6.83e-03 |
| GO:BP | GO:0035270 | endocrine system development | 66 | 86 | 6.83e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 202 | 296 | 7.02e-03 |
| GO:BP | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 90 | 122 | 7.08e-03 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 34 | 40 | 7.15e-03 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 86 | 116 | 7.20e-03 |
| GO:BP | GO:0031623 | receptor internalization | 74 | 98 | 7.23e-03 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 122 | 171 | 7.27e-03 |
| GO:BP | GO:0014074 | response to purine-containing compound | 80 | 107 | 7.27e-03 |
| GO:BP | GO:0019915 | lipid storage | 55 | 70 | 7.40e-03 |
| GO:BP | GO:0014032 | neural crest cell development | 55 | 70 | 7.40e-03 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 46 | 57 | 7.46e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 414 | 637 | 7.59e-03 |
| GO:BP | GO:0045663 | positive regulation of myoblast differentiation | 31 | 36 | 8.08e-03 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 31 | 36 | 8.08e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 99 | 136 | 8.08e-03 |
| GO:BP | GO:0031641 | regulation of myelination | 31 | 36 | 8.08e-03 |
| GO:BP | GO:0051899 | membrane depolarization | 48 | 60 | 8.10e-03 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 114 | 159 | 8.10e-03 |
| GO:BP | GO:0000003 | reproduction | 604 | 948 | 8.15e-03 |
| GO:BP | GO:0031102 | neuron projection regeneration | 41 | 50 | 8.15e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 41 | 50 | 8.15e-03 |
| GO:BP | GO:0051640 | organelle localization | 352 | 537 | 8.20e-03 |
| GO:BP | GO:0046942 | carboxylic acid transport | 152 | 218 | 8.20e-03 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 61 | 79 | 8.25e-03 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 93 | 127 | 8.40e-03 |
| GO:BP | GO:0031103 | axon regeneration | 36 | 43 | 8.44e-03 |
| GO:BP | GO:0046777 | protein autophosphorylation | 110 | 153 | 8.45e-03 |
| GO:BP | GO:0006941 | striated muscle contraction | 110 | 153 | 8.45e-03 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 50 | 63 | 8.60e-03 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 108 | 150 | 8.66e-03 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 28 | 32 | 8.78e-03 |
| GO:BP | GO:0072073 | kidney epithelium development | 85 | 115 | 8.81e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 69 | 91 | 8.85e-03 |
| GO:BP | GO:0048863 | stem cell differentiation | 139 | 198 | 8.85e-03 |
| GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 22 | 24 | 8.97e-03 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 77 | 103 | 8.97e-03 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 22 | 24 | 8.97e-03 |
| GO:BP | GO:0006082 | organic acid metabolic process | 428 | 661 | 9.13e-03 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 25 | 28 | 9.18e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 54 | 69 | 9.51e-03 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 2802 | 4637 | 9.51e-03 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 54 | 69 | 9.51e-03 |
| GO:BP | GO:0042100 | B cell proliferation | 38 | 46 | 9.69e-03 |
| GO:BP | GO:0032787 | monocarboxylic acid metabolic process | 290 | 438 | 9.73e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 693 | 1096 | 9.74e-03 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 45 | 56 | 9.77e-03 |
| GO:BP | GO:0042246 | tissue regeneration | 45 | 56 | 9.77e-03 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 111 | 155 | 9.84e-03 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 56 | 72 | 9.84e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 58 | 75 | 1.02e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 120 | 169 | 1.02e-02 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 182 | 266 | 1.02e-02 |
| GO:BP | GO:0043436 | oxoacid metabolic process | 425 | 657 | 1.05e-02 |
| GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 60 | 78 | 1.05e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 88 | 120 | 1.05e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 118 | 166 | 1.05e-02 |
| GO:BP | GO:0021543 | pallium development | 105 | 146 | 1.06e-02 |
| GO:BP | GO:0015849 | organic acid transport | 152 | 219 | 1.08e-02 |
| GO:BP | GO:0001755 | neural crest cell migration | 40 | 49 | 1.08e-02 |
| GO:BP | GO:0051293 | establishment of spindle localization | 40 | 49 | 1.08e-02 |
| GO:BP | GO:0002027 | regulation of heart rate | 64 | 84 | 1.08e-02 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 143 | 205 | 1.09e-02 |
| GO:BP | GO:0048259 | regulation of receptor-mediated endocytosis | 66 | 87 | 1.09e-02 |
| GO:BP | GO:0006954 | inflammatory response | 302 | 458 | 1.10e-02 |
| GO:BP | GO:0048732 | gland development | 219 | 325 | 1.10e-02 |
| GO:BP | GO:0048565 | digestive tract development | 68 | 90 | 1.10e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 49 | 62 | 1.11e-02 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 74 | 99 | 1.11e-02 |
| GO:BP | GO:0051649 | establishment of localization in cell | 1033 | 1661 | 1.11e-02 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 99 | 137 | 1.13e-02 |
| GO:BP | GO:0045453 | bone resorption | 35 | 42 | 1.13e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 112 | 157 | 1.14e-02 |
| GO:BP | GO:0071378 | cellular response to growth hormone stimulus | 18 | 19 | 1.14e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 162 | 235 | 1.15e-02 |
| GO:BP | GO:0086069 | bundle of His cell to Purkinje myocyte communication | 14 | 14 | 1.15e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 121 | 171 | 1.16e-02 |
| GO:BP | GO:0098739 | import across plasma membrane | 95 | 131 | 1.18e-02 |
| GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 179 | 262 | 1.22e-02 |
| GO:BP | GO:0009306 | protein secretion | 179 | 262 | 1.22e-02 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 27 | 31 | 1.22e-02 |
| GO:BP | GO:0042060 | wound healing | 208 | 308 | 1.22e-02 |
| GO:BP | GO:1990776 | response to angiotensin | 27 | 31 | 1.22e-02 |
| GO:BP | GO:0008361 | regulation of cell size | 117 | 165 | 1.24e-02 |
| GO:BP | GO:0032835 | glomerulus development | 44 | 55 | 1.28e-02 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 37 | 45 | 1.29e-02 |
| GO:BP | GO:0045665 | negative regulation of neuron differentiation | 37 | 45 | 1.29e-02 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 37 | 45 | 1.29e-02 |
| GO:BP | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 21 | 23 | 1.30e-02 |
| GO:BP | GO:0090077 | foam cell differentiation | 21 | 23 | 1.30e-02 |
| GO:BP | GO:0010742 | macrophage derived foam cell differentiation | 21 | 23 | 1.30e-02 |
| GO:BP | GO:0060416 | response to growth hormone | 24 | 27 | 1.30e-02 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 83 | 113 | 1.30e-02 |
| GO:BP | GO:0051648 | vesicle localization | 140 | 201 | 1.31e-02 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 32 | 38 | 1.32e-02 |
| GO:BP | GO:0022414 | reproductive process | 596 | 939 | 1.34e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 264 | 398 | 1.34e-02 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 46 | 58 | 1.35e-02 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 75 | 101 | 1.36e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 244 | 366 | 1.36e-02 |
| GO:BP | GO:0045927 | positive regulation of growth | 138 | 198 | 1.36e-02 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 73 | 98 | 1.36e-02 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 69 | 92 | 1.36e-02 |
| GO:BP | GO:0043500 | muscle adaptation | 69 | 92 | 1.36e-02 |
| GO:BP | GO:0009914 | hormone transport | 152 | 220 | 1.38e-02 |
| GO:BP | GO:0097006 | regulation of plasma lipoprotein particle levels | 39 | 48 | 1.42e-02 |
| GO:BP | GO:0044255 | cellular lipid metabolic process | 473 | 738 | 1.51e-02 |
| GO:BP | GO:0006813 | potassium ion transport | 103 | 144 | 1.52e-02 |
| GO:BP | GO:0030073 | insulin secretion | 103 | 144 | 1.52e-02 |
| GO:BP | GO:0099173 | postsynapse organization | 114 | 161 | 1.52e-02 |
| GO:BP | GO:0007260 | tyrosine phosphorylation of STAT protein | 29 | 34 | 1.52e-02 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 179 | 263 | 1.54e-02 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 41 | 51 | 1.55e-02 |
| GO:BP | GO:0031016 | pancreas development | 41 | 51 | 1.55e-02 |
| GO:BP | GO:0042733 | embryonic digit morphogenesis | 41 | 51 | 1.55e-02 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 41 | 51 | 1.55e-02 |
| GO:BP | GO:0019752 | carboxylic acid metabolic process | 414 | 642 | 1.59e-02 |
| GO:BP | GO:0019222 | regulation of metabolic process | 2960 | 4914 | 1.62e-02 |
| GO:BP | GO:0060541 | respiratory system development | 119 | 169 | 1.63e-02 |
| GO:BP | GO:0016049 | cell growth | 272 | 412 | 1.67e-02 |
| GO:BP | GO:0007611 | learning or memory | 142 | 205 | 1.68e-02 |
| GO:BP | GO:0002685 | regulation of leukocyte migration | 95 | 132 | 1.68e-02 |
| GO:BP | GO:0031644 | regulation of nervous system process | 60 | 79 | 1.69e-02 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 180 | 265 | 1.69e-02 |
| GO:BP | GO:0007613 | memory | 70 | 94 | 1.69e-02 |
| GO:BP | GO:0010996 | response to auditory stimulus | 17 | 18 | 1.69e-02 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 68 | 91 | 1.69e-02 |
| GO:BP | GO:0015918 | sterol transport | 70 | 94 | 1.69e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 64 | 85 | 1.69e-02 |
| GO:BP | GO:0060396 | growth hormone receptor signaling pathway | 17 | 18 | 1.69e-02 |
| GO:BP | GO:0060402 | calcium ion transport into cytosol | 17 | 18 | 1.69e-02 |
| GO:BP | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 26 | 30 | 1.69e-02 |
| GO:BP | GO:0008037 | cell recognition | 62 | 82 | 1.69e-02 |
| GO:BP | GO:1901890 | positive regulation of cell junction assembly | 62 | 82 | 1.69e-02 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 70 | 94 | 1.69e-02 |
| GO:BP | GO:0072583 | clathrin-dependent endocytosis | 36 | 44 | 1.70e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 36 | 44 | 1.70e-02 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 115 | 163 | 1.71e-02 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 232 | 348 | 1.71e-02 |
| GO:BP | GO:0022607 | cellular component assembly | 1520 | 2481 | 1.72e-02 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 102 | 143 | 1.78e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 31 | 37 | 1.78e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 709 | 1128 | 1.78e-02 |
| GO:BP | GO:0050708 | regulation of protein secretion | 129 | 185 | 1.82e-02 |
| GO:BP | GO:0006024 | glycosaminoglycan biosynthetic process | 47 | 60 | 1.83e-02 |
| GO:BP | GO:1904407 | positive regulation of nitric oxide metabolic process | 23 | 26 | 1.83e-02 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 111 | 157 | 1.83e-02 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 23 | 26 | 1.83e-02 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 20 | 22 | 1.87e-02 |
| GO:BP | GO:0043542 | endothelial cell migration | 127 | 182 | 1.88e-02 |
| GO:BP | GO:0044272 | sulfur compound biosynthetic process | 98 | 137 | 1.88e-02 |
| GO:BP | GO:1904377 | positive regulation of protein localization to cell periphery | 49 | 63 | 1.90e-02 |
| GO:BP | GO:0046879 | hormone secretion | 148 | 215 | 1.92e-02 |
| GO:BP | GO:0042110 | T cell activation | 216 | 323 | 1.94e-02 |
| GO:BP | GO:0003170 | heart valve development | 51 | 66 | 1.96e-02 |
| GO:BP | GO:0030217 | T cell differentiation | 132 | 190 | 1.98e-02 |
| GO:BP | GO:0007369 | gastrulation | 105 | 148 | 2.01e-02 |
| GO:BP | GO:0071230 | cellular response to amino acid stimulus | 53 | 69 | 2.01e-02 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 75 | 102 | 2.01e-02 |
| GO:BP | GO:0046503 | glycerolipid catabolic process | 33 | 40 | 2.04e-02 |
| GO:BP | GO:0006631 | fatty acid metabolic process | 187 | 277 | 2.05e-02 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 333 | 512 | 2.07e-02 |
| GO:BP | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 28 | 33 | 2.07e-02 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 28 | 33 | 2.07e-02 |
| GO:BP | GO:1904645 | response to amyloid-beta | 28 | 33 | 2.07e-02 |
| GO:BP | GO:0001823 | mesonephros development | 59 | 78 | 2.08e-02 |
| GO:BP | GO:0045445 | myoblast differentiation | 67 | 90 | 2.08e-02 |
| GO:BP | GO:0051650 | establishment of vesicle localization | 128 | 184 | 2.12e-02 |
| GO:BP | GO:0007626 | locomotory behavior | 101 | 142 | 2.12e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 88 | 122 | 2.13e-02 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 88 | 122 | 2.13e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 88 | 122 | 2.13e-02 |
| GO:BP | GO:1990874 | vascular associated smooth muscle cell proliferation | 42 | 53 | 2.14e-02 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 86 | 119 | 2.18e-02 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 99 | 139 | 2.18e-02 |
| GO:BP | GO:0072006 | nephron development | 86 | 119 | 2.18e-02 |
| GO:BP | GO:0031214 | biomineral tissue development | 84 | 116 | 2.23e-02 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 84 | 116 | 2.23e-02 |
| GO:BP | GO:0045806 | negative regulation of endocytosis | 44 | 56 | 2.25e-02 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 44 | 56 | 2.25e-02 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 35 | 43 | 2.25e-02 |
| GO:BP | GO:0019229 | regulation of vasoconstriction | 35 | 43 | 2.25e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 35 | 43 | 2.25e-02 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 82 | 113 | 2.27e-02 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 181 | 268 | 2.29e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 80 | 110 | 2.32e-02 |
| GO:BP | GO:0051592 | response to calcium ion | 80 | 110 | 2.32e-02 |
| GO:BP | GO:1904385 | cellular response to angiotensin | 25 | 29 | 2.34e-02 |
| GO:BP | GO:0033555 | multicellular organismal response to stress | 46 | 59 | 2.34e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 25 | 29 | 2.34e-02 |
| GO:BP | GO:1904646 | cellular response to amyloid-beta | 25 | 29 | 2.34e-02 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 280 | 427 | 2.35e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 78 | 107 | 2.35e-02 |
| GO:BP | GO:0006470 | protein dephosphorylation | 129 | 186 | 2.36e-02 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 129 | 186 | 2.36e-02 |
| GO:BP | GO:0006023 | aminoglycan biosynthetic process | 48 | 62 | 2.40e-02 |
| GO:BP | GO:0051591 | response to cAMP | 48 | 62 | 2.40e-02 |
| GO:BP | GO:0051261 | protein depolymerization | 74 | 101 | 2.43e-02 |
| GO:BP | GO:0002064 | epithelial cell development | 111 | 158 | 2.44e-02 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 37 | 46 | 2.44e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 141 | 205 | 2.45e-02 |
| GO:BP | GO:0035264 | multicellular organism growth | 89 | 124 | 2.48e-02 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 16 | 17 | 2.50e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 52 | 68 | 2.51e-02 |
| GO:BP | GO:0019538 | protein metabolic process | 2327 | 3848 | 2.53e-02 |
| GO:BP | GO:0045124 | regulation of bone resorption | 22 | 25 | 2.56e-02 |
| GO:BP | GO:0042476 | odontogenesis | 62 | 83 | 2.56e-02 |
| GO:BP | GO:0030216 | keratinocyte differentiation | 58 | 77 | 2.56e-02 |
| GO:BP | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 22 | 25 | 2.56e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 58 | 77 | 2.56e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 58 | 77 | 2.56e-02 |
| GO:BP | GO:0030282 | bone mineralization | 64 | 86 | 2.56e-02 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 22 | 25 | 2.56e-02 |
| GO:BP | GO:0007017 | microtubule-based process | 485 | 762 | 2.57e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 39 | 49 | 2.60e-02 |
| GO:BP | GO:0015711 | organic anion transport | 185 | 275 | 2.60e-02 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 205 | 307 | 2.63e-02 |
| GO:BP | GO:0007389 | pattern specification process | 205 | 307 | 2.63e-02 |
| GO:BP | GO:0014742 | positive regulation of muscle hypertrophy | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0051043 | regulation of membrane protein ectodomain proteolysis | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0010613 | positive regulation of cardiac muscle hypertrophy | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0015740 | C4-dicarboxylate transport | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0022038 | corpus callosum development | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0044409 | symbiont entry into host | 83 | 115 | 2.64e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 94 | 132 | 2.70e-02 |
| GO:BP | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 12 | 12 | 2.71e-02 |
| GO:BP | GO:0098911 | regulation of ventricular cardiac muscle cell action potential | 12 | 12 | 2.71e-02 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 12 | 12 | 2.71e-02 |
| GO:BP | GO:0005513 | detection of calcium ion | 12 | 12 | 2.71e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 41 | 52 | 2.72e-02 |
| GO:BP | GO:1903078 | positive regulation of protein localization to plasma membrane | 41 | 52 | 2.72e-02 |
| GO:BP | GO:0002263 | cell activation involved in immune response | 112 | 160 | 2.73e-02 |
| GO:BP | GO:0050853 | B cell receptor signaling pathway | 27 | 32 | 2.77e-02 |
| GO:BP | GO:0071825 | protein-lipid complex organization | 27 | 32 | 2.77e-02 |
| GO:BP | GO:0051656 | establishment of organelle localization | 270 | 412 | 2.83e-02 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 43 | 55 | 2.85e-02 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 396 | 617 | 2.86e-02 |
| GO:BP | GO:0002682 | regulation of immune system process | 590 | 936 | 2.91e-02 |
| GO:BP | GO:0030323 | respiratory tube development | 108 | 154 | 2.94e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 88 | 123 | 2.94e-02 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 71 | 97 | 2.98e-02 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 329 | 508 | 2.98e-02 |
| GO:BP | GO:1903076 | regulation of protein localization to plasma membrane | 69 | 94 | 3.03e-02 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 49 | 64 | 3.10e-02 |
| GO:BP | GO:0046661 | male sex differentiation | 82 | 114 | 3.18e-02 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 55 | 73 | 3.18e-02 |
| GO:BP | GO:0106027 | neuron projection organization | 57 | 76 | 3.18e-02 |
| GO:BP | GO:0071675 | regulation of mononuclear cell migration | 55 | 73 | 3.18e-02 |
| GO:BP | GO:0006939 | smooth muscle contraction | 53 | 70 | 3.18e-02 |
| GO:BP | GO:0001657 | ureteric bud development | 57 | 76 | 3.18e-02 |
| GO:BP | GO:0014013 | regulation of gliogenesis | 53 | 70 | 3.18e-02 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 55 | 73 | 3.18e-02 |
| GO:BP | GO:0050850 | positive regulation of calcium-mediated signaling | 24 | 28 | 3.20e-02 |
| GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 24 | 28 | 3.20e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 29 | 35 | 3.20e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 163 | 241 | 3.23e-02 |
| GO:BP | GO:0015833 | peptide transport | 132 | 192 | 3.27e-02 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 275 | 421 | 3.31e-02 |
| GO:BP | GO:0071466 | cellular response to xenobiotic stimulus | 78 | 108 | 3.34e-02 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 109 | 156 | 3.34e-02 |
| GO:BP | GO:0030042 | actin filament depolymerization | 38 | 48 | 3.38e-02 |
| GO:BP | GO:0015031 | protein transport | 755 | 1211 | 3.49e-02 |
| GO:BP | GO:0017157 | regulation of exocytosis | 98 | 139 | 3.49e-02 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 74 | 102 | 3.50e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 87 | 122 | 3.53e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 128 | 186 | 3.55e-02 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 164 | 243 | 3.55e-02 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 40 | 51 | 3.55e-02 |
| GO:BP | GO:0002790 | peptide secretion | 121 | 175 | 3.55e-02 |
| GO:BP | GO:0001704 | formation of primary germ layer | 72 | 99 | 3.56e-02 |
| GO:BP | GO:0032878 | regulation of establishment or maintenance of cell polarity | 21 | 24 | 3.58e-02 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 21 | 24 | 3.58e-02 |
| GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 21 | 24 | 3.58e-02 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 21 | 24 | 3.58e-02 |
| GO:BP | GO:0030324 | lung development | 105 | 150 | 3.58e-02 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 85 | 119 | 3.59e-02 |
| GO:BP | GO:0050796 | regulation of insulin secretion | 85 | 119 | 3.59e-02 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 85 | 119 | 3.59e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 112 | 161 | 3.63e-02 |
| GO:BP | GO:0000271 | polysaccharide biosynthetic process | 42 | 54 | 3.65e-02 |
| GO:BP | GO:0042310 | vasoconstriction | 44 | 57 | 3.77e-02 |
| GO:BP | GO:0046209 | nitric oxide metabolic process | 44 | 57 | 3.77e-02 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 26 | 31 | 3.80e-02 |
| GO:BP | GO:0008217 | regulation of blood pressure | 81 | 113 | 3.81e-02 |
| GO:BP | GO:2000114 | regulation of establishment of cell polarity | 18 | 20 | 3.81e-02 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 101 | 144 | 3.82e-02 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 46 | 60 | 3.83e-02 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 46 | 60 | 3.83e-02 |
| GO:BP | GO:0045661 | regulation of myoblast differentiation | 46 | 60 | 3.83e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 543 | 861 | 3.87e-02 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 361 | 562 | 3.87e-02 |
| GO:BP | GO:0015800 | acidic amino acid transport | 33 | 41 | 3.87e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 48 | 63 | 3.88e-02 |
| GO:BP | GO:0007492 | endoderm development | 50 | 66 | 3.91e-02 |
| GO:BP | GO:1903034 | regulation of response to wounding | 90 | 127 | 3.91e-02 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 90 | 127 | 3.91e-02 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 218 | 330 | 3.91e-02 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 52 | 69 | 3.91e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 56 | 75 | 3.91e-02 |
| GO:BP | GO:1901879 | regulation of protein depolymerization | 56 | 75 | 3.91e-02 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 507 | 802 | 4.02e-02 |
| GO:BP | GO:0045055 | regulated exocytosis | 106 | 152 | 4.02e-02 |
| GO:BP | GO:0003002 | regionalization | 183 | 274 | 4.05e-02 |
| GO:BP | GO:0030522 | intracellular receptor signaling pathway | 183 | 274 | 4.05e-02 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 75 | 104 | 4.08e-02 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 35 | 44 | 4.12e-02 |
| GO:BP | GO:0016032 | viral process | 229 | 348 | 4.12e-02 |
| GO:BP | GO:1904375 | regulation of protein localization to cell periphery | 86 | 121 | 4.15e-02 |
| GO:BP | GO:0022612 | gland morphogenesis | 73 | 101 | 4.18e-02 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 303 | 468 | 4.18e-02 |
| GO:BP | GO:0110011 | regulation of basement membrane organization | 11 | 11 | 4.18e-02 |
| GO:BP | GO:0038180 | nerve growth factor signaling pathway | 11 | 11 | 4.18e-02 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 432 | 679 | 4.20e-02 |
| GO:BP | GO:0030072 | peptide hormone secretion | 118 | 171 | 4.21e-02 |
| GO:BP | GO:0021700 | developmental maturation | 149 | 220 | 4.22e-02 |
| GO:BP | GO:0006638 | neutral lipid metabolic process | 69 | 95 | 4.36e-02 |
| GO:BP | GO:0045184 | establishment of protein localization | 906 | 1465 | 4.36e-02 |
| GO:BP | GO:0002366 | leukocyte activation involved in immune response | 109 | 157 | 4.37e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 985 | 1597 | 4.37e-02 |
| GO:BP | GO:1902656 | calcium ion import into cytosol | 23 | 27 | 4.37e-02 |
| GO:BP | GO:1901185 | negative regulation of ERBB signaling pathway | 23 | 27 | 4.37e-02 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 23 | 27 | 4.37e-02 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 82 | 115 | 4.37e-02 |
| GO:BP | GO:0008544 | epidermis development | 147 | 217 | 4.37e-02 |
| GO:BP | GO:0050863 | regulation of T cell activation | 147 | 217 | 4.37e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 152 | 225 | 4.43e-02 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 100 | 143 | 4.43e-02 |
| GO:BP | GO:0098876 | vesicle-mediated transport to the plasma membrane | 100 | 143 | 4.43e-02 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 65 | 89 | 4.51e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 89 | 126 | 4.61e-02 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 809 | 1304 | 4.61e-02 |
| GO:BP | GO:0006809 | nitric oxide biosynthetic process | 41 | 53 | 4.63e-02 |
| GO:BP | GO:0046718 | symbiont entry into host cell | 78 | 109 | 4.63e-02 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 41 | 53 | 4.63e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 61 | 83 | 4.66e-02 |
| GO:BP | GO:1901654 | response to ketone | 105 | 151 | 4.67e-02 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 30 | 37 | 4.68e-02 |
| GO:BP | GO:0021795 | cerebral cortex cell migration | 30 | 37 | 4.68e-02 |
| GO:BP | GO:0000209 | protein polyubiquitination | 160 | 238 | 4.68e-02 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 165 | 246 | 4.71e-02 |
| GO:BP | GO:0050764 | regulation of phagocytosis | 43 | 56 | 4.71e-02 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 807 | 1301 | 4.72e-02 |
| GO:BP | GO:0051047 | positive regulation of secretion | 143 | 211 | 4.72e-02 |
| GO:BP | GO:0048675 | axon extension | 76 | 106 | 4.73e-02 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 57 | 77 | 4.75e-02 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 247 | 378 | 4.77e-02 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 148 | 219 | 4.77e-02 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 55 | 74 | 4.79e-02 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 47 | 62 | 4.81e-02 |
| GO:BP | GO:0001556 | oocyte maturation | 20 | 23 | 4.95e-02 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 20 | 23 | 4.95e-02 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 72 | 100 | 4.98e-02 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 72 | 100 | 4.98e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 101 | 145 | 5.00e-02 |
LRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04015 | Rap1 signaling pathway | 133 | 164 | 1.65e-07 |
| KEGG | KEGG:04360 | Axon guidance | 130 | 162 | 2.41e-07 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 109 | 132 | 2.41e-07 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 132 | 164 | 2.41e-07 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 122 | 151 | 2.70e-07 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 81 | 94 | 2.93e-07 |
| KEGG | KEGG:04971 | Gastric acid secretion | 49 | 52 | 3.12e-07 |
| KEGG | KEGG:00000 | KEGG root term | 3552 | 5802 | 4.02e-07 |
| KEGG | KEGG:04520 | Adherens junction | 74 | 86 | 1.04e-06 |
| KEGG | KEGG:04611 | Platelet activation | 76 | 89 | 1.24e-06 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 67 | 77 | 1.50e-06 |
| KEGG | KEGG:04014 | Ras signaling pathway | 134 | 172 | 1.51e-06 |
| KEGG | KEGG:05200 | Pathways in cancer | 290 | 408 | 1.54e-06 |
| KEGG | KEGG:04911 | Insulin secretion | 57 | 64 | 1.94e-06 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 102 | 127 | 3.04e-06 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 189 | 256 | 3.68e-06 |
| KEGG | KEGG:04510 | Focal adhesion | 136 | 177 | 3.83e-06 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 137 | 179 | 4.93e-06 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 62 | 72 | 6.44e-06 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 69 | 82 | 8.87e-06 |
| KEGG | KEGG:04970 | Salivary secretion | 49 | 55 | 1.08e-05 |
| KEGG | KEGG:04713 | Circadian entrainment | 59 | 69 | 1.80e-05 |
| KEGG | KEGG:05146 | Amoebiasis | 55 | 64 | 2.86e-05 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 43 | 48 | 3.37e-05 |
| KEGG | KEGG:04972 | Pancreatic secretion | 50 | 58 | 6.47e-05 |
| KEGG | KEGG:04924 | Renin secretion | 44 | 50 | 7.23e-05 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 177 | 246 | 8.53e-05 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 37 | 41 | 1.02e-04 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 126 | 170 | 1.64e-04 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 47 | 55 | 1.75e-04 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 57 | 69 | 1.76e-04 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 57 | 69 | 1.76e-04 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 77 | 98 | 2.20e-04 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 81 | 104 | 2.34e-04 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 51 | 61 | 2.34e-04 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 72 | 91 | 2.37e-04 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 85 | 110 | 2.37e-04 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 67 | 84 | 2.61e-04 |
| KEGG | KEGG:04148 | Efferocytosis | 95 | 125 | 2.61e-04 |
| KEGG | KEGG:04976 | Bile secretion | 37 | 42 | 2.61e-04 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 82 | 106 | 2.76e-04 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 88 | 115 | 2.96e-04 |
| KEGG | KEGG:04725 | Cholinergic synapse | 66 | 83 | 3.26e-04 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 79 | 102 | 3.32e-04 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 60 | 75 | 5.01e-04 |
| KEGG | KEGG:05135 | Yersinia infection | 85 | 112 | 6.19e-04 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 62 | 79 | 1.00e-03 |
| KEGG | KEGG:04730 | Long-term depression | 36 | 42 | 1.00e-03 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 62 | 79 | 1.00e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 126 | 176 | 1.36e-03 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 73 | 96 | 1.58e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 58 | 74 | 1.65e-03 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 66 | 86 | 1.89e-03 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 78 | 104 | 2.00e-03 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 59 | 76 | 2.17e-03 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 59 | 76 | 2.17e-03 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 110 | 153 | 2.28e-03 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 79 | 106 | 2.41e-03 |
| KEGG | KEGG:04144 | Endocytosis | 159 | 230 | 2.97e-03 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 57 | 74 | 3.55e-03 |
| KEGG | KEGG:04720 | Long-term potentiation | 44 | 55 | 3.55e-03 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 102 | 142 | 3.55e-03 |
| KEGG | KEGG:04916 | Melanogenesis | 59 | 77 | 3.56e-03 |
| KEGG | KEGG:05131 | Shigellosis | 145 | 210 | 5.13e-03 |
| KEGG | KEGG:04726 | Serotonergic synapse | 49 | 63 | 5.46e-03 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 75 | 102 | 5.76e-03 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 63 | 84 | 5.81e-03 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 59 | 78 | 5.81e-03 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 57 | 75 | 5.81e-03 |
| KEGG | KEGG:05032 | Morphine addiction | 44 | 56 | 6.25e-03 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 82 | 113 | 6.25e-03 |
| KEGG | KEGG:04934 | Cushing syndrome | 87 | 121 | 7.11e-03 |
| KEGG | KEGG:04530 | Tight junction | 98 | 138 | 7.13e-03 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 81 | 112 | 7.54e-03 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 79 | 109 | 7.64e-03 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 69 | 94 | 8.42e-03 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 95 | 134 | 8.52e-03 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 49 | 64 | 8.52e-03 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 82 | 114 | 8.59e-03 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 29 | 35 | 8.59e-03 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 100 | 142 | 8.98e-03 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 64 | 87 | 1.03e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 33 | 41 | 1.04e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 62 | 84 | 1.04e-02 |
| KEGG | KEGG:04931 | Insulin resistance | 69 | 95 | 1.19e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 67 | 92 | 1.20e-02 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 39 | 50 | 1.21e-02 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 105 | 151 | 1.26e-02 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 34 | 43 | 1.46e-02 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 38 | 49 | 1.58e-02 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 56 | 76 | 1.60e-02 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 22 | 26 | 1.63e-02 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 78 | 110 | 1.72e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 103 | 149 | 1.72e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 19 | 22 | 1.89e-02 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 57 | 78 | 1.91e-02 |
| KEGG | KEGG:04740 | Olfactory transduction | 21 | 25 | 2.27e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 69 | 97 | 2.37e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 65 | 91 | 2.52e-02 |
| KEGG | KEGG:04814 | Motor proteins | 102 | 149 | 2.63e-02 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 178 | 271 | 2.91e-02 |
| KEGG | KEGG:04668 | TNF signaling pathway | 62 | 87 | 3.10e-02 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 20 | 24 | 3.10e-02 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 29 | 37 | 3.10e-02 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 99 | 145 | 3.12e-02 |
| KEGG | KEGG:04727 | GABAergic synapse | 41 | 55 | 3.22e-02 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 37 | 49 | 3.22e-02 |
| KEGG | KEGG:05142 | Chagas disease | 54 | 75 | 3.43e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 63 | 89 | 3.53e-02 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 61 | 86 | 3.60e-02 |
| KEGG | KEGG:05215 | Prostate cancer | 61 | 86 | 3.60e-02 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 26 | 33 | 3.74e-02 |
| KEGG | KEGG:05213 | Endometrial cancer | 42 | 57 | 3.85e-02 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 83 | 121 | 4.23e-02 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 69 | 99 | 4.23e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 47 | 65 | 4.43e-02 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 41 | 56 | 4.78e-02 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 39 | 53 | 4.81e-02 |
| KEGG | KEGG:04929 | GnRH secretion | 39 | 53 | 4.81e-02 |
| KEGG | KEGG:04540 | Gap junction | 52 | 73 | 4.82e-02 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 37 | 50 | 4.82e-02 |
| KEGG | KEGG:05216 | Thyroid cancer | 27 | 35 | 4.84e-02 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 29 | 38 | 4.87e-02 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 59 | 84 | 4.90e-02 |
| KEGG | KEGG:05152 | Tuberculosis | 73 | 106 | 4.94e-02 |
LRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(fill="#00BFC4")+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
NR response genes
# NR_resgenes <- gost(query = NR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(NR_resgenes,"data/GO_KEGG_analysis/NR_resgenes.RDS")
# NRnom <- gostplot(NR_resgenes, capped = FALSE, interactive = TRUE)
# NRnom
NRnomtable <- NR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
NRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0008150 | biological_process | 10636 | 12051 | 1.10e-41 |
| GO:BP | GO:0009987 | cellular process | 10111 | 11450 | 1.41e-31 |
| GO:BP | GO:0065007 | biological regulation | 7350 | 8275 | 9.03e-17 |
| GO:BP | GO:0050789 | regulation of biological process | 7144 | 8037 | 9.57e-17 |
| GO:BP | GO:0050794 | regulation of cellular process | 6806 | 7651 | 6.38e-16 |
| GO:BP | GO:0051716 | cellular response to stimulus | 4437 | 4933 | 5.27e-15 |
| GO:BP | GO:0050896 | response to stimulus | 5133 | 5732 | 1.05e-14 |
| GO:BP | GO:0048518 | positive regulation of biological process | 4105 | 4561 | 7.79e-14 |
| GO:BP | GO:0008152 | metabolic process | 7489 | 8464 | 1.19e-12 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 3776 | 4198 | 9.06e-12 |
| GO:BP | GO:0071704 | organic substance metabolic process | 7161 | 8096 | 6.72e-11 |
| GO:BP | GO:0044238 | primary metabolic process | 6816 | 7701 | 2.56e-10 |
| GO:BP | GO:0048856 | anatomical structure development | 3708 | 4130 | 2.69e-10 |
| GO:BP | GO:0007154 | cell communication | 3811 | 4248 | 2.94e-10 |
| GO:BP | GO:0043170 | macromolecule metabolic process | 6199 | 6990 | 3.60e-10 |
| GO:BP | GO:0007275 | multicellular organism development | 3050 | 3383 | 5.43e-10 |
| GO:BP | GO:0006807 | nitrogen compound metabolic process | 6532 | 7376 | 5.43e-10 |
| GO:BP | GO:0023052 | signaling | 3749 | 4180 | 6.27e-10 |
| GO:BP | GO:0007165 | signal transduction | 3456 | 3846 | 6.49e-10 |
| GO:BP | GO:0032501 | multicellular organismal process | 4317 | 4830 | 7.11e-10 |
| GO:BP | GO:0044237 | cellular metabolic process | 6673 | 7545 | 2.76e-09 |
| GO:BP | GO:0032502 | developmental process | 4001 | 4475 | 5.92e-09 |
| GO:BP | GO:0016043 | cellular component organization | 4579 | 5139 | 1.11e-08 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1778 | 1951 | 1.73e-08 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 2312 | 2555 | 1.86e-08 |
| GO:BP | GO:0048731 | system development | 2618 | 2903 | 2.49e-08 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 1158 | 1256 | 3.76e-08 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 4749 | 5340 | 5.69e-08 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 3813 | 4269 | 8.10e-08 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 3406 | 3804 | 8.10e-08 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 1006 | 1088 | 1.00e-07 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 2506 | 2780 | 1.00e-07 |
| GO:BP | GO:0019222 | regulation of metabolic process | 4375 | 4914 | 1.18e-07 |
| GO:BP | GO:0042221 | response to chemical | 2202 | 2436 | 1.34e-07 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 4026 | 4515 | 1.38e-07 |
| GO:BP | GO:0048869 | cellular developmental process | 2688 | 2988 | 1.38e-07 |
| GO:BP | GO:0030154 | cell differentiation | 2687 | 2987 | 1.39e-07 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 3724 | 4170 | 1.53e-07 |
| GO:BP | GO:0051179 | localization | 3554 | 3978 | 3.06e-07 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1726 | 1900 | 3.36e-07 |
| GO:BP | GO:0048468 | cell development | 1813 | 1999 | 4.40e-07 |
| GO:BP | GO:0010646 | regulation of cell communication | 2344 | 2601 | 4.81e-07 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 1054 | 1145 | 5.29e-07 |
| GO:BP | GO:0072359 | circulatory system development | 831 | 896 | 5.36e-07 |
| GO:BP | GO:0023051 | regulation of signaling | 2340 | 2597 | 5.36e-07 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 2088 | 2311 | 5.36e-07 |
| GO:BP | GO:0006996 | organelle organization | 2695 | 3001 | 6.08e-07 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 5215 | 5886 | 6.62e-07 |
| GO:BP | GO:0051234 | establishment of localization | 3086 | 3447 | 6.89e-07 |
| GO:BP | GO:0006810 | transport | 2848 | 3176 | 7.44e-07 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 5164 | 5828 | 7.45e-07 |
| GO:BP | GO:0009888 | tissue development | 1302 | 1425 | 1.02e-06 |
| GO:BP | GO:0050793 | regulation of developmental process | 1635 | 1801 | 1.29e-06 |
| GO:BP | GO:0009058 | biosynthetic process | 5248 | 5927 | 1.32e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 2229 | 2474 | 1.35e-06 |
| GO:BP | GO:0048513 | animal organ development | 1925 | 2130 | 1.77e-06 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 4022 | 4521 | 1.93e-06 |
| GO:BP | GO:0048519 | negative regulation of biological process | 3599 | 4037 | 2.00e-06 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 4122 | 4637 | 2.75e-06 |
| GO:BP | GO:0010033 | response to organic substance | 1663 | 1835 | 3.05e-06 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 4573 | 5155 | 3.17e-06 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1452 | 1597 | 3.34e-06 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 810 | 876 | 3.34e-06 |
| GO:BP | GO:0009966 | regulation of signal transduction | 2079 | 2307 | 3.73e-06 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 3323 | 3724 | 3.73e-06 |
| GO:BP | GO:0022008 | neurogenesis | 1212 | 1327 | 3.85e-06 |
| GO:BP | GO:0019538 | protein metabolic process | 3431 | 3848 | 4.26e-06 |
| GO:BP | GO:0009725 | response to hormone | 592 | 634 | 4.67e-06 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 2601 | 2902 | 5.86e-06 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1676 | 1852 | 6.46e-06 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 695 | 749 | 6.46e-06 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1876 | 2079 | 7.63e-06 |
| GO:BP | GO:0007010 | cytoskeleton organization | 1113 | 1218 | 1.08e-05 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 3421 | 3841 | 1.35e-05 |
| GO:BP | GO:0010468 | regulation of gene expression | 3221 | 3613 | 1.59e-05 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 3323 | 3730 | 1.76e-05 |
| GO:BP | GO:0071702 | organic substance transport | 1644 | 1819 | 2.07e-05 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 2761 | 3089 | 2.16e-05 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1715 | 1900 | 2.50e-05 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 3396 | 3815 | 2.53e-05 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 768 | 833 | 2.65e-05 |
| GO:BP | GO:0071310 | cellular response to organic substance | 1246 | 1370 | 2.65e-05 |
| GO:BP | GO:0043412 | macromolecule modification | 2358 | 2631 | 2.93e-05 |
| GO:BP | GO:0036211 | protein modification process | 2175 | 2423 | 3.10e-05 |
| GO:BP | GO:0051641 | cellular localization | 2500 | 2793 | 3.13e-05 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 425 | 452 | 3.29e-05 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 443 | 472 | 3.58e-05 |
| GO:BP | GO:0035295 | tube development | 762 | 827 | 3.66e-05 |
| GO:BP | GO:0051649 | establishment of localization in cell | 1502 | 1661 | 5.05e-05 |
| GO:BP | GO:0022402 | cell cycle process | 985 | 1078 | 5.71e-05 |
| GO:BP | GO:0033036 | macromolecule localization | 2199 | 2453 | 6.74e-05 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 586 | 632 | 8.48e-05 |
| GO:BP | GO:0010467 | gene expression | 4214 | 4758 | 9.17e-05 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 661 | 716 | 1.01e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 1296 | 1430 | 1.01e-04 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1845 | 2052 | 1.01e-04 |
| GO:BP | GO:0030029 | actin filament-based process | 626 | 677 | 1.03e-04 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 2539 | 2842 | 1.04e-04 |
| GO:BP | GO:0048699 | generation of neurons | 1043 | 1145 | 1.16e-04 |
| GO:BP | GO:0007399 | nervous system development | 1713 | 1903 | 1.27e-04 |
| GO:BP | GO:0006915 | apoptotic process | 1321 | 1459 | 1.27e-04 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1775 | 1974 | 1.55e-04 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 265 | 278 | 1.59e-04 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 432 | 462 | 1.62e-04 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 1032 | 1134 | 2.01e-04 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1790 | 1992 | 2.05e-04 |
| GO:BP | GO:0008283 | cell population proliferation | 1255 | 1386 | 2.25e-04 |
| GO:BP | GO:0034641 | cellular nitrogen compound metabolic process | 4396 | 4972 | 2.49e-04 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 1168 | 1288 | 2.49e-04 |
| GO:BP | GO:1901698 | response to nitrogen compound | 711 | 774 | 2.76e-04 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1760 | 1959 | 2.77e-04 |
| GO:BP | GO:0001944 | vasculature development | 531 | 573 | 2.96e-04 |
| GO:BP | GO:0023056 | positive regulation of signaling | 1171 | 1292 | 3.05e-04 |
| GO:BP | GO:0060429 | epithelium development | 766 | 836 | 3.14e-04 |
| GO:BP | GO:0030182 | neuron differentiation | 983 | 1080 | 3.14e-04 |
| GO:BP | GO:0007049 | cell cycle | 1372 | 1520 | 3.81e-04 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 1048 | 1154 | 4.16e-04 |
| GO:BP | GO:0012501 | programmed cell death | 1358 | 1505 | 5.09e-04 |
| GO:BP | GO:0007507 | heart development | 478 | 515 | 5.37e-04 |
| GO:BP | GO:0035239 | tube morphogenesis | 615 | 668 | 5.64e-04 |
| GO:BP | GO:0008219 | cell death | 1361 | 1509 | 6.15e-04 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 1847 | 2061 | 6.67e-04 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 4066 | 4599 | 8.15e-04 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1914 | 2138 | 8.19e-04 |
| GO:BP | GO:0003008 | system process | 1088 | 1201 | 8.19e-04 |
| GO:BP | GO:0009790 | embryo development | 789 | 864 | 8.20e-04 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 1179 | 1304 | 8.47e-04 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 2785 | 3132 | 8.83e-04 |
| GO:BP | GO:0001568 | blood vessel development | 505 | 546 | 8.83e-04 |
| GO:BP | GO:0048870 | cell motility | 1078 | 1190 | 8.83e-04 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 2784 | 3131 | 9.05e-04 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 2727 | 3066 | 9.32e-04 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 1176 | 1301 | 9.37e-04 |
| GO:BP | GO:0032879 | regulation of localization | 1370 | 1521 | 1.04e-03 |
| GO:BP | GO:0008104 | protein localization | 1904 | 2128 | 1.13e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 1568 | 1746 | 1.14e-03 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 1110 | 1227 | 1.15e-03 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 3576 | 4039 | 1.16e-03 |
| GO:BP | GO:0016477 | cell migration | 978 | 1078 | 1.19e-03 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 1522 | 1694 | 1.19e-03 |
| GO:BP | GO:0007267 | cell-cell signaling | 1047 | 1156 | 1.19e-03 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 1440 | 1601 | 1.19e-03 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 4218 | 4776 | 1.19e-03 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 1115 | 1233 | 1.25e-03 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 2876 | 3238 | 1.26e-03 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 574 | 624 | 1.30e-03 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 1028 | 1135 | 1.39e-03 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 1241 | 1376 | 1.41e-03 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 2296 | 2576 | 1.43e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 744 | 815 | 1.45e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 297 | 316 | 1.51e-03 |
| GO:BP | GO:0030030 | cell projection organization | 1140 | 1262 | 1.55e-03 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 2307 | 2589 | 1.56e-03 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 227 | 239 | 1.56e-03 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 553 | 601 | 1.61e-03 |
| GO:BP | GO:0006351 | DNA-templated transcription | 2389 | 2683 | 1.70e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 1867 | 2088 | 1.77e-03 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 3959 | 4481 | 1.77e-03 |
| GO:BP | GO:0043434 | response to peptide hormone | 304 | 324 | 1.78e-03 |
| GO:BP | GO:0010035 | response to inorganic substance | 368 | 395 | 1.88e-03 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 4079 | 4620 | 2.21e-03 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 1553 | 1732 | 2.44e-03 |
| GO:BP | GO:0000278 | mitotic cell cycle | 732 | 803 | 2.63e-03 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 2410 | 2709 | 2.67e-03 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 510 | 554 | 2.78e-03 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 1563 | 1744 | 2.85e-03 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 467 | 506 | 2.85e-03 |
| GO:BP | GO:0007423 | sensory organ development | 371 | 399 | 2.85e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 432 | 467 | 2.93e-03 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 877 | 967 | 3.21e-03 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 208 | 219 | 3.21e-03 |
| GO:BP | GO:0071705 | nitrogen compound transport | 1382 | 1539 | 3.35e-03 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 930 | 1027 | 3.35e-03 |
| GO:BP | GO:1901653 | cellular response to peptide | 267 | 284 | 3.35e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 991 | 1096 | 3.41e-03 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 1262 | 1403 | 3.49e-03 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 621 | 679 | 3.49e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 2003 | 2246 | 3.56e-03 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 685 | 751 | 3.56e-03 |
| GO:BP | GO:0070848 | response to growth factor | 529 | 576 | 3.78e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 1516 | 1692 | 4.03e-03 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 101 | 103 | 4.06e-03 |
| GO:BP | GO:0007155 | cell adhesion | 909 | 1004 | 4.18e-03 |
| GO:BP | GO:0002520 | immune system development | 139 | 144 | 4.18e-03 |
| GO:BP | GO:1901652 | response to peptide | 354 | 381 | 4.70e-03 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 937 | 1036 | 4.74e-03 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 353 | 380 | 5.00e-03 |
| GO:BP | GO:0007017 | microtubule-based process | 694 | 762 | 5.01e-03 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 280 | 299 | 5.03e-03 |
| GO:BP | GO:0033043 | regulation of organelle organization | 919 | 1016 | 5.28e-03 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 352 | 379 | 5.28e-03 |
| GO:BP | GO:0042592 | homeostatic process | 1085 | 1204 | 5.51e-03 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 333 | 358 | 5.70e-03 |
| GO:BP | GO:0015031 | protein transport | 1091 | 1211 | 5.84e-03 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 259 | 276 | 5.84e-03 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 123 | 127 | 6.13e-03 |
| GO:BP | GO:0048880 | sensory system development | 258 | 275 | 6.29e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 486 | 529 | 6.35e-03 |
| GO:BP | GO:0016070 | RNA metabolic process | 3174 | 3588 | 6.40e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 145 | 151 | 6.97e-03 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 647 | 710 | 6.97e-03 |
| GO:BP | GO:0033993 | response to lipid | 550 | 601 | 7.03e-03 |
| GO:BP | GO:0032880 | regulation of protein localization | 662 | 727 | 7.19e-03 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 177 | 186 | 7.19e-03 |
| GO:BP | GO:0150063 | visual system development | 256 | 273 | 7.19e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 1017 | 1128 | 7.27e-03 |
| GO:BP | GO:0048666 | neuron development | 810 | 894 | 7.48e-03 |
| GO:BP | GO:0001654 | eye development | 255 | 272 | 7.65e-03 |
| GO:BP | GO:0048729 | tissue morphogenesis | 440 | 478 | 7.80e-03 |
| GO:BP | GO:0010608 | post-transcriptional regulation of gene expression | 440 | 478 | 7.80e-03 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 571 | 625 | 8.20e-03 |
| GO:BP | GO:0046907 | intracellular transport | 1111 | 1235 | 8.30e-03 |
| GO:BP | GO:0007015 | actin filament organization | 353 | 381 | 8.36e-03 |
| GO:BP | GO:0045184 | establishment of protein localization | 1313 | 1465 | 1.02e-02 |
| GO:BP | GO:0002200 | somatic diversification of immune receptors | 61 | 61 | 1.02e-02 |
| GO:BP | GO:0000902 | cell morphogenesis | 694 | 764 | 1.02e-02 |
| GO:BP | GO:0001525 | angiogenesis | 367 | 397 | 1.04e-02 |
| GO:BP | GO:0043010 | camera-type eye development | 222 | 236 | 1.07e-02 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 532 | 582 | 1.16e-02 |
| GO:BP | GO:0060485 | mesenchyme development | 240 | 256 | 1.16e-02 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 365 | 395 | 1.17e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 499 | 545 | 1.17e-02 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 399 | 433 | 1.18e-02 |
| GO:BP | GO:0051726 | regulation of cell cycle | 845 | 935 | 1.19e-02 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 912 | 1011 | 1.28e-02 |
| GO:BP | GO:0051049 | regulation of transport | 1047 | 1164 | 1.29e-02 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 90 | 92 | 1.29e-02 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 1031 | 1146 | 1.34e-02 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 405 | 440 | 1.35e-02 |
| GO:BP | GO:0003007 | heart morphogenesis | 209 | 222 | 1.35e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 362 | 392 | 1.38e-02 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 379 | 411 | 1.39e-02 |
| GO:BP | GO:0031032 | actomyosin structure organization | 179 | 189 | 1.39e-02 |
| GO:BP | GO:0061061 | muscle structure development | 511 | 559 | 1.44e-02 |
| GO:BP | GO:0032868 | response to insulin | 197 | 209 | 1.62e-02 |
| GO:BP | GO:0051640 | organelle localization | 491 | 537 | 1.77e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 759 | 839 | 1.77e-02 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 87 | 89 | 1.78e-02 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 391 | 425 | 1.86e-02 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 570 | 626 | 1.89e-02 |
| GO:BP | GO:1903311 | regulation of mRNA metabolic process | 242 | 259 | 1.91e-02 |
| GO:BP | GO:0034504 | protein localization to nucleus | 260 | 279 | 1.94e-02 |
| GO:BP | GO:0050877 | nervous system process | 577 | 634 | 1.96e-02 |
| GO:BP | GO:0006468 | protein phosphorylation | 908 | 1008 | 1.98e-02 |
| GO:BP | GO:0040007 | growth | 670 | 739 | 2.07e-02 |
| GO:BP | GO:0032940 | secretion by cell | 528 | 579 | 2.07e-02 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 372 | 404 | 2.07e-02 |
| GO:BP | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 55 | 55 | 2.09e-02 |
| GO:BP | GO:0016444 | somatic cell DNA recombination | 55 | 55 | 2.09e-02 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 936 | 1040 | 2.12e-02 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 503 | 551 | 2.13e-02 |
| GO:BP | GO:0048285 | organelle fission | 362 | 393 | 2.25e-02 |
| GO:BP | GO:0046903 | secretion | 596 | 656 | 2.42e-02 |
| GO:BP | GO:0048534 | hematopoietic or lymphoid organ development | 70 | 71 | 2.46e-02 |
| GO:BP | GO:0051301 | cell division | 516 | 566 | 2.49e-02 |
| GO:BP | GO:0042692 | muscle cell differentiation | 309 | 334 | 2.49e-02 |
| GO:BP | GO:0031099 | regeneration | 141 | 148 | 2.50e-02 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 210 | 224 | 2.50e-02 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 579 | 637 | 2.53e-02 |
| GO:BP | GO:0072001 | renal system development | 237 | 254 | 2.63e-02 |
| GO:BP | GO:0034248 | regulation of amide metabolic process | 359 | 390 | 2.65e-02 |
| GO:BP | GO:0016445 | somatic diversification of immunoglobulins | 53 | 53 | 2.65e-02 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 867 | 963 | 2.98e-02 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 520 | 571 | 3.01e-02 |
| GO:BP | GO:0006310 | DNA recombination | 244 | 262 | 3.02e-02 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 253 | 272 | 3.02e-02 |
| GO:BP | GO:0006282 | regulation of DNA repair | 188 | 200 | 3.13e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 339 | 368 | 3.16e-02 |
| GO:BP | GO:0040011 | locomotion | 774 | 858 | 3.23e-02 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 438 | 479 | 3.23e-02 |
| GO:BP | GO:0065008 | regulation of biological quality | 1812 | 2039 | 3.30e-02 |
| GO:BP | GO:0080135 | regulation of cellular response to stress | 429 | 469 | 3.36e-02 |
| GO:BP | GO:0023057 | negative regulation of signaling | 997 | 1111 | 3.43e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 404 | 441 | 3.43e-02 |
| GO:BP | GO:0016310 | phosphorylation | 1085 | 1211 | 3.44e-02 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 412 | 450 | 3.44e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 196 | 209 | 3.44e-02 |
| GO:BP | GO:0006950 | response to stress | 2403 | 2715 | 3.44e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 157 | 166 | 3.51e-02 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1802 | 2028 | 3.51e-02 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 104 | 108 | 3.59e-02 |
| GO:BP | GO:0045739 | positive regulation of DNA repair | 115 | 120 | 3.64e-02 |
| GO:BP | GO:0009611 | response to wounding | 369 | 402 | 3.75e-02 |
| GO:BP | GO:0033365 | protein localization to organelle | 777 | 862 | 3.77e-02 |
| GO:BP | GO:0061013 | regulation of mRNA catabolic process | 156 | 165 | 3.77e-02 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 352 | 383 | 3.80e-02 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 600 | 662 | 3.89e-02 |
| GO:BP | GO:0040012 | regulation of locomotion | 692 | 766 | 3.97e-02 |
| GO:BP | GO:0006417 | regulation of translation | 309 | 335 | 3.97e-02 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 521 | 573 | 3.98e-02 |
| GO:BP | GO:0006886 | intracellular protein transport | 560 | 617 | 4.04e-02 |
| GO:BP | GO:0001822 | kidney development | 230 | 247 | 4.04e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 367 | 400 | 4.11e-02 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 1144 | 1279 | 4.21e-02 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 247 | 266 | 4.26e-02 |
| GO:BP | GO:1901566 | organonitrogen compound biosynthetic process | 1295 | 1451 | 4.35e-02 |
| GO:BP | GO:0140352 | export from cell | 566 | 624 | 4.35e-02 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 996 | 1111 | 4.39e-02 |
| GO:BP | GO:0051276 | chromosome organization | 487 | 535 | 4.39e-02 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 255 | 275 | 4.45e-02 |
| GO:BP | GO:0030334 | regulation of cell migration | 642 | 710 | 4.58e-02 |
| GO:BP | GO:0060284 | regulation of cell development | 549 | 605 | 4.58e-02 |
| GO:BP | GO:0016447 | somatic recombination of immunoglobulin gene segments | 48 | 48 | 4.68e-02 |
| GO:BP | GO:0030042 | actin filament depolymerization | 48 | 48 | 4.68e-02 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 994 | 1109 | 4.68e-02 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 618 | 683 | 4.72e-02 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 421 | 461 | 4.76e-02 |
| GO:BP | GO:0048144 | fibroblast proliferation | 89 | 92 | 4.78e-02 |
| GO:BP | GO:0051046 | regulation of secretion | 380 | 415 | 4.82e-02 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 262 | 283 | 4.88e-02 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1781 | 2006 | 4.89e-02 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 63 | 64 | 4.97e-02 |
| GO:BP | GO:0051783 | regulation of nuclear division | 111 | 116 | 4.97e-02 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 1780 | 2005 | 4.99e-02 |
NRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:00000 | KEGG root term | 5180 | 5802 | 8.18e-13 |
| KEGG | KEGG:05200 | Pathways in cancer | 381 | 408 | 1.38e-03 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 241 | 256 | 8.73e-03 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 143 | 149 | 1.10e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 117 | 121 | 1.21e-02 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 73 | 74 | 1.78e-02 |
| KEGG | KEGG:04115 | p53 signaling pathway | 65 | 66 | 3.81e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 155 | 164 | 3.81e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 89 | 92 | 4.15e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 119 | 125 | 4.66e-02 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 98 | 102 | 4.66e-02 |
NRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(fill="purple")+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")
Peaks within 20,000 bps of assigned nearest expressed gene, GO and KEGG enrichment
exp_neargene_table <- read_delim("data/n45_bedfiles/exp_neargene_table.tsv",
delim = "\t", escape_double = FALSE,
trim_ws = TRUE)
# col_ng_peak <- exp_neargene_table %>%
# group_by(chr, start, end, peakid) %>%
# summarise(NCBI_gene = paste(unique(ENTREZID),collapse=","),
# ensembl_ID= paste(unique(ensembl_id),collapse = ","),
# SYMBOL= paste(unique(SYMBOL),collapse = ",") ,
# dist_to_NG =min(dist_to_NG)) %>%
# ungroup()
# write.csv(col_ng_peak, "data/Collapsed_expressed_NG_peak_table.csv")
# col_ng_peak <- read.csv("data/Collapsed_expressed_NG_peak_table.csv", row.names = 1)
EAR_peak_list_20k <- exp_neargene_table %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::filter(peakid %in% EAR_df$id)
ESR_peak_list_20k <- exp_neargene_table %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::filter(peakid %in% ESR_df$id)
LR_peak_list_20k <- exp_neargene_table %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::filter(peakid %in% LR_df$id)
NR_peak_list_20k <- exp_neargene_table %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::filter(peakid %in% NR_df$id) EAR 20,000 bp NG
# EAR_resgenes_20k <- gost(query = EAR_peak_list_20k$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(EAR_resgenes_20k,"data/GO_KEGG_analysis/EAR_resgenes_20k.RDS")
# EARnom <- gostplot(EAR_resgenes_20k, capped = FALSE, interactive = TRUE)
# EARnom
EARnomtable_20k <- EAR_resgenes_20k$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
EARnomtable_20k %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in EAR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 700 | 1951 | 1.00e-22 |
| GO:BP | GO:0048856 | anatomical structure development | 1307 | 4130 | 1.05e-20 |
| GO:BP | GO:0032502 | developmental process | 1397 | 4475 | 3.46e-20 |
| GO:BP | GO:0050789 | regulation of biological process | 2316 | 8037 | 4.82e-19 |
| GO:BP | GO:0032501 | multicellular organismal process | 1481 | 4830 | 2.13e-18 |
| GO:BP | GO:0007275 | multicellular organism development | 1086 | 3383 | 2.22e-18 |
| GO:BP | GO:0065007 | biological regulation | 2368 | 8275 | 5.07e-18 |
| GO:BP | GO:0048731 | system development | 948 | 2903 | 7.37e-18 |
| GO:BP | GO:0048869 | cellular developmental process | 972 | 2988 | 7.37e-18 |
| GO:BP | GO:0030154 | cell differentiation | 971 | 2987 | 8.69e-18 |
| GO:BP | GO:0050793 | regulation of developmental process | 629 | 1801 | 1.56e-17 |
| GO:BP | GO:0050794 | regulation of cellular process | 2207 | 7651 | 1.56e-17 |
| GO:BP | GO:0023052 | signaling | 1286 | 4180 | 1.48e-15 |
| GO:BP | GO:0007154 | cell communication | 1304 | 4248 | 1.60e-15 |
| GO:BP | GO:0007165 | signal transduction | 1187 | 3846 | 2.60e-14 |
| GO:BP | GO:0072359 | circulatory system development | 340 | 896 | 5.96e-14 |
| GO:BP | GO:0022008 | neurogenesis | 469 | 1327 | 2.04e-13 |
| GO:BP | GO:0048699 | generation of neurons | 414 | 1145 | 2.21e-13 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 680 | 2052 | 2.72e-13 |
| GO:BP | GO:0050896 | response to stimulus | 1681 | 5732 | 4.74e-13 |
| GO:BP | GO:0051716 | cellular response to stimulus | 1468 | 4933 | 8.85e-13 |
| GO:BP | GO:0048468 | cell development | 658 | 1999 | 4.15e-12 |
| GO:BP | GO:0016477 | cell migration | 387 | 1078 | 6.39e-12 |
| GO:BP | GO:0030182 | neuron differentiation | 387 | 1080 | 8.42e-12 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1360 | 4561 | 1.23e-11 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1219 | 4037 | 1.28e-11 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1153 | 3804 | 3.19e-11 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1257 | 4198 | 6.45e-11 |
| GO:BP | GO:0048513 | animal organ development | 687 | 2130 | 8.28e-11 |
| GO:BP | GO:0048870 | cell motility | 415 | 1190 | 8.28e-11 |
| GO:BP | GO:0007399 | nervous system development | 621 | 1903 | 1.41e-10 |
| GO:BP | GO:0009987 | cellular process | 3085 | 11450 | 1.91e-10 |
| GO:BP | GO:0008150 | biological_process | 3221 | 12051 | 3.84e-10 |
| GO:BP | GO:2000145 | regulation of cell motility | 277 | 745 | 3.89e-10 |
| GO:BP | GO:0035556 | intracellular signal transduction | 668 | 2079 | 3.89e-10 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 474 | 1403 | 3.89e-10 |
| GO:BP | GO:0030334 | regulation of cell migration | 266 | 710 | 4.10e-10 |
| GO:BP | GO:0048666 | neuron development | 322 | 894 | 5.18e-10 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 642 | 1992 | 5.84e-10 |
| GO:BP | GO:0030029 | actin filament-based process | 255 | 677 | 5.84e-10 |
| GO:BP | GO:0040012 | regulation of locomotion | 282 | 766 | 7.83e-10 |
| GO:BP | GO:0031175 | neuron projection development | 289 | 794 | 1.83e-09 |
| GO:BP | GO:0010646 | regulation of cell communication | 809 | 2601 | 1.98e-09 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 158 | 380 | 1.98e-09 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 209 | 540 | 3.16e-09 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 213 | 553 | 3.33e-09 |
| GO:BP | GO:0040011 | locomotion | 307 | 858 | 3.53e-09 |
| GO:BP | GO:0000902 | cell morphogenesis | 278 | 764 | 4.29e-09 |
| GO:BP | GO:0034330 | cell junction organization | 224 | 591 | 5.61e-09 |
| GO:BP | GO:0023051 | regulation of signaling | 804 | 2597 | 6.27e-09 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 243 | 653 | 6.47e-09 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 260 | 710 | 8.76e-09 |
| GO:BP | GO:0007507 | heart development | 199 | 515 | 9.98e-09 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 337 | 967 | 1.19e-08 |
| GO:BP | GO:0007155 | cell adhesion | 347 | 1004 | 1.87e-08 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 308 | 876 | 2.71e-08 |
| GO:BP | GO:0003008 | system process | 403 | 1201 | 4.24e-08 |
| GO:BP | GO:0009966 | regulation of signal transduction | 717 | 2307 | 4.42e-08 |
| GO:BP | GO:0009888 | tissue development | 467 | 1425 | 5.83e-08 |
| GO:BP | GO:0065008 | regulation of biological quality | 641 | 2039 | 6.23e-08 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 368 | 1088 | 9.07e-08 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 381 | 1134 | 1.09e-07 |
| GO:BP | GO:0009790 | embryo development | 301 | 864 | 1.23e-07 |
| GO:BP | GO:0035239 | tube morphogenesis | 241 | 668 | 1.92e-07 |
| GO:BP | GO:0007423 | sensory organ development | 157 | 399 | 2.08e-07 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 343 | 1011 | 2.35e-07 |
| GO:BP | GO:0016043 | cellular component organization | 1474 | 5139 | 2.52e-07 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1525 | 5340 | 3.88e-07 |
| GO:BP | GO:0035295 | tube development | 287 | 827 | 4.51e-07 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 218 | 601 | 6.69e-07 |
| GO:BP | GO:0001568 | blood vessel development | 201 | 546 | 6.99e-07 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 403 | 1227 | 7.03e-07 |
| GO:BP | GO:0030030 | cell projection organization | 413 | 1262 | 7.18e-07 |
| GO:BP | GO:0070848 | response to growth factor | 210 | 576 | 7.59e-07 |
| GO:BP | GO:0001944 | vasculature development | 209 | 573 | 7.82e-07 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 203 | 554 | 8.42e-07 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 224 | 625 | 1.19e-06 |
| GO:BP | GO:0048589 | developmental growth | 194 | 527 | 1.19e-06 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 409 | 1256 | 1.57e-06 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 91 | 208 | 1.61e-06 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 591 | 1900 | 1.69e-06 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 189 | 515 | 2.31e-06 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 174 | 467 | 2.48e-06 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 193 | 530 | 3.14e-06 |
| GO:BP | GO:0016358 | dendrite development | 86 | 196 | 3.21e-06 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 259 | 749 | 3.24e-06 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 194 | 534 | 3.42e-06 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 863 | 2902 | 4.72e-06 |
| GO:BP | GO:0001525 | angiogenesis | 150 | 397 | 8.04e-06 |
| GO:BP | GO:0048880 | sensory system development | 111 | 275 | 8.34e-06 |
| GO:BP | GO:0001654 | eye development | 110 | 272 | 8.38e-06 |
| GO:BP | GO:0001501 | skeletal system development | 141 | 369 | 8.73e-06 |
| GO:BP | GO:0014706 | striated muscle tissue development | 92 | 218 | 9.35e-06 |
| GO:BP | GO:0150063 | visual system development | 110 | 273 | 1.02e-05 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 158 | 425 | 1.14e-05 |
| GO:BP | GO:0008360 | regulation of cell shape | 56 | 115 | 1.14e-05 |
| GO:BP | GO:0042221 | response to chemical | 732 | 2436 | 1.16e-05 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 302 | 909 | 1.61e-05 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 436 | 1376 | 1.61e-05 |
| GO:BP | GO:0043010 | camera-type eye development | 97 | 236 | 1.80e-05 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 87 | 206 | 1.83e-05 |
| GO:BP | GO:0061061 | muscle structure development | 198 | 559 | 1.83e-05 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 218 | 626 | 1.95e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 694 | 2311 | 2.91e-05 |
| GO:BP | GO:0040007 | growth | 250 | 739 | 3.77e-05 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 272 | 815 | 4.20e-05 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 160 | 440 | 4.31e-05 |
| GO:BP | GO:0060537 | muscle tissue development | 133 | 353 | 4.38e-05 |
| GO:BP | GO:0007417 | central nervous system development | 252 | 748 | 4.76e-05 |
| GO:BP | GO:0044057 | regulation of system process | 147 | 399 | 5.13e-05 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 168 | 468 | 5.57e-05 |
| GO:BP | GO:0006468 | protein phosphorylation | 327 | 1008 | 5.65e-05 |
| GO:BP | GO:0007267 | cell-cell signaling | 369 | 1156 | 6.34e-05 |
| GO:BP | GO:0030900 | forebrain development | 113 | 292 | 6.56e-05 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 162 | 450 | 6.98e-05 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 150 | 411 | 7.11e-05 |
| GO:BP | GO:0001764 | neuron migration | 62 | 138 | 7.42e-05 |
| GO:BP | GO:0007010 | cytoskeleton organization | 386 | 1218 | 7.49e-05 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 225 | 662 | 8.79e-05 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 106 | 272 | 9.27e-05 |
| GO:BP | GO:0034329 | cell junction assembly | 130 | 349 | 1.07e-04 |
| GO:BP | GO:0060322 | head development | 201 | 583 | 1.10e-04 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 153 | 425 | 1.32e-04 |
| GO:BP | GO:0060284 | regulation of cell development | 207 | 605 | 1.37e-04 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 167 | 472 | 1.49e-04 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 119 | 316 | 1.54e-04 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 155 | 433 | 1.60e-04 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 560 | 1852 | 1.80e-04 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 95 | 242 | 2.13e-04 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 364 | 1154 | 2.38e-04 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 50 | 108 | 2.60e-04 |
| GO:BP | GO:0007015 | actin filament organization | 138 | 381 | 2.74e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 99 | 256 | 2.79e-04 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 115 | 307 | 2.88e-04 |
| GO:BP | GO:0003007 | heart morphogenesis | 88 | 222 | 2.96e-04 |
| GO:BP | GO:0023056 | positive regulation of signaling | 402 | 1292 | 3.04e-04 |
| GO:BP | GO:0007420 | brain development | 185 | 539 | 3.57e-04 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 400 | 1288 | 3.90e-04 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 114 | 306 | 4.12e-04 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 56 | 127 | 4.20e-04 |
| GO:BP | GO:0051960 | regulation of nervous system development | 130 | 358 | 4.22e-04 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 748 | 2555 | 4.54e-04 |
| GO:BP | GO:0050808 | synapse organization | 135 | 375 | 4.62e-04 |
| GO:BP | GO:0099536 | synaptic signaling | 178 | 518 | 4.74e-04 |
| GO:BP | GO:0051179 | localization | 1129 | 3978 | 4.76e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 183 | 535 | 4.78e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 34 | 66 | 4.90e-04 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 349 | 1111 | 5.13e-04 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 184 | 540 | 5.77e-04 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 111 | 299 | 6.07e-04 |
| GO:BP | GO:0050773 | regulation of dendrite development | 40 | 83 | 6.40e-04 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 129 | 358 | 6.59e-04 |
| GO:BP | GO:0051049 | regulation of transport | 363 | 1164 | 6.67e-04 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 65 | 156 | 7.12e-04 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 225 | 683 | 8.09e-04 |
| GO:BP | GO:0032879 | regulation of localization | 462 | 1521 | 8.12e-04 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 52 | 118 | 8.15e-04 |
| GO:BP | GO:0051641 | cellular localization | 809 | 2793 | 8.41e-04 |
| GO:BP | GO:0003013 | circulatory system process | 155 | 446 | 8.48e-04 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 58 | 136 | 8.77e-04 |
| GO:BP | GO:0016310 | phosphorylation | 375 | 1211 | 9.05e-04 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 103 | 276 | 9.05e-04 |
| GO:BP | GO:0048588 | developmental cell growth | 77 | 194 | 9.13e-04 |
| GO:BP | GO:0048638 | regulation of developmental growth | 97 | 257 | 9.25e-04 |
| GO:BP | GO:0021795 | cerebral cortex cell migration | 22 | 37 | 9.70e-04 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 77 | 195 | 1.11e-03 |
| GO:BP | GO:0060021 | roof of mouth development | 35 | 71 | 1.11e-03 |
| GO:BP | GO:0030048 | actin filament-based movement | 49 | 111 | 1.27e-03 |
| GO:BP | GO:0007409 | axonogenesis | 129 | 363 | 1.27e-03 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 69 | 171 | 1.27e-03 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 345 | 1109 | 1.27e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 25 | 45 | 1.28e-03 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 803 | 2780 | 1.29e-03 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 65 | 159 | 1.31e-03 |
| GO:BP | GO:0051216 | cartilage development | 63 | 153 | 1.33e-03 |
| GO:BP | GO:0048511 | rhythmic process | 88 | 231 | 1.41e-03 |
| GO:BP | GO:0060429 | epithelium development | 267 | 836 | 1.49e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 49 | 112 | 1.60e-03 |
| GO:BP | GO:1990089 | response to nerve growth factor | 24 | 43 | 1.61e-03 |
| GO:BP | GO:1990090 | cellular response to nerve growth factor stimulus | 24 | 43 | 1.61e-03 |
| GO:BP | GO:0010033 | response to organic substance | 545 | 1835 | 1.71e-03 |
| GO:BP | GO:0061564 | axon development | 140 | 402 | 1.71e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 344 | 1111 | 1.87e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 433 | 1430 | 1.87e-03 |
| GO:BP | GO:0090132 | epithelium migration | 94 | 252 | 1.88e-03 |
| GO:BP | GO:0010631 | epithelial cell migration | 94 | 252 | 1.88e-03 |
| GO:BP | GO:0051234 | establishment of localization | 979 | 3447 | 1.98e-03 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 169 | 501 | 1.99e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 200 | 607 | 2.00e-03 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 141 | 407 | 2.04e-03 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 190 | 573 | 2.04e-03 |
| GO:BP | GO:0042692 | muscle cell differentiation | 119 | 334 | 2.04e-03 |
| GO:BP | GO:0048729 | tissue morphogenesis | 162 | 478 | 2.12e-03 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 121 | 342 | 2.49e-03 |
| GO:BP | GO:0016049 | cell growth | 142 | 412 | 2.50e-03 |
| GO:BP | GO:0071310 | cellular response to organic substance | 415 | 1370 | 2.50e-03 |
| GO:BP | GO:0035265 | organ growth | 55 | 132 | 2.58e-03 |
| GO:BP | GO:0050877 | nervous system process | 207 | 634 | 2.61e-03 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 167 | 497 | 2.62e-03 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 167 | 497 | 2.62e-03 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 121 | 343 | 2.78e-03 |
| GO:BP | GO:0007623 | circadian rhythm | 64 | 160 | 2.87e-03 |
| GO:BP | GO:0048568 | embryonic organ development | 113 | 317 | 2.92e-03 |
| GO:BP | GO:0006897 | endocytosis | 174 | 522 | 2.95e-03 |
| GO:BP | GO:0061448 | connective tissue development | 82 | 217 | 3.14e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 56 | 136 | 3.14e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 113 | 318 | 3.33e-03 |
| GO:BP | GO:0090130 | tissue migration | 94 | 256 | 3.36e-03 |
| GO:BP | GO:0031032 | actomyosin structure organization | 73 | 189 | 3.39e-03 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 122 | 348 | 3.39e-03 |
| GO:BP | GO:0050807 | regulation of synapse organization | 72 | 186 | 3.44e-03 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 72 | 186 | 3.44e-03 |
| GO:BP | GO:0006810 | transport | 903 | 3176 | 3.48e-03 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 241 | 756 | 3.49e-03 |
| GO:BP | GO:0043583 | ear development | 62 | 155 | 3.49e-03 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 41 | 92 | 3.50e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 395 | 1304 | 3.51e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 394 | 1301 | 3.65e-03 |
| GO:BP | GO:2001222 | regulation of neuron migration | 22 | 40 | 3.84e-03 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 73 | 190 | 3.91e-03 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 205 | 632 | 3.91e-03 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 137 | 400 | 4.14e-03 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 40 | 90 | 4.43e-03 |
| GO:BP | GO:1990138 | neuron projection extension | 59 | 147 | 4.43e-03 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 160 | 479 | 4.67e-03 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 43 | 99 | 4.69e-03 |
| GO:BP | GO:0046328 | regulation of JNK cascade | 47 | 111 | 4.85e-03 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 62 | 157 | 5.10e-03 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 373 | 1231 | 5.22e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 31 | 65 | 5.31e-03 |
| GO:BP | GO:0021885 | forebrain cell migration | 24 | 46 | 5.34e-03 |
| GO:BP | GO:0001503 | ossification | 113 | 322 | 5.35e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 712 | 2474 | 5.38e-03 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 238 | 751 | 5.38e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 83 | 224 | 5.43e-03 |
| GO:BP | GO:0021537 | telencephalon development | 78 | 208 | 5.45e-03 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 86 | 234 | 5.66e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 706 | 2453 | 5.66e-03 |
| GO:BP | GO:0042592 | homeostatic process | 365 | 1204 | 5.67e-03 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 28 | 57 | 5.67e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 46 | 109 | 5.91e-03 |
| GO:BP | GO:0065009 | regulation of molecular function | 416 | 1389 | 5.94e-03 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 69 | 180 | 5.95e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 83 | 225 | 6.22e-03 |
| GO:BP | GO:0140352 | export from cell | 201 | 624 | 6.39e-03 |
| GO:BP | GO:0021543 | pallium development | 58 | 146 | 6.41e-03 |
| GO:BP | GO:0007610 | behavior | 149 | 445 | 6.41e-03 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 77 | 206 | 6.45e-03 |
| GO:BP | GO:0022029 | telencephalon cell migration | 23 | 44 | 6.59e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 55 | 137 | 6.69e-03 |
| GO:BP | GO:0046834 | lipid phosphorylation | 9 | 11 | 6.88e-03 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 42 | 98 | 7.23e-03 |
| GO:BP | GO:0099643 | signal release from synapse | 45 | 107 | 7.25e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 32 | 69 | 7.25e-03 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 45 | 107 | 7.25e-03 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 17 | 29 | 7.53e-03 |
| GO:BP | GO:0060419 | heart growth | 33 | 72 | 7.57e-03 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 65 | 169 | 7.68e-03 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 112 | 322 | 7.68e-03 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 598 | 2061 | 7.87e-03 |
| GO:BP | GO:0003012 | muscle system process | 117 | 339 | 7.88e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 648 | 2246 | 7.88e-03 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 153 | 461 | 7.91e-03 |
| GO:BP | GO:0030001 | metal ion transport | 180 | 554 | 7.94e-03 |
| GO:BP | GO:0048839 | inner ear development | 54 | 135 | 8.05e-03 |
| GO:BP | GO:0010720 | positive regulation of cell development | 113 | 326 | 8.11e-03 |
| GO:BP | GO:0021801 | cerebral cortex radial glia-guided migration | 14 | 22 | 8.11e-03 |
| GO:BP | GO:0022030 | telencephalon glial cell migration | 14 | 22 | 8.11e-03 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 296 | 963 | 8.13e-03 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 22 | 42 | 8.13e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 52 | 129 | 8.16e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 59 | 151 | 8.68e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 471 | 1597 | 8.70e-03 |
| GO:BP | GO:0001508 | action potential | 45 | 108 | 8.70e-03 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 26 | 53 | 8.77e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 31 | 67 | 8.86e-03 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 70 | 186 | 8.92e-03 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 317 | 1040 | 9.10e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 55 | 139 | 9.33e-03 |
| GO:BP | GO:0098657 | import into cell | 210 | 661 | 9.58e-03 |
| GO:BP | GO:0007517 | muscle organ development | 99 | 281 | 9.64e-03 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 67 | 177 | 9.72e-03 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 35 | 79 | 1.01e-02 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 21 | 40 | 1.03e-02 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 37 | 85 | 1.05e-02 |
| GO:BP | GO:0097485 | neuron projection guidance | 69 | 184 | 1.06e-02 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 39 | 91 | 1.06e-02 |
| GO:BP | GO:0007411 | axon guidance | 69 | 184 | 1.06e-02 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 39 | 91 | 1.06e-02 |
| GO:BP | GO:1903522 | regulation of blood circulation | 74 | 200 | 1.06e-02 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 187 | 582 | 1.06e-02 |
| GO:BP | GO:0048617 | embryonic foregut morphogenesis | 6 | 6 | 1.06e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 19 | 35 | 1.10e-02 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 200 | 628 | 1.10e-02 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 67 | 178 | 1.12e-02 |
| GO:BP | GO:0006811 | monoatomic ion transport | 240 | 769 | 1.12e-02 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 17 | 30 | 1.14e-02 |
| GO:BP | GO:0040008 | regulation of growth | 161 | 493 | 1.15e-02 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 284 | 926 | 1.16e-02 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 93 | 263 | 1.18e-02 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 495 | 1692 | 1.20e-02 |
| GO:BP | GO:0008015 | blood circulation | 126 | 374 | 1.24e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 45 | 110 | 1.29e-02 |
| GO:BP | GO:0048878 | chemical homeostasis | 222 | 708 | 1.36e-02 |
| GO:BP | GO:0007611 | learning or memory | 75 | 205 | 1.36e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 24 | 49 | 1.40e-02 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 52 | 132 | 1.40e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 615 | 2138 | 1.41e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 51 | 129 | 1.42e-02 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 30 | 66 | 1.44e-02 |
| GO:BP | GO:0003170 | heart valve development | 30 | 66 | 1.44e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 49 | 123 | 1.47e-02 |
| GO:BP | GO:0008104 | protein localization | 612 | 2128 | 1.47e-02 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 469 | 1601 | 1.49e-02 |
| GO:BP | GO:0002363 | alpha-beta T cell lineage commitment | 10 | 14 | 1.50e-02 |
| GO:BP | GO:0007612 | learning | 47 | 117 | 1.51e-02 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 47 | 117 | 1.51e-02 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 32 | 72 | 1.51e-02 |
| GO:BP | GO:0031399 | regulation of protein modification process | 292 | 959 | 1.51e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 33 | 75 | 1.54e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 42 | 102 | 1.59e-02 |
| GO:BP | GO:0060996 | dendritic spine development | 36 | 84 | 1.59e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 22 | 44 | 1.59e-02 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 139 | 421 | 1.59e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 38 | 90 | 1.59e-02 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 38 | 90 | 1.59e-02 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 64 | 171 | 1.62e-02 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 169 | 525 | 1.62e-02 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 157 | 484 | 1.72e-02 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 157 | 484 | 1.72e-02 |
| GO:BP | GO:0050709 | negative regulation of protein secretion | 23 | 47 | 1.73e-02 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 71 | 194 | 1.73e-02 |
| GO:BP | GO:0035025 | positive regulation of Rho protein signal transduction | 15 | 26 | 1.76e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 177 | 554 | 1.78e-02 |
| GO:BP | GO:0030198 | extracellular matrix organization | 84 | 237 | 1.84e-02 |
| GO:BP | GO:0007254 | JNK cascade | 53 | 137 | 1.89e-02 |
| GO:BP | GO:0048675 | axon extension | 43 | 106 | 1.90e-02 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 42 | 103 | 1.93e-02 |
| GO:BP | GO:0045995 | regulation of embryonic development | 34 | 79 | 1.96e-02 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 35 | 82 | 1.97e-02 |
| GO:BP | GO:0030516 | regulation of axon extension | 35 | 82 | 1.97e-02 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 38 | 91 | 1.97e-02 |
| GO:BP | GO:0050890 | cognition | 82 | 231 | 1.97e-02 |
| GO:BP | GO:0002360 | T cell lineage commitment | 12 | 19 | 2.01e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 144 | 441 | 2.01e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 74 | 205 | 2.03e-02 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 66 | 179 | 2.03e-02 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 84 | 238 | 2.05e-02 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 26 | 56 | 2.05e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 342 | 1145 | 2.05e-02 |
| GO:BP | GO:0043062 | extracellular structure organization | 84 | 238 | 2.05e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 48 | 122 | 2.06e-02 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 127 | 383 | 2.06e-02 |
| GO:BP | GO:0045444 | fat cell differentiation | 69 | 189 | 2.08e-02 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 80 | 225 | 2.08e-02 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 16 | 29 | 2.12e-02 |
| GO:BP | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 16 | 29 | 2.12e-02 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 92 | 265 | 2.13e-02 |
| GO:BP | GO:0046339 | diacylglycerol metabolic process | 14 | 24 | 2.15e-02 |
| GO:BP | GO:0051591 | response to cAMP | 28 | 62 | 2.17e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 44 | 110 | 2.20e-02 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 71 | 196 | 2.21e-02 |
| GO:BP | GO:0042391 | regulation of membrane potential | 102 | 299 | 2.22e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 43 | 107 | 2.22e-02 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 256 | 837 | 2.22e-02 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 78 | 219 | 2.22e-02 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 62 | 167 | 2.23e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 51 | 132 | 2.24e-02 |
| GO:BP | GO:0003407 | neural retina development | 23 | 48 | 2.25e-02 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 41 | 101 | 2.26e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 131 | 398 | 2.26e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 598 | 2088 | 2.26e-02 |
| GO:BP | GO:0006812 | monoatomic cation transport | 204 | 653 | 2.31e-02 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 163 | 509 | 2.31e-02 |
| GO:BP | GO:0032940 | secretion by cell | 183 | 579 | 2.31e-02 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 95 | 276 | 2.31e-02 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 11 | 17 | 2.32e-02 |
| GO:BP | GO:0030097 | hemopoiesis | 207 | 664 | 2.37e-02 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 97 | 283 | 2.38e-02 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 53 | 139 | 2.48e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 173 | 545 | 2.50e-02 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 45 | 114 | 2.53e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 56 | 149 | 2.68e-02 |
| GO:BP | GO:0009725 | response to hormone | 198 | 634 | 2.71e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 79 | 224 | 2.71e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 41 | 102 | 2.72e-02 |
| GO:BP | GO:0021987 | cerebral cortex development | 41 | 102 | 2.72e-02 |
| GO:BP | GO:0051050 | positive regulation of transport | 190 | 606 | 2.75e-02 |
| GO:BP | GO:0044872 | lipoprotein localization | 10 | 15 | 2.79e-02 |
| GO:BP | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 10 | 15 | 2.79e-02 |
| GO:BP | GO:0060065 | uterus development | 10 | 15 | 2.79e-02 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 22 | 46 | 2.83e-02 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 34 | 81 | 2.88e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 34 | 81 | 2.88e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 32 | 75 | 2.88e-02 |
| GO:BP | GO:0008283 | cell population proliferation | 406 | 1386 | 2.92e-02 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 46 | 118 | 2.92e-02 |
| GO:BP | GO:0055001 | muscle cell development | 62 | 169 | 2.92e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 62 | 169 | 2.92e-02 |
| GO:BP | GO:0036211 | protein modification process | 686 | 2423 | 2.95e-02 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 128 | 391 | 2.96e-02 |
| GO:BP | GO:0061038 | uterus morphogenesis | 5 | 5 | 2.96e-02 |
| GO:BP | GO:0003186 | tricuspid valve morphogenesis | 5 | 5 | 2.96e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 45 | 115 | 2.96e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 79 | 225 | 2.96e-02 |
| GO:BP | GO:0051046 | regulation of secretion | 135 | 415 | 2.96e-02 |
| GO:BP | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 5 | 5 | 2.96e-02 |
| GO:BP | GO:1905274 | regulation of modification of postsynaptic actin cytoskeleton | 5 | 5 | 2.96e-02 |
| GO:BP | GO:0044319 | wound healing, spreading of cells | 16 | 30 | 3.02e-02 |
| GO:BP | GO:0090505 | epiboly involved in wound healing | 16 | 30 | 3.02e-02 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 503 | 1744 | 3.02e-02 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 545 | 1900 | 3.11e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 74 | 209 | 3.16e-02 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 110 | 330 | 3.16e-02 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 25 | 55 | 3.17e-02 |
| GO:BP | GO:0032486 | Rap protein signal transduction | 9 | 13 | 3.17e-02 |
| GO:BP | GO:0045176 | apical protein localization | 9 | 13 | 3.17e-02 |
| GO:BP | GO:0043368 | positive T cell selection | 12 | 20 | 3.17e-02 |
| GO:BP | GO:0006836 | neurotransmitter transport | 54 | 144 | 3.17e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 70 | 196 | 3.19e-02 |
| GO:BP | GO:0048048 | embryonic eye morphogenesis | 14 | 25 | 3.19e-02 |
| GO:BP | GO:0007605 | sensory perception of sound | 40 | 100 | 3.19e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 58 | 157 | 3.22e-02 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 376 | 1279 | 3.22e-02 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 88 | 256 | 3.25e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 499 | 1732 | 3.36e-02 |
| GO:BP | GO:0060323 | head morphogenesis | 17 | 33 | 3.38e-02 |
| GO:BP | GO:0001570 | vasculogenesis | 29 | 67 | 3.38e-02 |
| GO:BP | GO:0097061 | dendritic spine organization | 29 | 67 | 3.38e-02 |
| GO:BP | GO:0007389 | pattern specification process | 103 | 307 | 3.38e-02 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 68 | 190 | 3.40e-02 |
| GO:BP | GO:0014896 | muscle hypertrophy | 32 | 76 | 3.42e-02 |
| GO:BP | GO:0046903 | secretion | 203 | 656 | 3.45e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 80 | 230 | 3.53e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 62 | 171 | 3.72e-02 |
| GO:BP | GO:0045216 | cell-cell junction organization | 58 | 158 | 3.72e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 48 | 126 | 3.74e-02 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 488 | 1694 | 3.74e-02 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 48 | 126 | 3.74e-02 |
| GO:BP | GO:0097484 | dendrite extension | 15 | 28 | 3.74e-02 |
| GO:BP | GO:0032924 | activin receptor signaling pathway | 18 | 36 | 3.74e-02 |
| GO:BP | GO:0060325 | face morphogenesis | 15 | 28 | 3.74e-02 |
| GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 15 | 28 | 3.74e-02 |
| GO:BP | GO:0007440 | foregut morphogenesis | 6 | 7 | 3.80e-02 |
| GO:BP | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration | 6 | 7 | 3.80e-02 |
| GO:BP | GO:0006915 | apoptotic process | 424 | 1459 | 3.86e-02 |
| GO:BP | GO:0032233 | positive regulation of actin filament bundle assembly | 24 | 53 | 3.90e-02 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 38 | 95 | 3.91e-02 |
| GO:BP | GO:0043149 | stress fiber assembly | 38 | 95 | 3.91e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 46 | 120 | 3.91e-02 |
| GO:BP | GO:1904353 | regulation of telomere capping | 13 | 23 | 3.96e-02 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 101 | 302 | 3.97e-02 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 93 | 275 | 4.02e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 19 | 39 | 4.02e-02 |
| GO:BP | GO:0014902 | myotube differentiation | 36 | 89 | 4.02e-02 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 26 | 59 | 4.05e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 54 | 146 | 4.16e-02 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 31 | 74 | 4.18e-02 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 31 | 74 | 4.18e-02 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 30 | 71 | 4.18e-02 |
| GO:BP | GO:0008219 | cell death | 437 | 1509 | 4.19e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 333 | 1128 | 4.19e-02 |
| GO:BP | GO:0090504 | epiboly | 16 | 31 | 4.21e-02 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 53 | 143 | 4.26e-02 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 324 | 1096 | 4.37e-02 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 41 | 105 | 4.37e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 103 | 310 | 4.41e-02 |
| GO:BP | GO:0043009 | chordate embryonic development | 166 | 529 | 4.42e-02 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 40 | 102 | 4.46e-02 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 144 | 452 | 4.47e-02 |
| GO:BP | GO:0010171 | body morphogenesis | 21 | 45 | 4.47e-02 |
| GO:BP | GO:0060324 | face development | 21 | 45 | 4.47e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 46 | 121 | 4.49e-02 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 46 | 121 | 4.49e-02 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 558 | 1959 | 4.52e-02 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 562 | 1974 | 4.54e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 55 | 150 | 4.55e-02 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 55 | 150 | 4.55e-02 |
| GO:BP | GO:0045058 | T cell selection | 14 | 26 | 4.63e-02 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 14 | 26 | 4.63e-02 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 75 | 216 | 4.63e-02 |
| GO:BP | GO:0007398 | ectoderm development | 10 | 16 | 4.64e-02 |
| GO:BP | GO:0032535 | regulation of cellular component size | 103 | 311 | 4.79e-02 |
| GO:BP | GO:0061337 | cardiac conduction | 35 | 87 | 4.84e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 12 | 21 | 4.89e-02 |
| GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 24 | 54 | 4.89e-02 |
| GO:BP | GO:0002027 | regulation of heart rate | 34 | 84 | 4.89e-02 |
| GO:BP | GO:0022607 | cellular component assembly | 697 | 2481 | 5.00e-02 |
| GO:BP | GO:0003015 | heart process | 73 | 210 | 5.00e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 18 | 37 | 5.00e-02 |
EARnomtable_20k %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in EAR neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04510 | Focal adhesion | 79 | 177 | 1.33e-05 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 73 | 164 | 2.47e-05 |
| KEGG | KEGG:04520 | Adherens junction | 42 | 86 | 4.14e-04 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 68 | 170 | 2.82e-03 |
| KEGG | KEGG:04360 | Axon guidance | 65 | 162 | 2.98e-03 |
| KEGG | KEGG:04713 | Circadian entrainment | 33 | 69 | 3.25e-03 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 58 | 142 | 3.25e-03 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 43 | 99 | 4.34e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 34 | 74 | 5.36e-03 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 31 | 69 | 1.52e-02 |
| KEGG | KEGG:05200 | Pathways in cancer | 135 | 408 | 1.65e-02 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 46 | 115 | 1.66e-02 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 35 | 82 | 1.69e-02 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 44 | 110 | 1.73e-02 |
| KEGG | KEGG:04530 | Tight junction | 53 | 138 | 1.73e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 30 | 69 | 2.27e-02 |
| KEGG | KEGG:04720 | Long-term potentiation | 25 | 55 | 2.54e-02 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 44 | 113 | 2.76e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 37 | 92 | 3.09e-02 |
| KEGG | KEGG:04730 | Long-term depression | 20 | 42 | 3.10e-02 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 48 | 127 | 3.10e-02 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 55 | 151 | 3.83e-02 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 26 | 61 | 3.96e-02 |
| KEGG | KEGG:04911 | Insulin secretion | 27 | 64 | 3.96e-02 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 22 | 49 | 3.96e-02 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 83 | 246 | 3.96e-02 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 63 | 179 | 3.96e-02 |
| KEGG | KEGG:04014 | Ras signaling pathway | 61 | 172 | 3.96e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 49 | 134 | 4.10e-02 |
| KEGG | KEGG:04742 | Taste transduction | 12 | 22 | 4.10e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 12 | 22 | 4.10e-02 |
| KEGG | KEGG:04725 | Cholinergic synapse | 33 | 83 | 4.10e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 47 | 128 | 4.19e-02 |
| KEGG | KEGG:05135 | Yersinia infection | 42 | 112 | 4.19e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 34 | 87 | 4.36e-02 |
EAR peaks overlapping enhancers
# EAR_resgenes_20k_enh <- gost(query = unique(EAR_enh_peaks_20k$NCBI_gene),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(EAR_resgenes_20k_enh,"data/GO_KEGG_analysis/EAR_resgenes_20k_enh.RDS")
# EARnom <- gostplot(EAR_resgenes_20k_enh, capped = FALSE, interactive = TRUE)
# EARnom
EARnomtable_20k_enh <- EAR_resgenes_20k_enh$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
EARnomtable_20k_enh %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in EAR enhancer neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0050789 | regulation of biological process | 579 | 8037 | 9.08e-15 |
| GO:BP | GO:0050794 | regulation of cellular process | 556 | 7651 | 2.27e-14 |
| GO:BP | GO:0065007 | biological regulation | 587 | 8275 | 7.02e-14 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 344 | 4198 | 5.25e-12 |
| GO:BP | GO:0048518 | positive regulation of biological process | 366 | 4561 | 6.29e-12 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 146 | 1430 | 2.17e-09 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 135 | 1301 | 4.81e-09 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 135 | 1304 | 4.97e-09 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 304 | 3804 | 1.12e-08 |
| GO:BP | GO:0048519 | negative regulation of biological process | 318 | 4037 | 1.46e-08 |
| GO:BP | GO:0032502 | developmental process | 339 | 4475 | 2.83e-07 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 150 | 1597 | 2.83e-07 |
| GO:BP | GO:0050793 | regulation of developmental process | 164 | 1801 | 3.24e-07 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 171 | 1900 | 3.24e-07 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 174 | 1951 | 3.98e-07 |
| GO:BP | GO:0048856 | anatomical structure development | 316 | 4130 | 4.27e-07 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 173 | 1959 | 8.25e-07 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 174 | 1974 | 8.25e-07 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 230 | 2842 | 2.29e-06 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 226 | 2780 | 2.29e-06 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 194 | 2311 | 3.39e-06 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 172 | 1992 | 4.02e-06 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 166 | 1908 | 4.39e-06 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 209 | 2555 | 5.50e-06 |
| GO:BP | GO:0008150 | biological_process | 741 | 12051 | 5.56e-06 |
| GO:BP | GO:0048869 | cellular developmental process | 237 | 2988 | 5.57e-06 |
| GO:BP | GO:0030154 | cell differentiation | 237 | 2987 | 5.57e-06 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 311 | 4170 | 7.02e-06 |
| GO:BP | GO:0032501 | multicellular organismal process | 351 | 4830 | 7.55e-06 |
| GO:BP | GO:0009987 | cellular process | 713 | 11450 | 7.55e-06 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 171 | 2005 | 7.75e-06 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 209 | 2576 | 8.08e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 202 | 2474 | 8.96e-06 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 209 | 2589 | 1.14e-05 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 315 | 4269 | 1.36e-05 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 281 | 3724 | 1.44e-05 |
| GO:BP | GO:0007275 | multicellular organism development | 259 | 3383 | 1.75e-05 |
| GO:BP | GO:0006351 | DNA-templated transcription | 214 | 2683 | 1.75e-05 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 240 | 3089 | 1.89e-05 |
| GO:BP | GO:0010468 | regulation of gene expression | 273 | 3613 | 2.01e-05 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 285 | 3815 | 2.45e-05 |
| GO:BP | GO:0050896 | response to stimulus | 401 | 5732 | 2.45e-05 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 92 | 926 | 2.45e-05 |
| GO:BP | GO:0048731 | system development | 227 | 2903 | 2.67e-05 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 286 | 3841 | 3.00e-05 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 214 | 2709 | 3.12e-05 |
| GO:BP | GO:0072359 | circulatory system development | 89 | 896 | 3.60e-05 |
| GO:BP | GO:0040007 | growth | 77 | 739 | 3.68e-05 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 170 | 2052 | 4.01e-05 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 170 | 2061 | 5.26e-05 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 148 | 1744 | 6.83e-05 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 325 | 4515 | 6.83e-05 |
| GO:BP | GO:0019222 | regulation of metabolic process | 349 | 4914 | 7.05e-05 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 147 | 1732 | 7.11e-05 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 144 | 1694 | 8.56e-05 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 123 | 1403 | 1.35e-04 |
| GO:BP | GO:0051716 | cellular response to stimulus | 348 | 4933 | 1.45e-04 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 323 | 4521 | 1.49e-04 |
| GO:BP | GO:0071310 | cellular response to organic substance | 120 | 1370 | 1.85e-04 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 232 | 3066 | 1.93e-04 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 179 | 2246 | 1.95e-04 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 110 | 1233 | 2.17e-04 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 103 | 1135 | 2.19e-04 |
| GO:BP | GO:0001568 | blood vessel development | 59 | 546 | 2.32e-04 |
| GO:BP | GO:0001944 | vasculature development | 61 | 573 | 2.46e-04 |
| GO:BP | GO:0010033 | response to organic substance | 151 | 1835 | 2.46e-04 |
| GO:BP | GO:0010586 | miRNA metabolic process | 18 | 90 | 3.00e-04 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 90 | 967 | 3.46e-04 |
| GO:BP | GO:0023052 | signaling | 299 | 4180 | 4.06e-04 |
| GO:BP | GO:0007154 | cell communication | 303 | 4248 | 4.22e-04 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 98 | 1088 | 4.88e-04 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 66 | 653 | 5.13e-04 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 50 | 450 | 5.60e-04 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 143 | 1746 | 5.60e-04 |
| GO:BP | GO:0048589 | developmental growth | 56 | 527 | 5.96e-04 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 93 | 1027 | 6.54e-04 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 109 | 1256 | 6.88e-04 |
| GO:BP | GO:0016043 | cellular component organization | 355 | 5139 | 6.88e-04 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 232 | 3131 | 7.18e-04 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 232 | 3132 | 7.26e-04 |
| GO:BP | GO:0048468 | cell development | 159 | 1999 | 7.43e-04 |
| GO:BP | GO:0061061 | muscle structure development | 58 | 559 | 7.72e-04 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 93 | 1036 | 8.52e-04 |
| GO:BP | GO:0060419 | heart growth | 15 | 72 | 9.13e-04 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 98 | 1109 | 9.13e-04 |
| GO:BP | GO:0048513 | animal organ development | 167 | 2130 | 9.13e-04 |
| GO:BP | GO:0010646 | regulation of cell communication | 197 | 2601 | 1.09e-03 |
| GO:BP | GO:0007165 | signal transduction | 275 | 3846 | 1.09e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 365 | 5340 | 1.13e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 14 | 65 | 1.13e-03 |
| GO:BP | GO:0035556 | intracellular signal transduction | 163 | 2079 | 1.13e-03 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 237 | 3238 | 1.16e-03 |
| GO:BP | GO:0042221 | response to chemical | 186 | 2436 | 1.19e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 50 | 467 | 1.21e-03 |
| GO:BP | GO:0040008 | regulation of growth | 52 | 493 | 1.23e-03 |
| GO:BP | GO:0016477 | cell migration | 95 | 1078 | 1.24e-03 |
| GO:BP | GO:0035295 | tube development | 77 | 827 | 1.27e-03 |
| GO:BP | GO:0023051 | regulation of signaling | 196 | 2597 | 1.28e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 163 | 2088 | 1.32e-03 |
| GO:BP | GO:0000165 | MAPK cascade | 55 | 535 | 1.37e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 97 | 1111 | 1.37e-03 |
| GO:BP | GO:0016070 | RNA metabolic process | 258 | 3588 | 1.37e-03 |
| GO:BP | GO:0001525 | angiogenesis | 44 | 397 | 1.52e-03 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 147 | 1852 | 1.53e-03 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 89 | 1011 | 2.21e-03 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 13 | 62 | 2.60e-03 |
| GO:BP | GO:0060644 | mammary gland epithelial cell differentiation | 6 | 13 | 2.63e-03 |
| GO:BP | GO:0048870 | cell motility | 101 | 1190 | 2.71e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 11 | 46 | 2.71e-03 |
| GO:BP | GO:0051641 | cellular localization | 206 | 2793 | 2.83e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 13 | 63 | 2.96e-03 |
| GO:BP | GO:0016049 | cell growth | 44 | 412 | 3.42e-03 |
| GO:BP | GO:0046328 | regulation of JNK cascade | 18 | 111 | 3.56e-03 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 78 | 876 | 4.34e-03 |
| GO:BP | GO:0035239 | tube morphogenesis | 63 | 668 | 4.34e-03 |
| GO:BP | GO:0051179 | localization | 278 | 3978 | 4.43e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 14 | 75 | 4.68e-03 |
| GO:BP | GO:0033500 | carbohydrate homeostasis | 24 | 178 | 4.96e-03 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 80 | 909 | 5.00e-03 |
| GO:BP | GO:2000145 | regulation of cell motility | 68 | 745 | 5.85e-03 |
| GO:BP | GO:0001678 | intracellular glucose homeostasis | 18 | 116 | 5.98e-03 |
| GO:BP | GO:0048699 | generation of neurons | 96 | 1145 | 5.98e-03 |
| GO:BP | GO:0042592 | homeostatic process | 100 | 1204 | 6.03e-03 |
| GO:BP | GO:0032879 | regulation of localization | 121 | 1521 | 6.99e-03 |
| GO:BP | GO:0040012 | regulation of locomotion | 69 | 766 | 7.37e-03 |
| GO:BP | GO:0030182 | neuron differentiation | 91 | 1080 | 7.37e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 17 | 108 | 7.37e-03 |
| GO:BP | GO:0014706 | striated muscle tissue development | 27 | 218 | 7.43e-03 |
| GO:BP | GO:0010842 | retina layer formation | 6 | 16 | 8.75e-03 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 95 | 1145 | 8.90e-03 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 11 | 53 | 8.90e-03 |
| GO:BP | GO:0009725 | response to hormone | 59 | 634 | 9.11e-03 |
| GO:BP | GO:0097240 | chromosome attachment to the nuclear envelope | 3 | 3 | 9.18e-03 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 260 | 3730 | 9.21e-03 |
| GO:BP | GO:0030029 | actin filament-based process | 62 | 677 | 9.53e-03 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 94 | 1134 | 9.53e-03 |
| GO:BP | GO:0035265 | organ growth | 19 | 132 | 9.55e-03 |
| GO:BP | GO:0022008 | neurogenesis | 107 | 1327 | 9.68e-03 |
| GO:BP | GO:0042593 | glucose homeostasis | 23 | 177 | 1.02e-02 |
| GO:BP | GO:0033036 | macromolecule localization | 180 | 2453 | 1.05e-02 |
| GO:BP | GO:0006325 | chromatin organization | 60 | 654 | 1.10e-02 |
| GO:BP | GO:0030334 | regulation of cell migration | 64 | 710 | 1.12e-02 |
| GO:BP | GO:0006810 | transport | 225 | 3176 | 1.13e-02 |
| GO:BP | GO:0061117 | negative regulation of heart growth | 6 | 17 | 1.14e-02 |
| GO:BP | GO:0055022 | negative regulation of cardiac muscle tissue growth | 6 | 17 | 1.14e-02 |
| GO:BP | GO:0033993 | response to lipid | 56 | 601 | 1.16e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 37 | 350 | 1.21e-02 |
| GO:BP | GO:0009966 | regulation of signal transduction | 170 | 2307 | 1.27e-02 |
| GO:BP | GO:0040011 | locomotion | 74 | 858 | 1.36e-02 |
| GO:BP | GO:0060537 | muscle tissue development | 37 | 353 | 1.40e-02 |
| GO:BP | GO:0060159 | regulation of dopamine receptor signaling pathway | 4 | 7 | 1.41e-02 |
| GO:BP | GO:0060044 | negative regulation of cardiac muscle cell proliferation | 4 | 7 | 1.41e-02 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 207 | 2902 | 1.43e-02 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 25 | 206 | 1.47e-02 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 52 | 554 | 1.51e-02 |
| GO:BP | GO:0051726 | regulation of cell cycle | 79 | 935 | 1.53e-02 |
| GO:BP | GO:0097306 | cellular response to alcohol | 13 | 76 | 1.53e-02 |
| GO:BP | GO:0071824 | protein-DNA complex organization | 65 | 736 | 1.58e-02 |
| GO:BP | GO:0048878 | chemical homeostasis | 63 | 708 | 1.58e-02 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 86 | 1040 | 1.66e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 66 | 752 | 1.66e-02 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 33 | 307 | 1.71e-02 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 276 | 4039 | 1.72e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 64 | 727 | 1.83e-02 |
| GO:BP | GO:0070848 | response to growth factor | 53 | 576 | 2.01e-02 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 7 | 26 | 2.01e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 45 | 468 | 2.06e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 24 | 200 | 2.06e-02 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 32 | 299 | 2.14e-02 |
| GO:BP | GO:0007399 | nervous system development | 142 | 1903 | 2.31e-02 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 51 | 553 | 2.33e-02 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 50 | 540 | 2.39e-02 |
| GO:BP | GO:0043933 | protein-containing complex organization | 148 | 2000 | 2.45e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 19 | 145 | 2.51e-02 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 38 | 380 | 2.51e-02 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 12 | 71 | 2.53e-02 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 56 | 626 | 2.57e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 20 | 157 | 2.57e-02 |
| GO:BP | GO:0007015 | actin filament organization | 38 | 381 | 2.57e-02 |
| GO:BP | GO:1903294 | regulation of glutamate secretion, neurotransmission | 3 | 4 | 2.60e-02 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 11 | 62 | 2.66e-02 |
| GO:BP | GO:0051234 | establishment of localization | 238 | 3447 | 2.66e-02 |
| GO:BP | GO:0034504 | protein localization to nucleus | 30 | 279 | 2.69e-02 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 27 | 242 | 2.76e-02 |
| GO:BP | GO:0060341 | regulation of cellular localization | 69 | 815 | 2.89e-02 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 36 | 358 | 2.92e-02 |
| GO:BP | GO:0048511 | rhythmic process | 26 | 231 | 2.95e-02 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 28 | 256 | 2.97e-02 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 43 | 452 | 2.98e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 13 | 83 | 3.01e-02 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 89 | 1111 | 3.02e-02 |
| GO:BP | GO:0007254 | JNK cascade | 18 | 137 | 3.02e-02 |
| GO:BP | GO:0048638 | regulation of developmental growth | 28 | 257 | 3.08e-02 |
| GO:BP | GO:0042692 | muscle cell differentiation | 34 | 334 | 3.12e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 39 | 400 | 3.12e-02 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 58 | 662 | 3.15e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 32 | 310 | 3.38e-02 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 91 | 1146 | 3.38e-02 |
| GO:BP | GO:0001654 | eye development | 29 | 272 | 3.44e-02 |
| GO:BP | GO:0006338 | chromatin remodeling | 48 | 525 | 3.44e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 22 | 186 | 3.48e-02 |
| GO:BP | GO:0048103 | somatic stem cell division | 4 | 9 | 3.48e-02 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 16 | 117 | 3.51e-02 |
| GO:BP | GO:0150063 | visual system development | 29 | 273 | 3.54e-02 |
| GO:BP | GO:0051049 | regulation of transport | 92 | 1164 | 3.54e-02 |
| GO:BP | GO:1902806 | regulation of cell cycle G1/S phase transition | 20 | 163 | 3.59e-02 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 55 | 625 | 3.62e-02 |
| GO:BP | GO:0043010 | camera-type eye development | 26 | 236 | 3.64e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 155 | 2138 | 3.65e-02 |
| GO:BP | GO:0010720 | positive regulation of cell development | 33 | 326 | 3.74e-02 |
| GO:BP | GO:0048880 | sensory system development | 29 | 275 | 3.85e-02 |
| GO:BP | GO:0050709 | negative regulation of protein secretion | 9 | 47 | 3.87e-02 |
| GO:BP | GO:0008104 | protein localization | 154 | 2128 | 4.02e-02 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 61 | 716 | 4.24e-02 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 10 | 57 | 4.24e-02 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 32 | 316 | 4.25e-02 |
| GO:BP | GO:0097305 | response to alcohol | 20 | 166 | 4.26e-02 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 298 | 4481 | 4.33e-02 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 69 | 833 | 4.33e-02 |
| GO:BP | GO:0003407 | neural retina development | 9 | 48 | 4.35e-02 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 55 | 632 | 4.37e-02 |
| GO:BP | GO:0071333 | cellular response to glucose stimulus | 14 | 99 | 4.61e-02 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 40 | 425 | 4.61e-02 |
| GO:BP | GO:0071322 | cellular response to carbohydrate stimulus | 15 | 110 | 4.62e-02 |
| GO:BP | GO:0051050 | positive regulation of transport | 53 | 606 | 4.66e-02 |
| GO:BP | GO:0010467 | gene expression | 314 | 4758 | 4.73e-02 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 31 | 306 | 4.73e-02 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 17 | 133 | 4.73e-02 |
| GO:BP | GO:1903719 | regulation of I-kappaB phosphorylation | 3 | 5 | 4.82e-02 |
| GO:BP | GO:0034380 | high-density lipoprotein particle assembly | 4 | 10 | 4.82e-02 |
| GO:BP | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production | 3 | 5 | 4.82e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 23 | 205 | 4.82e-02 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 41 | 441 | 4.84e-02 |
| GO:BP | GO:0071331 | cellular response to hexose stimulus | 14 | 100 | 4.84e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 81 | 1016 | 4.84e-02 |
EARnomtable_20k_enh %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in EAR enhancer neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:05205 | Proteoglycans in cancer | 23 | 170 | 2.61e-02 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 22 | 163 | 2.61e-02 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 13 | 74 | 2.85e-02 |
| KEGG | KEGG:04218 | Cellular senescence | 19 | 144 | 3.13e-02 |
| KEGG | KEGG:04510 | Focal adhesion | 22 | 177 | 3.13e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 21 | 164 | 3.13e-02 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 28 | 256 | 3.74e-02 |
| KEGG | KEGG:05200 | Pathways in cancer | 39 | 408 | 4.59e-02 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 21 | 176 | 4.59e-02 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 21 | 179 | 4.68e-02 |
ESR 20,000 bp NG
# ESR_resgenes_20k <- gost(query = ESR_peak_list_20k$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(ESR_resgenes_20k,"data/GO_KEGG_analysis/ESR_resgenes_20k.RDS")
# ESRnom <- gostplot(ESR_resgenes_20k, capped = FALSE, interactive = TRUE)
# ESRnom
ESRnomtable_20k <- ESR_resgenes_20k$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
ESRnomtable_20k %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in ESR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 2259 | 4830 | 6.45e-54 |
| GO:BP | GO:0048856 | anatomical structure development | 1964 | 4130 | 2.22e-50 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1034 | 1951 | 4.52e-46 |
| GO:BP | GO:0007154 | cell communication | 1992 | 4248 | 8.11e-46 |
| GO:BP | GO:0023052 | signaling | 1962 | 4180 | 2.92e-45 |
| GO:BP | GO:0007275 | multicellular organism development | 1633 | 3383 | 4.24e-44 |
| GO:BP | GO:0032502 | developmental process | 2072 | 4475 | 1.64e-43 |
| GO:BP | GO:0048731 | system development | 1424 | 2903 | 1.23e-41 |
| GO:BP | GO:0050896 | response to stimulus | 2549 | 5732 | 3.18e-40 |
| GO:BP | GO:0007165 | signal transduction | 1794 | 3846 | 1.01e-37 |
| GO:BP | GO:0051716 | cellular response to stimulus | 2225 | 4933 | 1.74e-37 |
| GO:BP | GO:0030154 | cell differentiation | 1438 | 2987 | 1.38e-36 |
| GO:BP | GO:0048869 | cellular developmental process | 1438 | 2988 | 1.61e-36 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1024 | 2052 | 2.62e-31 |
| GO:BP | GO:0048468 | cell development | 998 | 1999 | 1.81e-30 |
| GO:BP | GO:0009888 | tissue development | 746 | 1425 | 1.35e-29 |
| GO:BP | GO:0007399 | nervous system development | 953 | 1903 | 1.67e-29 |
| GO:BP | GO:0048513 | animal organ development | 1049 | 2130 | 2.25e-29 |
| GO:BP | GO:0007155 | cell adhesion | 553 | 1004 | 2.78e-28 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 943 | 1900 | 2.28e-27 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 491 | 876 | 3.32e-27 |
| GO:BP | GO:0010646 | regulation of cell communication | 1236 | 2601 | 3.87e-27 |
| GO:BP | GO:0050793 | regulation of developmental process | 899 | 1801 | 5.32e-27 |
| GO:BP | GO:0023051 | regulation of signaling | 1231 | 2597 | 1.88e-26 |
| GO:BP | GO:0050789 | regulation of biological process | 3343 | 8037 | 1.88e-26 |
| GO:BP | GO:0003008 | system process | 633 | 1201 | 9.66e-26 |
| GO:BP | GO:0048870 | cell motility | 625 | 1190 | 7.53e-25 |
| GO:BP | GO:0022008 | neurogenesis | 684 | 1327 | 1.73e-24 |
| GO:BP | GO:0065007 | biological regulation | 3418 | 8275 | 2.42e-24 |
| GO:BP | GO:0016477 | cell migration | 571 | 1078 | 1.16e-23 |
| GO:BP | GO:0050794 | regulation of cellular process | 3179 | 7651 | 6.29e-23 |
| GO:BP | GO:0035239 | tube morphogenesis | 381 | 668 | 1.19e-22 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 360 | 625 | 2.31e-22 |
| GO:BP | GO:0030029 | actin filament-based process | 384 | 677 | 3.02e-22 |
| GO:BP | GO:0035295 | tube development | 452 | 827 | 6.74e-22 |
| GO:BP | GO:0048699 | generation of neurons | 594 | 1145 | 7.79e-22 |
| GO:BP | GO:0072359 | circulatory system development | 483 | 896 | 7.79e-22 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 416 | 749 | 7.82e-22 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 704 | 1403 | 3.11e-21 |
| GO:BP | GO:0000902 | cell morphogenesis | 421 | 764 | 3.12e-21 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1986 | 4561 | 1.12e-20 |
| GO:BP | GO:0030182 | neuron differentiation | 560 | 1080 | 1.99e-20 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 392 | 710 | 7.19e-20 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1838 | 4198 | 8.13e-20 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 365 | 653 | 1.22e-19 |
| GO:BP | GO:0034330 | cell junction organization | 336 | 591 | 1.38e-19 |
| GO:BP | GO:0031175 | neuron projection development | 428 | 794 | 3.38e-19 |
| GO:BP | GO:0007267 | cell-cell signaling | 588 | 1156 | 4.46e-19 |
| GO:BP | GO:0044057 | regulation of system process | 243 | 399 | 4.52e-19 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 568 | 1111 | 5.28e-19 |
| GO:BP | GO:0048666 | neuron development | 472 | 894 | 5.74e-19 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1073 | 2307 | 5.74e-19 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 618 | 1227 | 6.64e-19 |
| GO:BP | GO:0048729 | tissue morphogenesis | 280 | 478 | 1.15e-18 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 337 | 601 | 2.12e-18 |
| GO:BP | GO:0030030 | cell projection organization | 631 | 1262 | 2.12e-18 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 521 | 1011 | 3.12e-18 |
| GO:BP | GO:0001944 | vasculature development | 323 | 573 | 4.51e-18 |
| GO:BP | GO:0001568 | blood vessel development | 310 | 546 | 6.16e-18 |
| GO:BP | GO:0035556 | intracellular signal transduction | 971 | 2079 | 1.66e-17 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 303 | 534 | 1.84e-17 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 301 | 530 | 2.02e-17 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1306 | 2902 | 2.22e-17 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 551 | 1088 | 2.51e-17 |
| GO:BP | GO:0040011 | locomotion | 449 | 858 | 4.25e-17 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 497 | 967 | 4.62e-17 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 270 | 467 | 5.86e-17 |
| GO:BP | GO:0065008 | regulation of biological quality | 951 | 2039 | 6.69e-17 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 929 | 1992 | 2.02e-16 |
| GO:BP | GO:2000145 | regulation of cell motility | 396 | 745 | 2.09e-16 |
| GO:BP | GO:0030334 | regulation of cell migration | 380 | 710 | 2.45e-16 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 619 | 1256 | 2.71e-16 |
| GO:BP | GO:0003013 | circulatory system process | 258 | 446 | 3.12e-16 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 289 | 515 | 9.19e-16 |
| GO:BP | GO:0040012 | regulation of locomotion | 403 | 766 | 9.47e-16 |
| GO:BP | GO:0060485 | mesenchyme development | 164 | 256 | 1.16e-15 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 563 | 1134 | 1.72e-15 |
| GO:BP | GO:0007010 | cytoskeleton organization | 599 | 1218 | 1.76e-15 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1743 | 4037 | 2.87e-15 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 267 | 472 | 4.07e-15 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 265 | 468 | 4.46e-15 |
| GO:BP | GO:0060429 | epithelium development | 430 | 836 | 1.07e-14 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 297 | 540 | 1.21e-14 |
| GO:BP | GO:0042221 | response to chemical | 1100 | 2436 | 1.35e-14 |
| GO:BP | GO:0008015 | blood circulation | 219 | 374 | 1.68e-14 |
| GO:BP | GO:0051049 | regulation of transport | 571 | 1164 | 2.00e-14 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 302 | 553 | 2.31e-14 |
| GO:BP | GO:0009790 | embryo development | 440 | 864 | 3.87e-14 |
| GO:BP | GO:0003012 | muscle system process | 201 | 339 | 4.79e-14 |
| GO:BP | GO:0030001 | metal ion transport | 301 | 554 | 6.34e-14 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1641 | 3804 | 7.16e-14 |
| GO:BP | GO:0098657 | import into cell | 349 | 661 | 7.65e-14 |
| GO:BP | GO:0070848 | response to growth factor | 310 | 576 | 1.22e-13 |
| GO:BP | GO:0098609 | cell-cell adhesion | 324 | 607 | 1.22e-13 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 300 | 554 | 1.22e-13 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 293 | 540 | 1.88e-13 |
| GO:BP | GO:0001525 | angiogenesis | 226 | 397 | 3.89e-13 |
| GO:BP | GO:0034329 | cell junction assembly | 203 | 349 | 5.08e-13 |
| GO:BP | GO:0061061 | muscle structure development | 300 | 559 | 5.63e-13 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 245 | 440 | 8.48e-13 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 217 | 380 | 8.54e-13 |
| GO:BP | GO:0016043 | cellular component organization | 2151 | 5139 | 1.10e-12 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 329 | 626 | 1.13e-12 |
| GO:BP | GO:0006810 | transport | 1383 | 3176 | 1.39e-12 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 137 | 216 | 1.44e-12 |
| GO:BP | GO:0048589 | developmental growth | 284 | 527 | 1.48e-12 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 221 | 391 | 2.04e-12 |
| GO:BP | GO:0009987 | cellular process | 4477 | 11450 | 2.26e-12 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 133 | 209 | 2.31e-12 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 613 | 1288 | 2.61e-12 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 164 | 272 | 2.68e-12 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 74 | 98 | 2.80e-12 |
| GO:BP | GO:0051960 | regulation of nervous system development | 205 | 358 | 2.95e-12 |
| GO:BP | GO:0023056 | positive regulation of signaling | 614 | 1292 | 3.43e-12 |
| GO:BP | GO:0008150 | biological_process | 4682 | 12051 | 3.92e-12 |
| GO:BP | GO:0006816 | calcium ion transport | 163 | 271 | 4.16e-12 |
| GO:BP | GO:0007507 | heart development | 276 | 515 | 7.76e-12 |
| GO:BP | GO:0006936 | muscle contraction | 160 | 267 | 1.10e-11 |
| GO:BP | GO:0006468 | protein phosphorylation | 491 | 1008 | 1.17e-11 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 226 | 407 | 1.20e-11 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 112 | 171 | 1.35e-11 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 69 | 91 | 1.35e-11 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 203 | 358 | 1.37e-11 |
| GO:BP | GO:0007423 | sensory organ development | 222 | 399 | 1.46e-11 |
| GO:BP | GO:0032879 | regulation of localization | 706 | 1521 | 1.46e-11 |
| GO:BP | GO:0007409 | axonogenesis | 205 | 363 | 1.76e-11 |
| GO:BP | GO:0051179 | localization | 1689 | 3978 | 2.27e-11 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 406 | 815 | 3.09e-11 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 380 | 756 | 3.78e-11 |
| GO:BP | GO:0061564 | axon development | 221 | 402 | 8.19e-11 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 231 | 425 | 1.19e-10 |
| GO:BP | GO:0140352 | export from cell | 320 | 624 | 1.28e-10 |
| GO:BP | GO:0023057 | negative regulation of signaling | 529 | 1111 | 1.53e-10 |
| GO:BP | GO:0016310 | phosphorylation | 571 | 1211 | 1.55e-10 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 181 | 318 | 1.70e-10 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 224 | 411 | 1.76e-10 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 234 | 433 | 1.79e-10 |
| GO:BP | GO:0014706 | striated muscle tissue development | 133 | 218 | 1.82e-10 |
| GO:BP | GO:0006897 | endocytosis | 274 | 522 | 1.91e-10 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 192 | 342 | 1.95e-10 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 230 | 425 | 2.20e-10 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 288 | 554 | 2.20e-10 |
| GO:BP | GO:0008283 | cell population proliferation | 643 | 1386 | 2.20e-10 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 527 | 1109 | 2.37e-10 |
| GO:BP | GO:0048568 | embryonic organ development | 180 | 317 | 2.43e-10 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 192 | 343 | 2.68e-10 |
| GO:BP | GO:0051234 | establishment of localization | 1471 | 3447 | 3.10e-10 |
| GO:BP | GO:0099536 | synaptic signaling | 271 | 518 | 3.85e-10 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 637 | 1376 | 4.42e-10 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 263 | 501 | 4.91e-10 |
| GO:BP | GO:1903522 | regulation of blood circulation | 123 | 200 | 5.14e-10 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 544 | 1154 | 5.19e-10 |
| GO:BP | GO:0010720 | positive regulation of cell development | 183 | 326 | 5.95e-10 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 106 | 167 | 9.09e-10 |
| GO:BP | GO:0048041 | focal adhesion assembly | 60 | 80 | 9.40e-10 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 265 | 508 | 9.55e-10 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 260 | 497 | 1.00e-09 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 260 | 497 | 1.00e-09 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 830 | 1852 | 1.00e-09 |
| GO:BP | GO:0009605 | response to external stimulus | 753 | 1664 | 1.11e-09 |
| GO:BP | GO:0060047 | heart contraction | 122 | 200 | 1.29e-09 |
| GO:BP | GO:0060284 | regulation of cell development | 307 | 605 | 1.52e-09 |
| GO:BP | GO:0046903 | secretion | 329 | 656 | 1.76e-09 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 593 | 1279 | 1.79e-09 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 158 | 276 | 1.94e-09 |
| GO:BP | GO:0042692 | muscle cell differentiation | 185 | 334 | 2.01e-09 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 172 | 306 | 2.01e-09 |
| GO:BP | GO:0050877 | nervous system process | 319 | 634 | 2.14e-09 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 537 | 1146 | 2.19e-09 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 271 | 525 | 2.25e-09 |
| GO:BP | GO:0003007 | heart morphogenesis | 132 | 222 | 2.33e-09 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 437 | 909 | 2.33e-09 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 340 | 683 | 2.45e-09 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 316 | 628 | 2.55e-09 |
| GO:BP | GO:0006811 | monoatomic ion transport | 377 | 769 | 2.55e-09 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 492 | 1040 | 2.66e-09 |
| GO:BP | GO:0003015 | heart process | 126 | 210 | 2.70e-09 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 148 | 256 | 2.82e-09 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 124 | 206 | 2.82e-09 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 147 | 254 | 2.92e-09 |
| GO:BP | GO:0060537 | muscle tissue development | 193 | 353 | 3.18e-09 |
| GO:BP | GO:0007411 | axon guidance | 113 | 184 | 3.45e-09 |
| GO:BP | GO:0097485 | neuron projection guidance | 113 | 184 | 3.45e-09 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 263 | 509 | 3.59e-09 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 83 | 125 | 4.48e-09 |
| GO:BP | GO:0007015 | actin filament organization | 205 | 381 | 5.31e-09 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 278 | 545 | 5.97e-09 |
| GO:BP | GO:0003205 | cardiac chamber development | 96 | 151 | 6.05e-09 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 123 | 206 | 6.76e-09 |
| GO:BP | GO:0009611 | response to wounding | 214 | 402 | 7.29e-09 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 151 | 265 | 7.40e-09 |
| GO:BP | GO:0010033 | response to organic substance | 816 | 1835 | 9.11e-09 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1105 | 2555 | 9.44e-09 |
| GO:BP | GO:0043009 | chordate embryonic development | 270 | 529 | 9.98e-09 |
| GO:BP | GO:0006812 | monoatomic cation transport | 324 | 653 | 1.05e-08 |
| GO:BP | GO:0055085 | transmembrane transport | 467 | 989 | 1.11e-08 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 110 | 181 | 1.42e-08 |
| GO:BP | GO:0090257 | regulation of muscle system process | 110 | 181 | 1.42e-08 |
| GO:BP | GO:0007417 | central nervous system development | 364 | 748 | 1.59e-08 |
| GO:BP | GO:0032940 | secretion by cell | 291 | 579 | 1.60e-08 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 327 | 662 | 1.61e-08 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 2188 | 5340 | 1.65e-08 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 74 | 110 | 1.74e-08 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1192 | 2780 | 1.74e-08 |
| GO:BP | GO:0071310 | cellular response to organic substance | 624 | 1370 | 1.80e-08 |
| GO:BP | GO:0006915 | apoptotic process | 660 | 1459 | 2.19e-08 |
| GO:BP | GO:0008016 | regulation of heart contraction | 104 | 170 | 2.44e-08 |
| GO:BP | GO:0040007 | growth | 359 | 739 | 2.65e-08 |
| GO:BP | GO:0042391 | regulation of membrane potential | 165 | 299 | 2.75e-08 |
| GO:BP | GO:0007610 | behavior | 231 | 445 | 2.75e-08 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 195 | 365 | 2.99e-08 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 108 | 179 | 3.51e-08 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 166 | 302 | 3.59e-08 |
| GO:BP | GO:0060322 | head development | 291 | 583 | 3.82e-08 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 138 | 242 | 3.85e-08 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 118 | 200 | 3.98e-08 |
| GO:BP | GO:0050808 | synapse organization | 199 | 375 | 4.08e-08 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 136 | 238 | 4.16e-08 |
| GO:BP | GO:0043062 | extracellular structure organization | 136 | 238 | 4.16e-08 |
| GO:BP | GO:0001775 | cell activation | 326 | 665 | 4.65e-08 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 715 | 1601 | 5.66e-08 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 129 | 224 | 5.66e-08 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 77 | 118 | 6.20e-08 |
| GO:BP | GO:0030198 | extracellular matrix organization | 135 | 237 | 6.24e-08 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 237 | 462 | 6.39e-08 |
| GO:BP | GO:0001654 | eye development | 151 | 272 | 7.95e-08 |
| GO:BP | GO:0048638 | regulation of developmental growth | 144 | 257 | 8.14e-08 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 119 | 204 | 8.40e-08 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 167 | 307 | 8.42e-08 |
| GO:BP | GO:0065009 | regulation of molecular function | 627 | 1389 | 8.93e-08 |
| GO:BP | GO:0008219 | cell death | 676 | 1509 | 9.04e-08 |
| GO:BP | GO:0007420 | brain development | 270 | 539 | 9.48e-08 |
| GO:BP | GO:0030048 | actin filament-based movement | 73 | 111 | 9.50e-08 |
| GO:BP | GO:0048588 | developmental cell growth | 114 | 194 | 9.90e-08 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 97 | 159 | 1.02e-07 |
| GO:BP | GO:0048880 | sensory system development | 152 | 275 | 1.02e-07 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 346 | 716 | 1.05e-07 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 310 | 632 | 1.05e-07 |
| GO:BP | GO:0150063 | visual system development | 151 | 273 | 1.06e-07 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 89 | 143 | 1.11e-07 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 397 | 837 | 1.19e-07 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 107 | 180 | 1.22e-07 |
| GO:BP | GO:0023061 | signal release | 179 | 335 | 1.31e-07 |
| GO:BP | GO:0012501 | programmed cell death | 673 | 1505 | 1.35e-07 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 47 | 63 | 1.37e-07 |
| GO:BP | GO:0031032 | actomyosin structure organization | 111 | 189 | 1.60e-07 |
| GO:BP | GO:0030900 | forebrain development | 159 | 292 | 1.74e-07 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 44 | 58 | 1.78e-07 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 44 | 58 | 1.78e-07 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1061 | 2474 | 1.95e-07 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 162 | 299 | 1.97e-07 |
| GO:BP | GO:0033002 | muscle cell proliferation | 95 | 157 | 2.55e-07 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 172 | 322 | 2.66e-07 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 72 | 111 | 2.76e-07 |
| GO:BP | GO:0003231 | cardiac ventricle development | 74 | 115 | 2.87e-07 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 523 | 1145 | 2.96e-07 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 81 | 129 | 3.00e-07 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 216 | 421 | 3.00e-07 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 127 | 225 | 3.58e-07 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 126 | 223 | 3.75e-07 |
| GO:BP | GO:0042060 | wound healing | 165 | 308 | 4.00e-07 |
| GO:BP | GO:0090130 | tissue migration | 141 | 256 | 4.74e-07 |
| GO:BP | GO:1901698 | response to nitrogen compound | 367 | 774 | 4.76e-07 |
| GO:BP | GO:0035265 | organ growth | 82 | 132 | 4.85e-07 |
| GO:BP | GO:0001501 | skeletal system development | 192 | 369 | 5.10e-07 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 119 | 209 | 5.19e-07 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 64 | 97 | 6.79e-07 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 112 | 195 | 7.13e-07 |
| GO:BP | GO:0001823 | mesonephros development | 54 | 78 | 7.13e-07 |
| GO:BP | GO:0043010 | camera-type eye development | 131 | 236 | 8.09e-07 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 161 | 302 | 9.08e-07 |
| GO:BP | GO:0051050 | positive regulation of transport | 294 | 606 | 9.62e-07 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 59 | 88 | 9.91e-07 |
| GO:BP | GO:0072001 | renal system development | 139 | 254 | 9.91e-07 |
| GO:BP | GO:0010631 | epithelial cell migration | 138 | 252 | 1.04e-06 |
| GO:BP | GO:0090132 | epithelium migration | 138 | 252 | 1.04e-06 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 61 | 92 | 1.07e-06 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 167 | 316 | 1.08e-06 |
| GO:BP | GO:1905314 | semi-lunar valve development | 33 | 41 | 1.13e-06 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 241 | 484 | 1.15e-06 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 241 | 484 | 1.15e-06 |
| GO:BP | GO:0055001 | muscle cell development | 99 | 169 | 1.17e-06 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 355 | 751 | 1.18e-06 |
| GO:BP | GO:0042592 | homeostatic process | 543 | 1204 | 1.22e-06 |
| GO:BP | GO:0003279 | cardiac septum development | 66 | 102 | 1.22e-06 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 53 | 77 | 1.24e-06 |
| GO:BP | GO:0072164 | mesonephric tubule development | 53 | 77 | 1.24e-06 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 250 | 506 | 1.48e-06 |
| GO:BP | GO:0006941 | striated muscle contraction | 91 | 153 | 1.51e-06 |
| GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 38 | 50 | 1.66e-06 |
| GO:BP | GO:0051046 | regulation of secretion | 210 | 415 | 1.80e-06 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 60 | 91 | 1.81e-06 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 206 | 406 | 1.83e-06 |
| GO:BP | GO:0061448 | connective tissue development | 121 | 217 | 1.83e-06 |
| GO:BP | GO:0060419 | heart growth | 50 | 72 | 1.89e-06 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 226 | 452 | 1.93e-06 |
| GO:BP | GO:0071772 | response to BMP | 77 | 125 | 2.02e-06 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 77 | 125 | 2.02e-06 |
| GO:BP | GO:0072073 | kidney epithelium development | 72 | 115 | 2.10e-06 |
| GO:BP | GO:0016358 | dendrite development | 111 | 196 | 2.10e-06 |
| GO:BP | GO:0001657 | ureteric bud development | 52 | 76 | 2.18e-06 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 110 | 194 | 2.19e-06 |
| GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 53 | 78 | 2.32e-06 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 986 | 2311 | 2.38e-06 |
| GO:BP | GO:0048878 | chemical homeostasis | 335 | 708 | 2.43e-06 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 47 | 67 | 2.80e-06 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 41 | 56 | 2.80e-06 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 47 | 67 | 2.80e-06 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 95 | 163 | 2.86e-06 |
| GO:BP | GO:0045321 | leukocyte activation | 273 | 563 | 2.88e-06 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 318 | 669 | 2.99e-06 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 59 | 90 | 2.99e-06 |
| GO:BP | GO:0045165 | cell fate commitment | 93 | 159 | 3.05e-06 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 77 | 126 | 3.12e-06 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 61 | 94 | 3.13e-06 |
| GO:BP | GO:0048844 | artery morphogenesis | 42 | 58 | 3.19e-06 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 91 | 155 | 3.25e-06 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 121 | 219 | 3.37e-06 |
| GO:BP | GO:0042330 | taxis | 142 | 265 | 3.45e-06 |
| GO:BP | GO:0006935 | chemotaxis | 142 | 265 | 3.45e-06 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 44 | 62 | 4.08e-06 |
| GO:BP | GO:0061572 | actin filament bundle organization | 83 | 139 | 4.18e-06 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 53 | 79 | 4.19e-06 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 82 | 137 | 4.28e-06 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 862 | 2006 | 4.47e-06 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 45 | 64 | 4.49e-06 |
| GO:BP | GO:0045216 | cell-cell junction organization | 92 | 158 | 4.59e-06 |
| GO:BP | GO:0060840 | artery development | 56 | 85 | 4.71e-06 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 91 | 156 | 4.74e-06 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 107 | 190 | 4.89e-06 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 74 | 121 | 5.04e-06 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 40 | 55 | 5.09e-06 |
| GO:BP | GO:0072006 | nephron development | 73 | 119 | 5.10e-06 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 870 | 2028 | 5.32e-06 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 206 | 411 | 5.32e-06 |
| GO:BP | GO:0050807 | regulation of synapse organization | 105 | 186 | 5.32e-06 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 87 | 148 | 5.40e-06 |
| GO:BP | GO:0001822 | kidney development | 133 | 247 | 5.71e-06 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 85 | 144 | 5.76e-06 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 848 | 1974 | 5.92e-06 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 131 | 243 | 6.40e-06 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 140 | 263 | 6.68e-06 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 396 | 861 | 7.19e-06 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 43 | 61 | 7.23e-06 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 227 | 461 | 7.38e-06 |
| GO:BP | GO:0051216 | cartilage development | 89 | 153 | 7.38e-06 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 33 | 43 | 7.38e-06 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 384 | 833 | 8.13e-06 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 222 | 450 | 8.29e-06 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 212 | 427 | 8.43e-06 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 59 | 92 | 8.44e-06 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 817 | 1900 | 8.44e-06 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 45 | 65 | 8.54e-06 |
| GO:BP | GO:0031399 | regulation of protein modification process | 436 | 959 | 8.54e-06 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 275 | 574 | 8.67e-06 |
| GO:BP | GO:0021915 | neural tube development | 82 | 139 | 9.32e-06 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 82 | 139 | 9.32e-06 |
| GO:BP | GO:0003281 | ventricular septum development | 47 | 69 | 9.82e-06 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 209 | 421 | 1.01e-05 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 234 | 479 | 1.03e-05 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 122 | 225 | 1.05e-05 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 97 | 171 | 1.07e-05 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 274 | 573 | 1.10e-05 |
| GO:BP | GO:0002521 | leukocyte differentiation | 197 | 394 | 1.14e-05 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 87 | 150 | 1.14e-05 |
| GO:BP | GO:1901342 | regulation of vasculature development | 114 | 208 | 1.20e-05 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 114 | 208 | 1.20e-05 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 839 | 1959 | 1.20e-05 |
| GO:BP | GO:0030509 | BMP signaling pathway | 71 | 117 | 1.24e-05 |
| GO:BP | GO:0051235 | maintenance of location | 138 | 261 | 1.26e-05 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 112 | 204 | 1.33e-05 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 43 | 62 | 1.38e-05 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 91 | 159 | 1.38e-05 |
| GO:BP | GO:0032409 | regulation of transporter activity | 91 | 159 | 1.38e-05 |
| GO:BP | GO:0072132 | mesenchyme morphogenesis | 37 | 51 | 1.48e-05 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 78 | 132 | 1.56e-05 |
| GO:BP | GO:0003170 | heart valve development | 45 | 66 | 1.60e-05 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 108 | 196 | 1.65e-05 |
| GO:BP | GO:0003176 | aortic valve development | 29 | 37 | 1.71e-05 |
| GO:BP | GO:1990138 | neuron projection extension | 85 | 147 | 1.78e-05 |
| GO:BP | GO:0006939 | smooth muscle contraction | 47 | 70 | 1.78e-05 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 387 | 846 | 1.80e-05 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 48 | 72 | 1.86e-05 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 144 | 276 | 1.92e-05 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 105 | 190 | 1.92e-05 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 435 | 963 | 1.96e-05 |
| GO:BP | GO:0060976 | coronary vasculature development | 34 | 46 | 2.04e-05 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 52 | 80 | 2.11e-05 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 332 | 715 | 2.15e-05 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 386 | 845 | 2.17e-05 |
| GO:BP | GO:0006949 | syncytium formation | 30 | 39 | 2.17e-05 |
| GO:BP | GO:0007517 | muscle organ development | 146 | 281 | 2.17e-05 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 61 | 98 | 2.21e-05 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 95 | 169 | 2.27e-05 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 212 | 433 | 2.75e-05 |
| GO:BP | GO:0099173 | postsynapse organization | 91 | 161 | 2.78e-05 |
| GO:BP | GO:0048771 | tissue remodeling | 71 | 119 | 2.87e-05 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 543 | 1231 | 2.99e-05 |
| GO:BP | GO:0048863 | stem cell differentiation | 108 | 198 | 3.03e-05 |
| GO:BP | GO:0030100 | regulation of endocytosis | 113 | 209 | 3.08e-05 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 190 | 383 | 3.30e-05 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 143 | 276 | 3.37e-05 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 93 | 166 | 3.54e-05 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 61 | 99 | 3.54e-05 |
| GO:BP | GO:0015833 | peptide transport | 105 | 192 | 3.56e-05 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 53 | 83 | 3.61e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 55 | 87 | 3.64e-05 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 283 | 602 | 3.93e-05 |
| GO:BP | GO:0002790 | peptide secretion | 97 | 175 | 3.99e-05 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 82 | 143 | 4.15e-05 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 41 | 60 | 4.30e-05 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 70 | 118 | 4.44e-05 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 188 | 380 | 4.57e-05 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 138 | 266 | 4.57e-05 |
| GO:BP | GO:0046879 | hormone secretion | 115 | 215 | 4.87e-05 |
| GO:BP | GO:0048839 | inner ear development | 78 | 135 | 4.89e-05 |
| GO:BP | GO:0007389 | pattern specification process | 156 | 307 | 4.90e-05 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 193 | 392 | 4.98e-05 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 65 | 108 | 5.06e-05 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 26 | 33 | 5.10e-05 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 75 | 129 | 5.49e-05 |
| GO:BP | GO:0009914 | hormone transport | 117 | 220 | 5.69e-05 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 74 | 127 | 5.69e-05 |
| GO:BP | GO:0006836 | neurotransmitter transport | 82 | 144 | 5.88e-05 |
| GO:BP | GO:0006813 | potassium ion transport | 82 | 144 | 5.88e-05 |
| GO:BP | GO:1901890 | positive regulation of cell junction assembly | 52 | 82 | 5.88e-05 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 187 | 379 | 5.88e-05 |
| GO:BP | GO:0002027 | regulation of heart rate | 53 | 84 | 5.88e-05 |
| GO:BP | GO:0061035 | regulation of cartilage development | 37 | 53 | 6.00e-05 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 196 | 400 | 6.05e-05 |
| GO:BP | GO:0050919 | negative chemotaxis | 31 | 42 | 6.05e-05 |
| GO:BP | GO:0043583 | ear development | 87 | 155 | 6.50e-05 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 424 | 946 | 6.70e-05 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 32 | 44 | 7.05e-05 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 485 | 1096 | 7.14e-05 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 67 | 113 | 7.16e-05 |
| GO:BP | GO:0000165 | MAPK cascade | 253 | 535 | 7.64e-05 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 125 | 239 | 7.73e-05 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 28 | 37 | 8.10e-05 |
| GO:BP | GO:0140253 | cell-cell fusion | 28 | 37 | 8.10e-05 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 74 | 128 | 8.19e-05 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 364 | 802 | 8.61e-05 |
| GO:BP | GO:0002376 | immune system process | 652 | 1512 | 8.84e-05 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 47 | 73 | 9.34e-05 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 47 | 73 | 9.34e-05 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 497 | 1128 | 9.40e-05 |
| GO:BP | GO:0048864 | stem cell development | 48 | 75 | 9.42e-05 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 195 | 400 | 9.44e-05 |
| GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 53 | 85 | 9.45e-05 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 50 | 79 | 9.47e-05 |
| GO:BP | GO:0031644 | regulation of nervous system process | 50 | 79 | 9.47e-05 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 159 | 317 | 9.66e-05 |
| GO:BP | GO:0003177 | pulmonary valve development | 19 | 22 | 9.76e-05 |
| GO:BP | GO:0031667 | response to nutrient levels | 181 | 368 | 1.03e-04 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 36 | 52 | 1.06e-04 |
| GO:BP | GO:0045927 | positive regulation of growth | 106 | 198 | 1.06e-04 |
| GO:BP | GO:0007369 | gastrulation | 83 | 148 | 1.09e-04 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 105 | 196 | 1.12e-04 |
| GO:BP | GO:0051641 | cellular localization | 1157 | 2793 | 1.12e-04 |
| GO:BP | GO:0048168 | regulation of neuronal synaptic plasticity | 30 | 41 | 1.12e-04 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 118 | 225 | 1.16e-04 |
| GO:BP | GO:0007611 | learning or memory | 109 | 205 | 1.16e-04 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 17 | 19 | 1.17e-04 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 122 | 234 | 1.17e-04 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 38 | 56 | 1.20e-04 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 242 | 512 | 1.23e-04 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 61 | 102 | 1.25e-04 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 70 | 121 | 1.37e-04 |
| GO:BP | GO:0072028 | nephron morphogenesis | 41 | 62 | 1.37e-04 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 42 | 64 | 1.42e-04 |
| GO:BP | GO:0021537 | telencephalon development | 110 | 208 | 1.44e-04 |
| GO:BP | GO:0008544 | epidermis development | 114 | 217 | 1.47e-04 |
| GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 134 | 262 | 1.48e-04 |
| GO:BP | GO:0009306 | protein secretion | 134 | 262 | 1.48e-04 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 100 | 186 | 1.48e-04 |
| GO:BP | GO:0014032 | neural crest cell development | 45 | 70 | 1.49e-04 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 47 | 74 | 1.50e-04 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 47 | 74 | 1.50e-04 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 47 | 74 | 1.50e-04 |
| GO:BP | GO:0016049 | cell growth | 199 | 412 | 1.50e-04 |
| GO:BP | GO:0014896 | muscle hypertrophy | 48 | 76 | 1.50e-04 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 47 | 74 | 1.50e-04 |
| GO:BP | GO:0042471 | ear morphogenesis | 48 | 76 | 1.50e-04 |
| GO:BP | GO:0003272 | endocardial cushion formation | 20 | 24 | 1.52e-04 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 216 | 452 | 1.53e-04 |
| GO:BP | GO:0030072 | peptide hormone secretion | 93 | 171 | 1.61e-04 |
| GO:BP | GO:0001755 | neural crest cell migration | 34 | 49 | 1.69e-04 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 34 | 49 | 1.69e-04 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 63 | 107 | 1.73e-04 |
| GO:BP | GO:0099643 | signal release from synapse | 63 | 107 | 1.73e-04 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 62 | 105 | 1.79e-04 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 184 | 378 | 1.80e-04 |
| GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 35 | 51 | 1.81e-04 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 35 | 51 | 1.81e-04 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 35 | 51 | 1.81e-04 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 96 | 178 | 1.81e-04 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 61 | 103 | 1.83e-04 |
| GO:BP | GO:0042886 | amide transport | 114 | 218 | 1.85e-04 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 24 | 31 | 1.89e-04 |
| GO:BP | GO:0022612 | gland morphogenesis | 60 | 101 | 1.89e-04 |
| GO:BP | GO:0048645 | animal organ formation | 36 | 53 | 1.91e-04 |
| GO:BP | GO:0050708 | regulation of protein secretion | 99 | 185 | 2.01e-04 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 29 | 40 | 2.01e-04 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 88 | 161 | 2.09e-04 |
| GO:BP | GO:0031099 | regeneration | 82 | 148 | 2.11e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 67 | 116 | 2.15e-04 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 55 | 91 | 2.15e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 67 | 116 | 2.15e-04 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 39 | 59 | 2.17e-04 |
| GO:BP | GO:0014902 | myotube differentiation | 54 | 89 | 2.19e-04 |
| GO:BP | GO:0035148 | tube formation | 74 | 131 | 2.24e-04 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 30 | 42 | 2.25e-04 |
| GO:BP | GO:0014888 | striated muscle adaptation | 30 | 42 | 2.25e-04 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 52 | 85 | 2.26e-04 |
| GO:BP | GO:0048736 | appendage development | 80 | 144 | 2.31e-04 |
| GO:BP | GO:0060173 | limb development | 80 | 144 | 2.31e-04 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 46 | 73 | 2.38e-04 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 47 | 75 | 2.38e-04 |
| GO:BP | GO:0060993 | kidney morphogenesis | 46 | 73 | 2.38e-04 |
| GO:BP | GO:0040008 | regulation of growth | 232 | 493 | 2.53e-04 |
| GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 181 | 373 | 2.56e-04 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 142 | 283 | 2.65e-04 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 32 | 46 | 2.71e-04 |
| GO:BP | GO:0003002 | regionalization | 138 | 274 | 2.74e-04 |
| GO:BP | GO:0006814 | sodium ion transport | 82 | 149 | 2.85e-04 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 22 | 28 | 2.86e-04 |
| GO:BP | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 22 | 28 | 2.86e-04 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 102 | 193 | 2.87e-04 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 130 | 256 | 2.87e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 303 | 664 | 2.89e-04 |
| GO:BP | GO:0048732 | gland development | 160 | 325 | 2.96e-04 |
| GO:BP | GO:0060348 | bone development | 86 | 158 | 3.10e-04 |
| GO:BP | GO:0007613 | memory | 56 | 94 | 3.12e-04 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 56 | 94 | 3.12e-04 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 91 | 169 | 3.12e-04 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 54 | 90 | 3.30e-04 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 79 | 143 | 3.31e-04 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 64 | 111 | 3.45e-04 |
| GO:BP | GO:0046649 | lymphocyte activation | 224 | 476 | 3.45e-04 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 51 | 84 | 3.54e-04 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 50 | 82 | 3.61e-04 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 147 | 296 | 3.62e-04 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 77 | 139 | 3.67e-04 |
| GO:BP | GO:0072088 | nephron epithelium morphogenesis | 39 | 60 | 3.70e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 40 | 62 | 3.76e-04 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 118 | 230 | 3.77e-04 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 44 | 70 | 3.82e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 42 | 66 | 3.82e-04 |
| GO:BP | GO:0055002 | striated muscle cell development | 44 | 70 | 3.82e-04 |
| GO:BP | GO:0035296 | regulation of tube diameter | 61 | 105 | 3.83e-04 |
| GO:BP | GO:0097746 | blood vessel diameter maintenance | 61 | 105 | 3.83e-04 |
| GO:BP | GO:0035150 | regulation of tube size | 61 | 105 | 3.83e-04 |
| GO:BP | GO:0006954 | inflammatory response | 216 | 458 | 3.98e-04 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 120 | 235 | 4.19e-04 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 20 | 25 | 4.26e-04 |
| GO:BP | GO:0001704 | formation of primary germ layer | 58 | 99 | 4.29e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 612 | 1430 | 4.38e-04 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 319 | 706 | 4.38e-04 |
| GO:BP | GO:0098739 | import across plasma membrane | 73 | 131 | 4.45e-04 |
| GO:BP | GO:0030073 | insulin secretion | 79 | 144 | 4.45e-04 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 98 | 186 | 4.67e-04 |
| GO:BP | GO:0050890 | cognition | 118 | 231 | 4.73e-04 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 560 | 1301 | 4.77e-04 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 71 | 127 | 4.92e-04 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 561 | 1304 | 5.01e-04 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 63 | 110 | 5.08e-04 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 290 | 637 | 5.15e-04 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 52 | 87 | 5.18e-04 |
| GO:BP | GO:1901653 | cellular response to peptide | 141 | 284 | 5.19e-04 |
| GO:BP | GO:0060675 | ureteric bud morphogenesis | 33 | 49 | 5.26e-04 |
| GO:BP | GO:0140115 | export across plasma membrane | 33 | 49 | 5.26e-04 |
| GO:BP | GO:0060977 | coronary vasculature morphogenesis | 15 | 17 | 5.34e-04 |
| GO:BP | GO:0019725 | cellular homeostasis | 272 | 594 | 5.43e-04 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 75 | 136 | 5.48e-04 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 61 | 106 | 5.49e-04 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 21 | 27 | 5.50e-04 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 115 | 225 | 5.64e-04 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 146 | 296 | 5.65e-04 |
| GO:BP | GO:0060541 | respiratory system development | 90 | 169 | 5.65e-04 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 26 | 36 | 5.76e-04 |
| GO:BP | GO:0050865 | regulation of cell activation | 176 | 366 | 5.80e-04 |
| GO:BP | GO:2001257 | regulation of cation channel activity | 45 | 73 | 5.95e-04 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 106 | 205 | 6.07e-04 |
| GO:BP | GO:0060079 | excitatory postsynaptic potential | 43 | 69 | 6.07e-04 |
| GO:BP | GO:0030239 | myofibril assembly | 42 | 67 | 6.10e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 40 | 63 | 6.10e-04 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 66 | 117 | 6.12e-04 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 18 | 22 | 6.12e-04 |
| GO:BP | GO:0007612 | learning | 66 | 117 | 6.12e-04 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 138 | 278 | 6.12e-04 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 18 | 22 | 6.12e-04 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 78 | 143 | 6.22e-04 |
| GO:BP | GO:0009725 | response to hormone | 288 | 634 | 6.42e-04 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 168 | 348 | 6.55e-04 |
| GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 22 | 29 | 6.71e-04 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 22 | 29 | 6.71e-04 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 22 | 29 | 6.71e-04 |
| GO:BP | GO:0007215 | glutamate receptor signaling pathway | 22 | 29 | 6.71e-04 |
| GO:BP | GO:1902414 | protein localization to cell junction | 55 | 94 | 6.81e-04 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 217 | 464 | 6.86e-04 |
| GO:BP | GO:0002791 | regulation of peptide secretion | 76 | 139 | 6.90e-04 |
| GO:BP | GO:0010817 | regulation of hormone levels | 164 | 339 | 6.93e-04 |
| GO:BP | GO:0070482 | response to oxygen levels | 139 | 281 | 7.01e-04 |
| GO:BP | GO:0043500 | muscle adaptation | 54 | 92 | 7.02e-04 |
| GO:BP | GO:0072009 | nephron epithelium development | 52 | 88 | 7.54e-04 |
| GO:BP | GO:1904064 | positive regulation of cation transmembrane transport | 52 | 88 | 7.54e-04 |
| GO:BP | GO:0072175 | epithelial tube formation | 68 | 122 | 7.64e-04 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 68 | 122 | 7.64e-04 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 68 | 122 | 7.64e-04 |
| GO:BP | GO:0003158 | endothelium development | 61 | 107 | 7.64e-04 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 68 | 122 | 7.64e-04 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 93 | 177 | 7.87e-04 |
| GO:BP | GO:0051651 | maintenance of location in cell | 93 | 177 | 7.87e-04 |
| GO:BP | GO:0098815 | modulation of excitatory postsynaptic potential | 30 | 44 | 7.96e-04 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 67 | 120 | 8.02e-04 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0032878 | regulation of establishment or maintenance of cell polarity | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0014887 | cardiac muscle adaptation | 19 | 24 | 8.16e-04 |
| GO:BP | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 59 | 103 | 8.25e-04 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 136 | 275 | 8.32e-04 |
| GO:BP | GO:0003197 | endocardial cushion development | 31 | 46 | 8.32e-04 |
| GO:BP | GO:0061326 | renal tubule development | 47 | 78 | 8.57e-04 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 77 | 142 | 8.64e-04 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 77 | 142 | 8.64e-04 |
| GO:BP | GO:0030031 | cell projection assembly | 223 | 480 | 8.68e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 157 | 324 | 8.70e-04 |
| GO:BP | GO:0050900 | leukocyte migration | 107 | 209 | 8.87e-04 |
| GO:BP | GO:0060420 | regulation of heart growth | 33 | 50 | 8.93e-04 |
| GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 33 | 50 | 8.93e-04 |
| GO:BP | GO:0006950 | response to stress | 1114 | 2715 | 9.07e-04 |
| GO:BP | GO:0001707 | mesoderm formation | 35 | 54 | 9.37e-04 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 36 | 56 | 9.47e-04 |
| GO:BP | GO:0048332 | mesoderm morphogenesis | 36 | 56 | 9.47e-04 |
| GO:BP | GO:0007492 | endoderm development | 41 | 66 | 9.47e-04 |
| GO:BP | GO:0140238 | presynaptic endocytosis | 40 | 64 | 9.52e-04 |
| GO:BP | GO:0072078 | nephron tubule morphogenesis | 37 | 58 | 9.52e-04 |
| GO:BP | GO:0061333 | renal tubule morphogenesis | 39 | 62 | 9.54e-04 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 55 | 95 | 9.61e-04 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 105 | 205 | 9.96e-04 |
| GO:BP | GO:0002064 | epithelial cell development | 84 | 158 | 1.01e-03 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 25 | 35 | 1.01e-03 |
| GO:BP | GO:0019933 | cAMP-mediated signaling | 25 | 35 | 1.01e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 74 | 136 | 1.01e-03 |
| GO:BP | GO:0001701 | in utero embryonic development | 166 | 346 | 1.02e-03 |
| GO:BP | GO:0014020 | primary neural tube formation | 53 | 91 | 1.03e-03 |
| GO:BP | GO:0007498 | mesoderm development | 53 | 91 | 1.03e-03 |
| GO:BP | GO:0030010 | establishment of cell polarity | 73 | 134 | 1.06e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 206 | 441 | 1.08e-03 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 159 | 330 | 1.09e-03 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 26 | 37 | 1.10e-03 |
| GO:BP | GO:0046883 | regulation of hormone secretion | 91 | 174 | 1.12e-03 |
| GO:BP | GO:0030323 | respiratory tube development | 82 | 154 | 1.12e-03 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 66 | 119 | 1.13e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 130 | 263 | 1.19e-03 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 98 | 190 | 1.20e-03 |
| GO:BP | GO:0090087 | regulation of peptide transport | 76 | 141 | 1.20e-03 |
| GO:BP | GO:0003171 | atrioventricular valve development | 21 | 28 | 1.24e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 64 | 115 | 1.26e-03 |
| GO:BP | GO:0030324 | lung development | 80 | 150 | 1.26e-03 |
| GO:BP | GO:0036211 | protein modification process | 998 | 2423 | 1.26e-03 |
| GO:BP | GO:0055123 | digestive system development | 56 | 98 | 1.31e-03 |
| GO:BP | GO:0010721 | negative regulation of cell development | 100 | 195 | 1.34e-03 |
| GO:BP | GO:0014812 | muscle cell migration | 45 | 75 | 1.34e-03 |
| GO:BP | GO:0090276 | regulation of peptide hormone secretion | 74 | 137 | 1.34e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 45 | 75 | 1.34e-03 |
| GO:BP | GO:0001841 | neural tube formation | 55 | 96 | 1.37e-03 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 217 | 469 | 1.40e-03 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 30 | 45 | 1.40e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 30 | 45 | 1.40e-03 |
| GO:BP | GO:0007520 | myoblast fusion | 22 | 30 | 1.44e-03 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 307 | 687 | 1.44e-03 |
| GO:BP | GO:0001570 | vasculogenesis | 41 | 67 | 1.46e-03 |
| GO:BP | GO:0050817 | coagulation | 82 | 155 | 1.46e-03 |
| GO:BP | GO:0097061 | dendritic spine organization | 41 | 67 | 1.46e-03 |
| GO:BP | GO:0048488 | synaptic vesicle endocytosis | 39 | 63 | 1.50e-03 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 39 | 63 | 1.50e-03 |
| GO:BP | GO:0042063 | gliogenesis | 126 | 255 | 1.50e-03 |
| GO:BP | GO:0045859 | regulation of protein kinase activity | 165 | 346 | 1.51e-03 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 38 | 61 | 1.51e-03 |
| GO:BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 34 | 53 | 1.52e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 35 | 55 | 1.52e-03 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 35 | 55 | 1.52e-03 |
| GO:BP | GO:0048565 | digestive tract development | 52 | 90 | 1.53e-03 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 52 | 90 | 1.53e-03 |
| GO:BP | GO:0046777 | protein autophosphorylation | 81 | 153 | 1.53e-03 |
| GO:BP | GO:0032535 | regulation of cellular component size | 150 | 311 | 1.55e-03 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 18 | 23 | 1.56e-03 |
| GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 23 | 32 | 1.61e-03 |
| GO:BP | GO:0042110 | T cell activation | 155 | 323 | 1.63e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 137 | 281 | 1.65e-03 |
| GO:BP | GO:0031214 | biomineral tissue development | 64 | 116 | 1.69e-03 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 64 | 116 | 1.69e-03 |
| GO:BP | GO:0010954 | positive regulation of protein processing | 15 | 18 | 1.71e-03 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 57 | 101 | 1.74e-03 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 57 | 101 | 1.74e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 709 | 1692 | 1.74e-03 |
| GO:BP | GO:0001764 | neuron migration | 74 | 138 | 1.75e-03 |
| GO:BP | GO:0007009 | plasma membrane organization | 63 | 114 | 1.77e-03 |
| GO:BP | GO:0003230 | cardiac atrium development | 24 | 34 | 1.77e-03 |
| GO:BP | GO:0007599 | hemostasis | 82 | 156 | 1.87e-03 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 82 | 156 | 1.87e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 62 | 112 | 1.87e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 112 | 224 | 1.91e-03 |
| GO:BP | GO:0106027 | neuron projection organization | 45 | 76 | 1.98e-03 |
| GO:BP | GO:0043149 | stress fiber assembly | 54 | 95 | 1.99e-03 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 54 | 95 | 1.99e-03 |
| GO:BP | GO:1901652 | response to peptide | 179 | 381 | 2.03e-03 |
| GO:BP | GO:0072080 | nephron tubule development | 44 | 74 | 2.03e-03 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 76 | 143 | 2.05e-03 |
| GO:BP | GO:0001508 | action potential | 60 | 108 | 2.07e-03 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 43 | 72 | 2.09e-03 |
| GO:BP | GO:0046620 | regulation of organ growth | 43 | 72 | 2.09e-03 |
| GO:BP | GO:0007596 | blood coagulation | 80 | 152 | 2.10e-03 |
| GO:BP | GO:0031503 | protein-containing complex localization | 88 | 170 | 2.15e-03 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 65 | 119 | 2.15e-03 |
| GO:BP | GO:0050796 | regulation of insulin secretion | 65 | 119 | 2.15e-03 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 52 | 91 | 2.16e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 52 | 91 | 2.16e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 52 | 91 | 2.16e-03 |
| GO:BP | GO:0051047 | positive regulation of secretion | 106 | 211 | 2.22e-03 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 51 | 89 | 2.26e-03 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 20 | 27 | 2.26e-03 |
| GO:BP | GO:1902656 | calcium ion import into cytosol | 20 | 27 | 2.26e-03 |
| GO:BP | GO:0043217 | myelin maintenance | 13 | 15 | 2.31e-03 |
| GO:BP | GO:0034332 | adherens junction organization | 29 | 44 | 2.31e-03 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 30 | 46 | 2.37e-03 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 37 | 60 | 2.37e-03 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 36 | 58 | 2.40e-03 |
| GO:BP | GO:0031102 | neuron projection regeneration | 32 | 50 | 2.43e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 68 | 126 | 2.43e-03 |
| GO:BP | GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 34 | 54 | 2.43e-03 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 33 | 52 | 2.43e-03 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 34 | 54 | 2.43e-03 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 49 | 85 | 2.44e-03 |
| GO:BP | GO:0010001 | glial cell differentiation | 97 | 191 | 2.47e-03 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 56 | 100 | 2.49e-03 |
| GO:BP | GO:0008217 | regulation of blood pressure | 62 | 113 | 2.50e-03 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 62 | 113 | 2.50e-03 |
| GO:BP | GO:0032906 | transforming growth factor beta2 production | 9 | 9 | 2.52e-03 |
| GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 9 | 9 | 2.52e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 48 | 83 | 2.52e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 48 | 83 | 2.52e-03 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 129 | 265 | 2.62e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 1005 | 2453 | 2.62e-03 |
| GO:BP | GO:0007416 | synapse assembly | 80 | 153 | 2.67e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 60 | 109 | 2.78e-03 |
| GO:BP | GO:0003222 | ventricular trabecula myocardium morphogenesis | 11 | 12 | 2.78e-03 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 11 | 12 | 2.78e-03 |
| GO:BP | GO:0097581 | lamellipodium organization | 45 | 77 | 2.85e-03 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 22 | 31 | 2.85e-03 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 295 | 664 | 2.90e-03 |
| GO:BP | GO:0051249 | regulation of lymphocyte activation | 142 | 296 | 2.93e-03 |
| GO:BP | GO:0001666 | response to hypoxia | 121 | 247 | 2.93e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 69 | 129 | 3.01e-03 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 57 | 103 | 3.27e-03 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 261 | 582 | 3.27e-03 |
| GO:BP | GO:0001892 | embryonic placenta development | 41 | 69 | 3.27e-03 |
| GO:BP | GO:0030316 | osteoclast differentiation | 41 | 69 | 3.27e-03 |
| GO:BP | GO:0060606 | tube closure | 50 | 88 | 3.32e-03 |
| GO:BP | GO:0048846 | axon extension involved in axon guidance | 24 | 35 | 3.32e-03 |
| GO:BP | GO:0008038 | neuron recognition | 24 | 35 | 3.32e-03 |
| GO:BP | GO:1902284 | neuron projection extension involved in neuron projection guidance | 24 | 35 | 3.32e-03 |
| GO:BP | GO:0001890 | placenta development | 62 | 114 | 3.37e-03 |
| GO:BP | GO:0021700 | developmental maturation | 109 | 220 | 3.40e-03 |
| GO:BP | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 14 | 17 | 3.44e-03 |
| GO:BP | GO:0051590 | positive regulation of neurotransmitter transport | 14 | 17 | 3.44e-03 |
| GO:BP | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 14 | 17 | 3.44e-03 |
| GO:BP | GO:0038084 | vascular endothelial growth factor signaling pathway | 25 | 37 | 3.49e-03 |
| GO:BP | GO:0071870 | cellular response to catecholamine stimulus | 25 | 37 | 3.49e-03 |
| GO:BP | GO:0071868 | cellular response to monoamine stimulus | 25 | 37 | 3.49e-03 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 38 | 63 | 3.53e-03 |
| GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 38 | 63 | 3.53e-03 |
| GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 18 | 24 | 3.58e-03 |
| GO:BP | GO:0060996 | dendritic spine development | 48 | 84 | 3.59e-03 |
| GO:BP | GO:0071869 | response to catecholamine | 26 | 39 | 3.61e-03 |
| GO:BP | GO:0071867 | response to monoamine | 26 | 39 | 3.61e-03 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 26 | 39 | 3.61e-03 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 36 | 59 | 3.68e-03 |
| GO:BP | GO:0050795 | regulation of behavior | 27 | 41 | 3.72e-03 |
| GO:BP | GO:0051592 | response to calcium ion | 60 | 110 | 3.72e-03 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 35 | 57 | 3.73e-03 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 54 | 97 | 3.73e-03 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 65 | 121 | 3.73e-03 |
| GO:BP | GO:0044344 | cellular response to fibroblast growth factor stimulus | 47 | 82 | 3.73e-03 |
| GO:BP | GO:0010038 | response to metal ion | 126 | 260 | 3.73e-03 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 47 | 82 | 3.73e-03 |
| GO:BP | GO:0019229 | regulation of vasoconstriction | 28 | 43 | 3.77e-03 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 107 | 216 | 3.77e-03 |
| GO:BP | GO:0001658 | branching involved in ureteric bud morphogenesis | 28 | 43 | 3.77e-03 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 28 | 43 | 3.77e-03 |
| GO:BP | GO:0097120 | receptor localization to synapse | 33 | 53 | 3.80e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 400 | 926 | 3.80e-03 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 33 | 53 | 3.80e-03 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 32 | 51 | 3.83e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 59 | 108 | 3.88e-03 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 125 | 258 | 3.93e-03 |
| GO:BP | GO:0010876 | lipid localization | 148 | 312 | 3.93e-03 |
| GO:BP | GO:0033993 | response to lipid | 268 | 601 | 4.00e-03 |
| GO:BP | GO:0098703 | calcium ion import across plasma membrane | 19 | 26 | 4.06e-03 |
| GO:BP | GO:0003209 | cardiac atrium morphogenesis | 19 | 26 | 4.06e-03 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 19 | 26 | 4.06e-03 |
| GO:BP | GO:0043542 | endothelial cell migration | 92 | 182 | 4.07e-03 |
| GO:BP | GO:0010595 | positive regulation of endothelial cell migration | 52 | 93 | 4.07e-03 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 52 | 93 | 4.07e-03 |
| GO:BP | GO:0048675 | axon extension | 58 | 106 | 4.07e-03 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 147 | 310 | 4.15e-03 |
| GO:BP | GO:0097306 | cellular response to alcohol | 44 | 76 | 4.16e-03 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 51 | 91 | 4.28e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 51 | 91 | 4.28e-03 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 57 | 104 | 4.29e-03 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 43 | 74 | 4.33e-03 |
| GO:BP | GO:1903319 | positive regulation of protein maturation | 15 | 19 | 4.50e-03 |
| GO:BP | GO:0051588 | regulation of neurotransmitter transport | 42 | 72 | 4.51e-03 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 20 | 28 | 4.53e-03 |
| GO:BP | GO:0048713 | regulation of oligodendrocyte differentiation | 20 | 28 | 4.53e-03 |
| GO:BP | GO:0006869 | lipid transport | 131 | 273 | 4.64e-03 |
| GO:BP | GO:0006887 | exocytosis | 122 | 252 | 4.69e-03 |
| GO:BP | GO:0001843 | neural tube closure | 49 | 87 | 4.72e-03 |
| GO:BP | GO:0007605 | sensory perception of sound | 55 | 100 | 4.78e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 40 | 68 | 4.84e-03 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 40 | 68 | 4.84e-03 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 186 | 404 | 4.91e-03 |
| GO:BP | GO:0060914 | heart formation | 21 | 30 | 4.95e-03 |
| GO:BP | GO:0048512 | circadian behavior | 21 | 30 | 4.95e-03 |
| GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 69 | 131 | 4.99e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 39 | 66 | 5.00e-03 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 64 | 120 | 5.13e-03 |
| GO:BP | GO:0030217 | T cell differentiation | 95 | 190 | 5.17e-03 |
| GO:BP | GO:0007622 | rhythmic behavior | 22 | 32 | 5.31e-03 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 182 | 395 | 5.34e-03 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 91 | 181 | 5.35e-03 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 46 | 81 | 5.43e-03 |
| GO:BP | GO:0014074 | response to purine-containing compound | 58 | 107 | 5.45e-03 |
| GO:BP | GO:0051899 | membrane depolarization | 36 | 60 | 5.49e-03 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 35 | 58 | 5.65e-03 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 45 | 79 | 5.68e-03 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0032924 | activin receptor signaling pathway | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 24 | 36 | 5.80e-03 |
| GO:BP | GO:0032674 | regulation of interleukin-5 production | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0060896 | neural plate pattern specification | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0003190 | atrioventricular valve formation | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0060982 | coronary artery morphogenesis | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0003418 | growth plate cartilage chondrocyte differentiation | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0032634 | interleukin-5 production | 8 | 8 | 5.84e-03 |
| GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 33 | 54 | 5.85e-03 |
| GO:BP | GO:0051480 | regulation of cytosolic calcium ion concentration | 25 | 38 | 5.94e-03 |
| GO:BP | GO:0021670 | lateral ventricle development | 10 | 11 | 5.98e-03 |
| GO:BP | GO:0051923 | sulfation | 10 | 11 | 5.98e-03 |
| GO:BP | GO:0045055 | regulated exocytosis | 78 | 152 | 6.01e-03 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 99 | 200 | 6.02e-03 |
| GO:BP | GO:0045685 | regulation of glial cell differentiation | 31 | 50 | 6.02e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 30 | 48 | 6.09e-03 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 28 | 44 | 6.10e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 29 | 46 | 6.10e-03 |
| GO:BP | GO:0050922 | negative regulation of chemotaxis | 28 | 44 | 6.10e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 50 | 90 | 6.10e-03 |
| GO:BP | GO:0048145 | regulation of fibroblast proliferation | 43 | 75 | 6.10e-03 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 95 | 191 | 6.27e-03 |
| GO:BP | GO:0036465 | synaptic vesicle recycling | 42 | 73 | 6.38e-03 |
| GO:BP | GO:0060037 | pharyngeal system development | 17 | 23 | 6.45e-03 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 104 | 212 | 6.55e-03 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 104 | 212 | 6.55e-03 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 107 | 219 | 6.59e-03 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 41 | 71 | 6.65e-03 |
| GO:BP | GO:0051051 | negative regulation of transport | 144 | 306 | 6.70e-03 |
| GO:BP | GO:0021846 | cell proliferation in forebrain | 13 | 16 | 6.70e-03 |
| GO:BP | GO:0071774 | response to fibroblast growth factor | 48 | 86 | 6.74e-03 |
| GO:BP | GO:0043549 | regulation of kinase activity | 172 | 373 | 6.94e-03 |
| GO:BP | GO:0022607 | cellular component assembly | 1009 | 2481 | 7.15e-03 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 86 | 171 | 7.18e-03 |
| GO:BP | GO:0045124 | regulation of bone resorption | 18 | 25 | 7.30e-03 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 18 | 25 | 7.30e-03 |
| GO:BP | GO:0043393 | regulation of protein binding | 62 | 117 | 7.43e-03 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 62 | 117 | 7.43e-03 |
| GO:BP | GO:1904018 | positive regulation of vasculature development | 62 | 117 | 7.43e-03 |
| GO:BP | GO:0008366 | axon ensheathment | 66 | 126 | 7.60e-03 |
| GO:BP | GO:0007272 | ensheathment of neurons | 66 | 126 | 7.60e-03 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 85 | 169 | 7.62e-03 |
| GO:BP | GO:0000082 | G1/S transition of mitotic cell cycle | 95 | 192 | 7.67e-03 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 45 | 80 | 7.84e-03 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 119 | 248 | 7.87e-03 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 61 | 115 | 7.87e-03 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 141 | 300 | 7.98e-03 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 19 | 27 | 7.98e-03 |
| GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 19 | 27 | 7.98e-03 |
| GO:BP | GO:0032941 | secretion by tissue | 19 | 27 | 7.98e-03 |
| GO:BP | GO:0046849 | bone remodeling | 36 | 61 | 8.02e-03 |
| GO:BP | GO:0042552 | myelination | 65 | 124 | 8.03e-03 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 35 | 59 | 8.31e-03 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 112 | 232 | 8.43e-03 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 55 | 102 | 8.44e-03 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 20 | 29 | 8.57e-03 |
| GO:BP | GO:0070570 | regulation of neuron projection regeneration | 20 | 29 | 8.57e-03 |
| GO:BP | GO:0008361 | regulation of cell size | 83 | 165 | 8.59e-03 |
| GO:BP | GO:0038094 | Fc-gamma receptor signaling pathway | 14 | 18 | 8.61e-03 |
| GO:BP | GO:0060445 | branching involved in salivary gland morphogenesis | 14 | 18 | 8.61e-03 |
| GO:BP | GO:0001708 | cell fate specification | 33 | 55 | 8.79e-03 |
| GO:BP | GO:0032835 | glomerulus development | 33 | 55 | 8.79e-03 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 33 | 55 | 8.79e-03 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 21 | 31 | 8.98e-03 |
| GO:BP | GO:0048841 | regulation of axon extension involved in axon guidance | 21 | 31 | 8.98e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 662 | 1597 | 8.98e-03 |
| GO:BP | GO:0051928 | positive regulation of calcium ion transport | 42 | 74 | 8.98e-03 |
| GO:BP | GO:0097106 | postsynaptic density organization | 21 | 31 | 8.98e-03 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 32 | 53 | 9.00e-03 |
| GO:BP | GO:0060326 | cell chemotaxis | 82 | 163 | 9.08e-03 |
| GO:BP | GO:0072089 | stem cell proliferation | 48 | 87 | 9.16e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 122 | 256 | 9.16e-03 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 31 | 51 | 9.21e-03 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 141 | 301 | 9.21e-03 |
| GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 22 | 33 | 9.31e-03 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 41 | 72 | 9.32e-03 |
| GO:BP | GO:1903532 | positive regulation of secretion by cell | 98 | 200 | 9.32e-03 |
| GO:BP | GO:0031623 | receptor internalization | 53 | 98 | 9.32e-03 |
| GO:BP | GO:0010232 | vascular transport | 41 | 72 | 9.32e-03 |
| GO:BP | GO:0060997 | dendritic spine morphogenesis | 30 | 49 | 9.36e-03 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 23 | 35 | 9.52e-03 |
| GO:BP | GO:1905330 | regulation of morphogenesis of an epithelium | 29 | 47 | 9.52e-03 |
| GO:BP | GO:0009880 | embryonic pattern specification | 29 | 47 | 9.52e-03 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 70 | 136 | 9.57e-03 |
| GO:BP | GO:0001956 | positive regulation of neurotransmitter secretion | 11 | 13 | 9.60e-03 |
| GO:BP | GO:0072578 | neurotransmitter-gated ion channel clustering | 11 | 13 | 9.60e-03 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 24 | 37 | 9.65e-03 |
| GO:BP | GO:0045214 | sarcomere organization | 27 | 43 | 9.71e-03 |
| GO:BP | GO:0030517 | negative regulation of axon extension | 26 | 41 | 9.75e-03 |
| GO:BP | GO:0006996 | organelle organization | 1208 | 3001 | 9.82e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 351 | 815 | 9.88e-03 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 100 | 205 | 9.88e-03 |
| GO:BP | GO:0042476 | odontogenesis | 46 | 83 | 1.01e-02 |
| GO:BP | GO:0035418 | protein localization to synapse | 39 | 68 | 1.01e-02 |
| GO:BP | GO:0061024 | membrane organization | 292 | 669 | 1.01e-02 |
| GO:BP | GO:2000114 | regulation of establishment of cell polarity | 15 | 20 | 1.01e-02 |
| GO:BP | GO:1990806 | ligand-gated ion channel signaling pathway | 15 | 20 | 1.01e-02 |
| GO:BP | GO:0031281 | positive regulation of cyclase activity | 15 | 20 | 1.01e-02 |
| GO:BP | GO:0030534 | adult behavior | 51 | 94 | 1.03e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 83 | 166 | 1.04e-02 |
| GO:BP | GO:0071900 | regulation of protein serine/threonine kinase activity | 99 | 203 | 1.05e-02 |
| GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 38 | 66 | 1.05e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 68 | 132 | 1.07e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 431 | 1016 | 1.08e-02 |
| GO:BP | GO:0010565 | regulation of cellular ketone metabolic process | 55 | 103 | 1.09e-02 |
| GO:BP | GO:0030168 | platelet activation | 50 | 92 | 1.09e-02 |
| GO:BP | GO:0032414 | positive regulation of ion transmembrane transporter activity | 37 | 64 | 1.10e-02 |
| GO:BP | GO:0051640 | organelle localization | 238 | 537 | 1.10e-02 |
| GO:BP | GO:0003014 | renal system process | 44 | 79 | 1.11e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 36 | 62 | 1.15e-02 |
| GO:BP | GO:0048499 | synaptic vesicle membrane organization | 16 | 22 | 1.16e-02 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 914 | 2246 | 1.17e-02 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 43 | 77 | 1.17e-02 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 35 | 60 | 1.19e-02 |
| GO:BP | GO:0097529 | myeloid leukocyte migration | 62 | 119 | 1.21e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 42 | 75 | 1.23e-02 |
| GO:BP | GO:0048709 | oligodendrocyte differentiation | 42 | 75 | 1.23e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 42 | 75 | 1.23e-02 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 270 | 617 | 1.28e-02 |
| GO:BP | GO:0030431 | sleep | 9 | 10 | 1.28e-02 |
| GO:BP | GO:0045761 | regulation of adenylate cyclase activity | 17 | 24 | 1.28e-02 |
| GO:BP | GO:0046847 | filopodium assembly | 33 | 56 | 1.28e-02 |
| GO:BP | GO:0002063 | chondrocyte development | 17 | 24 | 1.28e-02 |
| GO:BP | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 9 | 10 | 1.28e-02 |
| GO:BP | GO:0022410 | circadian sleep/wake cycle process | 9 | 10 | 1.28e-02 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 17 | 24 | 1.28e-02 |
| GO:BP | GO:0045906 | negative regulation of vasoconstriction | 9 | 10 | 1.28e-02 |
| GO:BP | GO:0007584 | response to nutrient | 61 | 117 | 1.28e-02 |
| GO:BP | GO:0035270 | endocrine system development | 47 | 86 | 1.28e-02 |
| GO:BP | GO:0007600 | sensory perception | 124 | 263 | 1.30e-02 |
| GO:BP | GO:0070571 | negative regulation of neuron projection regeneration | 12 | 15 | 1.30e-02 |
| GO:BP | GO:1902932 | positive regulation of alcohol biosynthetic process | 12 | 15 | 1.30e-02 |
| GO:BP | GO:0090103 | cochlea morphogenesis | 12 | 15 | 1.30e-02 |
| GO:BP | GO:0071396 | cellular response to lipid | 184 | 407 | 1.32e-02 |
| GO:BP | GO:0051098 | regulation of binding | 101 | 209 | 1.33e-02 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 152 | 330 | 1.35e-02 |
| GO:BP | GO:0008104 | protein localization | 867 | 2128 | 1.35e-02 |
| GO:BP | GO:0010761 | fibroblast migration | 31 | 52 | 1.36e-02 |
| GO:BP | GO:0035904 | aorta development | 31 | 52 | 1.36e-02 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 18 | 26 | 1.37e-02 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 251 | 571 | 1.37e-02 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 18 | 26 | 1.37e-02 |
| GO:BP | GO:0048668 | collateral sprouting | 18 | 26 | 1.37e-02 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 18 | 26 | 1.37e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 314 | 727 | 1.40e-02 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 39 | 69 | 1.41e-02 |
| GO:BP | GO:0051223 | regulation of protein transport | 156 | 340 | 1.42e-02 |
| GO:BP | GO:0030516 | regulation of axon extension | 45 | 82 | 1.42e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 29 | 48 | 1.44e-02 |
| GO:BP | GO:0051649 | establishment of localization in cell | 684 | 1661 | 1.46e-02 |
| GO:BP | GO:0042100 | B cell proliferation | 28 | 46 | 1.47e-02 |
| GO:BP | GO:0098661 | inorganic anion transmembrane transport | 38 | 67 | 1.47e-02 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 38 | 67 | 1.47e-02 |
| GO:BP | GO:1904036 | negative regulation of epithelial cell apoptotic process | 28 | 46 | 1.47e-02 |
| GO:BP | GO:0050714 | positive regulation of protein secretion | 54 | 102 | 1.49e-02 |
| GO:BP | GO:0052652 | cyclic purine nucleotide metabolic process | 20 | 30 | 1.49e-02 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 20 | 30 | 1.49e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 27 | 44 | 1.50e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 27 | 44 | 1.50e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 27 | 44 | 1.50e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 27 | 44 | 1.50e-02 |
| GO:BP | GO:0051606 | detection of stimulus | 58 | 111 | 1.52e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 870 | 2138 | 1.52e-02 |
| GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 21 | 32 | 1.52e-02 |
| GO:BP | GO:0045453 | bone resorption | 26 | 42 | 1.52e-02 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 840 | 2061 | 1.52e-02 |
| GO:BP | GO:0060391 | positive regulation of SMAD protein signal transduction | 21 | 32 | 1.52e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 21 | 32 | 1.52e-02 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 21 | 32 | 1.52e-02 |
| GO:BP | GO:0006909 | phagocytosis | 73 | 145 | 1.52e-02 |
| GO:BP | GO:0051703 | biological process involved in intraspecies interaction between organisms | 22 | 34 | 1.53e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 25 | 40 | 1.53e-02 |
| GO:BP | GO:1903351 | cellular response to dopamine | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0003161 | cardiac conduction system development | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0090102 | cochlea development | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0035176 | social behavior | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0060711 | labyrinthine layer development | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0010656 | negative regulation of muscle cell apoptotic process | 22 | 34 | 1.53e-02 |
| GO:BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 24 | 38 | 1.53e-02 |
| GO:BP | GO:0050863 | regulation of T cell activation | 104 | 217 | 1.54e-02 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 53 | 100 | 1.56e-02 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 48 | 89 | 1.58e-02 |
| GO:BP | GO:0061323 | cell proliferation involved in heart morphogenesis | 13 | 17 | 1.58e-02 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 48 | 89 | 1.58e-02 |
| GO:BP | GO:0032814 | regulation of natural killer cell activation | 13 | 17 | 1.58e-02 |
| GO:BP | GO:2000136 | regulation of cell proliferation involved in heart morphogenesis | 13 | 17 | 1.58e-02 |
| GO:BP | GO:0072673 | lamellipodium morphogenesis | 13 | 17 | 1.58e-02 |
| GO:BP | GO:0048678 | response to axon injury | 36 | 63 | 1.58e-02 |
| GO:BP | GO:0002682 | regulation of immune system process | 397 | 936 | 1.60e-02 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 476 | 1135 | 1.63e-02 |
| GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 42 | 76 | 1.63e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 114 | 241 | 1.65e-02 |
| GO:BP | GO:0003073 | regulation of systemic arterial blood pressure | 35 | 61 | 1.66e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 56 | 107 | 1.68e-02 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 78 | 157 | 1.68e-02 |
| GO:BP | GO:0070509 | calcium ion import | 34 | 59 | 1.73e-02 |
| GO:BP | GO:0043954 | cellular component maintenance | 34 | 59 | 1.73e-02 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 243 | 554 | 1.78e-02 |
| GO:BP | GO:0010256 | endomembrane system organization | 221 | 500 | 1.79e-02 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 59 | 114 | 1.80e-02 |
| GO:BP | GO:0042310 | vasoconstriction | 33 | 57 | 1.81e-02 |
| GO:BP | GO:0042116 | macrophage activation | 33 | 57 | 1.81e-02 |
| GO:BP | GO:0070168 | negative regulation of biomineral tissue development | 14 | 19 | 1.83e-02 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0019934 | cGMP-mediated signaling | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0098884 | postsynaptic neurotransmitter receptor internalization | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0010878 | cholesterol storage | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0042092 | type 2 immune response | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0048169 | regulation of long-term neuronal synaptic plasticity | 14 | 19 | 1.83e-02 |
| GO:BP | GO:0140239 | postsynaptic endocytosis | 14 | 19 | 1.83e-02 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 436 | 1036 | 1.86e-02 |
| GO:BP | GO:0071871 | response to epinephrine | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0045651 | positive regulation of macrophage differentiation | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0036302 | atrioventricular canal development | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 39 | 70 | 1.90e-02 |
| GO:BP | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 10 | 12 | 1.90e-02 |
| GO:BP | GO:0002263 | cell activation involved in immune response | 79 | 160 | 1.92e-02 |
| GO:BP | GO:0032868 | response to insulin | 100 | 209 | 1.94e-02 |
| GO:BP | GO:0052548 | regulation of endopeptidase activity | 82 | 167 | 1.94e-02 |
| GO:BP | GO:0048144 | fibroblast proliferation | 49 | 92 | 1.95e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 44 | 81 | 1.96e-02 |
| GO:BP | GO:0072523 | purine-containing compound catabolic process | 65 | 128 | 1.96e-02 |
| GO:BP | GO:0043588 | skin development | 88 | 181 | 1.96e-02 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 65 | 128 | 1.96e-02 |
| GO:BP | GO:0009166 | nucleotide catabolic process | 72 | 144 | 1.96e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 432 | 1027 | 2.00e-02 |
| GO:BP | GO:0022414 | reproductive process | 397 | 939 | 2.01e-02 |
| GO:BP | GO:0099637 | neurotransmitter receptor transport | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0099590 | neurotransmitter receptor internalization | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0098810 | neurotransmitter reuptake | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0035024 | negative regulation of Rho protein signal transduction | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 15 | 21 | 2.02e-02 |
| GO:BP | GO:0015698 | inorganic anion transport | 48 | 90 | 2.05e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 96 | 200 | 2.06e-02 |
| GO:BP | GO:0006955 | immune response | 394 | 932 | 2.09e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 123 | 264 | 2.10e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 123 | 264 | 2.10e-02 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 67 | 133 | 2.16e-02 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 47 | 88 | 2.18e-02 |
| GO:BP | GO:0002021 | response to dietary excess | 16 | 23 | 2.18e-02 |
| GO:BP | GO:0060343 | trabecula formation | 16 | 23 | 2.18e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 16 | 23 | 2.18e-02 |
| GO:BP | GO:0010469 | regulation of signaling receptor activity | 36 | 64 | 2.19e-02 |
| GO:BP | GO:0001503 | ossification | 147 | 322 | 2.25e-02 |
| GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 26 | 43 | 2.28e-02 |
| GO:BP | GO:0031103 | axon regeneration | 26 | 43 | 2.28e-02 |
| GO:BP | GO:0051965 | positive regulation of synapse assembly | 26 | 43 | 2.28e-02 |
| GO:BP | GO:0048146 | positive regulation of fibroblast proliferation | 26 | 43 | 2.28e-02 |
| GO:BP | GO:0010664 | negative regulation of striated muscle cell apoptotic process | 17 | 25 | 2.29e-02 |
| GO:BP | GO:0060074 | synapse maturation | 17 | 25 | 2.29e-02 |
| GO:BP | GO:0032292 | peripheral nervous system axon ensheathment | 17 | 25 | 2.29e-02 |
| GO:BP | GO:0022011 | myelination in peripheral nervous system | 17 | 25 | 2.29e-02 |
| GO:BP | GO:0002793 | positive regulation of peptide secretion | 41 | 75 | 2.30e-02 |
| GO:BP | GO:0030705 | cytoskeleton-dependent intracellular transport | 94 | 196 | 2.31e-02 |
| GO:BP | GO:0031334 | positive regulation of protein-containing complex assembly | 79 | 161 | 2.31e-02 |
| GO:BP | GO:0045103 | intermediate filament-based process | 25 | 41 | 2.33e-02 |
| GO:BP | GO:0001649 | osteoblast differentiation | 88 | 182 | 2.33e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 62 | 122 | 2.34e-02 |
| GO:BP | GO:0010092 | specification of animal organ identity | 18 | 27 | 2.36e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 18 | 27 | 2.36e-02 |
| GO:BP | GO:1990573 | potassium ion import across plasma membrane | 18 | 27 | 2.36e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 24 | 39 | 2.36e-02 |
| GO:BP | GO:0042311 | vasodilation | 24 | 39 | 2.36e-02 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 18 | 27 | 2.36e-02 |
| GO:BP | GO:2001259 | positive regulation of cation channel activity | 24 | 39 | 2.36e-02 |
| GO:BP | GO:0050905 | neuromuscular process | 58 | 113 | 2.37e-02 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 54 | 104 | 2.38e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 72 | 145 | 2.38e-02 |
| GO:BP | GO:0033173 | calcineurin-NFAT signaling cascade | 23 | 37 | 2.40e-02 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 23 | 37 | 2.40e-02 |
| GO:BP | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 19 | 29 | 2.40e-02 |
| GO:BP | GO:0021591 | ventricular system development | 19 | 29 | 2.40e-02 |
| GO:BP | GO:0048483 | autonomic nervous system development | 19 | 29 | 2.40e-02 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 19 | 29 | 2.40e-02 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 19 | 29 | 2.40e-02 |
| GO:BP | GO:0009187 | cyclic nucleotide metabolic process | 20 | 31 | 2.41e-02 |
| GO:BP | GO:2000648 | positive regulation of stem cell proliferation | 21 | 33 | 2.41e-02 |
| GO:BP | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0034405 | response to fluid shear stress | 20 | 31 | 2.41e-02 |
| GO:BP | GO:0046321 | positive regulation of fatty acid oxidation | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0046579 | positive regulation of Ras protein signal transduction | 11 | 14 | 2.41e-02 |
| GO:BP | GO:1903350 | response to dopamine | 22 | 35 | 2.41e-02 |
| GO:BP | GO:0010885 | regulation of cholesterol storage | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0030888 | regulation of B cell proliferation | 22 | 35 | 2.41e-02 |
| GO:BP | GO:0010763 | positive regulation of fibroblast migration | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0007616 | long-term memory | 21 | 33 | 2.41e-02 |
| GO:BP | GO:0038166 | angiotensin-activated signaling pathway | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter | 11 | 14 | 2.41e-02 |
| GO:BP | GO:0071711 | basement membrane organization | 22 | 35 | 2.41e-02 |
| GO:BP | GO:0009261 | ribonucleotide catabolic process | 61 | 120 | 2.43e-02 |
| GO:BP | GO:1905952 | regulation of lipid localization | 57 | 111 | 2.48e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 53 | 102 | 2.49e-02 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 235 | 538 | 2.49e-02 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 98 | 206 | 2.50e-02 |
| GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 39 | 71 | 2.50e-02 |
| GO:BP | GO:0043412 | macromolecule modification | 1057 | 2631 | 2.51e-02 |
| GO:BP | GO:1903034 | regulation of response to wounding | 64 | 127 | 2.52e-02 |
| GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 74 | 150 | 2.52e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 74 | 150 | 2.52e-02 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 127 | 275 | 2.52e-02 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 83 | 171 | 2.57e-02 |
| GO:BP | GO:0042113 | B cell activation | 83 | 171 | 2.57e-02 |
| GO:BP | GO:0046942 | carboxylic acid transport | 103 | 218 | 2.57e-02 |
| GO:BP | GO:1904063 | negative regulation of cation transmembrane transport | 32 | 56 | 2.57e-02 |
| GO:BP | GO:0050802 | circadian sleep/wake cycle, sleep | 8 | 9 | 2.57e-02 |
| GO:BP | GO:0071361 | cellular response to ethanol | 8 | 9 | 2.57e-02 |
| GO:BP | GO:0061626 | pharyngeal arch artery morphogenesis | 8 | 9 | 2.57e-02 |
| GO:BP | GO:0003162 | atrioventricular node development | 8 | 9 | 2.57e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 158 | 350 | 2.60e-02 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 38 | 69 | 2.62e-02 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 38 | 69 | 2.62e-02 |
| GO:BP | GO:0042594 | response to starvation | 88 | 183 | 2.71e-02 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 47 | 89 | 2.76e-02 |
| GO:BP | GO:0043534 | blood vessel endothelial cell migration | 51 | 98 | 2.80e-02 |
| GO:BP | GO:0034097 | response to cytokine | 268 | 621 | 2.81e-02 |
| GO:BP | GO:0071621 | granulocyte chemotaxis | 30 | 52 | 2.82e-02 |
| GO:BP | GO:0003188 | heart valve formation | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 62 | 123 | 2.84e-02 |
| GO:BP | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0014047 | glutamate secretion | 12 | 16 | 2.84e-02 |
| GO:BP | GO:1900242 | regulation of synaptic vesicle endocytosis | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0097091 | synaptic vesicle clustering | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0046128 | purine ribonucleoside metabolic process | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0045762 | positive regulation of adenylate cyclase activity | 12 | 16 | 2.84e-02 |
| GO:BP | GO:1903540 | establishment of protein localization to postsynaptic membrane | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0001759 | organ induction | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0048339 | paraxial mesoderm development | 12 | 16 | 2.84e-02 |
| GO:BP | GO:0006817 | phosphate ion transport | 12 | 16 | 2.84e-02 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 78 | 160 | 2.87e-02 |
| GO:BP | GO:0030902 | hindbrain development | 58 | 114 | 2.89e-02 |
| GO:BP | GO:0030595 | leukocyte chemotaxis | 58 | 114 | 2.89e-02 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 46 | 87 | 2.90e-02 |
| GO:BP | GO:0032754 | positive regulation of interleukin-5 production | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0060897 | neural plate regionalization | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0031223 | auditory behavior | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0003175 | tricuspid valve development | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0014031 | mesenchymal cell development | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0060710 | chorio-allantoic fusion | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0050861 | positive regulation of B cell receptor signaling pathway | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0099545 | trans-synaptic signaling by trans-synaptic complex | 6 | 6 | 2.92e-02 |
| GO:BP | GO:1903903 | regulation of establishment of T cell polarity | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 355 | 839 | 2.92e-02 |
| GO:BP | GO:0023041 | neuronal signal transduction | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0003415 | chondrocyte hypertrophy | 6 | 6 | 2.92e-02 |
| GO:BP | GO:0072173 | metanephric tubule morphogenesis | 6 | 6 | 2.92e-02 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 68 | 137 | 2.93e-02 |
| GO:BP | GO:0015849 | organic acid transport | 103 | 219 | 2.96e-02 |
| GO:BP | GO:0070613 | regulation of protein processing | 28 | 48 | 3.00e-02 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 86 | 179 | 3.00e-02 |
| GO:BP | GO:0003407 | neural retina development | 28 | 48 | 3.00e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 845 | 2088 | 3.00e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 108 | 231 | 3.01e-02 |
| GO:BP | GO:0006835 | dicarboxylic acid transport | 35 | 63 | 3.03e-02 |
| GO:BP | GO:0090277 | positive regulation of peptide hormone secretion | 40 | 74 | 3.11e-02 |
| GO:BP | GO:0000003 | reproduction | 398 | 948 | 3.12e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 27 | 46 | 3.12e-02 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 27 | 46 | 3.12e-02 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0010996 | response to auditory stimulus | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0060706 | cell differentiation involved in embryonic placenta development | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0060402 | calcium ion transport into cytosol | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0055093 | response to hyperoxia | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0060392 | negative regulation of SMAD protein signal transduction | 13 | 18 | 3.15e-02 |
| GO:BP | GO:0042593 | glucose homeostasis | 85 | 177 | 3.18e-02 |
| GO:BP | GO:1901292 | nucleoside phosphate catabolic process | 73 | 149 | 3.18e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 56 | 110 | 3.23e-02 |
| GO:BP | GO:0051489 | regulation of filopodium assembly | 26 | 44 | 3.23e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 63 | 126 | 3.23e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 39 | 72 | 3.27e-02 |
| GO:BP | GO:0032024 | positive regulation of insulin secretion | 33 | 59 | 3.35e-02 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 59 | 117 | 3.35e-02 |
| GO:BP | GO:0030032 | lamellipodium assembly | 33 | 59 | 3.35e-02 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 711 | 1746 | 3.38e-02 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 72 | 147 | 3.38e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 143 | 316 | 3.40e-02 |
| GO:BP | GO:0003156 | regulation of animal organ formation | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0032526 | response to retinoic acid | 43 | 81 | 3.40e-02 |
| GO:BP | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0062009 | secondary palate development | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0042278 | purine nucleoside metabolic process | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0051349 | positive regulation of lyase activity | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0010460 | positive regulation of heart rate | 14 | 20 | 3.40e-02 |
| GO:BP | GO:0098781 | ncRNA transcription | 62 | 124 | 3.42e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 24 | 40 | 3.42e-02 |
| GO:BP | GO:0048013 | ephrin receptor signaling pathway | 24 | 40 | 3.42e-02 |
| GO:BP | GO:0045104 | intermediate filament cytoskeleton organization | 24 | 40 | 3.42e-02 |
| GO:BP | GO:0030858 | positive regulation of epithelial cell differentiation | 24 | 40 | 3.42e-02 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 271 | 631 | 3.42e-02 |
| GO:BP | GO:0022405 | hair cycle process | 38 | 70 | 3.43e-02 |
| GO:BP | GO:0034109 | homotypic cell-cell adhesion | 38 | 70 | 3.43e-02 |
| GO:BP | GO:0022404 | molting cycle process | 38 | 70 | 3.43e-02 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 710 | 1744 | 3.44e-02 |
| GO:BP | GO:0046660 | female sex differentiation | 47 | 90 | 3.44e-02 |
| GO:BP | GO:0046434 | organophosphate catabolic process | 89 | 187 | 3.48e-02 |
| GO:BP | GO:0050848 | regulation of calcium-mediated signaling | 32 | 57 | 3.48e-02 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 123 | 268 | 3.49e-02 |
| GO:BP | GO:0006940 | regulation of smooth muscle contraction | 23 | 38 | 3.51e-02 |
| GO:BP | GO:0009154 | purine ribonucleotide catabolic process | 58 | 115 | 3.51e-02 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 23 | 38 | 3.51e-02 |
| GO:BP | GO:0097720 | calcineurin-mediated signaling | 23 | 38 | 3.51e-02 |
| GO:BP | GO:0031400 | negative regulation of protein modification process | 156 | 348 | 3.56e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 705 | 1732 | 3.56e-02 |
| GO:BP | GO:0031641 | regulation of myelination | 22 | 36 | 3.56e-02 |
| GO:BP | GO:0030852 | regulation of granulocyte differentiation | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0042633 | hair cycle | 42 | 79 | 3.56e-02 |
| GO:BP | GO:0042303 | molting cycle | 42 | 79 | 3.56e-02 |
| GO:BP | GO:0042451 | purine nucleoside biosynthetic process | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0043666 | regulation of phosphoprotein phosphatase activity | 22 | 36 | 3.56e-02 |
| GO:BP | GO:0042455 | ribonucleoside biosynthetic process | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0035435 | phosphate ion transmembrane transport | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0035272 | exocrine system development | 22 | 36 | 3.56e-02 |
| GO:BP | GO:0046635 | positive regulation of alpha-beta T cell activation | 22 | 36 | 3.56e-02 |
| GO:BP | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 15 | 22 | 3.56e-02 |
| GO:BP | GO:0060033 | anatomical structure regression | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0042745 | circadian sleep/wake cycle | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0032717 | negative regulation of interleukin-8 production | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0046129 | purine ribonucleoside biosynthetic process | 9 | 11 | 3.56e-02 |
| GO:BP | GO:0001942 | hair follicle development | 37 | 68 | 3.57e-02 |
| GO:BP | GO:0019217 | regulation of fatty acid metabolic process | 37 | 68 | 3.57e-02 |
| GO:BP | GO:0035640 | exploration behavior | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0071402 | cellular response to lipoprotein particle stimulus | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0098868 | bone growth | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0055078 | sodium ion homeostasis | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0002792 | negative regulation of peptide secretion | 21 | 34 | 3.63e-02 |
| GO:BP | GO:1901889 | negative regulation of cell junction assembly | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 16 | 24 | 3.63e-02 |
| GO:BP | GO:0106056 | regulation of calcineurin-mediated signaling | 20 | 32 | 3.67e-02 |
| GO:BP | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 20 | 32 | 3.67e-02 |
| GO:BP | GO:1902930 | regulation of alcohol biosynthetic process | 20 | 32 | 3.67e-02 |
| GO:BP | GO:0001659 | temperature homeostasis | 67 | 136 | 3.67e-02 |
| GO:BP | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 20 | 32 | 3.67e-02 |
| GO:BP | GO:0033500 | carbohydrate homeostasis | 85 | 178 | 3.67e-02 |
| GO:BP | GO:0071825 | protein-lipid complex organization | 20 | 32 | 3.67e-02 |
| GO:BP | GO:0048679 | regulation of axon regeneration | 17 | 26 | 3.68e-02 |
| GO:BP | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 17 | 26 | 3.68e-02 |
| GO:BP | GO:0048843 | negative regulation of axon extension involved in axon guidance | 17 | 26 | 3.68e-02 |
| GO:BP | GO:1902742 | apoptotic process involved in development | 19 | 30 | 3.69e-02 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 19 | 30 | 3.69e-02 |
| GO:BP | GO:0051339 | regulation of lyase activity | 19 | 30 | 3.69e-02 |
| GO:BP | GO:1904861 | excitatory synapse assembly | 18 | 28 | 3.69e-02 |
| GO:BP | GO:0007212 | dopamine receptor signaling pathway | 18 | 28 | 3.69e-02 |
| GO:BP | GO:0050850 | positive regulation of calcium-mediated signaling | 18 | 28 | 3.69e-02 |
| GO:BP | GO:0002366 | leukocyte activation involved in immune response | 76 | 157 | 3.70e-02 |
| GO:BP | GO:0032092 | positive regulation of protein binding | 30 | 53 | 3.75e-02 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 30 | 53 | 3.75e-02 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 121 | 264 | 3.80e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 100 | 214 | 3.95e-02 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 29 | 51 | 3.95e-02 |
| GO:BP | GO:1903317 | regulation of protein maturation | 29 | 51 | 3.95e-02 |
| GO:BP | GO:0140029 | exocytic process | 35 | 64 | 3.95e-02 |
| GO:BP | GO:0001656 | metanephros development | 35 | 64 | 3.95e-02 |
| GO:BP | GO:0071702 | organic substance transport | 738 | 1819 | 3.96e-02 |
| GO:BP | GO:0046888 | negative regulation of hormone secretion | 28 | 49 | 4.15e-02 |
| GO:BP | GO:0044843 | cell cycle G1/S phase transition | 99 | 212 | 4.20e-02 |
| GO:BP | GO:0007589 | body fluid secretion | 34 | 62 | 4.20e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 71 | 146 | 4.20e-02 |
| GO:BP | GO:0006470 | protein dephosphorylation | 88 | 186 | 4.26e-02 |
| GO:BP | GO:0015850 | organic hydroxy compound transport | 88 | 186 | 4.26e-02 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 58 | 116 | 4.26e-02 |
| GO:BP | GO:0032368 | regulation of lipid transport | 47 | 91 | 4.31e-02 |
| GO:BP | GO:0002252 | immune effector process | 145 | 323 | 4.31e-02 |
| GO:BP | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 27 | 47 | 4.33e-02 |
| GO:BP | GO:0002275 | myeloid cell activation involved in immune response | 27 | 47 | 4.33e-02 |
| GO:BP | GO:0061458 | reproductive system development | 101 | 217 | 4.33e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 27 | 47 | 4.33e-02 |
| GO:BP | GO:0001816 | cytokine production | 211 | 485 | 4.34e-02 |
| GO:BP | GO:0006195 | purine nucleotide catabolic process | 61 | 123 | 4.34e-02 |
| GO:BP | GO:0060347 | heart trabecula formation | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0060841 | venous blood vessel development | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0003159 | morphogenesis of an endothelium | 10 | 13 | 4.35e-02 |
| GO:BP | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0048681 | negative regulation of axon regeneration | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0048368 | lateral mesoderm development | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0061154 | endothelial tube morphogenesis | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0051547 | regulation of keratinocyte migration | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0045780 | positive regulation of bone resorption | 10 | 13 | 4.35e-02 |
| GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 54 | 107 | 4.37e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 67 | 137 | 4.40e-02 |
| GO:BP | GO:0060021 | roof of mouth development | 38 | 71 | 4.40e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 318 | 752 | 4.41e-02 |
| GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 26 | 45 | 4.49e-02 |
| GO:BP | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 57 | 114 | 4.49e-02 |
| GO:BP | GO:0045123 | cellular extravasation | 26 | 45 | 4.49e-02 |
| GO:BP | GO:0015711 | organic anion transport | 125 | 275 | 4.53e-02 |
| GO:BP | GO:0019216 | regulation of lipid metabolic process | 105 | 227 | 4.59e-02 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 32 | 58 | 4.64e-02 |
| GO:BP | GO:0046634 | regulation of alpha-beta T cell activation | 32 | 58 | 4.64e-02 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 63 | 128 | 4.65e-02 |
| GO:BP | GO:1903035 | negative regulation of response to wounding | 37 | 69 | 4.67e-02 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 37 | 69 | 4.67e-02 |
| GO:BP | GO:0031638 | zymogen activation | 25 | 43 | 4.69e-02 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 688 | 1694 | 4.69e-02 |
| GO:BP | GO:0001817 | regulation of cytokine production | 209 | 481 | 4.71e-02 |
| GO:BP | GO:0051048 | negative regulation of secretion | 56 | 112 | 4.78e-02 |
| GO:BP | GO:0045931 | positive regulation of mitotic cell cycle | 56 | 112 | 4.78e-02 |
| GO:BP | GO:0010035 | response to inorganic substance | 174 | 395 | 4.85e-02 |
| GO:BP | GO:0070227 | lymphocyte apoptotic process | 31 | 56 | 4.89e-02 |
| GO:BP | GO:0010827 | regulation of glucose transmembrane transport | 31 | 56 | 4.89e-02 |
| GO:BP | GO:0015800 | acidic amino acid transport | 24 | 41 | 4.89e-02 |
| GO:BP | GO:0010950 | positive regulation of endopeptidase activity | 52 | 103 | 4.95e-02 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 68 | 140 | 4.96e-02 |
| GO:BP | GO:0003417 | growth plate cartilage development | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0002828 | regulation of type 2 immune response | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0051546 | keratinocyte migration | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0072170 | metanephric tubule development | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0009267 | cellular response to starvation | 74 | 154 | 4.96e-02 |
| GO:BP | GO:0016082 | synaptic vesicle priming | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0060413 | atrial septum morphogenesis | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0060142 | regulation of syncytium formation by plasma membrane fusion | 11 | 15 | 4.96e-02 |
| GO:BP | GO:0034616 | response to laminar fluid shear stress | 11 | 15 | 4.96e-02 |
ESRnomtable_20k %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in ESR neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04020 | Calcium signaling pathway | 107 | 164 | 1.79e-10 |
| KEGG | KEGG:05200 | Pathways in cancer | 223 | 408 | 1.79e-10 |
| KEGG | KEGG:04510 | Focal adhesion | 113 | 177 | 1.79e-10 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 106 | 164 | 1.92e-10 |
| KEGG | KEGG:04360 | Axon guidance | 104 | 162 | 4.61e-10 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 98 | 151 | 6.04e-10 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 57 | 77 | 4.85e-09 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 105 | 170 | 6.84e-09 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 84 | 132 | 5.09e-08 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 54 | 75 | 5.87e-08 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 74 | 115 | 1.73e-07 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 58 | 84 | 1.73e-07 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 80 | 127 | 1.73e-07 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 62 | 94 | 6.46e-07 |
| KEGG | KEGG:04911 | Insulin secretion | 46 | 64 | 6.93e-07 |
| KEGG | KEGG:04924 | Renin secretion | 38 | 50 | 8.73e-07 |
| KEGG | KEGG:04611 | Platelet activation | 59 | 89 | 8.73e-07 |
| KEGG | KEGG:04713 | Circadian entrainment | 48 | 69 | 1.54e-06 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 53 | 79 | 2.08e-06 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 49 | 72 | 2.86e-06 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 137 | 256 | 2.86e-06 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 101 | 179 | 4.20e-06 |
| KEGG | KEGG:04934 | Cushing syndrome | 73 | 121 | 5.55e-06 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 83 | 142 | 5.71e-06 |
| KEGG | KEGG:04725 | Cholinergic synapse | 54 | 83 | 5.71e-06 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 68 | 112 | 8.77e-06 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 35 | 48 | 1.01e-05 |
| KEGG | KEGG:04014 | Ras signaling pathway | 96 | 172 | 1.19e-05 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 46 | 69 | 1.19e-05 |
| KEGG | KEGG:04971 | Gastric acid secretion | 37 | 52 | 1.19e-05 |
| KEGG | KEGG:04520 | Adherens junction | 54 | 86 | 2.37e-05 |
| KEGG | KEGG:04970 | Salivary secretion | 38 | 55 | 2.56e-05 |
| KEGG | KEGG:00000 | KEGG root term | 2317 | 5802 | 3.51e-05 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 30 | 41 | 4.30e-05 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 65 | 110 | 4.30e-05 |
| KEGG | KEGG:04972 | Pancreatic secretion | 39 | 58 | 4.78e-05 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 76 | 134 | 5.63e-05 |
| KEGG | KEGG:04726 | Serotonergic synapse | 41 | 63 | 8.95e-05 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 49 | 79 | 8.95e-05 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 44 | 69 | 8.95e-05 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 60 | 102 | 1.03e-04 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 82 | 149 | 1.04e-04 |
| KEGG | KEGG:05032 | Morphine addiction | 37 | 56 | 1.29e-04 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 125 | 246 | 1.41e-04 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 61 | 106 | 2.05e-04 |
| KEGG | KEGG:04929 | GnRH secretion | 35 | 53 | 2.05e-04 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 60 | 104 | 2.05e-04 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 39 | 61 | 2.16e-04 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 57 | 98 | 2.24e-04 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 49 | 82 | 2.95e-04 |
| KEGG | KEGG:04148 | Efferocytosis | 69 | 125 | 3.58e-04 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 52 | 89 | 3.92e-04 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 28 | 41 | 4.66e-04 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 55 | 96 | 4.95e-04 |
| KEGG | KEGG:04530 | Tight junction | 74 | 138 | 6.48e-04 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 77 | 145 | 7.12e-04 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 132 | 271 | 7.97e-04 |
| KEGG | KEGG:04730 | Long-term depression | 28 | 42 | 7.97e-04 |
| KEGG | KEGG:05226 | Gastric cancer | 64 | 117 | 7.97e-04 |
| KEGG | KEGG:04976 | Bile secretion | 28 | 42 | 7.97e-04 |
| KEGG | KEGG:05146 | Amoebiasis | 39 | 64 | 7.97e-04 |
| KEGG | KEGG:04916 | Melanogenesis | 45 | 77 | 1.01e-03 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 44 | 75 | 1.03e-03 |
| KEGG | KEGG:05224 | Breast cancer | 63 | 117 | 1.51e-03 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 44 | 76 | 1.51e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 43 | 74 | 1.53e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 51 | 91 | 1.53e-03 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 56 | 102 | 1.56e-03 |
| KEGG | KEGG:05131 | Shigellosis | 104 | 210 | 1.56e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 89 | 176 | 1.68e-03 |
| KEGG | KEGG:04814 | Motor proteins | 77 | 149 | 1.74e-03 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 65 | 123 | 2.18e-03 |
| KEGG | KEGG:04540 | Gap junction | 42 | 73 | 2.21e-03 |
| KEGG | KEGG:05214 | Glioma | 39 | 67 | 2.49e-03 |
| KEGG | KEGG:04740 | Olfactory transduction | 18 | 25 | 2.49e-03 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 19 | 27 | 2.73e-03 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 44 | 78 | 2.78e-03 |
| KEGG | KEGG:04720 | Long-term potentiation | 33 | 55 | 2.98e-03 |
| KEGG | KEGG:05031 | Amphetamine addiction | 30 | 49 | 3.15e-03 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 30 | 49 | 3.15e-03 |
| KEGG | KEGG:01522 | Endocrine resistance | 47 | 85 | 3.15e-03 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 23 | 35 | 3.15e-03 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 51 | 94 | 3.42e-03 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 50 | 92 | 3.58e-03 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 37 | 64 | 3.58e-03 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 46 | 84 | 4.49e-03 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 41 | 74 | 6.00e-03 |
| KEGG | KEGG:04727 | GABAergic synapse | 32 | 55 | 6.55e-03 |
| KEGG | KEGG:05135 | Yersinia infection | 58 | 112 | 6.59e-03 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 30 | 51 | 6.99e-03 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 55 | 106 | 7.91e-03 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 35 | 62 | 7.99e-03 |
| KEGG | KEGG:04931 | Insulin resistance | 50 | 95 | 8.20e-03 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 45 | 84 | 8.37e-03 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 41 | 76 | 1.07e-02 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 61 | 121 | 1.08e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 64 | 128 | 1.10e-02 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 70 | 142 | 1.13e-02 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 51 | 99 | 1.26e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 15 | 22 | 1.29e-02 |
| KEGG | KEGG:00052 | Galactose metabolism | 15 | 22 | 1.29e-02 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 57 | 113 | 1.34e-02 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 53 | 104 | 1.37e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 44 | 84 | 1.47e-02 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 28 | 49 | 1.50e-02 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 57 | 114 | 1.65e-02 |
| KEGG | KEGG:05218 | Melanoma | 32 | 58 | 1.69e-02 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 66 | 135 | 1.69e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 35 | 65 | 1.91e-02 |
| KEGG | KEGG:05030 | Cocaine addiction | 21 | 35 | 1.98e-02 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 19 | 31 | 2.09e-02 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 16 | 25 | 2.18e-02 |
| KEGG | KEGG:05212 | Pancreatic cancer | 39 | 75 | 2.53e-02 |
| KEGG | KEGG:05142 | Chagas disease | 39 | 75 | 2.53e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 46 | 91 | 2.60e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 44 | 87 | 2.97e-02 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 35 | 67 | 3.24e-02 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 35 | 67 | 3.24e-02 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 17 | 28 | 3.38e-02 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 16 | 26 | 3.46e-02 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 29 | 54 | 3.55e-02 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 27 | 50 | 4.04e-02 |
| KEGG | KEGG:05219 | Bladder cancer | 21 | 37 | 4.13e-02 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 68 | 145 | 4.19e-02 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 38 | 75 | 4.25e-02 |
ESR peaks overlapping enhancers
# ESR_resgenes_20k_enh <- gost(query = unique(ESR_enh_peaks_20k$NCBI_gene),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(ESR_resgenes_20k_enh,"data/GO_KEGG_analysis/ESR_resgenes_20k_enh.RDS")
# ESRnom <- gostplot(ESR_resgenes_20k_enh, capped = FALSE, interactive = TRUE)
# ESRnom
ESRnomtable_20k_enh <- ESR_resgenes_20k_enh$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
ESRnomtable_20k_enh %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in ESR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 623 | 4830 | 7.96e-21 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 318 | 2052 | 1.19e-18 |
| GO:BP | GO:0048856 | anatomical structure development | 536 | 4130 | 4.27e-17 |
| GO:BP | GO:0048869 | cellular developmental process | 415 | 2988 | 5.60e-17 |
| GO:BP | GO:0030154 | cell differentiation | 415 | 2987 | 5.60e-17 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 299 | 1951 | 6.62e-17 |
| GO:BP | GO:0032502 | developmental process | 567 | 4475 | 1.65e-16 |
| GO:BP | GO:0050896 | response to stimulus | 680 | 5732 | 3.03e-14 |
| GO:BP | GO:0007154 | cell communication | 533 | 4248 | 4.68e-14 |
| GO:BP | GO:0050789 | regulation of biological process | 891 | 8037 | 5.52e-14 |
| GO:BP | GO:0072359 | circulatory system development | 161 | 896 | 6.65e-14 |
| GO:BP | GO:0023052 | signaling | 523 | 4180 | 1.72e-13 |
| GO:BP | GO:0007275 | multicellular organism development | 440 | 3383 | 2.91e-13 |
| GO:BP | GO:0065007 | biological regulation | 908 | 8275 | 3.07e-13 |
| GO:BP | GO:0048731 | system development | 389 | 2903 | 3.07e-13 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 156 | 876 | 3.37e-13 |
| GO:BP | GO:0003013 | circulatory system process | 96 | 446 | 1.66e-12 |
| GO:BP | GO:0007165 | signal transduction | 483 | 3846 | 2.29e-12 |
| GO:BP | GO:0008015 | blood circulation | 85 | 374 | 2.29e-12 |
| GO:BP | GO:0003008 | system process | 193 | 1201 | 3.53e-12 |
| GO:BP | GO:0030029 | actin filament-based process | 125 | 677 | 1.74e-11 |
| GO:BP | GO:0051716 | cellular response to stimulus | 587 | 4933 | 1.74e-11 |
| GO:BP | GO:0061061 | muscle structure development | 109 | 559 | 1.92e-11 |
| GO:BP | GO:0050793 | regulation of developmental process | 260 | 1801 | 1.92e-11 |
| GO:BP | GO:0048468 | cell development | 282 | 1999 | 2.08e-11 |
| GO:BP | GO:0050794 | regulation of cellular process | 842 | 7651 | 2.40e-11 |
| GO:BP | GO:0048518 | positive regulation of biological process | 547 | 4561 | 6.23e-11 |
| GO:BP | GO:0060047 | heart contraction | 54 | 200 | 1.21e-10 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 508 | 4198 | 2.01e-10 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 192 | 1256 | 3.69e-10 |
| GO:BP | GO:0009888 | tissue development | 211 | 1425 | 5.49e-10 |
| GO:BP | GO:0003015 | heart process | 54 | 210 | 8.82e-10 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 170 | 1088 | 1.29e-09 |
| GO:BP | GO:0048519 | negative regulation of biological process | 487 | 4037 | 1.41e-09 |
| GO:BP | GO:0008016 | regulation of heart contraction | 46 | 170 | 4.91e-09 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 259 | 1900 | 9.77e-09 |
| GO:BP | GO:0035239 | tube morphogenesis | 115 | 668 | 1.24e-08 |
| GO:BP | GO:0003012 | muscle system process | 71 | 339 | 1.24e-08 |
| GO:BP | GO:0016477 | cell migration | 165 | 1078 | 1.26e-08 |
| GO:BP | GO:0042692 | muscle cell differentiation | 70 | 334 | 1.56e-08 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 106 | 601 | 1.57e-08 |
| GO:BP | GO:0044057 | regulation of system process | 79 | 399 | 1.69e-08 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 457 | 3804 | 1.72e-08 |
| GO:BP | GO:0035295 | tube development | 134 | 827 | 1.90e-08 |
| GO:BP | GO:0040011 | locomotion | 137 | 858 | 3.17e-08 |
| GO:BP | GO:2000145 | regulation of cell motility | 123 | 745 | 3.40e-08 |
| GO:BP | GO:1903522 | regulation of blood circulation | 49 | 200 | 3.80e-08 |
| GO:BP | GO:0055001 | muscle cell development | 44 | 169 | 3.84e-08 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 87 | 467 | 4.27e-08 |
| GO:BP | GO:0040012 | regulation of locomotion | 125 | 766 | 4.75e-08 |
| GO:BP | GO:0030334 | regulation of cell migration | 118 | 710 | 4.88e-08 |
| GO:BP | GO:0007507 | heart development | 93 | 515 | 5.33e-08 |
| GO:BP | GO:0001568 | blood vessel development | 97 | 546 | 5.39e-08 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 55 | 242 | 5.59e-08 |
| GO:BP | GO:0008283 | cell population proliferation | 197 | 1386 | 7.30e-08 |
| GO:BP | GO:0048513 | animal organ development | 279 | 2130 | 7.30e-08 |
| GO:BP | GO:0001944 | vasculature development | 100 | 573 | 7.30e-08 |
| GO:BP | GO:0048870 | cell motility | 174 | 1190 | 9.88e-08 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 91 | 508 | 1.13e-07 |
| GO:BP | GO:0030048 | actin filament-based movement | 33 | 111 | 1.41e-07 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 121 | 749 | 1.45e-07 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 109 | 653 | 1.55e-07 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 29 | 90 | 1.71e-07 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 163 | 1111 | 2.62e-07 |
| GO:BP | GO:0060537 | muscle tissue development | 69 | 353 | 3.06e-07 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 115 | 710 | 3.07e-07 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 165 | 1134 | 3.59e-07 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 34 | 121 | 3.59e-07 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 356 | 2902 | 3.93e-07 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 166 | 1146 | 4.32e-07 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 69 | 358 | 5.17e-07 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 150 | 1011 | 5.19e-07 |
| GO:BP | GO:0014706 | striated muscle tissue development | 49 | 218 | 5.55e-07 |
| GO:BP | GO:0007155 | cell adhesion | 149 | 1004 | 5.62e-07 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 108 | 662 | 5.69e-07 |
| GO:BP | GO:0006936 | muscle contraction | 56 | 267 | 6.36e-07 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 47 | 206 | 6.52e-07 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 92 | 540 | 9.32e-07 |
| GO:BP | GO:0000902 | cell morphogenesis | 119 | 764 | 1.39e-06 |
| GO:BP | GO:0023051 | regulation of signaling | 320 | 2597 | 1.95e-06 |
| GO:BP | GO:0010646 | regulation of cell communication | 320 | 2601 | 2.27e-06 |
| GO:BP | GO:0003007 | heart morphogenesis | 48 | 222 | 2.63e-06 |
| GO:BP | GO:0001525 | angiogenesis | 72 | 397 | 2.90e-06 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 54 | 265 | 3.03e-06 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 116 | 756 | 4.63e-06 |
| GO:BP | GO:0006941 | striated muscle contraction | 37 | 153 | 4.78e-06 |
| GO:BP | GO:0065009 | regulation of molecular function | 188 | 1389 | 5.76e-06 |
| GO:BP | GO:0090130 | tissue migration | 52 | 256 | 5.80e-06 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 106 | 683 | 9.45e-06 |
| GO:BP | GO:0002027 | regulation of heart rate | 25 | 84 | 9.45e-06 |
| GO:BP | GO:0070848 | response to growth factor | 93 | 576 | 9.45e-06 |
| GO:BP | GO:0042221 | response to chemical | 298 | 2436 | 1.31e-05 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 78 | 462 | 1.60e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 25 | 87 | 1.94e-05 |
| GO:BP | GO:0031032 | actomyosin structure organization | 41 | 189 | 2.03e-05 |
| GO:BP | GO:0090132 | epithelium migration | 50 | 252 | 2.03e-05 |
| GO:BP | GO:0010631 | epithelial cell migration | 50 | 252 | 2.03e-05 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 89 | 554 | 2.03e-05 |
| GO:BP | GO:0098657 | import into cell | 102 | 661 | 2.03e-05 |
| GO:BP | GO:0009605 | response to external stimulus | 215 | 1664 | 2.03e-05 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 300 | 2474 | 2.50e-05 |
| GO:BP | GO:0003205 | cardiac chamber development | 35 | 151 | 2.75e-05 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 108 | 716 | 2.75e-05 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 97 | 625 | 2.88e-05 |
| GO:BP | GO:0065008 | regulation of biological quality | 254 | 2039 | 2.88e-05 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 137 | 967 | 2.88e-05 |
| GO:BP | GO:0009966 | regulation of signal transduction | 282 | 2307 | 2.99e-05 |
| GO:BP | GO:0048568 | embryonic organ development | 58 | 317 | 3.65e-05 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 82 | 506 | 3.87e-05 |
| GO:BP | GO:0003231 | cardiac ventricle development | 29 | 115 | 3.99e-05 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 41 | 195 | 4.34e-05 |
| GO:BP | GO:0071310 | cellular response to organic substance | 181 | 1370 | 4.38e-05 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 233 | 1852 | 4.38e-05 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 28 | 110 | 4.89e-05 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 329 | 2780 | 5.39e-05 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 78 | 479 | 5.70e-05 |
| GO:BP | GO:0035556 | intracellular signal transduction | 256 | 2079 | 6.15e-05 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 71 | 425 | 6.68e-05 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 72 | 433 | 6.68e-05 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 123 | 861 | 6.79e-05 |
| GO:BP | GO:0007517 | muscle organ development | 52 | 281 | 8.86e-05 |
| GO:BP | GO:0048729 | tissue morphogenesis | 77 | 478 | 9.78e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 304 | 2555 | 9.84e-05 |
| GO:BP | GO:0090257 | regulation of muscle system process | 38 | 181 | 1.03e-04 |
| GO:BP | GO:1901698 | response to nitrogen compound | 112 | 774 | 1.10e-04 |
| GO:BP | GO:0007010 | cytoskeleton organization | 162 | 1218 | 1.11e-04 |
| GO:BP | GO:0030239 | myofibril assembly | 20 | 67 | 1.18e-04 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 16 | 46 | 1.33e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 19 | 62 | 1.35e-04 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 68 | 411 | 1.46e-04 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 94 | 626 | 1.54e-04 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 153 | 1145 | 1.63e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 19 | 63 | 1.71e-04 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 181 | 1403 | 1.77e-04 |
| GO:BP | GO:0014888 | striated muscle adaptation | 15 | 42 | 1.79e-04 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 19 | 64 | 2.17e-04 |
| GO:BP | GO:0009987 | cellular process | 1129 | 11450 | 2.23e-04 |
| GO:BP | GO:0055002 | striated muscle cell development | 20 | 70 | 2.31e-04 |
| GO:BP | GO:0006915 | apoptotic process | 186 | 1459 | 2.63e-04 |
| GO:BP | GO:0010033 | response to organic substance | 226 | 1835 | 2.63e-04 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 40 | 204 | 2.93e-04 |
| GO:BP | GO:0010720 | positive regulation of cell development | 56 | 326 | 3.30e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 19 | 66 | 3.42e-04 |
| GO:BP | GO:0022008 | neurogenesis | 171 | 1327 | 3.45e-04 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 107 | 752 | 3.54e-04 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 29 | 129 | 3.64e-04 |
| GO:BP | GO:0070482 | response to oxygen levels | 50 | 281 | 3.67e-04 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 116 | 833 | 3.91e-04 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 18 | 61 | 3.91e-04 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 239 | 1974 | 4.36e-04 |
| GO:BP | GO:1901342 | regulation of vasculature development | 40 | 208 | 4.46e-04 |
| GO:BP | GO:0043500 | muscle adaptation | 23 | 92 | 4.90e-04 |
| GO:BP | GO:0048589 | developmental growth | 80 | 527 | 4.98e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 181 | 1430 | 5.06e-04 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 39 | 204 | 6.43e-04 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 20 | 75 | 6.43e-04 |
| GO:BP | GO:0009725 | response to hormone | 92 | 634 | 6.79e-04 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 236 | 1959 | 6.86e-04 |
| GO:BP | GO:0014074 | response to purine-containing compound | 25 | 107 | 7.00e-04 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 17 | 58 | 7.17e-04 |
| GO:BP | GO:0012501 | programmed cell death | 188 | 1505 | 7.20e-04 |
| GO:BP | GO:0009790 | embryo development | 118 | 864 | 7.43e-04 |
| GO:BP | GO:0008150 | biological_process | 1175 | 12051 | 7.43e-04 |
| GO:BP | GO:0008219 | cell death | 188 | 1509 | 8.32e-04 |
| GO:BP | GO:0014902 | myotube differentiation | 22 | 89 | 8.50e-04 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 229 | 1900 | 8.76e-04 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 10 | 23 | 8.82e-04 |
| GO:BP | GO:0032879 | regulation of localization | 189 | 1521 | 9.02e-04 |
| GO:BP | GO:0042092 | type 2 immune response | 9 | 19 | 9.91e-04 |
| GO:BP | GO:0007015 | actin filament organization | 61 | 381 | 1.04e-03 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 72 | 472 | 1.05e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 165 | 1301 | 1.06e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 18 | 66 | 1.12e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 46 | 263 | 1.12e-03 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 68 | 440 | 1.13e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 212 | 1746 | 1.13e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 165 | 1304 | 1.17e-03 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 66 | 425 | 1.25e-03 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 270 | 2311 | 1.32e-03 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 237 | 1992 | 1.37e-03 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 45 | 258 | 1.42e-03 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 69 | 452 | 1.42e-03 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 11 | 29 | 1.44e-03 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 146 | 1135 | 1.52e-03 |
| GO:BP | GO:0048699 | generation of neurons | 147 | 1145 | 1.56e-03 |
| GO:BP | GO:0051049 | regulation of transport | 149 | 1164 | 1.59e-03 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 135 | 1036 | 1.63e-03 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 134 | 1027 | 1.63e-03 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 161 | 1279 | 1.83e-03 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 156 | 1233 | 1.85e-03 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 10 | 25 | 1.85e-03 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 38 | 208 | 1.91e-03 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 36 | 193 | 1.91e-03 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 12 | 35 | 1.94e-03 |
| GO:BP | GO:0051960 | regulation of nervous system development | 57 | 358 | 1.95e-03 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 24 | 108 | 2.01e-03 |
| GO:BP | GO:0001666 | response to hypoxia | 43 | 247 | 2.02e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 25 | 115 | 2.06e-03 |
| GO:BP | GO:0060284 | regulation of cell development | 86 | 605 | 2.19e-03 |
| GO:BP | GO:0007399 | nervous system development | 226 | 1903 | 2.22e-03 |
| GO:BP | GO:0030001 | metal ion transport | 80 | 554 | 2.30e-03 |
| GO:BP | GO:0007267 | cell-cell signaling | 147 | 1156 | 2.31e-03 |
| GO:BP | GO:0040007 | growth | 101 | 739 | 2.40e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 142 | 1111 | 2.40e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 261 | 2246 | 2.40e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 47 | 281 | 2.47e-03 |
| GO:BP | GO:0035272 | exocrine system development | 12 | 36 | 2.50e-03 |
| GO:BP | GO:0034330 | cell junction organization | 84 | 591 | 2.57e-03 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 50 | 306 | 2.67e-03 |
| GO:BP | GO:0043542 | endothelial cell migration | 34 | 182 | 2.73e-03 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 20 | 84 | 2.80e-03 |
| GO:BP | GO:0030182 | neuron differentiation | 138 | 1080 | 2.99e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 27 | 132 | 2.99e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 51 | 316 | 3.07e-03 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 141 | 1109 | 3.12e-03 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 241 | 2061 | 3.12e-03 |
| GO:BP | GO:0099625 | ventricular cardiac muscle cell membrane repolarization | 9 | 22 | 3.20e-03 |
| GO:BP | GO:0038084 | vascular endothelial growth factor signaling pathway | 12 | 37 | 3.21e-03 |
| GO:BP | GO:0042592 | homeostatic process | 151 | 1204 | 3.35e-03 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 123 | 946 | 3.43e-03 |
| GO:BP | GO:1990573 | potassium ion import across plasma membrane | 10 | 27 | 3.46e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 51 | 318 | 3.49e-03 |
| GO:BP | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential | 6 | 10 | 3.58e-03 |
| GO:BP | GO:0045064 | T-helper 2 cell differentiation | 6 | 10 | 3.58e-03 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 18 | 73 | 3.66e-03 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 77 | 538 | 3.75e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 139 | 1096 | 3.75e-03 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 17 | 67 | 3.81e-03 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 15 | 55 | 3.93e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 15 | 55 | 3.93e-03 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 19 | 80 | 3.97e-03 |
| GO:BP | GO:0006897 | endocytosis | 75 | 522 | 3.97e-03 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 28 | 142 | 3.98e-03 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 45 | 272 | 4.02e-03 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 26 | 128 | 4.11e-03 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 18 | 74 | 4.19e-03 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 18 | 74 | 4.19e-03 |
| GO:BP | GO:0006468 | protein phosphorylation | 129 | 1008 | 4.32e-03 |
| GO:BP | GO:0046683 | response to organophosphorus | 21 | 94 | 4.38e-03 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 13 | 44 | 4.38e-03 |
| GO:BP | GO:0002026 | regulation of the force of heart contraction | 9 | 23 | 4.38e-03 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 16 | 62 | 4.57e-03 |
| GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 14 | 50 | 4.59e-03 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 15 | 56 | 4.63e-03 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 110 | 837 | 4.77e-03 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 12 | 39 | 4.99e-03 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 132 | 1040 | 4.99e-03 |
| GO:BP | GO:0045444 | fat cell differentiation | 34 | 189 | 4.99e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 191 | 1597 | 5.07e-03 |
| GO:BP | GO:0003279 | cardiac septum development | 22 | 102 | 5.08e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 13 | 45 | 5.41e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 18 | 76 | 5.67e-03 |
| GO:BP | GO:0098739 | import across plasma membrane | 26 | 131 | 5.67e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 141 | 1128 | 5.83e-03 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 67 | 461 | 5.89e-03 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 48 | 302 | 5.97e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 19 | 83 | 5.98e-03 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 19 | 83 | 5.98e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 119 | 926 | 6.16e-03 |
| GO:BP | GO:0002828 | regulation of type 2 immune response | 7 | 15 | 6.18e-03 |
| GO:BP | GO:0014733 | regulation of skeletal muscle adaptation | 6 | 11 | 6.18e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 20 | 90 | 6.18e-03 |
| GO:BP | GO:0036363 | transforming growth factor beta activation | 6 | 11 | 6.18e-03 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 40 | 239 | 6.49e-03 |
| GO:BP | GO:0060976 | coronary vasculature development | 13 | 46 | 6.51e-03 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 15 | 58 | 6.51e-03 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 27 | 140 | 6.69e-03 |
| GO:BP | GO:0002376 | immune system process | 181 | 1512 | 6.82e-03 |
| GO:BP | GO:0048846 | axon extension involved in axon guidance | 11 | 35 | 6.87e-03 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 43 | 264 | 6.87e-03 |
| GO:BP | GO:1902284 | neuron projection extension involved in neuron projection guidance | 11 | 35 | 6.87e-03 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 43 | 264 | 6.87e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 42 | 256 | 6.87e-03 |
| GO:BP | GO:0060485 | mesenchyme development | 42 | 256 | 6.87e-03 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 86 | 632 | 7.24e-03 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 38 | 225 | 7.24e-03 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 50 | 322 | 7.24e-03 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 38 | 225 | 7.24e-03 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 190 | 1601 | 7.24e-03 |
| GO:BP | GO:0048638 | regulation of developmental growth | 42 | 257 | 7.32e-03 |
| GO:BP | GO:0048588 | developmental cell growth | 34 | 194 | 7.33e-03 |
| GO:BP | GO:0043501 | skeletal muscle adaptation | 8 | 20 | 7.39e-03 |
| GO:BP | GO:0030224 | monocyte differentiation | 9 | 25 | 7.73e-03 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 9 | 25 | 7.73e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 78 | 563 | 7.73e-03 |
| GO:BP | GO:0060419 | heart growth | 17 | 72 | 7.78e-03 |
| GO:BP | GO:0043434 | response to peptide hormone | 50 | 324 | 8.17e-03 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 59 | 400 | 8.38e-03 |
| GO:BP | GO:0019222 | regulation of metabolic process | 518 | 4914 | 8.69e-03 |
| GO:BP | GO:0007009 | plasma membrane organization | 23 | 114 | 8.89e-03 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 44 | 276 | 8.91e-03 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 17 | 73 | 9.05e-03 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 17 | 73 | 9.05e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 26 | 136 | 9.08e-03 |
| GO:BP | GO:0050873 | brown fat cell differentiation | 12 | 42 | 9.10e-03 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 30 | 166 | 9.13e-03 |
| GO:BP | GO:1901490 | regulation of lymphangiogenesis | 4 | 5 | 9.47e-03 |
| GO:BP | GO:0048841 | regulation of axon extension involved in axon guidance | 10 | 31 | 9.53e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 16 | 67 | 9.58e-03 |
| GO:BP | GO:0045165 | cell fate commitment | 29 | 159 | 9.58e-03 |
| GO:BP | GO:0001570 | vasculogenesis | 16 | 67 | 9.58e-03 |
| GO:BP | GO:0030198 | extracellular matrix organization | 39 | 237 | 9.58e-03 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 47 | 302 | 9.58e-03 |
| GO:BP | GO:0001843 | neural tube closure | 19 | 87 | 9.66e-03 |
| GO:BP | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance | 6 | 12 | 9.76e-03 |
| GO:BP | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance | 6 | 12 | 9.76e-03 |
| GO:BP | GO:0001817 | regulation of cytokine production | 68 | 481 | 9.79e-03 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 21 | 101 | 9.79e-03 |
| GO:BP | GO:0016049 | cell growth | 60 | 412 | 9.80e-03 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 8 | 21 | 9.98e-03 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 74 | 534 | 9.98e-03 |
| GO:BP | GO:0043062 | extracellular structure organization | 39 | 238 | 1.00e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 38 | 230 | 1.00e-02 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 39 | 238 | 1.00e-02 |
| GO:BP | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 17 | 74 | 1.00e-02 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 17 | 74 | 1.00e-02 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 14 | 55 | 1.05e-02 |
| GO:BP | GO:0045214 | sarcomere organization | 12 | 43 | 1.07e-02 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 22 | 109 | 1.07e-02 |
| GO:BP | GO:0060606 | tube closure | 19 | 88 | 1.07e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 16 | 68 | 1.08e-02 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 16 | 68 | 1.08e-02 |
| GO:BP | GO:0035148 | tube formation | 25 | 131 | 1.10e-02 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 59 | 406 | 1.10e-02 |
| GO:BP | GO:0040008 | regulation of growth | 69 | 493 | 1.12e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 17 | 75 | 1.13e-02 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 41 | 256 | 1.13e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 17 | 75 | 1.13e-02 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 26 | 139 | 1.15e-02 |
| GO:BP | GO:0021915 | neural tube development | 26 | 139 | 1.15e-02 |
| GO:BP | GO:0001816 | cytokine production | 68 | 485 | 1.15e-02 |
| GO:BP | GO:0006950 | response to stress | 301 | 2715 | 1.15e-02 |
| GO:BP | GO:0048878 | chemical homeostasis | 93 | 708 | 1.16e-02 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 21 | 103 | 1.18e-02 |
| GO:BP | GO:0042330 | taxis | 42 | 265 | 1.18e-02 |
| GO:BP | GO:0035265 | organ growth | 25 | 132 | 1.18e-02 |
| GO:BP | GO:0006935 | chemotaxis | 42 | 265 | 1.18e-02 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 54 | 365 | 1.18e-02 |
| GO:BP | GO:0046323 | glucose import | 14 | 56 | 1.19e-02 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 73 | 530 | 1.19e-02 |
| GO:BP | GO:0032868 | response to insulin | 35 | 209 | 1.19e-02 |
| GO:BP | GO:0016310 | phosphorylation | 147 | 1211 | 1.19e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 16 | 69 | 1.20e-02 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 24 | 125 | 1.21e-02 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 28 | 155 | 1.22e-02 |
| GO:BP | GO:0001775 | cell activation | 88 | 665 | 1.23e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 12 | 44 | 1.23e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 12 | 44 | 1.23e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 12 | 44 | 1.23e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 12 | 44 | 1.23e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 57 | 392 | 1.24e-02 |
| GO:BP | GO:0048666 | neuron development | 113 | 894 | 1.24e-02 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 38 | 234 | 1.27e-02 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 30 | 171 | 1.28e-02 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 31 | 179 | 1.31e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 24 | 126 | 1.32e-02 |
| GO:BP | GO:0061564 | axon development | 58 | 402 | 1.33e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 33 | 195 | 1.34e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 237 | 2088 | 1.34e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 54 | 368 | 1.34e-02 |
| GO:BP | GO:0007405 | neuroblast proliferation | 14 | 57 | 1.36e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 16 | 70 | 1.36e-02 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 72 | 525 | 1.38e-02 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 148 | 1227 | 1.41e-02 |
| GO:BP | GO:0006811 | monoatomic ion transport | 99 | 769 | 1.41e-02 |
| GO:BP | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 5 | 9 | 1.42e-02 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 20 | 98 | 1.43e-02 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 24 | 127 | 1.43e-02 |
| GO:BP | GO:0014020 | primary neural tube formation | 19 | 91 | 1.43e-02 |
| GO:BP | GO:0006949 | syncytium formation | 11 | 39 | 1.43e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 11 | 39 | 1.43e-02 |
| GO:BP | GO:0043086 | negative regulation of catalytic activity | 48 | 319 | 1.47e-02 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 70 | 509 | 1.47e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 75 | 554 | 1.51e-02 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 140 | 1154 | 1.52e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 43 | 278 | 1.52e-02 |
| GO:BP | GO:0006812 | monoatomic cation transport | 86 | 653 | 1.52e-02 |
| GO:BP | GO:0060429 | epithelium development | 106 | 836 | 1.52e-02 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 228 | 2006 | 1.53e-02 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 218 | 1908 | 1.54e-02 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 154 | 1288 | 1.54e-02 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 40 | 254 | 1.59e-02 |
| GO:BP | GO:0007409 | axonogenesis | 53 | 363 | 1.59e-02 |
| GO:BP | GO:0060840 | artery development | 18 | 85 | 1.59e-02 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 476 | 4521 | 1.60e-02 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 230 | 2028 | 1.61e-02 |
| GO:BP | GO:0010954 | positive regulation of protein processing | 7 | 18 | 1.61e-02 |
| GO:BP | GO:0030903 | notochord development | 7 | 18 | 1.61e-02 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 87 | 664 | 1.62e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 13 | 52 | 1.62e-02 |
| GO:BP | GO:0006816 | calcium ion transport | 42 | 271 | 1.62e-02 |
| GO:BP | GO:0070664 | negative regulation of leukocyte proliferation | 13 | 52 | 1.62e-02 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 34 | 206 | 1.62e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 15 | 65 | 1.64e-02 |
| GO:BP | GO:1901491 | negative regulation of lymphangiogenesis | 3 | 3 | 1.64e-02 |
| GO:BP | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential | 3 | 3 | 1.64e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 12 | 46 | 1.67e-02 |
| GO:BP | GO:0023056 | positive regulation of signaling | 154 | 1292 | 1.69e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 11 | 40 | 1.69e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 23 | 122 | 1.74e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 23 | 122 | 1.74e-02 |
| GO:BP | GO:0072175 | epithelial tube formation | 23 | 122 | 1.74e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 36 | 224 | 1.85e-02 |
| GO:BP | GO:0097485 | neuron projection guidance | 31 | 184 | 1.85e-02 |
| GO:BP | GO:0007411 | axon guidance | 31 | 184 | 1.85e-02 |
| GO:BP | GO:0001508 | action potential | 21 | 108 | 1.88e-02 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 103 | 815 | 1.88e-02 |
| GO:BP | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis | 4 | 6 | 1.91e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 28 | 161 | 1.91e-02 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 89 | 687 | 1.91e-02 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 19 | 94 | 1.95e-02 |
| GO:BP | GO:0042129 | regulation of T cell proliferation | 19 | 94 | 1.95e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 36 | 225 | 1.96e-02 |
| GO:BP | GO:1902307 | positive regulation of sodium ion transmembrane transport | 6 | 14 | 1.97e-02 |
| GO:BP | GO:0032633 | interleukin-4 production | 6 | 14 | 1.97e-02 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 474 | 4515 | 1.97e-02 |
| GO:BP | GO:0051179 | localization | 422 | 3978 | 1.97e-02 |
| GO:BP | GO:1903729 | regulation of plasma membrane organization | 6 | 14 | 1.97e-02 |
| GO:BP | GO:0010885 | regulation of cholesterol storage | 6 | 14 | 1.97e-02 |
| GO:BP | GO:0032673 | regulation of interleukin-4 production | 6 | 14 | 1.97e-02 |
| GO:BP | GO:0002521 | leukocyte differentiation | 56 | 394 | 2.00e-02 |
| GO:BP | GO:0014887 | cardiac muscle adaptation | 8 | 24 | 2.04e-02 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 8 | 24 | 2.04e-02 |
| GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 8 | 24 | 2.04e-02 |
| GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 8 | 24 | 2.04e-02 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 29 | 170 | 2.06e-02 |
| GO:BP | GO:0001501 | skeletal system development | 53 | 369 | 2.09e-02 |
| GO:BP | GO:0050868 | negative regulation of T cell activation | 15 | 67 | 2.10e-02 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 32 | 194 | 2.10e-02 |
| GO:BP | GO:1903319 | positive regulation of protein maturation | 7 | 19 | 2.11e-02 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 42 | 276 | 2.12e-02 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 42 | 276 | 2.12e-02 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 19 | 95 | 2.12e-02 |
| GO:BP | GO:0006810 | transport | 343 | 3176 | 2.14e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 46 | 310 | 2.16e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 17 | 81 | 2.16e-02 |
| GO:BP | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 5 | 10 | 2.18e-02 |
| GO:BP | GO:0030097 | hemopoiesis | 86 | 664 | 2.18e-02 |
| GO:BP | GO:1901388 | regulation of transforming growth factor beta activation | 5 | 10 | 2.18e-02 |
| GO:BP | GO:0010832 | negative regulation of myotube differentiation | 5 | 10 | 2.18e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 121 | 989 | 2.19e-02 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 29 | 171 | 2.19e-02 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 30 | 179 | 2.20e-02 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 82 | 628 | 2.20e-02 |
| GO:BP | GO:0071772 | response to BMP | 23 | 125 | 2.21e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 23 | 125 | 2.21e-02 |
| GO:BP | GO:0043010 | camera-type eye development | 37 | 236 | 2.28e-02 |
| GO:BP | GO:0001819 | positive regulation of cytokine production | 43 | 286 | 2.29e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 27 | 156 | 2.29e-02 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 10 | 36 | 2.32e-02 |
| GO:BP | GO:0046324 | regulation of glucose import | 11 | 42 | 2.32e-02 |
| GO:BP | GO:0071320 | cellular response to cAMP | 10 | 36 | 2.32e-02 |
| GO:BP | GO:0001841 | neural tube formation | 19 | 96 | 2.32e-02 |
| GO:BP | GO:0050994 | regulation of lipid catabolic process | 10 | 36 | 2.32e-02 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 34 | 212 | 2.33e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 32 | 196 | 2.35e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 16 | 75 | 2.36e-02 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 17 | 82 | 2.37e-02 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 21 | 111 | 2.39e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 26 | 149 | 2.41e-02 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 13 | 55 | 2.41e-02 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 44 | 296 | 2.47e-02 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 44 | 296 | 2.47e-02 |
| GO:BP | GO:0071398 | cellular response to fatty acid | 8 | 25 | 2.52e-02 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 55 | 391 | 2.54e-02 |
| GO:BP | GO:0051591 | response to cAMP | 14 | 62 | 2.55e-02 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 19 | 97 | 2.55e-02 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 50 | 348 | 2.57e-02 |
| GO:BP | GO:0030030 | cell projection organization | 149 | 1262 | 2.58e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 12 | 49 | 2.58e-02 |
| GO:BP | GO:0016043 | cellular component organization | 532 | 5139 | 2.58e-02 |
| GO:BP | GO:0009266 | response to temperature stimulus | 23 | 127 | 2.61e-02 |
| GO:BP | GO:0001657 | ureteric bud development | 16 | 76 | 2.64e-02 |
| GO:BP | GO:0001654 | eye development | 41 | 272 | 2.64e-02 |
| GO:BP | GO:0050996 | positive regulation of lipid catabolic process | 6 | 15 | 2.66e-02 |
| GO:BP | GO:0070661 | leukocyte proliferation | 31 | 190 | 2.68e-02 |
| GO:BP | GO:0086009 | membrane repolarization | 11 | 43 | 2.70e-02 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 9 | 31 | 2.71e-02 |
| GO:BP | GO:0010830 | regulation of myotube differentiation | 9 | 31 | 2.71e-02 |
| GO:BP | GO:0098609 | cell-cell adhesion | 79 | 607 | 2.71e-02 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 25 | 143 | 2.74e-02 |
| GO:BP | GO:0070228 | regulation of lymphocyte apoptotic process | 10 | 37 | 2.75e-02 |
| GO:BP | GO:0150063 | visual system development | 41 | 273 | 2.78e-02 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 18 | 91 | 2.88e-02 |
| GO:BP | GO:0042391 | regulation of membrane potential | 44 | 299 | 2.88e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 14 | 63 | 2.88e-02 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 14 | 63 | 2.88e-02 |
| GO:BP | GO:0042060 | wound healing | 45 | 308 | 2.94e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 16 | 77 | 2.94e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 16 | 77 | 2.94e-02 |
| GO:BP | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 15 | 70 | 2.94e-02 |
| GO:BP | GO:0006813 | potassium ion transport | 25 | 144 | 2.96e-02 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 34 | 216 | 2.96e-02 |
| GO:BP | GO:0031175 | neuron projection development | 99 | 794 | 2.98e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 32 | 200 | 3.02e-02 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 32 | 200 | 3.02e-02 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 23 | 129 | 3.06e-02 |
| GO:BP | GO:0048880 | sensory system development | 41 | 275 | 3.10e-02 |
| GO:BP | GO:0048843 | negative regulation of axon extension involved in axon guidance | 8 | 26 | 3.10e-02 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 8 | 26 | 3.10e-02 |
| GO:BP | GO:1901653 | cellular response to peptide | 42 | 284 | 3.19e-02 |
| GO:BP | GO:0033275 | actin-myosin filament sliding | 5 | 11 | 3.22e-02 |
| GO:BP | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 5 | 11 | 3.22e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 9 | 32 | 3.28e-02 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 28 | 169 | 3.28e-02 |
| GO:BP | GO:0099622 | cardiac muscle cell membrane repolarization | 9 | 32 | 3.28e-02 |
| GO:BP | GO:0001823 | mesonephros development | 16 | 78 | 3.28e-02 |
| GO:BP | GO:0044351 | macropinocytosis | 4 | 7 | 3.28e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 63 | 468 | 3.28e-02 |
| GO:BP | GO:0014883 | transition between fast and slow fiber | 4 | 7 | 3.28e-02 |
| GO:BP | GO:0002830 | positive regulation of type 2 immune response | 4 | 7 | 3.28e-02 |
| GO:BP | GO:0051346 | negative regulation of hydrolase activity | 23 | 130 | 3.28e-02 |
| GO:BP | GO:0045628 | regulation of T-helper 2 cell differentiation | 4 | 7 | 3.28e-02 |
| GO:BP | GO:0045657 | positive regulation of monocyte differentiation | 4 | 7 | 3.28e-02 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 23 | 130 | 3.28e-02 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 53 | 380 | 3.33e-02 |
| GO:BP | GO:0009894 | regulation of catabolic process | 109 | 892 | 3.37e-02 |
| GO:BP | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 7 | 21 | 3.41e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 36 | 235 | 3.41e-02 |
| GO:BP | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 7 | 21 | 3.41e-02 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 7 | 21 | 3.41e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 18 | 93 | 3.45e-02 |
| GO:BP | GO:1901652 | response to peptide | 53 | 381 | 3.47e-02 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 192 | 1694 | 3.50e-02 |
| GO:BP | GO:0048844 | artery morphogenesis | 13 | 58 | 3.53e-02 |
| GO:BP | GO:0140352 | export from cell | 80 | 624 | 3.53e-02 |
| GO:BP | GO:0006817 | phosphate ion transport | 6 | 16 | 3.53e-02 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 68 | 515 | 3.53e-02 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 16 | 79 | 3.60e-02 |
| GO:BP | GO:0010232 | vascular transport | 15 | 72 | 3.62e-02 |
| GO:BP | GO:0050877 | nervous system process | 81 | 634 | 3.62e-02 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 15 | 72 | 3.62e-02 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 15 | 72 | 3.62e-02 |
| GO:BP | GO:0098781 | ncRNA transcription | 22 | 124 | 3.77e-02 |
| GO:BP | GO:0007435 | salivary gland morphogenesis | 8 | 27 | 3.77e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 8 | 27 | 3.77e-02 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 8 | 27 | 3.77e-02 |
| GO:BP | GO:0042130 | negative regulation of T cell proliferation | 10 | 39 | 3.78e-02 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 223 | 2005 | 3.85e-02 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 9 | 33 | 3.86e-02 |
| GO:BP | GO:0014904 | myotube cell development | 9 | 33 | 3.86e-02 |
| GO:BP | GO:0046651 | lymphocyte proliferation | 27 | 164 | 3.99e-02 |
| GO:BP | GO:0042110 | T cell activation | 46 | 323 | 3.99e-02 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 76 | 591 | 3.99e-02 |
| GO:BP | GO:0048041 | focal adhesion assembly | 16 | 80 | 3.99e-02 |
| GO:BP | GO:0008286 | insulin receptor signaling pathway | 19 | 102 | 3.99e-02 |
| GO:BP | GO:0009611 | response to wounding | 55 | 402 | 4.01e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 195 | 1732 | 4.17e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 49 | 350 | 4.17e-02 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 18 | 95 | 4.17e-02 |
| GO:BP | GO:0043149 | stress fiber assembly | 18 | 95 | 4.17e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 26 | 157 | 4.28e-02 |
| GO:BP | GO:0048499 | synaptic vesicle membrane organization | 7 | 22 | 4.31e-02 |
| GO:BP | GO:0001945 | lymph vessel development | 7 | 22 | 4.31e-02 |
| GO:BP | GO:0050892 | intestinal absorption | 7 | 22 | 4.31e-02 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 17 | 88 | 4.31e-02 |
| GO:BP | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 3 | 4 | 4.32e-02 |
| GO:BP | GO:0045760 | positive regulation of action potential | 3 | 4 | 4.32e-02 |
| GO:BP | GO:0086017 | Purkinje myocyte action potential | 3 | 4 | 4.32e-02 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 196 | 1744 | 4.34e-02 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 103 | 845 | 4.40e-02 |
| GO:BP | GO:0085029 | extracellular matrix assembly | 10 | 40 | 4.42e-02 |
| GO:BP | GO:0010906 | regulation of glucose metabolic process | 16 | 81 | 4.42e-02 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 5 | 12 | 4.51e-02 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 103 | 846 | 4.51e-02 |
| GO:BP | GO:0006883 | intracellular sodium ion homeostasis | 5 | 12 | 4.51e-02 |
| GO:BP | GO:0001818 | negative regulation of cytokine production | 28 | 174 | 4.51e-02 |
| GO:BP | GO:0045725 | positive regulation of glycogen biosynthetic process | 5 | 12 | 4.51e-02 |
| GO:BP | GO:0001946 | lymphangiogenesis | 5 | 12 | 4.51e-02 |
| GO:BP | GO:0030308 | negative regulation of cell growth | 26 | 158 | 4.52e-02 |
| GO:BP | GO:0009409 | response to cold | 9 | 34 | 4.52e-02 |
| GO:BP | GO:0007431 | salivary gland development | 8 | 28 | 4.52e-02 |
| GO:BP | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 8 | 28 | 4.52e-02 |
| GO:BP | GO:0003230 | cardiac atrium development | 9 | 34 | 4.52e-02 |
| GO:BP | GO:1903351 | cellular response to dopamine | 9 | 34 | 4.52e-02 |
| GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 9 | 34 | 4.52e-02 |
| GO:BP | GO:0021545 | cranial nerve development | 9 | 34 | 4.52e-02 |
| GO:BP | GO:0045216 | cell-cell junction organization | 26 | 158 | 4.52e-02 |
| GO:BP | GO:0097320 | plasma membrane tubulation | 6 | 17 | 4.56e-02 |
| GO:BP | GO:0006907 | pinocytosis | 6 | 17 | 4.56e-02 |
| GO:BP | GO:0097529 | myeloid leukocyte migration | 21 | 119 | 4.56e-02 |
| GO:BP | GO:0036303 | lymph vessel morphogenesis | 6 | 17 | 4.56e-02 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 34 | 224 | 4.59e-02 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 17 | 89 | 4.64e-02 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 17 | 89 | 4.64e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 36 | 241 | 4.64e-02 |
| GO:BP | GO:0032945 | negative regulation of mononuclear cell proliferation | 11 | 47 | 4.68e-02 |
| GO:BP | GO:0050672 | negative regulation of lymphocyte proliferation | 11 | 47 | 4.68e-02 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 26 | 159 | 4.78e-02 |
| GO:BP | GO:0006006 | glucose metabolic process | 25 | 151 | 4.78e-02 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 444 | 4269 | 4.79e-02 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 98 | 802 | 4.83e-02 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 55 | 407 | 4.83e-02 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 34 | 225 | 4.85e-02 |
| GO:BP | GO:0048709 | oligodendrocyte differentiation | 15 | 75 | 4.87e-02 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 12 | 54 | 4.87e-02 |
| GO:BP | GO:0045582 | positive regulation of T cell differentiation | 15 | 75 | 4.87e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 15 | 75 | 4.87e-02 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 18 | 97 | 4.87e-02 |
| GO:BP | GO:0061448 | connective tissue development | 33 | 217 | 4.93e-02 |
| GO:BP | GO:0032535 | regulation of cellular component size | 44 | 311 | 4.98e-02 |
| GO:BP | GO:0007423 | sensory organ development | 54 | 399 | 4.98e-02 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 22 | 128 | 4.99e-02 |
| GO:BP | GO:1905314 | semi-lunar valve development | 10 | 41 | 5.00e-02 |
ESRnomtable_20k_enh %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in ESR enhancer neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 37 | 127 | 6.51e-08 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 37 | 132 | 1.09e-07 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 25 | 77 | 1.69e-06 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 26 | 84 | 2.01e-06 |
| KEGG | KEGG:05200 | Pathways in cancer | 73 | 408 | 2.82e-06 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 35 | 151 | 1.94e-05 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 22 | 79 | 1.00e-04 |
| KEGG | KEGG:04976 | Bile secretion | 15 | 42 | 1.24e-04 |
| KEGG | KEGG:04931 | Insulin resistance | 24 | 95 | 1.80e-04 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 27 | 115 | 1.91e-04 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 34 | 164 | 2.22e-04 |
| KEGG | KEGG:04360 | Axon guidance | 33 | 162 | 4.06e-04 |
| KEGG | KEGG:04725 | Cholinergic synapse | 21 | 83 | 4.57e-04 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 15 | 48 | 4.57e-04 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 24 | 104 | 5.60e-04 |
| KEGG | KEGG:04971 | Gastric acid secretion | 15 | 52 | 1.13e-03 |
| KEGG | KEGG:04911 | Insulin secretion | 17 | 64 | 1.13e-03 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 31 | 164 | 2.00e-03 |
| KEGG | KEGG:04934 | Cushing syndrome | 25 | 121 | 2.00e-03 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 33 | 179 | 2.00e-03 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 19 | 82 | 2.55e-03 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 30 | 163 | 3.34e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 20 | 91 | 3.34e-03 |
| KEGG | KEGG:00000 | KEGG root term | 604 | 5802 | 3.34e-03 |
| KEGG | KEGG:04014 | Ras signaling pathway | 31 | 172 | 3.47e-03 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 22 | 106 | 3.47e-03 |
| KEGG | KEGG:04740 | Olfactory transduction | 9 | 25 | 3.47e-03 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 16 | 67 | 4.26e-03 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 20 | 96 | 5.44e-03 |
| KEGG | KEGG:04713 | Circadian entrainment | 16 | 69 | 5.44e-03 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 19 | 89 | 5.44e-03 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 13 | 50 | 5.44e-03 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 40 | 256 | 8.57e-03 |
| KEGG | KEGG:04520 | Adherens junction | 18 | 86 | 8.57e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 30 | 176 | 8.68e-03 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 19 | 94 | 9.11e-03 |
| KEGG | KEGG:05030 | Cocaine addiction | 10 | 35 | 9.11e-03 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 11 | 41 | 9.11e-03 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 20 | 102 | 9.43e-03 |
| KEGG | KEGG:04814 | Motor proteins | 26 | 149 | 1.14e-02 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 19 | 98 | 1.35e-02 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 17 | 84 | 1.38e-02 |
| KEGG | KEGG:04916 | Melanogenesis | 16 | 77 | 1.38e-02 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 15 | 72 | 1.76e-02 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 16 | 79 | 1.76e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 25 | 149 | 2.10e-02 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 8 | 28 | 2.23e-02 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 24 | 142 | 2.23e-02 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 20 | 112 | 2.39e-02 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 10 | 41 | 2.48e-02 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 21 | 121 | 2.59e-02 |
| KEGG | KEGG:04510 | Focal adhesion | 28 | 177 | 2.59e-02 |
| KEGG | KEGG:04970 | Salivary secretion | 12 | 55 | 2.64e-02 |
| KEGG | KEGG:05031 | Amphetamine addiction | 11 | 49 | 2.95e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 12 | 56 | 2.97e-02 |
| KEGG | KEGG:05146 | Amoebiasis | 13 | 64 | 3.29e-02 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 13 | 64 | 3.29e-02 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 19 | 109 | 3.29e-02 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 11 | 51 | 3.59e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 13 | 65 | 3.59e-02 |
| KEGG | KEGG:04972 | Pancreatic secretion | 12 | 58 | 3.59e-02 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 9 | 38 | 3.83e-02 |
| KEGG | KEGG:05034 | Alcoholism | 19 | 113 | 4.47e-02 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 14 | 75 | 4.48e-02 |
| KEGG | KEGG:05212 | Pancreatic cancer | 14 | 75 | 4.48e-02 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 14 | 75 | 4.48e-02 |
| KEGG | KEGG:05142 | Chagas disease | 14 | 75 | 4.48e-02 |
| KEGG | KEGG:05152 | Tuberculosis | 18 | 106 | 4.51e-02 |
LR 20,000 bp NG
# LR_resgenes_20k <- gost(query = LR_peak_list_20k$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(LR_resgenes_20k,"data/GO_KEGG_analysis/LR_resgenes_20k.RDS")
# LRnom <- gostplot(LR_resgenes_20k, capped = FALSE, interactive = TRUE)
# LRnom
LRnomtable_20k <- LR_resgenes_20k$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
LRnomtable_20k %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 3247 | 4830 | 2.72e-50 |
| GO:BP | GO:0048856 | anatomical structure development | 2795 | 4130 | 3.32e-44 |
| GO:BP | GO:0007275 | multicellular organism development | 2324 | 3383 | 1.10e-41 |
| GO:BP | GO:0007154 | cell communication | 2854 | 4248 | 2.21e-41 |
| GO:BP | GO:0032502 | developmental process | 2991 | 4475 | 2.69e-41 |
| GO:BP | GO:0048731 | system development | 2022 | 2903 | 2.69e-41 |
| GO:BP | GO:0023052 | signaling | 2810 | 4180 | 4.92e-41 |
| GO:BP | GO:0050896 | response to stimulus | 3737 | 5732 | 1.83e-39 |
| GO:BP | GO:0007165 | signal transduction | 2587 | 3846 | 8.24e-37 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1401 | 1951 | 1.04e-36 |
| GO:BP | GO:0051716 | cellular response to stimulus | 3243 | 4933 | 3.56e-36 |
| GO:BP | GO:0048869 | cellular developmental process | 2041 | 2988 | 4.80e-33 |
| GO:BP | GO:0030154 | cell differentiation | 2040 | 2987 | 5.44e-33 |
| GO:BP | GO:0050789 | regulation of biological process | 5035 | 8037 | 6.02e-30 |
| GO:BP | GO:0065007 | biological regulation | 5159 | 8275 | 1.19e-27 |
| GO:BP | GO:0007399 | nervous system development | 1335 | 1903 | 4.38e-27 |
| GO:BP | GO:0010646 | regulation of cell communication | 1772 | 2601 | 1.05e-26 |
| GO:BP | GO:0022008 | neurogenesis | 963 | 1327 | 1.58e-26 |
| GO:BP | GO:0050794 | regulation of cellular process | 4791 | 7651 | 2.47e-26 |
| GO:BP | GO:0008150 | biological_process | 7248 | 12051 | 7.45e-26 |
| GO:BP | GO:0023051 | regulation of signaling | 1765 | 2597 | 8.50e-26 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1327 | 1900 | 1.13e-25 |
| GO:BP | GO:0048513 | animal organ development | 1472 | 2130 | 1.24e-25 |
| GO:BP | GO:0050793 | regulation of developmental process | 1263 | 1801 | 2.04e-25 |
| GO:BP | GO:0048518 | positive regulation of biological process | 2959 | 4561 | 6.87e-25 |
| GO:BP | GO:0048468 | cell development | 1386 | 1999 | 7.34e-25 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1416 | 2052 | 4.52e-24 |
| GO:BP | GO:0048699 | generation of neurons | 834 | 1145 | 1.56e-23 |
| GO:BP | GO:0009987 | cellular process | 6915 | 11450 | 2.06e-23 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1940 | 2902 | 4.41e-23 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 2728 | 4198 | 8.22e-23 |
| GO:BP | GO:0003008 | system process | 864 | 1201 | 1.06e-21 |
| GO:BP | GO:0030182 | neuron differentiation | 785 | 1080 | 1.32e-21 |
| GO:BP | GO:0007155 | cell adhesion | 732 | 1004 | 1.36e-20 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1557 | 2307 | 3.65e-20 |
| GO:BP | GO:0031175 | neuron projection development | 592 | 794 | 4.78e-20 |
| GO:BP | GO:0048666 | neuron development | 656 | 894 | 2.05e-19 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 872 | 1227 | 2.34e-19 |
| GO:BP | GO:0030030 | cell projection organization | 894 | 1262 | 3.07e-19 |
| GO:BP | GO:0072359 | circulatory system development | 656 | 896 | 4.85e-19 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 475 | 625 | 1.27e-18 |
| GO:BP | GO:0000902 | cell morphogenesis | 567 | 764 | 2.10e-18 |
| GO:BP | GO:0048870 | cell motility | 843 | 1190 | 4.90e-18 |
| GO:BP | GO:0009888 | tissue development | 993 | 1425 | 5.07e-18 |
| GO:BP | GO:0016477 | cell migration | 770 | 1078 | 8.01e-18 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 551 | 749 | 1.73e-16 |
| GO:BP | GO:0007267 | cell-cell signaling | 815 | 1156 | 1.73e-16 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 691 | 967 | 7.07e-16 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 406 | 534 | 8.10e-16 |
| GO:BP | GO:0001568 | blood vessel development | 414 | 546 | 8.39e-16 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 969 | 1403 | 9.24e-16 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 631 | 876 | 1.25e-15 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 392 | 515 | 2.10e-15 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 402 | 530 | 2.22e-15 |
| GO:BP | GO:0065008 | regulation of biological quality | 1364 | 2039 | 3.52e-15 |
| GO:BP | GO:0001944 | vasculature development | 430 | 573 | 4.05e-15 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 520 | 710 | 6.50e-15 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 794 | 1134 | 7.14e-15 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 764 | 1088 | 9.83e-15 |
| GO:BP | GO:0040012 | regulation of locomotion | 556 | 766 | 9.85e-15 |
| GO:BP | GO:0040011 | locomotion | 615 | 858 | 1.68e-14 |
| GO:BP | GO:2000145 | regulation of cell motility | 541 | 745 | 2.26e-14 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 357 | 468 | 3.04e-14 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1383 | 2079 | 3.38e-14 |
| GO:BP | GO:0006810 | transport | 2054 | 3176 | 3.74e-14 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 868 | 1256 | 4.25e-14 |
| GO:BP | GO:0051179 | localization | 2537 | 3978 | 4.99e-14 |
| GO:BP | GO:0035295 | tube development | 593 | 827 | 5.01e-14 |
| GO:BP | GO:0016043 | cellular component organization | 3229 | 5139 | 6.49e-14 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 403 | 540 | 1.63e-13 |
| GO:BP | GO:0030334 | regulation of cell migration | 515 | 710 | 1.63e-13 |
| GO:BP | GO:0044057 | regulation of system process | 308 | 399 | 1.99e-13 |
| GO:BP | GO:0032879 | regulation of localization | 1031 | 1521 | 2.48e-13 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 708 | 1011 | 3.40e-13 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1323 | 1992 | 3.58e-13 |
| GO:BP | GO:0003013 | circulatory system process | 339 | 446 | 3.75e-13 |
| GO:BP | GO:0042221 | response to chemical | 1596 | 2436 | 3.75e-13 |
| GO:BP | GO:0035239 | tube morphogenesis | 486 | 668 | 4.12e-13 |
| GO:BP | GO:0048519 | negative regulation of biological process | 2565 | 4037 | 4.25e-13 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 294 | 380 | 4.77e-13 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 770 | 1111 | 7.74e-13 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 409 | 553 | 1.01e-12 |
| GO:BP | GO:0098657 | import into cell | 480 | 661 | 1.01e-12 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 2422 | 3804 | 1.05e-12 |
| GO:BP | GO:0030029 | actin filament-based process | 490 | 677 | 1.33e-12 |
| GO:BP | GO:0051234 | establishment of localization | 2205 | 3447 | 1.97e-12 |
| GO:BP | GO:0034330 | cell junction organization | 433 | 591 | 2.05e-12 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 473 | 653 | 3.09e-12 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 454 | 626 | 7.53e-12 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 349 | 467 | 8.41e-12 |
| GO:BP | GO:0051049 | regulation of transport | 798 | 1164 | 1.11e-11 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 875 | 1288 | 1.80e-11 |
| GO:BP | GO:0023056 | positive regulation of signaling | 877 | 1292 | 2.20e-11 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 351 | 472 | 2.20e-11 |
| GO:BP | GO:0007409 | axonogenesis | 278 | 363 | 2.20e-11 |
| GO:BP | GO:0006897 | endocytosis | 384 | 522 | 2.31e-11 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1225 | 1852 | 2.52e-11 |
| GO:BP | GO:0061564 | axon development | 304 | 402 | 2.65e-11 |
| GO:BP | GO:0048589 | developmental growth | 386 | 527 | 5.57e-11 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 474 | 662 | 6.06e-11 |
| GO:BP | GO:0098609 | cell-cell adhesion | 437 | 607 | 1.33e-10 |
| GO:BP | GO:0030001 | metal ion transport | 402 | 554 | 1.73e-10 |
| GO:BP | GO:0008015 | blood circulation | 282 | 374 | 3.46e-10 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 1062 | 1601 | 4.72e-10 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 340 | 462 | 4.93e-10 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 3312 | 5340 | 7.52e-10 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 782 | 1154 | 8.47e-10 |
| GO:BP | GO:0007507 | heart development | 374 | 515 | 8.49e-10 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 430 | 601 | 8.54e-10 |
| GO:BP | GO:0007010 | cytoskeleton organization | 822 | 1218 | 8.65e-10 |
| GO:BP | GO:0071310 | cellular response to organic substance | 916 | 1370 | 1.23e-09 |
| GO:BP | GO:0016310 | phosphorylation | 816 | 1211 | 1.70e-09 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 388 | 540 | 3.61e-09 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 624 | 909 | 4.28e-09 |
| GO:BP | GO:0061061 | muscle structure development | 400 | 559 | 4.38e-09 |
| GO:BP | GO:0006468 | protein phosphorylation | 686 | 1008 | 5.25e-09 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 312 | 425 | 5.66e-09 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 317 | 433 | 6.77e-09 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 347 | 479 | 7.51e-09 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 302 | 411 | 9.49e-09 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 824 | 1231 | 1.02e-08 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 770 | 1145 | 1.15e-08 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 499 | 716 | 1.28e-08 |
| GO:BP | GO:0001525 | angiogenesis | 292 | 397 | 1.58e-08 |
| GO:BP | GO:0070848 | response to growth factor | 408 | 576 | 2.40e-08 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1769 | 2780 | 2.61e-08 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 197 | 256 | 2.78e-08 |
| GO:BP | GO:0010033 | response to organic substance | 1193 | 1835 | 4.01e-08 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 910 | 1376 | 4.62e-08 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 81 | 92 | 4.92e-08 |
| GO:BP | GO:1903522 | regulation of blood circulation | 158 | 200 | 5.06e-08 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 361 | 506 | 6.35e-08 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 392 | 554 | 6.35e-08 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 392 | 554 | 6.35e-08 |
| GO:BP | GO:0014706 | striated muscle tissue development | 170 | 218 | 7.11e-08 |
| GO:BP | GO:0051960 | regulation of nervous system development | 264 | 358 | 7.12e-08 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 308 | 425 | 7.31e-08 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 254 | 343 | 7.38e-08 |
| GO:BP | GO:0006811 | monoatomic ion transport | 529 | 769 | 7.40e-08 |
| GO:BP | GO:0009790 | embryo development | 589 | 864 | 7.56e-08 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 439 | 628 | 8.09e-08 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 569 | 833 | 9.06e-08 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1308 | 2028 | 9.06e-08 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 253 | 342 | 9.06e-08 |
| GO:BP | GO:0140352 | export from cell | 436 | 624 | 9.94e-08 |
| GO:BP | GO:0003015 | heart process | 164 | 210 | 1.07e-07 |
| GO:BP | GO:0060047 | heart contraction | 157 | 200 | 1.21e-07 |
| GO:BP | GO:1901698 | response to nitrogen compound | 531 | 774 | 1.22e-07 |
| GO:BP | GO:0007423 | sensory organ development | 290 | 399 | 1.27e-07 |
| GO:BP | GO:0006812 | monoatomic cation transport | 454 | 653 | 1.27e-07 |
| GO:BP | GO:0060429 | epithelium development | 570 | 836 | 1.29e-07 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 473 | 683 | 1.33e-07 |
| GO:BP | GO:1901652 | response to peptide | 278 | 381 | 1.42e-07 |
| GO:BP | GO:0099536 | synaptic signaling | 367 | 518 | 1.54e-07 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 356 | 501 | 1.54e-07 |
| GO:BP | GO:0003012 | muscle system process | 250 | 339 | 1.74e-07 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1292 | 2006 | 1.81e-07 |
| GO:BP | GO:0007417 | central nervous system development | 513 | 748 | 2.36e-07 |
| GO:BP | GO:0042391 | regulation of membrane potential | 223 | 299 | 2.41e-07 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1624 | 2555 | 2.45e-07 |
| GO:BP | GO:0090257 | regulation of muscle system process | 143 | 181 | 2.71e-07 |
| GO:BP | GO:0051641 | cellular localization | 1767 | 2793 | 2.84e-07 |
| GO:BP | GO:0001501 | skeletal system development | 269 | 369 | 2.84e-07 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 360 | 509 | 2.86e-07 |
| GO:BP | GO:0046903 | secretion | 454 | 656 | 3.04e-07 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 352 | 497 | 3.26e-07 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 352 | 497 | 3.26e-07 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 227 | 306 | 3.72e-07 |
| GO:BP | GO:0008016 | regulation of heart contraction | 135 | 170 | 3.83e-07 |
| GO:BP | GO:0031032 | actomyosin structure organization | 148 | 189 | 4.24e-07 |
| GO:BP | GO:0061448 | connective tissue development | 167 | 217 | 4.69e-07 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 204 | 272 | 4.79e-07 |
| GO:BP | GO:0034329 | cell junction assembly | 255 | 349 | 4.80e-07 |
| GO:BP | GO:0001503 | ossification | 237 | 322 | 5.52e-07 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 369 | 525 | 5.55e-07 |
| GO:BP | GO:0006816 | calcium ion transport | 203 | 271 | 6.06e-07 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 274 | 379 | 7.27e-07 |
| GO:BP | GO:0009725 | response to hormone | 438 | 634 | 7.65e-07 |
| GO:BP | GO:0048729 | tissue morphogenesis | 338 | 478 | 8.26e-07 |
| GO:BP | GO:0040007 | growth | 504 | 739 | 9.63e-07 |
| GO:BP | GO:1901653 | cellular response to peptide | 211 | 284 | 9.71e-07 |
| GO:BP | GO:0048638 | regulation of developmental growth | 193 | 257 | 9.71e-07 |
| GO:BP | GO:0042592 | homeostatic process | 794 | 1204 | 1.05e-06 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 274 | 380 | 1.06e-06 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 287 | 400 | 1.08e-06 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1470 | 2311 | 1.18e-06 |
| GO:BP | GO:0032940 | secretion by cell | 402 | 579 | 1.18e-06 |
| GO:BP | GO:0050877 | nervous system process | 437 | 634 | 1.18e-06 |
| GO:BP | GO:0051216 | cartilage development | 122 | 153 | 1.19e-06 |
| GO:BP | GO:0043434 | response to peptide hormone | 237 | 324 | 1.27e-06 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 165 | 216 | 1.33e-06 |
| GO:BP | GO:0048771 | tissue remodeling | 98 | 119 | 1.36e-06 |
| GO:BP | GO:0060284 | regulation of cell development | 418 | 605 | 1.52e-06 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 259 | 358 | 1.52e-06 |
| GO:BP | GO:0010720 | positive regulation of cell development | 238 | 326 | 1.53e-06 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 839 | 1279 | 1.57e-06 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 158 | 206 | 1.58e-06 |
| GO:BP | GO:0035265 | organ growth | 107 | 132 | 1.63e-06 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 312 | 440 | 1.74e-06 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 564 | 837 | 1.76e-06 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 513 | 756 | 1.84e-06 |
| GO:BP | GO:0048880 | sensory system development | 204 | 275 | 1.84e-06 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 204 | 275 | 1.84e-06 |
| GO:BP | GO:0043010 | camera-type eye development | 178 | 236 | 1.84e-06 |
| GO:BP | GO:0001654 | eye development | 202 | 272 | 1.85e-06 |
| GO:BP | GO:0072001 | renal system development | 190 | 254 | 1.87e-06 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 397 | 573 | 1.94e-06 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 225 | 307 | 2.03e-06 |
| GO:BP | GO:0030900 | forebrain development | 215 | 292 | 2.17e-06 |
| GO:BP | GO:0007015 | actin filament organization | 273 | 381 | 2.61e-06 |
| GO:BP | GO:0150063 | visual system development | 202 | 273 | 2.93e-06 |
| GO:BP | GO:0009605 | response to external stimulus | 1073 | 1664 | 2.96e-06 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 641 | 963 | 3.25e-06 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 230 | 316 | 3.68e-06 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 179 | 239 | 3.85e-06 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 548 | 815 | 4.09e-06 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 318 | 452 | 4.23e-06 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 82 | 98 | 4.23e-06 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 231 | 318 | 4.42e-06 |
| GO:BP | GO:0065009 | regulation of molecular function | 903 | 1389 | 4.72e-06 |
| GO:BP | GO:0036211 | protein modification process | 1531 | 2423 | 5.53e-06 |
| GO:BP | GO:0023057 | negative regulation of signaling | 731 | 1111 | 6.01e-06 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 288 | 407 | 7.29e-06 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 297 | 421 | 7.36e-06 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 137 | 178 | 8.08e-06 |
| GO:BP | GO:0097485 | neuron projection guidance | 141 | 184 | 8.51e-06 |
| GO:BP | GO:0007411 | axon guidance | 141 | 184 | 8.51e-06 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 337 | 484 | 8.97e-06 |
| GO:BP | GO:0060322 | head development | 400 | 583 | 8.97e-06 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 337 | 484 | 8.97e-06 |
| GO:BP | GO:0001822 | kidney development | 183 | 247 | 9.72e-06 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 132 | 171 | 9.74e-06 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 177 | 238 | 9.77e-06 |
| GO:BP | GO:0043062 | extracellular structure organization | 177 | 238 | 9.77e-06 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 101 | 126 | 9.98e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1559 | 2474 | 1.01e-05 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 728 | 1109 | 1.04e-05 |
| GO:BP | GO:0045216 | cell-cell junction organization | 123 | 158 | 1.07e-05 |
| GO:BP | GO:0030198 | extracellular matrix organization | 176 | 237 | 1.23e-05 |
| GO:BP | GO:0060537 | muscle tissue development | 252 | 353 | 1.27e-05 |
| GO:BP | GO:0003205 | cardiac chamber development | 118 | 151 | 1.29e-05 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 86 | 105 | 1.30e-05 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 76 | 91 | 1.35e-05 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 286 | 406 | 1.43e-05 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 393 | 574 | 1.54e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 73 | 87 | 1.57e-05 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 684 | 1040 | 1.59e-05 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 130 | 169 | 1.61e-05 |
| GO:BP | GO:0030048 | actin filament-based movement | 90 | 111 | 1.64e-05 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 303 | 433 | 1.68e-05 |
| GO:BP | GO:0055085 | transmembrane transport | 652 | 989 | 1.82e-05 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 390 | 571 | 2.49e-05 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 167 | 225 | 2.50e-05 |
| GO:BP | GO:0003007 | heart morphogenesis | 165 | 222 | 2.50e-05 |
| GO:BP | GO:0008283 | cell population proliferation | 895 | 1386 | 2.70e-05 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 170 | 230 | 3.11e-05 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 187 | 256 | 3.45e-05 |
| GO:BP | GO:0090130 | tissue migration | 187 | 256 | 3.45e-05 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 78 | 95 | 3.63e-05 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 217 | 302 | 3.64e-05 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 561 | 846 | 3.99e-05 |
| GO:BP | GO:0016358 | dendrite development | 147 | 196 | 4.07e-05 |
| GO:BP | GO:0030010 | establishment of cell polarity | 105 | 134 | 4.25e-05 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 120 | 156 | 4.30e-05 |
| GO:BP | GO:0090132 | epithelium migration | 184 | 252 | 4.30e-05 |
| GO:BP | GO:0010631 | epithelial cell migration | 184 | 252 | 4.30e-05 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 287 | 411 | 4.32e-05 |
| GO:BP | GO:0032409 | regulation of transporter activity | 122 | 159 | 4.37e-05 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 560 | 845 | 4.45e-05 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 111 | 143 | 4.83e-05 |
| GO:BP | GO:0033036 | macromolecule localization | 1539 | 2453 | 4.90e-05 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 152 | 204 | 5.07e-05 |
| GO:BP | GO:0007420 | brain development | 368 | 539 | 5.15e-05 |
| GO:BP | GO:0042692 | muscle cell differentiation | 237 | 334 | 5.45e-05 |
| GO:BP | GO:0007610 | behavior | 308 | 445 | 6.05e-05 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 108 | 139 | 6.06e-05 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 229 | 322 | 6.19e-05 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 30 | 31 | 6.29e-05 |
| GO:BP | GO:0030100 | regulation of endocytosis | 155 | 209 | 6.29e-05 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 311 | 450 | 6.51e-05 |
| GO:BP | GO:0001775 | cell activation | 446 | 665 | 8.42e-05 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 115 | 150 | 9.13e-05 |
| GO:BP | GO:0045165 | cell fate commitment | 121 | 159 | 9.75e-05 |
| GO:BP | GO:0060341 | regulation of cellular localization | 539 | 815 | 9.96e-05 |
| GO:BP | GO:0031399 | regulation of protein modification process | 628 | 959 | 1.04e-04 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 106 | 137 | 1.05e-04 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 1076 | 1692 | 1.06e-04 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 95 | 121 | 1.10e-04 |
| GO:BP | GO:0050808 | synapse organization | 262 | 375 | 1.11e-04 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 72 | 88 | 1.13e-04 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 164 | 224 | 1.16e-04 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 220 | 310 | 1.21e-04 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 272 | 391 | 1.24e-04 |
| GO:BP | GO:0009611 | response to wounding | 279 | 402 | 1.25e-04 |
| GO:BP | GO:0006936 | muscle contraction | 192 | 267 | 1.27e-04 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 126 | 167 | 1.27e-04 |
| GO:BP | GO:0048588 | developmental cell growth | 144 | 194 | 1.28e-04 |
| GO:BP | GO:0001649 | osteoblast differentiation | 136 | 182 | 1.29e-04 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 134 | 179 | 1.29e-04 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 105 | 136 | 1.34e-04 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 424 | 632 | 1.35e-04 |
| GO:BP | GO:0061572 | actin filament bundle organization | 107 | 139 | 1.37e-04 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 498 | 751 | 1.46e-04 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 113 | 148 | 1.48e-04 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 87 | 110 | 1.57e-04 |
| GO:BP | GO:0048041 | focal adhesion assembly | 66 | 80 | 1.59e-04 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 183 | 254 | 1.70e-04 |
| GO:BP | GO:0051050 | positive regulation of transport | 407 | 606 | 1.76e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 91 | 116 | 1.76e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 91 | 116 | 1.76e-04 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 158 | 216 | 1.80e-04 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1343 | 2138 | 1.80e-04 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 97 | 125 | 2.04e-04 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 128 | 171 | 2.04e-04 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 469 | 706 | 2.04e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 362 | 535 | 2.06e-04 |
| GO:BP | GO:0008104 | protein localization | 1336 | 2128 | 2.21e-04 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 72 | 89 | 2.30e-04 |
| GO:BP | GO:0003231 | cardiac ventricle development | 90 | 115 | 2.32e-04 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 147 | 200 | 2.40e-04 |
| GO:BP | GO:0046849 | bone remodeling | 52 | 61 | 2.45e-04 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 474 | 715 | 2.49e-04 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 74 | 92 | 2.52e-04 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 62 | 75 | 2.61e-04 |
| GO:BP | GO:0032535 | regulation of cellular component size | 219 | 311 | 2.76e-04 |
| GO:BP | GO:0021537 | telencephalon development | 152 | 208 | 2.84e-04 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 265 | 383 | 2.89e-04 |
| GO:BP | GO:0031099 | regeneration | 112 | 148 | 3.17e-04 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 211 | 299 | 3.18e-04 |
| GO:BP | GO:0051046 | regulation of secretion | 285 | 415 | 3.39e-04 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 73 | 91 | 3.42e-04 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 196 | 276 | 3.43e-04 |
| GO:BP | GO:0060485 | mesenchyme development | 183 | 256 | 3.50e-04 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 390 | 582 | 3.59e-04 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 61 | 74 | 3.59e-04 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 253 | 365 | 3.66e-04 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 143 | 195 | 3.73e-04 |
| GO:BP | GO:0001764 | neuron migration | 105 | 138 | 3.86e-04 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 738 | 1146 | 3.91e-04 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 70 | 87 | 4.18e-04 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 152 | 209 | 4.24e-04 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 58 | 70 | 4.26e-04 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 58 | 70 | 4.26e-04 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 150 | 206 | 4.29e-04 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 72 | 90 | 4.54e-04 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 142 | 194 | 4.61e-04 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 212 | 302 | 5.04e-04 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 108 | 143 | 5.05e-04 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 277 | 404 | 5.18e-04 |
| GO:BP | GO:0048592 | eye morphogenesis | 87 | 112 | 5.18e-04 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 313 | 461 | 5.22e-04 |
| GO:BP | GO:0042330 | taxis | 188 | 265 | 5.41e-04 |
| GO:BP | GO:0006935 | chemotaxis | 188 | 265 | 5.41e-04 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 443 | 669 | 5.42e-04 |
| GO:BP | GO:0032880 | regulation of protein localization | 479 | 727 | 5.42e-04 |
| GO:BP | GO:0043412 | macromolecule modification | 1633 | 2631 | 5.46e-04 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 162 | 225 | 5.46e-04 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 143 | 196 | 5.49e-04 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 143 | 196 | 5.49e-04 |
| GO:BP | GO:0014896 | muscle hypertrophy | 62 | 76 | 5.49e-04 |
| GO:BP | GO:0003279 | cardiac septum development | 80 | 102 | 5.81e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 52 | 62 | 5.81e-04 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 182 | 256 | 5.84e-04 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 44 | 51 | 6.03e-04 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 32 | 35 | 6.52e-04 |
| GO:BP | GO:0043149 | stress fiber assembly | 75 | 95 | 6.87e-04 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 75 | 95 | 6.87e-04 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 90 | 117 | 7.10e-04 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 613 | 946 | 7.33e-04 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 132 | 180 | 7.40e-04 |
| GO:BP | GO:0050900 | leukocyte migration | 151 | 209 | 7.50e-04 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 98 | 129 | 7.69e-04 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 186 | 263 | 7.69e-04 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 270 | 395 | 8.82e-04 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 58 | 71 | 9.15e-04 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 131 | 179 | 9.22e-04 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 150 | 208 | 9.22e-04 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 194 | 276 | 9.35e-04 |
| GO:BP | GO:0033043 | regulation of organelle organization | 655 | 1016 | 9.35e-04 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 273 | 400 | 9.35e-04 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 48 | 57 | 9.44e-04 |
| GO:BP | GO:0006950 | response to stress | 1680 | 2715 | 9.44e-04 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 40 | 46 | 9.45e-04 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 76 | 97 | 9.51e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 438 | 664 | 9.82e-04 |
| GO:BP | GO:0060348 | bone development | 117 | 158 | 9.86e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 269 | 394 | 1.01e-03 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 140 | 193 | 1.02e-03 |
| GO:BP | GO:0006996 | organelle organization | 1850 | 3001 | 1.05e-03 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 71 | 90 | 1.13e-03 |
| GO:BP | GO:0002376 | immune system process | 956 | 1512 | 1.13e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 399 | 602 | 1.15e-03 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 198 | 283 | 1.17e-03 |
| GO:BP | GO:0042063 | gliogenesis | 180 | 255 | 1.17e-03 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 124 | 169 | 1.17e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 116 | 157 | 1.23e-03 |
| GO:BP | GO:0006909 | phagocytosis | 108 | 145 | 1.26e-03 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 106 | 142 | 1.26e-03 |
| GO:BP | GO:0031667 | response to nutrient levels | 252 | 368 | 1.26e-03 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 102 | 136 | 1.26e-03 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 27 | 29 | 1.27e-03 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 52 | 63 | 1.28e-03 |
| GO:BP | GO:0050807 | regulation of synapse organization | 135 | 186 | 1.28e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 52 | 63 | 1.28e-03 |
| GO:BP | GO:0033993 | response to lipid | 398 | 601 | 1.28e-03 |
| GO:BP | GO:0006835 | dicarboxylic acid transport | 52 | 63 | 1.28e-03 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 150 | 209 | 1.29e-03 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 129 | 177 | 1.36e-03 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 159 | 223 | 1.36e-03 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 83 | 108 | 1.41e-03 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 23 | 24 | 1.44e-03 |
| GO:BP | GO:0098868 | bone growth | 23 | 24 | 1.44e-03 |
| GO:BP | GO:0002063 | chondrocyte development | 23 | 24 | 1.44e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 54 | 66 | 1.45e-03 |
| GO:BP | GO:0010876 | lipid localization | 216 | 312 | 1.47e-03 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 117 | 159 | 1.48e-03 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 49 | 59 | 1.51e-03 |
| GO:BP | GO:1990138 | neuron projection extension | 109 | 147 | 1.53e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 95 | 126 | 1.54e-03 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 171 | 242 | 1.56e-03 |
| GO:BP | GO:0010817 | regulation of hormone levels | 233 | 339 | 1.58e-03 |
| GO:BP | GO:0048568 | embryonic organ development | 219 | 317 | 1.59e-03 |
| GO:BP | GO:0007517 | muscle organ development | 196 | 281 | 1.60e-03 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 41 | 48 | 1.69e-03 |
| GO:BP | GO:0051235 | maintenance of location | 183 | 261 | 1.75e-03 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 58 | 72 | 1.76e-03 |
| GO:BP | GO:0010232 | vascular transport | 58 | 72 | 1.76e-03 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 304 | 452 | 1.76e-03 |
| GO:BP | GO:0060419 | heart growth | 58 | 72 | 1.76e-03 |
| GO:BP | GO:0046620 | regulation of organ growth | 58 | 72 | 1.76e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 46 | 55 | 1.76e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 297 | 441 | 1.81e-03 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 84 | 110 | 1.82e-03 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 26 | 28 | 1.86e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 159 | 224 | 1.86e-03 |
| GO:BP | GO:0016266 | O-glycan processing | 26 | 28 | 1.86e-03 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 106 | 143 | 1.89e-03 |
| GO:BP | GO:0010743 | regulation of macrophage derived foam cell differentiation | 18 | 18 | 1.89e-03 |
| GO:BP | GO:0023061 | signal release | 230 | 335 | 1.89e-03 |
| GO:BP | GO:0060349 | bone morphogenesis | 60 | 75 | 1.89e-03 |
| GO:BP | GO:0043588 | skin development | 131 | 181 | 1.89e-03 |
| GO:BP | GO:0048864 | stem cell development | 60 | 75 | 1.89e-03 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 102 | 137 | 1.90e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 53 | 65 | 1.91e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 71 | 91 | 1.92e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 71 | 91 | 1.92e-03 |
| GO:BP | GO:0006915 | apoptotic process | 921 | 1459 | 1.95e-03 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 48 | 58 | 2.01e-03 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 48 | 58 | 2.01e-03 |
| GO:BP | GO:0055001 | muscle cell development | 123 | 169 | 2.04e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1231 | 1974 | 2.14e-03 |
| GO:BP | GO:0003416 | endochondral bone growth | 22 | 23 | 2.16e-03 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 64 | 81 | 2.16e-03 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 79 | 103 | 2.19e-03 |
| GO:BP | GO:0071396 | cellular response to lipid | 275 | 407 | 2.25e-03 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 165 | 234 | 2.31e-03 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 40 | 47 | 2.31e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1186 | 1900 | 2.34e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 87 | 115 | 2.34e-03 |
| GO:BP | GO:0001659 | temperature homeostasis | 101 | 136 | 2.35e-03 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 89 | 118 | 2.35e-03 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 91 | 121 | 2.35e-03 |
| GO:BP | GO:0051051 | negative regulation of transport | 211 | 306 | 2.36e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1221 | 1959 | 2.53e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 159 | 225 | 2.54e-03 |
| GO:BP | GO:1901342 | regulation of vasculature development | 148 | 208 | 2.55e-03 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 226 | 330 | 2.62e-03 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 155 | 219 | 2.71e-03 |
| GO:BP | GO:0006629 | lipid metabolic process | 629 | 981 | 2.72e-03 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 54 | 67 | 2.83e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 54 | 67 | 2.83e-03 |
| GO:BP | GO:0060173 | limb development | 106 | 144 | 2.84e-03 |
| GO:BP | GO:0048736 | appendage development | 106 | 144 | 2.84e-03 |
| GO:BP | GO:0010638 | positive regulation of organelle organization | 290 | 432 | 2.87e-03 |
| GO:BP | GO:0001508 | action potential | 82 | 108 | 2.88e-03 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 84 | 111 | 2.91e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 98 | 132 | 2.93e-03 |
| GO:BP | GO:0008366 | axon ensheathment | 94 | 126 | 2.94e-03 |
| GO:BP | GO:0048469 | cell maturation | 88 | 117 | 2.94e-03 |
| GO:BP | GO:0007272 | ensheathment of neurons | 94 | 126 | 2.94e-03 |
| GO:BP | GO:0008038 | neuron recognition | 31 | 35 | 2.96e-03 |
| GO:BP | GO:0040008 | regulation of growth | 328 | 493 | 2.96e-03 |
| GO:BP | GO:0071711 | basement membrane organization | 31 | 35 | 2.96e-03 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 136 | 190 | 2.99e-03 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 145 | 204 | 3.12e-03 |
| GO:BP | GO:0051653 | spindle localization | 44 | 53 | 3.24e-03 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 130 | 181 | 3.25e-03 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 130 | 181 | 3.25e-03 |
| GO:BP | GO:0006814 | sodium ion transport | 109 | 149 | 3.38e-03 |
| GO:BP | GO:0048678 | response to axon injury | 51 | 63 | 3.42e-03 |
| GO:BP | GO:0055123 | digestive system development | 75 | 98 | 3.46e-03 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 191 | 276 | 3.46e-03 |
| GO:BP | GO:0071702 | organic substance transport | 1135 | 1819 | 3.46e-03 |
| GO:BP | GO:0032868 | response to insulin | 148 | 209 | 3.51e-03 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 217 | 317 | 3.52e-03 |
| GO:BP | GO:0006869 | lipid transport | 189 | 273 | 3.58e-03 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 95 | 128 | 3.65e-03 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 120 | 166 | 3.65e-03 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 46 | 56 | 3.68e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 53 | 66 | 3.71e-03 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 192 | 278 | 3.89e-03 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 264 | 392 | 3.93e-03 |
| GO:BP | GO:0060840 | artery development | 66 | 85 | 3.99e-03 |
| GO:BP | GO:0001894 | tissue homeostasis | 125 | 174 | 4.13e-03 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 68 | 88 | 4.13e-03 |
| GO:BP | GO:0060249 | anatomical structure homeostasis | 125 | 174 | 4.13e-03 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 312 | 469 | 4.16e-03 |
| GO:BP | GO:0046683 | response to organophosphorus | 72 | 94 | 4.35e-03 |
| GO:BP | GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation | 27 | 30 | 4.37e-03 |
| GO:BP | GO:0008219 | cell death | 947 | 1509 | 4.37e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 359 | 545 | 4.52e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 59 | 75 | 4.56e-03 |
| GO:BP | GO:0021954 | central nervous system neuron development | 50 | 62 | 4.56e-03 |
| GO:BP | GO:0042552 | myelination | 92 | 124 | 4.56e-03 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 88 | 118 | 4.60e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 349 | 529 | 4.60e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 203 | 296 | 4.65e-03 |
| GO:BP | GO:0006887 | exocytosis | 175 | 252 | 4.65e-03 |
| GO:BP | GO:0021846 | cell proliferation in forebrain | 16 | 16 | 4.67e-03 |
| GO:BP | GO:0012501 | programmed cell death | 944 | 1505 | 4.86e-03 |
| GO:BP | GO:0019725 | cellular homeostasis | 389 | 594 | 4.96e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 63 | 81 | 4.96e-03 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 135 | 190 | 5.04e-03 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 65 | 84 | 5.14e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 40 | 48 | 5.23e-03 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 183 | 265 | 5.29e-03 |
| GO:BP | GO:0050921 | positive regulation of chemotaxis | 67 | 87 | 5.29e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 459 | 708 | 5.32e-03 |
| GO:BP | GO:0071695 | anatomical structure maturation | 118 | 164 | 5.37e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 69 | 90 | 5.40e-03 |
| GO:BP | GO:0030031 | cell projection assembly | 318 | 480 | 5.44e-03 |
| GO:BP | GO:0010721 | negative regulation of cell development | 138 | 195 | 5.67e-03 |
| GO:BP | GO:0007584 | response to nutrient | 87 | 117 | 5.71e-03 |
| GO:BP | GO:0021987 | cerebral cortex development | 77 | 102 | 5.71e-03 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 87 | 117 | 5.71e-03 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 77 | 102 | 5.71e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 81 | 108 | 5.74e-03 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 42 | 51 | 5.99e-03 |
| GO:BP | GO:0050890 | cognition | 161 | 231 | 6.02e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 369 | 563 | 6.31e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 64 | 83 | 6.66e-03 |
| GO:BP | GO:0030278 | regulation of ossification | 66 | 86 | 6.83e-03 |
| GO:BP | GO:0035270 | endocrine system development | 66 | 86 | 6.83e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 202 | 296 | 7.02e-03 |
| GO:BP | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 90 | 122 | 7.08e-03 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 34 | 40 | 7.15e-03 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 86 | 116 | 7.20e-03 |
| GO:BP | GO:0031623 | receptor internalization | 74 | 98 | 7.23e-03 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 122 | 171 | 7.27e-03 |
| GO:BP | GO:0014074 | response to purine-containing compound | 80 | 107 | 7.27e-03 |
| GO:BP | GO:0019915 | lipid storage | 55 | 70 | 7.40e-03 |
| GO:BP | GO:0014032 | neural crest cell development | 55 | 70 | 7.40e-03 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 46 | 57 | 7.46e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 414 | 637 | 7.59e-03 |
| GO:BP | GO:0045663 | positive regulation of myoblast differentiation | 31 | 36 | 8.08e-03 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 31 | 36 | 8.08e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 99 | 136 | 8.08e-03 |
| GO:BP | GO:0031641 | regulation of myelination | 31 | 36 | 8.08e-03 |
| GO:BP | GO:0051899 | membrane depolarization | 48 | 60 | 8.10e-03 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 114 | 159 | 8.10e-03 |
| GO:BP | GO:0000003 | reproduction | 604 | 948 | 8.15e-03 |
| GO:BP | GO:0031102 | neuron projection regeneration | 41 | 50 | 8.15e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 41 | 50 | 8.15e-03 |
| GO:BP | GO:0051640 | organelle localization | 352 | 537 | 8.20e-03 |
| GO:BP | GO:0046942 | carboxylic acid transport | 152 | 218 | 8.20e-03 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 61 | 79 | 8.25e-03 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 93 | 127 | 8.40e-03 |
| GO:BP | GO:0031103 | axon regeneration | 36 | 43 | 8.44e-03 |
| GO:BP | GO:0046777 | protein autophosphorylation | 110 | 153 | 8.45e-03 |
| GO:BP | GO:0006941 | striated muscle contraction | 110 | 153 | 8.45e-03 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 50 | 63 | 8.60e-03 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 108 | 150 | 8.66e-03 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 28 | 32 | 8.78e-03 |
| GO:BP | GO:0072073 | kidney epithelium development | 85 | 115 | 8.81e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 69 | 91 | 8.85e-03 |
| GO:BP | GO:0048863 | stem cell differentiation | 139 | 198 | 8.85e-03 |
| GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 22 | 24 | 8.97e-03 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 77 | 103 | 8.97e-03 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 22 | 24 | 8.97e-03 |
| GO:BP | GO:0006082 | organic acid metabolic process | 428 | 661 | 9.13e-03 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 25 | 28 | 9.18e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 54 | 69 | 9.51e-03 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 2802 | 4637 | 9.51e-03 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 54 | 69 | 9.51e-03 |
| GO:BP | GO:0042100 | B cell proliferation | 38 | 46 | 9.69e-03 |
| GO:BP | GO:0032787 | monocarboxylic acid metabolic process | 290 | 438 | 9.73e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 693 | 1096 | 9.74e-03 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 45 | 56 | 9.77e-03 |
| GO:BP | GO:0042246 | tissue regeneration | 45 | 56 | 9.77e-03 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 111 | 155 | 9.84e-03 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 56 | 72 | 9.84e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 58 | 75 | 1.02e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 120 | 169 | 1.02e-02 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 182 | 266 | 1.02e-02 |
| GO:BP | GO:0043436 | oxoacid metabolic process | 425 | 657 | 1.05e-02 |
| GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 60 | 78 | 1.05e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 88 | 120 | 1.05e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 118 | 166 | 1.05e-02 |
| GO:BP | GO:0021543 | pallium development | 105 | 146 | 1.06e-02 |
| GO:BP | GO:0015849 | organic acid transport | 152 | 219 | 1.08e-02 |
| GO:BP | GO:0001755 | neural crest cell migration | 40 | 49 | 1.08e-02 |
| GO:BP | GO:0051293 | establishment of spindle localization | 40 | 49 | 1.08e-02 |
| GO:BP | GO:0002027 | regulation of heart rate | 64 | 84 | 1.08e-02 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 143 | 205 | 1.09e-02 |
| GO:BP | GO:0048259 | regulation of receptor-mediated endocytosis | 66 | 87 | 1.09e-02 |
| GO:BP | GO:0006954 | inflammatory response | 302 | 458 | 1.10e-02 |
| GO:BP | GO:0048732 | gland development | 219 | 325 | 1.10e-02 |
| GO:BP | GO:0048565 | digestive tract development | 68 | 90 | 1.10e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 49 | 62 | 1.11e-02 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 74 | 99 | 1.11e-02 |
| GO:BP | GO:0051649 | establishment of localization in cell | 1033 | 1661 | 1.11e-02 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 99 | 137 | 1.13e-02 |
| GO:BP | GO:0045453 | bone resorption | 35 | 42 | 1.13e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 112 | 157 | 1.14e-02 |
| GO:BP | GO:0071378 | cellular response to growth hormone stimulus | 18 | 19 | 1.14e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 162 | 235 | 1.15e-02 |
| GO:BP | GO:0086069 | bundle of His cell to Purkinje myocyte communication | 14 | 14 | 1.15e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 121 | 171 | 1.16e-02 |
| GO:BP | GO:0098739 | import across plasma membrane | 95 | 131 | 1.18e-02 |
| GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 179 | 262 | 1.22e-02 |
| GO:BP | GO:0009306 | protein secretion | 179 | 262 | 1.22e-02 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 27 | 31 | 1.22e-02 |
| GO:BP | GO:0042060 | wound healing | 208 | 308 | 1.22e-02 |
| GO:BP | GO:1990776 | response to angiotensin | 27 | 31 | 1.22e-02 |
| GO:BP | GO:0008361 | regulation of cell size | 117 | 165 | 1.24e-02 |
| GO:BP | GO:0032835 | glomerulus development | 44 | 55 | 1.28e-02 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 37 | 45 | 1.29e-02 |
| GO:BP | GO:0045665 | negative regulation of neuron differentiation | 37 | 45 | 1.29e-02 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 37 | 45 | 1.29e-02 |
| GO:BP | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 21 | 23 | 1.30e-02 |
| GO:BP | GO:0090077 | foam cell differentiation | 21 | 23 | 1.30e-02 |
| GO:BP | GO:0010742 | macrophage derived foam cell differentiation | 21 | 23 | 1.30e-02 |
| GO:BP | GO:0060416 | response to growth hormone | 24 | 27 | 1.30e-02 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 83 | 113 | 1.30e-02 |
| GO:BP | GO:0051648 | vesicle localization | 140 | 201 | 1.31e-02 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 32 | 38 | 1.32e-02 |
| GO:BP | GO:0022414 | reproductive process | 596 | 939 | 1.34e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 264 | 398 | 1.34e-02 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 46 | 58 | 1.35e-02 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 75 | 101 | 1.36e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 244 | 366 | 1.36e-02 |
| GO:BP | GO:0045927 | positive regulation of growth | 138 | 198 | 1.36e-02 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 73 | 98 | 1.36e-02 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 69 | 92 | 1.36e-02 |
| GO:BP | GO:0043500 | muscle adaptation | 69 | 92 | 1.36e-02 |
| GO:BP | GO:0009914 | hormone transport | 152 | 220 | 1.38e-02 |
| GO:BP | GO:0097006 | regulation of plasma lipoprotein particle levels | 39 | 48 | 1.42e-02 |
| GO:BP | GO:0044255 | cellular lipid metabolic process | 473 | 738 | 1.51e-02 |
| GO:BP | GO:0006813 | potassium ion transport | 103 | 144 | 1.52e-02 |
| GO:BP | GO:0030073 | insulin secretion | 103 | 144 | 1.52e-02 |
| GO:BP | GO:0099173 | postsynapse organization | 114 | 161 | 1.52e-02 |
| GO:BP | GO:0007260 | tyrosine phosphorylation of STAT protein | 29 | 34 | 1.52e-02 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 179 | 263 | 1.54e-02 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 41 | 51 | 1.55e-02 |
| GO:BP | GO:0031016 | pancreas development | 41 | 51 | 1.55e-02 |
| GO:BP | GO:0042733 | embryonic digit morphogenesis | 41 | 51 | 1.55e-02 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 41 | 51 | 1.55e-02 |
| GO:BP | GO:0019752 | carboxylic acid metabolic process | 414 | 642 | 1.59e-02 |
| GO:BP | GO:0019222 | regulation of metabolic process | 2960 | 4914 | 1.62e-02 |
| GO:BP | GO:0060541 | respiratory system development | 119 | 169 | 1.63e-02 |
| GO:BP | GO:0016049 | cell growth | 272 | 412 | 1.67e-02 |
| GO:BP | GO:0007611 | learning or memory | 142 | 205 | 1.68e-02 |
| GO:BP | GO:0002685 | regulation of leukocyte migration | 95 | 132 | 1.68e-02 |
| GO:BP | GO:0031644 | regulation of nervous system process | 60 | 79 | 1.69e-02 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 180 | 265 | 1.69e-02 |
| GO:BP | GO:0007613 | memory | 70 | 94 | 1.69e-02 |
| GO:BP | GO:0010996 | response to auditory stimulus | 17 | 18 | 1.69e-02 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 68 | 91 | 1.69e-02 |
| GO:BP | GO:0015918 | sterol transport | 70 | 94 | 1.69e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 64 | 85 | 1.69e-02 |
| GO:BP | GO:0060396 | growth hormone receptor signaling pathway | 17 | 18 | 1.69e-02 |
| GO:BP | GO:0060402 | calcium ion transport into cytosol | 17 | 18 | 1.69e-02 |
| GO:BP | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 26 | 30 | 1.69e-02 |
| GO:BP | GO:0008037 | cell recognition | 62 | 82 | 1.69e-02 |
| GO:BP | GO:1901890 | positive regulation of cell junction assembly | 62 | 82 | 1.69e-02 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 70 | 94 | 1.69e-02 |
| GO:BP | GO:0072583 | clathrin-dependent endocytosis | 36 | 44 | 1.70e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 36 | 44 | 1.70e-02 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 115 | 163 | 1.71e-02 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 232 | 348 | 1.71e-02 |
| GO:BP | GO:0022607 | cellular component assembly | 1520 | 2481 | 1.72e-02 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 102 | 143 | 1.78e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 31 | 37 | 1.78e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 709 | 1128 | 1.78e-02 |
| GO:BP | GO:0050708 | regulation of protein secretion | 129 | 185 | 1.82e-02 |
| GO:BP | GO:0006024 | glycosaminoglycan biosynthetic process | 47 | 60 | 1.83e-02 |
| GO:BP | GO:1904407 | positive regulation of nitric oxide metabolic process | 23 | 26 | 1.83e-02 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 111 | 157 | 1.83e-02 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 23 | 26 | 1.83e-02 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 20 | 22 | 1.87e-02 |
| GO:BP | GO:0043542 | endothelial cell migration | 127 | 182 | 1.88e-02 |
| GO:BP | GO:0044272 | sulfur compound biosynthetic process | 98 | 137 | 1.88e-02 |
| GO:BP | GO:1904377 | positive regulation of protein localization to cell periphery | 49 | 63 | 1.90e-02 |
| GO:BP | GO:0046879 | hormone secretion | 148 | 215 | 1.92e-02 |
| GO:BP | GO:0042110 | T cell activation | 216 | 323 | 1.94e-02 |
| GO:BP | GO:0003170 | heart valve development | 51 | 66 | 1.96e-02 |
| GO:BP | GO:0030217 | T cell differentiation | 132 | 190 | 1.98e-02 |
| GO:BP | GO:0007369 | gastrulation | 105 | 148 | 2.01e-02 |
| GO:BP | GO:0071230 | cellular response to amino acid stimulus | 53 | 69 | 2.01e-02 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 75 | 102 | 2.01e-02 |
| GO:BP | GO:0046503 | glycerolipid catabolic process | 33 | 40 | 2.04e-02 |
| GO:BP | GO:0006631 | fatty acid metabolic process | 187 | 277 | 2.05e-02 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 333 | 512 | 2.07e-02 |
| GO:BP | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 28 | 33 | 2.07e-02 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 28 | 33 | 2.07e-02 |
| GO:BP | GO:1904645 | response to amyloid-beta | 28 | 33 | 2.07e-02 |
| GO:BP | GO:0001823 | mesonephros development | 59 | 78 | 2.08e-02 |
| GO:BP | GO:0045445 | myoblast differentiation | 67 | 90 | 2.08e-02 |
| GO:BP | GO:0051650 | establishment of vesicle localization | 128 | 184 | 2.12e-02 |
| GO:BP | GO:0007626 | locomotory behavior | 101 | 142 | 2.12e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 88 | 122 | 2.13e-02 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 88 | 122 | 2.13e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 88 | 122 | 2.13e-02 |
| GO:BP | GO:1990874 | vascular associated smooth muscle cell proliferation | 42 | 53 | 2.14e-02 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 86 | 119 | 2.18e-02 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 99 | 139 | 2.18e-02 |
| GO:BP | GO:0072006 | nephron development | 86 | 119 | 2.18e-02 |
| GO:BP | GO:0031214 | biomineral tissue development | 84 | 116 | 2.23e-02 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 84 | 116 | 2.23e-02 |
| GO:BP | GO:0045806 | negative regulation of endocytosis | 44 | 56 | 2.25e-02 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 44 | 56 | 2.25e-02 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 35 | 43 | 2.25e-02 |
| GO:BP | GO:0019229 | regulation of vasoconstriction | 35 | 43 | 2.25e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 35 | 43 | 2.25e-02 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 82 | 113 | 2.27e-02 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 181 | 268 | 2.29e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 80 | 110 | 2.32e-02 |
| GO:BP | GO:0051592 | response to calcium ion | 80 | 110 | 2.32e-02 |
| GO:BP | GO:1904385 | cellular response to angiotensin | 25 | 29 | 2.34e-02 |
| GO:BP | GO:0033555 | multicellular organismal response to stress | 46 | 59 | 2.34e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 25 | 29 | 2.34e-02 |
| GO:BP | GO:1904646 | cellular response to amyloid-beta | 25 | 29 | 2.34e-02 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 280 | 427 | 2.35e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 78 | 107 | 2.35e-02 |
| GO:BP | GO:0006470 | protein dephosphorylation | 129 | 186 | 2.36e-02 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 129 | 186 | 2.36e-02 |
| GO:BP | GO:0006023 | aminoglycan biosynthetic process | 48 | 62 | 2.40e-02 |
| GO:BP | GO:0051591 | response to cAMP | 48 | 62 | 2.40e-02 |
| GO:BP | GO:0051261 | protein depolymerization | 74 | 101 | 2.43e-02 |
| GO:BP | GO:0002064 | epithelial cell development | 111 | 158 | 2.44e-02 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 37 | 46 | 2.44e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 141 | 205 | 2.45e-02 |
| GO:BP | GO:0035264 | multicellular organism growth | 89 | 124 | 2.48e-02 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 16 | 17 | 2.50e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 52 | 68 | 2.51e-02 |
| GO:BP | GO:0019538 | protein metabolic process | 2327 | 3848 | 2.53e-02 |
| GO:BP | GO:0045124 | regulation of bone resorption | 22 | 25 | 2.56e-02 |
| GO:BP | GO:0042476 | odontogenesis | 62 | 83 | 2.56e-02 |
| GO:BP | GO:0030216 | keratinocyte differentiation | 58 | 77 | 2.56e-02 |
| GO:BP | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 22 | 25 | 2.56e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 58 | 77 | 2.56e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 58 | 77 | 2.56e-02 |
| GO:BP | GO:0030282 | bone mineralization | 64 | 86 | 2.56e-02 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 22 | 25 | 2.56e-02 |
| GO:BP | GO:0007017 | microtubule-based process | 485 | 762 | 2.57e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 39 | 49 | 2.60e-02 |
| GO:BP | GO:0015711 | organic anion transport | 185 | 275 | 2.60e-02 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 205 | 307 | 2.63e-02 |
| GO:BP | GO:0007389 | pattern specification process | 205 | 307 | 2.63e-02 |
| GO:BP | GO:0014742 | positive regulation of muscle hypertrophy | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0051043 | regulation of membrane protein ectodomain proteolysis | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0010613 | positive regulation of cardiac muscle hypertrophy | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0015740 | C4-dicarboxylate transport | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0022038 | corpus callosum development | 19 | 21 | 2.64e-02 |
| GO:BP | GO:0044409 | symbiont entry into host | 83 | 115 | 2.64e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 94 | 132 | 2.70e-02 |
| GO:BP | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 12 | 12 | 2.71e-02 |
| GO:BP | GO:0098911 | regulation of ventricular cardiac muscle cell action potential | 12 | 12 | 2.71e-02 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 12 | 12 | 2.71e-02 |
| GO:BP | GO:0005513 | detection of calcium ion | 12 | 12 | 2.71e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 41 | 52 | 2.72e-02 |
| GO:BP | GO:1903078 | positive regulation of protein localization to plasma membrane | 41 | 52 | 2.72e-02 |
| GO:BP | GO:0002263 | cell activation involved in immune response | 112 | 160 | 2.73e-02 |
| GO:BP | GO:0050853 | B cell receptor signaling pathway | 27 | 32 | 2.77e-02 |
| GO:BP | GO:0071825 | protein-lipid complex organization | 27 | 32 | 2.77e-02 |
| GO:BP | GO:0051656 | establishment of organelle localization | 270 | 412 | 2.83e-02 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 43 | 55 | 2.85e-02 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 396 | 617 | 2.86e-02 |
| GO:BP | GO:0002682 | regulation of immune system process | 590 | 936 | 2.91e-02 |
| GO:BP | GO:0030323 | respiratory tube development | 108 | 154 | 2.94e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 88 | 123 | 2.94e-02 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 71 | 97 | 2.98e-02 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 329 | 508 | 2.98e-02 |
| GO:BP | GO:1903076 | regulation of protein localization to plasma membrane | 69 | 94 | 3.03e-02 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 49 | 64 | 3.10e-02 |
| GO:BP | GO:0046661 | male sex differentiation | 82 | 114 | 3.18e-02 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 55 | 73 | 3.18e-02 |
| GO:BP | GO:0106027 | neuron projection organization | 57 | 76 | 3.18e-02 |
| GO:BP | GO:0071675 | regulation of mononuclear cell migration | 55 | 73 | 3.18e-02 |
| GO:BP | GO:0006939 | smooth muscle contraction | 53 | 70 | 3.18e-02 |
| GO:BP | GO:0001657 | ureteric bud development | 57 | 76 | 3.18e-02 |
| GO:BP | GO:0014013 | regulation of gliogenesis | 53 | 70 | 3.18e-02 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 55 | 73 | 3.18e-02 |
| GO:BP | GO:0050850 | positive regulation of calcium-mediated signaling | 24 | 28 | 3.20e-02 |
| GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 24 | 28 | 3.20e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 29 | 35 | 3.20e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 163 | 241 | 3.23e-02 |
| GO:BP | GO:0015833 | peptide transport | 132 | 192 | 3.27e-02 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 275 | 421 | 3.31e-02 |
| GO:BP | GO:0071466 | cellular response to xenobiotic stimulus | 78 | 108 | 3.34e-02 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 109 | 156 | 3.34e-02 |
| GO:BP | GO:0030042 | actin filament depolymerization | 38 | 48 | 3.38e-02 |
| GO:BP | GO:0015031 | protein transport | 755 | 1211 | 3.49e-02 |
| GO:BP | GO:0017157 | regulation of exocytosis | 98 | 139 | 3.49e-02 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 74 | 102 | 3.50e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 87 | 122 | 3.53e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 128 | 186 | 3.55e-02 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 164 | 243 | 3.55e-02 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 40 | 51 | 3.55e-02 |
| GO:BP | GO:0002790 | peptide secretion | 121 | 175 | 3.55e-02 |
| GO:BP | GO:0001704 | formation of primary germ layer | 72 | 99 | 3.56e-02 |
| GO:BP | GO:0032878 | regulation of establishment or maintenance of cell polarity | 21 | 24 | 3.58e-02 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 21 | 24 | 3.58e-02 |
| GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 21 | 24 | 3.58e-02 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 21 | 24 | 3.58e-02 |
| GO:BP | GO:0030324 | lung development | 105 | 150 | 3.58e-02 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 85 | 119 | 3.59e-02 |
| GO:BP | GO:0050796 | regulation of insulin secretion | 85 | 119 | 3.59e-02 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 85 | 119 | 3.59e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 112 | 161 | 3.63e-02 |
| GO:BP | GO:0000271 | polysaccharide biosynthetic process | 42 | 54 | 3.65e-02 |
| GO:BP | GO:0042310 | vasoconstriction | 44 | 57 | 3.77e-02 |
| GO:BP | GO:0046209 | nitric oxide metabolic process | 44 | 57 | 3.77e-02 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 26 | 31 | 3.80e-02 |
| GO:BP | GO:0008217 | regulation of blood pressure | 81 | 113 | 3.81e-02 |
| GO:BP | GO:2000114 | regulation of establishment of cell polarity | 18 | 20 | 3.81e-02 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 101 | 144 | 3.82e-02 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 46 | 60 | 3.83e-02 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 46 | 60 | 3.83e-02 |
| GO:BP | GO:0045661 | regulation of myoblast differentiation | 46 | 60 | 3.83e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 543 | 861 | 3.87e-02 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 361 | 562 | 3.87e-02 |
| GO:BP | GO:0015800 | acidic amino acid transport | 33 | 41 | 3.87e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 48 | 63 | 3.88e-02 |
| GO:BP | GO:0007492 | endoderm development | 50 | 66 | 3.91e-02 |
| GO:BP | GO:1903034 | regulation of response to wounding | 90 | 127 | 3.91e-02 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 90 | 127 | 3.91e-02 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 218 | 330 | 3.91e-02 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 52 | 69 | 3.91e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 56 | 75 | 3.91e-02 |
| GO:BP | GO:1901879 | regulation of protein depolymerization | 56 | 75 | 3.91e-02 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 507 | 802 | 4.02e-02 |
| GO:BP | GO:0045055 | regulated exocytosis | 106 | 152 | 4.02e-02 |
| GO:BP | GO:0003002 | regionalization | 183 | 274 | 4.05e-02 |
| GO:BP | GO:0030522 | intracellular receptor signaling pathway | 183 | 274 | 4.05e-02 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 75 | 104 | 4.08e-02 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 35 | 44 | 4.12e-02 |
| GO:BP | GO:0016032 | viral process | 229 | 348 | 4.12e-02 |
| GO:BP | GO:1904375 | regulation of protein localization to cell periphery | 86 | 121 | 4.15e-02 |
| GO:BP | GO:0022612 | gland morphogenesis | 73 | 101 | 4.18e-02 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 303 | 468 | 4.18e-02 |
| GO:BP | GO:0110011 | regulation of basement membrane organization | 11 | 11 | 4.18e-02 |
| GO:BP | GO:0038180 | nerve growth factor signaling pathway | 11 | 11 | 4.18e-02 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 432 | 679 | 4.20e-02 |
| GO:BP | GO:0030072 | peptide hormone secretion | 118 | 171 | 4.21e-02 |
| GO:BP | GO:0021700 | developmental maturation | 149 | 220 | 4.22e-02 |
| GO:BP | GO:0006638 | neutral lipid metabolic process | 69 | 95 | 4.36e-02 |
| GO:BP | GO:0045184 | establishment of protein localization | 906 | 1465 | 4.36e-02 |
| GO:BP | GO:0002366 | leukocyte activation involved in immune response | 109 | 157 | 4.37e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 985 | 1597 | 4.37e-02 |
| GO:BP | GO:1902656 | calcium ion import into cytosol | 23 | 27 | 4.37e-02 |
| GO:BP | GO:1901185 | negative regulation of ERBB signaling pathway | 23 | 27 | 4.37e-02 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 23 | 27 | 4.37e-02 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 82 | 115 | 4.37e-02 |
| GO:BP | GO:0008544 | epidermis development | 147 | 217 | 4.37e-02 |
| GO:BP | GO:0050863 | regulation of T cell activation | 147 | 217 | 4.37e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 152 | 225 | 4.43e-02 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 100 | 143 | 4.43e-02 |
| GO:BP | GO:0098876 | vesicle-mediated transport to the plasma membrane | 100 | 143 | 4.43e-02 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 65 | 89 | 4.51e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 89 | 126 | 4.61e-02 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 809 | 1304 | 4.61e-02 |
| GO:BP | GO:0006809 | nitric oxide biosynthetic process | 41 | 53 | 4.63e-02 |
| GO:BP | GO:0046718 | symbiont entry into host cell | 78 | 109 | 4.63e-02 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 41 | 53 | 4.63e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 61 | 83 | 4.66e-02 |
| GO:BP | GO:1901654 | response to ketone | 105 | 151 | 4.67e-02 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 30 | 37 | 4.68e-02 |
| GO:BP | GO:0021795 | cerebral cortex cell migration | 30 | 37 | 4.68e-02 |
| GO:BP | GO:0000209 | protein polyubiquitination | 160 | 238 | 4.68e-02 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 165 | 246 | 4.71e-02 |
| GO:BP | GO:0050764 | regulation of phagocytosis | 43 | 56 | 4.71e-02 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 807 | 1301 | 4.72e-02 |
| GO:BP | GO:0051047 | positive regulation of secretion | 143 | 211 | 4.72e-02 |
| GO:BP | GO:0048675 | axon extension | 76 | 106 | 4.73e-02 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 57 | 77 | 4.75e-02 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 247 | 378 | 4.77e-02 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 148 | 219 | 4.77e-02 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 55 | 74 | 4.79e-02 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 47 | 62 | 4.81e-02 |
| GO:BP | GO:0001556 | oocyte maturation | 20 | 23 | 4.95e-02 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 20 | 23 | 4.95e-02 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 72 | 100 | 4.98e-02 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 72 | 100 | 4.98e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 101 | 145 | 5.00e-02 |
LRnomtable_20k %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04015 | Rap1 signaling pathway | 133 | 164 | 1.65e-07 |
| KEGG | KEGG:04360 | Axon guidance | 130 | 162 | 2.41e-07 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 109 | 132 | 2.41e-07 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 132 | 164 | 2.41e-07 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 122 | 151 | 2.70e-07 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 81 | 94 | 2.93e-07 |
| KEGG | KEGG:04971 | Gastric acid secretion | 49 | 52 | 3.12e-07 |
| KEGG | KEGG:00000 | KEGG root term | 3552 | 5802 | 4.02e-07 |
| KEGG | KEGG:04520 | Adherens junction | 74 | 86 | 1.04e-06 |
| KEGG | KEGG:04611 | Platelet activation | 76 | 89 | 1.24e-06 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 67 | 77 | 1.50e-06 |
| KEGG | KEGG:04014 | Ras signaling pathway | 134 | 172 | 1.51e-06 |
| KEGG | KEGG:05200 | Pathways in cancer | 290 | 408 | 1.54e-06 |
| KEGG | KEGG:04911 | Insulin secretion | 57 | 64 | 1.94e-06 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 102 | 127 | 3.04e-06 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 189 | 256 | 3.68e-06 |
| KEGG | KEGG:04510 | Focal adhesion | 136 | 177 | 3.83e-06 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 137 | 179 | 4.93e-06 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 62 | 72 | 6.44e-06 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 69 | 82 | 8.87e-06 |
| KEGG | KEGG:04970 | Salivary secretion | 49 | 55 | 1.08e-05 |
| KEGG | KEGG:04713 | Circadian entrainment | 59 | 69 | 1.80e-05 |
| KEGG | KEGG:05146 | Amoebiasis | 55 | 64 | 2.86e-05 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 43 | 48 | 3.37e-05 |
| KEGG | KEGG:04972 | Pancreatic secretion | 50 | 58 | 6.47e-05 |
| KEGG | KEGG:04924 | Renin secretion | 44 | 50 | 7.23e-05 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 177 | 246 | 8.53e-05 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 37 | 41 | 1.02e-04 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 126 | 170 | 1.64e-04 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 47 | 55 | 1.75e-04 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 57 | 69 | 1.76e-04 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 57 | 69 | 1.76e-04 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 77 | 98 | 2.20e-04 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 81 | 104 | 2.34e-04 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 51 | 61 | 2.34e-04 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 72 | 91 | 2.37e-04 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 85 | 110 | 2.37e-04 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 67 | 84 | 2.61e-04 |
| KEGG | KEGG:04148 | Efferocytosis | 95 | 125 | 2.61e-04 |
| KEGG | KEGG:04976 | Bile secretion | 37 | 42 | 2.61e-04 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 82 | 106 | 2.76e-04 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 88 | 115 | 2.96e-04 |
| KEGG | KEGG:04725 | Cholinergic synapse | 66 | 83 | 3.26e-04 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 79 | 102 | 3.32e-04 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 60 | 75 | 5.01e-04 |
| KEGG | KEGG:05135 | Yersinia infection | 85 | 112 | 6.19e-04 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 62 | 79 | 1.00e-03 |
| KEGG | KEGG:04730 | Long-term depression | 36 | 42 | 1.00e-03 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 62 | 79 | 1.00e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 126 | 176 | 1.36e-03 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 73 | 96 | 1.58e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 58 | 74 | 1.65e-03 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 66 | 86 | 1.89e-03 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 78 | 104 | 2.00e-03 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 59 | 76 | 2.17e-03 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 59 | 76 | 2.17e-03 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 110 | 153 | 2.28e-03 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 79 | 106 | 2.41e-03 |
| KEGG | KEGG:04144 | Endocytosis | 159 | 230 | 2.97e-03 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 57 | 74 | 3.55e-03 |
| KEGG | KEGG:04720 | Long-term potentiation | 44 | 55 | 3.55e-03 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 102 | 142 | 3.55e-03 |
| KEGG | KEGG:04916 | Melanogenesis | 59 | 77 | 3.56e-03 |
| KEGG | KEGG:05131 | Shigellosis | 145 | 210 | 5.13e-03 |
| KEGG | KEGG:04726 | Serotonergic synapse | 49 | 63 | 5.46e-03 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 75 | 102 | 5.76e-03 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 63 | 84 | 5.81e-03 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 59 | 78 | 5.81e-03 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 57 | 75 | 5.81e-03 |
| KEGG | KEGG:05032 | Morphine addiction | 44 | 56 | 6.25e-03 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 82 | 113 | 6.25e-03 |
| KEGG | KEGG:04934 | Cushing syndrome | 87 | 121 | 7.11e-03 |
| KEGG | KEGG:04530 | Tight junction | 98 | 138 | 7.13e-03 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 81 | 112 | 7.54e-03 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 79 | 109 | 7.64e-03 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 69 | 94 | 8.42e-03 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 95 | 134 | 8.52e-03 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 49 | 64 | 8.52e-03 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 82 | 114 | 8.59e-03 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 29 | 35 | 8.59e-03 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 100 | 142 | 8.98e-03 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 64 | 87 | 1.03e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 33 | 41 | 1.04e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 62 | 84 | 1.04e-02 |
| KEGG | KEGG:04931 | Insulin resistance | 69 | 95 | 1.19e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 67 | 92 | 1.20e-02 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 39 | 50 | 1.21e-02 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 105 | 151 | 1.26e-02 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 34 | 43 | 1.46e-02 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 38 | 49 | 1.58e-02 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 56 | 76 | 1.60e-02 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 22 | 26 | 1.63e-02 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 78 | 110 | 1.72e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 103 | 149 | 1.72e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 19 | 22 | 1.89e-02 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 57 | 78 | 1.91e-02 |
| KEGG | KEGG:04740 | Olfactory transduction | 21 | 25 | 2.27e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 69 | 97 | 2.37e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 65 | 91 | 2.52e-02 |
| KEGG | KEGG:04814 | Motor proteins | 102 | 149 | 2.63e-02 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 178 | 271 | 2.91e-02 |
| KEGG | KEGG:04668 | TNF signaling pathway | 62 | 87 | 3.10e-02 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 20 | 24 | 3.10e-02 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 29 | 37 | 3.10e-02 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 99 | 145 | 3.12e-02 |
| KEGG | KEGG:04727 | GABAergic synapse | 41 | 55 | 3.22e-02 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 37 | 49 | 3.22e-02 |
| KEGG | KEGG:05142 | Chagas disease | 54 | 75 | 3.43e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 63 | 89 | 3.53e-02 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 61 | 86 | 3.60e-02 |
| KEGG | KEGG:05215 | Prostate cancer | 61 | 86 | 3.60e-02 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 26 | 33 | 3.74e-02 |
| KEGG | KEGG:05213 | Endometrial cancer | 42 | 57 | 3.85e-02 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 83 | 121 | 4.23e-02 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 69 | 99 | 4.23e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 47 | 65 | 4.43e-02 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 41 | 56 | 4.78e-02 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 39 | 53 | 4.81e-02 |
| KEGG | KEGG:04929 | GnRH secretion | 39 | 53 | 4.81e-02 |
| KEGG | KEGG:04540 | Gap junction | 52 | 73 | 4.82e-02 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 37 | 50 | 4.82e-02 |
| KEGG | KEGG:05216 | Thyroid cancer | 27 | 35 | 4.84e-02 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 29 | 38 | 4.87e-02 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 59 | 84 | 4.90e-02 |
| KEGG | KEGG:05152 | Tuberculosis | 73 | 106 | 4.94e-02 |
LR peaks overlapping enhancers
# LR_resgenes_20k_enh <- gost(query = unique(LR_enh_peaks_20k$NCBI_gene),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(LR_resgenes_20k_enh,"data/GO_KEGG_analysis/LR_resgenes_20k_enh.RDS")
# LRnom <- gostplot(LR_resgenes_20k_enh, capped = FALSE, interactive = TRUE)
# LRnom
LRnomtable_20k_enh <- LR_resgenes_20k_enh$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
LRnomtable_20k_enh %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0050896 | response to stimulus | 1012 | 5732 | 1.33e-20 |
| GO:BP | GO:0007154 | cell communication | 789 | 4248 | 5.91e-20 |
| GO:BP | GO:0023052 | signaling | 778 | 4180 | 5.91e-20 |
| GO:BP | GO:0048856 | anatomical structure development | 768 | 4130 | 1.54e-19 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 418 | 1951 | 9.94e-19 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 434 | 2052 | 1.47e-18 |
| GO:BP | GO:0007165 | signal transduction | 718 | 3846 | 2.69e-18 |
| GO:BP | GO:0032501 | multicellular organismal process | 864 | 4830 | 5.55e-18 |
| GO:BP | GO:0051716 | cellular response to stimulus | 878 | 4933 | 8.63e-18 |
| GO:BP | GO:0007275 | multicellular organism development | 641 | 3383 | 3.27e-17 |
| GO:BP | GO:0032502 | developmental process | 803 | 4475 | 1.98e-16 |
| GO:BP | GO:0072359 | circulatory system development | 220 | 896 | 2.63e-15 |
| GO:BP | GO:0050789 | regulation of biological process | 1301 | 8037 | 2.93e-15 |
| GO:BP | GO:0048731 | system development | 553 | 2903 | 1.43e-14 |
| GO:BP | GO:0030029 | actin filament-based process | 176 | 677 | 1.90e-14 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 390 | 1900 | 2.82e-14 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 690 | 3804 | 3.00e-14 |
| GO:BP | GO:0048519 | negative regulation of biological process | 725 | 4037 | 3.11e-14 |
| GO:BP | GO:0065007 | biological regulation | 1326 | 8275 | 4.38e-14 |
| GO:BP | GO:0010646 | regulation of cell communication | 501 | 2601 | 8.10e-14 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 547 | 2902 | 1.47e-13 |
| GO:BP | GO:0048513 | animal organ development | 424 | 2130 | 1.47e-13 |
| GO:BP | GO:0061061 | muscle structure development | 149 | 559 | 4.09e-13 |
| GO:BP | GO:0007155 | cell adhesion | 231 | 1004 | 5.99e-13 |
| GO:BP | GO:0023051 | regulation of signaling | 495 | 2597 | 8.44e-13 |
| GO:BP | GO:0009966 | regulation of signal transduction | 446 | 2307 | 3.19e-12 |
| GO:BP | GO:0009888 | tissue development | 301 | 1425 | 3.42e-12 |
| GO:BP | GO:0008150 | biological_process | 1789 | 12051 | 3.52e-12 |
| GO:BP | GO:0016477 | cell migration | 240 | 1078 | 6.92e-12 |
| GO:BP | GO:0048518 | positive regulation of biological process | 788 | 4561 | 9.18e-12 |
| GO:BP | GO:0009987 | cellular process | 1718 | 11450 | 9.18e-12 |
| GO:BP | GO:0050794 | regulation of cellular process | 1227 | 7651 | 9.52e-12 |
| GO:BP | GO:0030154 | cell differentiation | 550 | 2987 | 9.65e-12 |
| GO:BP | GO:0048869 | cellular developmental process | 550 | 2988 | 1.00e-11 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 86 | 272 | 1.69e-11 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 79 | 242 | 2.61e-11 |
| GO:BP | GO:0044057 | regulation of system process | 111 | 399 | 6.60e-11 |
| GO:BP | GO:0048870 | cell motility | 255 | 1190 | 7.24e-11 |
| GO:BP | GO:0050793 | regulation of developmental process | 357 | 1801 | 7.24e-11 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 61 | 171 | 2.08e-10 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 725 | 4198 | 2.33e-10 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 148 | 601 | 2.92e-10 |
| GO:BP | GO:0042692 | muscle cell differentiation | 96 | 334 | 3.04e-10 |
| GO:BP | GO:0003013 | circulatory system process | 118 | 446 | 4.06e-10 |
| GO:BP | GO:0003012 | muscle system process | 96 | 339 | 7.53e-10 |
| GO:BP | GO:0008015 | blood circulation | 103 | 374 | 7.70e-10 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 173 | 749 | 1.12e-09 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 195 | 876 | 1.58e-09 |
| GO:BP | GO:0001568 | blood vessel development | 135 | 546 | 1.89e-09 |
| GO:BP | GO:0001944 | vasculature development | 140 | 573 | 1.90e-09 |
| GO:BP | GO:0003008 | system process | 250 | 1201 | 2.55e-09 |
| GO:BP | GO:0060537 | muscle tissue development | 97 | 353 | 3.35e-09 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 133 | 540 | 3.35e-09 |
| GO:BP | GO:0040011 | locomotion | 190 | 858 | 4.32e-09 |
| GO:BP | GO:2000145 | regulation of cell motility | 169 | 745 | 8.05e-09 |
| GO:BP | GO:0060047 | heart contraction | 64 | 200 | 9.77e-09 |
| GO:BP | GO:0003015 | heart process | 66 | 210 | 1.17e-08 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 256 | 1256 | 1.22e-08 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 381 | 2028 | 1.48e-08 |
| GO:BP | GO:0035239 | tube morphogenesis | 154 | 668 | 1.60e-08 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 117 | 467 | 1.60e-08 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 227 | 1088 | 1.68e-08 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 377 | 2006 | 1.72e-08 |
| GO:BP | GO:0040012 | regulation of locomotion | 171 | 766 | 2.03e-08 |
| GO:BP | GO:0030334 | regulation of cell migration | 161 | 710 | 2.06e-08 |
| GO:BP | GO:0090257 | regulation of muscle system process | 59 | 181 | 2.06e-08 |
| GO:BP | GO:0014706 | striated muscle tissue development | 67 | 218 | 2.12e-08 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 218 | 1040 | 2.42e-08 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 258 | 1279 | 2.58e-08 |
| GO:BP | GO:0035295 | tube development | 181 | 827 | 2.84e-08 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 233 | 1134 | 3.71e-08 |
| GO:BP | GO:0023057 | negative regulation of signaling | 228 | 1111 | 6.56e-08 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 94 | 358 | 7.09e-08 |
| GO:BP | GO:0055001 | muscle cell development | 55 | 169 | 8.11e-08 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 275 | 1403 | 1.23e-07 |
| GO:BP | GO:0006941 | striated muscle contraction | 51 | 153 | 1.28e-07 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 226 | 1109 | 1.43e-07 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 202 | 967 | 1.45e-07 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 149 | 662 | 1.51e-07 |
| GO:BP | GO:0030048 | actin filament-based movement | 41 | 111 | 1.68e-07 |
| GO:BP | GO:0032879 | regulation of localization | 293 | 1521 | 1.96e-07 |
| GO:BP | GO:0007507 | heart development | 122 | 515 | 2.02e-07 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 62 | 206 | 2.08e-07 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 43 | 121 | 2.57e-07 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 84 | 316 | 2.67e-07 |
| GO:BP | GO:0008016 | regulation of heart contraction | 54 | 170 | 2.67e-07 |
| GO:BP | GO:0090130 | tissue migration | 72 | 256 | 2.74e-07 |
| GO:BP | GO:0048468 | cell development | 368 | 1999 | 3.07e-07 |
| GO:BP | GO:0090132 | epithelium migration | 71 | 252 | 3.14e-07 |
| GO:BP | GO:0010631 | epithelial cell migration | 71 | 252 | 3.14e-07 |
| GO:BP | GO:0035556 | intracellular signal transduction | 380 | 2079 | 3.71e-07 |
| GO:BP | GO:1903522 | regulation of blood circulation | 60 | 200 | 3.91e-07 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 30 | 70 | 3.98e-07 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 35 | 90 | 4.68e-07 |
| GO:BP | GO:0031032 | actomyosin structure organization | 57 | 189 | 7.47e-07 |
| GO:BP | GO:0051049 | regulation of transport | 231 | 1164 | 8.64e-07 |
| GO:BP | GO:0043500 | muscle adaptation | 35 | 92 | 8.91e-07 |
| GO:BP | GO:0065008 | regulation of biological quality | 371 | 2039 | 9.74e-07 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 36 | 97 | 1.16e-06 |
| GO:BP | GO:0043542 | endothelial cell migration | 55 | 182 | 1.18e-06 |
| GO:BP | GO:0065009 | regulation of molecular function | 267 | 1389 | 1.18e-06 |
| GO:BP | GO:0001525 | angiogenesis | 97 | 397 | 1.53e-06 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 54 | 179 | 1.68e-06 |
| GO:BP | GO:0009605 | response to external stimulus | 310 | 1664 | 1.85e-06 |
| GO:BP | GO:0042221 | response to chemical | 430 | 2436 | 2.32e-06 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 361 | 1992 | 2.41e-06 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 56 | 193 | 4.01e-06 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 159 | 756 | 4.38e-06 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 152 | 716 | 4.64e-06 |
| GO:BP | GO:0055006 | cardiac cell development | 31 | 81 | 4.64e-06 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 35 | 98 | 5.09e-06 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 146 | 683 | 5.38e-06 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 27 | 66 | 6.36e-06 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 217 | 1111 | 8.15e-06 |
| GO:BP | GO:0032409 | regulation of transporter activity | 48 | 159 | 8.92e-06 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 29 | 75 | 9.02e-06 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 37 | 109 | 9.34e-06 |
| GO:BP | GO:0007010 | cytoskeleton organization | 234 | 1218 | 9.66e-06 |
| GO:BP | GO:0009611 | response to wounding | 95 | 402 | 1.02e-05 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 67 | 254 | 1.06e-05 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 222 | 1146 | 1.06e-05 |
| GO:BP | GO:0009725 | response to hormone | 136 | 634 | 1.15e-05 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 149 | 710 | 1.19e-05 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 55 | 195 | 1.29e-05 |
| GO:BP | GO:0008283 | cell population proliferation | 260 | 1386 | 1.44e-05 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 107 | 472 | 1.49e-05 |
| GO:BP | GO:0098657 | import into cell | 140 | 661 | 1.58e-05 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 40 | 125 | 1.63e-05 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 26 | 66 | 2.36e-05 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 42 | 136 | 2.43e-05 |
| GO:BP | GO:0071310 | cellular response to organic substance | 256 | 1370 | 2.43e-05 |
| GO:BP | GO:0034330 | cell junction organization | 127 | 591 | 2.50e-05 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 78 | 318 | 2.50e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 31 | 87 | 2.51e-05 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 70 | 276 | 2.57e-05 |
| GO:BP | GO:0016310 | phosphorylation | 230 | 1211 | 2.79e-05 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 107 | 479 | 2.95e-05 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 32 | 92 | 2.98e-05 |
| GO:BP | GO:0006936 | muscle contraction | 68 | 267 | 3.09e-05 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 25 | 63 | 3.10e-05 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 34 | 101 | 3.12e-05 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 197 | 1011 | 3.22e-05 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 331 | 1852 | 3.28e-05 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 137 | 653 | 3.33e-05 |
| GO:BP | GO:0030198 | extracellular matrix organization | 62 | 237 | 3.51e-05 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 62 | 238 | 4.03e-05 |
| GO:BP | GO:0014902 | myotube differentiation | 31 | 89 | 4.03e-05 |
| GO:BP | GO:0043062 | extracellular structure organization | 62 | 238 | 4.03e-05 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 218 | 1145 | 4.39e-05 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 74 | 302 | 4.59e-05 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 32 | 94 | 4.69e-05 |
| GO:BP | GO:0007517 | muscle organ development | 70 | 281 | 4.69e-05 |
| GO:BP | GO:0006816 | calcium ion transport | 68 | 271 | 5.04e-05 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 32 | 95 | 6.01e-05 |
| GO:BP | GO:0043149 | stress fiber assembly | 32 | 95 | 6.01e-05 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 54 | 200 | 6.01e-05 |
| GO:BP | GO:0042391 | regulation of membrane potential | 73 | 299 | 6.01e-05 |
| GO:BP | GO:0007015 | actin filament organization | 88 | 381 | 6.20e-05 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 131 | 626 | 6.20e-05 |
| GO:BP | GO:1901652 | response to peptide | 88 | 381 | 6.20e-05 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 31 | 91 | 6.40e-05 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 31 | 91 | 6.40e-05 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 57 | 216 | 6.53e-05 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 42 | 142 | 6.96e-05 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 102 | 461 | 7.25e-05 |
| GO:BP | GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 22 | 54 | 7.44e-05 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 93 | 411 | 7.66e-05 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 102 | 462 | 7.90e-05 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 118 | 554 | 8.15e-05 |
| GO:BP | GO:0010033 | response to organic substance | 325 | 1835 | 8.60e-05 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 66 | 265 | 8.62e-05 |
| GO:BP | GO:1901698 | response to nitrogen compound | 155 | 774 | 9.45e-05 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 58 | 224 | 9.50e-05 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 29 | 84 | 9.50e-05 |
| GO:BP | GO:0002027 | regulation of heart rate | 29 | 84 | 9.50e-05 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 58 | 224 | 9.50e-05 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 95 | 425 | 9.80e-05 |
| GO:BP | GO:0006810 | transport | 528 | 3176 | 9.85e-05 |
| GO:BP | GO:0051235 | maintenance of location | 65 | 261 | 9.87e-05 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 22 | 55 | 9.93e-05 |
| GO:BP | GO:0016043 | cellular component organization | 815 | 5139 | 1.01e-04 |
| GO:BP | GO:0048041 | focal adhesion assembly | 28 | 80 | 1.01e-04 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 59 | 230 | 1.03e-04 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 58 | 225 | 1.06e-04 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 32 | 98 | 1.08e-04 |
| GO:BP | GO:0043534 | blood vessel endothelial cell migration | 32 | 98 | 1.08e-04 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 43 | 150 | 1.15e-04 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 96 | 433 | 1.19e-04 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 112 | 525 | 1.25e-04 |
| GO:BP | GO:0051899 | membrane depolarization | 23 | 60 | 1.32e-04 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 32 | 99 | 1.35e-04 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 109 | 509 | 1.39e-04 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 99 | 452 | 1.42e-04 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 39 | 132 | 1.44e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 76 | 324 | 1.49e-04 |
| GO:BP | GO:0000902 | cell morphogenesis | 152 | 764 | 1.54e-04 |
| GO:BP | GO:0006897 | endocytosis | 111 | 522 | 1.55e-04 |
| GO:BP | GO:0070848 | response to growth factor | 120 | 576 | 1.79e-04 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 41 | 143 | 1.83e-04 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 13 | 24 | 2.03e-04 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 308 | 1746 | 2.07e-04 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 40 | 139 | 2.13e-04 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 250 | 1376 | 2.13e-04 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 44 | 159 | 2.24e-04 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 15 | 31 | 2.29e-04 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 64 | 263 | 2.34e-04 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 22 | 58 | 2.43e-04 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 22 | 58 | 2.43e-04 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 164 | 845 | 2.69e-04 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 164 | 846 | 2.87e-04 |
| GO:BP | GO:0061448 | connective tissue development | 55 | 217 | 2.89e-04 |
| GO:BP | GO:0006470 | protein dephosphorylation | 49 | 186 | 2.90e-04 |
| GO:BP | GO:0051050 | positive regulation of transport | 124 | 606 | 2.90e-04 |
| GO:BP | GO:0007399 | nervous system development | 331 | 1903 | 2.90e-04 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 23 | 63 | 3.07e-04 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 115 | 554 | 3.10e-04 |
| GO:BP | GO:0030001 | metal ion transport | 115 | 554 | 3.10e-04 |
| GO:BP | GO:0006468 | protein phosphorylation | 190 | 1008 | 3.20e-04 |
| GO:BP | GO:0040007 | growth | 146 | 739 | 3.21e-04 |
| GO:BP | GO:0001508 | action potential | 33 | 108 | 3.23e-04 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 18 | 43 | 3.23e-04 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 20 | 51 | 3.35e-04 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 15 | 32 | 3.44e-04 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 29 | 90 | 3.52e-04 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 27 | 81 | 3.52e-04 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 29 | 90 | 3.52e-04 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 99 | 464 | 3.93e-04 |
| GO:BP | GO:0043010 | camera-type eye development | 58 | 236 | 4.19e-04 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 35 | 119 | 4.28e-04 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 17 | 40 | 4.33e-04 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 14 | 29 | 4.33e-04 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 14 | 29 | 4.33e-04 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 71 | 307 | 4.34e-04 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 29 | 91 | 4.34e-04 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 37 | 129 | 4.45e-04 |
| GO:BP | GO:0051234 | establishment of localization | 561 | 3447 | 4.73e-04 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 75 | 330 | 4.73e-04 |
| GO:BP | GO:0051179 | localization | 639 | 3978 | 4.73e-04 |
| GO:BP | GO:0006950 | response to stress | 452 | 2715 | 4.89e-04 |
| GO:BP | GO:0006915 | apoptotic process | 260 | 1459 | 5.14e-04 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 282 | 1601 | 5.33e-04 |
| GO:BP | GO:0051928 | positive regulation of calcium ion transport | 25 | 74 | 5.38e-04 |
| GO:BP | GO:0022008 | neurogenesis | 239 | 1327 | 5.60e-04 |
| GO:BP | GO:0010762 | regulation of fibroblast migration | 16 | 37 | 5.67e-04 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 57 | 234 | 6.13e-04 |
| GO:BP | GO:0001654 | eye development | 64 | 272 | 6.22e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 61 | 256 | 6.43e-04 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 73 | 322 | 6.43e-04 |
| GO:BP | GO:0010595 | positive regulation of endothelial cell migration | 29 | 93 | 6.50e-04 |
| GO:BP | GO:0051248 | negative regulation of protein metabolic process | 130 | 654 | 6.60e-04 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 105 | 506 | 6.77e-04 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 211 | 1154 | 6.80e-04 |
| GO:BP | GO:0150063 | visual system development | 64 | 273 | 6.84e-04 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 38 | 137 | 7.32e-04 |
| GO:BP | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 9 | 14 | 7.77e-04 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 159 | 833 | 7.87e-04 |
| GO:BP | GO:0010649 | regulation of cell communication by electrical coupling | 10 | 17 | 7.95e-04 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 110 | 538 | 8.21e-04 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 13 | 27 | 8.24e-04 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 13 | 27 | 8.24e-04 |
| GO:BP | GO:0042060 | wound healing | 70 | 308 | 8.24e-04 |
| GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 13 | 27 | 8.24e-04 |
| GO:BP | GO:0048880 | sensory system development | 64 | 275 | 8.38e-04 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 51 | 205 | 8.51e-04 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 177 | 946 | 8.54e-04 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 171 | 909 | 8.62e-04 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 46 | 179 | 8.66e-04 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 459 | 2780 | 8.82e-04 |
| GO:BP | GO:0006812 | monoatomic cation transport | 129 | 653 | 8.96e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 85 | 394 | 9.08e-04 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 231 | 1288 | 9.49e-04 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 159 | 837 | 9.64e-04 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 36 | 129 | 9.64e-04 |
| GO:BP | GO:0061572 | actin filament bundle organization | 38 | 139 | 9.67e-04 |
| GO:BP | GO:0006629 | lipid metabolic process | 182 | 981 | 1.04e-03 |
| GO:BP | GO:0016311 | dephosphorylation | 58 | 245 | 1.12e-03 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 26 | 82 | 1.13e-03 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 36 | 130 | 1.13e-03 |
| GO:BP | GO:0023056 | positive regulation of signaling | 231 | 1292 | 1.14e-03 |
| GO:BP | GO:2001257 | regulation of cation channel activity | 24 | 73 | 1.14e-03 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 104 | 508 | 1.19e-03 |
| GO:BP | GO:0042592 | homeostatic process | 217 | 1204 | 1.19e-03 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 11 | 21 | 1.20e-03 |
| GO:BP | GO:0012501 | programmed cell death | 264 | 1505 | 1.20e-03 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 21 | 60 | 1.20e-03 |
| GO:BP | GO:0001501 | skeletal system development | 80 | 369 | 1.22e-03 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 58 | 246 | 1.22e-03 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 124 | 628 | 1.23e-03 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 28 | 92 | 1.27e-03 |
| GO:BP | GO:0060284 | regulation of cell development | 120 | 605 | 1.32e-03 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 68 | 302 | 1.32e-03 |
| GO:BP | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading | 8 | 12 | 1.38e-03 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 30 | 102 | 1.39e-03 |
| GO:BP | GO:0008219 | cell death | 264 | 1509 | 1.41e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 41 | 157 | 1.42e-03 |
| GO:BP | GO:1904064 | positive regulation of cation transmembrane transport | 27 | 88 | 1.44e-03 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 27 | 88 | 1.44e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 32 | 112 | 1.46e-03 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 17 | 44 | 1.47e-03 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 123 | 625 | 1.47e-03 |
| GO:BP | GO:0009790 | embryo development | 162 | 864 | 1.50e-03 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 12 | 25 | 1.53e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 376 | 2246 | 1.62e-03 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 69 | 310 | 1.63e-03 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 20 | 57 | 1.63e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 829 | 5340 | 1.64e-03 |
| GO:BP | GO:0051216 | cartilage development | 40 | 153 | 1.64e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 24 | 75 | 1.70e-03 |
| GO:BP | GO:0030097 | hemopoiesis | 129 | 664 | 1.73e-03 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 35 | 128 | 1.73e-03 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 13 | 29 | 1.78e-03 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 56 | 239 | 1.83e-03 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 70 | 317 | 1.83e-03 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 21 | 62 | 1.89e-03 |
| GO:BP | GO:0019222 | regulation of metabolic process | 767 | 4914 | 1.92e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 17 | 45 | 1.95e-03 |
| GO:BP | GO:1901653 | cellular response to peptide | 64 | 284 | 1.96e-03 |
| GO:BP | GO:0048771 | tissue remodeling | 33 | 119 | 1.99e-03 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 35 | 129 | 1.99e-03 |
| GO:BP | GO:0140253 | cell-cell fusion | 15 | 37 | 1.99e-03 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 15 | 37 | 1.99e-03 |
| GO:BP | GO:0002376 | immune system process | 263 | 1512 | 2.01e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 24 | 76 | 2.06e-03 |
| GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 24 | 76 | 2.06e-03 |
| GO:BP | GO:0030030 | cell projection organization | 224 | 1262 | 2.08e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 119 | 607 | 2.13e-03 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 30 | 105 | 2.26e-03 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 12 | 26 | 2.29e-03 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 59 | 258 | 2.31e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 53 | 225 | 2.31e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 21 | 63 | 2.34e-03 |
| GO:BP | GO:0051651 | maintenance of location in cell | 44 | 177 | 2.42e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 27 | 91 | 2.45e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 39 | 151 | 2.46e-03 |
| GO:BP | GO:0070482 | response to oxygen levels | 63 | 281 | 2.46e-03 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 49 | 204 | 2.48e-03 |
| GO:BP | GO:0007520 | myoblast fusion | 13 | 30 | 2.53e-03 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 111 | 562 | 2.61e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 135 | 708 | 2.62e-03 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 30 | 106 | 2.63e-03 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 31 | 111 | 2.65e-03 |
| GO:BP | GO:0045655 | regulation of monocyte differentiation | 8 | 13 | 2.68e-03 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 218 | 1231 | 2.86e-03 |
| GO:BP | GO:0002026 | regulation of the force of heart contraction | 11 | 23 | 2.90e-03 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 11 | 23 | 2.90e-03 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 82 | 392 | 2.98e-03 |
| GO:BP | GO:0035265 | organ growth | 35 | 132 | 3.04e-03 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 52 | 223 | 3.35e-03 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 12 | 27 | 3.38e-03 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 44 | 180 | 3.47e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 23 | 74 | 3.49e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 90 | 441 | 3.50e-03 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 77 | 365 | 3.52e-03 |
| GO:BP | GO:0006811 | monoatomic ion transport | 144 | 769 | 3.58e-03 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 29 | 103 | 3.61e-03 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 15 | 39 | 3.62e-03 |
| GO:BP | GO:0006949 | syncytium formation | 15 | 39 | 3.62e-03 |
| GO:BP | GO:0006644 | phospholipid metabolic process | 67 | 308 | 3.64e-03 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 49 | 208 | 3.85e-03 |
| GO:BP | GO:1901342 | regulation of vasculature development | 49 | 208 | 3.85e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 288 | 1692 | 3.86e-03 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 344 | 2061 | 3.89e-03 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 18 | 52 | 3.91e-03 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 61 | 275 | 3.98e-03 |
| GO:BP | GO:0048589 | developmental growth | 104 | 527 | 4.11e-03 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 216 | 1227 | 4.13e-03 |
| GO:BP | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 17 | 48 | 4.24e-03 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 17 | 48 | 4.24e-03 |
| GO:BP | GO:0032787 | monocarboxylic acid metabolic process | 89 | 438 | 4.24e-03 |
| GO:BP | GO:0031667 | response to nutrient levels | 77 | 368 | 4.41e-03 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 669 | 4269 | 4.42e-03 |
| GO:BP | GO:0051346 | negative regulation of hydrolase activity | 34 | 130 | 4.69e-03 |
| GO:BP | GO:0040008 | regulation of growth | 98 | 493 | 4.69e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 195 | 1096 | 4.77e-03 |
| GO:BP | GO:0085029 | extracellular matrix assembly | 15 | 40 | 4.80e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 31 | 115 | 4.85e-03 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 28 | 100 | 4.85e-03 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 28 | 100 | 4.85e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 347 | 2088 | 4.87e-03 |
| GO:BP | GO:0044255 | cellular lipid metabolic process | 138 | 738 | 4.89e-03 |
| GO:BP | GO:2000649 | regulation of sodium ion transmembrane transporter activity | 13 | 32 | 4.90e-03 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 20 | 62 | 4.90e-03 |
| GO:BP | GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 8 | 14 | 4.90e-03 |
| GO:BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 18 | 53 | 4.90e-03 |
| GO:BP | GO:0007423 | sensory organ development | 82 | 399 | 4.93e-03 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 39 | 157 | 5.18e-03 |
| GO:BP | GO:0007267 | cell-cell signaling | 204 | 1156 | 5.22e-03 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 65 | 301 | 5.22e-03 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 134 | 715 | 5.33e-03 |
| GO:BP | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process | 10 | 21 | 5.54e-03 |
| GO:BP | GO:0019637 | organophosphate metabolic process | 152 | 828 | 5.60e-03 |
| GO:BP | GO:1905952 | regulation of lipid localization | 30 | 111 | 5.60e-03 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 86 | 425 | 5.88e-03 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 11 | 25 | 6.31e-03 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 32 | 122 | 6.31e-03 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 32 | 122 | 6.31e-03 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 32 | 122 | 6.31e-03 |
| GO:BP | GO:0030224 | monocyte differentiation | 11 | 25 | 6.31e-03 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 25 | 87 | 6.38e-03 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 31 | 117 | 6.40e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 21 | 68 | 6.50e-03 |
| GO:BP | GO:0001558 | regulation of cell growth | 73 | 350 | 6.53e-03 |
| GO:BP | GO:0045165 | cell fate commitment | 39 | 159 | 6.56e-03 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 12 | 29 | 6.60e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 115 | 602 | 6.60e-03 |
| GO:BP | GO:1903670 | regulation of sprouting angiogenesis | 12 | 29 | 6.60e-03 |
| GO:BP | GO:0001666 | response to hypoxia | 55 | 247 | 6.61e-03 |
| GO:BP | GO:0010743 | regulation of macrophage derived foam cell differentiation | 9 | 18 | 6.89e-03 |
| GO:BP | GO:0060402 | calcium ion transport into cytosol | 9 | 18 | 6.89e-03 |
| GO:BP | GO:0031399 | regulation of protein modification process | 172 | 959 | 7.01e-03 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 60 | 276 | 7.02e-03 |
| GO:BP | GO:0030832 | regulation of actin filament length | 32 | 123 | 7.15e-03 |
| GO:BP | GO:0001775 | cell activation | 125 | 665 | 7.15e-03 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 48 | 209 | 7.31e-03 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 64 | 300 | 7.73e-03 |
| GO:BP | GO:0030010 | establishment of cell polarity | 34 | 134 | 7.78e-03 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 21 | 69 | 7.81e-03 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 378 | 2311 | 7.97e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 198 | 1128 | 8.01e-03 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 81 | 400 | 8.03e-03 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 156 | 861 | 8.09e-03 |
| GO:BP | GO:0006909 | phagocytosis | 36 | 145 | 8.21e-03 |
| GO:BP | GO:0090559 | regulation of membrane permeability | 19 | 60 | 8.29e-03 |
| GO:BP | GO:1903589 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 4 | 4 | 8.36e-03 |
| GO:BP | GO:0019725 | cellular homeostasis | 113 | 594 | 8.36e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 402 | 2474 | 8.38e-03 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 17 | 51 | 8.38e-03 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 414 | 2555 | 8.43e-03 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 718 | 4637 | 8.45e-03 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 25 | 89 | 8.68e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 63 | 296 | 8.77e-03 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 125 | 669 | 8.77e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 56 | 256 | 8.80e-03 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 119 | 632 | 8.80e-03 |
| GO:BP | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation | 6 | 9 | 9.17e-03 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 6 | 9 | 9.17e-03 |
| GO:BP | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 6 | 9 | 9.17e-03 |
| GO:BP | GO:0014894 | response to denervation involved in regulation of muscle adaptation | 6 | 9 | 9.17e-03 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 16 | 47 | 9.18e-03 |
| GO:BP | GO:0071871 | response to epinephrine | 7 | 12 | 9.24e-03 |
| GO:BP | GO:0048699 | generation of neurons | 200 | 1145 | 9.27e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 22 | 75 | 9.54e-03 |
| GO:BP | GO:0006096 | glycolytic process | 22 | 75 | 9.54e-03 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 29 | 110 | 9.77e-03 |
| GO:BP | GO:1990849 | vacuolar localization | 19 | 61 | 9.94e-03 |
| GO:BP | GO:0032418 | lysosome localization | 19 | 61 | 9.94e-03 |
| GO:BP | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 24 | 85 | 9.94e-03 |
| GO:BP | GO:0086009 | membrane repolarization | 15 | 43 | 1.00e-02 |
| GO:BP | GO:0010761 | fibroblast migration | 17 | 52 | 1.03e-02 |
| GO:BP | GO:0006658 | phosphatidylserine metabolic process | 9 | 19 | 1.04e-02 |
| GO:BP | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 9 | 19 | 1.04e-02 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 9 | 19 | 1.04e-02 |
| GO:BP | GO:0043304 | regulation of mast cell degranulation | 9 | 19 | 1.04e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 53 | 241 | 1.04e-02 |
| GO:BP | GO:0060429 | epithelium development | 151 | 836 | 1.07e-02 |
| GO:BP | GO:0036211 | protein modification process | 393 | 2423 | 1.07e-02 |
| GO:BP | GO:0003254 | regulation of membrane depolarization | 14 | 39 | 1.08e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 181 | 1027 | 1.08e-02 |
| GO:BP | GO:0006082 | organic acid metabolic process | 123 | 661 | 1.08e-02 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 30 | 116 | 1.08e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 34 | 137 | 1.08e-02 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 34 | 137 | 1.08e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 50 | 225 | 1.12e-02 |
| GO:BP | GO:0031099 | regeneration | 36 | 148 | 1.13e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 10 | 23 | 1.15e-02 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 80 | 400 | 1.16e-02 |
| GO:BP | GO:0016049 | cell growth | 82 | 412 | 1.16e-02 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 35 | 143 | 1.18e-02 |
| GO:BP | GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 11 | 27 | 1.20e-02 |
| GO:BP | GO:0010876 | lipid localization | 65 | 312 | 1.21e-02 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 30 | 117 | 1.23e-02 |
| GO:BP | GO:0007584 | response to nutrient | 30 | 117 | 1.23e-02 |
| GO:BP | GO:0032233 | positive regulation of actin filament bundle assembly | 17 | 53 | 1.25e-02 |
| GO:BP | GO:0031529 | ruffle organization | 15 | 44 | 1.25e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 36 | 149 | 1.26e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 21 | 72 | 1.28e-02 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 147 | 815 | 1.28e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 28 | 107 | 1.28e-02 |
| GO:BP | GO:0046032 | ADP catabolic process | 22 | 77 | 1.31e-02 |
| GO:BP | GO:0046031 | ADP metabolic process | 23 | 82 | 1.33e-02 |
| GO:BP | GO:0009135 | purine nucleoside diphosphate metabolic process | 25 | 92 | 1.33e-02 |
| GO:BP | GO:0009179 | purine ribonucleoside diphosphate metabolic process | 25 | 92 | 1.33e-02 |
| GO:BP | GO:0048844 | artery morphogenesis | 18 | 58 | 1.34e-02 |
| GO:BP | GO:0006869 | lipid transport | 58 | 273 | 1.36e-02 |
| GO:BP | GO:0034329 | cell junction assembly | 71 | 349 | 1.36e-02 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 698 | 4521 | 1.36e-02 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 83 | 421 | 1.40e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 19 | 63 | 1.42e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 38 | 161 | 1.43e-02 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 647 | 4170 | 1.44e-02 |
| GO:BP | GO:0019752 | carboxylic acid metabolic process | 119 | 642 | 1.44e-02 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 28 | 108 | 1.46e-02 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 13 | 36 | 1.47e-02 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 86 | 440 | 1.48e-02 |
| GO:BP | GO:0045017 | glycerolipid biosynthetic process | 48 | 217 | 1.49e-02 |
| GO:BP | GO:1905709 | negative regulation of membrane permeability | 9 | 20 | 1.50e-02 |
| GO:BP | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 9 | 20 | 1.50e-02 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 181 | 1036 | 1.52e-02 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 24 | 88 | 1.54e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 65 | 316 | 1.61e-02 |
| GO:BP | GO:0098868 | bone growth | 10 | 24 | 1.61e-02 |
| GO:BP | GO:0045657 | positive regulation of monocyte differentiation | 5 | 7 | 1.63e-02 |
| GO:BP | GO:0043436 | oxoacid metabolic process | 121 | 657 | 1.63e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 35 | 146 | 1.63e-02 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 122 | 664 | 1.69e-02 |
| GO:BP | GO:0032414 | positive regulation of ion transmembrane transporter activity | 19 | 64 | 1.69e-02 |
| GO:BP | GO:0060341 | regulation of cellular localization | 146 | 815 | 1.69e-02 |
| GO:BP | GO:0014870 | response to muscle inactivity | 6 | 10 | 1.73e-02 |
| GO:BP | GO:0032530 | regulation of microvillus organization | 6 | 10 | 1.73e-02 |
| GO:BP | GO:0043306 | positive regulation of mast cell degranulation | 6 | 10 | 1.73e-02 |
| GO:BP | GO:0071872 | cellular response to epinephrine stimulus | 6 | 10 | 1.73e-02 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 20 | 69 | 1.74e-02 |
| GO:BP | GO:0015918 | sterol transport | 25 | 94 | 1.76e-02 |
| GO:BP | GO:1905954 | positive regulation of lipid localization | 21 | 74 | 1.77e-02 |
| GO:BP | GO:0009181 | purine ribonucleoside diphosphate catabolic process | 22 | 79 | 1.77e-02 |
| GO:BP | GO:0009137 | purine nucleoside diphosphate catabolic process | 22 | 79 | 1.77e-02 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 24 | 89 | 1.77e-02 |
| GO:BP | GO:0019364 | pyridine nucleotide catabolic process | 22 | 79 | 1.77e-02 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 56 | 265 | 1.77e-02 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 29 | 115 | 1.81e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 29 | 115 | 1.81e-02 |
| GO:BP | GO:0045216 | cell-cell junction organization | 37 | 158 | 1.81e-02 |
| GO:BP | GO:0002064 | epithelial cell development | 37 | 158 | 1.81e-02 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 53 | 248 | 1.81e-02 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 695 | 4515 | 1.84e-02 |
| GO:BP | GO:0030182 | neuron differentiation | 187 | 1080 | 1.84e-02 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 13 | 37 | 1.85e-02 |
| GO:BP | GO:0051496 | positive regulation of stress fiber assembly | 15 | 46 | 1.89e-02 |
| GO:BP | GO:1904036 | negative regulation of epithelial cell apoptotic process | 15 | 46 | 1.89e-02 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 15 | 46 | 1.89e-02 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 52 | 243 | 1.92e-02 |
| GO:BP | GO:0034383 | low-density lipoprotein particle clearance | 8 | 17 | 1.92e-02 |
| GO:BP | GO:0043086 | negative regulation of catalytic activity | 65 | 319 | 1.95e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 46 | 209 | 1.96e-02 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 107 | 574 | 1.96e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 19 | 65 | 1.96e-02 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 41 | 181 | 1.96e-02 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 83 | 427 | 1.97e-02 |
| GO:BP | GO:0001974 | blood vessel remodeling | 12 | 33 | 1.98e-02 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 50 | 232 | 1.98e-02 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 20 | 70 | 1.99e-02 |
| GO:BP | GO:0055002 | striated muscle cell development | 20 | 70 | 1.99e-02 |
| GO:BP | GO:0019915 | lipid storage | 20 | 70 | 1.99e-02 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 61 | 296 | 2.00e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 32 | 132 | 2.01e-02 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 16 | 51 | 2.02e-02 |
| GO:BP | GO:0046902 | regulation of mitochondrial membrane permeability | 16 | 51 | 2.02e-02 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 16 | 51 | 2.02e-02 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 87 | 452 | 2.02e-02 |
| GO:BP | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 9 | 21 | 2.08e-02 |
| GO:BP | GO:0044238 | primary metabolic process | 1145 | 7701 | 2.08e-02 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 31 | 127 | 2.08e-02 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 17 | 56 | 2.15e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 17 | 56 | 2.15e-02 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 39 | 171 | 2.16e-02 |
| GO:BP | GO:0003007 | heart morphogenesis | 48 | 222 | 2.22e-02 |
| GO:BP | GO:1904018 | positive regulation of vasculature development | 29 | 117 | 2.25e-02 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 29 | 117 | 2.25e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 172 | 989 | 2.25e-02 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 220 | 1301 | 2.28e-02 |
| GO:BP | GO:0032368 | regulation of lipid transport | 24 | 91 | 2.28e-02 |
| GO:BP | GO:1905475 | regulation of protein localization to membrane | 36 | 155 | 2.29e-02 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 13 | 38 | 2.29e-02 |
| GO:BP | GO:1904035 | regulation of epithelial cell apoptotic process | 21 | 76 | 2.34e-02 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 287 | 1744 | 2.35e-02 |
| GO:BP | GO:0048666 | neuron development | 157 | 894 | 2.36e-02 |
| GO:BP | GO:1901203 | positive regulation of extracellular matrix assembly | 7 | 14 | 2.40e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 35 | 150 | 2.40e-02 |
| GO:BP | GO:0009132 | nucleoside diphosphate metabolic process | 27 | 107 | 2.40e-02 |
| GO:BP | GO:0009185 | ribonucleoside diphosphate metabolic process | 26 | 102 | 2.48e-02 |
| GO:BP | GO:0043409 | negative regulation of MAPK cascade | 32 | 134 | 2.50e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 89 | 468 | 2.51e-02 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 220 | 1304 | 2.51e-02 |
| GO:BP | GO:0002262 | myeloid cell homeostasis | 34 | 145 | 2.52e-02 |
| GO:BP | GO:0030162 | regulation of proteolysis | 87 | 456 | 2.54e-02 |
| GO:BP | GO:0006090 | pyruvate metabolic process | 25 | 97 | 2.54e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 14 | 43 | 2.56e-02 |
| GO:BP | GO:0031638 | zymogen activation | 14 | 43 | 2.56e-02 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 239 | 1430 | 2.60e-02 |
| GO:BP | GO:0140352 | export from cell | 114 | 624 | 2.62e-02 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 96 | 512 | 2.62e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 18 | 62 | 2.63e-02 |
| GO:BP | GO:0030239 | myofibril assembly | 19 | 67 | 2.63e-02 |
| GO:BP | GO:0021960 | anterior commissure morphogenesis | 4 | 5 | 2.63e-02 |
| GO:BP | GO:0032376 | positive regulation of cholesterol transport | 11 | 30 | 2.63e-02 |
| GO:BP | GO:1902267 | regulation of polyamine transmembrane transport | 4 | 5 | 2.63e-02 |
| GO:BP | GO:0009191 | ribonucleoside diphosphate catabolic process | 22 | 82 | 2.63e-02 |
| GO:BP | GO:0097190 | apoptotic signaling pathway | 94 | 500 | 2.63e-02 |
| GO:BP | GO:1904261 | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 4 | 5 | 2.63e-02 |
| GO:BP | GO:0072526 | pyridine-containing compound catabolic process | 22 | 82 | 2.63e-02 |
| GO:BP | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis | 4 | 5 | 2.63e-02 |
| GO:BP | GO:0046898 | response to cycloheximide | 4 | 5 | 2.63e-02 |
| GO:BP | GO:2000669 | negative regulation of dendritic cell apoptotic process | 4 | 5 | 2.63e-02 |
| GO:BP | GO:1904978 | regulation of endosome organization | 4 | 5 | 2.63e-02 |
| GO:BP | GO:2001197 | basement membrane assembly involved in embryonic body morphogenesis | 4 | 5 | 2.63e-02 |
| GO:BP | GO:0051153 | regulation of striated muscle cell differentiation | 19 | 67 | 2.63e-02 |
| GO:BP | GO:0001938 | positive regulation of endothelial cell proliferation | 20 | 72 | 2.63e-02 |
| GO:BP | GO:0060419 | heart growth | 20 | 72 | 2.63e-02 |
| GO:BP | GO:0032373 | positive regulation of sterol transport | 11 | 30 | 2.63e-02 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 124 | 687 | 2.63e-02 |
| GO:BP | GO:0098781 | ncRNA transcription | 30 | 124 | 2.63e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 43 | 196 | 2.63e-02 |
| GO:BP | GO:0030206 | chondroitin sulfate biosynthetic process | 8 | 18 | 2.67e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 264 | 1597 | 2.67e-02 |
| GO:BP | GO:0055093 | response to hyperoxia | 8 | 18 | 2.67e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 15 | 48 | 2.67e-02 |
| GO:BP | GO:0006790 | sulfur compound metabolic process | 52 | 248 | 2.67e-02 |
| GO:BP | GO:0097006 | regulation of plasma lipoprotein particle levels | 15 | 48 | 2.67e-02 |
| GO:BP | GO:0030042 | actin filament depolymerization | 15 | 48 | 2.67e-02 |
| GO:BP | GO:0070613 | regulation of protein processing | 15 | 48 | 2.67e-02 |
| GO:BP | GO:1904738 | vascular associated smooth muscle cell migration | 10 | 26 | 2.72e-02 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 10 | 26 | 2.72e-02 |
| GO:BP | GO:0010883 | regulation of lipid storage | 13 | 39 | 2.75e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 13 | 39 | 2.75e-02 |
| GO:BP | GO:2001259 | positive regulation of cation channel activity | 13 | 39 | 2.75e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 13 | 39 | 2.75e-02 |
| GO:BP | GO:1903671 | negative regulation of sprouting angiogenesis | 6 | 11 | 2.75e-02 |
| GO:BP | GO:0033275 | actin-myosin filament sliding | 6 | 11 | 2.75e-02 |
| GO:BP | GO:0010172 | embryonic body morphogenesis | 6 | 11 | 2.75e-02 |
| GO:BP | GO:0033993 | response to lipid | 110 | 601 | 2.75e-02 |
| GO:BP | GO:0001945 | lymph vessel development | 9 | 22 | 2.75e-02 |
| GO:BP | GO:0014733 | regulation of skeletal muscle adaptation | 6 | 11 | 2.75e-02 |
| GO:BP | GO:0007519 | skeletal muscle tissue development | 31 | 130 | 2.75e-02 |
| GO:BP | GO:1990874 | vascular associated smooth muscle cell proliferation | 16 | 53 | 2.78e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 16 | 53 | 2.78e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 284 | 1732 | 2.79e-02 |
| GO:BP | GO:0051258 | protein polymerization | 51 | 243 | 2.80e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 175 | 1016 | 2.81e-02 |
| GO:BP | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 30 | 125 | 2.88e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 17 | 58 | 2.89e-02 |
| GO:BP | GO:0010720 | positive regulation of cell development | 65 | 326 | 2.89e-02 |
| GO:BP | GO:0019538 | protein metabolic process | 595 | 3848 | 2.90e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 22 | 83 | 2.92e-02 |
| GO:BP | GO:0030301 | cholesterol transport | 22 | 83 | 2.92e-02 |
| GO:BP | GO:0008152 | metabolic process | 1248 | 8464 | 2.94e-02 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 26 | 104 | 3.00e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 12 | 35 | 3.00e-02 |
| GO:BP | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway | 5 | 8 | 3.02e-02 |
| GO:BP | GO:0060485 | mesenchyme development | 53 | 256 | 3.10e-02 |
| GO:BP | GO:0005975 | carbohydrate metabolic process | 82 | 430 | 3.10e-02 |
| GO:BP | GO:0046434 | organophosphate catabolic process | 41 | 187 | 3.16e-02 |
| GO:BP | GO:0031175 | neuron projection development | 140 | 794 | 3.17e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 30 | 126 | 3.21e-02 |
| GO:BP | GO:0051155 | positive regulation of striated muscle cell differentiation | 11 | 31 | 3.30e-02 |
| GO:BP | GO:0010830 | regulation of myotube differentiation | 11 | 31 | 3.30e-02 |
| GO:BP | GO:0035914 | skeletal muscle cell differentiation | 16 | 54 | 3.34e-02 |
| GO:BP | GO:0009134 | nucleoside diphosphate catabolic process | 22 | 84 | 3.37e-02 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 54 | 263 | 3.37e-02 |
| GO:BP | GO:0060142 | regulation of syncytium formation by plasma membrane fusion | 7 | 15 | 3.45e-02 |
| GO:BP | GO:0003417 | growth plate cartilage development | 7 | 15 | 3.45e-02 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 19 | 69 | 3.49e-02 |
| GO:BP | GO:0035108 | limb morphogenesis | 28 | 116 | 3.51e-02 |
| GO:BP | GO:0035107 | appendage morphogenesis | 28 | 116 | 3.51e-02 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 10 | 27 | 3.53e-02 |
| GO:BP | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 10 | 27 | 3.53e-02 |
| GO:BP | GO:0045923 | positive regulation of fatty acid metabolic process | 10 | 27 | 3.53e-02 |
| GO:BP | GO:1901185 | negative regulation of ERBB signaling pathway | 10 | 27 | 3.53e-02 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 277 | 1694 | 3.55e-02 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 160 | 926 | 3.64e-02 |
| GO:BP | GO:0010742 | macrophage derived foam cell differentiation | 9 | 23 | 3.68e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 71 | 366 | 3.68e-02 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 9 | 23 | 3.68e-02 |
| GO:BP | GO:0051497 | negative regulation of stress fiber assembly | 9 | 23 | 3.68e-02 |
| GO:BP | GO:0090077 | foam cell differentiation | 9 | 23 | 3.68e-02 |
| GO:BP | GO:0033688 | regulation of osteoblast proliferation | 9 | 23 | 3.68e-02 |
| GO:BP | GO:0031400 | negative regulation of protein modification process | 68 | 348 | 3.70e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 23 | 90 | 3.71e-02 |
| GO:BP | GO:0051147 | regulation of muscle cell differentiation | 29 | 122 | 3.71e-02 |
| GO:BP | GO:0002157 | positive regulation of thyroid hormone mediated signaling pathway | 3 | 3 | 3.73e-02 |
| GO:BP | GO:0032385 | positive regulation of intracellular cholesterol transport | 3 | 3 | 3.73e-02 |
| GO:BP | GO:0086048 | membrane depolarization during bundle of His cell action potential | 3 | 3 | 3.73e-02 |
| GO:BP | GO:0032382 | positive regulation of intracellular sterol transport | 3 | 3 | 3.73e-02 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 207 | 1233 | 3.73e-02 |
| GO:BP | GO:0010650 | positive regulation of cell communication by electrical coupling | 3 | 3 | 3.73e-02 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 192 | 1135 | 3.73e-02 |
| GO:BP | GO:0030917 | midbrain-hindbrain boundary development | 3 | 3 | 3.73e-02 |
| GO:BP | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion | 3 | 3 | 3.73e-02 |
| GO:BP | GO:0021648 | vestibulocochlear nerve morphogenesis | 3 | 3 | 3.73e-02 |
| GO:BP | GO:0060840 | artery development | 22 | 85 | 3.76e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 42 | 195 | 3.76e-02 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 39 | 178 | 3.80e-02 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 21 | 80 | 3.85e-02 |
| GO:BP | GO:0006631 | fatty acid metabolic process | 56 | 277 | 3.85e-02 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 16 | 55 | 3.87e-02 |
| GO:BP | GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 16 | 55 | 3.87e-02 |
| GO:BP | GO:0060538 | skeletal muscle organ development | 32 | 139 | 3.87e-02 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 99 | 540 | 3.89e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 20 | 75 | 3.89e-02 |
| GO:BP | GO:0006024 | glycosaminoglycan biosynthetic process | 17 | 60 | 3.93e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 98 | 534 | 3.93e-02 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 83 | 441 | 3.94e-02 |
| GO:BP | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 11 | 32 | 4.09e-02 |
| GO:BP | GO:0045746 | negative regulation of Notch signaling pathway | 11 | 32 | 4.09e-02 |
| GO:BP | GO:0000165 | MAPK cascade | 98 | 535 | 4.14e-02 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 62 | 314 | 4.15e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 26 | 107 | 4.18e-02 |
| GO:BP | GO:0006006 | glucose metabolic process | 34 | 151 | 4.22e-02 |
| GO:BP | GO:0010889 | regulation of sequestering of triglyceride | 6 | 12 | 4.26e-02 |
| GO:BP | GO:0014854 | response to inactivity | 6 | 12 | 4.26e-02 |
| GO:BP | GO:0032410 | negative regulation of transporter activity | 14 | 46 | 4.26e-02 |
| GO:BP | GO:0006883 | intracellular sodium ion homeostasis | 6 | 12 | 4.26e-02 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 6 | 12 | 4.26e-02 |
| GO:BP | GO:0072537 | fibroblast activation | 6 | 12 | 4.26e-02 |
| GO:BP | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction | 6 | 12 | 4.26e-02 |
| GO:BP | GO:0060976 | coronary vasculature development | 14 | 46 | 4.26e-02 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 14 | 46 | 4.26e-02 |
| GO:BP | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity | 6 | 12 | 4.26e-02 |
| GO:BP | GO:0030278 | regulation of ossification | 22 | 86 | 4.26e-02 |
| GO:BP | GO:0036376 | sodium ion export across plasma membrane | 6 | 12 | 4.26e-02 |
| GO:BP | GO:1901739 | regulation of myoblast fusion | 6 | 12 | 4.26e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 35 | 157 | 4.32e-02 |
| GO:BP | GO:0010817 | regulation of hormone levels | 66 | 339 | 4.33e-02 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 114 | 637 | 4.33e-02 |
| GO:BP | GO:0008217 | regulation of blood pressure | 27 | 113 | 4.40e-02 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 10 | 28 | 4.40e-02 |
| GO:BP | GO:1903317 | regulation of protein maturation | 15 | 51 | 4.40e-02 |
| GO:BP | GO:0002068 | glandular epithelial cell development | 10 | 28 | 4.40e-02 |
| GO:BP | GO:0030837 | negative regulation of actin filament polymerization | 16 | 56 | 4.50e-02 |
| GO:BP | GO:1904063 | negative regulation of cation transmembrane transport | 16 | 56 | 4.50e-02 |
| GO:BP | GO:0032868 | response to insulin | 44 | 209 | 4.50e-02 |
| GO:BP | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 12 | 37 | 4.50e-02 |
| GO:BP | GO:0071396 | cellular response to lipid | 77 | 407 | 4.55e-02 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 37 | 169 | 4.58e-02 |
| GO:BP | GO:0030522 | intracellular receptor signaling pathway | 55 | 274 | 4.61e-02 |
| GO:BP | GO:1900027 | regulation of ruffle assembly | 9 | 24 | 4.71e-02 |
| GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 9 | 24 | 4.71e-02 |
| GO:BP | GO:0030204 | chondroitin sulfate metabolic process | 9 | 24 | 4.71e-02 |
| GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 9 | 24 | 4.71e-02 |
| GO:BP | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade | 7 | 16 | 4.79e-02 |
| GO:BP | GO:0031338 | regulation of vesicle fusion | 7 | 16 | 4.79e-02 |
| GO:BP | GO:0106058 | positive regulation of calcineurin-mediated signaling | 7 | 16 | 4.79e-02 |
| GO:BP | GO:0014888 | striated muscle adaptation | 13 | 42 | 4.83e-02 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 8 | 20 | 4.85e-02 |
| GO:BP | GO:0001659 | temperature homeostasis | 31 | 136 | 4.85e-02 |
| GO:BP | GO:1903318 | negative regulation of protein maturation | 8 | 20 | 4.85e-02 |
| GO:BP | GO:0048638 | regulation of developmental growth | 52 | 257 | 4.85e-02 |
| GO:BP | GO:0010955 | negative regulation of protein processing | 8 | 20 | 4.85e-02 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 8 | 20 | 4.85e-02 |
| GO:BP | GO:0043267 | negative regulation of potassium ion transport | 8 | 20 | 4.85e-02 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 8 | 20 | 4.85e-02 |
| GO:BP | GO:0070555 | response to interleukin-1 | 21 | 82 | 4.87e-02 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 56 | 281 | 4.88e-02 |
| GO:BP | GO:0002682 | regulation of immune system process | 160 | 936 | 4.98e-02 |
LRnomtable_20k_enh %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR enhancer neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 43 | 127 | 4.33e-06 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 32 | 84 | 6.68e-06 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 30 | 79 | 1.28e-05 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 21 | 50 | 1.11e-04 |
| KEGG | KEGG:04510 | Focal adhesion | 48 | 177 | 1.72e-04 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 25 | 69 | 1.72e-04 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 27 | 77 | 1.72e-04 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 62 | 256 | 3.72e-04 |
| KEGG | KEGG:04971 | Gastric acid secretion | 20 | 52 | 4.37e-04 |
| KEGG | KEGG:05200 | Pathways in cancer | 88 | 408 | 6.73e-04 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 63 | 271 | 9.00e-04 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 26 | 82 | 9.81e-04 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 31 | 106 | 9.99e-04 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 22 | 67 | 1.83e-03 |
| KEGG | KEGG:00000 | KEGG root term | 893 | 5802 | 1.84e-03 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 22 | 69 | 2.47e-03 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 31 | 112 | 2.47e-03 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 17 | 48 | 3.26e-03 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 40 | 164 | 4.51e-03 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 34 | 132 | 4.51e-03 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 40 | 164 | 4.51e-03 |
| KEGG | KEGG:04911 | Insulin secretion | 20 | 64 | 5.17e-03 |
| KEGG | KEGG:04148 | Efferocytosis | 32 | 125 | 6.28e-03 |
| KEGG | KEGG:04360 | Axon guidance | 39 | 162 | 6.28e-03 |
| KEGG | KEGG:04931 | Insulin resistance | 26 | 95 | 6.49e-03 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 19 | 61 | 6.49e-03 |
| KEGG | KEGG:05215 | Prostate cancer | 24 | 86 | 7.19e-03 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 40 | 170 | 7.19e-03 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 12 | 31 | 7.19e-03 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 21 | 72 | 7.67e-03 |
| KEGG | KEGG:04972 | Pancreatic secretion | 18 | 58 | 7.86e-03 |
| KEGG | KEGG:05146 | Amoebiasis | 19 | 64 | 1.01e-02 |
| KEGG | KEGG:04611 | Platelet activation | 24 | 89 | 1.01e-02 |
| KEGG | KEGG:04713 | Circadian entrainment | 20 | 69 | 1.01e-02 |
| KEGG | KEGG:05131 | Shigellosis | 46 | 210 | 1.22e-02 |
| KEGG | KEGG:04740 | Olfactory transduction | 10 | 25 | 1.22e-02 |
| KEGG | KEGG:04520 | Adherens junction | 23 | 86 | 1.32e-02 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 35 | 151 | 1.48e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 23 | 87 | 1.48e-02 |
| KEGG | KEGG:04330 | Notch signaling pathway | 16 | 53 | 1.63e-02 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 12 | 35 | 1.75e-02 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 39 | 176 | 1.87e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 29 | 121 | 1.90e-02 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 13 | 41 | 2.39e-02 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 23 | 91 | 2.40e-02 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 36 | 163 | 2.61e-02 |
| KEGG | KEGG:04976 | Bile secretion | 13 | 42 | 2.81e-02 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 27 | 114 | 2.81e-02 |
| KEGG | KEGG:04725 | Cholinergic synapse | 21 | 83 | 3.09e-02 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 12 | 38 | 3.09e-02 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 27 | 115 | 3.09e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 33 | 149 | 3.15e-02 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 23 | 94 | 3.15e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 22 | 89 | 3.24e-02 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 8 | 21 | 3.41e-02 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 38 | 179 | 3.41e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 19 | 74 | 3.47e-02 |
| KEGG | KEGG:01522 | Endocrine resistance | 21 | 85 | 3.65e-02 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 19 | 75 | 3.91e-02 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 24 | 102 | 3.93e-02 |
| KEGG | KEGG:04924 | Renin secretion | 14 | 50 | 4.01e-02 |
| KEGG | KEGG:04720 | Long-term potentiation | 15 | 55 | 4.01e-02 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 15 | 55 | 4.01e-02 |
| KEGG | KEGG:04970 | Salivary secretion | 15 | 55 | 4.01e-02 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 19 | 76 | 4.12e-02 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 21 | 87 | 4.24e-02 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 24 | 104 | 4.52e-02 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 25 | 110 | 4.69e-02 |
| KEGG | KEGG:05214 | Glioma | 17 | 67 | 4.90e-02 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 22 | 94 | 4.90e-02 |
NR 20,000 bp NG
# NR_resgenes_20k <- gost(query = unique(NR_peak_list_20k$ENTREZID),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(NR_resgenes_20k,"data/GO_KEGG_analysis/NR_resgenes_20k.RDS")
# NRnom <- gostplot(NR_resgenes_20k, capped = FALSE, interactive = TRUE)
# NRnom
NRnomtable_20k <- NR_resgenes_20k$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
NRnomtable_20k %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR nESRgenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0008150 | biological_process | 10636 | 12051 | 1.10e-41 |
| GO:BP | GO:0009987 | cellular process | 10111 | 11450 | 1.41e-31 |
| GO:BP | GO:0065007 | biological regulation | 7350 | 8275 | 9.03e-17 |
| GO:BP | GO:0050789 | regulation of biological process | 7144 | 8037 | 9.57e-17 |
| GO:BP | GO:0050794 | regulation of cellular process | 6806 | 7651 | 6.38e-16 |
| GO:BP | GO:0051716 | cellular response to stimulus | 4437 | 4933 | 5.27e-15 |
| GO:BP | GO:0050896 | response to stimulus | 5133 | 5732 | 1.05e-14 |
| GO:BP | GO:0048518 | positive regulation of biological process | 4105 | 4561 | 7.79e-14 |
| GO:BP | GO:0008152 | metabolic process | 7489 | 8464 | 1.19e-12 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 3776 | 4198 | 9.06e-12 |
| GO:BP | GO:0071704 | organic substance metabolic process | 7161 | 8096 | 6.72e-11 |
| GO:BP | GO:0044238 | primary metabolic process | 6816 | 7701 | 2.56e-10 |
| GO:BP | GO:0048856 | anatomical structure development | 3708 | 4130 | 2.69e-10 |
| GO:BP | GO:0007154 | cell communication | 3811 | 4248 | 2.94e-10 |
| GO:BP | GO:0043170 | macromolecule metabolic process | 6199 | 6990 | 3.60e-10 |
| GO:BP | GO:0007275 | multicellular organism development | 3050 | 3383 | 5.43e-10 |
| GO:BP | GO:0006807 | nitrogen compound metabolic process | 6532 | 7376 | 5.43e-10 |
| GO:BP | GO:0023052 | signaling | 3749 | 4180 | 6.27e-10 |
| GO:BP | GO:0007165 | signal transduction | 3456 | 3846 | 6.49e-10 |
| GO:BP | GO:0032501 | multicellular organismal process | 4317 | 4830 | 7.11e-10 |
| GO:BP | GO:0044237 | cellular metabolic process | 6673 | 7545 | 2.76e-09 |
| GO:BP | GO:0032502 | developmental process | 4001 | 4475 | 5.92e-09 |
| GO:BP | GO:0016043 | cellular component organization | 4579 | 5139 | 1.11e-08 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1778 | 1951 | 1.73e-08 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 2312 | 2555 | 1.86e-08 |
| GO:BP | GO:0048731 | system development | 2618 | 2903 | 2.49e-08 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 1158 | 1256 | 3.76e-08 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 4749 | 5340 | 5.69e-08 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 3813 | 4269 | 8.10e-08 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 3406 | 3804 | 8.10e-08 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 1006 | 1088 | 1.00e-07 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 2506 | 2780 | 1.00e-07 |
| GO:BP | GO:0019222 | regulation of metabolic process | 4375 | 4914 | 1.18e-07 |
| GO:BP | GO:0042221 | response to chemical | 2202 | 2436 | 1.34e-07 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 4026 | 4515 | 1.38e-07 |
| GO:BP | GO:0048869 | cellular developmental process | 2688 | 2988 | 1.38e-07 |
| GO:BP | GO:0030154 | cell differentiation | 2687 | 2987 | 1.39e-07 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 3724 | 4170 | 1.53e-07 |
| GO:BP | GO:0051179 | localization | 3554 | 3978 | 3.06e-07 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1726 | 1900 | 3.36e-07 |
| GO:BP | GO:0048468 | cell development | 1813 | 1999 | 4.40e-07 |
| GO:BP | GO:0010646 | regulation of cell communication | 2344 | 2601 | 4.81e-07 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 1054 | 1145 | 5.29e-07 |
| GO:BP | GO:0072359 | circulatory system development | 831 | 896 | 5.36e-07 |
| GO:BP | GO:0023051 | regulation of signaling | 2340 | 2597 | 5.36e-07 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 2088 | 2311 | 5.36e-07 |
| GO:BP | GO:0006996 | organelle organization | 2695 | 3001 | 6.08e-07 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 5215 | 5886 | 6.62e-07 |
| GO:BP | GO:0051234 | establishment of localization | 3086 | 3447 | 6.89e-07 |
| GO:BP | GO:0006810 | transport | 2848 | 3176 | 7.44e-07 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 5164 | 5828 | 7.45e-07 |
| GO:BP | GO:0009888 | tissue development | 1302 | 1425 | 1.02e-06 |
| GO:BP | GO:0050793 | regulation of developmental process | 1635 | 1801 | 1.29e-06 |
| GO:BP | GO:0009058 | biosynthetic process | 5248 | 5927 | 1.32e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 2229 | 2474 | 1.35e-06 |
| GO:BP | GO:0048513 | animal organ development | 1925 | 2130 | 1.77e-06 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 4022 | 4521 | 1.93e-06 |
| GO:BP | GO:0048519 | negative regulation of biological process | 3599 | 4037 | 2.00e-06 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 4122 | 4637 | 2.75e-06 |
| GO:BP | GO:0010033 | response to organic substance | 1663 | 1835 | 3.05e-06 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 4573 | 5155 | 3.17e-06 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1452 | 1597 | 3.34e-06 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 810 | 876 | 3.34e-06 |
| GO:BP | GO:0009966 | regulation of signal transduction | 2079 | 2307 | 3.73e-06 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 3323 | 3724 | 3.73e-06 |
| GO:BP | GO:0022008 | neurogenesis | 1212 | 1327 | 3.85e-06 |
| GO:BP | GO:0019538 | protein metabolic process | 3431 | 3848 | 4.26e-06 |
| GO:BP | GO:0009725 | response to hormone | 592 | 634 | 4.67e-06 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 2601 | 2902 | 5.86e-06 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1676 | 1852 | 6.46e-06 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 695 | 749 | 6.46e-06 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1876 | 2079 | 7.63e-06 |
| GO:BP | GO:0007010 | cytoskeleton organization | 1113 | 1218 | 1.08e-05 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 3421 | 3841 | 1.35e-05 |
| GO:BP | GO:0010468 | regulation of gene expression | 3221 | 3613 | 1.59e-05 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 3323 | 3730 | 1.76e-05 |
| GO:BP | GO:0071702 | organic substance transport | 1644 | 1819 | 2.07e-05 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 2761 | 3089 | 2.16e-05 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1715 | 1900 | 2.50e-05 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 3396 | 3815 | 2.53e-05 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 768 | 833 | 2.65e-05 |
| GO:BP | GO:0071310 | cellular response to organic substance | 1246 | 1370 | 2.65e-05 |
| GO:BP | GO:0043412 | macromolecule modification | 2358 | 2631 | 2.93e-05 |
| GO:BP | GO:0036211 | protein modification process | 2175 | 2423 | 3.10e-05 |
| GO:BP | GO:0051641 | cellular localization | 2500 | 2793 | 3.13e-05 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 425 | 452 | 3.29e-05 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 443 | 472 | 3.58e-05 |
| GO:BP | GO:0035295 | tube development | 762 | 827 | 3.66e-05 |
| GO:BP | GO:0051649 | establishment of localization in cell | 1502 | 1661 | 5.05e-05 |
| GO:BP | GO:0022402 | cell cycle process | 985 | 1078 | 5.71e-05 |
| GO:BP | GO:0033036 | macromolecule localization | 2199 | 2453 | 6.74e-05 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 586 | 632 | 8.48e-05 |
| GO:BP | GO:0010467 | gene expression | 4214 | 4758 | 9.17e-05 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 661 | 716 | 1.01e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 1296 | 1430 | 1.01e-04 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1845 | 2052 | 1.01e-04 |
| GO:BP | GO:0030029 | actin filament-based process | 626 | 677 | 1.03e-04 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 2539 | 2842 | 1.04e-04 |
| GO:BP | GO:0048699 | generation of neurons | 1043 | 1145 | 1.16e-04 |
| GO:BP | GO:0007399 | nervous system development | 1713 | 1903 | 1.27e-04 |
| GO:BP | GO:0006915 | apoptotic process | 1321 | 1459 | 1.27e-04 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1775 | 1974 | 1.55e-04 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 265 | 278 | 1.59e-04 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 432 | 462 | 1.62e-04 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 1032 | 1134 | 2.01e-04 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1790 | 1992 | 2.05e-04 |
| GO:BP | GO:0008283 | cell population proliferation | 1255 | 1386 | 2.25e-04 |
| GO:BP | GO:0034641 | cellular nitrogen compound metabolic process | 4396 | 4972 | 2.49e-04 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 1168 | 1288 | 2.49e-04 |
| GO:BP | GO:1901698 | response to nitrogen compound | 711 | 774 | 2.76e-04 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1760 | 1959 | 2.77e-04 |
| GO:BP | GO:0001944 | vasculature development | 531 | 573 | 2.96e-04 |
| GO:BP | GO:0023056 | positive regulation of signaling | 1171 | 1292 | 3.05e-04 |
| GO:BP | GO:0060429 | epithelium development | 766 | 836 | 3.14e-04 |
| GO:BP | GO:0030182 | neuron differentiation | 983 | 1080 | 3.14e-04 |
| GO:BP | GO:0007049 | cell cycle | 1372 | 1520 | 3.81e-04 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 1048 | 1154 | 4.16e-04 |
| GO:BP | GO:0012501 | programmed cell death | 1358 | 1505 | 5.09e-04 |
| GO:BP | GO:0007507 | heart development | 478 | 515 | 5.37e-04 |
| GO:BP | GO:0035239 | tube morphogenesis | 615 | 668 | 5.64e-04 |
| GO:BP | GO:0008219 | cell death | 1361 | 1509 | 6.15e-04 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 1847 | 2061 | 6.67e-04 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 4066 | 4599 | 8.15e-04 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1914 | 2138 | 8.19e-04 |
| GO:BP | GO:0003008 | system process | 1088 | 1201 | 8.19e-04 |
| GO:BP | GO:0009790 | embryo development | 789 | 864 | 8.20e-04 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 1179 | 1304 | 8.47e-04 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 2785 | 3132 | 8.83e-04 |
| GO:BP | GO:0001568 | blood vessel development | 505 | 546 | 8.83e-04 |
| GO:BP | GO:0048870 | cell motility | 1078 | 1190 | 8.83e-04 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 2784 | 3131 | 9.05e-04 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 2727 | 3066 | 9.32e-04 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 1176 | 1301 | 9.37e-04 |
| GO:BP | GO:0032879 | regulation of localization | 1370 | 1521 | 1.04e-03 |
| GO:BP | GO:0008104 | protein localization | 1904 | 2128 | 1.13e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 1568 | 1746 | 1.14e-03 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 1110 | 1227 | 1.15e-03 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 3576 | 4039 | 1.16e-03 |
| GO:BP | GO:0016477 | cell migration | 978 | 1078 | 1.19e-03 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 1522 | 1694 | 1.19e-03 |
| GO:BP | GO:0007267 | cell-cell signaling | 1047 | 1156 | 1.19e-03 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 1440 | 1601 | 1.19e-03 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 4218 | 4776 | 1.19e-03 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 1115 | 1233 | 1.25e-03 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 2876 | 3238 | 1.26e-03 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 574 | 624 | 1.30e-03 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 1028 | 1135 | 1.39e-03 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 1241 | 1376 | 1.41e-03 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 2296 | 2576 | 1.43e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 744 | 815 | 1.45e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 297 | 316 | 1.51e-03 |
| GO:BP | GO:0030030 | cell projection organization | 1140 | 1262 | 1.55e-03 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 2307 | 2589 | 1.56e-03 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 227 | 239 | 1.56e-03 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 553 | 601 | 1.61e-03 |
| GO:BP | GO:0006351 | DNA-templated transcription | 2389 | 2683 | 1.70e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 1867 | 2088 | 1.77e-03 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 3959 | 4481 | 1.77e-03 |
| GO:BP | GO:0043434 | response to peptide hormone | 304 | 324 | 1.78e-03 |
| GO:BP | GO:0010035 | response to inorganic substance | 368 | 395 | 1.88e-03 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 4079 | 4620 | 2.21e-03 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 1553 | 1732 | 2.44e-03 |
| GO:BP | GO:0000278 | mitotic cell cycle | 732 | 803 | 2.63e-03 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 2410 | 2709 | 2.67e-03 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 510 | 554 | 2.78e-03 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 1563 | 1744 | 2.85e-03 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 467 | 506 | 2.85e-03 |
| GO:BP | GO:0007423 | sensory organ development | 371 | 399 | 2.85e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 432 | 467 | 2.93e-03 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 877 | 967 | 3.21e-03 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 208 | 219 | 3.21e-03 |
| GO:BP | GO:0071705 | nitrogen compound transport | 1382 | 1539 | 3.35e-03 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 930 | 1027 | 3.35e-03 |
| GO:BP | GO:1901653 | cellular response to peptide | 267 | 284 | 3.35e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 991 | 1096 | 3.41e-03 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 1262 | 1403 | 3.49e-03 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 621 | 679 | 3.49e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 2003 | 2246 | 3.56e-03 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 685 | 751 | 3.56e-03 |
| GO:BP | GO:0070848 | response to growth factor | 529 | 576 | 3.78e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 1516 | 1692 | 4.03e-03 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 101 | 103 | 4.06e-03 |
| GO:BP | GO:0007155 | cell adhesion | 909 | 1004 | 4.18e-03 |
| GO:BP | GO:0002520 | immune system development | 139 | 144 | 4.18e-03 |
| GO:BP | GO:1901652 | response to peptide | 354 | 381 | 4.70e-03 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 937 | 1036 | 4.74e-03 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 353 | 380 | 5.00e-03 |
| GO:BP | GO:0007017 | microtubule-based process | 694 | 762 | 5.01e-03 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 280 | 299 | 5.03e-03 |
| GO:BP | GO:0033043 | regulation of organelle organization | 919 | 1016 | 5.28e-03 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 352 | 379 | 5.28e-03 |
| GO:BP | GO:0042592 | homeostatic process | 1085 | 1204 | 5.51e-03 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 333 | 358 | 5.70e-03 |
| GO:BP | GO:0015031 | protein transport | 1091 | 1211 | 5.84e-03 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 259 | 276 | 5.84e-03 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 123 | 127 | 6.13e-03 |
| GO:BP | GO:0048880 | sensory system development | 258 | 275 | 6.29e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 486 | 529 | 6.35e-03 |
| GO:BP | GO:0016070 | RNA metabolic process | 3174 | 3588 | 6.40e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 145 | 151 | 6.97e-03 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 647 | 710 | 6.97e-03 |
| GO:BP | GO:0033993 | response to lipid | 550 | 601 | 7.03e-03 |
| GO:BP | GO:0032880 | regulation of protein localization | 662 | 727 | 7.19e-03 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 177 | 186 | 7.19e-03 |
| GO:BP | GO:0150063 | visual system development | 256 | 273 | 7.19e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 1017 | 1128 | 7.27e-03 |
| GO:BP | GO:0048666 | neuron development | 810 | 894 | 7.48e-03 |
| GO:BP | GO:0001654 | eye development | 255 | 272 | 7.65e-03 |
| GO:BP | GO:0048729 | tissue morphogenesis | 440 | 478 | 7.80e-03 |
| GO:BP | GO:0010608 | post-transcriptional regulation of gene expression | 440 | 478 | 7.80e-03 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 571 | 625 | 8.20e-03 |
| GO:BP | GO:0046907 | intracellular transport | 1111 | 1235 | 8.30e-03 |
| GO:BP | GO:0007015 | actin filament organization | 353 | 381 | 8.36e-03 |
| GO:BP | GO:0045184 | establishment of protein localization | 1313 | 1465 | 1.02e-02 |
| GO:BP | GO:0002200 | somatic diversification of immune receptors | 61 | 61 | 1.02e-02 |
| GO:BP | GO:0000902 | cell morphogenesis | 694 | 764 | 1.02e-02 |
| GO:BP | GO:0001525 | angiogenesis | 367 | 397 | 1.04e-02 |
| GO:BP | GO:0043010 | camera-type eye development | 222 | 236 | 1.07e-02 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 532 | 582 | 1.16e-02 |
| GO:BP | GO:0060485 | mesenchyme development | 240 | 256 | 1.16e-02 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 365 | 395 | 1.17e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 499 | 545 | 1.17e-02 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 399 | 433 | 1.18e-02 |
| GO:BP | GO:0051726 | regulation of cell cycle | 845 | 935 | 1.19e-02 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 912 | 1011 | 1.28e-02 |
| GO:BP | GO:0051049 | regulation of transport | 1047 | 1164 | 1.29e-02 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 90 | 92 | 1.29e-02 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 1031 | 1146 | 1.34e-02 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 405 | 440 | 1.35e-02 |
| GO:BP | GO:0003007 | heart morphogenesis | 209 | 222 | 1.35e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 362 | 392 | 1.38e-02 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 379 | 411 | 1.39e-02 |
| GO:BP | GO:0031032 | actomyosin structure organization | 179 | 189 | 1.39e-02 |
| GO:BP | GO:0061061 | muscle structure development | 511 | 559 | 1.44e-02 |
| GO:BP | GO:0032868 | response to insulin | 197 | 209 | 1.62e-02 |
| GO:BP | GO:0051640 | organelle localization | 491 | 537 | 1.77e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 759 | 839 | 1.77e-02 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 87 | 89 | 1.78e-02 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 391 | 425 | 1.86e-02 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 570 | 626 | 1.89e-02 |
| GO:BP | GO:1903311 | regulation of mRNA metabolic process | 242 | 259 | 1.91e-02 |
| GO:BP | GO:0034504 | protein localization to nucleus | 260 | 279 | 1.94e-02 |
| GO:BP | GO:0050877 | nervous system process | 577 | 634 | 1.96e-02 |
| GO:BP | GO:0006468 | protein phosphorylation | 908 | 1008 | 1.98e-02 |
| GO:BP | GO:0040007 | growth | 670 | 739 | 2.07e-02 |
| GO:BP | GO:0032940 | secretion by cell | 528 | 579 | 2.07e-02 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 372 | 404 | 2.07e-02 |
| GO:BP | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 55 | 55 | 2.09e-02 |
| GO:BP | GO:0016444 | somatic cell DNA recombination | 55 | 55 | 2.09e-02 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 936 | 1040 | 2.12e-02 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 503 | 551 | 2.13e-02 |
| GO:BP | GO:0048285 | organelle fission | 362 | 393 | 2.25e-02 |
| GO:BP | GO:0046903 | secretion | 596 | 656 | 2.42e-02 |
| GO:BP | GO:0048534 | hematopoietic or lymphoid organ development | 70 | 71 | 2.46e-02 |
| GO:BP | GO:0051301 | cell division | 516 | 566 | 2.49e-02 |
| GO:BP | GO:0042692 | muscle cell differentiation | 309 | 334 | 2.49e-02 |
| GO:BP | GO:0031099 | regeneration | 141 | 148 | 2.50e-02 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 210 | 224 | 2.50e-02 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 579 | 637 | 2.53e-02 |
| GO:BP | GO:0072001 | renal system development | 237 | 254 | 2.63e-02 |
| GO:BP | GO:0034248 | regulation of amide metabolic process | 359 | 390 | 2.65e-02 |
| GO:BP | GO:0016445 | somatic diversification of immunoglobulins | 53 | 53 | 2.65e-02 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 867 | 963 | 2.98e-02 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 520 | 571 | 3.01e-02 |
| GO:BP | GO:0006310 | DNA recombination | 244 | 262 | 3.02e-02 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 253 | 272 | 3.02e-02 |
| GO:BP | GO:0006282 | regulation of DNA repair | 188 | 200 | 3.13e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 339 | 368 | 3.16e-02 |
| GO:BP | GO:0040011 | locomotion | 774 | 858 | 3.23e-02 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 438 | 479 | 3.23e-02 |
| GO:BP | GO:0065008 | regulation of biological quality | 1812 | 2039 | 3.30e-02 |
| GO:BP | GO:0080135 | regulation of cellular response to stress | 429 | 469 | 3.36e-02 |
| GO:BP | GO:0023057 | negative regulation of signaling | 997 | 1111 | 3.43e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 404 | 441 | 3.43e-02 |
| GO:BP | GO:0016310 | phosphorylation | 1085 | 1211 | 3.44e-02 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 412 | 450 | 3.44e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 196 | 209 | 3.44e-02 |
| GO:BP | GO:0006950 | response to stress | 2403 | 2715 | 3.44e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 157 | 166 | 3.51e-02 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1802 | 2028 | 3.51e-02 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 104 | 108 | 3.59e-02 |
| GO:BP | GO:0045739 | positive regulation of DNA repair | 115 | 120 | 3.64e-02 |
| GO:BP | GO:0009611 | response to wounding | 369 | 402 | 3.75e-02 |
| GO:BP | GO:0033365 | protein localization to organelle | 777 | 862 | 3.77e-02 |
| GO:BP | GO:0061013 | regulation of mRNA catabolic process | 156 | 165 | 3.77e-02 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 352 | 383 | 3.80e-02 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 600 | 662 | 3.89e-02 |
| GO:BP | GO:0040012 | regulation of locomotion | 692 | 766 | 3.97e-02 |
| GO:BP | GO:0006417 | regulation of translation | 309 | 335 | 3.97e-02 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 521 | 573 | 3.98e-02 |
| GO:BP | GO:0006886 | intracellular protein transport | 560 | 617 | 4.04e-02 |
| GO:BP | GO:0001822 | kidney development | 230 | 247 | 4.04e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 367 | 400 | 4.11e-02 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 1144 | 1279 | 4.21e-02 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 247 | 266 | 4.26e-02 |
| GO:BP | GO:1901566 | organonitrogen compound biosynthetic process | 1295 | 1451 | 4.35e-02 |
| GO:BP | GO:0140352 | export from cell | 566 | 624 | 4.35e-02 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 996 | 1111 | 4.39e-02 |
| GO:BP | GO:0051276 | chromosome organization | 487 | 535 | 4.39e-02 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 255 | 275 | 4.45e-02 |
| GO:BP | GO:0030334 | regulation of cell migration | 642 | 710 | 4.58e-02 |
| GO:BP | GO:0060284 | regulation of cell development | 549 | 605 | 4.58e-02 |
| GO:BP | GO:0016447 | somatic recombination of immunoglobulin gene segments | 48 | 48 | 4.68e-02 |
| GO:BP | GO:0030042 | actin filament depolymerization | 48 | 48 | 4.68e-02 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 994 | 1109 | 4.68e-02 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 618 | 683 | 4.72e-02 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 421 | 461 | 4.76e-02 |
| GO:BP | GO:0048144 | fibroblast proliferation | 89 | 92 | 4.78e-02 |
| GO:BP | GO:0051046 | regulation of secretion | 380 | 415 | 4.82e-02 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 262 | 283 | 4.88e-02 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1781 | 2006 | 4.89e-02 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 63 | 64 | 4.97e-02 |
| GO:BP | GO:0051783 | regulation of nuclear division | 111 | 116 | 4.97e-02 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 1780 | 2005 | 4.99e-02 |
NRnomtable_20k %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR nESRgenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:00000 | KEGG root term | 5180 | 5802 | 8.18e-13 |
| KEGG | KEGG:05200 | Pathways in cancer | 381 | 408 | 1.38e-03 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 241 | 256 | 8.73e-03 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 143 | 149 | 1.10e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 117 | 121 | 1.21e-02 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 73 | 74 | 1.78e-02 |
| KEGG | KEGG:04115 | p53 signaling pathway | 65 | 66 | 3.81e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 155 | 164 | 3.81e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 89 | 92 | 4.15e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 119 | 125 | 4.66e-02 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 98 | 102 | 4.66e-02 |
NR peaks overlapping enhancers
# NR_resgenes_20k_enh <- gost(query = unique(NR_enh_peaks_20k$NCBI_gene),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(NR_resgenes_20k_enh,"data/GO_KEGG_analysis/NR_resgenes_20k_enh.RDS")
# NRnom <- gostplot(NR_resgenes_20k_enh, capped = FALSE, interactive = TRUE)
# NRnom
NRnomtable_20k_enh <- NR_resgenes_20k_enh$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
NRnomtable_20k_enh %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0008150 | biological_process | 5864 | 12051 | 4.01e-41 |
| GO:BP | GO:0065007 | biological regulation | 4230 | 8275 | 2.80e-37 |
| GO:BP | GO:0050789 | regulation of biological process | 4120 | 8037 | 5.06e-37 |
| GO:BP | GO:0050794 | regulation of cellular process | 3931 | 7651 | 1.42e-34 |
| GO:BP | GO:0009987 | cellular process | 5587 | 11450 | 1.41e-31 |
| GO:BP | GO:0051716 | cellular response to stimulus | 2632 | 4933 | 3.42e-30 |
| GO:BP | GO:0050896 | response to stimulus | 3012 | 5732 | 4.05e-30 |
| GO:BP | GO:0007165 | signal transduction | 2097 | 3846 | 9.96e-29 |
| GO:BP | GO:0048518 | positive regulation of biological process | 2442 | 4561 | 2.55e-28 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 2068 | 3804 | 3.41e-27 |
| GO:BP | GO:0048519 | negative regulation of biological process | 2176 | 4037 | 3.56e-26 |
| GO:BP | GO:0023052 | signaling | 2243 | 4180 | 9.19e-26 |
| GO:BP | GO:0007154 | cell communication | 2275 | 4248 | 1.26e-25 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 2243 | 4198 | 2.81e-24 |
| GO:BP | GO:0019222 | regulation of metabolic process | 2585 | 4914 | 7.27e-24 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1539 | 2780 | 7.47e-23 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 2263 | 4269 | 6.42e-22 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 2378 | 4515 | 2.26e-21 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1063 | 1852 | 3.08e-21 |
| GO:BP | GO:0042221 | response to chemical | 1358 | 2436 | 3.65e-21 |
| GO:BP | GO:0071310 | cellular response to organic substance | 813 | 1370 | 5.07e-21 |
| GO:BP | GO:0010033 | response to organic substance | 1053 | 1835 | 5.18e-21 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1416 | 2555 | 6.34e-21 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 2208 | 4170 | 6.88e-21 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1588 | 2902 | 7.33e-21 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 752 | 1256 | 8.68e-21 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1292 | 2311 | 1.19e-20 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 840 | 1430 | 4.21e-20 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 2370 | 4521 | 7.42e-20 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1284 | 2307 | 1.60e-19 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 658 | 1088 | 1.95e-19 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 1549 | 2842 | 2.71e-19 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 997 | 1746 | 6.70e-19 |
| GO:BP | GO:0032502 | developmental process | 2340 | 4475 | 1.03e-18 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1362 | 2474 | 1.44e-18 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 1155 | 2061 | 1.44e-18 |
| GO:BP | GO:0048856 | anatomical structure development | 2172 | 4130 | 1.92e-18 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 1247 | 2246 | 2.12e-18 |
| GO:BP | GO:0010468 | regulation of gene expression | 1921 | 3613 | 2.27e-18 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1162 | 2079 | 3.26e-18 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 917 | 1597 | 3.54e-18 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 1165 | 2088 | 6.15e-18 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1070 | 1900 | 6.33e-18 |
| GO:BP | GO:0030029 | actin filament-based process | 431 | 677 | 8.73e-18 |
| GO:BP | GO:0010646 | regulation of cell communication | 1419 | 2601 | 1.43e-17 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 1969 | 3724 | 1.61e-17 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 1412 | 2589 | 2.09e-17 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 1405 | 2576 | 2.52e-17 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 617 | 1027 | 2.52e-17 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1092 | 1951 | 3.02e-17 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 761 | 1304 | 3.64e-17 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 673 | 1135 | 3.64e-17 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 621 | 1036 | 3.64e-17 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 759 | 1301 | 4.52e-17 |
| GO:BP | GO:0023051 | regulation of signaling | 1413 | 2597 | 5.81e-17 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 2021 | 3841 | 6.73e-17 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 2007 | 3815 | 1.08e-16 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1653 | 3089 | 1.33e-16 |
| GO:BP | GO:1901698 | response to nitrogen compound | 479 | 774 | 1.65e-16 |
| GO:BP | GO:0006351 | DNA-templated transcription | 1452 | 2683 | 2.10e-16 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 957 | 1694 | 2.28e-16 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 447 | 716 | 2.56e-16 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 1464 | 2709 | 2.75e-16 |
| GO:BP | GO:0036211 | protein modification process | 1322 | 2423 | 3.19e-16 |
| GO:BP | GO:0048869 | cellular developmental process | 1600 | 2988 | 4.24e-16 |
| GO:BP | GO:0030154 | cell differentiation | 1599 | 2987 | 5.03e-16 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1059 | 1900 | 5.56e-16 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 974 | 1732 | 5.78e-16 |
| GO:BP | GO:0050793 | regulation of developmental process | 1008 | 1801 | 8.56e-16 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 979 | 1744 | 9.11e-16 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 716 | 1233 | 2.03e-15 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 670 | 1145 | 2.43e-15 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 381 | 601 | 2.57e-15 |
| GO:BP | GO:0008152 | metabolic process | 4177 | 8464 | 2.70e-15 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1091 | 1974 | 4.44e-15 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 505 | 833 | 4.44e-15 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 662 | 1134 | 7.60e-15 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1082 | 1959 | 7.97e-15 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 1055 | 1908 | 1.41e-14 |
| GO:BP | GO:0044238 | primary metabolic process | 3816 | 7701 | 6.77e-14 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 300 | 462 | 6.89e-14 |
| GO:BP | GO:0009725 | response to hormone | 394 | 634 | 7.09e-14 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 1654 | 3131 | 8.40e-14 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 1705 | 3238 | 1.19e-13 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 1621 | 3066 | 1.27e-13 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 323 | 506 | 1.73e-13 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 1097 | 2005 | 1.77e-13 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 1652 | 3132 | 1.80e-13 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 793 | 1403 | 2.29e-13 |
| GO:BP | GO:0071704 | organic substance metabolic process | 3992 | 8096 | 2.89e-13 |
| GO:BP | GO:0007275 | multicellular organism development | 1772 | 3383 | 3.23e-13 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 453 | 749 | 3.23e-13 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 777 | 1376 | 6.03e-13 |
| GO:BP | GO:0032501 | multicellular organismal process | 2464 | 4830 | 6.23e-13 |
| GO:BP | GO:0072359 | circulatory system development | 529 | 896 | 7.37e-13 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 291 | 452 | 8.52e-13 |
| GO:BP | GO:0043170 | macromolecule metabolic process | 3474 | 6990 | 2.06e-12 |
| GO:BP | GO:0043434 | response to peptide hormone | 218 | 324 | 2.60e-12 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1113 | 2052 | 2.60e-12 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 542 | 926 | 2.92e-12 |
| GO:BP | GO:1901652 | response to peptide | 249 | 381 | 6.25e-12 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 303 | 479 | 6.46e-12 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 884 | 1601 | 9.92e-12 |
| GO:BP | GO:0006807 | nitrogen compound metabolic process | 3646 | 7376 | 1.17e-11 |
| GO:BP | GO:0001944 | vasculature development | 353 | 573 | 1.18e-11 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 720 | 1279 | 1.55e-11 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 400 | 662 | 1.63e-11 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 1926 | 3730 | 1.63e-11 |
| GO:BP | GO:0019538 | protein metabolic process | 1982 | 3848 | 1.99e-11 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 597 | 1040 | 2.02e-11 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 446 | 752 | 3.83e-11 |
| GO:BP | GO:0043412 | macromolecule modification | 1390 | 2631 | 3.96e-11 |
| GO:BP | GO:0044237 | cellular metabolic process | 3716 | 7545 | 8.50e-11 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 295 | 472 | 1.07e-10 |
| GO:BP | GO:0007010 | cytoskeleton organization | 684 | 1218 | 1.24e-10 |
| GO:BP | GO:0051179 | localization | 2037 | 3978 | 1.42e-10 |
| GO:BP | GO:0023057 | negative regulation of signaling | 629 | 1111 | 1.48e-10 |
| GO:BP | GO:0016477 | cell migration | 612 | 1078 | 1.55e-10 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 407 | 683 | 1.59e-10 |
| GO:BP | GO:0001568 | blood vessel development | 334 | 546 | 1.81e-10 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 627 | 1109 | 2.21e-10 |
| GO:BP | GO:0009888 | tissue development | 787 | 1425 | 2.40e-10 |
| GO:BP | GO:0048513 | animal organ development | 1138 | 2130 | 2.45e-10 |
| GO:BP | GO:0007015 | actin filament organization | 244 | 381 | 2.45e-10 |
| GO:BP | GO:0048731 | system development | 1515 | 2903 | 3.60e-10 |
| GO:BP | GO:0006810 | transport | 1647 | 3176 | 3.94e-10 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1086 | 2028 | 4.13e-10 |
| GO:BP | GO:0032868 | response to insulin | 146 | 209 | 5.42e-10 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 163 | 239 | 7.34e-10 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1073 | 2006 | 8.24e-10 |
| GO:BP | GO:0009605 | response to external stimulus | 903 | 1664 | 9.11e-10 |
| GO:BP | GO:0016310 | phosphorylation | 675 | 1211 | 1.07e-09 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 916 | 1692 | 1.26e-09 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 503 | 876 | 1.51e-09 |
| GO:BP | GO:0061061 | muscle structure development | 337 | 559 | 1.76e-09 |
| GO:BP | GO:1901653 | cellular response to peptide | 187 | 284 | 2.56e-09 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 2339 | 4637 | 2.70e-09 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 371 | 626 | 3.81e-09 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 325 | 540 | 5.23e-09 |
| GO:BP | GO:0035295 | tube development | 475 | 827 | 5.26e-09 |
| GO:BP | GO:0008283 | cell population proliferation | 759 | 1386 | 5.26e-09 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 2925 | 5886 | 5.62e-09 |
| GO:BP | GO:0048468 | cell development | 1063 | 1999 | 6.30e-09 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 2897 | 5828 | 6.63e-09 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 373 | 632 | 6.77e-09 |
| GO:BP | GO:0006468 | protein phosphorylation | 567 | 1008 | 7.35e-09 |
| GO:BP | GO:0065009 | regulation of molecular function | 759 | 1389 | 8.83e-09 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 249 | 400 | 9.08e-09 |
| GO:BP | GO:0030334 | regulation of cell migration | 413 | 710 | 9.69e-09 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 238 | 380 | 9.89e-09 |
| GO:BP | GO:0002376 | immune system process | 820 | 1512 | 1.03e-08 |
| GO:BP | GO:0009058 | biosynthetic process | 2941 | 5927 | 1.09e-08 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 237 | 379 | 1.32e-08 |
| GO:BP | GO:0016043 | cellular component organization | 2569 | 5139 | 1.44e-08 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 639 | 1154 | 1.64e-08 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 202 | 316 | 1.93e-08 |
| GO:BP | GO:0051234 | establishment of localization | 1762 | 3447 | 2.06e-08 |
| GO:BP | GO:0016070 | RNA metabolic process | 1829 | 3588 | 2.42e-08 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 2574 | 5155 | 2.49e-08 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 543 | 967 | 2.52e-08 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 283 | 467 | 2.94e-08 |
| GO:BP | GO:0065008 | regulation of biological quality | 1077 | 2039 | 3.24e-08 |
| GO:BP | GO:0006915 | apoptotic process | 790 | 1459 | 3.34e-08 |
| GO:BP | GO:0007155 | cell adhesion | 561 | 1004 | 3.47e-08 |
| GO:BP | GO:0042592 | homeostatic process | 662 | 1204 | 3.63e-08 |
| GO:BP | GO:0046907 | intracellular transport | 677 | 1235 | 4.51e-08 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 632 | 1146 | 4.83e-08 |
| GO:BP | GO:0012501 | programmed cell death | 811 | 1505 | 6.24e-08 |
| GO:BP | GO:0030097 | hemopoiesis | 385 | 664 | 6.51e-08 |
| GO:BP | GO:0007507 | heart development | 307 | 515 | 6.51e-08 |
| GO:BP | GO:0006950 | response to stress | 1404 | 2715 | 6.55e-08 |
| GO:BP | GO:0048870 | cell motility | 653 | 1190 | 7.28e-08 |
| GO:BP | GO:0031399 | regulation of protein modification process | 536 | 959 | 7.91e-08 |
| GO:BP | GO:0040011 | locomotion | 484 | 858 | 9.74e-08 |
| GO:BP | GO:2000145 | regulation of cell motility | 426 | 745 | 9.74e-08 |
| GO:BP | GO:0035239 | tube morphogenesis | 386 | 668 | 1.07e-07 |
| GO:BP | GO:0008219 | cell death | 811 | 1509 | 1.15e-07 |
| GO:BP | GO:0040012 | regulation of locomotion | 436 | 766 | 1.39e-07 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 115 | 166 | 1.52e-07 |
| GO:BP | GO:0033993 | response to lipid | 350 | 601 | 1.87e-07 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 476 | 846 | 2.09e-07 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 276 | 461 | 2.41e-07 |
| GO:BP | GO:0042692 | muscle cell differentiation | 208 | 334 | 2.42e-07 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 475 | 845 | 2.53e-07 |
| GO:BP | GO:0023056 | positive regulation of signaling | 700 | 1292 | 2.96e-07 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 165 | 256 | 2.96e-07 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 249 | 411 | 3.02e-07 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 277 | 464 | 3.25e-07 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 609 | 1111 | 3.25e-07 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 697 | 1288 | 4.10e-07 |
| GO:BP | GO:0010467 | gene expression | 2372 | 4758 | 4.77e-07 |
| GO:BP | GO:0043687 | post-translational protein modification | 483 | 865 | 6.03e-07 |
| GO:BP | GO:0070848 | response to growth factor | 334 | 576 | 7.70e-07 |
| GO:BP | GO:0070647 | protein modification by small protein conjugation or removal | 459 | 820 | 9.37e-07 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 373 | 653 | 1.14e-06 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 313 | 538 | 1.39e-06 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1040 | 1992 | 1.49e-06 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 236 | 392 | 1.56e-06 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 321 | 554 | 1.61e-06 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 173 | 275 | 1.62e-06 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 554 | 1011 | 1.72e-06 |
| GO:BP | GO:0032879 | regulation of localization | 808 | 1521 | 1.75e-06 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 467 | 839 | 1.76e-06 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 521 | 946 | 1.86e-06 |
| GO:BP | GO:0060284 | regulation of cell development | 347 | 605 | 1.92e-06 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 253 | 425 | 1.97e-06 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 596 | 1096 | 2.13e-06 |
| GO:BP | GO:0001525 | angiogenesis | 238 | 397 | 2.17e-06 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 173 | 276 | 2.25e-06 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 2638 | 5340 | 2.42e-06 |
| GO:BP | GO:0051641 | cellular localization | 1426 | 2793 | 2.68e-06 |
| GO:BP | GO:0016567 | protein ubiquitination | 377 | 665 | 2.78e-06 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 154 | 242 | 2.94e-06 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 611 | 1128 | 2.94e-06 |
| GO:BP | GO:0034097 | response to cytokine | 354 | 621 | 3.25e-06 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 256 | 433 | 3.65e-06 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 216 | 358 | 4.36e-06 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 527 | 963 | 4.51e-06 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 139 | 216 | 4.72e-06 |
| GO:BP | GO:0032446 | protein modification by small protein conjugation | 416 | 744 | 4.82e-06 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 419 | 751 | 6.03e-06 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 318 | 554 | 6.06e-06 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 660 | 1231 | 6.10e-06 |
| GO:BP | GO:0009894 | regulation of catabolic process | 490 | 892 | 6.93e-06 |
| GO:BP | GO:0071396 | cellular response to lipid | 241 | 407 | 7.12e-06 |
| GO:BP | GO:0051248 | negative regulation of protein metabolic process | 369 | 654 | 7.27e-06 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 184 | 300 | 7.59e-06 |
| GO:BP | GO:0031667 | response to nutrient levels | 220 | 368 | 8.81e-06 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 234 | 395 | 1.01e-05 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 184 | 301 | 1.05e-05 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 134 | 209 | 1.05e-05 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 192 | 316 | 1.06e-05 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 258 | 441 | 1.07e-05 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 209 | 348 | 1.08e-05 |
| GO:BP | GO:0006996 | organelle organization | 1518 | 3001 | 1.46e-05 |
| GO:BP | GO:0044419 | biological process involved in interspecies interaction between organisms | 544 | 1004 | 1.46e-05 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 398 | 715 | 1.66e-05 |
| GO:BP | GO:0031400 | negative regulation of protein modification process | 208 | 348 | 1.87e-05 |
| GO:BP | GO:0031032 | actomyosin structure organization | 122 | 189 | 2.06e-05 |
| GO:BP | GO:0003012 | muscle system process | 203 | 339 | 2.11e-05 |
| GO:BP | GO:0033036 | macromolecule localization | 1252 | 2453 | 2.35e-05 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 354 | 631 | 2.66e-05 |
| GO:BP | GO:0006897 | endocytosis | 298 | 522 | 2.75e-05 |
| GO:BP | GO:0010631 | epithelial cell migration | 156 | 252 | 2.75e-05 |
| GO:BP | GO:0090132 | epithelium migration | 156 | 252 | 2.75e-05 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 373 | 669 | 3.03e-05 |
| GO:BP | GO:0060485 | mesenchyme development | 158 | 256 | 3.03e-05 |
| GO:BP | GO:0090257 | regulation of muscle system process | 117 | 181 | 3.07e-05 |
| GO:BP | GO:0000902 | cell morphogenesis | 421 | 764 | 3.20e-05 |
| GO:BP | GO:0080134 | regulation of response to stress | 539 | 999 | 3.20e-05 |
| GO:BP | GO:0033554 | cellular response to stress | 805 | 1538 | 3.72e-05 |
| GO:BP | GO:0002682 | regulation of immune system process | 507 | 936 | 3.76e-05 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 236 | 404 | 3.81e-05 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 171 | 281 | 3.85e-05 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 457 | 837 | 4.19e-05 |
| GO:BP | GO:0098657 | import into cell | 368 | 661 | 4.24e-05 |
| GO:BP | GO:0030522 | intracellular receptor signaling pathway | 167 | 274 | 4.44e-05 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 123 | 193 | 4.71e-05 |
| GO:BP | GO:0061448 | connective tissue development | 136 | 217 | 5.13e-05 |
| GO:BP | GO:0006470 | protein dephosphorylation | 119 | 186 | 5.21e-05 |
| GO:BP | GO:0090130 | tissue migration | 157 | 256 | 5.39e-05 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 95 | 143 | 5.39e-05 |
| GO:BP | GO:0016311 | dephosphorylation | 151 | 245 | 5.64e-05 |
| GO:BP | GO:0003170 | heart valve development | 50 | 66 | 5.69e-05 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 196 | 330 | 6.67e-05 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 171 | 283 | 6.97e-05 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 63 | 88 | 7.34e-05 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 2004 | 4039 | 7.46e-05 |
| GO:BP | GO:0051049 | regulation of transport | 618 | 1164 | 7.63e-05 |
| GO:BP | GO:0070936 | protein K48-linked ubiquitination | 57 | 78 | 7.71e-05 |
| GO:BP | GO:0003205 | cardiac chamber development | 99 | 151 | 7.81e-05 |
| GO:BP | GO:0003007 | heart morphogenesis | 138 | 222 | 7.91e-05 |
| GO:BP | GO:0051649 | establishment of localization in cell | 862 | 1661 | 7.91e-05 |
| GO:BP | GO:0048878 | chemical homeostasis | 390 | 708 | 8.00e-05 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 414 | 756 | 8.65e-05 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 2212 | 4481 | 9.01e-05 |
| GO:BP | GO:0006955 | immune response | 502 | 932 | 9.29e-05 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 320 | 571 | 9.32e-05 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 55 | 75 | 9.44e-05 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 443 | 815 | 1.07e-04 |
| GO:BP | GO:0060341 | regulation of cellular localization | 443 | 815 | 1.07e-04 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1092 | 2138 | 1.16e-04 |
| GO:BP | GO:0009790 | embryo development | 467 | 864 | 1.27e-04 |
| GO:BP | GO:0030323 | respiratory tube development | 100 | 154 | 1.27e-04 |
| GO:BP | GO:0014902 | myotube differentiation | 63 | 89 | 1.29e-04 |
| GO:BP | GO:0050776 | regulation of immune response | 292 | 518 | 1.32e-04 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 2265 | 4599 | 1.39e-04 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 54 | 74 | 1.46e-04 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 138 | 224 | 1.51e-04 |
| GO:BP | GO:0045444 | fat cell differentiation | 119 | 189 | 1.52e-04 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 43 | 56 | 1.55e-04 |
| GO:BP | GO:0006886 | intracellular protein transport | 342 | 617 | 1.55e-04 |
| GO:BP | GO:0055001 | muscle cell development | 108 | 169 | 1.55e-04 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 389 | 710 | 1.56e-04 |
| GO:BP | GO:0001775 | cell activation | 366 | 665 | 1.73e-04 |
| GO:BP | GO:0014896 | muscle hypertrophy | 55 | 76 | 1.76e-04 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 319 | 573 | 1.97e-04 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 2346 | 4776 | 2.03e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 227 | 394 | 2.08e-04 |
| GO:BP | GO:0008286 | insulin receptor signaling pathway | 70 | 102 | 2.10e-04 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 163 | 272 | 2.15e-04 |
| GO:BP | GO:0030324 | lung development | 97 | 150 | 2.18e-04 |
| GO:BP | GO:0008104 | protein localization | 1084 | 2128 | 2.18e-04 |
| GO:BP | GO:0010586 | miRNA metabolic process | 63 | 90 | 2.20e-04 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 265 | 468 | 2.22e-04 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 141 | 231 | 2.29e-04 |
| GO:BP | GO:0060429 | epithelium development | 451 | 836 | 2.29e-04 |
| GO:BP | GO:0051235 | maintenance of location | 157 | 261 | 2.30e-04 |
| GO:BP | GO:0007520 | myoblast fusion | 26 | 30 | 2.33e-04 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 323 | 582 | 2.37e-04 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 150 | 248 | 2.38e-04 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 54 | 75 | 2.63e-04 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 81 | 122 | 2.82e-04 |
| GO:BP | GO:0071702 | organic substance transport | 933 | 1819 | 2.86e-04 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 140 | 230 | 2.96e-04 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 433 | 802 | 3.09e-04 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 242 | 425 | 3.14e-04 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 108 | 171 | 3.14e-04 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 108 | 171 | 3.14e-04 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 178 | 302 | 3.19e-04 |
| GO:BP | GO:0009611 | response to wounding | 230 | 402 | 3.30e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 46 | 62 | 3.31e-04 |
| GO:BP | GO:0001570 | vasculogenesis | 49 | 67 | 3.32e-04 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 137 | 225 | 3.51e-04 |
| GO:BP | GO:0034101 | erythrocyte homeostasis | 79 | 119 | 3.53e-04 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 284 | 508 | 3.85e-04 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 188 | 322 | 4.00e-04 |
| GO:BP | GO:0010921 | regulation of phosphatase activity | 36 | 46 | 4.07e-04 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 18 | 19 | 4.17e-04 |
| GO:BP | GO:0009056 | catabolic process | 1052 | 2069 | 4.25e-04 |
| GO:BP | GO:0030832 | regulation of actin filament length | 81 | 123 | 4.26e-04 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 2267 | 4620 | 4.47e-04 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 317 | 574 | 4.65e-04 |
| GO:BP | GO:0048872 | homeostasis of number of cells | 145 | 241 | 4.68e-04 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 154 | 258 | 4.71e-04 |
| GO:BP | GO:0046649 | lymphocyte activation | 267 | 476 | 4.90e-04 |
| GO:BP | GO:0034641 | cellular nitrogen compound metabolic process | 2432 | 4972 | 4.97e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 297 | 535 | 4.98e-04 |
| GO:BP | GO:0002262 | myeloid cell homeostasis | 93 | 145 | 4.99e-04 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 58 | 83 | 5.01e-04 |
| GO:BP | GO:0030048 | actin filament-based movement | 74 | 111 | 5.11e-04 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 140 | 232 | 5.17e-04 |
| GO:BP | GO:0050778 | positive regulation of immune response | 235 | 414 | 5.26e-04 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 126 | 206 | 5.47e-04 |
| GO:BP | GO:0080135 | regulation of cellular response to stress | 263 | 469 | 5.68e-04 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 127 | 208 | 5.69e-04 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 63 | 92 | 5.91e-04 |
| GO:BP | GO:0009607 | response to biotic stimulus | 472 | 885 | 5.91e-04 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 342 | 625 | 5.91e-04 |
| GO:BP | GO:0003176 | aortic valve development | 30 | 37 | 5.96e-04 |
| GO:BP | GO:0032922 | circadian regulation of gene expression | 46 | 63 | 6.13e-04 |
| GO:BP | GO:0003231 | cardiac ventricle development | 76 | 115 | 6.13e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 46 | 63 | 6.13e-04 |
| GO:BP | GO:0003013 | circulatory system process | 251 | 446 | 6.13e-04 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 156 | 263 | 6.32e-04 |
| GO:BP | GO:0010720 | positive regulation of cell development | 189 | 326 | 6.32e-04 |
| GO:BP | GO:0031331 | positive regulation of cellular catabolic process | 168 | 286 | 6.63e-04 |
| GO:BP | GO:0022008 | neurogenesis | 689 | 1327 | 7.04e-04 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 73 | 110 | 7.04e-04 |
| GO:BP | GO:0034109 | homotypic cell-cell adhesion | 50 | 70 | 7.13e-04 |
| GO:BP | GO:0071383 | cellular response to steroid hormone stimulus | 105 | 168 | 7.13e-04 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 99 | 157 | 7.15e-04 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 173 | 296 | 7.37e-04 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 324 | 591 | 7.68e-04 |
| GO:BP | GO:0030218 | erythrocyte differentiation | 74 | 112 | 7.69e-04 |
| GO:BP | GO:0051707 | response to other organism | 457 | 857 | 7.83e-04 |
| GO:BP | GO:0043207 | response to external biotic stimulus | 457 | 857 | 7.83e-04 |
| GO:BP | GO:0005975 | carbohydrate metabolic process | 242 | 430 | 8.26e-04 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 110 | 178 | 9.20e-04 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 76 | 116 | 9.21e-04 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 76 | 116 | 9.21e-04 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 125 | 206 | 9.33e-04 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 162 | 276 | 9.42e-04 |
| GO:BP | GO:0060537 | muscle tissue development | 202 | 353 | 9.69e-04 |
| GO:BP | GO:0060541 | respiratory system development | 105 | 169 | 9.89e-04 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 269 | 484 | 1.01e-03 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 269 | 484 | 1.01e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 309 | 563 | 1.01e-03 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 156 | 265 | 1.04e-03 |
| GO:BP | GO:0035966 | response to topologically incorrect protein | 89 | 140 | 1.12e-03 |
| GO:BP | GO:0000302 | response to reactive oxygen species | 102 | 164 | 1.18e-03 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 161 | 275 | 1.18e-03 |
| GO:BP | GO:2000737 | negative regulation of stem cell differentiation | 21 | 24 | 1.18e-03 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 90 | 142 | 1.19e-03 |
| GO:BP | GO:1905314 | semi-lunar valve development | 32 | 41 | 1.20e-03 |
| GO:BP | GO:0035886 | vascular associated smooth muscle cell differentiation | 23 | 27 | 1.20e-03 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 23 | 27 | 1.20e-03 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 23 | 27 | 1.20e-03 |
| GO:BP | GO:0010035 | response to inorganic substance | 223 | 395 | 1.23e-03 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 110 | 179 | 1.23e-03 |
| GO:BP | GO:0070482 | response to oxygen levels | 164 | 281 | 1.23e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 328 | 602 | 1.23e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 75 | 115 | 1.24e-03 |
| GO:BP | GO:0042060 | wound healing | 178 | 308 | 1.27e-03 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 380 | 706 | 1.27e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 98 | 157 | 1.30e-03 |
| GO:BP | GO:0001666 | response to hypoxia | 146 | 247 | 1.33e-03 |
| GO:BP | GO:0030182 | neuron differentiation | 565 | 1080 | 1.33e-03 |
| GO:BP | GO:0043393 | regulation of protein binding | 76 | 117 | 1.33e-03 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 76 | 117 | 1.33e-03 |
| GO:BP | GO:0007584 | response to nutrient | 76 | 117 | 1.33e-03 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 87 | 137 | 1.37e-03 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 38 | 51 | 1.38e-03 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 82 | 128 | 1.41e-03 |
| GO:BP | GO:0040007 | growth | 396 | 739 | 1.44e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 345 | 637 | 1.45e-03 |
| GO:BP | GO:0000209 | protein polyubiquitination | 141 | 238 | 1.49e-03 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 228 | 406 | 1.53e-03 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 60 | 89 | 1.65e-03 |
| GO:BP | GO:0062197 | cellular response to chemical stress | 156 | 267 | 1.66e-03 |
| GO:BP | GO:0048568 | embryonic organ development | 182 | 317 | 1.66e-03 |
| GO:BP | GO:0002253 | activation of immune response | 182 | 317 | 1.66e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 171 | 296 | 1.75e-03 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 65 | 98 | 1.75e-03 |
| GO:BP | GO:0051169 | nuclear transport | 172 | 298 | 1.77e-03 |
| GO:BP | GO:0006913 | nucleocytoplasmic transport | 172 | 298 | 1.77e-03 |
| GO:BP | GO:0045216 | cell-cell junction organization | 98 | 158 | 1.78e-03 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 250 | 450 | 1.78e-03 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 70 | 107 | 1.79e-03 |
| GO:BP | GO:0097581 | lamellipodium organization | 53 | 77 | 1.82e-03 |
| GO:BP | GO:0052547 | regulation of peptidase activity | 113 | 186 | 1.82e-03 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 150 | 256 | 1.83e-03 |
| GO:BP | GO:0035303 | regulation of dephosphorylation | 57 | 84 | 1.83e-03 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 31 | 40 | 1.84e-03 |
| GO:BP | GO:0010608 | post-transcriptional regulation of gene expression | 264 | 478 | 1.90e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 329 | 607 | 1.91e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 82 | 129 | 2.00e-03 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 20 | 23 | 2.00e-03 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 281 | 512 | 2.03e-03 |
| GO:BP | GO:0003279 | cardiac septum development | 67 | 102 | 2.07e-03 |
| GO:BP | GO:0030866 | cortical actin cytoskeleton organization | 29 | 37 | 2.17e-03 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 29 | 37 | 2.17e-03 |
| GO:BP | GO:0140253 | cell-cell fusion | 29 | 37 | 2.17e-03 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 29 | 37 | 2.17e-03 |
| GO:BP | GO:0006325 | chromatin organization | 352 | 654 | 2.22e-03 |
| GO:BP | GO:0042594 | response to starvation | 111 | 183 | 2.24e-03 |
| GO:BP | GO:0048193 | Golgi vesicle transport | 162 | 280 | 2.30e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 55 | 81 | 2.30e-03 |
| GO:BP | GO:0098781 | ncRNA transcription | 79 | 124 | 2.34e-03 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 44 | 62 | 2.34e-03 |
| GO:BP | GO:0006338 | chromatin remodeling | 287 | 525 | 2.41e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 289 | 529 | 2.42e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 297 | 545 | 2.46e-03 |
| GO:BP | GO:0032880 | regulation of protein localization | 388 | 727 | 2.46e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 86 | 137 | 2.50e-03 |
| GO:BP | GO:0002764 | immune response-regulating signaling pathway | 168 | 292 | 2.52e-03 |
| GO:BP | GO:0060612 | adipose tissue development | 35 | 47 | 2.53e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 87 | 139 | 2.64e-03 |
| GO:BP | GO:0061013 | regulation of mRNA catabolic process | 101 | 165 | 2.71e-03 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 234 | 421 | 2.71e-03 |
| GO:BP | GO:0048511 | rhythmic process | 136 | 231 | 2.72e-03 |
| GO:BP | GO:0043500 | muscle adaptation | 61 | 92 | 2.73e-03 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 237 | 427 | 2.74e-03 |
| GO:BP | GO:0050851 | antigen receptor-mediated signaling pathway | 71 | 110 | 2.80e-03 |
| GO:BP | GO:0009267 | cellular response to starvation | 95 | 154 | 2.82e-03 |
| GO:BP | GO:0002757 | immune response-activating signaling pathway | 162 | 281 | 2.83e-03 |
| GO:BP | GO:0006949 | syncytium formation | 30 | 39 | 2.88e-03 |
| GO:BP | GO:0014706 | striated muscle tissue development | 129 | 218 | 2.93e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 83 | 132 | 2.94e-03 |
| GO:BP | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 72 | 112 | 3.00e-03 |
| GO:BP | GO:0060317 | cardiac epithelial to mesenchymal transition | 23 | 28 | 3.16e-03 |
| GO:BP | GO:0007623 | circadian rhythm | 98 | 160 | 3.21e-03 |
| GO:BP | GO:1903902 | positive regulation of viral life cycle | 17 | 19 | 3.23e-03 |
| GO:BP | GO:0043549 | regulation of kinase activity | 209 | 373 | 3.25e-03 |
| GO:BP | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 106 | 175 | 3.25e-03 |
| GO:BP | GO:0048589 | developmental growth | 287 | 527 | 3.26e-03 |
| GO:BP | GO:0001659 | temperature homeostasis | 85 | 136 | 3.26e-03 |
| GO:BP | GO:0034614 | cellular response to reactive oxygen species | 79 | 125 | 3.27e-03 |
| GO:BP | GO:0051098 | regulation of binding | 124 | 209 | 3.29e-03 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 300 | 553 | 3.30e-03 |
| GO:BP | GO:0051651 | maintenance of location in cell | 107 | 177 | 3.34e-03 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 21 | 25 | 3.35e-03 |
| GO:BP | GO:0043666 | regulation of phosphoprotein phosphatase activity | 28 | 36 | 3.39e-03 |
| GO:BP | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 100 | 164 | 3.43e-03 |
| GO:BP | GO:0032535 | regulation of cellular component size | 177 | 311 | 3.44e-03 |
| GO:BP | GO:0006986 | response to unfolded protein | 80 | 127 | 3.44e-03 |
| GO:BP | GO:0043488 | regulation of mRNA stability | 93 | 151 | 3.45e-03 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 117 | 196 | 3.47e-03 |
| GO:BP | GO:0033043 | regulation of organelle organization | 529 | 1016 | 3.60e-03 |
| GO:BP | GO:0010256 | endomembrane system organization | 273 | 500 | 3.65e-03 |
| GO:BP | GO:0042110 | T cell activation | 183 | 323 | 3.68e-03 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 60 | 91 | 3.70e-03 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 293 | 540 | 3.77e-03 |
| GO:BP | GO:0030865 | cortical cytoskeleton organization | 34 | 46 | 3.79e-03 |
| GO:BP | GO:0019725 | cellular homeostasis | 320 | 594 | 3.82e-03 |
| GO:BP | GO:0008015 | blood circulation | 209 | 374 | 3.82e-03 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 239 | 433 | 3.82e-03 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 26 | 33 | 3.94e-03 |
| GO:BP | GO:0006900 | vesicle budding from membrane | 52 | 77 | 3.97e-03 |
| GO:BP | GO:0022411 | cellular component disassembly | 250 | 455 | 3.97e-03 |
| GO:BP | GO:0019915 | lipid storage | 48 | 70 | 3.97e-03 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 48 | 70 | 3.97e-03 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 174 | 306 | 4.01e-03 |
| GO:BP | GO:0046822 | regulation of nucleocytoplasmic transport | 66 | 102 | 4.01e-03 |
| GO:BP | GO:0034504 | protein localization to nucleus | 160 | 279 | 4.11e-03 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 452 | 861 | 4.28e-03 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 67 | 104 | 4.32e-03 |
| GO:BP | GO:0035967 | cellular response to topologically incorrect protein | 62 | 95 | 4.33e-03 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 116 | 195 | 4.33e-03 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 92 | 150 | 4.41e-03 |
| GO:BP | GO:0045646 | regulation of erythrocyte differentiation | 29 | 38 | 4.41e-03 |
| GO:BP | GO:0044409 | symbiont entry into host | 73 | 115 | 4.44e-03 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 49 | 72 | 4.44e-03 |
| GO:BP | GO:0030042 | actin filament depolymerization | 35 | 48 | 4.59e-03 |
| GO:BP | GO:1901575 | organic substance catabolic process | 845 | 1669 | 4.79e-03 |
| GO:BP | GO:0007267 | cell-cell signaling | 596 | 1156 | 4.90e-03 |
| GO:BP | GO:0016032 | viral process | 195 | 348 | 4.93e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 46 | 67 | 5.01e-03 |
| GO:BP | GO:0009755 | hormone-mediated signaling pathway | 88 | 143 | 5.04e-03 |
| GO:BP | GO:0072538 | T-helper 17 type immune response | 22 | 27 | 5.10e-03 |
| GO:BP | GO:0043086 | negative regulation of catalytic activity | 180 | 319 | 5.22e-03 |
| GO:BP | GO:0043244 | regulation of protein-containing complex disassembly | 70 | 110 | 5.26e-03 |
| GO:BP | GO:0075294 | positive regulation by symbiont of entry into host | 11 | 11 | 5.35e-03 |
| GO:BP | GO:0046598 | positive regulation of viral entry into host cell | 11 | 11 | 5.35e-03 |
| GO:BP | GO:0048732 | gland development | 183 | 325 | 5.35e-03 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 65 | 101 | 5.39e-03 |
| GO:BP | GO:0051261 | protein depolymerization | 65 | 101 | 5.39e-03 |
| GO:BP | GO:0051338 | regulation of transferase activity | 255 | 467 | 5.51e-03 |
| GO:BP | GO:0030903 | notochord development | 16 | 18 | 5.57e-03 |
| GO:BP | GO:0010952 | positive regulation of peptidase activity | 71 | 112 | 5.57e-03 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 47 | 69 | 5.60e-03 |
| GO:BP | GO:0038066 | p38MAPK cascade | 33 | 45 | 5.66e-03 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 131 | 225 | 6.13e-03 |
| GO:BP | GO:0007517 | muscle organ development | 160 | 281 | 6.23e-03 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 241 | 440 | 6.24e-03 |
| GO:BP | GO:1900744 | regulation of p38MAPK cascade | 25 | 32 | 6.25e-03 |
| GO:BP | GO:0001501 | skeletal system development | 205 | 369 | 6.29e-03 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 44 | 64 | 6.29e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 147 | 256 | 6.41e-03 |
| GO:BP | GO:0006952 | defense response | 512 | 987 | 6.52e-03 |
| GO:BP | GO:0071219 | cellular response to molecule of bacterial origin | 74 | 118 | 6.61e-03 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 53 | 80 | 6.71e-03 |
| GO:BP | GO:0048699 | generation of neurons | 589 | 1145 | 6.76e-03 |
| GO:BP | GO:0044057 | regulation of system process | 220 | 399 | 6.76e-03 |
| GO:BP | GO:0002520 | immune system development | 88 | 144 | 6.76e-03 |
| GO:BP | GO:0036294 | cellular response to decreased oxygen levels | 81 | 131 | 6.76e-03 |
| GO:BP | GO:0030032 | lamellipodium assembly | 41 | 59 | 6.93e-03 |
| GO:BP | GO:0015031 | protein transport | 621 | 1211 | 6.93e-03 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 226 | 411 | 6.93e-03 |
| GO:BP | GO:0046718 | symbiont entry into host cell | 69 | 109 | 6.93e-03 |
| GO:BP | GO:0071705 | nitrogen compound transport | 780 | 1539 | 6.93e-03 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 89 | 146 | 6.95e-03 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 140 | 243 | 7.05e-03 |
| GO:BP | GO:0009057 | macromolecule catabolic process | 598 | 1164 | 7.05e-03 |
| GO:BP | GO:0098542 | defense response to other organism | 347 | 653 | 7.12e-03 |
| GO:BP | GO:0043542 | endothelial cell migration | 108 | 182 | 7.42e-03 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 210 | 380 | 7.62e-03 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 65 | 102 | 7.64e-03 |
| GO:BP | GO:0052548 | regulation of endopeptidase activity | 100 | 167 | 7.64e-03 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 84 | 137 | 7.64e-03 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 65 | 102 | 7.64e-03 |
| GO:BP | GO:1901879 | regulation of protein depolymerization | 50 | 75 | 7.64e-03 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 42 | 61 | 7.82e-03 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 42 | 61 | 7.82e-03 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 35 | 49 | 8.07e-03 |
| GO:BP | GO:0032386 | regulation of intracellular transport | 135 | 234 | 8.08e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 150 | 263 | 8.10e-03 |
| GO:BP | GO:0030217 | T cell differentiation | 112 | 190 | 8.14e-03 |
| GO:BP | GO:0034332 | adherens junction organization | 32 | 44 | 8.44e-03 |
| GO:BP | GO:1901203 | positive regulation of extracellular matrix assembly | 13 | 14 | 8.44e-03 |
| GO:BP | GO:0003008 | system process | 615 | 1201 | 8.54e-03 |
| GO:BP | GO:0048729 | tissue morphogenesis | 259 | 478 | 8.62e-03 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 80 | 130 | 8.67e-03 |
| GO:BP | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 47 | 70 | 8.67e-03 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 105 | 177 | 8.75e-03 |
| GO:BP | GO:0030041 | actin filament polymerization | 81 | 132 | 9.05e-03 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 68 | 108 | 9.12e-03 |
| GO:BP | GO:0090077 | foam cell differentiation | 19 | 23 | 9.16e-03 |
| GO:BP | GO:0010742 | macrophage derived foam cell differentiation | 19 | 23 | 9.16e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 130 | 225 | 9.22e-03 |
| GO:BP | GO:0071824 | protein-DNA complex organization | 387 | 736 | 9.22e-03 |
| GO:BP | GO:0005996 | monosaccharide metabolic process | 118 | 202 | 9.24e-03 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 472 | 909 | 9.36e-03 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 63 | 99 | 9.52e-03 |
| GO:BP | GO:0001701 | in utero embryonic development | 192 | 346 | 9.61e-03 |
| GO:BP | GO:0019318 | hexose metabolic process | 109 | 185 | 9.61e-03 |
| GO:BP | GO:0045859 | regulation of protein kinase activity | 192 | 346 | 9.61e-03 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 15 | 17 | 9.62e-03 |
| GO:BP | GO:0071474 | cellular hyperosmotic response | 15 | 17 | 9.62e-03 |
| GO:BP | GO:0034655 | nucleobase-containing compound catabolic process | 242 | 445 | 9.64e-03 |
| GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 17 | 20 | 9.64e-03 |
| GO:BP | GO:0070935 | 3’-UTR-mediated mRNA stabilization | 17 | 20 | 9.64e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 83 | 136 | 9.64e-03 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 40 | 58 | 9.69e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 33 | 46 | 9.90e-03 |
| GO:BP | GO:0046777 | protein autophosphorylation | 92 | 153 | 9.99e-03 |
| GO:BP | GO:0033673 | negative regulation of kinase activity | 84 | 138 | 1.00e-02 |
| GO:BP | GO:2000479 | regulation of cAMP-dependent protein kinase activity | 10 | 10 | 1.00e-02 |
| GO:BP | GO:0071320 | cellular response to cAMP | 27 | 36 | 1.02e-02 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 59 | 92 | 1.04e-02 |
| GO:BP | GO:0051258 | protein polymerization | 139 | 243 | 1.04e-02 |
| GO:BP | GO:0007009 | plasma membrane organization | 71 | 114 | 1.05e-02 |
| GO:BP | GO:0007249 | canonical NF-kappaB signal transduction | 140 | 245 | 1.05e-02 |
| GO:BP | GO:0048545 | response to steroid hormone | 140 | 245 | 1.05e-02 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 37 | 53 | 1.07e-02 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 79 | 129 | 1.10e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 286 | 534 | 1.12e-02 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 284 | 530 | 1.12e-02 |
| GO:BP | GO:0060840 | artery development | 55 | 85 | 1.13e-02 |
| GO:BP | GO:0003171 | atrioventricular valve development | 22 | 28 | 1.13e-02 |
| GO:BP | GO:0097190 | apoptotic signaling pathway | 269 | 500 | 1.13e-02 |
| GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 80 | 131 | 1.14e-02 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 34 | 48 | 1.16e-02 |
| GO:BP | GO:0003158 | endothelium development | 67 | 107 | 1.18e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 46 | 69 | 1.18e-02 |
| GO:BP | GO:0007369 | gastrulation | 89 | 148 | 1.18e-02 |
| GO:BP | GO:0043242 | negative regulation of protein-containing complex disassembly | 46 | 69 | 1.18e-02 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 134 | 234 | 1.19e-02 |
| GO:BP | GO:0006936 | muscle contraction | 151 | 267 | 1.19e-02 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 56 | 87 | 1.21e-02 |
| GO:BP | GO:0072089 | stem cell proliferation | 56 | 87 | 1.21e-02 |
| GO:BP | GO:0048524 | positive regulation of viral process | 38 | 55 | 1.21e-02 |
| GO:BP | GO:0035304 | regulation of protein dephosphorylation | 42 | 62 | 1.21e-02 |
| GO:BP | GO:0030834 | regulation of actin filament depolymerization | 31 | 43 | 1.22e-02 |
| GO:BP | GO:0043933 | protein-containing complex organization | 998 | 2000 | 1.22e-02 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 68 | 109 | 1.22e-02 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 100 | 169 | 1.23e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 75 | 122 | 1.23e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 75 | 122 | 1.23e-02 |
| GO:BP | GO:0006979 | response to oxidative stress | 182 | 328 | 1.25e-02 |
| GO:BP | GO:0042113 | B cell activation | 101 | 171 | 1.26e-02 |
| GO:BP | GO:1903828 | negative regulation of protein localization | 101 | 171 | 1.26e-02 |
| GO:BP | GO:0019058 | viral life cycle | 140 | 246 | 1.27e-02 |
| GO:BP | GO:0048534 | hematopoietic or lymphoid organ development | 47 | 71 | 1.28e-02 |
| GO:BP | GO:0071456 | cellular response to hypoxia | 76 | 124 | 1.28e-02 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 126 | 219 | 1.29e-02 |
| GO:BP | GO:1903580 | positive regulation of ATP metabolic process | 20 | 25 | 1.29e-02 |
| GO:BP | GO:0007399 | nervous system development | 951 | 1903 | 1.30e-02 |
| GO:BP | GO:0040029 | epigenetic regulation of gene expression | 103 | 175 | 1.31e-02 |
| GO:BP | GO:0048863 | stem cell differentiation | 115 | 198 | 1.33e-02 |
| GO:BP | GO:0001889 | liver development | 70 | 113 | 1.33e-02 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 167 | 299 | 1.34e-02 |
| GO:BP | GO:0032984 | protein-containing complex disassembly | 129 | 225 | 1.34e-02 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 39 | 57 | 1.34e-02 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 105 | 179 | 1.37e-02 |
| GO:BP | GO:0032103 | positive regulation of response to external stimulus | 207 | 378 | 1.37e-02 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 207 | 378 | 1.37e-02 |
| GO:BP | GO:0043401 | steroid hormone mediated signaling pathway | 71 | 115 | 1.39e-02 |
| GO:BP | GO:0051090 | regulation of DNA-binding transcription factor activity | 150 | 266 | 1.40e-02 |
| GO:BP | GO:0016050 | vesicle organization | 176 | 317 | 1.41e-02 |
| GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 32 | 45 | 1.41e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 134 | 235 | 1.42e-02 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 72 | 117 | 1.45e-02 |
| GO:BP | GO:0046700 | heterocycle catabolic process | 253 | 470 | 1.45e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 252 | 468 | 1.45e-02 |
| GO:BP | GO:0060914 | heart formation | 23 | 30 | 1.46e-02 |
| GO:BP | GO:0003174 | mitral valve development | 12 | 13 | 1.46e-02 |
| GO:BP | GO:0048385 | regulation of retinoic acid receptor signaling pathway | 12 | 13 | 1.46e-02 |
| GO:BP | GO:0060841 | venous blood vessel development | 12 | 13 | 1.46e-02 |
| GO:BP | GO:0070527 | platelet aggregation | 36 | 52 | 1.48e-02 |
| GO:BP | GO:0043124 | negative regulation of canonical NF-kappaB signal transduction | 29 | 40 | 1.48e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 49 | 75 | 1.48e-02 |
| GO:BP | GO:0071229 | cellular response to acid chemical | 49 | 75 | 1.48e-02 |
| GO:BP | GO:0001101 | response to acid chemical | 66 | 106 | 1.48e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 36 | 52 | 1.48e-02 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 66 | 106 | 1.48e-02 |
| GO:BP | GO:0034599 | cellular response to oxidative stress | 123 | 214 | 1.49e-02 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 60 | 95 | 1.49e-02 |
| GO:BP | GO:0043149 | stress fiber assembly | 60 | 95 | 1.49e-02 |
| GO:BP | GO:0030835 | negative regulation of actin filament depolymerization | 26 | 35 | 1.49e-02 |
| GO:BP | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 124 | 216 | 1.50e-02 |
| GO:BP | GO:0006006 | glucose metabolic process | 90 | 151 | 1.52e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 74 | 121 | 1.55e-02 |
| GO:BP | GO:0034976 | response to endoplasmic reticulum stress | 113 | 195 | 1.57e-02 |
| GO:BP | GO:0006402 | mRNA catabolic process | 127 | 222 | 1.57e-02 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 61 | 97 | 1.58e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 33 | 47 | 1.62e-02 |
| GO:BP | GO:1901880 | negative regulation of protein depolymerization | 41 | 61 | 1.64e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 93 | 157 | 1.65e-02 |
| GO:BP | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 76 | 125 | 1.67e-02 |
| GO:BP | GO:0071900 | regulation of protein serine/threonine kinase activity | 117 | 203 | 1.68e-02 |
| GO:BP | GO:0097193 | intrinsic apoptotic signaling pathway | 152 | 271 | 1.68e-02 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 360 | 687 | 1.68e-02 |
| GO:BP | GO:0006816 | calcium ion transport | 152 | 271 | 1.68e-02 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 51 | 79 | 1.71e-02 |
| GO:BP | GO:0002831 | regulation of response to biotic stimulus | 184 | 334 | 1.71e-02 |
| GO:BP | GO:1900544 | positive regulation of purine nucleotide metabolic process | 21 | 27 | 1.71e-02 |
| GO:BP | GO:0045981 | positive regulation of nucleotide metabolic process | 21 | 27 | 1.71e-02 |
| GO:BP | GO:0009166 | nucleotide catabolic process | 86 | 144 | 1.74e-02 |
| GO:BP | GO:0030100 | regulation of endocytosis | 120 | 209 | 1.74e-02 |
| GO:BP | GO:0006606 | protein import into nucleus | 86 | 144 | 1.74e-02 |
| GO:BP | GO:0071453 | cellular response to oxygen levels | 86 | 144 | 1.74e-02 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 57 | 90 | 1.75e-02 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 57 | 90 | 1.75e-02 |
| GO:BP | GO:0071222 | cellular response to lipopolysaccharide | 70 | 114 | 1.75e-02 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 78 | 129 | 1.77e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 78 | 129 | 1.77e-02 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 108 | 186 | 1.77e-02 |
| GO:BP | GO:0035107 | appendage morphogenesis | 71 | 116 | 1.81e-02 |
| GO:BP | GO:0035108 | limb morphogenesis | 71 | 116 | 1.81e-02 |
| GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 24 | 32 | 1.81e-02 |
| GO:BP | GO:0010950 | positive regulation of endopeptidase activity | 64 | 103 | 1.81e-02 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 623 | 1227 | 1.82e-02 |
| GO:BP | GO:0048845 | venous blood vessel morphogenesis | 9 | 9 | 1.82e-02 |
| GO:BP | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death | 9 | 9 | 1.82e-02 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 110 | 190 | 1.82e-02 |
| GO:BP | GO:0060397 | growth hormone receptor signaling pathway via JAK-STAT | 9 | 9 | 1.82e-02 |
| GO:BP | GO:0046323 | glucose import | 38 | 56 | 1.82e-02 |
| GO:BP | GO:0031099 | regeneration | 88 | 148 | 1.82e-02 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 38 | 56 | 1.82e-02 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 65 | 105 | 1.89e-02 |
| GO:BP | GO:0051701 | biological process involved in interaction with host | 91 | 154 | 1.98e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 507 | 989 | 1.98e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 66 | 107 | 1.98e-02 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 19 | 24 | 1.99e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 92 | 156 | 2.02e-02 |
| GO:BP | GO:0006611 | protein export from nucleus | 39 | 58 | 2.03e-02 |
| GO:BP | GO:0042306 | regulation of protein import into nucleus | 35 | 51 | 2.06e-02 |
| GO:BP | GO:0045814 | negative regulation of gene expression, epigenetic | 67 | 109 | 2.06e-02 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 199 | 365 | 2.06e-02 |
| GO:BP | GO:0007409 | axonogenesis | 198 | 363 | 2.06e-02 |
| GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 203 | 373 | 2.07e-02 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 212 | 391 | 2.10e-02 |
| GO:BP | GO:0019439 | aromatic compound catabolic process | 255 | 477 | 2.10e-02 |
| GO:BP | GO:0071216 | cellular response to biotic stimulus | 84 | 141 | 2.10e-02 |
| GO:BP | GO:0044270 | cellular nitrogen compound catabolic process | 250 | 467 | 2.10e-02 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 44 | 67 | 2.10e-02 |
| GO:BP | GO:0003015 | heart process | 120 | 210 | 2.11e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 28 | 39 | 2.12e-02 |
| GO:BP | GO:0061014 | positive regulation of mRNA catabolic process | 61 | 98 | 2.12e-02 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 121 | 212 | 2.13e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 76 | 126 | 2.14e-02 |
| GO:BP | GO:1903313 | positive regulation of mRNA metabolic process | 76 | 126 | 2.14e-02 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 85 | 143 | 2.14e-02 |
| GO:BP | GO:1904385 | cellular response to angiotensin | 22 | 29 | 2.17e-02 |
| GO:BP | GO:0072331 | signal transduction by p53 class mediator | 96 | 164 | 2.18e-02 |
| GO:BP | GO:0003230 | cardiac atrium development | 25 | 34 | 2.20e-02 |
| GO:BP | GO:0006909 | phagocytosis | 86 | 145 | 2.20e-02 |
| GO:BP | GO:0048708 | astrocyte differentiation | 40 | 60 | 2.21e-02 |
| GO:BP | GO:1903311 | regulation of mRNA metabolic process | 145 | 259 | 2.22e-02 |
| GO:BP | GO:0001503 | ossification | 177 | 322 | 2.23e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 32 | 46 | 2.26e-02 |
| GO:BP | GO:0050852 | T cell receptor signaling pathway | 56 | 89 | 2.26e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 17 | 21 | 2.26e-02 |
| GO:BP | GO:0048710 | regulation of astrocyte differentiation | 17 | 21 | 2.26e-02 |
| GO:BP | GO:0044403 | biological process involved in symbiotic interaction | 127 | 224 | 2.26e-02 |
| GO:BP | GO:0006469 | negative regulation of protein kinase activity | 78 | 130 | 2.26e-02 |
| GO:BP | GO:0001783 | B cell apoptotic process | 17 | 21 | 2.26e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 36 | 53 | 2.26e-02 |
| GO:BP | GO:0061008 | hepaticobiliary system development | 70 | 115 | 2.27e-02 |
| GO:BP | GO:0051170 | import into nucleus | 88 | 149 | 2.29e-02 |
| GO:BP | GO:1901292 | nucleoside phosphate catabolic process | 88 | 149 | 2.29e-02 |
| GO:BP | GO:0030518 | intracellular steroid hormone receptor signaling pathway | 63 | 102 | 2.29e-02 |
| GO:BP | GO:0031347 | regulation of defense response | 261 | 490 | 2.33e-02 |
| GO:BP | GO:1901654 | response to ketone | 89 | 151 | 2.34e-02 |
| GO:BP | GO:0048041 | focal adhesion assembly | 51 | 80 | 2.35e-02 |
| GO:BP | GO:1904018 | positive regulation of vasculature development | 71 | 117 | 2.35e-02 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 57 | 91 | 2.35e-02 |
| GO:BP | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 204 | 376 | 2.35e-02 |
| GO:BP | GO:0051216 | cartilage development | 90 | 153 | 2.39e-02 |
| GO:BP | GO:0019221 | cytokine-mediated signaling pathway | 160 | 289 | 2.41e-02 |
| GO:BP | GO:0045184 | establishment of protein localization | 736 | 1465 | 2.42e-02 |
| GO:BP | GO:0043632 | modification-dependent macromolecule catabolic process | 299 | 567 | 2.43e-02 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 117 | 205 | 2.43e-02 |
| GO:BP | GO:0031396 | regulation of protein ubiquitination | 103 | 178 | 2.44e-02 |
| GO:BP | GO:0030030 | cell projection organization | 638 | 1262 | 2.45e-02 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 37 | 55 | 2.49e-02 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 37 | 55 | 2.49e-02 |
| GO:BP | GO:0060396 | growth hormone receptor signaling pathway | 15 | 18 | 2.49e-02 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 73 | 121 | 2.49e-02 |
| GO:BP | GO:0003183 | mitral valve morphogenesis | 11 | 12 | 2.49e-02 |
| GO:BP | GO:0042149 | cellular response to glucose starvation | 33 | 48 | 2.51e-02 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 33 | 48 | 2.51e-02 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 93 | 159 | 2.53e-02 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 142 | 254 | 2.55e-02 |
| GO:BP | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 20 | 26 | 2.55e-02 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 20 | 26 | 2.55e-02 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 273 | 515 | 2.55e-02 |
| GO:BP | GO:0045616 | regulation of keratinocyte differentiation | 20 | 26 | 2.55e-02 |
| GO:BP | GO:0006109 | regulation of carbohydrate metabolic process | 83 | 140 | 2.55e-02 |
| GO:BP | GO:0061024 | membrane organization | 349 | 669 | 2.56e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 94 | 161 | 2.56e-02 |
| GO:BP | GO:0006417 | regulation of translation | 183 | 335 | 2.59e-02 |
| GO:BP | GO:0034620 | cellular response to unfolded protein | 53 | 84 | 2.60e-02 |
| GO:BP | GO:0060428 | lung epithelium development | 23 | 31 | 2.61e-02 |
| GO:BP | GO:1990776 | response to angiotensin | 23 | 31 | 2.61e-02 |
| GO:BP | GO:0071772 | response to BMP | 75 | 125 | 2.61e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 75 | 125 | 2.61e-02 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 23 | 31 | 2.61e-02 |
| GO:BP | GO:0043487 | regulation of RNA stability | 95 | 163 | 2.61e-02 |
| GO:BP | GO:0035305 | negative regulation of dephosphorylation | 23 | 31 | 2.61e-02 |
| GO:BP | GO:0034389 | lipid droplet organization | 23 | 31 | 2.61e-02 |
| GO:BP | GO:1900180 | regulation of protein localization to nucleus | 75 | 125 | 2.61e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 48 | 75 | 2.70e-02 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 296 | 562 | 2.70e-02 |
| GO:BP | GO:0031175 | neuron projection development | 410 | 794 | 2.70e-02 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 111 | 194 | 2.70e-02 |
| GO:BP | GO:0042542 | response to hydrogen peroxide | 54 | 86 | 2.72e-02 |
| GO:BP | GO:0007492 | endoderm development | 43 | 66 | 2.75e-02 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 34 | 50 | 2.77e-02 |
| GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 34 | 50 | 2.77e-02 |
| GO:BP | GO:0060047 | heart contraction | 114 | 200 | 2.81e-02 |
| GO:BP | GO:0030163 | protein catabolic process | 440 | 856 | 2.85e-02 |
| GO:BP | GO:0140546 | defense response to symbiont | 315 | 601 | 2.85e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 135 | 241 | 2.85e-02 |
| GO:BP | GO:0051051 | negative regulation of transport | 168 | 306 | 2.87e-02 |
| GO:BP | GO:1901361 | organic cyclic compound catabolic process | 262 | 494 | 2.92e-02 |
| GO:BP | GO:1901342 | regulation of vasculature development | 118 | 208 | 2.94e-02 |
| GO:BP | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 27 | 38 | 3.00e-02 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 63 | 103 | 3.01e-02 |
| GO:BP | GO:0045445 | myoblast differentiation | 56 | 90 | 3.01e-02 |
| GO:BP | GO:0035767 | endothelial cell chemotaxis | 18 | 23 | 3.02e-02 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 50 | 79 | 3.04e-02 |
| GO:BP | GO:0061564 | axon development | 216 | 402 | 3.07e-02 |
| GO:BP | GO:0034248 | regulation of amide metabolic process | 210 | 390 | 3.07e-02 |
| GO:BP | GO:0035904 | aorta development | 35 | 52 | 3.08e-02 |
| GO:BP | GO:0009261 | ribonucleotide catabolic process | 72 | 120 | 3.09e-02 |
| GO:BP | GO:0016052 | carbohydrate catabolic process | 72 | 120 | 3.09e-02 |
| GO:BP | GO:0045665 | negative regulation of neuron differentiation | 31 | 45 | 3.11e-02 |
| GO:BP | GO:1903320 | regulation of protein modification by small protein conjugation or removal | 124 | 220 | 3.11e-02 |
| GO:BP | GO:0030168 | platelet activation | 57 | 92 | 3.14e-02 |
| GO:BP | GO:0014013 | regulation of gliogenesis | 45 | 70 | 3.15e-02 |
| GO:BP | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 24 | 33 | 3.15e-02 |
| GO:BP | GO:0033627 | cell adhesion mediated by integrin | 40 | 61 | 3.18e-02 |
| GO:BP | GO:0051147 | regulation of muscle cell differentiation | 73 | 122 | 3.18e-02 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 21 | 28 | 3.19e-02 |
| GO:BP | GO:0015918 | sterol transport | 58 | 94 | 3.28e-02 |
| GO:BP | GO:0098876 | vesicle-mediated transport to the plasma membrane | 84 | 143 | 3.28e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 111 | 195 | 3.29e-02 |
| GO:BP | GO:0060896 | neural plate pattern specification | 8 | 8 | 3.31e-02 |
| GO:BP | GO:0003211 | cardiac ventricle formation | 8 | 8 | 3.31e-02 |
| GO:BP | GO:1902306 | negative regulation of sodium ion transmembrane transport | 8 | 8 | 3.31e-02 |
| GO:BP | GO:1905064 | negative regulation of vascular associated smooth muscle cell differentiation | 8 | 8 | 3.31e-02 |
| GO:BP | GO:0009415 | response to water | 8 | 8 | 3.31e-02 |
| GO:BP | GO:0060509 | type I pneumocyte differentiation | 8 | 8 | 3.31e-02 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 46 | 72 | 3.34e-02 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 46 | 72 | 3.34e-02 |
| GO:BP | GO:0050792 | regulation of viral process | 75 | 126 | 3.34e-02 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 52 | 83 | 3.35e-02 |
| GO:BP | GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 36 | 54 | 3.35e-02 |
| GO:BP | GO:0019941 | modification-dependent protein catabolic process | 292 | 556 | 3.39e-02 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 41 | 63 | 3.39e-02 |
| GO:BP | GO:0048013 | ephrin receptor signaling pathway | 28 | 40 | 3.39e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 41 | 63 | 3.39e-02 |
| GO:BP | GO:0034766 | negative regulation of monoatomic ion transmembrane transport | 41 | 63 | 3.39e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 28 | 40 | 3.39e-02 |
| GO:BP | GO:0085029 | extracellular matrix assembly | 28 | 40 | 3.39e-02 |
| GO:BP | GO:0072523 | purine-containing compound catabolic process | 76 | 128 | 3.40e-02 |
| GO:BP | GO:0031929 | TOR signaling | 87 | 149 | 3.44e-02 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 345 | 664 | 3.48e-02 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 146 | 264 | 3.58e-02 |
| GO:BP | GO:0009154 | purine ribonucleotide catabolic process | 69 | 115 | 3.63e-02 |
| GO:BP | GO:0002285 | lymphocyte activation involved in immune response | 69 | 115 | 3.63e-02 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 69 | 115 | 3.63e-02 |
| GO:BP | GO:1904063 | negative regulation of cation transmembrane transport | 37 | 56 | 3.64e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 37 | 56 | 3.64e-02 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 90 | 155 | 3.64e-02 |
| GO:BP | GO:0061337 | cardiac conduction | 54 | 87 | 3.67e-02 |
| GO:BP | GO:0048666 | neuron development | 457 | 894 | 3.71e-02 |
| GO:BP | GO:0030509 | BMP signaling pathway | 70 | 117 | 3.74e-02 |
| GO:BP | GO:0010498 | proteasomal protein catabolic process | 245 | 462 | 3.79e-02 |
| GO:BP | GO:0019216 | regulation of lipid metabolic process | 127 | 227 | 3.79e-02 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 55 | 89 | 3.85e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 169 | 310 | 3.85e-02 |
| GO:BP | GO:0010573 | vascular endothelial growth factor production | 19 | 25 | 3.85e-02 |
| GO:BP | GO:0048286 | lung alveolus development | 29 | 42 | 3.85e-02 |
| GO:BP | GO:0034110 | regulation of homotypic cell-cell adhesion | 19 | 25 | 3.85e-02 |
| GO:BP | GO:0035994 | response to muscle stretch | 19 | 25 | 3.85e-02 |
| GO:BP | GO:0050873 | brown fat cell differentiation | 29 | 42 | 3.85e-02 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 173 | 318 | 3.88e-02 |
| GO:BP | GO:0060326 | cell chemotaxis | 94 | 163 | 3.88e-02 |
| GO:BP | GO:0030239 | myofibril assembly | 43 | 67 | 3.88e-02 |
| GO:BP | GO:1904892 | regulation of receptor signaling pathway via STAT | 38 | 58 | 3.92e-02 |
| GO:BP | GO:0048844 | artery morphogenesis | 38 | 58 | 3.92e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 38 | 58 | 3.92e-02 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 38 | 58 | 3.92e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 197 | 366 | 3.92e-02 |
| GO:BP | GO:0038095 | Fc-epsilon receptor signaling pathway | 14 | 17 | 3.92e-02 |
| GO:BP | GO:0010922 | positive regulation of phosphatase activity | 14 | 17 | 3.92e-02 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 14 | 17 | 3.92e-02 |
| GO:BP | GO:0072539 | T-helper 17 cell differentiation | 14 | 17 | 3.92e-02 |
| GO:BP | GO:0072111 | cell proliferation involved in kidney development | 14 | 17 | 3.92e-02 |
| GO:BP | GO:0060977 | coronary vasculature morphogenesis | 14 | 17 | 3.92e-02 |
| GO:BP | GO:0010649 | regulation of cell communication by electrical coupling | 14 | 17 | 3.92e-02 |
| GO:BP | GO:0051960 | regulation of nervous system development | 193 | 358 | 3.92e-02 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 56 | 91 | 3.94e-02 |
| GO:BP | GO:0006195 | purine nucleotide catabolic process | 73 | 123 | 3.99e-02 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 115 | 204 | 4.05e-02 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 44 | 69 | 4.10e-02 |
| GO:BP | GO:0061157 | mRNA destabilization | 57 | 93 | 4.11e-02 |
| GO:BP | GO:0042752 | regulation of circadian rhythm | 57 | 93 | 4.11e-02 |
| GO:BP | GO:0001508 | action potential | 65 | 108 | 4.11e-02 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 34 | 51 | 4.12e-02 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 34 | 51 | 4.12e-02 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 34 | 51 | 4.12e-02 |
| GO:BP | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 34 | 51 | 4.12e-02 |
| GO:BP | GO:0006513 | protein monoubiquitination | 34 | 51 | 4.12e-02 |
| GO:BP | GO:0042330 | taxis | 146 | 265 | 4.12e-02 |
| GO:BP | GO:0006935 | chemotaxis | 146 | 265 | 4.12e-02 |
| GO:BP | GO:0006511 | ubiquitin-dependent protein catabolic process | 286 | 546 | 4.20e-02 |
| GO:BP | GO:0090085 | regulation of protein deubiquitination | 10 | 11 | 4.20e-02 |
| GO:BP | GO:1904177 | regulation of adipose tissue development | 10 | 11 | 4.20e-02 |
| GO:BP | GO:0032688 | negative regulation of interferon-beta production | 10 | 11 | 4.20e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 30 | 44 | 4.21e-02 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 121 | 216 | 4.21e-02 |
| GO:BP | GO:0072234 | metanephric nephron tubule development | 12 | 14 | 4.21e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 30 | 44 | 4.21e-02 |
| GO:BP | GO:1905063 | regulation of vascular associated smooth muscle cell differentiation | 12 | 14 | 4.21e-02 |
| GO:BP | GO:0048009 | insulin-like growth factor receptor signaling pathway | 30 | 44 | 4.21e-02 |
| GO:BP | GO:1903729 | regulation of plasma membrane organization | 12 | 14 | 4.21e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 30 | 44 | 4.21e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 30 | 44 | 4.21e-02 |
| GO:BP | GO:0030968 | endoplasmic reticulum unfolded protein response | 45 | 71 | 4.28e-02 |
| GO:BP | GO:0016051 | carbohydrate biosynthetic process | 89 | 154 | 4.33e-02 |
| GO:BP | GO:0007599 | hemostasis | 90 | 156 | 4.41e-02 |
| GO:BP | GO:0046434 | organophosphate catabolic process | 106 | 187 | 4.42e-02 |
| GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 78 | 133 | 4.42e-02 |
| GO:BP | GO:1905039 | carboxylic acid transmembrane transport | 68 | 114 | 4.44e-02 |
| GO:BP | GO:0032092 | positive regulation of protein binding | 35 | 53 | 4.45e-02 |
| GO:BP | GO:0061035 | regulation of cartilage development | 35 | 53 | 4.45e-02 |
| GO:BP | GO:0048645 | animal organ formation | 35 | 53 | 4.45e-02 |
| GO:BP | GO:0050853 | B cell receptor signaling pathway | 23 | 32 | 4.46e-02 |
| GO:BP | GO:0051693 | actin filament capping | 23 | 32 | 4.46e-02 |
| GO:BP | GO:0043010 | camera-type eye development | 131 | 236 | 4.48e-02 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 108 | 191 | 4.49e-02 |
| GO:BP | GO:0003177 | pulmonary valve development | 17 | 22 | 4.51e-02 |
| GO:BP | GO:1901186 | positive regulation of ERBB signaling pathway | 17 | 22 | 4.51e-02 |
| GO:BP | GO:1900745 | positive regulation of p38MAPK cascade | 17 | 22 | 4.51e-02 |
| GO:BP | GO:0051224 | negative regulation of protein transport | 53 | 86 | 4.60e-02 |
| GO:BP | GO:0035909 | aorta morphogenesis | 20 | 27 | 4.63e-02 |
| GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 20 | 27 | 4.63e-02 |
| GO:BP | GO:0090075 | relaxation of muscle | 20 | 27 | 4.63e-02 |
| GO:BP | GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 70 | 118 | 4.64e-02 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 70 | 118 | 4.64e-02 |
| GO:BP | GO:0060976 | coronary vasculature development | 31 | 46 | 4.64e-02 |
| GO:BP | GO:0072001 | renal system development | 140 | 254 | 4.65e-02 |
| GO:BP | GO:0045604 | regulation of epidermal cell differentiation | 27 | 39 | 4.68e-02 |
| GO:BP | GO:0030162 | regulation of proteolysis | 241 | 456 | 4.68e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 27 | 39 | 4.68e-02 |
| GO:BP | GO:0032273 | positive regulation of protein polymerization | 47 | 75 | 4.72e-02 |
| GO:BP | GO:0048145 | regulation of fibroblast proliferation | 47 | 75 | 4.72e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 47 | 75 | 4.72e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 145 | 264 | 4.72e-02 |
| GO:BP | GO:0072524 | pyridine-containing compound metabolic process | 82 | 141 | 4.72e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 145 | 264 | 4.72e-02 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 36 | 55 | 4.76e-02 |
| GO:BP | GO:0032835 | glomerulus development | 36 | 55 | 4.76e-02 |
| GO:BP | GO:0001654 | eye development | 149 | 272 | 4.77e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 152 | 278 | 4.82e-02 |
| GO:BP | GO:0010876 | lipid localization | 169 | 312 | 4.99e-02 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 42 | 66 | 4.99e-02 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 42 | 66 | 4.99e-02 |
NRnomtable_20k_enh %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR enhancer neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:00000 | KEGG root term | 2946 | 5802 | 2.59e-15 |
| KEGG | KEGG:05200 | Pathways in cancer | 249 | 408 | 3.04e-07 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 51 | 64 | 6.16e-06 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 67 | 94 | 7.90e-05 |
| KEGG | KEGG:04510 | Focal adhesion | 114 | 177 | 7.90e-05 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 76 | 110 | 7.92e-05 |
| KEGG | KEGG:05131 | Shigellosis | 131 | 210 | 1.22e-04 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 54 | 74 | 1.50e-04 |
| KEGG | KEGG:04931 | Insulin resistance | 66 | 95 | 1.84e-04 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 88 | 134 | 1.84e-04 |
| KEGG | KEGG:04148 | Efferocytosis | 83 | 125 | 1.84e-04 |
| KEGG | KEGG:05135 | Yersinia infection | 75 | 112 | 2.84e-04 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 70 | 104 | 3.95e-04 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 103 | 164 | 4.42e-04 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 60 | 87 | 4.42e-04 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 66 | 98 | 5.43e-04 |
| KEGG | KEGG:04520 | Adherens junction | 59 | 86 | 5.85e-04 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 105 | 170 | 7.94e-04 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 62 | 92 | 7.94e-04 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 41 | 56 | 7.97e-04 |
| KEGG | KEGG:04934 | Cushing syndrome | 78 | 121 | 8.18e-04 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 78 | 121 | 8.18e-04 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 39 | 53 | 8.80e-04 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 150 | 256 | 8.81e-04 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 61 | 91 | 8.81e-04 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 93 | 149 | 8.83e-04 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 67 | 102 | 9.40e-04 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 73 | 113 | 9.98e-04 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 93 | 151 | 1.56e-03 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 59 | 89 | 1.56e-03 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 88 | 142 | 1.66e-03 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 56 | 84 | 1.68e-03 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 89 | 145 | 2.20e-03 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 89 | 145 | 2.20e-03 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 70 | 110 | 2.20e-03 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 51 | 76 | 2.27e-03 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 142 | 246 | 2.39e-03 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 50 | 75 | 3.15e-03 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 66 | 104 | 3.15e-03 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 35 | 49 | 3.15e-03 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 72 | 115 | 3.15e-03 |
| KEGG | KEGG:05226 | Gastric cancer | 73 | 117 | 3.19e-03 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 56 | 86 | 3.19e-03 |
| KEGG | KEGG:04360 | Axon guidance | 97 | 162 | 3.33e-03 |
| KEGG | KEGG:05132 | Salmonella infection | 124 | 214 | 3.82e-03 |
| KEGG | KEGG:04611 | Platelet activation | 57 | 89 | 4.90e-03 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 20 | 25 | 4.90e-03 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 39 | 57 | 5.06e-03 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 105 | 179 | 5.06e-03 |
| KEGG | KEGG:05224 | Breast cancer | 72 | 117 | 5.12e-03 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 80 | 132 | 5.12e-03 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 49 | 75 | 5.12e-03 |
| KEGG | KEGG:04217 | Necroptosis | 65 | 104 | 5.12e-03 |
| KEGG | KEGG:05210 | Colorectal cancer | 54 | 84 | 5.12e-03 |
| KEGG | KEGG:04014 | Ras signaling pathway | 101 | 172 | 5.37e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 103 | 176 | 5.54e-03 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 38 | 56 | 6.37e-03 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 81 | 135 | 6.69e-03 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 67 | 109 | 7.07e-03 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 50 | 78 | 7.60e-03 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 77 | 128 | 7.60e-03 |
| KEGG | KEGG:04330 | Notch signaling pathway | 36 | 53 | 7.68e-03 |
| KEGG | KEGG:04144 | Endocytosis | 130 | 230 | 7.83e-03 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 90 | 153 | 7.98e-03 |
| KEGG | KEGG:04218 | Cellular senescence | 85 | 144 | 9.11e-03 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 69 | 114 | 9.65e-03 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 35 | 52 | 1.06e-02 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 24 | 33 | 1.08e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 47 | 74 | 1.23e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 42 | 65 | 1.26e-02 |
| KEGG | KEGG:04730 | Long-term depression | 29 | 42 | 1.31e-02 |
| KEGG | KEGG:04710 | Circadian rhythm | 22 | 30 | 1.31e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 44 | 69 | 1.41e-02 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 102 | 179 | 1.47e-02 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 60 | 99 | 1.55e-02 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 92 | 160 | 1.55e-02 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 31 | 46 | 1.59e-02 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 94 | 165 | 1.99e-02 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 47 | 76 | 2.30e-02 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 66 | 112 | 2.44e-02 |
| KEGG | KEGG:05214 | Glioma | 42 | 67 | 2.46e-02 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 50 | 82 | 2.56e-02 |
| KEGG | KEGG:05215 | Prostate cancer | 52 | 86 | 2.74e-02 |
| KEGG | KEGG:05212 | Pancreatic cancer | 46 | 75 | 2.93e-02 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 24 | 35 | 2.93e-02 |
| KEGG | KEGG:05146 | Amoebiasis | 40 | 64 | 3.02e-02 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 57 | 96 | 3.07e-02 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 48 | 79 | 3.07e-02 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 62 | 106 | 3.48e-02 |
| KEGG | KEGG:04668 | TNF signaling pathway | 52 | 87 | 3.48e-02 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 47 | 78 | 3.92e-02 |
| KEGG | KEGG:04140 | Autophagy - animal | 88 | 157 | 3.92e-02 |
| KEGG | KEGG:04530 | Tight junction | 78 | 138 | 4.32e-02 |
| KEGG | KEGG:04713 | Circadian entrainment | 42 | 69 | 4.32e-02 |
| KEGG | KEGG:05161 | Hepatitis B | 77 | 136 | 4.32e-02 |
| KEGG | KEGG:04540 | Gap junction | 44 | 73 | 4.63e-02 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 55 | 94 | 4.71e-02 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 93 | 168 | 4.72e-02 |
| KEGG | KEGG:04137 | Mitophagy - animal | 58 | 100 | 4.92e-02 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 47 | 79 | 4.92e-02 |
intersection of EAR_ATAC and RNA-response genes
EAR
# EAR_int_resgenes <- gost(query = int_EAR_n_RNAresp,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(EAR_int_resgenes,"data/GO_KEGG_analysis/EAR_int_resgenes.RDS")
EAR_int_restable <- EAR_int_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
EAR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in EAR neargenes intersected with RNA response genes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0065007 | biological regulation | 1165 | 8275 | 3.38e-16 |
| GO:BP | GO:0050789 | regulation of biological process | 1139 | 8037 | 3.38e-16 |
| GO:BP | GO:0050794 | regulation of cellular process | 1092 | 7651 | 4.33e-16 |
| GO:BP | GO:0032502 | developmental process | 689 | 4475 | 3.94e-13 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 348 | 1951 | 9.97e-13 |
| GO:BP | GO:0050793 | regulation of developmental process | 326 | 1801 | 1.11e-12 |
| GO:BP | GO:0007275 | multicellular organism development | 542 | 3383 | 2.09e-12 |
| GO:BP | GO:0048856 | anatomical structure development | 637 | 4130 | 5.87e-12 |
| GO:BP | GO:0072359 | circulatory system development | 186 | 896 | 1.35e-11 |
| GO:BP | GO:0023052 | signaling | 640 | 4180 | 2.05e-11 |
| GO:BP | GO:0007154 | cell communication | 648 | 4248 | 2.14e-11 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 591 | 3804 | 2.14e-11 |
| GO:BP | GO:0048519 | negative regulation of biological process | 621 | 4037 | 2.14e-11 |
| GO:BP | GO:0048731 | system development | 471 | 2903 | 2.56e-11 |
| GO:BP | GO:0048869 | cellular developmental process | 481 | 2988 | 4.37e-11 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 353 | 2052 | 4.37e-11 |
| GO:BP | GO:0051716 | cellular response to stimulus | 732 | 4933 | 5.51e-11 |
| GO:BP | GO:0030154 | cell differentiation | 480 | 2987 | 5.57e-11 |
| GO:BP | GO:0007165 | signal transduction | 592 | 3846 | 8.30e-11 |
| GO:BP | GO:0032501 | multicellular organismal process | 715 | 4830 | 2.21e-10 |
| GO:BP | GO:0048518 | positive regulation of biological process | 681 | 4561 | 2.21e-10 |
| GO:BP | GO:0050896 | response to stimulus | 823 | 5732 | 1.05e-09 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 629 | 4198 | 1.90e-09 |
| GO:BP | GO:0014706 | striated muscle tissue development | 63 | 218 | 5.20e-09 |
| GO:BP | GO:0048513 | animal organ development | 353 | 2130 | 5.23e-09 |
| GO:BP | GO:0009888 | tissue development | 250 | 1425 | 3.81e-08 |
| GO:BP | GO:0048589 | developmental growth | 114 | 527 | 6.23e-08 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 58 | 206 | 8.84e-08 |
| GO:BP | GO:0007507 | heart development | 111 | 515 | 1.27e-07 |
| GO:BP | GO:0048468 | cell development | 323 | 1999 | 8.40e-07 |
| GO:BP | GO:0022008 | neurogenesis | 229 | 1327 | 1.04e-06 |
| GO:BP | GO:0035556 | intracellular signal transduction | 333 | 2079 | 1.13e-06 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 129 | 662 | 3.54e-06 |
| GO:BP | GO:0048699 | generation of neurons | 200 | 1145 | 4.07e-06 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 174 | 967 | 4.47e-06 |
| GO:BP | GO:0007417 | central nervous system development | 141 | 748 | 6.01e-06 |
| GO:BP | GO:0060537 | muscle tissue development | 79 | 353 | 6.33e-06 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 135 | 710 | 6.53e-06 |
| GO:BP | GO:0030334 | regulation of cell migration | 135 | 710 | 6.53e-06 |
| GO:BP | GO:0016477 | cell migration | 189 | 1078 | 6.81e-06 |
| GO:BP | GO:2000145 | regulation of cell motility | 140 | 745 | 7.24e-06 |
| GO:BP | GO:0040012 | regulation of locomotion | 142 | 766 | 1.31e-05 |
| GO:BP | GO:0040007 | growth | 138 | 739 | 1.31e-05 |
| GO:BP | GO:0007399 | nervous system development | 302 | 1903 | 1.39e-05 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 233 | 1403 | 1.49e-05 |
| GO:BP | GO:0035239 | tube morphogenesis | 127 | 668 | 1.49e-05 |
| GO:BP | GO:0035295 | tube development | 150 | 827 | 2.07e-05 |
| GO:BP | GO:0060419 | heart growth | 26 | 72 | 2.07e-05 |
| GO:BP | GO:0045444 | fat cell differentiation | 49 | 189 | 2.11e-05 |
| GO:BP | GO:0040011 | locomotion | 154 | 858 | 2.61e-05 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 24 | 65 | 3.59e-05 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 123 | 653 | 3.59e-05 |
| GO:BP | GO:0009790 | embryo development | 154 | 864 | 3.86e-05 |
| GO:BP | GO:0030900 | forebrain development | 66 | 292 | 4.09e-05 |
| GO:BP | GO:0010646 | regulation of cell communication | 391 | 2601 | 4.70e-05 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 192 | 1134 | 5.11e-05 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 233 | 1430 | 5.79e-05 |
| GO:BP | GO:0030182 | neuron differentiation | 184 | 1080 | 5.79e-05 |
| GO:BP | GO:0060322 | head development | 111 | 583 | 7.17e-05 |
| GO:BP | GO:0030029 | actin filament-based process | 125 | 677 | 7.47e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 351 | 2311 | 7.65e-05 |
| GO:BP | GO:0007420 | brain development | 104 | 539 | 8.21e-05 |
| GO:BP | GO:0001568 | blood vessel development | 105 | 546 | 8.27e-05 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 214 | 1301 | 8.27e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 59 | 257 | 8.40e-05 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 412 | 2780 | 8.41e-05 |
| GO:BP | GO:0001944 | vasculature development | 109 | 573 | 8.41e-05 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 173 | 1011 | 8.53e-05 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 79 | 380 | 8.65e-05 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 214 | 1304 | 8.96e-05 |
| GO:BP | GO:0048870 | cell motility | 198 | 1190 | 9.21e-05 |
| GO:BP | GO:0009966 | regulation of signal transduction | 349 | 2307 | 1.05e-04 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 371 | 2474 | 1.05e-04 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 153 | 876 | 1.07e-04 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 94 | 479 | 1.10e-04 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 381 | 2555 | 1.23e-04 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 135 | 756 | 1.38e-04 |
| GO:BP | GO:0023051 | regulation of signaling | 386 | 2597 | 1.40e-04 |
| GO:BP | GO:0007423 | sensory organ development | 81 | 399 | 1.49e-04 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 315 | 2061 | 1.51e-04 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 304 | 1992 | 2.74e-04 |
| GO:BP | GO:0044057 | regulation of system process | 80 | 399 | 2.76e-04 |
| GO:BP | GO:0048666 | neuron development | 153 | 894 | 3.22e-04 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 90 | 467 | 3.67e-04 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 263 | 1694 | 3.79e-04 |
| GO:BP | GO:0035265 | organ growth | 35 | 132 | 4.28e-04 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 269 | 1744 | 4.77e-04 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 421 | 2902 | 4.96e-04 |
| GO:BP | GO:0048568 | embryonic organ development | 66 | 317 | 5.17e-04 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 267 | 1732 | 5.27e-04 |
| GO:BP | GO:0016358 | dendrite development | 46 | 196 | 5.37e-04 |
| GO:BP | GO:0021537 | telencephalon development | 48 | 208 | 5.51e-04 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 335 | 2246 | 5.53e-04 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 314 | 2088 | 5.77e-04 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 100 | 540 | 5.81e-04 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 298 | 1974 | 7.54e-04 |
| GO:BP | GO:0008360 | regulation of cell shape | 31 | 115 | 9.13e-04 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 247 | 1597 | 9.13e-04 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 101 | 553 | 9.14e-04 |
| GO:BP | GO:0042221 | response to chemical | 358 | 2436 | 9.14e-04 |
| GO:BP | GO:0031175 | neuron projection development | 136 | 794 | 9.17e-04 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 19 | 55 | 1.02e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 287 | 1900 | 1.02e-03 |
| GO:BP | GO:0001764 | neuron migration | 35 | 138 | 1.03e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 23 | 75 | 1.20e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 294 | 1959 | 1.29e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 37 | 151 | 1.32e-03 |
| GO:BP | GO:0016043 | cellular component organization | 698 | 5139 | 1.38e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 21 | 66 | 1.44e-03 |
| GO:BP | GO:0065008 | regulation of biological quality | 304 | 2039 | 1.48e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 29 | 109 | 1.99e-03 |
| GO:BP | GO:0007010 | cytoskeleton organization | 193 | 1218 | 2.00e-03 |
| GO:BP | GO:0006468 | protein phosphorylation | 164 | 1008 | 2.02e-03 |
| GO:BP | GO:0048729 | tissue morphogenesis | 88 | 478 | 2.17e-03 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 178 | 1111 | 2.19e-03 |
| GO:BP | GO:0043583 | ear development | 37 | 155 | 2.26e-03 |
| GO:BP | GO:0003008 | system process | 190 | 1201 | 2.44e-03 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 82 | 440 | 2.49e-03 |
| GO:BP | GO:0003007 | heart morphogenesis | 48 | 222 | 2.63e-03 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 194 | 1233 | 2.72e-03 |
| GO:BP | GO:0060284 | regulation of cell development | 106 | 605 | 2.85e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 17 | 50 | 3.06e-03 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 27 | 101 | 3.07e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 22 | 75 | 3.32e-03 |
| GO:BP | GO:0048839 | inner ear development | 33 | 135 | 3.33e-03 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 573 | 4170 | 3.39e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 151 | 926 | 3.39e-03 |
| GO:BP | GO:0016310 | phosphorylation | 190 | 1211 | 3.65e-03 |
| GO:BP | GO:0000902 | cell morphogenesis | 128 | 764 | 3.75e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 23 | 81 | 3.79e-03 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 173 | 1088 | 3.81e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 22 | 76 | 3.87e-03 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 13 | 33 | 3.87e-03 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 45 | 208 | 3.97e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 20 | 66 | 4.00e-03 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 179 | 1135 | 4.31e-03 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 615 | 4521 | 4.65e-03 |
| GO:BP | GO:0003231 | cardiac ventricle development | 29 | 115 | 4.65e-03 |
| GO:BP | GO:0065009 | regulation of molecular function | 213 | 1389 | 4.85e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 23 | 83 | 5.28e-03 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 15 | 43 | 5.28e-03 |
| GO:BP | GO:0043010 | camera-type eye development | 49 | 236 | 5.39e-03 |
| GO:BP | GO:0060429 | epithelium development | 137 | 836 | 5.39e-03 |
| GO:BP | GO:0003013 | circulatory system process | 81 | 446 | 5.68e-03 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 613 | 4515 | 5.83e-03 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 14 | 39 | 6.11e-03 |
| GO:BP | GO:0048588 | developmental cell growth | 42 | 194 | 6.16e-03 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 74 | 401 | 6.53e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 31 | 129 | 6.55e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 21 | 74 | 6.80e-03 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 24 | 90 | 6.80e-03 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 13 | 35 | 6.91e-03 |
| GO:BP | GO:0034329 | cell junction assembly | 66 | 349 | 6.99e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 259 | 1746 | 7.02e-03 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 17 | 54 | 7.19e-03 |
| GO:BP | GO:0010616 | negative regulation of cardiac muscle adaptation | 5 | 6 | 7.32e-03 |
| GO:BP | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress | 5 | 6 | 7.32e-03 |
| GO:BP | GO:0019222 | regulation of metabolic process | 661 | 4914 | 7.32e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 32 | 136 | 7.34e-03 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 12 | 31 | 7.52e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 15 | 45 | 8.22e-03 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 15 | 45 | 8.22e-03 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 11 | 27 | 8.22e-03 |
| GO:BP | GO:0034330 | cell junction organization | 101 | 591 | 8.44e-03 |
| GO:BP | GO:0003012 | muscle system process | 64 | 339 | 8.57e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 712 | 5340 | 9.30e-03 |
| GO:BP | GO:0008283 | cell population proliferation | 210 | 1386 | 9.30e-03 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 6 | 9 | 9.32e-03 |
| GO:BP | GO:0048880 | sensory system development | 54 | 275 | 9.52e-03 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 102 | 601 | 9.81e-03 |
| GO:BP | GO:0061061 | muscle structure development | 96 | 559 | 9.81e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 52 | 263 | 1.01e-02 |
| GO:BP | GO:0090257 | regulation of muscle system process | 39 | 181 | 1.01e-02 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 579 | 4269 | 1.01e-02 |
| GO:BP | GO:0075732 | viral penetration into host nucleus | 4 | 4 | 1.02e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 27 | 110 | 1.02e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 27 | 110 | 1.02e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 161 | 1027 | 1.04e-02 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 192 | 1256 | 1.04e-02 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 271 | 1852 | 1.04e-02 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 60 | 316 | 1.05e-02 |
| GO:BP | GO:0070848 | response to growth factor | 98 | 576 | 1.12e-02 |
| GO:BP | GO:0001525 | angiogenesis | 72 | 397 | 1.12e-02 |
| GO:BP | GO:0040008 | regulation of growth | 86 | 493 | 1.14e-02 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 74 | 411 | 1.15e-02 |
| GO:BP | GO:0001654 | eye development | 53 | 272 | 1.20e-02 |
| GO:BP | GO:0051960 | regulation of nervous system development | 66 | 358 | 1.22e-02 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 47 | 234 | 1.27e-02 |
| GO:BP | GO:0150063 | visual system development | 53 | 273 | 1.30e-02 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 58 | 306 | 1.32e-02 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 207 | 1376 | 1.36e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 93 | 545 | 1.36e-02 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 276 | 1900 | 1.37e-02 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 13 | 38 | 1.40e-02 |
| GO:BP | GO:0009214 | cyclic nucleotide catabolic process | 7 | 13 | 1.41e-02 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 11 | 29 | 1.42e-02 |
| GO:BP | GO:0008015 | blood circulation | 68 | 374 | 1.42e-02 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 11 | 29 | 1.42e-02 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 161 | 1036 | 1.43e-02 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 397 | 2842 | 1.45e-02 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 94 | 554 | 1.48e-02 |
| GO:BP | GO:0007267 | cell-cell signaling | 177 | 1156 | 1.52e-02 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 428 | 3089 | 1.56e-02 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 38 | 180 | 1.56e-02 |
| GO:BP | GO:0001501 | skeletal system development | 67 | 369 | 1.56e-02 |
| GO:BP | GO:0001508 | action potential | 26 | 108 | 1.58e-02 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 8 | 17 | 1.58e-02 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 8 | 17 | 1.58e-02 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 8 | 17 | 1.58e-02 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 18 | 64 | 1.65e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 45 | 225 | 1.65e-02 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 276 | 1908 | 1.65e-02 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 121 | 749 | 1.66e-02 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 42 | 206 | 1.66e-02 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 75 | 425 | 1.67e-02 |
| GO:BP | GO:0043009 | chordate embryonic development | 90 | 529 | 1.67e-02 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 17 | 59 | 1.68e-02 |
| GO:BP | GO:0032879 | regulation of localization | 225 | 1521 | 1.71e-02 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 133 | 837 | 1.72e-02 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 76 | 433 | 1.76e-02 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 65 | 358 | 1.76e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 28 | 121 | 1.78e-02 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 11 | 30 | 1.78e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 133 | 839 | 1.85e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 121 | 752 | 1.85e-02 |
| GO:BP | GO:0061337 | cardiac conduction | 22 | 87 | 1.91e-02 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 22 | 87 | 1.91e-02 |
| GO:BP | GO:0099536 | synaptic signaling | 88 | 518 | 1.91e-02 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 10 | 26 | 1.99e-02 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 10 | 26 | 1.99e-02 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 16 | 55 | 2.05e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 13 | 40 | 2.06e-02 |
| GO:BP | GO:0042592 | homeostatic process | 182 | 1204 | 2.07e-02 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 15 | 50 | 2.08e-02 |
| GO:BP | GO:0010468 | regulation of gene expression | 492 | 3613 | 2.09e-02 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 103 | 626 | 2.09e-02 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 109 | 669 | 2.09e-02 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 34 | 159 | 2.09e-02 |
| GO:BP | GO:0030048 | actin filament-based movement | 26 | 111 | 2.14e-02 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 47 | 242 | 2.18e-02 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 175 | 1154 | 2.20e-02 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 11 | 31 | 2.26e-02 |
| GO:BP | GO:0001503 | ossification | 59 | 322 | 2.27e-02 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 17 | 61 | 2.28e-02 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 85 | 501 | 2.30e-02 |
| GO:BP | GO:0061448 | connective tissue development | 43 | 217 | 2.31e-02 |
| GO:BP | GO:0046620 | regulation of organ growth | 19 | 72 | 2.35e-02 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 30 | 136 | 2.41e-02 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 22 | 89 | 2.43e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 15 | 51 | 2.46e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 38 | 186 | 2.49e-02 |
| GO:BP | GO:0001570 | vasculogenesis | 18 | 67 | 2.51e-02 |
| GO:BP | GO:0051591 | response to cAMP | 17 | 62 | 2.64e-02 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 286 | 2005 | 2.64e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 25 | 107 | 2.64e-02 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 84 | 497 | 2.64e-02 |
| GO:BP | GO:0002027 | regulation of heart rate | 21 | 84 | 2.64e-02 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 84 | 497 | 2.64e-02 |
| GO:BP | GO:0046834 | lipid phosphorylation | 6 | 11 | 2.65e-02 |
| GO:BP | GO:0043584 | nose development | 6 | 11 | 2.65e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 6 | 11 | 2.65e-02 |
| GO:BP | GO:0086070 | SA node cell to atrial cardiac muscle cell communication | 6 | 11 | 2.65e-02 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 71 | 407 | 2.67e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 22 | 90 | 2.70e-02 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 359 | 2576 | 2.76e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 11 | 32 | 2.79e-02 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 55 | 299 | 2.81e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 24 | 102 | 2.83e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 18 | 68 | 2.84e-02 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 77 | 450 | 2.85e-02 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 28 | 126 | 2.88e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 27 | 120 | 2.88e-02 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 132 | 845 | 2.90e-02 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 13 | 42 | 2.91e-02 |
| GO:BP | GO:0071878 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway | 4 | 5 | 2.91e-02 |
| GO:BP | GO:0023056 | positive regulation of signaling | 192 | 1292 | 2.91e-02 |
| GO:BP | GO:0009987 | cellular process | 1426 | 11450 | 2.91e-02 |
| GO:BP | GO:0055012 | ventricular cardiac muscle cell differentiation | 7 | 15 | 2.92e-02 |
| GO:BP | GO:0007389 | pattern specification process | 56 | 307 | 2.92e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 33 | 157 | 2.92e-02 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 19 | 74 | 2.92e-02 |
| GO:BP | GO:0014020 | primary neural tube formation | 22 | 91 | 2.92e-02 |
| GO:BP | GO:0030878 | thyroid gland development | 8 | 19 | 2.92e-02 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 132 | 846 | 2.92e-02 |
| GO:BP | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 7 | 15 | 2.92e-02 |
| GO:BP | GO:0010033 | response to organic substance | 263 | 1835 | 2.98e-02 |
| GO:BP | GO:0008016 | regulation of heart contraction | 35 | 170 | 2.99e-02 |
| GO:BP | GO:0021915 | neural tube development | 30 | 139 | 3.01e-02 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 503 | 3724 | 3.04e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 18 | 69 | 3.17e-02 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 191 | 1288 | 3.17e-02 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 514 | 3815 | 3.23e-02 |
| GO:BP | GO:0007155 | cell adhesion | 153 | 1004 | 3.23e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 31 | 146 | 3.25e-02 |
| GO:BP | GO:0021543 | pallium development | 31 | 146 | 3.25e-02 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 68 | 391 | 3.28e-02 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 14 | 48 | 3.37e-02 |
| GO:BP | GO:0003015 | heart process | 41 | 210 | 3.38e-02 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 28 | 128 | 3.38e-02 |
| GO:BP | GO:0035107 | appendage morphogenesis | 26 | 116 | 3.41e-02 |
| GO:BP | GO:0035108 | limb morphogenesis | 26 | 116 | 3.41e-02 |
| GO:BP | GO:0007416 | synapse assembly | 32 | 153 | 3.45e-02 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 359 | 2589 | 3.45e-02 |
| GO:BP | GO:0006941 | striated muscle contraction | 32 | 153 | 3.45e-02 |
| GO:BP | GO:0046339 | diacylglycerol metabolic process | 9 | 24 | 3.50e-02 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 9 | 24 | 3.50e-02 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 9 | 24 | 3.50e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 22 | 93 | 3.67e-02 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 57 | 318 | 3.73e-02 |
| GO:BP | GO:0071824 | protein-DNA complex organization | 116 | 736 | 3.74e-02 |
| GO:BP | GO:0071310 | cellular response to organic substance | 201 | 1370 | 3.74e-02 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 26 | 117 | 3.75e-02 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 516 | 3841 | 3.82e-02 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 8 | 20 | 3.84e-02 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 8 | 20 | 3.84e-02 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 10 | 29 | 3.84e-02 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 8 | 20 | 3.84e-02 |
| GO:BP | GO:0043368 | positive T cell selection | 8 | 20 | 3.84e-02 |
| GO:BP | GO:0021591 | ventricular system development | 10 | 29 | 3.84e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 10 | 29 | 3.84e-02 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 113 | 715 | 3.84e-02 |
| GO:BP | GO:0043373 | CD4-positive, alpha-beta T cell lineage commitment | 6 | 12 | 3.87e-02 |
| GO:BP | GO:0060606 | tube closure | 21 | 88 | 3.96e-02 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 171 | 1146 | 3.96e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 13 | 44 | 3.96e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 13 | 44 | 3.96e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 13 | 44 | 3.96e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 13 | 44 | 3.96e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 13 | 44 | 3.96e-02 |
| GO:BP | GO:0046683 | response to organophosphorus | 22 | 94 | 3.98e-02 |
| GO:BP | GO:0048592 | eye morphogenesis | 25 | 112 | 4.05e-02 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 286 | 2028 | 4.11e-02 |
| GO:BP | GO:0042692 | muscle cell differentiation | 59 | 334 | 4.12e-02 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 283 | 2006 | 4.24e-02 |
| GO:BP | GO:0030030 | cell projection organization | 186 | 1262 | 4.27e-02 |
| GO:BP | GO:0044773 | mitotic DNA damage checkpoint signaling | 20 | 83 | 4.31e-02 |
| GO:BP | GO:0035148 | tube formation | 28 | 131 | 4.34e-02 |
| GO:BP | GO:0038138 | ERBB4-ERBB4 signaling pathway | 3 | 3 | 4.35e-02 |
| GO:BP | GO:0021563 | glossopharyngeal nerve development | 3 | 3 | 4.35e-02 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 100 | 625 | 4.40e-02 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 9 | 25 | 4.40e-02 |
| GO:BP | GO:0055001 | muscle cell development | 34 | 169 | 4.43e-02 |
| GO:BP | GO:0099643 | signal release from synapse | 24 | 107 | 4.46e-02 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 24 | 107 | 4.46e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 38 | 195 | 4.49e-02 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 18 | 72 | 4.49e-02 |
| GO:BP | GO:0048736 | appendage development | 30 | 144 | 4.49e-02 |
| GO:BP | GO:0060173 | limb development | 30 | 144 | 4.49e-02 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 181 | 1227 | 4.54e-02 |
| GO:BP | GO:0042063 | gliogenesis | 47 | 255 | 4.68e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 27 | 126 | 4.80e-02 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 24 | 108 | 4.88e-02 |
| GO:BP | GO:0086015 | SA node cell action potential | 5 | 9 | 4.88e-02 |
| GO:BP | GO:0001841 | neural tube formation | 22 | 96 | 4.88e-02 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 50 | 276 | 4.88e-02 |
| GO:BP | GO:0046847 | filopodium assembly | 15 | 56 | 4.88e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 8 | 21 | 4.88e-02 |
| GO:BP | GO:0086018 | SA node cell to atrial cardiac muscle cell signaling | 5 | 9 | 4.88e-02 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 17 | 67 | 4.88e-02 |
| GO:BP | GO:0030902 | hindbrain development | 25 | 114 | 4.88e-02 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 8 | 21 | 4.88e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 23 | 102 | 4.88e-02 |
| GO:BP | GO:0006198 | cAMP catabolic process | 5 | 9 | 4.88e-02 |
| GO:BP | GO:0030097 | hemopoiesis | 105 | 664 | 4.88e-02 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 37 | 190 | 4.90e-02 |
| GO:BP | GO:0000165 | MAPK cascade | 87 | 535 | 4.95e-02 |
EAR_int_restable %>%
filter(source=="KEGG") %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in EAR neargenes intersected with RNA response genes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04015 | Rap1 signaling pathway | 33 | 164 | 3.35e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 23 | 99 | 3.35e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 17 | 83 | 8.09e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 18 | 91 | 8.09e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 27 | 142 | 8.09e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 15 | 69 | 8.09e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 4 | 10 | 8.09e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 30 | 172 | 8.09e-01 |
| KEGG | KEGG:04730 | Long-term depression | 10 | 42 | 8.09e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 24 | 128 | 8.09e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 24 | 134 | 8.18e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 12 | 55 | 8.18e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 9 | 39 | 8.46e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 15 | 76 | 8.46e-01 |
| KEGG | KEGG:00230 | Purine metabolism | 18 | 97 | 8.46e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 19 | 104 | 8.46e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 10 | 50 | 8.68e-01 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 26 | 164 | 8.68e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 20 | 117 | 8.68e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 24 | 151 | 8.68e-01 |
| KEGG | KEGG:04520 | Adherens junction | 15 | 86 | 8.68e-01 |
| KEGG | KEGG:04360 | Axon guidance | 26 | 162 | 8.68e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 19 | 115 | 8.68e-01 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 10 | 50 | 8.68e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 20 | 121 | 8.68e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 23 | 144 | 8.68e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 6 | 25 | 8.68e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 6 | 24 | 8.68e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 4 | 12 | 8.68e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 10 | 53 | 8.68e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 19 | 109 | 8.68e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 10 | 51 | 8.68e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 14 | 74 | 8.68e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 16 | 92 | 8.68e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 10 | 49 | 8.68e-01 |
| KEGG | KEGG:05034 | Alcoholism | 20 | 113 | 8.68e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 11 | 56 | 8.68e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 17 | 102 | 8.84e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 18 | 110 | 9.12e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 2 | 5 | 9.13e-01 |
| KEGG | KEGG:04742 | Taste transduction | 5 | 22 | 9.21e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 10 | 56 | 9.58e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 36 | 246 | 9.58e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 16 | 99 | 9.58e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 13 | 78 | 9.58e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 20 | 127 | 9.58e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 6 | 30 | 9.58e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 11 | 64 | 9.58e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 11 | 64 | 9.58e-01 |
| KEGG | KEGG:04530 | Tight junction | 21 | 138 | 9.89e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 12 | 72 | 9.89e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 20 | 132 | 9.92e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 10 | 59 | 9.92e-01 |
| KEGG | KEGG:04744 | Phototransduction | 3 | 12 | 9.92e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 9 | 52 | 9.92e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 3 | 41 | 1.00e+00 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 12 | 99 | 1.00e+00 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 6 | 41 | 1.00e+00 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 1 | 38 | 1.00e+00 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 10 | 75 | 1.00e+00 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 8 | 86 | 1.00e+00 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 1 | 20 | 1.00e+00 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 2 | 19 | 1.00e+00 |
| KEGG | KEGG:04725 | Cholinergic synapse | 11 | 83 | 1.00e+00 |
| KEGG | KEGG:04726 | Serotonergic synapse | 10 | 63 | 1.00e+00 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 2 | 28 | 1.00e+00 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 9 | 76 | 1.00e+00 |
| KEGG | KEGG:04727 | GABAergic synapse | 6 | 55 | 1.00e+00 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 13 | 102 | 1.00e+00 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 17 | 121 | 1.00e+00 |
| KEGG | KEGG:04814 | Motor proteins | 13 | 149 | 1.00e+00 |
| KEGG | KEGG:04970 | Salivary secretion | 9 | 55 | 1.00e+00 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 18 | 179 | 1.00e+00 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 12 | 110 | 1.00e+00 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 3 | 26 | 1.00e+00 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 8 | 96 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 21 | 195 | 1.00e+00 |
| KEGG | KEGG:04924 | Renin secretion | 7 | 50 | 1.00e+00 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 11 | 77 | 1.00e+00 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 7 | 104 | 1.00e+00 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 6 | 48 | 1.00e+00 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 13 | 82 | 1.00e+00 |
| KEGG | KEGG:04929 | GnRH secretion | 6 | 53 | 1.00e+00 |
| KEGG | KEGG:04931 | Insulin resistance | 14 | 95 | 1.00e+00 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 12 | 131 | 1.00e+00 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 10 | 84 | 1.00e+00 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 12 | 91 | 1.00e+00 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 17 | 112 | 1.00e+00 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 14 | 98 | 1.00e+00 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 14 | 97 | 1.00e+00 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 5 | 55 | 1.00e+00 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 2 | 15 | 1.00e+00 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 6 | 56 | 1.00e+00 |
| KEGG | KEGG:04916 | Melanogenesis | 11 | 77 | 1.00e+00 |
| KEGG | KEGG:04971 | Gastric acid secretion | 8 | 52 | 1.00e+00 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 5 | 35 | 1.00e+00 |
| KEGG | KEGG:05200 | Pathways in cancer | 50 | 408 | 1.00e+00 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 1 | 31 | 1.00e+00 |
| KEGG | KEGG:05215 | Prostate cancer | 10 | 86 | 1.00e+00 |
| KEGG | KEGG:05214 | Glioma | 10 | 67 | 1.00e+00 |
| KEGG | KEGG:05213 | Endometrial cancer | 8 | 57 | 1.00e+00 |
| KEGG | KEGG:05212 | Pancreatic cancer | 12 | 75 | 1.00e+00 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 9 | 65 | 1.00e+00 |
| KEGG | KEGG:05210 | Colorectal cancer | 13 | 84 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 10 | 185 | 1.00e+00 |
| KEGG | KEGG:05216 | Thyroid cancer | 6 | 35 | 1.00e+00 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 17 | 142 | 1.00e+00 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 23 | 170 | 1.00e+00 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 20 | 163 | 1.00e+00 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 8 | 79 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 9 | 162 | 1.00e+00 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 17 | 165 | 1.00e+00 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 15 | 153 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 24 | 416 | 1.00e+00 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 20 | 149 | 1.00e+00 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 20 | 145 | 1.00e+00 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 8 | 49 | 1.00e+00 |
| KEGG | KEGG:05219 | Bladder cancer | 4 | 37 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 4 | 46 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 16 | 168 | 1.00e+00 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 8 | 84 | 1.00e+00 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 11 | 69 | 1.00e+00 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 9 | 79 | 1.00e+00 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 4 | 43 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 8 | 52 | 1.00e+00 |
| KEGG | KEGG:05218 | Melanoma | 9 | 58 | 1.00e+00 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 4 | 22 | 1.00e+00 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 13 | 84 | 1.00e+00 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 2 | 62 | 1.00e+00 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 19 | 145 | 1.00e+00 |
| KEGG | KEGG:05224 | Breast cancer | 16 | 117 | 1.00e+00 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 10 | 67 | 1.00e+00 |
| KEGG | KEGG:05222 | Small cell lung cancer | 8 | 87 | 1.00e+00 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 10 | 75 | 1.00e+00 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8 | 69 | 1.00e+00 |
| KEGG | KEGG:04972 | Pancreatic secretion | 9 | 58 | 1.00e+00 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 21 | 179 | 1.00e+00 |
| KEGG | KEGG:05164 | Influenza A | 12 | 102 | 1.00e+00 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 10 | 74 | 1.00e+00 |
| KEGG | KEGG:05031 | Amphetamine addiction | 8 | 49 | 1.00e+00 |
| KEGG | KEGG:05030 | Cocaine addiction | 3 | 35 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 37 | 384 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 17 | 218 | 1.00e+00 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 15 | 123 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 20 | 255 | 1.00e+00 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 5 | 43 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 34 | 303 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 27 | 314 | 1.00e+00 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 4 | 33 | 1.00e+00 |
| KEGG | KEGG:04978 | Mineral absorption | 5 | 42 | 1.00e+00 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 3 | 14 | 1.00e+00 |
| KEGG | KEGG:04976 | Bile secretion | 6 | 42 | 1.00e+00 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 2 | 19 | 1.00e+00 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 9 | 61 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 19 | 225 | 1.00e+00 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 28 | 271 | 1.00e+00 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 5 | 58 | 1.00e+00 |
| KEGG | KEGG:05131 | Shigellosis | 20 | 210 | 1.00e+00 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 21 | 176 | 1.00e+00 |
| KEGG | KEGG:05162 | Measles | 8 | 97 | 1.00e+00 |
| KEGG | KEGG:05161 | Hepatitis B | 14 | 136 | 1.00e+00 |
| KEGG | KEGG:05160 | Hepatitis C | 16 | 116 | 1.00e+00 |
| KEGG | KEGG:05152 | Tuberculosis | 9 | 106 | 1.00e+00 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 1 | 18 | 1.00e+00 |
| KEGG | KEGG:05146 | Amoebiasis | 1 | 64 | 1.00e+00 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 15 | 151 | 1.00e+00 |
| KEGG | KEGG:05145 | Toxoplasmosis | 7 | 81 | 1.00e+00 |
| KEGG | KEGG:05143 | African trypanosomiasis | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:05142 | Chagas disease | 4 | 75 | 1.00e+00 |
| KEGG | KEGG:05140 | Leishmaniasis | 4 | 42 | 1.00e+00 |
| KEGG | KEGG:05135 | Yersinia infection | 12 | 112 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 3 | 38 | 1.00e+00 |
| KEGG | KEGG:05133 | Pertussis | 4 | 45 | 1.00e+00 |
| KEGG | KEGG:05132 | Salmonella infection | 16 | 214 | 1.00e+00 |
| KEGG | KEGG:05144 | Malaria | 1 | 20 | 1.00e+00 |
| KEGG | KEGG:04668 | TNF signaling pathway | 10 | 87 | 1.00e+00 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 13 | 113 | 1.00e+00 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 2 | 46 | 1.00e+00 |
| KEGG | KEGG:00730 | Thiamine metabolism | 2 | 10 | 1.00e+00 |
| KEGG | KEGG:00670 | One carbon pool by folate | 2 | 18 | 1.00e+00 |
| KEGG | KEGG:00650 | Butanoate metabolism | 2 | 17 | 1.00e+00 |
| KEGG | KEGG:00640 | Propanoate metabolism | 2 | 28 | 1.00e+00 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 2 | 25 | 1.00e+00 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 2 | 33 | 1.00e+00 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 1 | 5 | 1.00e+00 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 1 | 14 | 1.00e+00 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 2 | 7 | 1.00e+00 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 3 | 26 | 1.00e+00 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 4 | 28 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 2 | 25 | 1.00e+00 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 7 | 66 | 1.00e+00 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4 | 20 | 1.00e+00 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 7 | 45 | 1.00e+00 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 2 | 21 | 1.00e+00 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 3 | 29 | 1.00e+00 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 4 | 24 | 1.00e+00 |
| KEGG | KEGG:01522 | Endocrine resistance | 9 | 85 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 3 | 35 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 11 | 115 | 1.00e+00 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 7 | 68 | 1.00e+00 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 5 | 60 | 1.00e+00 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 3 | 15 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 6 | 98 | 1.00e+00 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 2 | 44 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 5 | 44 | 1.00e+00 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 2 | 21 | 1.00e+00 |
| KEGG | KEGG:00830 | Retinol metabolism | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:00790 | Folate biosynthesis | 1 | 18 | 1.00e+00 |
| KEGG | KEGG:01100 | Metabolic pathways | 119 | 1149 | 1.00e+00 |
| KEGG | KEGG:01524 | Platinum drug resistance | 5 | 65 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 3 | 46 | 1.00e+00 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 4 | 37 | 1.00e+00 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 6 | 106 | 1.00e+00 |
| KEGG | KEGG:00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:00071 | Fatty acid degradation | 5 | 32 | 1.00e+00 |
| KEGG | KEGG:00062 | Fatty acid elongation | 3 | 24 | 1.00e+00 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 3 | 45 | 1.00e+00 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 2 | 27 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 4 | 25 | 1.00e+00 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 2 | 28 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 3 | 44 | 1.00e+00 |
| KEGG | KEGG:00000 | KEGG root term | 713 | 5802 | 1.00e+00 |
| KEGG | KEGG:00052 | Galactose metabolism | 2 | 22 | 1.00e+00 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 1 | 19 | 1.00e+00 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 2 | 29 | 1.00e+00 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 1 | 39 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 2 | 39 | 1.00e+00 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 2 | 22 | 1.00e+00 |
| KEGG | KEGG:00511 | Other glycan degradation | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 4 | 51 | 1.00e+00 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 2 | 23 | 1.00e+00 |
| KEGG | KEGG:00480 | Glutathione metabolism | 2 | 44 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 1 | 31 | 1.00e+00 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 1 | 4 | 1.00e+00 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 1 | 6 | 1.00e+00 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 3 | 22 | 1.00e+00 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 1 | 23 | 1.00e+00 |
| KEGG | KEGG:00340 | Histidine metabolism | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 5 | 38 | 1.00e+00 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 4 | 43 | 1.00e+00 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 2 | 14 | 1.00e+00 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 10 | 75 | 1.00e+00 |
| KEGG | KEGG:02010 | ABC transporters | 4 | 29 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 4 | 127 | 1.00e+00 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 12 | 83 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 4 | 69 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 18 | 177 | 1.00e+00 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 5 | 25 | 1.00e+00 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 13 | 94 | 1.00e+00 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 10 | 106 | 1.00e+00 |
| KEGG | KEGG:04540 | Gap junction | 8 | 73 | 1.00e+00 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 3 | 49 | 1.00e+00 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 13 | 94 | 1.00e+00 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 7 | 67 | 1.00e+00 |
| KEGG | KEGG:04217 | Necroptosis | 10 | 104 | 1.00e+00 |
| KEGG | KEGG:04216 | Ferroptosis | 6 | 33 | 1.00e+00 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 6 | 54 | 1.00e+00 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 9 | 78 | 1.00e+00 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 5 | 49 | 1.00e+00 |
| KEGG | KEGG:04210 | Apoptosis | 11 | 117 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 2 | 40 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 3 | 41 | 1.00e+00 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 3 | 56 | 1.00e+00 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 6 | 86 | 1.00e+00 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 7 | 53 | 1.00e+00 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 6 | 57 | 1.00e+00 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 5 | 63 | 1.00e+00 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 5 | 30 | 1.00e+00 |
| KEGG | KEGG:04611 | Platelet activation | 13 | 89 | 1.00e+00 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 10 | 87 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 4 | 50 | 1.00e+00 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 4 | 49 | 1.00e+00 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 8 | 117 | 1.00e+00 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 6 | 64 | 1.00e+00 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 14 | 100 | 1.00e+00 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 11 | 76 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 4 | 75 | 1.00e+00 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 24 | 256 | 1.00e+00 |
| KEGG | KEGG:04148 | Efferocytosis | 17 | 125 | 1.00e+00 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 19 | 153 | 1.00e+00 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 5 | 48 | 1.00e+00 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:03430 | Mismatch repair | 4 | 22 | 1.00e+00 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 5 | 59 | 1.00e+00 |
| KEGG | KEGG:03410 | Base excision repair | 5 | 44 | 1.00e+00 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 8 | 99 | 1.00e+00 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 6 | 56 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 3 | 42 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 8 | 132 | 1.00e+00 |
| KEGG | KEGG:03030 | DNA replication | 5 | 35 | 1.00e+00 |
| KEGG | KEGG:03022 | Basal transcription factors | 4 | 40 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 6 | 74 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 7 | 85 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 3 | 30 | 1.00e+00 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 16 | 135 | 1.00e+00 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 2 | 20 | 1.00e+00 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 13 | 89 | 1.00e+00 |
| KEGG | KEGG:04146 | Peroxisome | 5 | 69 | 1.00e+00 |
| KEGG | KEGG:04145 | Phagosome | 6 | 99 | 1.00e+00 |
| KEGG | KEGG:04144 | Endocytosis | 27 | 230 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 6 | 117 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 12 | 160 | 1.00e+00 |
| KEGG | KEGG:04140 | Autophagy - animal | 14 | 157 | 1.00e+00 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 9 | 71 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 10 | 100 | 1.00e+00 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 20 | 134 | 1.00e+00 |
| KEGG | KEGG:04115 | p53 signaling pathway | 7 | 66 | 1.00e+00 |
| KEGG | KEGG:04114 | Oocyte meiosis | 12 | 108 | 1.00e+00 |
| KEGG | KEGG:04110 | Cell cycle | 18 | 151 | 1.00e+00 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 13 | 108 | 1.00e+00 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 12 | 106 | 1.00e+00 |
| KEGG | KEGG:04136 | Autophagy - other | 3 | 31 | 1.00e+00 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 8 | 114 | 1.00e+00 |
EAR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(aes(fill="#F8766D"))+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")+
theme(axis.text.y = element_text(color="black"))+
ggtitle("Intersection EAR")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
ESR
# ESR_int_resgenes <- gost(query = int_ESR_n_RNAresp,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(ESR_int_resgenes,"data/GO_KEGG_analysis/ESR_int_resgenes.RDS")
ESR_int_restable <- ESR_int_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
ESR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in ESR neargenes intersected with RNA response genes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 1141 | 4830 | 7.54e-23 |
| GO:BP | GO:0007275 | multicellular organism development | 845 | 3383 | 4.22e-22 |
| GO:BP | GO:0048856 | anatomical structure development | 995 | 4130 | 7.28e-22 |
| GO:BP | GO:0048869 | cellular developmental process | 755 | 2988 | 1.03e-20 |
| GO:BP | GO:0030154 | cell differentiation | 755 | 2987 | 1.03e-20 |
| GO:BP | GO:0032502 | developmental process | 1056 | 4475 | 1.43e-20 |
| GO:BP | GO:0050896 | response to stimulus | 1298 | 5732 | 3.98e-20 |
| GO:BP | GO:0048731 | system development | 733 | 2903 | 5.55e-20 |
| GO:BP | GO:0007154 | cell communication | 1004 | 4248 | 2.21e-19 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 526 | 1951 | 2.91e-19 |
| GO:BP | GO:0051716 | cellular response to stimulus | 1136 | 4933 | 6.97e-19 |
| GO:BP | GO:0023052 | signaling | 986 | 4180 | 1.21e-18 |
| GO:BP | GO:0050794 | regulation of cellular process | 1638 | 7651 | 4.84e-17 |
| GO:BP | GO:0009888 | tissue development | 399 | 1425 | 7.82e-17 |
| GO:BP | GO:0007165 | signal transduction | 909 | 3846 | 8.15e-17 |
| GO:BP | GO:0050789 | regulation of biological process | 1705 | 8037 | 1.40e-16 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 535 | 2052 | 1.91e-16 |
| GO:BP | GO:0065007 | biological regulation | 1742 | 8275 | 1.38e-15 |
| GO:BP | GO:0048468 | cell development | 519 | 1999 | 1.79e-15 |
| GO:BP | GO:0048513 | animal organ development | 546 | 2130 | 2.92e-15 |
| GO:BP | GO:0050793 | regulation of developmental process | 471 | 1801 | 2.32e-14 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 261 | 876 | 8.27e-14 |
| GO:BP | GO:0007399 | nervous system development | 485 | 1903 | 1.06e-12 |
| GO:BP | GO:0072359 | circulatory system development | 261 | 896 | 1.59e-12 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 951 | 4198 | 3.22e-12 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 308 | 1111 | 5.54e-12 |
| GO:BP | GO:0022008 | neurogenesis | 356 | 1327 | 6.12e-12 |
| GO:BP | GO:0010646 | regulation of cell communication | 627 | 2601 | 6.46e-12 |
| GO:BP | GO:0044057 | regulation of system process | 138 | 399 | 7.00e-12 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1019 | 4561 | 8.57e-12 |
| GO:BP | GO:0035239 | tube morphogenesis | 202 | 668 | 4.18e-11 |
| GO:BP | GO:0023051 | regulation of signaling | 621 | 2597 | 4.57e-11 |
| GO:BP | GO:0035295 | tube development | 237 | 827 | 1.66e-10 |
| GO:BP | GO:0003008 | system process | 321 | 1201 | 2.01e-10 |
| GO:BP | GO:0048519 | negative regulation of biological process | 905 | 4037 | 3.32e-10 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 305 | 1134 | 3.44e-10 |
| GO:BP | GO:0048699 | generation of neurons | 307 | 1145 | 4.22e-10 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 267 | 967 | 4.37e-10 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 208 | 710 | 4.37e-10 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 276 | 1011 | 7.00e-10 |
| GO:BP | GO:0014706 | striated muscle tissue development | 84 | 218 | 1.21e-09 |
| GO:BP | GO:0034330 | cell junction organization | 178 | 591 | 1.40e-09 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 853 | 3804 | 1.92e-09 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 466 | 1900 | 1.92e-09 |
| GO:BP | GO:0048729 | tissue morphogenesis | 150 | 478 | 2.25e-09 |
| GO:BP | GO:0009966 | regulation of signal transduction | 550 | 2307 | 2.47e-09 |
| GO:BP | GO:0030182 | neuron differentiation | 287 | 1080 | 5.84e-09 |
| GO:BP | GO:0030029 | actin filament-based process | 195 | 677 | 9.47e-09 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 667 | 2902 | 1.16e-08 |
| GO:BP | GO:0048589 | developmental growth | 158 | 527 | 2.81e-08 |
| GO:BP | GO:0060429 | epithelium development | 229 | 836 | 3.40e-08 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 77 | 206 | 4.05e-08 |
| GO:BP | GO:0060537 | muscle tissue development | 115 | 353 | 4.32e-08 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 180 | 626 | 5.70e-08 |
| GO:BP | GO:0035556 | intracellular signal transduction | 494 | 2079 | 5.76e-08 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 95 | 276 | 5.95e-08 |
| GO:BP | GO:0009790 | embryo development | 234 | 864 | 6.05e-08 |
| GO:BP | GO:0007155 | cell adhesion | 265 | 1004 | 6.33e-08 |
| GO:BP | GO:0048870 | cell motility | 305 | 1190 | 8.56e-08 |
| GO:BP | GO:0007423 | sensory organ development | 125 | 399 | 1.05e-07 |
| GO:BP | GO:0016477 | cell migration | 280 | 1078 | 1.09e-07 |
| GO:BP | GO:0060485 | mesenchyme development | 89 | 256 | 1.09e-07 |
| GO:BP | GO:0001944 | vasculature development | 166 | 573 | 1.35e-07 |
| GO:BP | GO:0007267 | cell-cell signaling | 296 | 1156 | 1.65e-07 |
| GO:BP | GO:0007507 | heart development | 152 | 515 | 1.68e-07 |
| GO:BP | GO:0031175 | neuron projection development | 216 | 794 | 1.74e-07 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 186 | 662 | 1.77e-07 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 207 | 756 | 2.14e-07 |
| GO:BP | GO:0008283 | cell population proliferation | 344 | 1386 | 2.79e-07 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 471 | 1992 | 2.79e-07 |
| GO:BP | GO:0048666 | neuron development | 237 | 894 | 3.17e-07 |
| GO:BP | GO:0048568 | embryonic organ development | 103 | 317 | 3.27e-07 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 347 | 1403 | 3.43e-07 |
| GO:BP | GO:0007010 | cytoskeleton organization | 307 | 1218 | 4.09e-07 |
| GO:BP | GO:0003012 | muscle system process | 108 | 339 | 4.44e-07 |
| GO:BP | GO:0001568 | blood vessel development | 157 | 546 | 5.78e-07 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 308 | 1227 | 5.86e-07 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 175 | 625 | 6.29e-07 |
| GO:BP | GO:0090257 | regulation of muscle system process | 67 | 181 | 6.29e-07 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 158 | 553 | 7.85e-07 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 155 | 540 | 7.85e-07 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 277 | 1088 | 8.65e-07 |
| GO:BP | GO:0060419 | heart growth | 35 | 72 | 9.96e-07 |
| GO:BP | GO:0030030 | cell projection organization | 314 | 1262 | 1.00e-06 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 202 | 749 | 1.03e-06 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 119 | 391 | 1.25e-06 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 137 | 467 | 1.29e-06 |
| GO:BP | GO:0008016 | regulation of heart contraction | 63 | 170 | 1.52e-06 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 116 | 380 | 1.54e-06 |
| GO:BP | GO:0061061 | muscle structure development | 158 | 559 | 1.59e-06 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 130 | 440 | 1.84e-06 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 311 | 1256 | 1.86e-06 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 179 | 653 | 1.96e-06 |
| GO:BP | GO:0030900 | forebrain development | 94 | 292 | 2.09e-06 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 167 | 601 | 2.13e-06 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 624 | 2780 | 2.17e-06 |
| GO:BP | GO:0035265 | organ growth | 52 | 132 | 2.42e-06 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 284 | 1135 | 2.77e-06 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 286 | 1146 | 3.19e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 561 | 2474 | 3.20e-06 |
| GO:BP | GO:0060322 | head development | 162 | 583 | 3.29e-06 |
| GO:BP | GO:0006915 | apoptotic process | 352 | 1459 | 3.51e-06 |
| GO:BP | GO:0032879 | regulation of localization | 365 | 1521 | 3.51e-06 |
| GO:BP | GO:0043009 | chordate embryonic development | 149 | 529 | 4.56e-06 |
| GO:BP | GO:0060284 | regulation of cell development | 166 | 605 | 5.44e-06 |
| GO:BP | GO:0007417 | central nervous system development | 198 | 748 | 5.49e-06 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 151 | 540 | 5.96e-06 |
| GO:BP | GO:0003013 | circulatory system process | 129 | 446 | 6.92e-06 |
| GO:BP | GO:0008015 | blood circulation | 112 | 374 | 6.97e-06 |
| GO:BP | GO:0021537 | telencephalon development | 71 | 208 | 7.47e-06 |
| GO:BP | GO:0009605 | response to external stimulus | 392 | 1664 | 8.74e-06 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 31 | 65 | 9.11e-06 |
| GO:BP | GO:0010720 | positive regulation of cell development | 100 | 326 | 9.29e-06 |
| GO:BP | GO:0016043 | cellular component organization | 1079 | 5139 | 9.29e-06 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 136 | 479 | 9.64e-06 |
| GO:BP | GO:0042221 | response to chemical | 549 | 2436 | 1.02e-05 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 151 | 545 | 1.02e-05 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 33 | 72 | 1.12e-05 |
| GO:BP | GO:0065008 | regulation of biological quality | 468 | 2039 | 1.16e-05 |
| GO:BP | GO:0040011 | locomotion | 220 | 858 | 1.34e-05 |
| GO:BP | GO:0007420 | brain development | 149 | 539 | 1.40e-05 |
| GO:BP | GO:0060047 | heart contraction | 68 | 200 | 1.48e-05 |
| GO:BP | GO:0008219 | cell death | 358 | 1509 | 1.48e-05 |
| GO:BP | GO:0012501 | programmed cell death | 357 | 1505 | 1.55e-05 |
| GO:BP | GO:0000902 | cell morphogenesis | 199 | 764 | 1.56e-05 |
| GO:BP | GO:0043010 | camera-type eye development | 77 | 236 | 1.59e-05 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 140 | 501 | 1.59e-05 |
| GO:BP | GO:0003205 | cardiac chamber development | 55 | 151 | 1.67e-05 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 49 | 129 | 1.73e-05 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 70 | 209 | 1.79e-05 |
| GO:BP | GO:0040007 | growth | 193 | 739 | 1.87e-05 |
| GO:BP | GO:0003015 | heart process | 70 | 210 | 2.17e-05 |
| GO:BP | GO:0034329 | cell junction assembly | 104 | 349 | 2.17e-05 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 257 | 1036 | 2.18e-05 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 255 | 1027 | 2.23e-05 |
| GO:BP | GO:0051960 | regulation of nervous system development | 106 | 358 | 2.31e-05 |
| GO:BP | GO:0030334 | regulation of cell migration | 186 | 710 | 2.36e-05 |
| GO:BP | GO:0048880 | sensory system development | 86 | 275 | 2.36e-05 |
| GO:BP | GO:0099536 | synaptic signaling | 143 | 518 | 2.36e-05 |
| GO:BP | GO:0006936 | muscle contraction | 84 | 267 | 2.39e-05 |
| GO:BP | GO:0098609 | cell-cell adhesion | 163 | 607 | 2.43e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 569 | 2555 | 2.56e-05 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 138 | 497 | 2.56e-05 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 138 | 497 | 2.56e-05 |
| GO:BP | GO:0001654 | eye development | 85 | 272 | 2.71e-05 |
| GO:BP | GO:0055001 | muscle cell development | 59 | 169 | 2.90e-05 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 404 | 1744 | 2.95e-05 |
| GO:BP | GO:0016310 | phosphorylation | 293 | 1211 | 3.10e-05 |
| GO:BP | GO:0150063 | visual system development | 85 | 273 | 3.14e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 81 | 257 | 3.31e-05 |
| GO:BP | GO:0050808 | synapse organization | 109 | 375 | 3.89e-05 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 450 | 1974 | 3.93e-05 |
| GO:BP | GO:0006468 | protein phosphorylation | 249 | 1008 | 4.28e-05 |
| GO:BP | GO:0051179 | localization | 847 | 3978 | 4.58e-05 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 400 | 1732 | 4.58e-05 |
| GO:BP | GO:0003231 | cardiac ventricle development | 44 | 115 | 4.62e-05 |
| GO:BP | GO:0042692 | muscle cell differentiation | 99 | 334 | 4.62e-05 |
| GO:BP | GO:0002521 | leukocyte differentiation | 113 | 394 | 4.84e-05 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 326 | 1376 | 5.08e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 36 | 87 | 5.09e-05 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 139 | 508 | 5.15e-05 |
| GO:BP | GO:0033002 | muscle cell proliferation | 55 | 157 | 5.61e-05 |
| GO:BP | GO:0040012 | regulation of locomotion | 196 | 766 | 5.66e-05 |
| GO:BP | GO:1903522 | regulation of blood circulation | 66 | 200 | 5.67e-05 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 391 | 1694 | 6.26e-05 |
| GO:BP | GO:2000145 | regulation of cell motility | 191 | 745 | 6.69e-05 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 295 | 1233 | 7.13e-05 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 100 | 342 | 7.56e-05 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 42 | 110 | 8.02e-05 |
| GO:BP | GO:0003007 | heart morphogenesis | 71 | 222 | 8.02e-05 |
| GO:BP | GO:0051049 | regulation of transport | 280 | 1164 | 8.30e-05 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 306 | 1288 | 8.30e-05 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 100 | 343 | 8.49e-05 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 22 | 43 | 9.38e-05 |
| GO:BP | GO:0042592 | homeostatic process | 288 | 1204 | 9.39e-05 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 148 | 554 | 9.39e-05 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 85 | 281 | 1.00e-04 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 27 | 59 | 1.05e-04 |
| GO:BP | GO:0060420 | regulation of heart growth | 24 | 50 | 1.35e-04 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 37 | 94 | 1.36e-04 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 442 | 1959 | 1.41e-04 |
| GO:BP | GO:0070848 | response to growth factor | 152 | 576 | 1.41e-04 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 430 | 1900 | 1.42e-04 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 75 | 242 | 1.43e-04 |
| GO:BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 20 | 38 | 1.48e-04 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 110 | 392 | 1.78e-04 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 102 | 358 | 1.93e-04 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 28 | 64 | 1.93e-04 |
| GO:BP | GO:0023056 | positive regulation of signaling | 304 | 1292 | 1.97e-04 |
| GO:BP | GO:0050877 | nervous system process | 164 | 634 | 1.97e-04 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 208 | 837 | 1.98e-04 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 51 | 148 | 2.02e-04 |
| GO:BP | GO:0001823 | mesonephros development | 32 | 78 | 2.12e-04 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 203 | 815 | 2.16e-04 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 113 | 407 | 2.16e-04 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 35 | 89 | 2.37e-04 |
| GO:BP | GO:0006941 | striated muscle contraction | 52 | 153 | 2.51e-04 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 25 | 55 | 2.62e-04 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 93 | 322 | 2.62e-04 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 510 | 2311 | 2.81e-04 |
| GO:BP | GO:0031644 | regulation of nervous system process | 32 | 79 | 2.81e-04 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 141 | 534 | 2.83e-04 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 27 | 62 | 2.96e-04 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 89 | 306 | 2.98e-04 |
| GO:BP | GO:0030217 | T cell differentiation | 61 | 190 | 3.14e-04 |
| GO:BP | GO:0001657 | ureteric bud development | 31 | 76 | 3.22e-04 |
| GO:BP | GO:0048839 | inner ear development | 47 | 135 | 3.22e-04 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 16 | 28 | 3.26e-04 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 17 | 31 | 3.55e-04 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 34 | 87 | 3.55e-04 |
| GO:BP | GO:0071310 | cellular response to organic substance | 318 | 1370 | 3.58e-04 |
| GO:BP | GO:0045165 | cell fate commitment | 53 | 159 | 3.61e-04 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 45 | 128 | 3.65e-04 |
| GO:BP | GO:0001501 | skeletal system development | 103 | 369 | 4.04e-04 |
| GO:BP | GO:0014032 | neural crest cell development | 29 | 70 | 4.19e-04 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 31 | 77 | 4.19e-04 |
| GO:BP | GO:0072164 | mesonephric tubule development | 31 | 77 | 4.19e-04 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 86 | 296 | 4.19e-04 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 139 | 530 | 4.43e-04 |
| GO:BP | GO:0065009 | regulation of molecular function | 321 | 1389 | 4.57e-04 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 78 | 263 | 4.70e-04 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 125 | 468 | 4.80e-04 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 64 | 205 | 4.80e-04 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 272 | 1154 | 4.98e-04 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 415 | 1852 | 5.07e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 329 | 1430 | 5.07e-04 |
| GO:BP | GO:0099173 | postsynapse organization | 53 | 161 | 5.07e-04 |
| GO:BP | GO:0030048 | actin filament-based movement | 40 | 111 | 5.47e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 76 | 256 | 5.60e-04 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 24 | 54 | 5.60e-04 |
| GO:BP | GO:0048863 | stem cell differentiation | 62 | 198 | 5.70e-04 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 60 | 190 | 5.83e-04 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 26 | 61 | 6.11e-04 |
| GO:BP | GO:0046634 | regulation of alpha-beta T cell activation | 25 | 58 | 7.00e-04 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 125 | 472 | 7.05e-04 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 31 | 79 | 7.14e-04 |
| GO:BP | GO:0043583 | ear development | 51 | 155 | 7.14e-04 |
| GO:BP | GO:0046620 | regulation of organ growth | 29 | 72 | 7.28e-04 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 34 | 90 | 7.28e-04 |
| GO:BP | GO:0030001 | metal ion transport | 143 | 554 | 7.28e-04 |
| GO:BP | GO:0048565 | digestive tract development | 34 | 90 | 7.28e-04 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 21 | 45 | 7.34e-04 |
| GO:BP | GO:0001525 | angiogenesis | 108 | 397 | 7.45e-04 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 24 | 55 | 7.69e-04 |
| GO:BP | GO:0009987 | cellular process | 2214 | 11450 | 8.14e-04 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 57 | 180 | 8.16e-04 |
| GO:BP | GO:0055123 | digestive system development | 36 | 98 | 8.31e-04 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 51 | 156 | 8.31e-04 |
| GO:BP | GO:0006950 | response to stress | 585 | 2715 | 8.32e-04 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 15 | 27 | 8.38e-04 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 134 | 515 | 8.46e-04 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 196 | 802 | 8.71e-04 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 17 | 33 | 8.81e-04 |
| GO:BP | GO:0031667 | response to nutrient levels | 101 | 368 | 8.92e-04 |
| GO:BP | GO:0007389 | pattern specification process | 87 | 307 | 8.98e-04 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 57 | 181 | 9.38e-04 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 32 | 84 | 9.75e-04 |
| GO:BP | GO:0002027 | regulation of heart rate | 32 | 84 | 9.75e-04 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 63 | 206 | 9.86e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 166 | 664 | 1.00e-03 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 170 | 683 | 1.04e-03 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 59 | 190 | 1.06e-03 |
| GO:BP | GO:0050807 | regulation of synapse organization | 58 | 186 | 1.07e-03 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 43 | 126 | 1.07e-03 |
| GO:BP | GO:0019222 | regulation of metabolic process | 1010 | 4914 | 1.10e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 84 | 296 | 1.12e-03 |
| GO:BP | GO:0010033 | response to organic substance | 408 | 1835 | 1.12e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1091 | 5340 | 1.14e-03 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 13 | 22 | 1.15e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 29 | 74 | 1.19e-03 |
| GO:BP | GO:0072073 | kidney epithelium development | 40 | 115 | 1.19e-03 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 245 | 1040 | 1.20e-03 |
| GO:BP | GO:0006816 | calcium ion transport | 78 | 271 | 1.21e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 27 | 67 | 1.21e-03 |
| GO:BP | GO:0048771 | tissue remodeling | 41 | 119 | 1.21e-03 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 65 | 216 | 1.21e-03 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 934 | 4521 | 1.21e-03 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 119 | 452 | 1.25e-03 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 14 | 25 | 1.26e-03 |
| GO:BP | GO:0035148 | tube formation | 44 | 131 | 1.27e-03 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 184 | 752 | 1.30e-03 |
| GO:BP | GO:0048713 | regulation of oligodendrocyte differentiation | 15 | 28 | 1.32e-03 |
| GO:BP | GO:0097106 | postsynaptic density organization | 16 | 31 | 1.33e-03 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 16 | 31 | 1.33e-03 |
| GO:BP | GO:0016358 | dendrite development | 60 | 196 | 1.33e-03 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 294 | 1279 | 1.33e-03 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 121 | 462 | 1.35e-03 |
| GO:BP | GO:0061448 | connective tissue development | 65 | 217 | 1.36e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 143 | 563 | 1.44e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 29 | 75 | 1.46e-03 |
| GO:BP | GO:0099545 | trans-synaptic signaling by trans-synaptic complex | 6 | 6 | 1.46e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 29 | 75 | 1.46e-03 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 452 | 2061 | 1.46e-03 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 141 | 554 | 1.46e-03 |
| GO:BP | GO:0048864 | stem cell development | 29 | 75 | 1.46e-03 |
| GO:BP | GO:0001775 | cell activation | 165 | 665 | 1.46e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 27 | 68 | 1.53e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 38 | 109 | 1.59e-03 |
| GO:BP | GO:0072132 | mesenchyme morphogenesis | 22 | 51 | 1.72e-03 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 41 | 121 | 1.72e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 488 | 2246 | 1.76e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 88 | 318 | 1.79e-03 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 59 | 194 | 1.79e-03 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 18 | 38 | 1.81e-03 |
| GO:BP | GO:0003279 | cardiac septum development | 36 | 102 | 1.82e-03 |
| GO:BP | GO:0042471 | ear morphogenesis | 29 | 76 | 1.87e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 29 | 76 | 1.87e-03 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 78 | 275 | 1.87e-03 |
| GO:BP | GO:0042110 | T cell activation | 89 | 323 | 1.88e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 21 | 48 | 1.90e-03 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 17 | 35 | 1.90e-03 |
| GO:BP | GO:0007015 | actin filament organization | 102 | 381 | 1.97e-03 |
| GO:BP | GO:0072001 | renal system development | 73 | 254 | 1.97e-03 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 30 | 80 | 2.00e-03 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 14 | 26 | 2.00e-03 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 41 | 122 | 2.01e-03 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 41 | 122 | 2.01e-03 |
| GO:BP | GO:0010721 | negative regulation of cell development | 59 | 195 | 2.01e-03 |
| GO:BP | GO:0042594 | response to starvation | 56 | 183 | 2.16e-03 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 66 | 225 | 2.18e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 297 | 1304 | 2.22e-03 |
| GO:BP | GO:0007517 | muscle organ development | 79 | 281 | 2.23e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 26 | 66 | 2.26e-03 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 38 | 111 | 2.30e-03 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 50 | 159 | 2.37e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 257 | 1111 | 2.40e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 296 | 1301 | 2.44e-03 |
| GO:BP | GO:0021915 | neural tube development | 45 | 139 | 2.44e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 30 | 81 | 2.50e-03 |
| GO:BP | GO:0060443 | mammary gland morphogenesis | 18 | 39 | 2.55e-03 |
| GO:BP | GO:0030903 | notochord development | 11 | 18 | 2.56e-03 |
| GO:BP | GO:0006810 | transport | 669 | 3176 | 2.56e-03 |
| GO:BP | GO:0061564 | axon development | 106 | 402 | 2.58e-03 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 31 | 85 | 2.63e-03 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 31 | 85 | 2.63e-03 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 67 | 231 | 2.68e-03 |
| GO:BP | GO:0046635 | positive regulation of alpha-beta T cell activation | 17 | 36 | 2.75e-03 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 256 | 1109 | 2.77e-03 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 46 | 144 | 2.84e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 44 | 136 | 2.86e-03 |
| GO:BP | GO:0001570 | vasculogenesis | 26 | 67 | 2.87e-03 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 26 | 67 | 2.87e-03 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 12 | 21 | 2.89e-03 |
| GO:BP | GO:0046649 | lymphocyte activation | 122 | 476 | 2.89e-03 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 16 | 33 | 2.90e-03 |
| GO:BP | GO:0051641 | cellular localization | 593 | 2793 | 3.04e-03 |
| GO:BP | GO:1902742 | apoptotic process involved in development | 15 | 30 | 3.05e-03 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 14 | 27 | 3.11e-03 |
| GO:BP | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 14 | 27 | 3.11e-03 |
| GO:BP | GO:0008150 | biological_process | 2312 | 12051 | 3.13e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 149 | 602 | 3.21e-03 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 40 | 121 | 3.34e-03 |
| GO:BP | GO:0060349 | bone morphogenesis | 28 | 75 | 3.38e-03 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 84 | 307 | 3.40e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 453 | 2088 | 3.43e-03 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 199 | 839 | 3.45e-03 |
| GO:BP | GO:0031503 | protein-containing complex localization | 52 | 170 | 3.48e-03 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 62 | 212 | 3.50e-03 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 128 | 506 | 3.50e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 217 | 926 | 3.62e-03 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 26 | 68 | 3.63e-03 |
| GO:BP | GO:0045216 | cell-cell junction organization | 49 | 158 | 3.65e-03 |
| GO:BP | GO:0042391 | regulation of membrane potential | 82 | 299 | 3.65e-03 |
| GO:BP | GO:0050863 | regulation of T cell activation | 63 | 217 | 3.83e-03 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 436 | 2006 | 3.88e-03 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 17 | 37 | 3.88e-03 |
| GO:BP | GO:0072175 | epithelial tube formation | 40 | 122 | 3.91e-03 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 601 | 2842 | 3.99e-03 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 51 | 167 | 4.07e-03 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 67 | 235 | 4.25e-03 |
| GO:BP | GO:0051235 | maintenance of location | 73 | 261 | 4.25e-03 |
| GO:BP | GO:0007409 | axonogenesis | 96 | 363 | 4.30e-03 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 19 | 44 | 4.30e-03 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 19 | 44 | 4.30e-03 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 19 | 44 | 4.30e-03 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 19 | 44 | 4.30e-03 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 19 | 44 | 4.30e-03 |
| GO:BP | GO:0045580 | regulation of T cell differentiation | 37 | 111 | 4.55e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 26 | 69 | 4.57e-03 |
| GO:BP | GO:0051234 | establishment of localization | 718 | 3447 | 4.67e-03 |
| GO:BP | GO:0060603 | mammary gland duct morphogenesis | 14 | 28 | 4.72e-03 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 60 | 206 | 4.72e-03 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 12 | 22 | 4.74e-03 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 32 | 92 | 4.99e-03 |
| GO:BP | GO:0048588 | developmental cell growth | 57 | 194 | 5.20e-03 |
| GO:BP | GO:0060173 | limb development | 45 | 144 | 5.20e-03 |
| GO:BP | GO:0048736 | appendage development | 45 | 144 | 5.20e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 170 | 708 | 5.20e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 73 | 263 | 5.23e-03 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 923 | 4515 | 5.30e-03 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 36 | 108 | 5.35e-03 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 41 | 128 | 5.38e-03 |
| GO:BP | GO:0035107 | appendage morphogenesis | 38 | 116 | 5.38e-03 |
| GO:BP | GO:0035108 | limb morphogenesis | 38 | 116 | 5.38e-03 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 49 | 161 | 5.55e-03 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 196 | 833 | 5.55e-03 |
| GO:BP | GO:0050865 | regulation of cell activation | 96 | 366 | 5.60e-03 |
| GO:BP | GO:0042063 | gliogenesis | 71 | 255 | 5.61e-03 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 21 | 52 | 5.88e-03 |
| GO:BP | GO:1901342 | regulation of vasculature development | 60 | 208 | 6.00e-03 |
| GO:BP | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 27 | 74 | 6.08e-03 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 438 | 2028 | 6.08e-03 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 59 | 204 | 6.20e-03 |
| GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 42 | 133 | 6.22e-03 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 73 | 265 | 6.41e-03 |
| GO:BP | GO:0042330 | taxis | 73 | 265 | 6.41e-03 |
| GO:BP | GO:0006935 | chemotaxis | 73 | 265 | 6.41e-03 |
| GO:BP | GO:0051249 | regulation of lymphocyte activation | 80 | 296 | 6.45e-03 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 15 | 32 | 6.45e-03 |
| GO:BP | GO:0060348 | bone development | 48 | 158 | 6.45e-03 |
| GO:BP | GO:0010468 | regulation of gene expression | 748 | 3613 | 6.45e-03 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 787 | 3815 | 6.47e-03 |
| GO:BP | GO:0006811 | monoatomic ion transport | 182 | 769 | 6.47e-03 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 22 | 56 | 6.47e-03 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 22 | 56 | 6.47e-03 |
| GO:BP | GO:0050919 | negative chemotaxis | 18 | 42 | 6.47e-03 |
| GO:BP | GO:0009267 | cellular response to starvation | 47 | 154 | 6.52e-03 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 60 | 209 | 6.61e-03 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 10 | 17 | 6.66e-03 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 10 | 17 | 6.66e-03 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 10 | 17 | 6.66e-03 |
| GO:BP | GO:0035270 | endocrine system development | 30 | 86 | 6.70e-03 |
| GO:BP | GO:0048483 | autonomic nervous system development | 14 | 29 | 6.79e-03 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 769 | 3724 | 6.79e-03 |
| GO:BP | GO:0001764 | neuron migration | 43 | 138 | 6.96e-03 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 32 | 94 | 7.03e-03 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 49 | 163 | 7.10e-03 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 13 | 26 | 7.16e-03 |
| GO:BP | GO:0050866 | negative regulation of cell activation | 39 | 122 | 7.25e-03 |
| GO:BP | GO:0048709 | oligodendrocyte differentiation | 27 | 75 | 7.28e-03 |
| GO:BP | GO:0045582 | positive regulation of T cell differentiation | 27 | 75 | 7.28e-03 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 12 | 23 | 7.29e-03 |
| GO:BP | GO:0048645 | animal organ formation | 21 | 53 | 7.32e-03 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 47 | 155 | 7.32e-03 |
| GO:BP | GO:0097120 | receptor localization to synapse | 21 | 53 | 7.32e-03 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 95 | 365 | 7.32e-03 |
| GO:BP | GO:0061035 | regulation of cartilage development | 21 | 53 | 7.32e-03 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 791 | 3841 | 7.32e-03 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 56 | 193 | 7.37e-03 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 19 | 46 | 7.41e-03 |
| GO:BP | GO:0031032 | actomyosin structure organization | 55 | 189 | 7.58e-03 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 105 | 411 | 7.58e-03 |
| GO:BP | GO:0045444 | fat cell differentiation | 55 | 189 | 7.58e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 84 | 316 | 7.61e-03 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 70 | 254 | 7.65e-03 |
| GO:BP | GO:0031641 | regulation of myelination | 16 | 36 | 7.93e-03 |
| GO:BP | GO:0072089 | stem cell proliferation | 30 | 87 | 7.93e-03 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 30 | 87 | 7.93e-03 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 140 | 574 | 7.96e-03 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 87 | 330 | 7.97e-03 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 8 | 12 | 8.02e-03 |
| GO:BP | GO:0014020 | primary neural tube formation | 31 | 91 | 8.03e-03 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 31 | 91 | 8.03e-03 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 351 | 1601 | 8.03e-03 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 126 | 509 | 8.13e-03 |
| GO:BP | GO:0002376 | immune system process | 333 | 1512 | 8.18e-03 |
| GO:BP | GO:0031099 | regeneration | 45 | 148 | 8.70e-03 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 152 | 632 | 8.75e-03 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 108 | 427 | 9.02e-03 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 116 | 464 | 9.08e-03 |
| GO:BP | GO:0001649 | osteoblast differentiation | 53 | 182 | 9.08e-03 |
| GO:BP | GO:0001822 | kidney development | 68 | 247 | 9.18e-03 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 30 | 88 | 9.56e-03 |
| GO:BP | GO:0060606 | tube closure | 30 | 88 | 9.56e-03 |
| GO:BP | GO:0010001 | glial cell differentiation | 55 | 191 | 9.60e-03 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 14 | 30 | 9.60e-03 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 38 | 120 | 9.74e-03 |
| GO:BP | GO:0031214 | biomineral tissue development | 37 | 116 | 9.79e-03 |
| GO:BP | GO:0001841 | neural tube formation | 32 | 96 | 9.79e-03 |
| GO:BP | GO:0030316 | osteoclast differentiation | 25 | 69 | 9.80e-03 |
| GO:BP | GO:0040008 | regulation of growth | 122 | 493 | 9.80e-03 |
| GO:BP | GO:0003417 | growth plate cartilage development | 9 | 15 | 9.90e-03 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 217 | 946 | 9.90e-03 |
| GO:BP | GO:0030033 | microvillus assembly | 9 | 15 | 9.90e-03 |
| GO:BP | GO:0072170 | metanephric tubule development | 9 | 15 | 9.90e-03 |
| GO:BP | GO:0048844 | artery morphogenesis | 22 | 58 | 1.01e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 349 | 1597 | 1.01e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 13 | 27 | 1.02e-02 |
| GO:BP | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 13 | 27 | 1.02e-02 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 20 | 51 | 1.07e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 20 | 51 | 1.07e-02 |
| GO:BP | GO:0003176 | aortic valve development | 16 | 37 | 1.07e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 23 | 62 | 1.08e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 23 | 62 | 1.08e-02 |
| GO:BP | GO:1901698 | response to nitrogen compound | 181 | 774 | 1.08e-02 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 107 | 425 | 1.08e-02 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 545 | 2589 | 1.08e-02 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 159 | 669 | 1.09e-02 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 39 | 125 | 1.09e-02 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 39 | 125 | 1.09e-02 |
| GO:BP | GO:0060561 | apoptotic process involved in morphogenesis | 11 | 21 | 1.10e-02 |
| GO:BP | GO:0060840 | artery development | 29 | 85 | 1.10e-02 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 50 | 171 | 1.10e-02 |
| GO:BP | GO:0051250 | negative regulation of lymphocyte activation | 30 | 89 | 1.12e-02 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 106 | 421 | 1.12e-02 |
| GO:BP | GO:0003170 | heart valve development | 24 | 66 | 1.12e-02 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 36 | 113 | 1.12e-02 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 24 | 66 | 1.12e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 31 | 93 | 1.12e-02 |
| GO:BP | GO:0022612 | gland morphogenesis | 33 | 101 | 1.13e-02 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 33 | 101 | 1.13e-02 |
| GO:BP | GO:0071872 | cellular response to epinephrine stimulus | 7 | 10 | 1.13e-02 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 542 | 2576 | 1.14e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 257 | 1145 | 1.15e-02 |
| GO:BP | GO:0003230 | cardiac atrium development | 15 | 34 | 1.17e-02 |
| GO:BP | GO:0010799 | regulation of peptidyl-threonine phosphorylation | 15 | 34 | 1.17e-02 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 138 | 571 | 1.17e-02 |
| GO:BP | GO:0003161 | cardiac conduction system development | 15 | 34 | 1.17e-02 |
| GO:BP | GO:0055002 | striated muscle cell development | 25 | 70 | 1.17e-02 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 150 | 628 | 1.18e-02 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 26 | 74 | 1.20e-02 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 26 | 74 | 1.20e-02 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 26 | 74 | 1.20e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 19 | 48 | 1.20e-02 |
| GO:BP | GO:1905314 | semi-lunar valve development | 17 | 41 | 1.22e-02 |
| GO:BP | GO:0043954 | cellular component maintenance | 22 | 59 | 1.22e-02 |
| GO:BP | GO:0006812 | monoatomic cation transport | 155 | 653 | 1.27e-02 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 28 | 82 | 1.27e-02 |
| GO:BP | GO:0045687 | positive regulation of glial cell differentiation | 14 | 31 | 1.30e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 30 | 90 | 1.30e-02 |
| GO:BP | GO:0033036 | macromolecule localization | 517 | 2453 | 1.30e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 35 | 110 | 1.30e-02 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 43 | 143 | 1.31e-02 |
| GO:BP | GO:0030879 | mammary gland development | 34 | 106 | 1.31e-02 |
| GO:BP | GO:0006996 | organelle organization | 624 | 3001 | 1.31e-02 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 32 | 98 | 1.31e-02 |
| GO:BP | GO:0007613 | memory | 31 | 94 | 1.31e-02 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 20 | 52 | 1.32e-02 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 119 | 484 | 1.32e-02 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 119 | 484 | 1.32e-02 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 168 | 716 | 1.32e-02 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 108 | 433 | 1.33e-02 |
| GO:BP | GO:0050868 | negative regulation of T cell activation | 24 | 67 | 1.35e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 62 | 225 | 1.35e-02 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 96 | 378 | 1.36e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 53 | 186 | 1.38e-02 |
| GO:BP | GO:0003002 | regionalization | 73 | 274 | 1.39e-02 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 13 | 28 | 1.40e-02 |
| GO:BP | GO:0001816 | cytokine production | 119 | 485 | 1.40e-02 |
| GO:BP | GO:0003171 | atrioventricular valve development | 13 | 28 | 1.40e-02 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 13 | 28 | 1.40e-02 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 21 | 56 | 1.41e-02 |
| GO:BP | GO:0048145 | regulation of fibroblast proliferation | 26 | 75 | 1.43e-02 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 26 | 75 | 1.43e-02 |
| GO:BP | GO:1905874 | regulation of postsynaptic density organization | 8 | 13 | 1.44e-02 |
| GO:BP | GO:0048486 | parasympathetic nervous system development | 8 | 13 | 1.44e-02 |
| GO:BP | GO:0072006 | nephron development | 37 | 119 | 1.44e-02 |
| GO:BP | GO:0001817 | regulation of cytokine production | 118 | 481 | 1.46e-02 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 27 | 79 | 1.46e-02 |
| GO:BP | GO:0009611 | response to wounding | 101 | 402 | 1.46e-02 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 54 | 191 | 1.47e-02 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 35 | 111 | 1.48e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 28 | 83 | 1.48e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 34 | 107 | 1.49e-02 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 42 | 140 | 1.49e-02 |
| GO:BP | GO:0001755 | neural crest cell migration | 19 | 49 | 1.49e-02 |
| GO:BP | GO:0001843 | neural tube closure | 29 | 87 | 1.49e-02 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 12 | 25 | 1.49e-02 |
| GO:BP | GO:0001818 | negative regulation of cytokine production | 50 | 174 | 1.49e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 12 | 25 | 1.49e-02 |
| GO:BP | GO:0003418 | growth plate cartilage chondrocyte differentiation | 6 | 8 | 1.50e-02 |
| GO:BP | GO:0032634 | interleukin-5 production | 6 | 8 | 1.50e-02 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 56 | 200 | 1.50e-02 |
| GO:BP | GO:0032674 | regulation of interleukin-5 production | 6 | 8 | 1.50e-02 |
| GO:BP | GO:0001659 | temperature homeostasis | 41 | 136 | 1.50e-02 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 56 | 200 | 1.50e-02 |
| GO:BP | GO:0045542 | positive regulation of cholesterol biosynthetic process | 6 | 8 | 1.50e-02 |
| GO:BP | GO:0106120 | positive regulation of sterol biosynthetic process | 6 | 8 | 1.50e-02 |
| GO:BP | GO:0048732 | gland development | 84 | 325 | 1.52e-02 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 49 | 170 | 1.52e-02 |
| GO:BP | GO:0051216 | cartilage development | 45 | 153 | 1.53e-02 |
| GO:BP | GO:0007416 | synapse assembly | 45 | 153 | 1.53e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 55 | 196 | 1.54e-02 |
| GO:BP | GO:0010893 | positive regulation of steroid biosynthetic process | 9 | 16 | 1.55e-02 |
| GO:BP | GO:0048339 | paraxial mesoderm development | 9 | 16 | 1.55e-02 |
| GO:BP | GO:0072207 | metanephric epithelium development | 9 | 16 | 1.55e-02 |
| GO:BP | GO:0140352 | export from cell | 148 | 624 | 1.55e-02 |
| GO:BP | GO:0048499 | synaptic vesicle membrane organization | 11 | 22 | 1.55e-02 |
| GO:BP | GO:0001780 | neutrophil homeostasis | 9 | 16 | 1.55e-02 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 376 | 1746 | 1.55e-02 |
| GO:BP | GO:1902106 | negative regulation of leukocyte differentiation | 24 | 68 | 1.58e-02 |
| GO:BP | GO:0019934 | cGMP-mediated signaling | 10 | 19 | 1.58e-02 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 10 | 19 | 1.58e-02 |
| GO:BP | GO:0031646 | positive regulation of nervous system process | 10 | 19 | 1.58e-02 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 127 | 525 | 1.58e-02 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 207 | 909 | 1.60e-02 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 61 | 223 | 1.65e-02 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 133 | 554 | 1.65e-02 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 245 | 1096 | 1.68e-02 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 34 | 108 | 1.68e-02 |
| GO:BP | GO:0003197 | endocardial cushion development | 18 | 46 | 1.69e-02 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 18 | 46 | 1.69e-02 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 41 | 137 | 1.69e-02 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 18 | 46 | 1.69e-02 |
| GO:BP | GO:0097485 | neuron projection guidance | 52 | 184 | 1.69e-02 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 124 | 512 | 1.69e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 100 | 400 | 1.69e-02 |
| GO:BP | GO:0007411 | axon guidance | 52 | 184 | 1.69e-02 |
| GO:BP | GO:0001503 | ossification | 83 | 322 | 1.69e-02 |
| GO:BP | GO:0043500 | muscle adaptation | 30 | 92 | 1.70e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 16 | 39 | 1.73e-02 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 39 | 129 | 1.75e-02 |
| GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 94 | 373 | 1.78e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 61 | 224 | 1.81e-02 |
| GO:BP | GO:0045685 | regulation of glial cell differentiation | 19 | 50 | 1.84e-02 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 36 | 117 | 1.87e-02 |
| GO:BP | GO:0098657 | import into cell | 155 | 661 | 1.87e-02 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 13 | 29 | 1.87e-02 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 13 | 29 | 1.87e-02 |
| GO:BP | GO:0045927 | positive regulation of growth | 55 | 198 | 1.87e-02 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 407 | 1908 | 1.87e-02 |
| GO:BP | GO:0021591 | ventricular system development | 13 | 29 | 1.87e-02 |
| GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 13 | 29 | 1.87e-02 |
| GO:BP | GO:0061026 | cardiac muscle tissue regeneration | 5 | 6 | 1.88e-02 |
| GO:BP | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress | 5 | 6 | 1.88e-02 |
| GO:BP | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway | 5 | 6 | 1.88e-02 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 24 | 69 | 1.88e-02 |
| GO:BP | GO:0030432 | peristalsis | 5 | 6 | 1.88e-02 |
| GO:BP | GO:0072173 | metanephric tubule morphogenesis | 5 | 6 | 1.88e-02 |
| GO:BP | GO:0010616 | negative regulation of cardiac muscle adaptation | 5 | 6 | 1.88e-02 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 25 | 73 | 1.91e-02 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 25 | 73 | 1.91e-02 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 25 | 73 | 1.91e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 17 | 43 | 1.92e-02 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 32 | 101 | 1.95e-02 |
| GO:BP | GO:0098910 | regulation of atrial cardiac muscle cell action potential | 4 | 4 | 1.95e-02 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 15 | 36 | 1.95e-02 |
| GO:BP | GO:0110030 | regulation of G2/MI transition of meiotic cell cycle | 4 | 4 | 1.95e-02 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 15 | 36 | 1.95e-02 |
| GO:BP | GO:0032898 | neurotrophin production | 4 | 4 | 1.95e-02 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 63 | 234 | 1.98e-02 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 43 | 147 | 2.00e-02 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 58 | 212 | 2.00e-02 |
| GO:BP | GO:0008366 | axon ensheathment | 38 | 126 | 2.01e-02 |
| GO:BP | GO:0007272 | ensheathment of neurons | 38 | 126 | 2.01e-02 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 21 | 58 | 2.03e-02 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 21 | 58 | 2.03e-02 |
| GO:BP | GO:0060033 | anatomical structure regression | 7 | 11 | 2.04e-02 |
| GO:BP | GO:0030852 | regulation of granulocyte differentiation | 7 | 11 | 2.04e-02 |
| GO:BP | GO:0021670 | lateral ventricle development | 7 | 11 | 2.04e-02 |
| GO:BP | GO:0035435 | phosphate ion transmembrane transport | 7 | 11 | 2.04e-02 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 78 | 302 | 2.07e-02 |
| GO:BP | GO:0051050 | positive regulation of transport | 143 | 606 | 2.09e-02 |
| GO:BP | GO:0061572 | actin filament bundle organization | 41 | 139 | 2.10e-02 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 41 | 139 | 2.10e-02 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 22 | 62 | 2.10e-02 |
| GO:BP | GO:0030902 | hindbrain development | 35 | 114 | 2.14e-02 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 34 | 110 | 2.18e-02 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 11 | 23 | 2.18e-02 |
| GO:BP | GO:0007548 | sex differentiation | 53 | 191 | 2.18e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 11 | 23 | 2.18e-02 |
| GO:BP | GO:0002021 | response to dietary excess | 11 | 23 | 2.18e-02 |
| GO:BP | GO:0009119 | ribonucleoside metabolic process | 11 | 23 | 2.18e-02 |
| GO:BP | GO:0003283 | atrial septum development | 11 | 23 | 2.18e-02 |
| GO:BP | GO:0006939 | smooth muscle contraction | 24 | 70 | 2.22e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 24 | 70 | 2.22e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 32 | 102 | 2.22e-02 |
| GO:BP | GO:0002695 | negative regulation of leukocyte activation | 32 | 102 | 2.22e-02 |
| GO:BP | GO:0031016 | pancreas development | 19 | 51 | 2.22e-02 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 145 | 617 | 2.25e-02 |
| GO:BP | GO:0046660 | female sex differentiation | 29 | 90 | 2.29e-02 |
| GO:BP | GO:1903312 | negative regulation of mRNA metabolic process | 28 | 86 | 2.29e-02 |
| GO:BP | GO:0030282 | bone mineralization | 28 | 86 | 2.29e-02 |
| GO:BP | GO:0072234 | metanephric nephron tubule development | 8 | 14 | 2.30e-02 |
| GO:BP | GO:0048485 | sympathetic nervous system development | 8 | 14 | 2.30e-02 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 8 | 14 | 2.30e-02 |
| GO:BP | GO:0010885 | regulation of cholesterol storage | 8 | 14 | 2.30e-02 |
| GO:BP | GO:0060444 | branching involved in mammary gland duct morphogenesis | 10 | 20 | 2.30e-02 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 106 | 433 | 2.32e-02 |
| GO:BP | GO:0046903 | secretion | 153 | 656 | 2.32e-02 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 9 | 17 | 2.35e-02 |
| GO:BP | GO:0019725 | cellular homeostasis | 140 | 594 | 2.35e-02 |
| GO:BP | GO:0097107 | postsynaptic density assembly | 9 | 17 | 2.35e-02 |
| GO:BP | GO:0032814 | regulation of natural killer cell activation | 9 | 17 | 2.35e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 56 | 205 | 2.35e-02 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 110 | 452 | 2.35e-02 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 192 | 845 | 2.35e-02 |
| GO:BP | GO:0098815 | modulation of excitatory postsynaptic potential | 17 | 44 | 2.38e-02 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 40 | 136 | 2.41e-02 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 47 | 166 | 2.42e-02 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 21 | 59 | 2.43e-02 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 165 | 715 | 2.46e-02 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 192 | 846 | 2.46e-02 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 863 | 4269 | 2.47e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 195 | 861 | 2.50e-02 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 59 | 219 | 2.51e-02 |
| GO:BP | GO:0061614 | miRNA transcription | 22 | 63 | 2.51e-02 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 59 | 219 | 2.51e-02 |
| GO:BP | GO:0001701 | in utero embryonic development | 87 | 346 | 2.51e-02 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 104 | 425 | 2.52e-02 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 101 | 411 | 2.52e-02 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 163 | 706 | 2.53e-02 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 38 | 128 | 2.53e-02 |
| GO:BP | GO:0014015 | positive regulation of gliogenesis | 18 | 48 | 2.56e-02 |
| GO:BP | GO:0030239 | myofibril assembly | 23 | 67 | 2.56e-02 |
| GO:BP | GO:0060021 | roof of mouth development | 24 | 71 | 2.60e-02 |
| GO:BP | GO:0042552 | myelination | 37 | 124 | 2.60e-02 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 29 | 91 | 2.61e-02 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 29 | 91 | 2.61e-02 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 29 | 91 | 2.61e-02 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 103 | 421 | 2.62e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 249 | 1128 | 2.64e-02 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 36 | 120 | 2.66e-02 |
| GO:BP | GO:0042490 | mechanoreceptor differentiation | 19 | 52 | 2.71e-02 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 135 | 573 | 2.73e-02 |
| GO:BP | GO:0014009 | glial cell proliferation | 16 | 41 | 2.75e-02 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 635 | 3089 | 2.77e-02 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 67 | 256 | 2.77e-02 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 109 | 450 | 2.77e-02 |
| GO:BP | GO:0046847 | filopodium assembly | 20 | 56 | 2.84e-02 |
| GO:BP | GO:2000106 | regulation of leukocyte apoptotic process | 20 | 56 | 2.84e-02 |
| GO:BP | GO:0010656 | negative regulation of muscle cell apoptotic process | 14 | 34 | 2.84e-02 |
| GO:BP | GO:0090102 | cochlea development | 14 | 34 | 2.84e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 42 | 146 | 2.85e-02 |
| GO:BP | GO:0032409 | regulation of transporter activity | 45 | 159 | 2.87e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 60 | 225 | 2.87e-02 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 77 | 302 | 2.89e-02 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 21 | 60 | 2.93e-02 |
| GO:BP | GO:0086027 | AV node cell to bundle of His cell signaling | 6 | 9 | 2.96e-02 |
| GO:BP | GO:0003162 | atrioventricular node development | 6 | 9 | 2.96e-02 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 6 | 9 | 2.96e-02 |
| GO:BP | GO:1900116 | extracellular negative regulation of signal transduction | 6 | 9 | 2.96e-02 |
| GO:BP | GO:0042693 | muscle cell fate commitment | 6 | 9 | 2.96e-02 |
| GO:BP | GO:0086016 | AV node cell action potential | 6 | 9 | 2.96e-02 |
| GO:BP | GO:1900115 | extracellular regulation of signal transduction | 6 | 9 | 2.96e-02 |
| GO:BP | GO:0048340 | paraxial mesoderm morphogenesis | 6 | 9 | 2.96e-02 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 17 | 45 | 2.96e-02 |
| GO:BP | GO:0098698 | postsynaptic specialization assembly | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0045761 | regulation of adenylate cyclase activity | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 61 | 230 | 2.96e-02 |
| GO:BP | GO:0003272 | endocardial cushion formation | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 63 | 239 | 2.96e-02 |
| GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0098868 | bone growth | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0099558 | maintenance of synapse structure | 11 | 24 | 2.96e-02 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 22 | 64 | 2.96e-02 |
| GO:BP | GO:0014887 | cardiac muscle adaptation | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0044342 | type B pancreatic cell proliferation | 11 | 24 | 2.96e-02 |
| GO:BP | GO:0070661 | leukocyte proliferation | 52 | 190 | 2.96e-02 |
| GO:BP | GO:0048144 | fibroblast proliferation | 29 | 92 | 2.96e-02 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 29 | 92 | 2.96e-02 |
| GO:BP | GO:0046651 | lymphocyte proliferation | 46 | 164 | 3.02e-02 |
| GO:BP | GO:0060996 | dendritic spine development | 27 | 84 | 3.02e-02 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 51 | 186 | 3.06e-02 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 34 | 113 | 3.12e-02 |
| GO:BP | GO:1903539 | protein localization to postsynaptic membrane | 15 | 38 | 3.12e-02 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 45 | 160 | 3.14e-02 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 71 | 276 | 3.16e-02 |
| GO:BP | GO:0006351 | DNA-templated transcription | 555 | 2683 | 3.19e-02 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 76 | 299 | 3.20e-02 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 98 | 401 | 3.21e-02 |
| GO:BP | GO:0035024 | negative regulation of Rho protein signal transduction | 10 | 21 | 3.23e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 10 | 21 | 3.23e-02 |
| GO:BP | GO:0099560 | synaptic membrane adhesion | 10 | 21 | 3.23e-02 |
| GO:BP | GO:0099637 | neurotransmitter receptor transport | 10 | 21 | 3.23e-02 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 138 | 591 | 3.24e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 44 | 156 | 3.24e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 19 | 53 | 3.24e-02 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 37 | 126 | 3.24e-02 |
| GO:BP | GO:0007600 | sensory perception | 68 | 263 | 3.32e-02 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 171 | 751 | 3.34e-02 |
| GO:BP | GO:0060392 | negative regulation of SMAD protein signal transduction | 9 | 18 | 3.40e-02 |
| GO:BP | GO:0045618 | positive regulation of keratinocyte differentiation | 7 | 12 | 3.40e-02 |
| GO:BP | GO:0060575 | intestinal epithelial cell differentiation | 9 | 18 | 3.40e-02 |
| GO:BP | GO:0071871 | response to epinephrine | 7 | 12 | 3.40e-02 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 9 | 18 | 3.40e-02 |
| GO:BP | GO:0008104 | protein localization | 446 | 2128 | 3.40e-02 |
| GO:BP | GO:0003222 | ventricular trabecula myocardium morphogenesis | 7 | 12 | 3.40e-02 |
| GO:BP | GO:1902373 | negative regulation of mRNA catabolic process | 21 | 61 | 3.40e-02 |
| GO:BP | GO:0003207 | cardiac chamber formation | 7 | 12 | 3.40e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 448 | 2138 | 3.40e-02 |
| GO:BP | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 7 | 12 | 3.40e-02 |
| GO:BP | GO:1904044 | response to aldosterone | 7 | 12 | 3.40e-02 |
| GO:BP | GO:0036302 | atrioventricular canal development | 7 | 12 | 3.40e-02 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 7 | 12 | 3.40e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 166 | 727 | 3.40e-02 |
| GO:BP | GO:0031643 | positive regulation of myelination | 7 | 12 | 3.40e-02 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 21 | 61 | 3.40e-02 |
| GO:BP | GO:0072273 | metanephric nephron morphogenesis | 9 | 18 | 3.40e-02 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 841 | 4170 | 3.40e-02 |
| GO:BP | GO:0034097 | response to cytokine | 144 | 621 | 3.40e-02 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 28 | 89 | 3.42e-02 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 28 | 89 | 3.42e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 57 | 214 | 3.42e-02 |
| GO:BP | GO:0048634 | regulation of muscle organ development | 8 | 15 | 3.45e-02 |
| GO:BP | GO:0043217 | myelin maintenance | 8 | 15 | 3.45e-02 |
| GO:BP | GO:0016082 | synaptic vesicle priming | 8 | 15 | 3.45e-02 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 23 | 69 | 3.45e-02 |
| GO:BP | GO:0060079 | excitatory postsynaptic potential | 23 | 69 | 3.45e-02 |
| GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 27 | 85 | 3.45e-02 |
| GO:BP | GO:0035590 | purinergic nucleotide receptor signaling pathway | 8 | 15 | 3.45e-02 |
| GO:BP | GO:1902932 | positive regulation of alcohol biosynthetic process | 8 | 15 | 3.45e-02 |
| GO:BP | GO:0034616 | response to laminar fluid shear stress | 8 | 15 | 3.45e-02 |
| GO:BP | GO:0072243 | metanephric nephron epithelium development | 8 | 15 | 3.45e-02 |
| GO:BP | GO:0055012 | ventricular cardiac muscle cell differentiation | 8 | 15 | 3.45e-02 |
| GO:BP | GO:1903707 | negative regulation of hemopoiesis | 24 | 73 | 3.45e-02 |
| GO:BP | GO:0060993 | kidney morphogenesis | 24 | 73 | 3.45e-02 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 25 | 77 | 3.45e-02 |
| GO:BP | GO:0008038 | neuron recognition | 14 | 35 | 3.49e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 14 | 35 | 3.49e-02 |
| GO:BP | GO:1904861 | excitatory synapse assembly | 12 | 28 | 3.49e-02 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 559 | 2709 | 3.55e-02 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 93 | 380 | 3.65e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 219 | 989 | 3.66e-02 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 31 | 102 | 3.71e-02 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 18 | 50 | 3.72e-02 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 30 | 98 | 3.80e-02 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 35 | 119 | 3.81e-02 |
| GO:BP | GO:0062237 | protein localization to postsynapse | 15 | 39 | 3.86e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 15 | 39 | 3.86e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 47 | 171 | 3.86e-02 |
| GO:BP | GO:0042129 | regulation of T cell proliferation | 29 | 94 | 3.86e-02 |
| GO:BP | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 15 | 39 | 3.86e-02 |
| GO:BP | GO:0002064 | epithelial cell development | 44 | 158 | 3.93e-02 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 28 | 90 | 3.93e-02 |
| GO:BP | GO:0045124 | regulation of bone resorption | 11 | 25 | 3.94e-02 |
| GO:BP | GO:0031122 | cytoplasmic microtubule organization | 20 | 58 | 3.94e-02 |
| GO:BP | GO:0051491 | positive regulation of filopodium assembly | 11 | 25 | 3.94e-02 |
| GO:BP | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 11 | 25 | 3.94e-02 |
| GO:BP | GO:0010664 | negative regulation of striated muscle cell apoptotic process | 11 | 25 | 3.94e-02 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 20 | 58 | 3.94e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 20 | 58 | 3.94e-02 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 11 | 25 | 3.94e-02 |
| GO:BP | GO:0033028 | myeloid cell apoptotic process | 11 | 25 | 3.94e-02 |
| GO:BP | GO:0030278 | regulation of ossification | 27 | 86 | 3.95e-02 |
| GO:BP | GO:0072028 | nephron morphogenesis | 21 | 62 | 3.99e-02 |
| GO:BP | GO:0051591 | response to cAMP | 21 | 62 | 3.99e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 224 | 1016 | 3.99e-02 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 13 | 32 | 4.02e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 59 | 225 | 4.03e-02 |
| GO:BP | GO:0061326 | renal tubule development | 25 | 78 | 4.03e-02 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 24 | 74 | 4.04e-02 |
| GO:BP | GO:0006166 | purine ribonucleoside salvage | 5 | 7 | 4.10e-02 |
| GO:BP | GO:0035588 | G protein-coupled purinergic receptor signaling pathway | 5 | 7 | 4.10e-02 |
| GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 16 | 43 | 4.10e-02 |
| GO:BP | GO:0001973 | G protein-coupled adenosine receptor signaling pathway | 5 | 7 | 4.10e-02 |
| GO:BP | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 5 | 7 | 4.10e-02 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 16 | 43 | 4.10e-02 |
| GO:BP | GO:0045214 | sarcomere organization | 16 | 43 | 4.10e-02 |
| GO:BP | GO:0060341 | regulation of cellular localization | 183 | 815 | 4.12e-02 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 42 | 150 | 4.17e-02 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 79 | 317 | 4.18e-02 |
| GO:BP | GO:0042060 | wound healing | 77 | 308 | 4.27e-02 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 44 | 159 | 4.31e-02 |
| GO:BP | GO:0009880 | embryonic pattern specification | 17 | 47 | 4.32e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 17 | 47 | 4.32e-02 |
| GO:BP | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 10 | 22 | 4.39e-02 |
| GO:BP | GO:0061458 | reproductive system development | 57 | 217 | 4.39e-02 |
| GO:BP | GO:0003177 | pulmonary valve development | 10 | 22 | 4.39e-02 |
| GO:BP | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 10 | 22 | 4.39e-02 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 14 | 36 | 4.45e-02 |
| GO:BP | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 14 | 36 | 4.45e-02 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 14 | 36 | 4.45e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 37 | 129 | 4.47e-02 |
| GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 18 | 51 | 4.48e-02 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 92 | 379 | 4.60e-02 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 19 | 55 | 4.62e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 12 | 29 | 4.62e-02 |
| GO:BP | GO:0050773 | regulation of dendrite development | 26 | 83 | 4.63e-02 |
| GO:BP | GO:0071772 | response to BMP | 36 | 125 | 4.63e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 36 | 125 | 4.63e-02 |
| GO:BP | GO:0001508 | action potential | 32 | 108 | 4.63e-02 |
| GO:BP | GO:0003014 | renal system process | 25 | 79 | 4.68e-02 |
| GO:BP | GO:0046854 | phosphatidylinositol phosphate biosynthetic process | 20 | 59 | 4.68e-02 |
| GO:BP | GO:0097009 | energy homeostasis | 20 | 59 | 4.68e-02 |
| GO:BP | GO:0032946 | positive regulation of mononuclear cell proliferation | 24 | 75 | 4.72e-02 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 22 | 67 | 4.75e-02 |
| GO:BP | GO:0097061 | dendritic spine organization | 22 | 67 | 4.75e-02 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 15 | 40 | 4.78e-02 |
| GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 15 | 40 | 4.78e-02 |
| GO:BP | GO:0002066 | columnar/cuboidal epithelial cell development | 15 | 40 | 4.78e-02 |
| GO:BP | GO:0048670 | regulation of collateral sprouting | 9 | 19 | 4.79e-02 |
| GO:BP | GO:0010878 | cholesterol storage | 9 | 19 | 4.79e-02 |
| GO:BP | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 9 | 19 | 4.79e-02 |
| GO:BP | GO:0033032 | regulation of myeloid cell apoptotic process | 9 | 19 | 4.79e-02 |
| GO:BP | GO:0032528 | microvillus organization | 9 | 19 | 4.79e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 46 | 169 | 4.81e-02 |
| GO:BP | GO:0007605 | sensory perception of sound | 30 | 100 | 4.86e-02 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 34 | 117 | 4.91e-02 |
| GO:BP | GO:0043434 | response to peptide hormone | 80 | 324 | 4.91e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 67 | 264 | 4.93e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 67 | 264 | 4.93e-02 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 40 | 143 | 4.98e-02 |
| GO:BP | GO:0009725 | response to hormone | 145 | 634 | 4.98e-02 |
| GO:BP | GO:0033554 | cellular response to stress | 327 | 1538 | 5.00e-02 |
ESR_int_restable %>%
filter(source=="KEGG") %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in ESR neargenes intersected with RNA response genes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04020 | Calcium signaling pathway | 51 | 164 | 1.63e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 43 | 134 | 1.63e-02 |
| KEGG | KEGG:04360 | Axon guidance | 50 | 162 | 1.63e-02 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 46 | 151 | 2.17e-02 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 26 | 72 | 2.17e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 39 | 121 | 2.17e-02 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 40 | 132 | 4.27e-02 |
| KEGG | KEGG:04924 | Renin secretion | 19 | 50 | 4.75e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 47 | 164 | 4.75e-02 |
| KEGG | KEGG:05224 | Breast cancer | 35 | 117 | 6.45e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 37 | 125 | 6.45e-02 |
| KEGG | KEGG:04911 | Insulin secretion | 22 | 64 | 6.45e-02 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 25 | 79 | 7.22e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 36 | 128 | 7.22e-02 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 17 | 48 | 7.22e-02 |
| KEGG | KEGG:04814 | Motor proteins | 41 | 149 | 7.22e-02 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 24 | 77 | 7.22e-02 |
| KEGG | KEGG:05226 | Gastric cancer | 34 | 117 | 7.22e-02 |
| KEGG | KEGG:00000 | KEGG root term | 1145 | 5802 | 7.22e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 29 | 97 | 7.22e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 22 | 69 | 7.22e-02 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 33 | 112 | 7.22e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 42 | 149 | 7.22e-02 |
| KEGG | KEGG:04611 | Platelet activation | 27 | 89 | 7.22e-02 |
| KEGG | KEGG:04740 | Olfactory transduction | 11 | 25 | 7.22e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 28 | 91 | 7.22e-02 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 26 | 84 | 7.22e-02 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 19 | 56 | 7.22e-02 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 37 | 127 | 7.22e-02 |
| KEGG | KEGG:04976 | Bile secretion | 15 | 42 | 7.74e-02 |
| KEGG | KEGG:04730 | Long-term depression | 15 | 42 | 7.74e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 23 | 74 | 7.74e-02 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 23 | 75 | 8.95e-02 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 21 | 67 | 9.08e-02 |
| KEGG | KEGG:04014 | Ras signaling pathway | 45 | 172 | 9.68e-02 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 20 | 64 | 1.05e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 38 | 142 | 1.05e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 18 | 56 | 1.05e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 9 | 22 | 1.16e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 36 | 135 | 1.18e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 29 | 104 | 1.18e-01 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 16 | 49 | 1.18e-01 |
| KEGG | KEGG:04115 | p53 signaling pathway | 20 | 66 | 1.25e-01 |
| KEGG | KEGG:05218 | Melanoma | 18 | 58 | 1.26e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 18 | 58 | 1.26e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 16 | 50 | 1.28e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 31 | 115 | 1.39e-01 |
| KEGG | KEGG:05164 | Influenza A | 28 | 102 | 1.41e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 26 | 94 | 1.53e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 3 | 4 | 1.54e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 22 | 77 | 1.56e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 10 | 28 | 1.57e-01 |
| KEGG | KEGG:04540 | Gap junction | 21 | 73 | 1.57e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 20 | 69 | 1.57e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 23 | 82 | 1.57e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 16 | 52 | 1.57e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 23 | 83 | 1.70e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 16 | 53 | 1.70e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 16 | 53 | 1.70e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 92 | 408 | 1.70e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 19 | 66 | 1.73e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 9 | 25 | 1.76e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 13 | 41 | 1.76e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 26 | 98 | 1.89e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 19 | 67 | 1.89e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 25 | 94 | 1.97e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 16 | 55 | 2.02e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 10 | 30 | 2.02e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 36 | 145 | 2.02e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 9 | 26 | 2.02e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 25 | 95 | 2.02e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 15 | 51 | 2.02e-01 |
| KEGG | KEGG:05034 | Alcoholism | 29 | 113 | 2.02e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 13 | 43 | 2.14e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 41 | 170 | 2.14e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 11 | 35 | 2.25e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 26 | 102 | 2.45e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 16 | 57 | 2.45e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 15 | 53 | 2.54e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 56 | 246 | 2.61e-01 |
| KEGG | KEGG:04210 | Apoptosis | 29 | 117 | 2.61e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 20 | 76 | 2.61e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 7 | 20 | 2.61e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 20 | 76 | 2.61e-01 |
| KEGG | KEGG:05214 | Glioma | 18 | 67 | 2.61e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 25 | 99 | 2.62e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 12 | 41 | 2.68e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 17 | 63 | 2.68e-01 |
| KEGG | KEGG:04530 | Tight junction | 33 | 138 | 2.92e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 15 | 55 | 2.92e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 27 | 110 | 2.92e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 26 | 106 | 3.08e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 29 | 121 | 3.15e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 17 | 65 | 3.15e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 25 | 102 | 3.15e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 15 | 56 | 3.15e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 15 | 56 | 3.15e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 34 | 145 | 3.16e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 21 | 84 | 3.25e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 4 | 10 | 3.36e-01 |
| KEGG | KEGG:04742 | Taste transduction | 7 | 22 | 3.36e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 26 | 108 | 3.36e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 7 | 22 | 3.36e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 21 | 85 | 3.36e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 10 | 35 | 3.36e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 10 | 35 | 3.36e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 29 | 123 | 3.36e-01 |
| KEGG | KEGG:03410 | Base excision repair | 12 | 44 | 3.39e-01 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 13 | 49 | 3.52e-01 |
| KEGG | KEGG:04520 | Adherens junction | 21 | 86 | 3.52e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 24 | 100 | 3.52e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 3.83e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 22 | 92 | 3.83e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 6 | 19 | 3.83e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 27 | 116 | 3.83e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 19 | 78 | 3.84e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 16 | 64 | 3.84e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 14 | 55 | 3.87e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 17 | 69 | 3.87e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 20 | 83 | 3.87e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 34 | 151 | 3.91e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 39 | 176 | 3.99e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 20 | 84 | 4.03e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 58 | 271 | 4.03e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 18 | 75 | 4.14e-01 |
| KEGG | KEGG:04217 | Necroptosis | 24 | 104 | 4.14e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 6 | 20 | 4.14e-01 |
| KEGG | KEGG:05142 | Chagas disease | 18 | 75 | 4.14e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 34 | 153 | 4.14e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 15 | 61 | 4.14e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 2 | 4 | 4.21e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 18 | 76 | 4.34e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 4 | 12 | 4.38e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 20 | 86 | 4.38e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 20 | 86 | 4.38e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 22 | 96 | 4.46e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 24 | 106 | 4.51e-01 |
| KEGG | KEGG:03260 | Virion - Human immunodeficiency virus | 1 | 1 | 4.51e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 30 | 136 | 4.51e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 14 | 58 | 4.51e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 20 | 87 | 4.51e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 54 | 256 | 4.51e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 15 | 63 | 4.52e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 12 | 49 | 4.62e-01 |
| KEGG | KEGG:03030 | DNA replication | 9 | 35 | 4.62e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 13 | 54 | 4.64e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 34 | 157 | 4.64e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 8 | 31 | 4.84e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 8 | 31 | 4.84e-01 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 17 | 74 | 4.84e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 6 | 22 | 4.93e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 24 | 109 | 4.94e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 38 | 179 | 4.94e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 17 | 75 | 5.06e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 17 | 75 | 5.06e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 2 | 5 | 5.15e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 2 | 5 | 5.15e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 20 | 91 | 5.37e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 10 | 42 | 5.37e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 6 | 23 | 5.37e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 4 | 14 | 5.46e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 4 | 14 | 5.46e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 30 | 142 | 5.49e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 19 | 87 | 5.52e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 19 | 87 | 5.52e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 8 | 33 | 5.52e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 5 | 19 | 5.64e-01 |
| KEGG | KEGG:04144 | Endocytosis | 47 | 230 | 5.65e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 24 | 113 | 5.69e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 3 | 10 | 5.69e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 17 | 78 | 5.69e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 30 | 144 | 5.75e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 4 | 15 | 6.02e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 5 | 20 | 6.20e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 14 | 65 | 6.39e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 18 | 86 | 6.64e-01 |
| KEGG | KEGG:05131 | Shigellosis | 42 | 210 | 6.68e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 4 | 16 | 6.74e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 5 | 21 | 6.76e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 20 | 97 | 6.76e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 22 | 108 | 6.96e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 13 | 62 | 7.04e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 3 | 12 | 7.10e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 11 | 52 | 7.10e-01 |
| KEGG | KEGG:04145 | Phagosome | 20 | 99 | 7.10e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 3 | 12 | 7.10e-01 |
| KEGG | KEGG:04744 | Phototransduction | 3 | 12 | 7.10e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 3 | 12 | 7.10e-01 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 8 | 37 | 7.10e-01 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 3 | 12 | 7.10e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 5 | 22 | 7.10e-01 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 18 | 89 | 7.14e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 16 | 79 | 7.24e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 9 | 43 | 7.32e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 12 | 59 | 7.49e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 22 | 112 | 7.68e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 8 | 39 | 7.83e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 11 | 55 | 7.92e-01 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 7.94e-01 |
| KEGG | KEGG:02010 | ABC transporters | 6 | 29 | 7.98e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 9 | 45 | 8.05e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 5 | 24 | 8.06e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 11 | 56 | 8.16e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 31 | 163 | 8.26e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 16 | 83 | 8.26e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 29 | 153 | 8.39e-01 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 10 | 52 | 8.57e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 31 | 165 | 8.60e-01 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 20 | 106 | 8.60e-01 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 6 | 31 | 8.73e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 8 | 42 | 8.77e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 12 | 64 | 8.86e-01 |
| KEGG | KEGG:04110 | Cell cycle | 28 | 151 | 8.95e-01 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1 | 4 | 8.99e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 13 | 71 | 9.18e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 18 | 99 | 9.18e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 19 | 104 | 9.18e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 3 | 16 | 9.18e-01 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 8 | 44 | 9.18e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 2 | 10 | 9.18e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 9 | 49 | 9.18e-01 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 5 | 27 | 9.18e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 3 | 16 | 9.18e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 39 | 214 | 9.23e-01 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 4 | 22 | 9.29e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 5 | 28 | 9.34e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 5 | 28 | 9.34e-01 |
| KEGG | KEGG:05133 | Pertussis | 8 | 45 | 9.34e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 15 | 84 | 9.34e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 12 | 68 | 9.46e-01 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 2 | 11 | 9.46e-01 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 32 | 179 | 9.52e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 20 | 114 | 9.76e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 5 | 30 | 9.87e-01 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 2 | 12 | 9.87e-01 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 19 | 110 | 9.87e-01 |
| KEGG | KEGG:00340 | Histidine metabolism | 2 | 12 | 9.87e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 10 | 59 | 9.87e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 5 | 30 | 9.87e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 17 | 99 | 9.89e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 8 | 48 | 9.92e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 23 | 134 | 9.99e-01 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 1 | 6 | 9.99e-01 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 1 | 6 | 9.99e-01 |
| KEGG | KEGG:05219 | Bladder cancer | 6 | 37 | 9.99e-01 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 40 | 255 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 47 | 303 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 31 | 225 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 54 | 314 | 1.00e+00 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 5 | 33 | 1.00e+00 |
| KEGG | KEGG:05332 | Graft-versus-host disease | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 2 | 25 | 1.00e+00 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 2 | 19 | 1.00e+00 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 4 | 26 | 1.00e+00 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 5 | 38 | 1.00e+00 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 2 | 15 | 1.00e+00 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 1 | 13 | 1.00e+00 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 4 | 33 | 1.00e+00 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 2 | 25 | 1.00e+00 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 17 | 131 | 1.00e+00 |
| KEGG | KEGG:00650 | Butanoate metabolism | 2 | 17 | 1.00e+00 |
| KEGG | KEGG:00670 | One carbon pool by folate | 1 | 18 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 25 | 168 | 1.00e+00 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 4 | 29 | 1.00e+00 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 2 | 17 | 1.00e+00 |
| KEGG | KEGG:00790 | Folate biosynthesis | 2 | 18 | 1.00e+00 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 1 | 22 | 1.00e+00 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 2 | 21 | 1.00e+00 |
| KEGG | KEGG:00920 | Sulfur metabolism | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 6 | 44 | 1.00e+00 |
| KEGG | KEGG:01100 | Metabolic pathways | 195 | 1149 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 11 | 98 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 7 | 46 | 1.00e+00 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 7 | 49 | 1.00e+00 |
| KEGG | KEGG:05330 | Allograft rejection | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 29 | 218 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 65 | 384 | 1.00e+00 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 2 | 19 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 6 | 106 | 1.00e+00 |
| KEGG | KEGG:00062 | Fatty acid elongation | 2 | 24 | 1.00e+00 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 5 | 45 | 1.00e+00 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 3 | 29 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 3 | 31 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 18 | 185 | 1.00e+00 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 4 | 43 | 1.00e+00 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 5 | 38 | 1.00e+00 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 1 | 8 | 1.00e+00 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 3 | 25 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 18 | 162 | 1.00e+00 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 2 | 14 | 1.00e+00 |
| KEGG | KEGG:00071 | Fatty acid degradation | 2 | 32 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 41 | 416 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 5 | 51 | 1.00e+00 |
| KEGG | KEGG:05162 | Measles | 16 | 97 | 1.00e+00 |
| KEGG | KEGG:00511 | Other glycan degradation | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 1 | 11 | 1.00e+00 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 1 | 18 | 1.00e+00 |
| KEGG | KEGG:05145 | Toxoplasmosis | 9 | 81 | 1.00e+00 |
| KEGG | KEGG:05144 | Malaria | 3 | 20 | 1.00e+00 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 1 | 28 | 1.00e+00 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 2 | 28 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 6 | 44 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 3 | 38 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 4 | 39 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 5 | 46 | 1.00e+00 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 2 | 13 | 1.00e+00 |
| KEGG | KEGG:00480 | Glutathione metabolism | 3 | 44 | 1.00e+00 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 6 | 50 | 1.00e+00 |
| KEGG | KEGG:03020 | RNA polymerase | 4 | 34 | 1.00e+00 |
| KEGG | KEGG:03440 | Homologous recombination | 6 | 39 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 15 | 117 | 1.00e+00 |
| KEGG | KEGG:04146 | Peroxisome | 10 | 69 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 13 | 85 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 6 | 74 | 1.00e+00 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 7 | 46 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 6 | 40 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 7 | 127 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 2 | 30 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 2 | 41 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 5 | 42 | 1.00e+00 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 9 | 57 | 1.00e+00 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 18 | 117 | 1.00e+00 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 5 | 49 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 5 | 50 | 1.00e+00 |
| KEGG | KEGG:03022 | Basal transcription factors | 5 | 40 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 21 | 160 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 10 | 132 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 5 | 75 | 1.00e+00 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 16 | 99 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 2 | 24 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 9 | 69 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 16 | 115 | 1.00e+00 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 6 | 60 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 5 | 35 | 1.00e+00 |
| KEGG | KEGG:04122 | Sulfur relay system | 1 | 8 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 28 | 177 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 24 | 195 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 15 | 100 | 1.00e+00 |
ESR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(fill="#7CAE00")+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")+
theme(axis.text.y = element_text(color="black"))+
ggtitle("Intersection ESR")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
LR
# LR_int_resgenes <- gost(query = int_LR_n_RNAresp,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(LR_int_resgenes,"data/GO_KEGG_analysis/LR_int_resgenes.RDS")
LR_int_restable <- LR_int_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
LR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR neargenes intersected with RNA response genes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0051716 | cellular response to stimulus | 1660 | 4933 | 9.34e-23 |
| GO:BP | GO:0050896 | response to stimulus | 1879 | 5732 | 6.73e-21 |
| GO:BP | GO:0007154 | cell communication | 1439 | 4248 | 9.74e-20 |
| GO:BP | GO:0023052 | signaling | 1413 | 4180 | 7.60e-19 |
| GO:BP | GO:0007165 | signal transduction | 1313 | 3846 | 8.00e-19 |
| GO:BP | GO:0050794 | regulation of cellular process | 2401 | 7651 | 1.87e-18 |
| GO:BP | GO:0032501 | multicellular organismal process | 1596 | 4830 | 9.19e-18 |
| GO:BP | GO:0050789 | regulation of biological process | 2502 | 8037 | 9.43e-18 |
| GO:BP | GO:0065007 | biological regulation | 2565 | 8275 | 1.79e-17 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1514 | 4561 | 2.24e-17 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1400 | 4198 | 2.95e-16 |
| GO:BP | GO:0048869 | cellular developmental process | 1034 | 2988 | 1.21e-15 |
| GO:BP | GO:0007275 | multicellular organism development | 1153 | 3383 | 1.21e-15 |
| GO:BP | GO:0032502 | developmental process | 1477 | 4475 | 1.21e-15 |
| GO:BP | GO:0030154 | cell differentiation | 1033 | 2987 | 1.34e-15 |
| GO:BP | GO:0048856 | anatomical structure development | 1372 | 4130 | 3.53e-15 |
| GO:BP | GO:0048731 | system development | 1002 | 2903 | 1.01e-14 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1335 | 4037 | 8.73e-14 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 703 | 1951 | 9.47e-14 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1265 | 3804 | 1.15e-13 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 727 | 2052 | 1.98e-12 |
| GO:BP | GO:0010646 | regulation of cell communication | 895 | 2601 | 2.46e-12 |
| GO:BP | GO:0048468 | cell development | 709 | 1999 | 3.39e-12 |
| GO:BP | GO:0048513 | animal organ development | 749 | 2130 | 4.11e-12 |
| GO:BP | GO:0050793 | regulation of developmental process | 644 | 1801 | 1.21e-11 |
| GO:BP | GO:0023051 | regulation of signaling | 888 | 2597 | 1.72e-11 |
| GO:BP | GO:0072359 | circulatory system development | 352 | 896 | 2.81e-11 |
| GO:BP | GO:0009966 | regulation of signal transduction | 798 | 2307 | 2.83e-11 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 978 | 2902 | 3.32e-11 |
| GO:BP | GO:0009888 | tissue development | 522 | 1425 | 4.65e-11 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 669 | 1900 | 1.01e-10 |
| GO:BP | GO:0035556 | intracellular signal transduction | 724 | 2079 | 1.10e-10 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 336 | 876 | 3.27e-09 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 364 | 967 | 6.95e-09 |
| GO:BP | GO:0048589 | developmental growth | 218 | 527 | 6.95e-09 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 502 | 1403 | 9.77e-09 |
| GO:BP | GO:0008283 | cell population proliferation | 495 | 1386 | 1.85e-08 |
| GO:BP | GO:0014706 | striated muscle tissue development | 106 | 218 | 2.68e-08 |
| GO:BP | GO:0022008 | neurogenesis | 475 | 1327 | 3.15e-08 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 406 | 1111 | 4.04e-08 |
| GO:BP | GO:0007507 | heart development | 210 | 515 | 6.47e-08 |
| GO:BP | GO:0044057 | regulation of system process | 170 | 399 | 6.75e-08 |
| GO:BP | GO:0007399 | nervous system development | 651 | 1903 | 7.21e-08 |
| GO:BP | GO:0003008 | system process | 432 | 1201 | 1.06e-07 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 911 | 2780 | 2.90e-07 |
| GO:BP | GO:0048699 | generation of neurons | 411 | 1145 | 3.88e-07 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 98 | 206 | 4.87e-07 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 405 | 1134 | 1.01e-06 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 187 | 462 | 1.06e-06 |
| GO:BP | GO:0035295 | tube development | 307 | 827 | 1.12e-06 |
| GO:BP | GO:0060419 | heart growth | 44 | 72 | 1.14e-06 |
| GO:BP | GO:0030900 | forebrain development | 128 | 292 | 1.14e-06 |
| GO:BP | GO:0035239 | tube morphogenesis | 255 | 668 | 1.24e-06 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 626 | 1852 | 1.24e-06 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 408 | 1146 | 1.24e-06 |
| GO:BP | GO:0042221 | response to chemical | 802 | 2436 | 1.35e-06 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 201 | 506 | 1.45e-06 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 268 | 710 | 1.63e-06 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 240 | 626 | 2.09e-06 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 478 | 1376 | 2.09e-06 |
| GO:BP | GO:0003013 | circulatory system process | 180 | 446 | 2.14e-06 |
| GO:BP | GO:0060537 | muscle tissue development | 148 | 353 | 2.40e-06 |
| GO:BP | GO:0040007 | growth | 276 | 739 | 2.88e-06 |
| GO:BP | GO:0006950 | response to stress | 881 | 2715 | 3.77e-06 |
| GO:BP | GO:0007010 | cytoskeleton organization | 427 | 1218 | 3.81e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 809 | 2474 | 3.86e-06 |
| GO:BP | GO:0009987 | cellular process | 3327 | 11450 | 4.45e-06 |
| GO:BP | GO:0008015 | blood circulation | 154 | 374 | 4.72e-06 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 429 | 1227 | 4.80e-06 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 361 | 1011 | 5.42e-06 |
| GO:BP | GO:0032879 | regulation of localization | 519 | 1521 | 6.12e-06 |
| GO:BP | GO:0007267 | cell-cell signaling | 406 | 1156 | 6.12e-06 |
| GO:BP | GO:0001944 | vasculature development | 220 | 573 | 6.12e-06 |
| GO:BP | GO:0030030 | cell projection organization | 439 | 1262 | 6.12e-06 |
| GO:BP | GO:0001568 | blood vessel development | 211 | 546 | 6.33e-06 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 662 | 1992 | 6.36e-06 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 384 | 1088 | 7.73e-06 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 303 | 833 | 9.12e-06 |
| GO:BP | GO:0030182 | neuron differentiation | 381 | 1080 | 9.12e-06 |
| GO:BP | GO:0071310 | cellular response to organic substance | 471 | 1370 | 9.15e-06 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 248 | 662 | 9.15e-06 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 276 | 749 | 9.30e-06 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 39 | 65 | 1.05e-05 |
| GO:BP | GO:0035265 | organ growth | 66 | 132 | 1.09e-05 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 435 | 1256 | 1.12e-05 |
| GO:BP | GO:0008150 | biological_process | 3479 | 12051 | 1.17e-05 |
| GO:BP | GO:0021537 | telencephalon development | 94 | 208 | 1.28e-05 |
| GO:BP | GO:0006915 | apoptotic process | 497 | 1459 | 1.31e-05 |
| GO:BP | GO:0090257 | regulation of muscle system process | 84 | 181 | 1.43e-05 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 207 | 540 | 1.46e-05 |
| GO:BP | GO:0016310 | phosphorylation | 420 | 1211 | 1.49e-05 |
| GO:BP | GO:0060322 | head development | 221 | 583 | 1.49e-05 |
| GO:BP | GO:0033002 | muscle cell proliferation | 75 | 157 | 1.51e-05 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 36 | 59 | 1.61e-05 |
| GO:BP | GO:0060420 | regulation of heart growth | 32 | 50 | 1.61e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 111 | 257 | 1.62e-05 |
| GO:BP | GO:0007417 | central nervous system development | 274 | 748 | 1.62e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 826 | 2555 | 1.70e-05 |
| GO:BP | GO:0016477 | cell migration | 378 | 1078 | 1.72e-05 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 276 | 756 | 1.99e-05 |
| GO:BP | GO:1901653 | cellular response to peptide | 120 | 284 | 2.09e-05 |
| GO:BP | GO:0009790 | embryo development | 310 | 864 | 2.23e-05 |
| GO:BP | GO:0060429 | epithelium development | 301 | 836 | 2.33e-05 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 210 | 553 | 2.33e-05 |
| GO:BP | GO:0008016 | regulation of heart contraction | 79 | 170 | 2.67e-05 |
| GO:BP | GO:0012501 | programmed cell death | 508 | 1505 | 2.85e-05 |
| GO:BP | GO:0016043 | cellular component organization | 1575 | 5139 | 3.01e-05 |
| GO:BP | GO:0008219 | cell death | 509 | 1509 | 3.01e-05 |
| GO:BP | GO:0003012 | muscle system process | 138 | 339 | 3.39e-05 |
| GO:BP | GO:1901652 | response to peptide | 152 | 381 | 3.78e-05 |
| GO:BP | GO:0045165 | cell fate commitment | 74 | 159 | 5.57e-05 |
| GO:BP | GO:0030029 | actin filament-based process | 248 | 677 | 5.59e-05 |
| GO:BP | GO:0034330 | cell junction organization | 220 | 591 | 6.39e-05 |
| GO:BP | GO:0006468 | protein phosphorylation | 352 | 1008 | 6.59e-05 |
| GO:BP | GO:0048729 | tissue morphogenesis | 183 | 478 | 6.85e-05 |
| GO:BP | GO:0048870 | cell motility | 408 | 1190 | 7.45e-05 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 391 | 1135 | 7.45e-05 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 115 | 276 | 7.51e-05 |
| GO:BP | GO:1901698 | response to nitrogen compound | 278 | 774 | 7.59e-05 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 170 | 440 | 8.36e-05 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 190 | 501 | 8.42e-05 |
| GO:BP | GO:0031175 | neuron projection development | 284 | 794 | 8.42e-05 |
| GO:BP | GO:0046620 | regulation of organ growth | 40 | 72 | 8.43e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 746 | 2311 | 8.66e-05 |
| GO:BP | GO:0007420 | brain development | 202 | 539 | 9.74e-05 |
| GO:BP | GO:0048666 | neuron development | 315 | 894 | 9.74e-05 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 437 | 1288 | 9.82e-05 |
| GO:BP | GO:0010033 | response to organic substance | 603 | 1835 | 9.85e-05 |
| GO:BP | GO:0065008 | regulation of biological quality | 664 | 2039 | 1.03e-04 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 654 | 2006 | 1.06e-04 |
| GO:BP | GO:0040012 | regulation of locomotion | 274 | 766 | 1.21e-04 |
| GO:BP | GO:0040011 | locomotion | 303 | 858 | 1.21e-04 |
| GO:BP | GO:0003015 | heart process | 91 | 210 | 1.29e-04 |
| GO:BP | GO:0030334 | regulation of cell migration | 256 | 710 | 1.31e-04 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 419 | 1233 | 1.31e-04 |
| GO:BP | GO:0023056 | positive regulation of signaling | 437 | 1292 | 1.34e-04 |
| GO:BP | GO:2000145 | regulation of cell motility | 267 | 745 | 1.34e-04 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 659 | 2028 | 1.49e-04 |
| GO:BP | GO:0099536 | synaptic signaling | 194 | 518 | 1.51e-04 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 179 | 472 | 1.51e-04 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 28 | 45 | 1.52e-04 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 187 | 497 | 1.59e-04 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 187 | 497 | 1.59e-04 |
| GO:BP | GO:0060047 | heart contraction | 87 | 200 | 1.66e-04 |
| GO:BP | GO:0042592 | homeostatic process | 409 | 1204 | 1.72e-04 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 257 | 716 | 1.73e-04 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 642 | 1974 | 1.73e-04 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 148 | 380 | 2.03e-04 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 390 | 1145 | 2.19e-04 |
| GO:BP | GO:0007423 | sensory organ development | 154 | 399 | 2.32e-04 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 357 | 1040 | 2.65e-04 |
| GO:BP | GO:0033554 | cellular response to stress | 509 | 1538 | 2.72e-04 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 392 | 1154 | 2.72e-04 |
| GO:BP | GO:0001503 | ossification | 128 | 322 | 2.75e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 239 | 664 | 2.95e-04 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 1384 | 4521 | 3.02e-04 |
| GO:BP | GO:1903522 | regulation of blood circulation | 86 | 200 | 3.06e-04 |
| GO:BP | GO:0007049 | cell cycle | 503 | 1520 | 3.06e-04 |
| GO:BP | GO:0045444 | fat cell differentiation | 82 | 189 | 3.30e-04 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 235 | 653 | 3.49e-04 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 175 | 467 | 3.97e-04 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 150 | 391 | 4.25e-04 |
| GO:BP | GO:0019222 | regulation of metabolic process | 1494 | 4914 | 4.77e-04 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 663 | 2061 | 5.16e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 55 | 116 | 5.16e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 55 | 116 | 5.16e-04 |
| GO:BP | GO:0048568 | embryonic organ development | 125 | 317 | 5.23e-04 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 525 | 1601 | 5.54e-04 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 178 | 479 | 5.65e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 34 | 62 | 5.80e-04 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 632 | 1959 | 5.80e-04 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 350 | 1027 | 6.04e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 127 | 324 | 6.04e-04 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 427 | 1279 | 6.21e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 150 | 394 | 6.37e-04 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 31 | 55 | 6.56e-04 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 567 | 1744 | 6.71e-04 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 9 | 9 | 6.94e-04 |
| GO:BP | GO:0043010 | camera-type eye development | 97 | 236 | 6.96e-04 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 98 | 239 | 7.03e-04 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 352 | 1036 | 7.29e-04 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 716 | 2246 | 7.32e-04 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 613 | 1900 | 7.58e-04 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 551 | 1694 | 8.30e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 34 | 63 | 8.46e-04 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 158 | 421 | 8.79e-04 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 668 | 2088 | 9.24e-04 |
| GO:BP | GO:0023057 | negative regulation of signaling | 374 | 1111 | 9.51e-04 |
| GO:BP | GO:0007155 | cell adhesion | 341 | 1004 | 9.99e-04 |
| GO:BP | GO:0061061 | muscle structure development | 202 | 559 | 1.01e-03 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 103 | 256 | 1.04e-03 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 373 | 1109 | 1.04e-03 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 561 | 1732 | 1.11e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 565 | 1746 | 1.16e-03 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 282 | 815 | 1.17e-03 |
| GO:BP | GO:0061337 | cardiac conduction | 43 | 87 | 1.17e-03 |
| GO:BP | GO:0022402 | cell cycle process | 363 | 1078 | 1.18e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 111 | 281 | 1.27e-03 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 21 | 33 | 1.28e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 368 | 1096 | 1.34e-03 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 58 | 128 | 1.34e-03 |
| GO:BP | GO:0051179 | localization | 1218 | 3978 | 1.34e-03 |
| GO:BP | GO:0035148 | tube formation | 59 | 131 | 1.42e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 431 | 1304 | 1.43e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 430 | 1301 | 1.44e-03 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 20 | 31 | 1.44e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 469 | 1430 | 1.44e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 66 | 151 | 1.55e-03 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 150 | 401 | 1.55e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 38 | 75 | 1.59e-03 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 57 | 126 | 1.59e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 38 | 75 | 1.59e-03 |
| GO:BP | GO:0042692 | muscle cell differentiation | 128 | 334 | 1.60e-03 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 221 | 625 | 1.86e-03 |
| GO:BP | GO:0009605 | response to external stimulus | 538 | 1664 | 1.89e-03 |
| GO:BP | GO:0001764 | neuron migration | 61 | 138 | 1.97e-03 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 17 | 25 | 2.05e-03 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 213 | 601 | 2.15e-03 |
| GO:BP | GO:0003007 | heart morphogenesis | 90 | 222 | 2.16e-03 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 31 | 58 | 2.17e-03 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 16 | 23 | 2.22e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 38 | 76 | 2.22e-03 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 151 | 407 | 2.23e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 190 | 529 | 2.27e-03 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 260 | 752 | 2.27e-03 |
| GO:BP | GO:0072175 | epithelial tube formation | 55 | 122 | 2.29e-03 |
| GO:BP | GO:0014856 | skeletal muscle cell proliferation | 13 | 17 | 2.42e-03 |
| GO:BP | GO:0042100 | B cell proliferation | 26 | 46 | 2.44e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 34 | 66 | 2.45e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 34 | 66 | 2.45e-03 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 286 | 837 | 2.46e-03 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 183 | 508 | 2.50e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 37 | 74 | 2.66e-03 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 64 | 148 | 2.68e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 43 | 90 | 2.75e-03 |
| GO:BP | GO:0000902 | cell morphogenesis | 263 | 764 | 2.75e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1603 | 5340 | 2.76e-03 |
| GO:BP | GO:0000278 | mitotic cell cycle | 275 | 803 | 2.79e-03 |
| GO:BP | GO:0001775 | cell activation | 232 | 665 | 2.89e-03 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 164 | 450 | 2.95e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 56 | 126 | 2.99e-03 |
| GO:BP | GO:0001654 | eye development | 106 | 272 | 3.01e-03 |
| GO:BP | GO:0048880 | sensory system development | 107 | 275 | 3.01e-03 |
| GO:BP | GO:0002376 | immune system process | 490 | 1512 | 3.02e-03 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 141 | 379 | 3.08e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 194 | 545 | 3.13e-03 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 149 | 404 | 3.14e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 374 | 1128 | 3.14e-03 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 236 | 679 | 3.15e-03 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 18 | 28 | 3.26e-03 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 202 | 571 | 3.30e-03 |
| GO:BP | GO:0034329 | cell junction assembly | 131 | 349 | 3.37e-03 |
| GO:BP | GO:0150063 | visual system development | 106 | 273 | 3.41e-03 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 141 | 380 | 3.41e-03 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 129 | 343 | 3.41e-03 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 244 | 706 | 3.47e-03 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 287 | 845 | 3.47e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 43 | 91 | 3.47e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 43 | 91 | 3.47e-03 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 17 | 26 | 3.59e-03 |
| GO:BP | GO:0060173 | limb development | 62 | 144 | 3.59e-03 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 17 | 26 | 3.59e-03 |
| GO:BP | GO:0048736 | appendage development | 62 | 144 | 3.59e-03 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 1365 | 4515 | 3.59e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 120 | 316 | 3.59e-03 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 35 | 70 | 3.67e-03 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 287 | 846 | 3.69e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 514 | 1597 | 3.85e-03 |
| GO:BP | GO:0048771 | tissue remodeling | 53 | 119 | 3.89e-03 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 16 | 24 | 4.04e-03 |
| GO:BP | GO:0042391 | regulation of membrane potential | 114 | 299 | 4.28e-03 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 246 | 715 | 4.29e-03 |
| GO:BP | GO:0002682 | regulation of immune system process | 314 | 936 | 4.32e-03 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 128 | 342 | 4.32e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 102 | 263 | 4.50e-03 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 22 | 38 | 4.68e-03 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 74 | 180 | 4.68e-03 |
| GO:BP | GO:0002683 | negative regulation of immune system process | 118 | 312 | 4.72e-03 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 14 | 20 | 4.86e-03 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 14 | 20 | 4.86e-03 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 14 | 20 | 4.86e-03 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 24 | 43 | 5.01e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 198 | 563 | 5.02e-03 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 231 | 669 | 5.20e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 210 | 602 | 5.37e-03 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 42 | 90 | 5.37e-03 |
| GO:BP | GO:0007015 | actin filament organization | 140 | 381 | 5.37e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 310 | 926 | 5.37e-03 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 46 | 101 | 5.38e-03 |
| GO:BP | GO:0007389 | pattern specification process | 116 | 307 | 5.38e-03 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 1291 | 4269 | 5.63e-03 |
| GO:BP | GO:0001501 | skeletal system development | 136 | 369 | 5.63e-03 |
| GO:BP | GO:0033043 | regulation of organelle organization | 337 | 1016 | 5.94e-03 |
| GO:BP | GO:0042246 | tissue regeneration | 29 | 56 | 5.96e-03 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 29 | 56 | 5.96e-03 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 27 | 51 | 6.14e-03 |
| GO:BP | GO:0060416 | response to growth hormone | 17 | 27 | 6.29e-03 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 49 | 110 | 6.29e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 112 | 296 | 6.29e-03 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 166 | 464 | 6.29e-03 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 49 | 110 | 6.29e-03 |
| GO:BP | GO:0003161 | cardiac conduction system development | 20 | 34 | 6.46e-03 |
| GO:BP | GO:0001649 | osteoblast differentiation | 74 | 182 | 6.46e-03 |
| GO:BP | GO:0051960 | regulation of nervous system development | 132 | 358 | 6.57e-03 |
| GO:BP | GO:0040008 | regulation of growth | 175 | 493 | 6.61e-03 |
| GO:BP | GO:0051641 | cellular localization | 863 | 2793 | 6.61e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 220 | 637 | 6.81e-03 |
| GO:BP | GO:0001659 | temperature homeostasis | 58 | 136 | 7.00e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 39 | 83 | 7.09e-03 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 16 | 25 | 7.22e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 36 | 75 | 7.22e-03 |
| GO:BP | GO:0030282 | bone mineralization | 40 | 86 | 7.67e-03 |
| GO:BP | GO:0031099 | regeneration | 62 | 148 | 7.72e-03 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 49 | 111 | 7.82e-03 |
| GO:BP | GO:0001823 | mesonephros development | 37 | 78 | 7.91e-03 |
| GO:BP | GO:0006974 | DNA damage response | 270 | 801 | 8.07e-03 |
| GO:BP | GO:0046661 | male sex differentiation | 50 | 114 | 8.14e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 38 | 81 | 8.62e-03 |
| GO:BP | GO:0055001 | muscle cell development | 69 | 169 | 8.64e-03 |
| GO:BP | GO:0051049 | regulation of transport | 380 | 1164 | 8.65e-03 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 1259 | 4170 | 8.91e-03 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 143 | 395 | 8.91e-03 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 18 | 30 | 9.02e-03 |
| GO:BP | GO:0030851 | granulocyte differentiation | 18 | 30 | 9.02e-03 |
| GO:BP | GO:0060284 | regulation of cell development | 209 | 605 | 9.10e-03 |
| GO:BP | GO:0002027 | regulation of heart rate | 39 | 84 | 9.17e-03 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 14 | 21 | 9.25e-03 |
| GO:BP | GO:0045017 | glycerolipid biosynthetic process | 85 | 217 | 9.25e-03 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 192 | 551 | 9.47e-03 |
| GO:BP | GO:0001657 | ureteric bud development | 36 | 76 | 9.47e-03 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 55 | 129 | 9.50e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 49 | 112 | 9.60e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 118 | 318 | 9.65e-03 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 20 | 35 | 1.01e-02 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 69 | 170 | 1.01e-02 |
| GO:BP | GO:0072001 | renal system development | 97 | 254 | 1.02e-02 |
| GO:BP | GO:0007017 | microtubule-based process | 257 | 762 | 1.03e-02 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 26 | 50 | 1.03e-02 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 93 | 242 | 1.04e-02 |
| GO:BP | GO:0007548 | sex differentiation | 76 | 191 | 1.05e-02 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 24 | 45 | 1.05e-02 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 195 | 562 | 1.06e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 246 | 727 | 1.08e-02 |
| GO:BP | GO:0061117 | negative regulation of heart growth | 12 | 17 | 1.09e-02 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 12 | 17 | 1.09e-02 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 12 | 17 | 1.09e-02 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 12 | 17 | 1.09e-02 |
| GO:BP | GO:0055022 | negative regulation of cardiac muscle tissue growth | 12 | 17 | 1.09e-02 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 29 | 58 | 1.10e-02 |
| GO:BP | GO:0006936 | muscle contraction | 101 | 267 | 1.11e-02 |
| GO:BP | GO:0006271 | DNA strand elongation involved in DNA replication | 11 | 15 | 1.16e-02 |
| GO:BP | GO:0009725 | response to hormone | 217 | 634 | 1.16e-02 |
| GO:BP | GO:0014841 | skeletal muscle satellite cell proliferation | 10 | 13 | 1.16e-02 |
| GO:BP | GO:1990874 | vascular associated smooth muscle cell proliferation | 27 | 53 | 1.17e-02 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 57 | 136 | 1.18e-02 |
| GO:BP | GO:0031347 | regulation of defense response | 172 | 490 | 1.19e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 36 | 77 | 1.19e-02 |
| GO:BP | GO:1904407 | positive regulation of nitric oxide metabolic process | 16 | 26 | 1.19e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 36 | 77 | 1.19e-02 |
| GO:BP | GO:0046474 | glycerophospholipid biosynthetic process | 74 | 186 | 1.19e-02 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 192 | 554 | 1.19e-02 |
| GO:BP | GO:0048863 | stem cell differentiation | 78 | 198 | 1.19e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 141 | 392 | 1.20e-02 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 154 | 433 | 1.20e-02 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 25 | 48 | 1.20e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 45 | 102 | 1.21e-02 |
| GO:BP | GO:0006955 | immune response | 308 | 932 | 1.21e-02 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 41 | 91 | 1.26e-02 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 34 | 72 | 1.33e-02 |
| GO:BP | GO:0065009 | regulation of molecular function | 445 | 1389 | 1.33e-02 |
| GO:BP | GO:0030048 | actin filament-based movement | 48 | 111 | 1.36e-02 |
| GO:BP | GO:0097106 | postsynaptic density organization | 18 | 31 | 1.38e-02 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 18 | 31 | 1.38e-02 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 15 | 24 | 1.38e-02 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 151 | 425 | 1.39e-02 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 26 | 51 | 1.39e-02 |
| GO:BP | GO:0030278 | regulation of ossification | 39 | 86 | 1.43e-02 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 32 | 67 | 1.45e-02 |
| GO:BP | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress | 6 | 6 | 1.45e-02 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 24 | 46 | 1.45e-02 |
| GO:BP | GO:0099545 | trans-synaptic signaling by trans-synaptic complex | 6 | 6 | 1.45e-02 |
| GO:BP | GO:0003166 | bundle of His development | 6 | 6 | 1.45e-02 |
| GO:BP | GO:0010616 | negative regulation of cardiac muscle adaptation | 6 | 6 | 1.45e-02 |
| GO:BP | GO:0021543 | pallium development | 60 | 146 | 1.45e-02 |
| GO:BP | GO:0070848 | response to growth factor | 198 | 576 | 1.48e-02 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 231 | 683 | 1.50e-02 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 300 | 909 | 1.50e-02 |
| GO:BP | GO:0045216 | cell-cell junction organization | 64 | 158 | 1.51e-02 |
| GO:BP | GO:0008654 | phospholipid biosynthetic process | 88 | 230 | 1.52e-02 |
| GO:BP | GO:0030879 | mammary gland development | 46 | 106 | 1.54e-02 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 27 | 54 | 1.56e-02 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 41 | 92 | 1.56e-02 |
| GO:BP | GO:0000165 | MAPK cascade | 185 | 535 | 1.57e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 30 | 62 | 1.59e-02 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 197 | 574 | 1.63e-02 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 146 | 411 | 1.63e-02 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 43 | 98 | 1.70e-02 |
| GO:BP | GO:0055123 | digestive system development | 43 | 98 | 1.70e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 88 | 231 | 1.75e-02 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 63 | 156 | 1.76e-02 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 164 | 469 | 1.76e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 63 | 156 | 1.76e-02 |
| GO:BP | GO:0060443 | mammary gland morphogenesis | 21 | 39 | 1.76e-02 |
| GO:BP | GO:1902117 | positive regulation of organelle assembly | 35 | 76 | 1.80e-02 |
| GO:BP | GO:0051726 | regulation of cell cycle | 307 | 935 | 1.80e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 73 | 186 | 1.82e-02 |
| GO:BP | GO:0031032 | actomyosin structure organization | 74 | 189 | 1.82e-02 |
| GO:BP | GO:0048565 | digestive tract development | 40 | 90 | 1.86e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 32 | 68 | 1.88e-02 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 16 | 27 | 1.90e-02 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 16 | 27 | 1.90e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 142 | 400 | 1.91e-02 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 47 | 110 | 1.93e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 41 | 93 | 1.93e-02 |
| GO:BP | GO:0050808 | synapse organization | 134 | 375 | 1.96e-02 |
| GO:BP | GO:0030031 | cell projection assembly | 167 | 480 | 1.98e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 24 | 47 | 1.99e-02 |
| GO:BP | GO:0061448 | connective tissue development | 83 | 217 | 2.01e-02 |
| GO:BP | GO:0060341 | regulation of cellular localization | 270 | 815 | 2.01e-02 |
| GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 12 | 18 | 2.01e-02 |
| GO:BP | GO:0031214 | biomineral tissue development | 49 | 116 | 2.01e-02 |
| GO:BP | GO:0060575 | intestinal epithelial cell differentiation | 12 | 18 | 2.01e-02 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 266 | 802 | 2.03e-02 |
| GO:BP | GO:0070661 | leukocyte proliferation | 74 | 190 | 2.08e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 38 | 85 | 2.10e-02 |
| GO:BP | GO:0021987 | cerebral cortex development | 44 | 102 | 2.14e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 44 | 102 | 2.14e-02 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 53 | 128 | 2.17e-02 |
| GO:BP | GO:0014842 | regulation of skeletal muscle satellite cell proliferation | 7 | 8 | 2.19e-02 |
| GO:BP | GO:0003093 | regulation of glomerular filtration | 7 | 8 | 2.19e-02 |
| GO:BP | GO:0001977 | renal system process involved in regulation of blood volume | 7 | 8 | 2.19e-02 |
| GO:BP | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 15 | 25 | 2.21e-02 |
| GO:BP | GO:0046621 | negative regulation of organ growth | 15 | 25 | 2.21e-02 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 15 | 25 | 2.21e-02 |
| GO:BP | GO:0030010 | establishment of cell polarity | 55 | 134 | 2.21e-02 |
| GO:BP | GO:0006996 | organelle organization | 914 | 3001 | 2.22e-02 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 35 | 77 | 2.24e-02 |
| GO:BP | GO:0031122 | cytoplasmic microtubule organization | 28 | 58 | 2.26e-02 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 40 | 91 | 2.26e-02 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 211 | 624 | 2.28e-02 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 80 | 209 | 2.31e-02 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 185 | 540 | 2.32e-02 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 41 | 94 | 2.34e-02 |
| GO:BP | GO:0043583 | ear development | 62 | 155 | 2.34e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 64 | 161 | 2.35e-02 |
| GO:BP | GO:0046649 | lymphocyte activation | 165 | 476 | 2.38e-02 |
| GO:BP | GO:0035721 | intraciliary retrograde transport | 10 | 14 | 2.39e-02 |
| GO:BP | GO:0072087 | renal vesicle development | 10 | 14 | 2.39e-02 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 10 | 14 | 2.39e-02 |
| GO:BP | GO:0021872 | forebrain generation of neurons | 17 | 30 | 2.40e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 21 | 40 | 2.44e-02 |
| GO:BP | GO:0014857 | regulation of skeletal muscle cell proliferation | 8 | 10 | 2.46e-02 |
| GO:BP | GO:0010889 | regulation of sequestering of triglyceride | 9 | 12 | 2.50e-02 |
| GO:BP | GO:0098792 | xenophagy | 9 | 12 | 2.50e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 85 | 225 | 2.53e-02 |
| GO:BP | GO:0001525 | angiogenesis | 140 | 397 | 2.55e-02 |
| GO:BP | GO:0035270 | endocrine system development | 38 | 86 | 2.56e-02 |
| GO:BP | GO:0021879 | forebrain neuron differentiation | 14 | 23 | 2.56e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 276 | 839 | 2.59e-02 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 95 | 256 | 2.59e-02 |
| GO:BP | GO:0048864 | stem cell development | 34 | 75 | 2.64e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 34 | 75 | 2.64e-02 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 111 | 306 | 2.66e-02 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 46 | 109 | 2.66e-02 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 167 | 484 | 2.68e-02 |
| GO:BP | GO:0098609 | cell-cell adhesion | 205 | 607 | 2.68e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 67 | 171 | 2.68e-02 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 157 | 452 | 2.68e-02 |
| GO:BP | GO:0019725 | cellular homeostasis | 201 | 594 | 2.68e-02 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 63 | 159 | 2.68e-02 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 167 | 484 | 2.68e-02 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 157 | 452 | 2.68e-02 |
| GO:BP | GO:0031399 | regulation of protein modification process | 312 | 959 | 2.69e-02 |
| GO:BP | GO:0043500 | muscle adaptation | 40 | 92 | 2.69e-02 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 249 | 751 | 2.69e-02 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 40 | 92 | 2.69e-02 |
| GO:BP | GO:0002285 | lymphocyte activation involved in immune response | 48 | 115 | 2.72e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 48 | 115 | 2.72e-02 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 31 | 67 | 2.75e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 22 | 43 | 2.75e-02 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 16 | 28 | 2.79e-02 |
| GO:BP | GO:1904861 | excitatory synapse assembly | 16 | 28 | 2.79e-02 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 16 | 28 | 2.79e-02 |
| GO:BP | GO:0060603 | mammary gland duct morphogenesis | 16 | 28 | 2.79e-02 |
| GO:BP | GO:0034097 | response to cytokine | 209 | 621 | 2.85e-02 |
| GO:BP | GO:0097009 | energy homeostasis | 28 | 59 | 2.85e-02 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 111 | 307 | 2.88e-02 |
| GO:BP | GO:0014032 | neural crest cell development | 32 | 70 | 2.90e-02 |
| GO:BP | GO:0003094 | glomerular filtration | 13 | 21 | 2.90e-02 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 13 | 21 | 2.90e-02 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 43 | 101 | 2.91e-02 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 37 | 84 | 2.95e-02 |
| GO:BP | GO:0021915 | neural tube development | 56 | 139 | 2.97e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 182 | 534 | 2.98e-02 |
| GO:BP | GO:0030217 | T cell differentiation | 73 | 190 | 2.99e-02 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 194 | 573 | 2.99e-02 |
| GO:BP | GO:0002262 | myeloid cell homeostasis | 58 | 145 | 2.99e-02 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 127 | 358 | 3.02e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 45 | 107 | 3.03e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 66 | 169 | 3.03e-02 |
| GO:BP | GO:0051591 | response to cAMP | 29 | 62 | 3.03e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 153 | 441 | 3.05e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 23 | 46 | 3.06e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 86 | 230 | 3.06e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 188 | 554 | 3.07e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 130 | 368 | 3.15e-02 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 936 | 3089 | 3.22e-02 |
| GO:BP | GO:0120034 | positive regulation of plasma membrane bounded cell projection assembly | 40 | 93 | 3.24e-02 |
| GO:BP | GO:0045724 | positive regulation of cilium assembly | 15 | 26 | 3.30e-02 |
| GO:BP | GO:0003002 | regionalization | 100 | 274 | 3.30e-02 |
| GO:BP | GO:0001841 | neural tube formation | 41 | 96 | 3.32e-02 |
| GO:BP | GO:0031644 | regulation of nervous system process | 35 | 79 | 3.32e-02 |
| GO:BP | GO:0031646 | positive regulation of nervous system process | 12 | 19 | 3.32e-02 |
| GO:BP | GO:0051234 | establishment of localization | 1039 | 3447 | 3.32e-02 |
| GO:BP | GO:0071378 | cellular response to growth hormone stimulus | 12 | 19 | 3.32e-02 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 35 | 79 | 3.32e-02 |
| GO:BP | GO:0019934 | cGMP-mediated signaling | 12 | 19 | 3.32e-02 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 55 | 137 | 3.42e-02 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 31 | 68 | 3.42e-02 |
| GO:BP | GO:0050890 | cognition | 86 | 231 | 3.44e-02 |
| GO:BP | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 64 | 164 | 3.47e-02 |
| GO:BP | GO:0046651 | lymphocyte proliferation | 64 | 164 | 3.47e-02 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 43 | 102 | 3.47e-02 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 150 | 433 | 3.47e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 139 | 398 | 3.54e-02 |
| GO:BP | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 32 | 71 | 3.61e-02 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 115 | 322 | 3.61e-02 |
| GO:BP | GO:0051301 | cell division | 191 | 566 | 3.62e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 22 | 44 | 3.65e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 22 | 44 | 3.65e-02 |
| GO:BP | GO:0001822 | kidney development | 91 | 247 | 3.65e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 22 | 44 | 3.65e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 22 | 44 | 3.65e-02 |
| GO:BP | GO:0060606 | tube closure | 38 | 88 | 3.67e-02 |
| GO:BP | GO:0071878 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway | 5 | 5 | 3.68e-02 |
| GO:BP | GO:0046898 | response to cycloheximide | 5 | 5 | 3.68e-02 |
| GO:BP | GO:0010886 | positive regulation of cholesterol storage | 5 | 5 | 3.68e-02 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 77 | 204 | 3.68e-02 |
| GO:BP | GO:0014020 | primary neural tube formation | 39 | 91 | 3.77e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 49 | 120 | 3.77e-02 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 211 | 632 | 3.77e-02 |
| GO:BP | GO:0050776 | regulation of immune response | 176 | 518 | 3.77e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 111 | 310 | 3.77e-02 |
| GO:BP | GO:0045761 | regulation of adenylate cyclase activity | 14 | 24 | 3.83e-02 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 40 | 94 | 3.84e-02 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 187 | 554 | 3.84e-02 |
| GO:BP | GO:0030001 | metal ion transport | 187 | 554 | 3.84e-02 |
| GO:BP | GO:0010720 | positive regulation of cell development | 116 | 326 | 3.84e-02 |
| GO:BP | GO:0048839 | inner ear development | 54 | 135 | 3.89e-02 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 83 | 223 | 3.91e-02 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 147 | 425 | 3.91e-02 |
| GO:BP | GO:0030500 | regulation of bone mineralization | 26 | 55 | 3.95e-02 |
| GO:BP | GO:0001708 | cell fate specification | 26 | 55 | 3.95e-02 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 35 | 80 | 4.01e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 16 | 29 | 4.01e-02 |
| GO:BP | GO:1904646 | cellular response to amyloid-beta | 16 | 29 | 4.01e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 77 | 205 | 4.15e-02 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 44 | 106 | 4.16e-02 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 31 | 69 | 4.23e-02 |
| GO:BP | GO:0044770 | cell cycle phase transition | 165 | 484 | 4.26e-02 |
| GO:BP | GO:0000003 | reproduction | 306 | 948 | 4.28e-02 |
| GO:BP | GO:0048634 | regulation of muscle organ development | 10 | 15 | 4.28e-02 |
| GO:BP | GO:0033036 | macromolecule localization | 749 | 2453 | 4.35e-02 |
| GO:BP | GO:0042063 | gliogenesis | 93 | 255 | 4.38e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 49 | 121 | 4.40e-02 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 83 | 224 | 4.40e-02 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 38 | 89 | 4.40e-02 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 38 | 89 | 4.40e-02 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 69 | 181 | 4.40e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 32 | 72 | 4.40e-02 |
| GO:BP | GO:0006810 | transport | 958 | 3176 | 4.46e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 657 | 2138 | 4.46e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 64 | 166 | 4.48e-02 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 13 | 22 | 4.48e-02 |
| GO:BP | GO:1901186 | positive regulation of ERBB signaling pathway | 13 | 22 | 4.48e-02 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 90 | 246 | 4.48e-02 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 13 | 22 | 4.48e-02 |
| GO:BP | GO:0040018 | positive regulation of multicellular organism growth | 13 | 22 | 4.48e-02 |
| GO:BP | GO:0002366 | leukocyte activation involved in immune response | 61 | 157 | 4.48e-02 |
| GO:BP | GO:0061572 | actin filament bundle organization | 55 | 139 | 4.48e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 78 | 209 | 4.57e-02 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 19 | 37 | 4.57e-02 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 142 | 411 | 4.58e-02 |
| GO:BP | GO:0032465 | regulation of cytokinesis | 34 | 78 | 4.72e-02 |
| GO:BP | GO:0030730 | sequestering of triglyceride | 9 | 13 | 4.72e-02 |
| GO:BP | GO:1905874 | regulation of postsynaptic density organization | 9 | 13 | 4.72e-02 |
| GO:BP | GO:0072077 | renal vesicle morphogenesis | 9 | 13 | 4.72e-02 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 1115 | 3724 | 4.74e-02 |
| GO:BP | GO:0010171 | body morphogenesis | 22 | 45 | 4.74e-02 |
| GO:BP | GO:0060324 | face development | 22 | 45 | 4.74e-02 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 17 | 32 | 4.74e-02 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 1141 | 3815 | 4.76e-02 |
| GO:BP | GO:0060485 | mesenchyme development | 93 | 256 | 4.76e-02 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 174 | 515 | 4.77e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 100 | 278 | 4.78e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 83 | 225 | 4.82e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 112 | 316 | 4.84e-02 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 99 | 275 | 4.84e-02 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 589 | 1908 | 4.85e-02 |
| GO:BP | GO:0071941 | nitrogen cycle metabolic process | 6 | 7 | 4.86e-02 |
| GO:BP | GO:0000050 | urea cycle | 6 | 7 | 4.86e-02 |
| GO:BP | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization | 6 | 7 | 4.86e-02 |
| GO:BP | GO:0001973 | G protein-coupled adenosine receptor signaling pathway | 6 | 7 | 4.86e-02 |
| GO:BP | GO:0035588 | G protein-coupled purinergic receptor signaling pathway | 6 | 7 | 4.86e-02 |
| GO:BP | GO:0019627 | urea metabolic process | 6 | 7 | 4.86e-02 |
| GO:BP | GO:0003164 | His-Purkinje system development | 6 | 7 | 4.86e-02 |
| GO:BP | GO:0060044 | negative regulation of cardiac muscle cell proliferation | 6 | 7 | 4.86e-02 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 1148 | 3841 | 4.93e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 8 | 11 | 4.98e-02 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 197 | 591 | 4.98e-02 |
| GO:BP | GO:0001843 | neural tube closure | 37 | 87 | 4.98e-02 |
| GO:BP | GO:0072089 | stem cell proliferation | 37 | 87 | 4.98e-02 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 37 | 87 | 4.98e-02 |
| GO:BP | GO:0106070 | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 8 | 11 | 4.98e-02 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 109 | 307 | 4.98e-02 |
| GO:BP | GO:0086070 | SA node cell to atrial cardiac muscle cell communication | 8 | 11 | 4.98e-02 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 50 | 125 | 4.98e-02 |
| GO:BP | GO:0060348 | bone development | 61 | 158 | 4.98e-02 |
| GO:BP | GO:1900180 | regulation of protein localization to nucleus | 50 | 125 | 4.98e-02 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 49 | 122 | 4.98e-02 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 51 | 128 | 4.98e-02 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 95 | 263 | 4.99e-02 |
| GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 20 | 40 | 4.99e-02 |
| GO:BP | GO:0043409 | negative regulation of MAPK cascade | 53 | 134 | 4.99e-02 |
| GO:BP | GO:0042110 | T cell activation | 114 | 323 | 5.00e-02 |
LR_int_restable %>%
filter(source=="KEGG") %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR neargenes intersected with RNA response genes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 39 | 91 | 7.80e-02 |
| KEGG | KEGG:04911 | Insulin secretion | 29 | 64 | 7.80e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 41 | 97 | 7.80e-02 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 59 | 151 | 7.80e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 64 | 164 | 7.80e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 50 | 125 | 7.80e-02 |
| KEGG | KEGG:04976 | Bile secretion | 21 | 42 | 7.80e-02 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 63 | 164 | 7.80e-02 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 33 | 77 | 7.80e-02 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 33 | 76 | 7.80e-02 |
| KEGG | KEGG:00000 | KEGG root term | 1718 | 5802 | 7.80e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 20 | 41 | 7.80e-02 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 24 | 48 | 7.80e-02 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 34 | 72 | 7.80e-02 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 23 | 49 | 7.80e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 32 | 74 | 7.80e-02 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 50 | 127 | 7.80e-02 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 46 | 109 | 7.80e-02 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 40 | 98 | 7.81e-02 |
| KEGG | KEGG:04611 | Platelet activation | 37 | 89 | 7.81e-02 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 42 | 104 | 7.81e-02 |
| KEGG | KEGG:05164 | Influenza A | 41 | 102 | 8.02e-02 |
| KEGG | KEGG:04924 | Renin secretion | 23 | 50 | 8.02e-02 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 51 | 132 | 8.02e-02 |
| KEGG | KEGG:04360 | Axon guidance | 61 | 162 | 8.02e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 25 | 56 | 8.14e-02 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 34 | 82 | 8.32e-02 |
| KEGG | KEGG:05161 | Hepatitis B | 52 | 136 | 8.43e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 51 | 134 | 9.50e-02 |
| KEGG | KEGG:03030 | DNA replication | 17 | 35 | 9.50e-02 |
| KEGG | KEGG:04014 | Ras signaling pathway | 63 | 172 | 1.01e-01 |
| KEGG | KEGG:04110 | Cell cycle | 56 | 151 | 1.01e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 9 | 15 | 1.01e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 35 | 87 | 1.01e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 54 | 145 | 1.01e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 24 | 55 | 1.01e-01 |
| KEGG | KEGG:03410 | Base excision repair | 20 | 44 | 1.01e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 46 | 121 | 1.07e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 24 | 56 | 1.15e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 33 | 83 | 1.25e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 37 | 95 | 1.25e-01 |
| KEGG | KEGG:05142 | Chagas disease | 30 | 75 | 1.44e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 28 | 69 | 1.44e-01 |
| KEGG | KEGG:04814 | Motor proteins | 54 | 149 | 1.50e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 22 | 52 | 1.50e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 23 | 55 | 1.50e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 40 | 106 | 1.50e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 30 | 76 | 1.50e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 36 | 94 | 1.50e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 26 | 64 | 1.50e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 84 | 246 | 1.53e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 133 | 408 | 1.68e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 23 | 56 | 1.68e-01 |
| KEGG | KEGG:04210 | Apoptosis | 43 | 117 | 1.68e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 43 | 117 | 1.68e-01 |
| KEGG | KEGG:04730 | Long-term depression | 18 | 42 | 1.77e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 53 | 149 | 1.77e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 29 | 75 | 1.79e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 13 | 28 | 1.79e-01 |
| KEGG | KEGG:04115 | p53 signaling pathway | 26 | 66 | 1.79e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 54 | 153 | 1.79e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 26 | 66 | 1.79e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 62 | 179 | 1.86e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 50 | 142 | 2.11e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 50 | 142 | 2.11e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 32 | 86 | 2.25e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 15 | 35 | 2.29e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 37 | 102 | 2.32e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 60 | 176 | 2.46e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 45 | 128 | 2.48e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 8 | 16 | 2.53e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 8 | 16 | 2.53e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 29 | 78 | 2.53e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 26 | 69 | 2.57e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 17 | 42 | 2.64e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 22 | 57 | 2.64e-01 |
| KEGG | KEGG:04540 | Gap junction | 27 | 73 | 2.86e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 11 | 25 | 2.93e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 53 | 157 | 2.93e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 3 | 4 | 2.93e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 21 | 55 | 2.93e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 22 | 58 | 2.93e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 36 | 102 | 2.93e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 3 | 4 | 2.93e-01 |
| KEGG | KEGG:05218 | Melanoma | 22 | 58 | 2.93e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 24 | 65 | 3.13e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 31 | 87 | 3.13e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 30 | 84 | 3.16e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 9 | 20 | 3.16e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 34 | 97 | 3.20e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 19 | 50 | 3.20e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 38 | 110 | 3.20e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 11 | 26 | 3.22e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 32 | 91 | 3.22e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 14 | 35 | 3.23e-01 |
| KEGG | KEGG:05224 | Breast cancer | 40 | 117 | 3.26e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 32 | 92 | 3.50e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 41 | 121 | 3.50e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 27 | 77 | 3.61e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 24 | 67 | 3.61e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 54 | 165 | 3.61e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 36 | 106 | 3.61e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 45 | 135 | 3.61e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 10 | 24 | 3.61e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 13 | 33 | 3.61e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 15 | 39 | 3.61e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 33 | 96 | 3.61e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 30 | 86 | 3.61e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 25 | 71 | 3.77e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 18 | 49 | 3.80e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 5 | 10 | 3.80e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 27 | 78 | 3.96e-01 |
| KEGG | KEGG:04742 | Taste transduction | 9 | 22 | 4.03e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 8 | 19 | 4.03e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 20 | 56 | 4.03e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 24 | 69 | 4.03e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 49 | 151 | 4.03e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 10 | 25 | 4.03e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 19 | 53 | 4.03e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 9 | 22 | 4.03e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 26 | 76 | 4.19e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 37 | 112 | 4.19e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 22 | 63 | 4.19e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 15 | 41 | 4.28e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 14 | 38 | 4.35e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 38 | 116 | 4.37e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 13 | 35 | 4.38e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 37 | 114 | 4.67e-01 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 28 | 84 | 4.67e-01 |
| KEGG | KEGG:00650 | Butanoate metabolism | 7 | 17 | 4.67e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 8 | 20 | 4.67e-01 |
| KEGG | KEGG:04217 | Necroptosis | 34 | 104 | 4.67e-01 |
| KEGG | KEGG:05133 | Pertussis | 16 | 45 | 4.67e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 79 | 256 | 4.78e-01 |
| KEGG | KEGG:04530 | Tight junction | 44 | 138 | 4.86e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 28 | 85 | 4.95e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 37 | 115 | 4.96e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 11 | 30 | 5.01e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 83 | 271 | 5.01e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 26 | 79 | 5.12e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 32 | 99 | 5.12e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 28 | 86 | 5.23e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 45 | 144 | 5.52e-01 |
| KEGG | KEGG:04744 | Phototransduction | 5 | 12 | 5.52e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 5 | 12 | 5.52e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 21 | 64 | 5.59e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 11 | 31 | 5.59e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 15 | 44 | 5.59e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 21 | 64 | 5.59e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 33 | 104 | 5.59e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 27 | 84 | 5.59e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 20 | 61 | 5.72e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 34 | 108 | 5.72e-01 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 15 | 45 | 5.80e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 8 | 22 | 5.80e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 22 | 68 | 5.80e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 8 | 22 | 5.80e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 15 | 45 | 5.80e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 21 | 65 | 5.80e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 24 | 75 | 5.80e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 19 | 58 | 5.80e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 7 | 19 | 5.84e-01 |
| KEGG | KEGG:04520 | Adherens junction | 27 | 86 | 5.95e-01 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 10 | 29 | 5.95e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 19 | 59 | 5.95e-01 |
| KEGG | KEGG:03260 | Virion - Human immunodeficiency virus | 1 | 1 | 5.95e-01 |
| KEGG | KEGG:00232 | Caffeine metabolism | 1 | 1 | 5.95e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 13 | 39 | 5.95e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 6 | 16 | 5.95e-01 |
| KEGG | KEGG:01100 | Metabolic pathways | 332 | 1149 | 5.99e-01 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 36 | 117 | 6.03e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 4 | 10 | 6.13e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 17 | 53 | 6.21e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 6.21e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 14 | 43 | 6.21e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 10 | 30 | 6.25e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 10 | 30 | 6.25e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 33 | 108 | 6.25e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 29 | 94 | 6.25e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 7 | 20 | 6.25e-01 |
| KEGG | KEGG:05214 | Glioma | 21 | 67 | 6.25e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 26 | 84 | 6.25e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 17 | 54 | 6.46e-01 |
| KEGG | KEGG:04144 | Endocytosis | 68 | 230 | 6.46e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 5 | 14 | 6.49e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 34 | 113 | 6.49e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 30 | 99 | 6.49e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 16 | 51 | 6.49e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 23 | 75 | 6.49e-01 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 30 | 99 | 6.49e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 23 | 75 | 6.49e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 5 | 14 | 6.49e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 63 | 214 | 6.55e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 24 | 79 | 6.63e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 10 | 31 | 6.63e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 43 | 145 | 6.66e-01 |
| KEGG | KEGG:04137 | Mitophagy - animal | 30 | 100 | 6.68e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 25 | 83 | 6.79e-01 |
| KEGG | KEGG:05162 | Measles | 29 | 97 | 6.81e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 13 | 42 | 6.97e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 15 | 49 | 7.00e-01 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 8 | 25 | 7.03e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 33 | 112 | 7.12e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 16 | 53 | 7.21e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 20 | 67 | 7.22e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 2 | 5 | 7.31e-01 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 31 | 106 | 7.31e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 39 | 134 | 7.31e-01 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 13 | 43 | 7.31e-01 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 26 | 89 | 7.44e-01 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 4 | 12 | 7.44e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 49 | 170 | 7.44e-01 |
| KEGG | KEGG:00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 1 | 2 | 7.78e-01 |
| KEGG | KEGG:03267 | Virion - Adenovirus | 1 | 2 | 7.78e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 24 | 83 | 7.78e-01 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 13 | 44 | 7.78e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 7 | 23 | 7.78e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 16 | 55 | 7.80e-01 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 51 | 179 | 7.80e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 25 | 87 | 7.82e-01 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 37 | 131 | 7.92e-01 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 4 | 13 | 7.92e-01 |
| KEGG | KEGG:05034 | Alcoholism | 32 | 113 | 7.92e-01 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 11 | 38 | 7.92e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 14 | 49 | 7.92e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 46 | 163 | 7.92e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 16 | 56 | 7.92e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 18 | 63 | 7.92e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 35 | 123 | 7.92e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 15 | 52 | 7.92e-01 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 9 | 31 | 7.92e-01 |
| KEGG | KEGG:05144 | Malaria | 6 | 20 | 7.92e-01 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 14 | 49 | 7.92e-01 |
| KEGG | KEGG:00062 | Fatty acid elongation | 7 | 24 | 7.95e-01 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 2 | 6 | 8.01e-01 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 8 | 28 | 8.13e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 8 | 28 | 8.13e-01 |
| KEGG | KEGG:00920 | Sulfur metabolism | 3 | 10 | 8.24e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 3 | 10 | 8.24e-01 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 6 | 21 | 8.24e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 12 | 43 | 8.29e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 4 | 14 | 8.46e-01 |
| KEGG | KEGG:04146 | Peroxisome | 19 | 69 | 8.49e-01 |
| KEGG | KEGG:02010 | ABC transporters | 8 | 29 | 8.54e-01 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 9 | 33 | 8.66e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 42 | 153 | 8.66e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 13 | 48 | 8.67e-01 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 30 | 110 | 8.67e-01 |
| KEGG | KEGG:05145 | Toxoplasmosis | 22 | 81 | 8.67e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 16 | 59 | 8.67e-01 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 20 | 74 | 8.71e-01 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 8.71e-01 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 4 | 15 | 8.92e-01 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 16 | 60 | 8.92e-01 |
| KEGG | KEGG:05131 | Shigellosis | 57 | 210 | 8.92e-01 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 13 | 49 | 8.92e-01 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 15 | 57 | 9.10e-01 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 12 | 46 | 9.15e-01 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 13 | 50 | 9.22e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 3 | 12 | 9.26e-01 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 3 | 12 | 9.26e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 26 | 99 | 9.26e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 3 | 12 | 9.26e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 3 | 12 | 9.26e-01 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 2 | 8 | 9.27e-01 |
| KEGG | KEGG:04122 | Sulfur relay system | 2 | 8 | 9.27e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 7 | 28 | 9.31e-01 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1 | 4 | 9.55e-01 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 8 | 33 | 9.57e-01 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 6 | 25 | 9.57e-01 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 4 | 17 | 9.57e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 5 | 21 | 9.57e-01 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 6 | 25 | 9.57e-01 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 4 | 17 | 9.57e-01 |
| KEGG | KEGG:00350 | Tyrosine metabolism | 3 | 13 | 9.58e-01 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 6 | 26 | 9.72e-01 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 5 | 22 | 9.72e-01 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 2 | 9 | 9.72e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 5 | 22 | 9.72e-01 |
| KEGG | KEGG:04145 | Phagosome | 25 | 99 | 9.72e-01 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 5 | 22 | 9.72e-01 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 6 | 26 | 9.72e-01 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 4 | 18 | 9.72e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 25 | 100 | 9.72e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 15 | 62 | 9.76e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 1 | 5 | 9.83e-01 |
| KEGG | KEGG:00360 | Phenylalanine metabolism | 1 | 5 | 9.83e-01 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 5 | 23 | 9.92e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 4 | 19 | 9.95e-01 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 4 | 19 | 9.95e-01 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 9 | 40 | 9.97e-01 |
| KEGG | KEGG:03022 | Basal transcription factors | 9 | 40 | 9.97e-01 |
| KEGG | KEGG:00071 | Fatty acid degradation | 7 | 32 | 9.99e-01 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 6 | 28 | 1.00e+00 |
| KEGG | KEGG:00670 | One carbon pool by folate | 3 | 18 | 1.00e+00 |
| KEGG | KEGG:00790 | Folate biosynthesis | 3 | 18 | 1.00e+00 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 6 | 29 | 1.00e+00 |
| KEGG | KEGG:05219 | Bladder cancer | 6 | 37 | 1.00e+00 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 1 | 6 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 45 | 195 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 63 | 255 | 1.00e+00 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 4 | 23 | 1.00e+00 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 2 | 13 | 1.00e+00 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 8 | 46 | 1.00e+00 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 8 | 37 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 5 | 39 | 1.00e+00 |
| KEGG | KEGG:00511 | Other glycan degradation | 2 | 16 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 8 | 51 | 1.00e+00 |
| KEGG | KEGG:00340 | Histidine metabolism | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 76 | 303 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 5 | 31 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 17 | 106 | 1.00e+00 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 1 | 11 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 49 | 225 | 1.00e+00 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 3 | 27 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 7 | 38 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 9 | 44 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 72 | 314 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 48 | 218 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 40 | 185 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 7 | 44 | 1.00e+00 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 3 | 21 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 10 | 46 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 40 | 168 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 10 | 50 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 5 | 41 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 78 | 416 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 11 | 69 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 34 | 177 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 26 | 117 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 27 | 160 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 93 | 384 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 5 | 52 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 5 | 30 | 1.00e+00 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 1 | 6 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 14 | 132 | 1.00e+00 |
| KEGG | KEGG:03020 | RNA polymerase | 6 | 34 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 17 | 74 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 17 | 85 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 15 | 127 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 10 | 75 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 30 | 162 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 4 | 24 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 5 | 35 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 28 | 115 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 22 | 98 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 6 | 42 | 1.00e+00 |
# intersect(unique(Resp_RNA$ENTREZID), unique(NR_peak_list_20k$ENTREZID)))
LR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(fill="#00BFC4")+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")+
theme(axis.text.y = element_text(color="black"))+
ggtitle("Intersection LR")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
NR
# NR_int_resgenes <- gost(query = int_NR_n_RNAresp,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(NR_int_resgenes,"data/GO_KEGG_analysis/NR_int_resgenes.RDS")
NR_int_resgenes <- readRDS("data/GO_KEGG_analysis/NR_int_resgenes.RDS")
NR_int_restable <- NR_int_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
NR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR neargenes intersected with RNA response genes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0050794 | regulation of cellular process | 3320 | 7651 | 3.76e-11 |
| GO:BP | GO:0050789 | regulation of biological process | 3463 | 8037 | 2.77e-10 |
| GO:BP | GO:0065007 | biological regulation | 3558 | 8275 | 2.77e-10 |
| GO:BP | GO:0007049 | cell cycle | 749 | 1520 | 3.84e-10 |
| GO:BP | GO:0022402 | cell cycle process | 548 | 1078 | 1.38e-09 |
| GO:BP | GO:0051716 | cellular response to stimulus | 2192 | 4933 | 2.09e-09 |
| GO:BP | GO:0007059 | chromosome segregation | 214 | 372 | 2.46e-08 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1709 | 3804 | 5.32e-08 |
| GO:BP | GO:0050896 | response to stimulus | 2496 | 5732 | 4.91e-07 |
| GO:BP | GO:0000280 | nuclear division | 198 | 349 | 5.14e-07 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1793 | 4037 | 9.99e-07 |
| GO:BP | GO:0000278 | mitotic cell cycle | 406 | 803 | 1.82e-06 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 349 | 679 | 2.37e-06 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 595 | 1233 | 3.84e-06 |
| GO:BP | GO:0098813 | nuclear chromosome segregation | 155 | 269 | 6.42e-06 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 321 | 624 | 7.69e-06 |
| GO:BP | GO:0006974 | DNA damage response | 400 | 801 | 1.15e-05 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1384 | 3089 | 1.21e-05 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1996 | 4561 | 1.33e-05 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 547 | 1135 | 1.53e-05 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 285 | 551 | 2.07e-05 |
| GO:BP | GO:0051726 | regulation of cell cycle | 457 | 935 | 2.41e-05 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1842 | 4198 | 2.41e-05 |
| GO:BP | GO:0061982 | meiosis I cell cycle process | 57 | 81 | 2.41e-05 |
| GO:BP | GO:0051276 | chromosome organization | 277 | 535 | 2.41e-05 |
| GO:BP | GO:0048285 | organelle fission | 211 | 393 | 2.70e-05 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 1275 | 2842 | 2.72e-05 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 1974 | 4521 | 2.78e-05 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 1774 | 4039 | 2.98e-05 |
| GO:BP | GO:0000819 | sister chromatid segregation | 127 | 218 | 2.98e-05 |
| GO:BP | GO:0000070 | mitotic sister chromatid segregation | 108 | 180 | 3.33e-05 |
| GO:BP | GO:0140013 | meiotic nuclear division | 78 | 122 | 4.94e-05 |
| GO:BP | GO:0051301 | cell division | 289 | 566 | 4.94e-05 |
| GO:BP | GO:0033554 | cellular response to stress | 717 | 1538 | 4.94e-05 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 494 | 1027 | 5.69e-05 |
| GO:BP | GO:1903046 | meiotic cell cycle process | 86 | 138 | 5.69e-05 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 875 | 1908 | 5.69e-05 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 1156 | 2576 | 9.67e-05 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 496 | 1036 | 1.05e-04 |
| GO:BP | GO:0019222 | regulation of metabolic process | 2126 | 4914 | 1.18e-04 |
| GO:BP | GO:0140014 | mitotic nuclear division | 141 | 252 | 1.18e-04 |
| GO:BP | GO:0007127 | meiosis I | 52 | 75 | 1.18e-04 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 1160 | 2589 | 1.18e-04 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 913 | 2005 | 1.18e-04 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 94 | 156 | 1.18e-04 |
| GO:BP | GO:0007154 | cell communication | 1851 | 4248 | 1.27e-04 |
| GO:BP | GO:0007010 | cytoskeleton organization | 574 | 1218 | 1.37e-04 |
| GO:BP | GO:0006260 | DNA replication | 142 | 255 | 1.40e-04 |
| GO:BP | GO:0007051 | spindle organization | 110 | 189 | 1.43e-04 |
| GO:BP | GO:0006351 | DNA-templated transcription | 1198 | 2683 | 1.46e-04 |
| GO:BP | GO:0007165 | signal transduction | 1683 | 3846 | 1.55e-04 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 1959 | 4515 | 1.69e-04 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 368 | 752 | 2.04e-04 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 1207 | 2709 | 2.05e-04 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 777 | 1694 | 2.09e-04 |
| GO:BP | GO:0007017 | microtubule-based process | 372 | 762 | 2.27e-04 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 797 | 1744 | 2.86e-04 |
| GO:BP | GO:0040007 | growth | 361 | 739 | 2.94e-04 |
| GO:BP | GO:0023052 | signaling | 1816 | 4180 | 3.59e-04 |
| GO:BP | GO:0072359 | circulatory system development | 429 | 896 | 4.35e-04 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 790 | 1732 | 4.35e-04 |
| GO:BP | GO:0008283 | cell population proliferation | 641 | 1386 | 5.23e-04 |
| GO:BP | GO:0021537 | telencephalon development | 117 | 208 | 5.33e-04 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 1351 | 3066 | 5.34e-04 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 1850 | 4269 | 5.34e-04 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 928 | 2061 | 6.05e-04 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 1808 | 4170 | 6.25e-04 |
| GO:BP | GO:0048589 | developmental growth | 264 | 527 | 6.25e-04 |
| GO:BP | GO:0010468 | regulation of gene expression | 1577 | 3613 | 6.74e-04 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 1376 | 3131 | 7.38e-04 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 1622 | 3724 | 7.79e-04 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 1376 | 3132 | 7.79e-04 |
| GO:BP | GO:0051321 | meiotic cell cycle | 107 | 189 | 8.11e-04 |
| GO:BP | GO:0007275 | multicellular organism development | 1479 | 3383 | 9.96e-04 |
| GO:BP | GO:0033043 | regulation of organelle organization | 478 | 1016 | 1.04e-03 |
| GO:BP | GO:0006261 | DNA-templated DNA replication | 88 | 151 | 1.12e-03 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 1668 | 3841 | 1.13e-03 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 1657 | 3815 | 1.16e-03 |
| GO:BP | GO:0030900 | forebrain development | 155 | 292 | 1.16e-03 |
| GO:BP | GO:0051983 | regulation of chromosome segregation | 73 | 121 | 1.17e-03 |
| GO:BP | GO:0045786 | negative regulation of cell cycle | 177 | 340 | 1.25e-03 |
| GO:BP | GO:0006281 | DNA repair | 269 | 543 | 1.25e-03 |
| GO:BP | GO:0009888 | tissue development | 653 | 1425 | 1.35e-03 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 1416 | 3238 | 1.44e-03 |
| GO:BP | GO:0007507 | heart development | 256 | 515 | 1.44e-03 |
| GO:BP | GO:0006996 | organelle organization | 1317 | 3001 | 1.49e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 934 | 2088 | 1.52e-03 |
| GO:BP | GO:0035556 | intracellular signal transduction | 930 | 2079 | 1.57e-03 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 1929 | 4481 | 1.62e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 998 | 2246 | 2.51e-03 |
| GO:BP | GO:0048513 | animal organ development | 949 | 2130 | 2.57e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 148 | 281 | 2.72e-03 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 915 | 2052 | 3.18e-03 |
| GO:BP | GO:0090068 | positive regulation of cell cycle process | 114 | 209 | 3.20e-03 |
| GO:BP | GO:0051310 | metaphase chromosome alignment | 59 | 96 | 3.24e-03 |
| GO:BP | GO:0000075 | cell cycle checkpoint signaling | 104 | 188 | 3.24e-03 |
| GO:BP | GO:0050000 | chromosome localization | 66 | 110 | 3.25e-03 |
| GO:BP | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 18 | 21 | 3.25e-03 |
| GO:BP | GO:0051303 | establishment of chromosome localization | 62 | 102 | 3.25e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 785 | 1746 | 3.41e-03 |
| GO:BP | GO:0007093 | mitotic cell cycle checkpoint signaling | 81 | 141 | 3.92e-03 |
| GO:BP | GO:0006259 | DNA metabolic process | 416 | 886 | 3.92e-03 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 1971 | 4599 | 3.96e-03 |
| GO:BP | GO:0044770 | cell cycle phase transition | 239 | 484 | 4.00e-03 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 888 | 1992 | 4.00e-03 |
| GO:BP | GO:0048468 | cell development | 891 | 1999 | 4.00e-03 |
| GO:BP | GO:0006950 | response to stress | 1191 | 2715 | 4.12e-03 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 54 | 87 | 4.22e-03 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 55 | 89 | 4.25e-03 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 19 | 23 | 4.79e-03 |
| GO:BP | GO:0009262 | deoxyribonucleotide metabolic process | 26 | 35 | 5.53e-03 |
| GO:BP | GO:0019692 | deoxyribose phosphate metabolic process | 26 | 35 | 5.53e-03 |
| GO:BP | GO:0007052 | mitotic spindle organization | 73 | 126 | 5.77e-03 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 526 | 1146 | 6.45e-03 |
| GO:BP | GO:0045444 | fat cell differentiation | 103 | 189 | 6.61e-03 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 20 | 25 | 6.70e-03 |
| GO:BP | GO:0060429 | epithelium development | 392 | 836 | 6.70e-03 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 1975 | 4620 | 6.97e-03 |
| GO:BP | GO:0050793 | regulation of developmental process | 804 | 1801 | 7.12e-03 |
| GO:BP | GO:0033047 | regulation of mitotic sister chromatid segregation | 35 | 52 | 8.29e-03 |
| GO:BP | GO:0045839 | negative regulation of mitotic nuclear division | 36 | 54 | 8.86e-03 |
| GO:BP | GO:0006915 | apoptotic process | 658 | 1459 | 8.87e-03 |
| GO:BP | GO:2001251 | negative regulation of chromosome organization | 54 | 89 | 8.92e-03 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 2037 | 4776 | 8.92e-03 |
| GO:BP | GO:1901987 | regulation of cell cycle phase transition | 194 | 389 | 8.92e-03 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 198 | 398 | 9.01e-03 |
| GO:BP | GO:0009394 | 2’-deoxyribonucleotide metabolic process | 25 | 34 | 9.05e-03 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 389 | 833 | 9.94e-03 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 865 | 1951 | 1.01e-02 |
| GO:BP | GO:0048731 | system development | 1263 | 2903 | 1.01e-02 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 141 | 273 | 1.01e-02 |
| GO:BP | GO:0043010 | camera-type eye development | 124 | 236 | 1.01e-02 |
| GO:BP | GO:0048869 | cellular developmental process | 1298 | 2988 | 1.05e-02 |
| GO:BP | GO:0030154 | cell differentiation | 1297 | 2987 | 1.15e-02 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 142 | 276 | 1.17e-02 |
| GO:BP | GO:0008608 | attachment of spindle microtubules to kinetochore | 34 | 51 | 1.23e-02 |
| GO:BP | GO:0060322 | head development | 279 | 583 | 1.24e-02 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 245 | 506 | 1.25e-02 |
| GO:BP | GO:0016070 | RNA metabolic process | 1545 | 3588 | 1.28e-02 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1210 | 2780 | 1.29e-02 |
| GO:BP | GO:0007098 | centrosome cycle | 72 | 127 | 1.33e-02 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 643 | 1430 | 1.37e-02 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1082 | 2474 | 1.37e-02 |
| GO:BP | GO:0051784 | negative regulation of nuclear division | 37 | 57 | 1.39e-02 |
| GO:BP | GO:0007423 | sensory organ development | 197 | 399 | 1.39e-02 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1012 | 2307 | 1.40e-02 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 225 | 462 | 1.41e-02 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 445 | 967 | 1.42e-02 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 24 | 33 | 1.42e-02 |
| GO:BP | GO:1901653 | cellular response to peptide | 145 | 284 | 1.42e-02 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 155 | 306 | 1.42e-02 |
| GO:BP | GO:0071174 | mitotic spindle checkpoint signaling | 30 | 44 | 1.45e-02 |
| GO:BP | GO:0071173 | spindle assembly checkpoint signaling | 30 | 44 | 1.45e-02 |
| GO:BP | GO:0007094 | mitotic spindle assembly checkpoint signaling | 30 | 44 | 1.45e-02 |
| GO:BP | GO:0012501 | programmed cell death | 674 | 1505 | 1.49e-02 |
| GO:BP | GO:2000816 | negative regulation of mitotic sister chromatid separation | 31 | 46 | 1.53e-02 |
| GO:BP | GO:0033046 | negative regulation of sister chromatid segregation | 31 | 46 | 1.53e-02 |
| GO:BP | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 31 | 46 | 1.53e-02 |
| GO:BP | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 31 | 46 | 1.53e-02 |
| GO:BP | GO:0048856 | anatomical structure development | 1766 | 4130 | 1.58e-02 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 135 | 263 | 1.62e-02 |
| GO:BP | GO:0010948 | negative regulation of cell cycle process | 140 | 274 | 1.62e-02 |
| GO:BP | GO:0008219 | cell death | 675 | 1509 | 1.63e-02 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 71 | 126 | 1.63e-02 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 158 | 314 | 1.70e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 120 | 231 | 1.85e-02 |
| GO:BP | GO:0031023 | microtubule organizing center organization | 77 | 139 | 1.86e-02 |
| GO:BP | GO:0009790 | embryo development | 399 | 864 | 1.92e-02 |
| GO:BP | GO:0045132 | meiotic chromosome segregation | 36 | 56 | 1.92e-02 |
| GO:BP | GO:0007080 | mitotic metaphase chromosome alignment | 37 | 58 | 1.98e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 711 | 1597 | 2.00e-02 |
| GO:BP | GO:0045930 | negative regulation of mitotic cell cycle | 111 | 212 | 2.02e-02 |
| GO:BP | GO:0007088 | regulation of mitotic nuclear division | 58 | 100 | 2.03e-02 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 9 | 9 | 2.03e-02 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 214 | 441 | 2.17e-02 |
| GO:BP | GO:1905818 | regulation of chromosome separation | 43 | 70 | 2.17e-02 |
| GO:BP | GO:0051304 | chromosome separation | 46 | 76 | 2.18e-02 |
| GO:BP | GO:0032465 | regulation of cytokinesis | 47 | 78 | 2.18e-02 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 44 | 72 | 2.18e-02 |
| GO:BP | GO:0032501 | multicellular organismal process | 2050 | 4830 | 2.18e-02 |
| GO:BP | GO:0051225 | spindle assembly | 68 | 121 | 2.21e-02 |
| GO:BP | GO:0007389 | pattern specification process | 154 | 307 | 2.21e-02 |
| GO:BP | GO:0009987 | cellular process | 4708 | 11450 | 2.22e-02 |
| GO:BP | GO:0031577 | spindle checkpoint signaling | 30 | 45 | 2.22e-02 |
| GO:BP | GO:0007420 | brain development | 257 | 539 | 2.22e-02 |
| GO:BP | GO:0007417 | central nervous system development | 348 | 748 | 2.22e-02 |
| GO:BP | GO:0032502 | developmental process | 1904 | 4475 | 2.26e-02 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 403 | 876 | 2.27e-02 |
| GO:BP | GO:0001654 | eye development | 138 | 272 | 2.27e-02 |
| GO:BP | GO:0051985 | negative regulation of chromosome segregation | 31 | 47 | 2.27e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 85 | 157 | 2.27e-02 |
| GO:BP | GO:0044057 | regulation of system process | 195 | 399 | 2.27e-02 |
| GO:BP | GO:1905819 | negative regulation of chromosome separation | 31 | 47 | 2.27e-02 |
| GO:BP | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 31 | 47 | 2.27e-02 |
| GO:BP | GO:1901988 | negative regulation of cell cycle phase transition | 122 | 237 | 2.27e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 387 | 839 | 2.27e-02 |
| GO:BP | GO:0022008 | neurogenesis | 595 | 1327 | 2.49e-02 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 71 | 128 | 2.52e-02 |
| GO:BP | GO:0051984 | positive regulation of chromosome segregation | 20 | 27 | 2.52e-02 |
| GO:BP | GO:0014706 | striated muscle tissue development | 113 | 218 | 2.53e-02 |
| GO:BP | GO:0048880 | sensory system development | 139 | 275 | 2.53e-02 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 585 | 1304 | 2.56e-02 |
| GO:BP | GO:0010646 | regulation of cell communication | 1129 | 2601 | 2.57e-02 |
| GO:BP | GO:0150063 | visual system development | 138 | 273 | 2.59e-02 |
| GO:BP | GO:0030217 | T cell differentiation | 100 | 190 | 2.59e-02 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 37 | 59 | 2.68e-02 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 294 | 626 | 2.68e-02 |
| GO:BP | GO:0051783 | regulation of nuclear division | 65 | 116 | 2.86e-02 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 583 | 1301 | 2.87e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 191 | 392 | 2.87e-02 |
| GO:BP | GO:0021988 | olfactory lobe development | 17 | 22 | 2.87e-02 |
| GO:BP | GO:1901652 | response to peptide | 186 | 381 | 2.96e-02 |
| GO:BP | GO:0031099 | regeneration | 80 | 148 | 3.14e-02 |
| GO:BP | GO:0043009 | chordate embryonic development | 251 | 529 | 3.15e-02 |
| GO:BP | GO:0007548 | sex differentiation | 100 | 191 | 3.15e-02 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 122 | 239 | 3.15e-02 |
| GO:BP | GO:0016043 | cellular component organization | 2172 | 5139 | 3.17e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 133 | 264 | 3.61e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 133 | 264 | 3.61e-02 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1251 | 2902 | 3.73e-02 |
| GO:BP | GO:0051299 | centrosome separation | 12 | 14 | 3.75e-02 |
| GO:BP | GO:0048729 | tissue morphogenesis | 228 | 478 | 3.75e-02 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 34 | 54 | 3.75e-02 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 12 | 14 | 3.75e-02 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 35 | 56 | 3.79e-02 |
| GO:BP | GO:0042246 | tissue regeneration | 35 | 56 | 3.79e-02 |
| GO:BP | GO:0023051 | regulation of signaling | 1124 | 2597 | 3.85e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 515 | 1145 | 3.85e-02 |
| GO:BP | GO:0060419 | heart growth | 43 | 72 | 3.92e-02 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 40 | 66 | 3.92e-02 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 813 | 1852 | 3.93e-02 |
| GO:BP | GO:0000731 | DNA synthesis involved in DNA repair | 25 | 37 | 4.09e-02 |
| GO:BP | GO:0046474 | glycerophospholipid biosynthetic process | 97 | 186 | 4.14e-02 |
| GO:BP | GO:0044771 | meiotic cell cycle phase transition | 10 | 11 | 4.21e-02 |
| GO:BP | GO:0043584 | nose development | 10 | 11 | 4.21e-02 |
| GO:BP | GO:0040008 | regulation of growth | 234 | 493 | 4.26e-02 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1004 | 2311 | 4.32e-02 |
| GO:BP | GO:0008654 | phospholipid biosynthetic process | 117 | 230 | 4.32e-02 |
| GO:BP | GO:0033045 | regulation of sister chromatid segregation | 56 | 99 | 4.36e-02 |
| GO:BP | GO:0009267 | cellular response to starvation | 82 | 154 | 4.41e-02 |
| GO:BP | GO:0045017 | glycerolipid biosynthetic process | 111 | 217 | 4.42e-02 |
| GO:BP | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 88 | 167 | 4.47e-02 |
| GO:BP | GO:0048568 | embryonic organ development | 156 | 317 | 4.53e-02 |
| GO:BP | GO:0035825 | homologous recombination | 28 | 43 | 4.64e-02 |
| GO:BP | GO:0035108 | limb morphogenesis | 64 | 116 | 4.64e-02 |
| GO:BP | GO:0035107 | appendage morphogenesis | 64 | 116 | 4.64e-02 |
| GO:BP | GO:0051656 | establishment of organelle localization | 198 | 412 | 4.67e-02 |
| GO:BP | GO:0035295 | tube development | 378 | 827 | 4.71e-02 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 16 | 21 | 4.71e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 49 | 85 | 4.87e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 256 | 545 | 4.96e-02 |
NR_int_restable %>%
filter(source=="KEGG") %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR neargenes intersected with RNA response genes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04115 | p53 signaling pathway | 44 | 66 | 5.29e-03 |
| KEGG | KEGG:04110 | Cell cycle | 85 | 151 | 1.04e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 56 | 97 | 3.82e-02 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 32 | 49 | 3.82e-02 |
| KEGG | KEGG:03410 | Base excision repair | 29 | 44 | 4.03e-02 |
| KEGG | KEGG:05224 | Breast cancer | 62 | 117 | 2.39e-01 |
| KEGG | KEGG:03030 | DNA replication | 22 | 35 | 3.12e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 15 | 22 | 3.47e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 88 | 179 | 3.47e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 36 | 65 | 3.47e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 48 | 91 | 3.47e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 60 | 117 | 3.47e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 61 | 121 | 4.33e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 31 | 56 | 4.33e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 53 | 104 | 4.54e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 63 | 128 | 4.55e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 44 | 86 | 4.55e-01 |
| KEGG | KEGG:04148 | Efferocytosis | 61 | 125 | 4.55e-01 |
| KEGG | KEGG:04814 | Motor proteins | 72 | 149 | 4.55e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 38 | 72 | 4.55e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 38 | 74 | 4.55e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 72 | 149 | 4.55e-01 |
| KEGG | KEGG:00000 | KEGG root term | 2405 | 5802 | 4.55e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 39 | 76 | 4.55e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 30 | 56 | 4.55e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 23 | 41 | 4.55e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 12 | 19 | 4.55e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 22 | 39 | 4.55e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 26 | 48 | 4.55e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 55 | 109 | 4.55e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 34 | 66 | 5.15e-01 |
| KEGG | KEGG:04217 | Necroptosis | 51 | 104 | 5.20e-01 |
| KEGG | KEGG:04146 | Peroxisome | 35 | 69 | 5.49e-01 |
| KEGG | KEGG:05218 | Melanoma | 30 | 58 | 5.49e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 64 | 134 | 5.49e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 34 | 67 | 5.58e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 19 | 35 | 6.22e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 18 | 33 | 6.22e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 25 | 48 | 6.22e-01 |
| KEGG | KEGG:05034 | Alcoholism | 54 | 113 | 6.22e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 29 | 57 | 6.22e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 41 | 84 | 6.29e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 22 | 42 | 6.29e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 47 | 98 | 6.29e-01 |
| KEGG | KEGG:04976 | Bile secretion | 22 | 42 | 6.29e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 42 | 87 | 6.55e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 28 | 56 | 6.68e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 63 | 136 | 6.68e-01 |
| KEGG | KEGG:04210 | Apoptosis | 55 | 117 | 6.68e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 67 | 145 | 6.68e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 11 | 19 | 6.68e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 9 | 15 | 6.88e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 45 | 95 | 6.88e-01 |
| KEGG | KEGG:04924 | Renin secretion | 25 | 50 | 7.10e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 29 | 59 | 7.10e-01 |
| KEGG | KEGG:04611 | Platelet activation | 42 | 89 | 7.48e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 18 | 35 | 7.80e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 39 | 83 | 8.30e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 47 | 102 | 8.61e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 9 | 16 | 8.61e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 64 | 142 | 8.61e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 9 | 16 | 8.61e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 6 | 10 | 8.79e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 70 | 157 | 8.79e-01 |
| KEGG | KEGG:00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 2 | 2 | 8.79e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 43 | 94 | 8.79e-01 |
| KEGG | KEGG:04540 | Gap junction | 34 | 73 | 8.79e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 35 | 75 | 8.79e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 13 | 25 | 8.79e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 49 | 108 | 8.79e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 21 | 44 | 8.91e-01 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 72 | 164 | 8.91e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 67 | 151 | 8.91e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 60 | 135 | 8.91e-01 |
| KEGG | KEGG:05164 | Influenza A | 46 | 102 | 8.91e-01 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 177 | 416 | 8.91e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 26 | 55 | 8.91e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 25 | 53 | 8.91e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 38 | 83 | 8.91e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 14 | 28 | 8.91e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 174 | 408 | 8.91e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 64 | 144 | 8.91e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 50 | 112 | 8.95e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 13 | 26 | 8.97e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 29 | 64 | 9.08e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 34 | 75 | 9.08e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 53 | 121 | 9.08e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 23 | 50 | 9.08e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 26 | 56 | 9.08e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 10 | 20 | 9.08e-01 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 21 | 45 | 9.08e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 35 | 78 | 9.08e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 34 | 75 | 9.08e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 105 | 246 | 9.08e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 44 | 99 | 9.08e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 41 | 92 | 9.08e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 43 | 97 | 9.08e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 34 | 76 | 9.08e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 38 | 85 | 9.08e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 31 | 68 | 9.08e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 58 | 132 | 9.08e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 31 | 69 | 9.09e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 38 | 86 | 9.45e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 55 | 127 | 9.73e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 23 | 51 | 9.95e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 36 | 82 | 9.99e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 14 | 30 | 1.00e+00 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 70 | 164 | 1.00e+00 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 43 | 99 | 1.00e+00 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 10 | 28 | 1.00e+00 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 14 | 31 | 1.00e+00 |
| KEGG | KEGG:04740 | Olfactory transduction | 11 | 25 | 1.00e+00 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 6 | 25 | 1.00e+00 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 5 | 15 | 1.00e+00 |
| KEGG | KEGG:00640 | Propanoate metabolism | 8 | 28 | 1.00e+00 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 59 | 142 | 1.00e+00 |
| KEGG | KEGG:05133 | Pertussis | 15 | 45 | 1.00e+00 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 4 | 18 | 1.00e+00 |
| KEGG | KEGG:00650 | Butanoate metabolism | 7 | 17 | 1.00e+00 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 37 | 110 | 1.00e+00 |
| KEGG | KEGG:04730 | Long-term depression | 19 | 42 | 1.00e+00 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 37 | 102 | 1.00e+00 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 2 | 4 | 1.00e+00 |
| KEGG | KEGG:00670 | One carbon pool by folate | 7 | 18 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 8 | 38 | 1.00e+00 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 31 | 84 | 1.00e+00 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 9 | 33 | 1.00e+00 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 3 | 13 | 1.00e+00 |
| KEGG | KEGG:05131 | Shigellosis | 78 | 210 | 1.00e+00 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 12 | 31 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 10 | 25 | 1.00e+00 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 10 | 28 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 25 | 127 | 1.00e+00 |
| KEGG | KEGG:04972 | Pancreatic secretion | 25 | 58 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 28 | 75 | 1.00e+00 |
| KEGG | KEGG:02010 | ABC transporters | 12 | 29 | 1.00e+00 |
| KEGG | KEGG:05152 | Tuberculosis | 43 | 106 | 1.00e+00 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 63 | 170 | 1.00e+00 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 30 | 79 | 1.00e+00 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 8 | 26 | 1.00e+00 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 29 | 69 | 1.00e+00 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 1.00e+00 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 4 | 10 | 1.00e+00 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 20 | 45 | 1.00e+00 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 26 | 79 | 1.00e+00 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 6 | 14 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 9 | 40 | 1.00e+00 |
| KEGG | KEGG:05132 | Salmonella infection | 82 | 214 | 1.00e+00 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 3 | 6 | 1.00e+00 |
| KEGG | KEGG:05135 | Yersinia infection | 38 | 112 | 1.00e+00 |
| KEGG | KEGG:04971 | Gastric acid secretion | 22 | 52 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 19 | 44 | 1.00e+00 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 9 | 20 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 54 | 195 | 1.00e+00 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 8 | 26 | 1.00e+00 |
| KEGG | KEGG:04720 | Long-term potentiation | 21 | 55 | 1.00e+00 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 5 | 21 | 1.00e+00 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 15 | 44 | 1.00e+00 |
| KEGG | KEGG:05143 | African trypanosomiasis | 6 | 16 | 1.00e+00 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 51 | 134 | 1.00e+00 |
| KEGG | KEGG:04530 | Tight junction | 52 | 138 | 1.00e+00 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 10 | 24 | 1.00e+00 |
| KEGG | KEGG:01100 | Metabolic pathways | 445 | 1149 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 48 | 168 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 26 | 98 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 10 | 35 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 45 | 115 | 1.00e+00 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 21 | 60 | 1.00e+00 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 15 | 50 | 1.00e+00 |
| KEGG | KEGG:05219 | Bladder cancer | 10 | 37 | 1.00e+00 |
| KEGG | KEGG:05142 | Chagas disease | 31 | 75 | 1.00e+00 |
| KEGG | KEGG:04710 | Circadian rhythm | 13 | 30 | 1.00e+00 |
| KEGG | KEGG:00920 | Sulfur metabolism | 3 | 10 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 46 | 185 | 1.00e+00 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 3 | 5 | 1.00e+00 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 15 | 41 | 1.00e+00 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 11 | 29 | 1.00e+00 |
| KEGG | KEGG:05144 | Malaria | 6 | 20 | 1.00e+00 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 14 | 38 | 1.00e+00 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 6 | 17 | 1.00e+00 |
| KEGG | KEGG:00790 | Folate biosynthesis | 5 | 18 | 1.00e+00 |
| KEGG | KEGG:05140 | Leishmaniasis | 13 | 42 | 1.00e+00 |
| KEGG | KEGG:00730 | Thiamine metabolism | 4 | 10 | 1.00e+00 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 9 | 22 | 1.00e+00 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 6 | 21 | 1.00e+00 |
| KEGG | KEGG:05146 | Amoebiasis | 23 | 64 | 1.00e+00 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 32 | 99 | 1.00e+00 |
| KEGG | KEGG:05214 | Glioma | 28 | 67 | 1.00e+00 |
| KEGG | KEGG:05145 | Toxoplasmosis | 24 | 81 | 1.00e+00 |
| KEGG | KEGG:04122 | Sulfur relay system | 3 | 8 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 12 | 46 | 1.00e+00 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 25 | 65 | 1.00e+00 |
| KEGG | KEGG:04726 | Serotonergic synapse | 26 | 63 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 9 | 24 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 17 | 50 | 1.00e+00 |
| KEGG | KEGG:04136 | Autophagy - other | 14 | 31 | 1.00e+00 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 6 | 12 | 1.00e+00 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 20 | 52 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 62 | 225 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 21 | 52 | 1.00e+00 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 13 | 30 | 1.00e+00 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 18 | 43 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 113 | 303 | 1.00e+00 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 107 | 271 | 1.00e+00 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 32 | 84 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 82 | 255 | 1.00e+00 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 23 | 55 | 1.00e+00 |
| KEGG | KEGG:04970 | Salivary secretion | 23 | 55 | 1.00e+00 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 46 | 123 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 63 | 218 | 1.00e+00 |
| KEGG | KEGG:04916 | Melanogenesis | 32 | 77 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 137 | 384 | 1.00e+00 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 36 | 96 | 1.00e+00 |
| KEGG | KEGG:05030 | Cocaine addiction | 16 | 35 | 1.00e+00 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 21 | 57 | 1.00e+00 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 23 | 53 | 1.00e+00 |
| KEGG | KEGG:05031 | Amphetamine addiction | 19 | 49 | 1.00e+00 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 6 | 19 | 1.00e+00 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 21 | 61 | 1.00e+00 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 33 | 77 | 1.00e+00 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 28 | 89 | 1.00e+00 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 28 | 69 | 1.00e+00 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 20 | 49 | 1.00e+00 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 61 | 145 | 1.00e+00 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 22 | 54 | 1.00e+00 |
| KEGG | KEGG:03267 | Virion - Adenovirus | 1 | 2 | 1.00e+00 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 1 | 6 | 1.00e+00 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 14 | 49 | 1.00e+00 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 8 | 22 | 1.00e+00 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 6 | 14 | 1.00e+00 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 29 | 84 | 1.00e+00 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 40 | 99 | 1.00e+00 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 41 | 117 | 1.00e+00 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 22 | 67 | 1.00e+00 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 11 | 33 | 1.00e+00 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 68 | 176 | 1.00e+00 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 3 | 5 | 1.00e+00 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 44 | 115 | 1.00e+00 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 41 | 113 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 7 | 30 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 11 | 42 | 1.00e+00 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 24 | 64 | 1.00e+00 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 29 | 71 | 1.00e+00 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 1 | 11 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 102 | 314 | 1.00e+00 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 31 | 94 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 39 | 132 | 1.00e+00 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 37 | 87 | 1.00e+00 |
| KEGG | KEGG:05160 | Hepatitis C | 50 | 116 | 1.00e+00 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 36 | 104 | 1.00e+00 |
| KEGG | KEGG:05162 | Measles | 37 | 97 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 34 | 162 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 13 | 69 | 1.00e+00 |
| KEGG | KEGG:04144 | Endocytosis | 92 | 230 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 32 | 117 | 1.00e+00 |
| KEGG | KEGG:05332 | Graft-versus-host disease | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 46 | 160 | 1.00e+00 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 24 | 58 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 36 | 100 | 1.00e+00 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 7 | 20 | 1.00e+00 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 59 | 151 | 1.00e+00 |
| KEGG | KEGG:04014 | Ras signaling pathway | 71 | 172 | 1.00e+00 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 24 | 83 | 1.00e+00 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 34 | 78 | 1.00e+00 |
| KEGG | KEGG:04520 | Adherens junction | 31 | 86 | 1.00e+00 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 39 | 131 | 1.00e+00 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 36 | 91 | 1.00e+00 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 42 | 108 | 1.00e+00 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 69 | 163 | 1.00e+00 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 6 | 23 | 1.00e+00 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:05222 | Small cell lung cancer | 35 | 87 | 1.00e+00 |
| KEGG | KEGG:04744 | Phototransduction | 6 | 12 | 1.00e+00 |
| KEGG | KEGG:04742 | Taste transduction | 10 | 22 | 1.00e+00 |
| KEGG | KEGG:04145 | Phagosome | 34 | 99 | 1.00e+00 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 18 | 43 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 27 | 85 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 48 | 177 | 1.00e+00 |
| KEGG | KEGG:05033 | Nicotine addiction | 4 | 12 | 1.00e+00 |
| KEGG | KEGG:04360 | Axon guidance | 68 | 162 | 1.00e+00 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 97 | 256 | 1.00e+00 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 18 | 49 | 1.00e+00 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 38 | 106 | 1.00e+00 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 19 | 62 | 1.00e+00 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 32 | 86 | 1.00e+00 |
| KEGG | KEGG:03022 | Basal transcription factors | 16 | 40 | 1.00e+00 |
| KEGG | KEGG:05330 | Allograft rejection | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 60 | 153 | 1.00e+00 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 40 | 100 | 1.00e+00 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 27 | 64 | 1.00e+00 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 29 | 76 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 8 | 41 | 1.00e+00 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 19 | 56 | 1.00e+00 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 58 | 179 | 1.00e+00 |
| KEGG | KEGG:03020 | RNA polymerase | 12 | 34 | 1.00e+00 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 14 | 46 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 26 | 74 | 1.00e+00 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 29 | 75 | 1.00e+00 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 43 | 106 | 1.00e+00 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 26 | 74 | 1.00e+00 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 47 | 110 | 1.00e+00 |
| KEGG | KEGG:04929 | GnRH secretion | 20 | 53 | 1.00e+00 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 66 | 165 | 1.00e+00 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 23 | 63 | 1.00e+00 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 41 | 114 | 1.00e+00 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 4 | 13 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 7 | 31 | 1.00e+00 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 11 | 29 | 1.00e+00 |
| KEGG | KEGG:00232 | Caffeine metabolism | 1 | 1 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 22 | 106 | 1.00e+00 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 5 | 19 | 1.00e+00 |
| KEGG | KEGG:00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 4 | 11 | 1.00e+00 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 7 | 17 | 1.00e+00 |
| KEGG | KEGG:00071 | Fatty acid degradation | 8 | 32 | 1.00e+00 |
| KEGG | KEGG:00062 | Fatty acid elongation | 7 | 24 | 1.00e+00 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 2 | 9 | 1.00e+00 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 6 | 27 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 9 | 25 | 1.00e+00 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 7 | 28 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 10 | 44 | 1.00e+00 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 21 | 49 | 1.00e+00 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 59 | 153 | 1.00e+00 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 17 | 39 | 1.00e+00 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 14 | 43 | 1.00e+00 |
| KEGG | KEGG:00052 | Galactose metabolism | 7 | 22 | 1.00e+00 |
| KEGG | KEGG:00310 | Lysine degradation | 20 | 59 | 1.00e+00 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1 | 4 | 1.00e+00 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 7 | 21 | 1.00e+00 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 14 | 46 | 1.00e+00 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 8 | 37 | 1.00e+00 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 5 | 22 | 1.00e+00 |
| KEGG | KEGG:00511 | Other glycan degradation | 2 | 16 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 11 | 51 | 1.00e+00 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 8 | 23 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 6 | 39 | 1.00e+00 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 6 | 14 | 1.00e+00 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 2 | 6 | 1.00e+00 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 3 | 8 | 1.00e+00 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 10 | 22 | 1.00e+00 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 16 | 38 | 1.00e+00 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 3 | 23 | 1.00e+00 |
| KEGG | KEGG:00360 | Phenylalanine metabolism | 2 | 5 | 1.00e+00 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 2 | 4 | 1.00e+00 |
| KEGG | KEGG:00340 | Histidine metabolism | 4 | 12 | 1.00e+00 |
| KEGG | KEGG:00350 | Tyrosine metabolism | 6 | 13 | 1.00e+00 |
# intersect(unique(Resp_RNA$ENTREZID), unique(NR_peak_list_20k$ENTREZID)))
NR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(fill="#C77CFF")+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")+
theme(axis.text.y = element_text(color="black"))+
ggtitle("Intersection NR")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
not intersected NR
Seeing about the other neargenes that did not intersect with RNA response genes
# not_NR_int_resgenes <- gost(query = setdiff(NR_NG_list$ENTREZID, Resp_RNA$ENTREZID),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(not_NR_int_resgenes,"data/GO_KEGG_analysis/not_NR_int_resgenes.RDS")
not_NR_int_resgenes <- readRDS("data/GO_KEGG_analysis/not_NR_int_resgenes.RDS")
not_NR_int_restable <- not_NR_int_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
not_NR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR neargenes intersected with RNA response genes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0008150 | biological_process | 5725 | 12051 | 1.61e-09 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 2339 | 4637 | 3.30e-08 |
| GO:BP | GO:0019538 | protein metabolic process | 1946 | 3848 | 1.90e-06 |
| GO:BP | GO:1901566 | organonitrogen compound biosynthetic process | 772 | 1451 | 6.75e-05 |
| GO:BP | GO:0009987 | cellular process | 5426 | 11450 | 8.74e-05 |
| GO:BP | GO:0043603 | amide metabolic process | 535 | 985 | 2.81e-04 |
| GO:BP | GO:0006518 | peptide metabolic process | 425 | 776 | 1.22e-03 |
| GO:BP | GO:0022904 | respiratory electron transport chain | 73 | 104 | 1.22e-03 |
| GO:BP | GO:0019646 | aerobic electron transport chain | 55 | 74 | 1.22e-03 |
| GO:BP | GO:0006412 | translation | 347 | 623 | 1.39e-03 |
| GO:BP | GO:0043413 | macromolecule glycosylation | 116 | 182 | 1.39e-03 |
| GO:BP | GO:0009100 | glycoprotein metabolic process | 179 | 299 | 1.39e-03 |
| GO:BP | GO:0006486 | protein glycosylation | 116 | 182 | 1.39e-03 |
| GO:BP | GO:0045333 | cellular respiration | 132 | 211 | 1.39e-03 |
| GO:BP | GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 59 | 82 | 1.52e-03 |
| GO:BP | GO:0042773 | ATP synthesis coupled electron transport | 59 | 82 | 1.52e-03 |
| GO:BP | GO:0009060 | aerobic respiration | 108 | 168 | 1.52e-03 |
| GO:BP | GO:0002181 | cytoplasmic translation | 99 | 152 | 1.52e-03 |
| GO:BP | GO:0070085 | glycosylation | 122 | 194 | 1.53e-03 |
| GO:BP | GO:0006119 | oxidative phosphorylation | 82 | 122 | 1.54e-03 |
| GO:BP | GO:0043043 | peptide biosynthetic process | 354 | 643 | 2.29e-03 |
| GO:BP | GO:0008152 | metabolic process | 4052 | 8464 | 2.39e-03 |
| GO:BP | GO:0043604 | amide biosynthetic process | 406 | 747 | 2.39e-03 |
| GO:BP | GO:0071704 | organic substance metabolic process | 3875 | 8096 | 7.94e-03 |
| GO:BP | GO:1901135 | carbohydrate derivative metabolic process | 464 | 872 | 8.63e-03 |
| GO:BP | GO:0006487 | protein N-linked glycosylation | 47 | 65 | 9.07e-03 |
| GO:BP | GO:0009101 | glycoprotein biosynthetic process | 148 | 249 | 9.08e-03 |
| GO:BP | GO:0022900 | electron transport chain | 90 | 141 | 9.08e-03 |
| GO:BP | GO:0006807 | nitrogen compound metabolic process | 3540 | 7376 | 9.99e-03 |
| GO:BP | GO:0015980 | energy derivation by oxidation of organic compounds | 165 | 285 | 2.17e-02 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 59 | 88 | 2.76e-02 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 139 | 238 | 4.26e-02 |
| GO:BP | GO:0051016 | barbed-end actin filament capping | 17 | 19 | 4.26e-02 |
| GO:BP | GO:0006091 | generation of precursor metabolites and energy | 233 | 422 | 4.89e-02 |
not_NR_int_restable %>%
filter(source=="KEGG") %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR neargenes intersected with RNA response genes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04510 | Focal adhesion | 117 | 177 | 2.94e-05 |
| KEGG | KEGG:03010 | Ribosome | 87 | 127 | 6.33e-05 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 105 | 162 | 1.86e-04 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 51 | 69 | 2.66e-04 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 115 | 185 | 7.28e-04 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 100 | 160 | 1.39e-03 |
| KEGG | KEGG:04714 | Thermogenesis | 119 | 195 | 1.39e-03 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 70 | 106 | 1.49e-03 |
| KEGG | KEGG:05016 | Huntington disease | 149 | 255 | 2.58e-03 |
| KEGG | KEGG:05012 | Parkinson disease | 133 | 225 | 2.70e-03 |
| KEGG | KEGG:05020 | Prion disease | 128 | 218 | 5.00e-03 |
| KEGG | KEGG:05010 | Alzheimer disease | 176 | 314 | 9.58e-03 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 29 | 39 | 9.79e-03 |
| KEGG | KEGG:00000 | KEGG root term | 2785 | 5802 | 1.29e-02 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 105 | 179 | 1.29e-02 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 210 | 384 | 1.29e-02 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 145 | 256 | 1.29e-02 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 99 | 168 | 1.36e-02 |
| KEGG | KEGG:00531 | Glycosaminoglycan degradation | 14 | 16 | 1.54e-02 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 35 | 51 | 1.94e-02 |
| KEGG | KEGG:04142 | Lysosome | 71 | 117 | 2.14e-02 |
| KEGG | KEGG:01100 | Metabolic pathways | 582 | 1149 | 2.23e-02 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 47 | 74 | 3.40e-02 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 77 | 131 | 4.19e-02 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 63 | 106 | 6.55e-02 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 51 | 84 | 7.78e-02 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 24 | 35 | 8.65e-02 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 56 | 94 | 8.65e-02 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 30 | 46 | 8.87e-02 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 25 | 37 | 8.87e-02 |
| KEGG | KEGG:05219 | Bladder cancer | 25 | 37 | 8.87e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 53 | 89 | 9.36e-02 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 19 | 27 | 1.06e-01 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 161 | 303 | 1.06e-01 |
| KEGG | KEGG:04520 | Adherens junction | 51 | 86 | 1.09e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 66 | 115 | 1.12e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 47 | 79 | 1.21e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 47 | 79 | 1.21e-01 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 50 | 85 | 1.25e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 64 | 112 | 1.25e-01 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 22 | 33 | 1.30e-01 |
| KEGG | KEGG:04530 | Tight junction | 77 | 138 | 1.34e-01 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 28 | 44 | 1.34e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 93 | 170 | 1.41e-01 |
| KEGG | KEGG:05131 | Shigellosis | 113 | 210 | 1.41e-01 |
| KEGG | KEGG:00511 | Other glycan degradation | 12 | 16 | 1.52e-01 |
| KEGG | KEGG:01200 | Carbon metabolism | 56 | 98 | 1.57e-01 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 27 | 43 | 1.59e-01 |
| KEGG | KEGG:00071 | Fatty acid degradation | 21 | 32 | 1.59e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 59 | 104 | 1.59e-01 |
| KEGG | KEGG:00790 | Folate biosynthesis | 13 | 18 | 1.69e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 38 | 64 | 1.70e-01 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 56 | 99 | 1.78e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 44 | 76 | 1.89e-01 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 15 | 22 | 2.11e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 208 | 408 | 2.11e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 43 | 75 | 2.30e-01 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 9 | 12 | 2.60e-01 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 18 | 28 | 2.60e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 18 | 28 | 2.60e-01 |
| KEGG | KEGG:03060 | Protein export | 19 | 30 | 2.66e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 112 | 214 | 2.66e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 48 | 86 | 2.76e-01 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 14 | 21 | 2.76e-01 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 60 | 110 | 2.81e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 62 | 114 | 2.81e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 34 | 59 | 2.85e-01 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 15 | 23 | 2.85e-01 |
| KEGG | KEGG:00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 7 | 9 | 2.88e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 38 | 67 | 2.88e-01 |
| KEGG | KEGG:05134 | Legionellosis | 23 | 38 | 2.88e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 39 | 69 | 2.88e-01 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 7 | 9 | 2.88e-01 |
| KEGG | KEGG:03050 | Proteasome | 25 | 42 | 2.89e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 61 | 113 | 2.95e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 66 | 123 | 2.95e-01 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 29 | 50 | 3.05e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 57 | 106 | 3.22e-01 |
| KEGG | KEGG:03040 | Spliceosome | 70 | 132 | 3.22e-01 |
| KEGG | KEGG:04144 | Endocytosis | 118 | 230 | 3.22e-01 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 20 | 33 | 3.22e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 35 | 62 | 3.22e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 46 | 84 | 3.22e-01 |
| KEGG | KEGG:05144 | Malaria | 13 | 20 | 3.22e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 14 | 22 | 3.27e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 24 | 41 | 3.27e-01 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 5 | 6 | 3.27e-01 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 9 | 13 | 3.34e-01 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 9 | 13 | 3.34e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 79 | 151 | 3.34e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 28 | 49 | 3.35e-01 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 32 | 57 | 3.45e-01 |
| KEGG | KEGG:04360 | Axon guidance | 84 | 162 | 3.55e-01 |
| KEGG | KEGG:00780 | Biotin metabolism | 3 | 3 | 3.77e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 58 | 110 | 4.01e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 54 | 102 | 4.04e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 136 | 271 | 4.19e-01 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 15 | 25 | 4.42e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 37 | 69 | 4.79e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 33 | 61 | 4.79e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 29 | 53 | 4.79e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 35 | 65 | 4.79e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 30 | 55 | 4.79e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 69 | 134 | 4.79e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 78 | 153 | 4.86e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 48 | 92 | 5.08e-01 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 83 | 164 | 5.08e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 50 | 96 | 5.08e-01 |
| KEGG | KEGG:04137 | Mitophagy - animal | 52 | 100 | 5.08e-01 |
| KEGG | KEGG:03020 | RNA polymerase | 19 | 34 | 5.31e-01 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 22 | 40 | 5.31e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 21 | 38 | 5.31e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 16 | 28 | 5.31e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 28 | 52 | 5.31e-01 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 59 | 115 | 5.31e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 31 | 58 | 5.31e-01 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 25 | 46 | 5.31e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 51 | 99 | 5.34e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 47 | 91 | 5.46e-01 |
| KEGG | KEGG:05145 | Toxoplasmosis | 42 | 81 | 5.53e-01 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 6 | 9 | 5.53e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 86 | 172 | 5.53e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 40 | 77 | 5.57e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 39 | 75 | 5.57e-01 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 82 | 164 | 5.58e-01 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 26 | 49 | 5.72e-01 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 13 | 23 | 5.72e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 29 | 55 | 5.72e-01 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 16 | 29 | 5.72e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 23 | 43 | 5.72e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 64 | 127 | 5.72e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 121 | 246 | 5.72e-01 |
| KEGG | KEGG:03271 | Virion - Rotavirus | 2 | 2 | 5.72e-01 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 26 | 49 | 5.72e-01 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 11 | 19 | 5.72e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 11 | 19 | 5.72e-01 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 16 | 29 | 5.72e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 13 | 23 | 5.72e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 40 | 78 | 5.74e-01 |
| KEGG | KEGG:03018 | RNA degradation | 38 | 74 | 5.81e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 44 | 87 | 6.26e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 42 | 83 | 6.35e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 39 | 77 | 6.43e-01 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 3 | 4 | 6.43e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 51 | 102 | 6.43e-01 |
| KEGG | KEGG:04540 | Gap junction | 37 | 73 | 6.50e-01 |
| KEGG | KEGG:00670 | One carbon pool by folate | 10 | 18 | 6.57e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 41 | 82 | 6.57e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 7 | 12 | 6.57e-01 |
| KEGG | KEGG:00062 | Fatty acid elongation | 13 | 24 | 6.57e-01 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 58 | 117 | 6.57e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 74 | 151 | 6.57e-01 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 14 | 26 | 6.57e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 42 | 84 | 6.57e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 8 | 14 | 6.57e-01 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 14 | 26 | 6.57e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 65 | 132 | 6.57e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 16 | 30 | 6.57e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 32 | 63 | 6.57e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 49 | 99 | 6.68e-01 |
| KEGG | KEGG:05133 | Pertussis | 23 | 45 | 6.89e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 43 | 87 | 7.05e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 32 | 64 | 7.06e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 85 | 176 | 7.18e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 29 | 58 | 7.24e-01 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 16 | 31 | 7.28e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 28 | 56 | 7.28e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 72 | 149 | 7.33e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 13 | 25 | 7.46e-01 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 13 | 25 | 7.46e-01 |
| KEGG | KEGG:05214 | Glioma | 33 | 67 | 7.53e-01 |
| KEGG | KEGG:05416 | Viral myocarditis | 23 | 46 | 7.53e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 11 | 21 | 7.56e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 65 | 135 | 7.59e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 21 | 42 | 7.62e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 27 | 55 | 7.90e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 75 | 157 | 7.90e-01 |
| KEGG | KEGG:04611 | Platelet activation | 43 | 89 | 7.92e-01 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 6 | 11 | 7.99e-01 |
| KEGG | KEGG:04145 | Phagosome | 47 | 99 | 8.08e-01 |
| KEGG | KEGG:04148 | Efferocytosis | 59 | 125 | 8.08e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 67 | 142 | 8.08e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 26 | 54 | 8.08e-01 |
| KEGG | KEGG:05142 | Chagas disease | 36 | 75 | 8.08e-01 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 2 | 3 | 8.08e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 15 | 30 | 8.08e-01 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 14 | 28 | 8.08e-01 |
| KEGG | KEGG:01523 | Antifolate resistance | 12 | 24 | 8.08e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 11 | 22 | 8.08e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 12 | 24 | 8.08e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 27 | 56 | 8.08e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 40 | 83 | 8.08e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 10 | 20 | 8.08e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 55 | 116 | 8.08e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 53 | 112 | 8.08e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 11 | 22 | 8.08e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 31 | 64 | 8.08e-01 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 24 | 50 | 8.08e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 25 | 52 | 8.08e-01 |
| KEGG | KEGG:03264 | Virion - Flavivirus | 1 | 1 | 8.08e-01 |
| KEGG | KEGG:04742 | Taste transduction | 11 | 22 | 8.08e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 22 | 45 | 8.08e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 17 | 35 | 8.08e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 36 | 75 | 8.08e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 51 | 108 | 8.09e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 50 | 106 | 8.09e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 37 | 78 | 8.09e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 57 | 121 | 8.09e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 8 | 16 | 8.11e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 15 | 31 | 8.11e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 15 | 31 | 8.11e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 46 | 98 | 8.16e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 7 | 14 | 8.16e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 40 | 85 | 8.16e-01 |
| KEGG | KEGG:04730 | Long-term depression | 20 | 42 | 8.16e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 7 | 14 | 8.16e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 26 | 55 | 8.19e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 12 | 25 | 8.21e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 6 | 12 | 8.21e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 25 | 53 | 8.21e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 6 | 12 | 8.21e-01 |
| KEGG | KEGG:00340 | Histidine metabolism | 6 | 12 | 8.21e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 24 | 51 | 8.22e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 67 | 144 | 8.23e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 23 | 49 | 8.23e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 66 | 142 | 8.23e-01 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 35 | 75 | 8.23e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 5 | 10 | 8.23e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 5 | 10 | 8.23e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 40 | 86 | 8.23e-01 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 10 | 21 | 8.30e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 56 | 121 | 8.34e-01 |
| KEGG | KEGG:04122 | Sulfur relay system | 4 | 8 | 8.43e-01 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 4 | 8 | 8.43e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 14 | 30 | 8.44e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 29 | 63 | 8.45e-01 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 8 | 17 | 8.45e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 18 | 39 | 8.45e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 76 | 165 | 8.45e-01 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 8 | 17 | 8.45e-01 |
| KEGG | KEGG:00650 | Butanoate metabolism | 8 | 17 | 8.45e-01 |
| KEGG | KEGG:04924 | Renin secretion | 23 | 50 | 8.46e-01 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 3 | 6 | 8.53e-01 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 3 | 6 | 8.53e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 31 | 68 | 8.69e-01 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 20 | 44 | 8.76e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 61 | 134 | 8.78e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 45 | 99 | 8.78e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 29 | 64 | 8.79e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 38 | 84 | 8.88e-01 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 27 | 60 | 8.97e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 22 | 49 | 8.97e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 31 | 69 | 9.00e-01 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 20 | 45 | 9.10e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 25 | 56 | 9.10e-01 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 8 | 18 | 9.10e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 34 | 76 | 9.10e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 42 | 94 | 9.19e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 65 | 145 | 9.25e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 65 | 145 | 9.25e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 22 | 50 | 9.30e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 21 | 48 | 9.38e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 43 | 97 | 9.38e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 33 | 75 | 9.44e-01 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 19 | 44 | 9.45e-01 |
| KEGG | KEGG:04976 | Bile secretion | 18 | 42 | 9.45e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 12 | 28 | 9.45e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 11 | 26 | 9.45e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 8 | 19 | 9.45e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 23 | 53 | 9.45e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 9.45e-01 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 5 | 12 | 9.45e-01 |
| KEGG | KEGG:04744 | Phototransduction | 5 | 12 | 9.45e-01 |
| KEGG | KEGG:03267 | Virion - Adenovirus | 1 | 2 | 9.45e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 41 | 95 | 9.53e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 31 | 72 | 9.53e-01 |
| KEGG | KEGG:05162 | Measles | 42 | 97 | 9.53e-01 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 13 | 31 | 9.53e-01 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 16 | 38 | 9.53e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 2 | 5 | 9.53e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 2 | 5 | 9.53e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 6 | 15 | 9.53e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 18 | 43 | 9.53e-01 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 9 | 22 | 9.53e-01 |
| KEGG | KEGG:03022 | Basal transcription factors | 17 | 40 | 9.53e-01 |
| KEGG | KEGG:00920 | Sulfur metabolism | 4 | 10 | 9.53e-01 |
| KEGG | KEGG:02010 | ABC transporters | 12 | 29 | 9.53e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 67 | 153 | 9.53e-01 |
| KEGG | KEGG:04814 | Motor proteins | 65 | 149 | 9.55e-01 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 17 | 41 | 9.56e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 8 | 20 | 9.56e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 8 | 20 | 9.56e-01 |
| KEGG | KEGG:00350 | Tyrosine metabolism | 5 | 13 | 9.65e-01 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 10 | 25 | 9.65e-01 |
| KEGG | KEGG:04146 | Peroxisome | 29 | 69 | 9.65e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 28 | 67 | 9.72e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 31 | 74 | 9.73e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 14 | 35 | 9.81e-01 |
| KEGG | KEGG:05164 | Influenza A | 43 | 102 | 9.87e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 46 | 109 | 9.89e-01 |
| KEGG | KEGG:05310 | Asthma | 1 | 3 | 9.98e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 23 | 59 | 9.99e-01 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 181 | 416 | 9.99e-01 |
| KEGG | KEGG:00230 | Purine metabolism | 36 | 97 | 9.99e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 3 | 16 | 9.99e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 5 | 16 | 9.99e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 70 | 179 | 9.99e-01 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 15 | 52 | 9.99e-01 |
| KEGG | KEGG:05330 | Allograft rejection | 1 | 10 | 9.99e-01 |
| KEGG | KEGG:04210 | Apoptosis | 49 | 117 | 9.99e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 56 | 136 | 9.99e-01 |
| KEGG | KEGG:05332 | Graft-versus-host disease | 1 | 10 | 9.99e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 12 | 33 | 9.99e-01 |
| KEGG | KEGG:04217 | Necroptosis | 41 | 104 | 9.99e-01 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 4 | 12 | 9.99e-01 |
| KEGG | KEGG:05034 | Alcoholism | 37 | 113 | 9.99e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 4 | 12 | 9.99e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 43 | 104 | 9.99e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 2 | 10 | 9.99e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 21 | 65 | 9.99e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 13 | 35 | 9.99e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 16 | 42 | 9.99e-01 |
| KEGG | KEGG:03030 | DNA replication | 9 | 35 | 9.99e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 31 | 83 | 9.99e-01 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 2 | 11 | 9.99e-01 |
| KEGG | KEGG:00360 | Phenylalanine metabolism | 1 | 5 | 9.99e-01 |
| KEGG | KEGG:05224 | Breast cancer | 46 | 117 | 9.99e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 49 | 117 | 9.99e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 6 | 22 | 9.99e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 18 | 56 | 9.99e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 15 | 39 | 9.99e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 27 | 76 | 9.99e-01 |
| KEGG | KEGG:05218 | Melanoma | 23 | 58 | 9.99e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 25 | 66 | 9.99e-01 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 16 | 49 | 9.99e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 21 | 56 | 9.99e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 18 | 48 | 9.99e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 29 | 71 | 9.99e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 5 | 19 | 9.99e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 34 | 91 | 9.99e-01 |
| KEGG | KEGG:04110 | Cell cycle | 55 | 151 | 9.99e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 23 | 57 | 9.99e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 45 | 108 | 9.99e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 17 | 44 | 9.99e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 1 | 4 | 9.99e-01 |
| KEGG | KEGG:04115 | p53 signaling pathway | 21 | 66 | 9.99e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 64 | 163 | 9.99e-01 |
| KEGG | KEGG:03410 | Base excision repair | 13 | 44 | 9.99e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 52 | 128 | 9.99e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 34 | 87 | 9.99e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 1 | 4 | 9.99e-01 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 2 | 15 | 9.99e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 30 | 86 | 9.99e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 37 | 100 | 9.99e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 14 | 41 | 9.99e-01 |
# intersect(unique(Resp_RNA$ENTREZID), unique(NR_peak_list_20k$ENTREZID)))
not_NR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(fill="#C77CFF")+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")+
theme(axis.text.y = element_text(color="black"))+
ggtitle("not Intersection NR")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
not intersected LR
# not_LR_int_resgenes <- gost(query =setdiff(LR_NG_list$ENTREZID, Resp_RNA$ENTREZID),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_genes$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(not_LR_int_resgenes,"data/GO_KEGG_analysis/not_LR_int_resgenes.RDS")
not_LR_int_resgenes <- readRDS("data/GO_KEGG_analysis/not_LR_int_resgenes.RDS")
not_LR_int_restable <- not_LR_int_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
not_LR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR neargenes intersected with RNA response genes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 1659 | 4830 | 2.41e-09 |
| GO:BP | GO:0048856 | anatomical structure development | 1430 | 4130 | 1.01e-08 |
| GO:BP | GO:0008150 | biological_process | 3787 | 12051 | 1.01e-08 |
| GO:BP | GO:0048731 | system development | 1026 | 2903 | 2.95e-07 |
| GO:BP | GO:0098657 | import into cell | 276 | 661 | 3.09e-07 |
| GO:BP | GO:0006897 | endocytosis | 226 | 522 | 3.09e-07 |
| GO:BP | GO:0032502 | developmental process | 1523 | 4475 | 3.09e-07 |
| GO:BP | GO:0007275 | multicellular organism development | 1177 | 3383 | 3.14e-07 |
| GO:BP | GO:0007155 | cell adhesion | 393 | 1004 | 9.01e-07 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 226 | 530 | 1.12e-06 |
| GO:BP | GO:0009987 | cellular process | 3604 | 11450 | 1.25e-06 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 220 | 515 | 1.30e-06 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 226 | 534 | 1.92e-06 |
| GO:BP | GO:0006810 | transport | 1101 | 3176 | 2.55e-06 |
| GO:BP | GO:0007399 | nervous system development | 689 | 1903 | 2.99e-06 |
| GO:BP | GO:0000902 | cell morphogenesis | 306 | 764 | 2.99e-06 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 704 | 1951 | 3.34e-06 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 200 | 468 | 4.62e-06 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 256 | 625 | 4.62e-06 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 113 | 238 | 1.17e-05 |
| GO:BP | GO:0030198 | extracellular matrix organization | 112 | 237 | 1.75e-05 |
| GO:BP | GO:0022008 | neurogenesis | 492 | 1327 | 1.75e-05 |
| GO:BP | GO:0043062 | extracellular structure organization | 112 | 238 | 2.14e-05 |
| GO:BP | GO:0031175 | neuron projection development | 311 | 794 | 2.14e-05 |
| GO:BP | GO:0048666 | neuron development | 345 | 894 | 2.28e-05 |
| GO:BP | GO:0030182 | neuron differentiation | 408 | 1080 | 2.28e-05 |
| GO:BP | GO:0023052 | signaling | 1402 | 4180 | 5.53e-05 |
| GO:BP | GO:0048699 | generation of neurons | 427 | 1145 | 5.79e-05 |
| GO:BP | GO:0051234 | establishment of localization | 1171 | 3447 | 5.83e-05 |
| GO:BP | GO:0007409 | axonogenesis | 156 | 363 | 8.29e-05 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 454 | 1231 | 9.26e-05 |
| GO:BP | GO:0007154 | cell communication | 1420 | 4248 | 9.26e-05 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 86 | 179 | 1.77e-04 |
| GO:BP | GO:0061564 | axon development | 168 | 402 | 2.26e-04 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 49 | 88 | 2.31e-04 |
| GO:BP | GO:0048870 | cell motility | 435 | 1190 | 4.48e-04 |
| GO:BP | GO:0030154 | cell differentiation | 1015 | 2987 | 4.54e-04 |
| GO:BP | GO:0048869 | cellular developmental process | 1015 | 2988 | 4.73e-04 |
| GO:BP | GO:0030030 | cell projection organization | 458 | 1262 | 5.32e-04 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 446 | 1227 | 5.92e-04 |
| GO:BP | GO:0051179 | localization | 1324 | 3978 | 7.36e-04 |
| GO:BP | GO:0050896 | response to stimulus | 1867 | 5732 | 7.95e-04 |
| GO:BP | GO:0003008 | system process | 435 | 1201 | 1.14e-03 |
| GO:BP | GO:0007165 | signal transduction | 1279 | 3846 | 1.39e-03 |
| GO:BP | GO:0030001 | metal ion transport | 216 | 554 | 1.95e-03 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 660 | 1900 | 2.10e-03 |
| GO:BP | GO:0016477 | cell migration | 392 | 1078 | 2.10e-03 |
| GO:BP | GO:0051049 | regulation of transport | 420 | 1164 | 2.32e-03 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 48 | 92 | 2.44e-03 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 116 | 272 | 2.63e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 233 | 607 | 2.73e-03 |
| GO:BP | GO:0023051 | regulation of signaling | 881 | 2597 | 2.82e-03 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 50 | 98 | 3.34e-03 |
| GO:BP | GO:0097485 | neuron projection guidance | 83 | 184 | 3.35e-03 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 182 | 461 | 3.35e-03 |
| GO:BP | GO:0010646 | regulation of cell communication | 881 | 2601 | 3.35e-03 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 1519 | 4637 | 3.35e-03 |
| GO:BP | GO:0071711 | basement membrane organization | 23 | 35 | 3.35e-03 |
| GO:BP | GO:0007411 | axon guidance | 83 | 184 | 3.35e-03 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 47 | 91 | 3.47e-03 |
| GO:BP | GO:0065005 | protein-lipid complex assembly | 16 | 21 | 3.65e-03 |
| GO:BP | GO:0065008 | regulation of biological quality | 701 | 2039 | 3.65e-03 |
| GO:BP | GO:0019538 | protein metabolic process | 1271 | 3848 | 4.66e-03 |
| GO:BP | GO:0006812 | monoatomic cation transport | 246 | 653 | 5.74e-03 |
| GO:BP | GO:0050793 | regulation of developmental process | 622 | 1801 | 6.24e-03 |
| GO:BP | GO:0006486 | protein glycosylation | 81 | 182 | 6.48e-03 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 237 | 628 | 6.48e-03 |
| GO:BP | GO:0048513 | animal organ development | 727 | 2130 | 6.48e-03 |
| GO:BP | GO:0043413 | macromolecule glycosylation | 81 | 182 | 6.48e-03 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 86 | 196 | 7.11e-03 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 158 | 400 | 9.12e-03 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 201 | 525 | 9.12e-03 |
| GO:BP | GO:0006811 | monoatomic ion transport | 283 | 769 | 9.38e-03 |
| GO:BP | GO:0040012 | regulation of locomotion | 282 | 766 | 9.38e-03 |
| GO:BP | GO:0048468 | cell development | 683 | 1999 | 9.38e-03 |
| GO:BP | GO:0030100 | regulation of endocytosis | 90 | 209 | 1.02e-02 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 276 | 749 | 1.02e-02 |
| GO:BP | GO:0040011 | locomotion | 312 | 858 | 1.08e-02 |
| GO:BP | GO:0007267 | cell-cell signaling | 410 | 1156 | 1.08e-02 |
| GO:BP | GO:0006816 | calcium ion transport | 112 | 271 | 1.15e-02 |
| GO:BP | GO:2000145 | regulation of cell motility | 274 | 745 | 1.19e-02 |
| GO:BP | GO:0009101 | glycoprotein biosynthetic process | 104 | 249 | 1.21e-02 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 967 | 2902 | 1.31e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 354 | 989 | 1.43e-02 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 165 | 425 | 1.53e-02 |
| GO:BP | GO:0051016 | barbed-end actin filament capping | 14 | 19 | 1.59e-02 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 160 | 411 | 1.59e-02 |
| GO:BP | GO:0034377 | plasma lipoprotein particle assembly | 14 | 19 | 1.59e-02 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 204 | 540 | 1.59e-02 |
| GO:BP | GO:0045663 | positive regulation of myoblast differentiation | 22 | 36 | 1.66e-02 |
| GO:BP | GO:0016043 | cellular component organization | 1661 | 5139 | 1.67e-02 |
| GO:BP | GO:0050789 | regulation of biological process | 2545 | 8037 | 1.67e-02 |
| GO:BP | GO:0140352 | export from cell | 232 | 624 | 1.70e-02 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 193 | 509 | 1.79e-02 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 167 | 433 | 1.84e-02 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 91 | 216 | 1.92e-02 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 326 | 909 | 1.94e-02 |
| GO:BP | GO:0070085 | glycosylation | 83 | 194 | 1.94e-02 |
| GO:BP | GO:0006909 | phagocytosis | 65 | 145 | 1.94e-02 |
| GO:BP | GO:0051693 | actin filament capping | 20 | 32 | 1.95e-02 |
| GO:BP | GO:0048041 | focal adhesion assembly | 40 | 80 | 2.09e-02 |
| GO:BP | GO:0090130 | tissue migration | 105 | 256 | 2.09e-02 |
| GO:BP | GO:0009100 | glycoprotein metabolic process | 120 | 299 | 2.22e-02 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 31 | 58 | 2.26e-02 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 31 | 58 | 2.26e-02 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 33 | 63 | 2.35e-02 |
| GO:BP | GO:0030334 | regulation of cell migration | 259 | 710 | 2.55e-02 |
| GO:BP | GO:0090132 | epithelium migration | 103 | 252 | 2.61e-02 |
| GO:BP | GO:0010631 | epithelial cell migration | 103 | 252 | 2.61e-02 |
| GO:BP | GO:0001568 | blood vessel development | 204 | 546 | 2.61e-02 |
| GO:BP | GO:0030835 | negative regulation of actin filament depolymerization | 21 | 35 | 2.75e-02 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 692 | 2052 | 2.97e-02 |
| GO:BP | GO:0001525 | angiogenesis | 153 | 397 | 2.97e-02 |
| GO:BP | GO:0051216 | cartilage development | 67 | 153 | 3.08e-02 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 147 | 380 | 3.13e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 206 | 554 | 3.13e-02 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 239 | 653 | 3.14e-02 |
| GO:BP | GO:0046903 | secretion | 240 | 656 | 3.14e-02 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 382 | 1088 | 3.14e-02 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 76 | 178 | 3.14e-02 |
| GO:BP | GO:0009914 | hormone transport | 91 | 220 | 3.25e-02 |
| GO:BP | GO:0071621 | granulocyte chemotaxis | 28 | 52 | 3.31e-02 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1716 | 5340 | 3.32e-02 |
| GO:BP | GO:0032940 | secretion by cell | 214 | 579 | 3.32e-02 |
| GO:BP | GO:0046879 | hormone secretion | 89 | 215 | 3.50e-02 |
| GO:BP | GO:0036211 | protein modification process | 808 | 2423 | 3.50e-02 |
| GO:BP | GO:0051716 | cellular response to stimulus | 1590 | 4933 | 3.55e-02 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 73 | 171 | 3.83e-02 |
| GO:BP | GO:0030834 | regulation of actin filament depolymerization | 24 | 43 | 4.03e-02 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 435 | 1256 | 4.04e-02 |
| GO:BP | GO:0006869 | lipid transport | 109 | 273 | 4.16e-02 |
| GO:BP | GO:0001944 | vasculature development | 211 | 573 | 4.25e-02 |
| GO:BP | GO:0070848 | response to growth factor | 212 | 576 | 4.25e-02 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 86 | 208 | 4.25e-02 |
| GO:BP | GO:0030042 | actin filament depolymerization | 26 | 48 | 4.25e-02 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 175 | 467 | 4.78e-02 |
not_LR_int_restable %>%
filter(source=="KEGG") %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR neargenes intersected with RNA response genes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04510 | Focal adhesion | 103 | 177 | 5.10e-12 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 46 | 69 | 1.01e-07 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 53 | 94 | 1.77e-05 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 87 | 179 | 2.11e-05 |
| KEGG | KEGG:04520 | Adherens junction | 47 | 86 | 1.76e-04 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 111 | 256 | 4.35e-04 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 77 | 170 | 1.49e-03 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 51 | 106 | 4.31e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 38 | 74 | 4.75e-03 |
| KEGG | KEGG:05146 | Amoebiasis | 34 | 64 | 4.75e-03 |
| KEGG | KEGG:05200 | Pathways in cancer | 158 | 408 | 5.98e-03 |
| KEGG | KEGG:05135 | Yersinia infection | 52 | 112 | 7.13e-03 |
| KEGG | KEGG:05131 | Shigellosis | 88 | 210 | 7.13e-03 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 59 | 132 | 8.90e-03 |
| KEGG | KEGG:04360 | Axon guidance | 70 | 162 | 8.90e-03 |
| KEGG | KEGG:04720 | Long-term potentiation | 29 | 55 | 1.01e-02 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 70 | 164 | 1.07e-02 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 48 | 104 | 1.07e-02 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 52 | 115 | 1.07e-02 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 40 | 84 | 1.10e-02 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 31 | 61 | 1.10e-02 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 65 | 151 | 1.10e-02 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 38 | 79 | 1.11e-02 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 21 | 37 | 1.15e-02 |
| KEGG | KEGG:04971 | Gastric acid secretion | 27 | 52 | 1.31e-02 |
| KEGG | KEGG:04014 | Ras signaling pathway | 72 | 172 | 1.31e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 69 | 164 | 1.31e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 14 | 22 | 1.65e-02 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 22 | 41 | 1.90e-02 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 37 | 79 | 1.90e-02 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 16 | 27 | 2.02e-02 |
| KEGG | KEGG:04144 | Endocytosis | 91 | 230 | 2.09e-02 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 48 | 110 | 2.45e-02 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 39 | 86 | 2.50e-02 |
| KEGG | KEGG:00000 | KEGG root term | 1843 | 5802 | 2.50e-02 |
| KEGG | KEGG:04972 | Pancreatic secretion | 28 | 58 | 3.17e-02 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 35 | 77 | 3.47e-02 |
| KEGG | KEGG:04713 | Circadian entrainment | 32 | 69 | 3.47e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 32 | 69 | 3.47e-02 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 44 | 102 | 3.50e-02 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 34 | 75 | 3.50e-02 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 47 | 110 | 3.50e-02 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 53 | 127 | 3.50e-02 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 48 | 113 | 3.50e-02 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 40 | 91 | 3.50e-02 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 9 | 13 | 3.50e-02 |
| KEGG | KEGG:04611 | Platelet activation | 39 | 89 | 3.86e-02 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 94 | 246 | 3.92e-02 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 37 | 84 | 4.11e-02 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 34 | 76 | 4.15e-02 |
| KEGG | KEGG:00071 | Fatty acid degradation | 17 | 32 | 4.23e-02 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 26 | 55 | 4.29e-02 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 24 | 50 | 4.50e-02 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 21 | 43 | 5.51e-02 |
| KEGG | KEGG:04911 | Insulin secretion | 29 | 64 | 5.51e-02 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 17 | 33 | 5.72e-02 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 22 | 46 | 5.95e-02 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 63 | 160 | 5.95e-02 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 23 | 49 | 6.35e-02 |
| KEGG | KEGG:05031 | Amphetamine addiction | 23 | 49 | 6.35e-02 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 23 | 49 | 6.35e-02 |
| KEGG | KEGG:04530 | Tight junction | 55 | 138 | 6.50e-02 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 5 | 6 | 6.50e-02 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 19 | 39 | 6.76e-02 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 40 | 96 | 6.76e-02 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 35 | 82 | 6.76e-02 |
| KEGG | KEGG:04726 | Serotonergic synapse | 28 | 63 | 6.85e-02 |
| KEGG | KEGG:04970 | Salivary secretion | 25 | 55 | 6.89e-02 |
| KEGG | KEGG:05219 | Bladder cancer | 18 | 37 | 7.74e-02 |
| KEGG | KEGG:04142 | Lysosome | 47 | 117 | 7.89e-02 |
| KEGG | KEGG:04929 | GnRH secretion | 24 | 53 | 7.90e-02 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 32 | 75 | 8.00e-02 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 43 | 106 | 8.00e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 37 | 89 | 8.00e-02 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 25 | 56 | 8.02e-02 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 33 | 78 | 8.02e-02 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 40 | 99 | 1.01e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 14 | 28 | 1.06e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 32 | 77 | 1.10e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 45 | 114 | 1.10e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 66 | 176 | 1.14e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 34 | 83 | 1.14e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 44 | 112 | 1.20e-01 |
| KEGG | KEGG:04924 | Renin secretion | 22 | 50 | 1.23e-01 |
| KEGG | KEGG:00062 | Fatty acid elongation | 12 | 24 | 1.44e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 26 | 62 | 1.48e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 27 | 65 | 1.52e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 16 | 35 | 1.62e-01 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 20 | 46 | 1.65e-01 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 62 | 168 | 1.65e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 22 | 52 | 1.79e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 56 | 151 | 1.80e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 38 | 98 | 1.81e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 34 | 87 | 1.96e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 34 | 87 | 1.96e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 13 | 28 | 2.00e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 95 | 271 | 2.06e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 56 | 153 | 2.12e-01 |
| KEGG | KEGG:04730 | Long-term depression | 18 | 42 | 2.12e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 20 | 48 | 2.29e-01 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 7 | 13 | 2.30e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 52 | 142 | 2.30e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 35 | 92 | 2.46e-01 |
| KEGG | KEGG:04148 | Efferocytosis | 46 | 125 | 2.54e-01 |
| KEGG | KEGG:05416 | Viral myocarditis | 19 | 46 | 2.58e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 28 | 72 | 2.59e-01 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 43 | 117 | 2.60e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 32 | 84 | 2.60e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 38 | 102 | 2.60e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 75 | 214 | 2.60e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 45 | 123 | 2.60e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 40 | 108 | 2.60e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 32 | 84 | 2.60e-01 |
| KEGG | KEGG:00531 | Glycosaminoglycan degradation | 8 | 16 | 2.60e-01 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 3 | 4 | 2.65e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 9 | 19 | 2.70e-01 |
| KEGG | KEGG:03271 | Virion - Rotavirus | 2 | 2 | 2.70e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 13 | 30 | 2.70e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 51 | 142 | 2.70e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 29 | 76 | 2.70e-01 |
| KEGG | KEGG:05214 | Glioma | 26 | 67 | 2.70e-01 |
| KEGG | KEGG:01100 | Metabolic pathways | 370 | 1149 | 2.76e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 20 | 50 | 2.76e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 10 | 22 | 2.77e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 7 | 14 | 2.77e-01 |
| KEGG | KEGG:04742 | Taste transduction | 10 | 22 | 2.77e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 23 | 59 | 2.79e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 31 | 83 | 2.93e-01 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 12 | 28 | 3.06e-01 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 20 | 51 | 3.09e-01 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 22 | 57 | 3.12e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 13 | 31 | 3.12e-01 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 128 | 384 | 3.13e-01 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 64 | 185 | 3.24e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 6 | 12 | 3.24e-01 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 6 | 12 | 3.24e-01 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 10 | 23 | 3.32e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 4 | 7 | 3.34e-01 |
| KEGG | KEGG:04714 | Thermogenesis | 67 | 195 | 3.36e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 11 | 26 | 3.39e-01 |
| KEGG | KEGG:05010 | Alzheimer disease | 105 | 314 | 3.39e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 24 | 64 | 3.41e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 47 | 134 | 3.48e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 57 | 165 | 3.51e-01 |
| KEGG | KEGG:05020 | Prion disease | 74 | 218 | 3.54e-01 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 14 | 35 | 3.56e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 15 | 38 | 3.57e-01 |
| KEGG | KEGG:00670 | One carbon pool by folate | 8 | 18 | 3.57e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 31 | 86 | 3.63e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 20 | 53 | 3.63e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 5 | 10 | 3.63e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 5 | 10 | 3.63e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 9 | 21 | 3.63e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 10 | 24 | 3.74e-01 |
| KEGG | KEGG:03060 | Protein export | 12 | 30 | 3.91e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 51 | 149 | 3.91e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 42 | 121 | 3.91e-01 |
| KEGG | KEGG:05145 | Toxoplasmosis | 29 | 81 | 3.91e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 23 | 63 | 3.91e-01 |
| KEGG | KEGG:04976 | Bile secretion | 16 | 42 | 3.91e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 42 | 121 | 3.91e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 28 | 78 | 3.91e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 7 | 16 | 3.99e-01 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 45 | 131 | 4.04e-01 |
| KEGG | KEGG:05012 | Parkinson disease | 75 | 225 | 4.04e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 33 | 94 | 4.04e-01 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 30 | 85 | 4.10e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 49 | 144 | 4.13e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 9 | 22 | 4.13e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 24 | 67 | 4.14e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 10 | 25 | 4.14e-01 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 4 | 8 | 4.14e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 36 | 104 | 4.16e-01 |
| KEGG | KEGG:01200 | Carbon metabolism | 34 | 98 | 4.20e-01 |
| KEGG | KEGG:05016 | Huntington disease | 84 | 255 | 4.20e-01 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 15 | 40 | 4.20e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 49 | 145 | 4.25e-01 |
| KEGG | KEGG:00780 | Biotin metabolism | 2 | 3 | 4.35e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 24 | 68 | 4.46e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 20 | 56 | 4.58e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 8 | 20 | 4.67e-01 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 14 | 38 | 4.67e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 9 | 23 | 4.67e-01 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 11 | 29 | 4.67e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 26 | 75 | 4.71e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 29 | 85 | 4.94e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 20 | 57 | 4.94e-01 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 3 | 6 | 4.94e-01 |
| KEGG | KEGG:04540 | Gap junction | 25 | 73 | 5.14e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 32 | 95 | 5.14e-01 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 4 | 9 | 5.14e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 11 | 30 | 5.25e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 29 | 86 | 5.26e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 20 | 58 | 5.33e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 19 | 55 | 5.37e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 25 | 74 | 5.39e-01 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 17 | 49 | 5.39e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 17 | 49 | 5.39e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 44 | 134 | 5.39e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 32 | 97 | 5.75e-01 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 11 | 31 | 5.78e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 25 | 75 | 5.78e-01 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 10 | 28 | 5.80e-01 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 9 | 25 | 5.85e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 23 | 69 | 5.86e-01 |
| KEGG | KEGG:04814 | Motor proteins | 48 | 149 | 5.93e-01 |
| KEGG | KEGG:00511 | Other glycan degradation | 6 | 16 | 6.00e-01 |
| KEGG | KEGG:00920 | Sulfur metabolism | 4 | 10 | 6.09e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 12 | 35 | 6.18e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 18 | 54 | 6.18e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 50 | 157 | 6.20e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 32 | 99 | 6.20e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 17 | 51 | 6.20e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 32 | 99 | 6.20e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 22 | 67 | 6.20e-01 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 15 | 45 | 6.29e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 15 | 45 | 6.29e-01 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 9 | 26 | 6.29e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 37 | 116 | 6.42e-01 |
| KEGG | KEGG:04137 | Mitophagy - animal | 32 | 100 | 6.44e-01 |
| KEGG | KEGG:05144 | Malaria | 7 | 20 | 6.47e-01 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 6 | 17 | 6.57e-01 |
| KEGG | KEGG:00650 | Butanoate metabolism | 6 | 17 | 6.57e-01 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 11 | 33 | 6.60e-01 |
| KEGG | KEGG:05142 | Chagas disease | 24 | 75 | 6.66e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 5 | 14 | 6.66e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 18 | 56 | 6.80e-01 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 4 | 11 | 6.80e-01 |
| KEGG | KEGG:03022 | Basal transcription factors | 13 | 40 | 6.83e-01 |
| KEGG | KEGG:01523 | Antifolate resistance | 8 | 24 | 6.91e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 45 | 145 | 7.13e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 33 | 106 | 7.18e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 2 | 5 | 7.21e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 27 | 87 | 7.28e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 9 | 28 | 7.28e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 20 | 64 | 7.28e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 13 | 41 | 7.28e-01 |
| KEGG | KEGG:03267 | Virion - Adenovirus | 1 | 2 | 7.34e-01 |
| KEGG | KEGG:04744 | Phototransduction | 4 | 12 | 7.34e-01 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 8 | 25 | 7.34e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 8 | 25 | 7.34e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 4 | 12 | 7.34e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 4 | 12 | 7.34e-01 |
| KEGG | KEGG:00340 | Histidine metabolism | 4 | 12 | 7.34e-01 |
| KEGG | KEGG:05133 | Pertussis | 14 | 45 | 7.34e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 50 | 163 | 7.34e-01 |
| KEGG | KEGG:05218 | Melanoma | 18 | 58 | 7.34e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 11 | 35 | 7.34e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 13 | 42 | 7.44e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 41 | 135 | 7.57e-01 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 3 | 9 | 7.61e-01 |
| KEGG | KEGG:00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 3 | 9 | 7.61e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 33 | 109 | 7.64e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 23 | 76 | 7.66e-01 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 8 | 26 | 7.66e-01 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 32 | 106 | 7.66e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 13 | 43 | 7.75e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 9 | 30 | 7.90e-01 |
| KEGG | KEGG:00230 | Purine metabolism | 29 | 97 | 7.90e-01 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 91 | 303 | 7.90e-01 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 2 | 6 | 7.90e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 32 | 108 | 8.05e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 21 | 71 | 8.05e-01 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 13 | 44 | 8.05e-01 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 13 | 44 | 8.05e-01 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 48 | 162 | 8.15e-01 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 5 | 17 | 8.20e-01 |
| KEGG | KEGG:04145 | Phagosome | 29 | 99 | 8.27e-01 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 9 | 31 | 8.27e-01 |
| KEGG | KEGG:05134 | Legionellosis | 11 | 38 | 8.28e-01 |
| KEGG | KEGG:04146 | Peroxisome | 20 | 69 | 8.37e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 34 | 117 | 8.39e-01 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 8.39e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 4 | 14 | 8.39e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 29 | 100 | 8.39e-01 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 6 | 21 | 8.39e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 26 | 91 | 8.70e-01 |
| KEGG | KEGG:02010 | ABC transporters | 8 | 29 | 8.70e-01 |
| KEGG | KEGG:03018 | RNA degradation | 21 | 74 | 8.70e-01 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 8 | 29 | 8.70e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 6 | 22 | 8.74e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 28 | 99 | 8.84e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 4 | 15 | 8.84e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 5 | 19 | 8.93e-01 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 12 | 44 | 8.93e-01 |
| KEGG | KEGG:04210 | Apoptosis | 33 | 117 | 8.93e-01 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 5 | 19 | 8.93e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 36 | 128 | 8.97e-01 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 6 | 23 | 8.97e-01 |
| KEGG | KEGG:05162 | Measles | 27 | 97 | 8.97e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 23 | 83 | 8.97e-01 |
| KEGG | KEGG:03020 | RNA polymerase | 9 | 34 | 8.98e-01 |
| KEGG | KEGG:03040 | Spliceosome | 37 | 132 | 9.03e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 1 | 4 | 9.06e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 11 | 42 | 9.06e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 5 | 20 | 9.06e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 5 | 20 | 9.06e-01 |
| KEGG | KEGG:05164 | Influenza A | 28 | 102 | 9.06e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 8 | 31 | 9.06e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 1 | 4 | 9.06e-01 |
| KEGG | KEGG:05224 | Breast cancer | 32 | 117 | 9.19e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 50 | 179 | 9.19e-01 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 13 | 50 | 9.19e-01 |
| KEGG | KEGG:00350 | Tyrosine metabolism | 3 | 13 | 9.27e-01 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 5 | 21 | 9.32e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 37 | 136 | 9.34e-01 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 6 | 25 | 9.34e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 11 | 44 | 9.38e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 17 | 66 | 9.38e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 8 | 33 | 9.38e-01 |
| KEGG | KEGG:00360 | Phenylalanine metabolism | 1 | 5 | 9.40e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 14 | 56 | 9.42e-01 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 4 | 18 | 9.42e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 14 | 56 | 9.42e-01 |
| KEGG | KEGG:00790 | Folate biosynthesis | 4 | 18 | 9.42e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 13 | 53 | 9.54e-01 |
| KEGG | KEGG:03050 | Proteasome | 10 | 42 | 9.55e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 9 | 39 | 9.66e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 9 | 39 | 9.66e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 10 | 43 | 9.67e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 40 | 153 | 9.75e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 3 | 16 | 9.80e-01 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 29 | 115 | 9.80e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 3 | 16 | 9.80e-01 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 18 | 75 | 9.81e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 2 | 12 | 9.85e-01 |
| KEGG | KEGG:05034 | Alcoholism | 28 | 113 | 9.87e-01 |
| KEGG | KEGG:04110 | Cell cycle | 38 | 151 | 9.91e-01 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 4 | 22 | 9.91e-01 |
| KEGG | KEGG:04122 | Sulfur relay system | 1 | 8 | 9.91e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 13 | 59 | 9.91e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 4 | 22 | 9.91e-01 |
| KEGG | KEGG:04217 | Necroptosis | 25 | 104 | 9.91e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 10 | 48 | 9.92e-01 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 13 | 60 | 9.92e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 14 | 65 | 9.97e-01 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 7 | 41 | 1.00e+00 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 1 | 11 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 27 | 127 | 1.00e+00 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:04115 | p53 signaling pathway | 10 | 66 | 1.00e+00 |
| KEGG | KEGG:03410 | Base excision repair | 4 | 44 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 80 | 416 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 5 | 52 | 1.00e+00 |
| KEGG | KEGG:03030 | DNA replication | 4 | 35 | 1.00e+00 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 2 | 19 | 1.00e+00 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 8 | 49 | 1.00e+00 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 1 | 10 | 1.00e+00 |
# intersect(unique(Resp_RNA$ENTREZID), unique(NR_peak_list_20k$ENTREZID)))
not_LR_int_restable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
slice_head(n=10) %>%
mutate(log10_p=(-log(p_value, base=10))) %>%
ggplot(., aes(x=log10_p, y=reorder(term_name, log10_p)))+
geom_col(fill="#00BFC4")+
theme_bw()+
ylab("")+
xlab(paste0("-log10 p-value"))+
guides(fill="none")+
theme(axis.text.y = element_text(color="black"))+
ggtitle("not Intersection LR")
| Version | Author | Date |
|---|---|---|
| 021ca5f | reneeisnowhere | 2024-06-07 |
Using Enrich go function to explore related similar term information. (Decided later not to use, because all the terms were the same)
# library(clusterProfiler)
# genes_go = list("EAR"=int_EAR_n_RNAresp,"ESR"=int_ESR_n_RNAresp, "LR"=int_LR_n_RNAresp)
# names(genes) = sub("_", "\n", names(genes))
compEAR <- enrichGO(int_EAR_n_RNAresp,
universe = as.character(background_genes$ENTREZID),
ont = "BP",
pvalueCutoff = 0.05,
OrgDb='org.Hs.eg.db',
pAdjustMethod = "BH")
# dotplot(compKEGG, showCategory = 15, title = "GO Enrichment Analysis")
compESR <- enrichGO(int_ESR_n_RNAresp,
universe = as.character(background_genes$ENTREZID),
ont = "BP",
pvalueCutoff = 0.05,
OrgDb='org.Hs.eg.db',
pAdjustMethod = "BH")
# dotplot(compESR, showCategory = 15, title = "GO Enrichment Analysis")
compLR <- enrichGO(int_LR_n_RNAresp,
universe = as.character(background_genes$ENTREZID),
ont = "BP",
pvalueCutoff = 0.05,
OrgDb='org.Hs.eg.db',
pAdjustMethod = "BH")
barplot(compLR,x="p.adjust", showCategory = 15, title = "GO Enrichment Analysis for LR")
barplot(compEAR,x="p.adjust", showCategory = 15, title = "GO Enrichment Analysis for EAR")
barplot(compESR,x="p.adjust", showCategory = 15, title = "GO Enrichment Analysis for ESR")
# goplot(compLR)
compEARx <- setReadable(compEAR, 'org.Hs.eg.db', 'ENTREZID')
compESRx <- setReadable(compESR, 'org.Hs.eg.db', 'ENTREZID')
compLRx <- setReadable(compLR, 'org.Hs.eg.db', 'ENTREZID')
cnetplot(compEARx)
cnetplot(compESRx)
cnetplot(compLRx, node_label="all")
# upsetplot(compLRx)EAR enrichment by hyper and hypo accessibility:
Starting with the neargene table (all peaks assigned to closest neargene, Filter peaklist by peaks from the response group I am interested in, then filter peaks by the DOX24 hour FOLD change list to create 2 groups for each response cluster.
Group 1: FC >0 is hyper-accessible Group 2: FC <0 is hypo-accessible
I will then filter by dist-to-neargene <20 kbs. I want to visualize the number of shared near-genes in each group for each response cluster using a venn of near-gene ENTREZIDs.
For GO enrichment analysis, I will use the expressed RNA gene list (14,084 genes)as background, with the intersection of hyper/hypo ENTREZIDS and the RNA-expressed ENTREZID.
EAR hyper/hypo
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0050789 | regulation of biological process | 742 | 8037 | 5.92e-11 |
| GO:BP | GO:0050794 | regulation of cellular process | 711 | 7651 | 1.06e-10 |
| GO:BP | GO:0065007 | biological regulation | 754 | 8275 | 3.27e-10 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 234 | 1951 | 1.60e-09 |
| GO:BP | GO:0050793 | regulation of developmental process | 217 | 1801 | 7.26e-09 |
| GO:BP | GO:0072359 | circulatory system development | 126 | 896 | 2.59e-08 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 388 | 3804 | 1.01e-07 |
| GO:BP | GO:0048519 | negative regulation of biological process | 407 | 4037 | 1.12e-07 |
| GO:BP | GO:0014706 | striated muscle tissue development | 46 | 218 | 2.45e-07 |
| GO:BP | GO:0048518 | positive regulation of biological process | 448 | 4561 | 2.45e-07 |
| GO:BP | GO:0032502 | developmental process | 439 | 4475 | 4.55e-07 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 231 | 2052 | 4.55e-07 |
| GO:BP | GO:0048731 | system development | 304 | 2903 | 1.07e-06 |
| GO:BP | GO:0048513 | animal organ development | 236 | 2130 | 1.07e-06 |
| GO:BP | GO:0048856 | anatomical structure development | 408 | 4130 | 1.07e-06 |
| GO:BP | GO:0007275 | multicellular organism development | 345 | 3383 | 1.08e-06 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 413 | 4198 | 1.16e-06 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 42 | 206 | 2.26e-06 |
| GO:BP | GO:0050896 | response to stimulus | 535 | 5732 | 2.36e-06 |
| GO:BP | GO:0007507 | heart development | 78 | 515 | 2.61e-06 |
| GO:BP | GO:0048589 | developmental growth | 79 | 527 | 2.96e-06 |
| GO:BP | GO:0048869 | cellular developmental process | 308 | 2988 | 2.96e-06 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 21 | 65 | 2.96e-06 |
| GO:BP | GO:0051716 | cellular response to stimulus | 469 | 4933 | 3.99e-06 |
| GO:BP | GO:0030154 | cell differentiation | 307 | 2987 | 3.99e-06 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 168 | 1430 | 4.03e-06 |
| GO:BP | GO:0032501 | multicellular organismal process | 460 | 4830 | 4.53e-06 |
| GO:BP | GO:0009888 | tissue development | 166 | 1425 | 8.42e-06 |
| GO:BP | GO:0060537 | muscle tissue development | 58 | 353 | 9.21e-06 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 154 | 1301 | 9.56e-06 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 154 | 1304 | 1.08e-05 |
| GO:BP | GO:0060419 | heart growth | 21 | 72 | 1.57e-05 |
| GO:BP | GO:0007417 | central nervous system development | 99 | 748 | 1.82e-05 |
| GO:BP | GO:0007154 | cell communication | 408 | 4248 | 1.87e-05 |
| GO:BP | GO:0023052 | signaling | 402 | 4180 | 2.10e-05 |
| GO:BP | GO:0048468 | cell development | 215 | 1999 | 3.12e-05 |
| GO:BP | GO:0007165 | signal transduction | 373 | 3846 | 3.30e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 45 | 257 | 3.66e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 242 | 2311 | 3.66e-05 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 88 | 653 | 3.69e-05 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 177 | 1597 | 6.16e-05 |
| GO:BP | GO:0060322 | head development | 80 | 583 | 6.16e-05 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 254 | 2474 | 7.60e-05 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 218 | 2061 | 7.60e-05 |
| GO:BP | GO:0007420 | brain development | 75 | 539 | 7.60e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 261 | 2555 | 7.60e-05 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 20 | 75 | 1.09e-04 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 121 | 1011 | 1.16e-04 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 279 | 2780 | 1.19e-04 |
| GO:BP | GO:0035556 | intracellular signal transduction | 218 | 2079 | 1.28e-04 |
| GO:BP | GO:0016477 | cell migration | 127 | 1078 | 1.33e-04 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 202 | 1900 | 1.33e-04 |
| GO:BP | GO:0022008 | neurogenesis | 150 | 1327 | 1.44e-04 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 91 | 710 | 1.59e-04 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 207 | 1974 | 2.39e-04 |
| GO:BP | GO:0035239 | tube morphogenesis | 86 | 668 | 2.54e-04 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 205 | 1959 | 3.03e-04 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 24 | 109 | 3.12e-04 |
| GO:BP | GO:0055006 | cardiac cell development | 20 | 81 | 3.23e-04 |
| GO:BP | GO:0035265 | organ growth | 27 | 132 | 3.30e-04 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 94 | 756 | 3.50e-04 |
| GO:BP | GO:0030900 | forebrain development | 46 | 292 | 3.65e-04 |
| GO:BP | GO:0040007 | growth | 92 | 739 | 4.12e-04 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 154 | 1403 | 4.70e-04 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 27 | 136 | 5.52e-04 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 228 | 2246 | 5.83e-04 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 113 | 967 | 6.25e-04 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 214 | 2088 | 6.28e-04 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 389 | 4170 | 6.32e-04 |
| GO:BP | GO:0030334 | regulation of cell migration | 88 | 710 | 7.27e-04 |
| GO:BP | GO:0048699 | generation of neurons | 129 | 1145 | 7.95e-04 |
| GO:BP | GO:0048870 | cell motility | 133 | 1190 | 8.40e-04 |
| GO:BP | GO:2000145 | regulation of cell motility | 91 | 745 | 8.75e-04 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 178 | 1694 | 9.89e-04 |
| GO:BP | GO:0007399 | nervous system development | 196 | 1903 | 1.15e-03 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 415 | 4521 | 1.23e-03 |
| GO:BP | GO:0035295 | tube development | 98 | 827 | 1.33e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 20 | 90 | 1.35e-03 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 82 | 662 | 1.36e-03 |
| GO:BP | GO:0048588 | developmental cell growth | 33 | 194 | 1.38e-03 |
| GO:BP | GO:0040012 | regulation of locomotion | 92 | 766 | 1.38e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 107 | 926 | 1.50e-03 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 180 | 1732 | 1.51e-03 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 181 | 1744 | 1.52e-03 |
| GO:BP | GO:0001764 | neuron migration | 26 | 138 | 1.67e-03 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 413 | 4515 | 1.69e-03 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 195 | 1908 | 1.70e-03 |
| GO:BP | GO:0040011 | locomotion | 100 | 858 | 1.89e-03 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 13 | 45 | 1.98e-03 |
| GO:BP | GO:0010646 | regulation of cell communication | 254 | 2601 | 2.02e-03 |
| GO:BP | GO:0021537 | telencephalon development | 34 | 208 | 2.13e-03 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 34 | 208 | 2.13e-03 |
| GO:BP | GO:0019222 | regulation of metabolic process | 444 | 4914 | 2.15e-03 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 134 | 1233 | 2.38e-03 |
| GO:BP | GO:0043010 | camera-type eye development | 37 | 236 | 2.39e-03 |
| GO:BP | GO:2001222 | regulation of neuron migration | 12 | 40 | 2.48e-03 |
| GO:BP | GO:0030029 | actin filament-based process | 82 | 677 | 2.51e-03 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 391 | 4269 | 2.67e-03 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 273 | 2842 | 2.83e-03 |
| GO:BP | GO:0000902 | cell morphogenesis | 90 | 764 | 2.84e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 17 | 74 | 2.84e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 179 | 1746 | 2.84e-03 |
| GO:BP | GO:0048880 | sensory system development | 41 | 275 | 2.84e-03 |
| GO:BP | GO:0007423 | sensory organ development | 54 | 399 | 2.96e-03 |
| GO:BP | GO:0048666 | neuron development | 102 | 894 | 3.09e-03 |
| GO:BP | GO:0003007 | heart morphogenesis | 35 | 222 | 3.09e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 17 | 75 | 3.22e-03 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 293 | 3089 | 3.22e-03 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 201 | 2005 | 3.25e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 24 | 129 | 3.28e-03 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 100 | 876 | 3.44e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 17 | 76 | 3.71e-03 |
| GO:BP | GO:0001654 | eye development | 40 | 272 | 4.32e-03 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 8 | 20 | 4.34e-03 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 8 | 20 | 4.34e-03 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 8 | 20 | 4.34e-03 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 12 | 43 | 4.49e-03 |
| GO:BP | GO:0150063 | visual system development | 40 | 273 | 4.49e-03 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 10 | 31 | 4.52e-03 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 10 | 31 | 4.52e-03 |
| GO:BP | GO:0030182 | neuron differentiation | 118 | 1080 | 4.57e-03 |
| GO:BP | GO:0023051 | regulation of signaling | 250 | 2597 | 4.78e-03 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 19 | 93 | 4.78e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 13 | 50 | 4.80e-03 |
| GO:BP | GO:0009966 | regulation of signal transduction | 225 | 2307 | 5.33e-03 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 9 | 26 | 5.33e-03 |
| GO:BP | GO:0016310 | phosphorylation | 129 | 1211 | 6.22e-03 |
| GO:BP | GO:0016358 | dendrite development | 31 | 196 | 6.40e-03 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 122 | 1135 | 6.52e-03 |
| GO:BP | GO:0010468 | regulation of gene expression | 333 | 3613 | 6.91e-03 |
| GO:BP | GO:0042221 | response to chemical | 235 | 2436 | 6.91e-03 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 9 | 27 | 7.02e-03 |
| GO:BP | GO:0009790 | embryo development | 97 | 864 | 7.02e-03 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 197 | 1992 | 7.06e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 59 | 467 | 7.36e-03 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 17 | 82 | 8.31e-03 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 246 | 2576 | 8.47e-03 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 50 | 380 | 8.59e-03 |
| GO:BP | GO:0001944 | vasculature development | 69 | 573 | 8.67e-03 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 341 | 3724 | 8.67e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 16 | 75 | 8.73e-03 |
| GO:BP | GO:0060284 | regulation of cell development | 72 | 605 | 8.90e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 26 | 157 | 9.38e-03 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 348 | 3815 | 9.43e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 21 | 115 | 9.44e-03 |
| GO:BP | GO:0001568 | blood vessel development | 66 | 546 | 1.03e-02 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 42 | 306 | 1.06e-02 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 246 | 2589 | 1.08e-02 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 14 | 62 | 1.11e-02 |
| GO:BP | GO:0021591 | ventricular system development | 9 | 29 | 1.14e-02 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 9 | 29 | 1.14e-02 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 9 | 29 | 1.14e-02 |
| GO:BP | GO:0060429 | epithelium development | 93 | 836 | 1.15e-02 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 118 | 1111 | 1.16e-02 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 349 | 3841 | 1.17e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 22 | 126 | 1.22e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 85 | 752 | 1.23e-02 |
| GO:BP | GO:0051960 | regulation of nervous system development | 47 | 358 | 1.23e-02 |
| GO:BP | GO:0061614 | miRNA transcription | 14 | 63 | 1.24e-02 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 51 | 401 | 1.47e-02 |
| GO:BP | GO:0040008 | regulation of growth | 60 | 493 | 1.50e-02 |
| GO:BP | GO:0046620 | regulation of organ growth | 15 | 72 | 1.58e-02 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 62 | 515 | 1.58e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 24 | 146 | 1.59e-02 |
| GO:BP | GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 10 | 37 | 1.68e-02 |
| GO:BP | GO:0061061 | muscle structure development | 66 | 559 | 1.75e-02 |
| GO:BP | GO:0031175 | neuron projection development | 88 | 794 | 1.75e-02 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 63 | 530 | 1.94e-02 |
| GO:BP | GO:0007389 | pattern specification process | 41 | 307 | 1.94e-02 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 13 | 59 | 2.07e-02 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 18 | 98 | 2.07e-02 |
| GO:BP | GO:0006468 | protein phosphorylation | 107 | 1008 | 2.07e-02 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 40 | 299 | 2.13e-02 |
| GO:BP | GO:0060324 | face development | 11 | 45 | 2.13e-02 |
| GO:BP | GO:0043368 | positive T cell selection | 7 | 20 | 2.15e-02 |
| GO:BP | GO:0021772 | olfactory bulb development | 7 | 20 | 2.15e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 9 | 32 | 2.21e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 63 | 534 | 2.24e-02 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 17 | 91 | 2.29e-02 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 17 | 91 | 2.29e-02 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 13 | 60 | 2.31e-02 |
| GO:BP | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 6 | 15 | 2.32e-02 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 19 | 108 | 2.39e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 10 | 39 | 2.39e-02 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 30 | 206 | 2.41e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 91 | 839 | 2.54e-02 |
| GO:BP | GO:0006351 | DNA-templated transcription | 250 | 2683 | 2.54e-02 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 12 | 54 | 2.82e-02 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 63 | 540 | 2.82e-02 |
| GO:BP | GO:0048729 | tissue morphogenesis | 57 | 478 | 2.91e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 19 | 110 | 2.91e-02 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 117 | 1134 | 2.99e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 18 | 102 | 3.02e-02 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 64 | 553 | 3.08e-02 |
| GO:BP | GO:0001525 | angiogenesis | 49 | 397 | 3.09e-02 |
| GO:BP | GO:1903312 | negative regulation of mRNA metabolic process | 16 | 86 | 3.15e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 5 | 11 | 3.15e-02 |
| GO:BP | GO:0046834 | lipid phosphorylation | 5 | 11 | 3.15e-02 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 12 | 55 | 3.17e-02 |
| GO:BP | GO:1990138 | neuron projection extension | 23 | 147 | 3.47e-02 |
| GO:BP | GO:0048592 | eye morphogenesis | 19 | 112 | 3.47e-02 |
| GO:BP | GO:0060021 | roof of mouth development | 14 | 71 | 3.51e-02 |
| GO:BP | GO:0021988 | olfactory lobe development | 7 | 22 | 3.58e-02 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 50 | 411 | 3.62e-02 |
| GO:BP | GO:0060044 | negative regulation of cardiac muscle cell proliferation | 4 | 7 | 3.66e-02 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 68 | 601 | 3.71e-02 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 33 | 242 | 3.82e-02 |
| GO:BP | GO:0003008 | system process | 122 | 1201 | 3.83e-02 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 10 | 42 | 3.90e-02 |
| GO:BP | GO:0050919 | negative chemotaxis | 10 | 42 | 3.90e-02 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 266 | 2902 | 3.93e-02 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 250 | 2709 | 3.94e-02 |
| GO:BP | GO:0042592 | homeostatic process | 122 | 1204 | 4.10e-02 |
| GO:BP | GO:0010649 | regulation of cell communication by electrical coupling | 6 | 17 | 4.20e-02 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 8 | 29 | 4.20e-02 |
| GO:BP | GO:0061117 | negative regulation of heart growth | 6 | 17 | 4.20e-02 |
| GO:BP | GO:0055022 | negative regulation of cardiac muscle tissue growth | 6 | 17 | 4.20e-02 |
| GO:BP | GO:0048675 | axon extension | 18 | 106 | 4.25e-02 |
| GO:BP | GO:0009154 | purine ribonucleotide catabolic process | 19 | 115 | 4.41e-02 |
| GO:BP | GO:0055001 | muscle cell development | 25 | 169 | 4.43e-02 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 56 | 479 | 4.43e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 106 | 1027 | 4.49e-02 |
| GO:BP | GO:0043373 | CD4-positive, alpha-beta T cell lineage commitment | 5 | 12 | 4.49e-02 |
| GO:BP | GO:0030516 | regulation of axon extension | 15 | 82 | 4.74e-02 |
| GO:BP | GO:0065008 | regulation of biological quality | 193 | 2039 | 4.80e-02 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 36 | 276 | 4.80e-02 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 26 | 180 | 4.95e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 11 | 51 | 4.95e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 17 | 110 | 5.84e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 12 | 74 | 5.84e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 13 | 83 | 5.84e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 6 | 25 | 5.84e-01 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 22 | 164 | 5.84e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 16 | 104 | 5.84e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 12 | 76 | 6.07e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 18 | 134 | 6.07e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 14 | 99 | 7.07e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 21 | 172 | 7.38e-01 |
| KEGG | KEGG:05034 | Alcoholism | 15 | 113 | 7.38e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 7 | 39 | 7.38e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 8 | 49 | 8.00e-01 |
| KEGG | KEGG:04530 | Tight junction | 17 | 138 | 8.13e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 16 | 128 | 8.13e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 16 | 132 | 8.20e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 13 | 99 | 8.20e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 8 | 53 | 8.20e-01 |
| KEGG | KEGG:04360 | Axon guidance | 19 | 162 | 8.20e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 10 | 75 | 8.62e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 16 | 134 | 8.62e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4 | 20 | 8.62e-01 |
| KEGG | KEGG:04744 | Phototransduction | 3 | 12 | 8.62e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 14 | 117 | 8.93e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 2 | 7 | 9.71e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 16 | 142 | 9.71e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 9 | 69 | 9.71e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 16 | 144 | 9.71e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 4 | 22 | 9.71e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 3 | 14 | 9.71e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 7 | 51 | 9.71e-01 |
| KEGG | KEGG:04730 | Long-term depression | 6 | 42 | 9.98e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 7 | 72 | 9.99e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 9 | 95 | 9.99e-01 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 9 | 110 | 9.99e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 6 | 55 | 9.99e-01 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 8 | 131 | 9.99e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 6 | 91 | 9.99e-01 |
| KEGG | KEGG:04714 | Thermogenesis | 17 | 195 | 9.99e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 13 | 121 | 9.99e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 4 | 30 | 9.99e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 8 | 98 | 9.99e-01 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 1 | 12 | 9.99e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 7 | 97 | 9.99e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 2 | 26 | 9.99e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 5 | 41 | 9.99e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 1 | 38 | 9.99e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 1 | 20 | 9.99e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 5 | 79 | 9.99e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 1 | 19 | 9.99e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 5 | 87 | 9.99e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 6 | 75 | 9.99e-01 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 1 | 46 | 9.99e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 1 | 56 | 9.99e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 6 | 55 | 9.99e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 5 | 52 | 9.99e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 3 | 35 | 9.99e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 3 | 53 | 9.99e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 8 | 82 | 9.99e-01 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 7 | 99 | 9.99e-01 |
| KEGG | KEGG:04742 | Taste transduction | 3 | 22 | 9.99e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 7 | 102 | 9.99e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 4 | 55 | 9.99e-01 |
| KEGG | KEGG:04814 | Motor proteins | 6 | 149 | 9.99e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 6 | 63 | 9.99e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 5 | 83 | 9.99e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 13 | 121 | 9.99e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 3 | 75 | 9.99e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 7 | 64 | 9.99e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 6 | 76 | 9.99e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 2 | 28 | 9.99e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 6 | 86 | 9.99e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 6 | 96 | 9.99e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 8 | 77 | 9.99e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 3 | 56 | 9.99e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 2 | 55 | 9.99e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 9 | 112 | 9.99e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 5 | 52 | 9.99e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 11 | 115 | 9.99e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 7 | 84 | 9.99e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 3 | 41 | 9.99e-01 |
| KEGG | KEGG:04924 | Renin secretion | 6 | 50 | 9.99e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 9 | 77 | 9.99e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 4 | 104 | 9.99e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 4 | 48 | 9.99e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 5 | 58 | 9.99e-01 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 15 | 179 | 9.99e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 7 | 56 | 9.99e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 1 | 19 | 9.99e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 3 | 35 | 9.99e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 6 | 86 | 9.99e-01 |
| KEGG | KEGG:05214 | Glioma | 7 | 67 | 9.99e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 5 | 57 | 9.99e-01 |
| KEGG | KEGG:05416 | Viral myocarditis | 2 | 46 | 9.99e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 3 | 65 | 9.99e-01 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 5 | 49 | 9.99e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 8 | 84 | 9.99e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 10 | 142 | 9.99e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 12 | 149 | 9.99e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 16 | 170 | 9.99e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 14 | 163 | 9.99e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 29 | 408 | 9.99e-01 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 7 | 162 | 9.99e-01 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 5 | 185 | 9.99e-01 |
| KEGG | KEGG:05218 | Melanoma | 6 | 58 | 9.99e-01 |
| KEGG | KEGG:05219 | Bladder cancer | 2 | 37 | 9.99e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 7 | 75 | 9.99e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 3 | 86 | 9.99e-01 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 10 | 168 | 9.99e-01 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 5 | 84 | 9.99e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 8 | 69 | 9.99e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 6 | 79 | 9.99e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 3 | 43 | 9.99e-01 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 6 | 52 | 9.99e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 6 | 69 | 9.99e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 9 | 84 | 9.99e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 2 | 62 | 9.99e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 12 | 145 | 9.99e-01 |
| KEGG | KEGG:05224 | Breast cancer | 11 | 117 | 9.99e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 5 | 67 | 9.99e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 4 | 87 | 9.99e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 5 | 56 | 9.99e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 10 | 165 | 9.99e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 11 | 153 | 9.99e-01 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 18 | 416 | 9.99e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 13 | 145 | 9.99e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 3 | 43 | 9.99e-01 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 8 | 74 | 9.99e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 2 | 12 | 9.99e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 5 | 49 | 9.99e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 2 | 35 | 9.99e-01 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 25 | 384 | 9.99e-01 |
| KEGG | KEGG:05020 | Prion disease | 10 | 218 | 9.99e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 8 | 123 | 9.99e-01 |
| KEGG | KEGG:05016 | Huntington disease | 13 | 255 | 9.99e-01 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 19 | 303 | 9.99e-01 |
| KEGG | KEGG:05012 | Parkinson disease | 12 | 225 | 9.99e-01 |
| KEGG | KEGG:05010 | Alzheimer disease | 20 | 314 | 9.99e-01 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 3 | 33 | 9.99e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 3 | 42 | 9.99e-01 |
| KEGG | KEGG:04976 | Bile secretion | 4 | 42 | 9.99e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 2 | 58 | 9.99e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 5 | 61 | 9.99e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 8 | 151 | 9.99e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 9 | 214 | 9.99e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 15 | 179 | 9.99e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 19 | 271 | 9.99e-01 |
| KEGG | KEGG:05164 | Influenza A | 8 | 102 | 9.99e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 12 | 176 | 9.99e-01 |
| KEGG | KEGG:05162 | Measles | 7 | 97 | 9.99e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 9 | 136 | 9.99e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 11 | 116 | 9.99e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 6 | 106 | 9.99e-01 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 1 | 18 | 9.99e-01 |
| KEGG | KEGG:05145 | Toxoplasmosis | 5 | 81 | 9.99e-01 |
| KEGG | KEGG:05142 | Chagas disease | 1 | 75 | 9.99e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 2 | 42 | 9.99e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 9 | 112 | 9.99e-01 |
| KEGG | KEGG:05134 | Legionellosis | 3 | 38 | 9.99e-01 |
| KEGG | KEGG:05133 | Pertussis | 3 | 45 | 9.99e-01 |
| KEGG | KEGG:05131 | Shigellosis | 12 | 210 | 9.99e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 7 | 64 | 9.99e-01 |
| KEGG | KEGG:00000 | KEGG root term | 465 | 5802 | 9.99e-01 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 4 | 57 | 9.99e-01 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 1 | 33 | 9.99e-01 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 2 | 25 | 9.99e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 1 | 28 | 9.99e-01 |
| KEGG | KEGG:00650 | Butanoate metabolism | 1 | 17 | 9.99e-01 |
| KEGG | KEGG:00670 | One carbon pool by folate | 2 | 18 | 9.99e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 1 | 10 | 9.99e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 1 | 5 | 9.99e-01 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 3 | 29 | 9.99e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 1 | 15 | 9.99e-01 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 1 | 17 | 9.99e-01 |
| KEGG | KEGG:00790 | Folate biosynthesis | 1 | 18 | 9.99e-01 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 1 | 21 | 9.99e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 1 | 10 | 9.99e-01 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 4 | 44 | 9.99e-01 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 1 | 44 | 9.99e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 2 | 24 | 9.99e-01 |
| KEGG | KEGG:01100 | Metabolic pathways | 72 | 1149 | 9.99e-01 |
| KEGG | KEGG:03018 | RNA degradation | 5 | 74 | 9.99e-01 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 4 | 85 | 9.99e-01 |
| KEGG | KEGG:03010 | Ribosome | 4 | 127 | 9.99e-01 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 3 | 75 | 9.99e-01 |
| KEGG | KEGG:02010 | ABC transporters | 4 | 29 | 9.99e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 2 | 65 | 9.99e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 1 | 14 | 9.99e-01 |
| KEGG | KEGG:01523 | Antifolate resistance | 3 | 24 | 9.99e-01 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 2 | 35 | 9.99e-01 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 8 | 115 | 9.99e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 3 | 68 | 9.99e-01 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 4 | 60 | 9.99e-01 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 5 | 50 | 9.99e-01 |
| KEGG | KEGG:01200 | Carbon metabolism | 5 | 98 | 9.99e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 5 | 85 | 9.99e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 2 | 45 | 9.99e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 2 | 10 | 9.99e-01 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 2 | 26 | 9.99e-01 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 2 | 45 | 9.99e-01 |
| KEGG | KEGG:00230 | Purine metabolism | 10 | 97 | 9.99e-01 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 4 | 106 | 9.99e-01 |
| KEGG | KEGG:00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 1 | 9 | 9.99e-01 |
| KEGG | KEGG:00071 | Fatty acid degradation | 2 | 32 | 9.99e-01 |
| KEGG | KEGG:00062 | Fatty acid elongation | 2 | 24 | 9.99e-01 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 1 | 31 | 9.99e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 2 | 12 | 9.99e-01 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 2 | 27 | 9.99e-01 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 9.99e-01 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 3 | 25 | 9.99e-01 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 2 | 28 | 9.99e-01 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 2 | 44 | 9.99e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 13 | 153 | 9.99e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 2 | 22 | 9.99e-01 |
| KEGG | KEGG:03022 | Basal transcription factors | 2 | 40 | 9.99e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 1 | 39 | 9.99e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 4 | 59 | 9.99e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 4 | 28 | 9.99e-01 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 2 | 25 | 9.99e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 4 | 66 | 9.99e-01 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 2 | 46 | 9.99e-01 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 2 | 37 | 9.99e-01 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 2 | 39 | 9.99e-01 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 2 | 43 | 9.99e-01 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 1 | 22 | 9.99e-01 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 3 | 51 | 9.99e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 1 | 23 | 9.99e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 1 | 44 | 9.99e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 1 | 14 | 9.99e-01 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 1 | 6 | 9.99e-01 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 2 | 38 | 9.99e-01 |
| KEGG | KEGG:00511 | Other glycan degradation | 1 | 16 | 9.99e-01 |
| KEGG | KEGG:03030 | DNA replication | 1 | 35 | 9.99e-01 |
| KEGG | KEGG:03040 | Spliceosome | 7 | 132 | 9.99e-01 |
| KEGG | KEGG:03050 | Proteasome | 2 | 42 | 9.99e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 4 | 25 | 9.99e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 9 | 94 | 9.99e-01 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 8 | 106 | 9.99e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 10 | 92 | 9.99e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 3 | 49 | 9.99e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 10 | 94 | 9.99e-01 |
| KEGG | KEGG:04510 | Focal adhesion | 10 | 177 | 9.99e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 12 | 127 | 9.99e-01 |
| KEGG | KEGG:04217 | Necroptosis | 8 | 104 | 9.99e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 3 | 33 | 9.99e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 4 | 54 | 9.99e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 7 | 78 | 9.99e-01 |
| KEGG | KEGG:04210 | Apoptosis | 8 | 117 | 9.99e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 10 | 102 | 9.99e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 4 | 67 | 9.99e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 18 | 256 | 9.99e-01 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 3 | 69 | 9.99e-01 |
| KEGG | KEGG:04520 | Adherens junction | 9 | 86 | 9.99e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 3 | 63 | 9.99e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 3 | 30 | 9.99e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 5 | 87 | 9.99e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 6 | 76 | 9.99e-01 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 2 | 50 | 9.99e-01 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 3 | 49 | 9.99e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 10 | 83 | 9.99e-01 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 6 | 117 | 9.99e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 1 | 12 | 9.99e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 9 | 100 | 9.99e-01 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 3 | 41 | 9.99e-01 |
| KEGG | KEGG:04611 | Platelet activation | 9 | 89 | 9.99e-01 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 1 | 40 | 9.99e-01 |
| KEGG | KEGG:04540 | Gap junction | 5 | 73 | 9.99e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 5 | 64 | 9.99e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 5 | 53 | 9.99e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 10 | 135 | 9.99e-01 |
| KEGG | KEGG:04146 | Peroxisome | 4 | 69 | 9.99e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 4 | 99 | 9.99e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 15 | 151 | 9.99e-01 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 15 | 164 | 9.99e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 8 | 78 | 9.99e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 24 | 246 | 9.99e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 2 | 48 | 9.99e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 1 | 20 | 9.99e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 2 | 12 | 9.99e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 3 | 59 | 9.99e-01 |
| KEGG | KEGG:03410 | Base excision repair | 2 | 44 | 9.99e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 4 | 50 | 9.99e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 1 | 5 | 9.99e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 4 | 56 | 9.99e-01 |
| KEGG | KEGG:03060 | Protein export | 1 | 30 | 9.99e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 1 | 22 | 9.99e-01 |
| KEGG | KEGG:04148 | Efferocytosis | 9 | 125 | 9.99e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 6 | 113 | 9.99e-01 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 8 | 89 | 9.99e-01 |
| KEGG | KEGG:04145 | Phagosome | 2 | 99 | 9.99e-01 |
| KEGG | KEGG:04144 | Endocytosis | 21 | 230 | 9.99e-01 |
| KEGG | KEGG:04142 | Lysosome | 6 | 117 | 9.99e-01 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 10 | 160 | 9.99e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 11 | 157 | 9.99e-01 |
| KEGG | KEGG:04137 | Mitophagy - animal | 8 | 100 | 9.99e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 6 | 71 | 9.99e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 3 | 31 | 9.99e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 9 | 108 | 9.99e-01 |
| KEGG | KEGG:04110 | Cell cycle | 12 | 151 | 9.99e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 8 | 108 | 9.99e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 4 | 106 | 9.99e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 10 | 91 | 9.99e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 10 | 109 | 9.99e-01 |
| KEGG | KEGG:04115 | p53 signaling pathway | 3 | 66 | 9.99e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 5 | 114 | 9.99e-01 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0065007 | biological regulation | 620 | 8275 | 1.66e-11 |
| GO:BP | GO:0032502 | developmental process | 383 | 4475 | 2.22e-11 |
| GO:BP | GO:0050789 | regulation of biological process | 600 | 8037 | 1.66e-10 |
| GO:BP | GO:0007275 | multicellular organism development | 304 | 3383 | 1.66e-10 |
| GO:BP | GO:0032501 | multicellular organismal process | 401 | 4830 | 1.83e-10 |
| GO:BP | GO:0048856 | anatomical structure development | 352 | 4130 | 5.63e-10 |
| GO:BP | GO:0007154 | cell communication | 359 | 4248 | 7.92e-10 |
| GO:BP | GO:0023052 | signaling | 354 | 4180 | 8.72e-10 |
| GO:BP | GO:0050794 | regulation of cellular process | 571 | 7651 | 2.24e-09 |
| GO:BP | GO:0007165 | signal transduction | 329 | 3846 | 2.47e-09 |
| GO:BP | GO:0048731 | system development | 262 | 2903 | 5.01e-09 |
| GO:BP | GO:0051716 | cellular response to stimulus | 397 | 4933 | 1.78e-08 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 189 | 1951 | 3.44e-08 |
| GO:BP | GO:0072359 | circulatory system development | 105 | 896 | 5.35e-08 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 195 | 2052 | 7.28e-08 |
| GO:BP | GO:0048869 | cellular developmental process | 260 | 2988 | 2.16e-07 |
| GO:BP | GO:0030154 | cell differentiation | 260 | 2987 | 2.16e-07 |
| GO:BP | GO:0050793 | regulation of developmental process | 173 | 1801 | 4.05e-07 |
| GO:BP | GO:0050896 | response to stimulus | 437 | 5732 | 1.81e-06 |
| GO:BP | GO:0048519 | negative regulation of biological process | 324 | 4037 | 5.80e-06 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 308 | 3804 | 6.60e-06 |
| GO:BP | GO:0030334 | regulation of cell migration | 82 | 710 | 8.40e-06 |
| GO:BP | GO:2000145 | regulation of cell motility | 85 | 745 | 8.40e-06 |
| GO:BP | GO:0065008 | regulation of biological quality | 184 | 2039 | 1.03e-05 |
| GO:BP | GO:0040012 | regulation of locomotion | 86 | 766 | 1.28e-05 |
| GO:BP | GO:0040011 | locomotion | 93 | 858 | 1.81e-05 |
| GO:BP | GO:0048518 | positive regulation of biological process | 354 | 4561 | 2.77e-05 |
| GO:BP | GO:0048513 | animal organ development | 188 | 2130 | 3.12e-05 |
| GO:BP | GO:0009888 | tissue development | 135 | 1425 | 5.89e-05 |
| GO:BP | GO:0007399 | nervous system development | 170 | 1903 | 6.40e-05 |
| GO:BP | GO:0035556 | intracellular signal transduction | 182 | 2079 | 8.51e-05 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 239 | 2902 | 1.10e-04 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 326 | 4198 | 1.13e-04 |
| GO:BP | GO:0022008 | neurogenesis | 126 | 1327 | 1.17e-04 |
| GO:BP | GO:0016477 | cell migration | 107 | 1078 | 1.17e-04 |
| GO:BP | GO:0007507 | heart development | 61 | 515 | 1.49e-04 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 131 | 1403 | 1.61e-04 |
| GO:BP | GO:0009966 | regulation of signal transduction | 196 | 2307 | 1.85e-04 |
| GO:BP | GO:0048699 | generation of neurons | 111 | 1145 | 2.01e-04 |
| GO:BP | GO:0010646 | regulation of cell communication | 216 | 2601 | 2.21e-04 |
| GO:BP | GO:0014706 | striated muscle tissue development | 33 | 218 | 2.85e-04 |
| GO:BP | GO:0048870 | cell motility | 113 | 1190 | 4.05e-04 |
| GO:BP | GO:0001944 | vasculature development | 64 | 573 | 5.06e-04 |
| GO:BP | GO:0044057 | regulation of system process | 49 | 399 | 5.39e-04 |
| GO:BP | GO:0048589 | developmental growth | 60 | 527 | 5.39e-04 |
| GO:BP | GO:0007155 | cell adhesion | 98 | 1004 | 5.79e-04 |
| GO:BP | GO:0030029 | actin filament-based process | 72 | 677 | 6.61e-04 |
| GO:BP | GO:0001568 | blood vessel development | 61 | 546 | 7.68e-04 |
| GO:BP | GO:0016043 | cellular component organization | 380 | 5139 | 9.15e-04 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 33 | 234 | 1.10e-03 |
| GO:BP | GO:0003013 | circulatory system process | 52 | 446 | 1.10e-03 |
| GO:BP | GO:0023051 | regulation of signaling | 211 | 2597 | 1.12e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 15 | 66 | 1.19e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 15 | 66 | 1.19e-03 |
| GO:BP | GO:0030182 | neuron differentiation | 102 | 1080 | 1.28e-03 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 106 | 1134 | 1.30e-03 |
| GO:BP | GO:0043954 | cellular component maintenance | 14 | 59 | 1.32e-03 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 69 | 662 | 1.68e-03 |
| GO:BP | GO:0048468 | cell development | 168 | 1999 | 1.70e-03 |
| GO:BP | GO:0045444 | fat cell differentiation | 28 | 189 | 1.74e-03 |
| GO:BP | GO:0040007 | growth | 75 | 739 | 1.74e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 35 | 263 | 1.76e-03 |
| GO:BP | GO:0034330 | cell junction organization | 63 | 591 | 1.84e-03 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 10 | 33 | 2.14e-03 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 92 | 967 | 2.29e-03 |
| GO:BP | GO:0007417 | central nervous system development | 75 | 748 | 2.40e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 31 | 225 | 2.47e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 20 | 115 | 2.47e-03 |
| GO:BP | GO:0030900 | forebrain development | 37 | 292 | 2.75e-03 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 29 | 206 | 2.87e-03 |
| GO:BP | GO:0031175 | neuron projection development | 78 | 794 | 3.12e-03 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 17 | 90 | 3.13e-03 |
| GO:BP | GO:0009790 | embryo development | 83 | 864 | 3.75e-03 |
| GO:BP | GO:0003008 | system process | 108 | 1201 | 4.23e-03 |
| GO:BP | GO:0048666 | neuron development | 85 | 894 | 4.26e-03 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 44 | 380 | 4.27e-03 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 52 | 479 | 5.11e-03 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 74 | 756 | 5.12e-03 |
| GO:BP | GO:0099558 | maintenance of synapse structure | 8 | 24 | 5.40e-03 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 8 | 24 | 5.40e-03 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 8 | 24 | 5.40e-03 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 83 | 876 | 5.42e-03 |
| GO:BP | GO:0008015 | blood circulation | 43 | 374 | 5.57e-03 |
| GO:BP | GO:0003012 | muscle system process | 40 | 339 | 5.57e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 385 | 5340 | 5.91e-03 |
| GO:BP | GO:0035295 | tube development | 79 | 827 | 5.95e-03 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 10 | 38 | 6.06e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 38 | 318 | 6.13e-03 |
| GO:BP | GO:0000902 | cell morphogenesis | 74 | 764 | 6.29e-03 |
| GO:BP | GO:0043583 | ear development | 23 | 155 | 6.42e-03 |
| GO:BP | GO:0048839 | inner ear development | 21 | 135 | 6.42e-03 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 5 | 9 | 6.86e-03 |
| GO:BP | GO:0034331 | cell junction maintenance | 10 | 39 | 7.21e-03 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 65 | 653 | 7.40e-03 |
| GO:BP | GO:0009987 | cellular process | 749 | 11450 | 7.57e-03 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 79 | 837 | 7.70e-03 |
| GO:BP | GO:0001508 | action potential | 18 | 108 | 7.70e-03 |
| GO:BP | GO:0035239 | tube morphogenesis | 66 | 668 | 7.70e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 50 | 467 | 7.70e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 12 | 55 | 7.70e-03 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 8 | 26 | 8.23e-03 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 32 | 256 | 8.23e-03 |
| GO:BP | GO:0090257 | regulation of muscle system process | 25 | 181 | 9.23e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 37 | 316 | 9.75e-03 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 118 | 1376 | 9.91e-03 |
| GO:BP | GO:0030048 | actin filament-based movement | 18 | 111 | 1.01e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 19 | 121 | 1.03e-02 |
| GO:BP | GO:0071872 | cellular response to epinephrine stimulus | 5 | 10 | 1.10e-02 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 21 | 142 | 1.10e-02 |
| GO:BP | GO:0032879 | regulation of localization | 128 | 1521 | 1.10e-02 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 161 | 1992 | 1.10e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 14 | 75 | 1.12e-02 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 7 | 21 | 1.12e-02 |
| GO:BP | GO:0007010 | cytoskeleton organization | 106 | 1218 | 1.14e-02 |
| GO:BP | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress | 4 | 6 | 1.14e-02 |
| GO:BP | GO:0034163 | regulation of toll-like receptor 9 signaling pathway | 4 | 6 | 1.14e-02 |
| GO:BP | GO:0060710 | chorio-allantoic fusion | 4 | 6 | 1.14e-02 |
| GO:BP | GO:0010616 | negative regulation of cardiac muscle adaptation | 4 | 6 | 1.14e-02 |
| GO:BP | GO:0048790 | maintenance of presynaptic active zone structure | 4 | 6 | 1.14e-02 |
| GO:BP | GO:0014896 | muscle hypertrophy | 14 | 76 | 1.20e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 9 | 35 | 1.20e-02 |
| GO:BP | GO:0021537 | telencephalon development | 27 | 208 | 1.23e-02 |
| GO:BP | GO:0065009 | regulation of molecular function | 118 | 1389 | 1.24e-02 |
| GO:BP | GO:0099536 | synaptic signaling | 53 | 518 | 1.24e-02 |
| GO:BP | GO:0038138 | ERBB4-ERBB4 signaling pathway | 3 | 3 | 1.28e-02 |
| GO:BP | GO:0021563 | glossopharyngeal nerve development | 3 | 3 | 1.28e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 13 | 68 | 1.29e-02 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 96 | 1088 | 1.32e-02 |
| GO:BP | GO:0003015 | heart process | 27 | 210 | 1.36e-02 |
| GO:BP | GO:0043116 | negative regulation of vascular permeability | 6 | 16 | 1.36e-02 |
| GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 6 | 16 | 1.36e-02 |
| GO:BP | GO:0034329 | cell junction assembly | 39 | 349 | 1.37e-02 |
| GO:BP | GO:0071320 | cellular response to cAMP | 9 | 36 | 1.38e-02 |
| GO:BP | GO:0061337 | cardiac conduction | 15 | 87 | 1.39e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 8 | 29 | 1.43e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 10 | 44 | 1.45e-02 |
| GO:BP | GO:0070848 | response to growth factor | 57 | 576 | 1.57e-02 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 51 | 501 | 1.63e-02 |
| GO:BP | GO:0060537 | muscle tissue development | 39 | 353 | 1.63e-02 |
| GO:BP | GO:0007420 | brain development | 54 | 539 | 1.63e-02 |
| GO:BP | GO:0008016 | regulation of heart contraction | 23 | 170 | 1.66e-02 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 54 | 540 | 1.68e-02 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 10 | 45 | 1.68e-02 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 46 | 440 | 1.70e-02 |
| GO:BP | GO:0051591 | response to cAMP | 12 | 62 | 1.73e-02 |
| GO:BP | GO:0007267 | cell-cell signaling | 100 | 1156 | 1.75e-02 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 6 | 17 | 1.75e-02 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 6 | 17 | 1.75e-02 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 6 | 17 | 1.75e-02 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 107 | 1256 | 1.85e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 17 | 110 | 1.90e-02 |
| GO:BP | GO:0003205 | cardiac chamber development | 21 | 151 | 1.90e-02 |
| GO:BP | GO:0060322 | head development | 57 | 583 | 1.90e-02 |
| GO:BP | GO:0060419 | heart growth | 13 | 72 | 1.92e-02 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 25 | 195 | 1.96e-02 |
| GO:BP | GO:0071871 | response to epinephrine | 5 | 12 | 2.14e-02 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 50 | 497 | 2.14e-02 |
| GO:BP | GO:0060766 | negative regulation of androgen receptor signaling pathway | 5 | 12 | 2.14e-02 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 50 | 497 | 2.14e-02 |
| GO:BP | GO:0006941 | striated muscle contraction | 21 | 153 | 2.15e-02 |
| GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 6 | 18 | 2.29e-02 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 43 | 411 | 2.29e-02 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 13 | 74 | 2.38e-02 |
| GO:BP | GO:0050808 | synapse organization | 40 | 375 | 2.38e-02 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 44 | 425 | 2.42e-02 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 44 | 425 | 2.42e-02 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 69 | 749 | 2.45e-02 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 7 | 25 | 2.48e-02 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 54 | 553 | 2.48e-02 |
| GO:BP | GO:0002027 | regulation of heart rate | 14 | 84 | 2.48e-02 |
| GO:BP | GO:0009611 | response to wounding | 42 | 402 | 2.53e-02 |
| GO:BP | GO:0060047 | heart contraction | 25 | 200 | 2.53e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 54 | 554 | 2.53e-02 |
| GO:BP | GO:1903522 | regulation of blood circulation | 25 | 200 | 2.53e-02 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 54 | 554 | 2.53e-02 |
| GO:BP | GO:0006468 | protein phosphorylation | 88 | 1008 | 2.53e-02 |
| GO:BP | GO:0048729 | tissue morphogenesis | 48 | 478 | 2.57e-02 |
| GO:BP | GO:0098609 | cell-cell adhesion | 58 | 607 | 2.59e-02 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 88 | 1011 | 2.67e-02 |
| GO:BP | GO:0051049 | regulation of transport | 99 | 1164 | 2.71e-02 |
| GO:BP | GO:0009214 | cyclic nucleotide catabolic process | 5 | 13 | 2.87e-02 |
| GO:BP | GO:2001212 | regulation of vasculogenesis | 5 | 13 | 2.87e-02 |
| GO:BP | GO:1903034 | regulation of response to wounding | 18 | 127 | 3.14e-02 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 44 | 433 | 3.21e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 20 | 149 | 3.31e-02 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 15 | 97 | 3.31e-02 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 139 | 1744 | 3.49e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 138 | 1732 | 3.67e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 7 | 27 | 3.69e-02 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 52 | 540 | 3.81e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 9 | 43 | 3.87e-02 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 94 | 1109 | 3.87e-02 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 89 | 1040 | 3.92e-02 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 106 | 1279 | 4.00e-02 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 25 | 208 | 4.00e-02 |
| GO:BP | GO:0023057 | negative regulation of signaling | 94 | 1111 | 4.00e-02 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 135 | 1694 | 4.00e-02 |
| GO:BP | GO:0006936 | muscle contraction | 30 | 267 | 4.10e-02 |
| GO:BP | GO:0007416 | synapse assembly | 20 | 153 | 4.31e-02 |
| GO:BP | GO:0048638 | regulation of developmental growth | 29 | 257 | 4.55e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 6 | 21 | 4.55e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 11 | 62 | 4.55e-02 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 8 | 36 | 4.55e-02 |
| GO:BP | GO:0099560 | synaptic membrane adhesion | 6 | 21 | 4.55e-02 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 15 | 101 | 4.57e-02 |
| GO:BP | GO:0086018 | SA node cell to atrial cardiac muscle cell signaling | 4 | 9 | 4.68e-02 |
| GO:BP | GO:0086015 | SA node cell action potential | 4 | 9 | 4.68e-02 |
| GO:BP | GO:0006198 | cAMP catabolic process | 4 | 9 | 4.68e-02 |
| GO:BP | GO:1990709 | presynaptic active zone organization | 4 | 9 | 4.68e-02 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 56 | 601 | 4.84e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04152 | AMPK signaling pathway | 12 | 102 | 5.53e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 10 | 78 | 5.53e-01 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 18 | 164 | 5.53e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 8 | 58 | 5.53e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 14 | 115 | 5.53e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 14 | 127 | 5.53e-01 |
| KEGG | KEGG:00230 | Purine metabolism | 12 | 97 | 5.53e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 8 | 56 | 5.53e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 9 | 56 | 5.53e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 4 | 12 | 5.53e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 12 | 91 | 5.53e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 3 | 10 | 5.53e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 9 | 55 | 5.53e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 10 | 69 | 5.53e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 8 | 59 | 5.65e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 15 | 142 | 5.66e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 10 | 83 | 5.66e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 10 | 84 | 5.68e-01 |
| KEGG | KEGG:04742 | Taste transduction | 4 | 22 | 5.68e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 12 | 109 | 5.68e-01 |
| KEGG | KEGG:04730 | Long-term depression | 6 | 42 | 5.68e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 8 | 64 | 5.68e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 9 | 75 | 5.68e-01 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 16 | 164 | 5.79e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 15 | 151 | 5.79e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 13 | 128 | 6.02e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 6 | 45 | 6.02e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 4 | 24 | 6.02e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 10 | 92 | 6.02e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 4 | 25 | 6.51e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 12 | 121 | 6.74e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 9 | 83 | 6.74e-01 |
| KEGG | KEGG:04520 | Adherens junction | 9 | 86 | 7.23e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 6 | 49 | 7.23e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 10 | 99 | 7.23e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 6 | 50 | 7.23e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 7 | 63 | 7.57e-01 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 9 | 89 | 7.63e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 8 | 76 | 7.63e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 6 | 53 | 7.69e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 7 | 65 | 7.69e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 15 | 170 | 7.69e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 8 | 79 | 7.70e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 6 | 54 | 7.70e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 5 | 42 | 7.70e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 2 | 10 | 8.00e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 7 | 69 | 8.22e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 8 | 82 | 8.22e-01 |
| KEGG | KEGG:04360 | Axon guidance | 14 | 162 | 8.22e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 3 | 22 | 8.59e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 3 | 22 | 8.59e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 9 | 97 | 8.59e-01 |
| KEGG | KEGG:04148 | Efferocytosis | 11 | 125 | 8.59e-01 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 9 | 99 | 8.67e-01 |
| KEGG | KEGG:03030 | DNA replication | 4 | 35 | 8.67e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 4 | 35 | 8.67e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 4 | 35 | 8.67e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 7 | 72 | 8.67e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 7 | 75 | 8.89e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 14 | 172 | 8.89e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 5 | 49 | 8.89e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 9 | 102 | 8.89e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 6 | 67 | 8.94e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 1 | 4 | 8.94e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 2 | 15 | 8.94e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 5 | 52 | 8.94e-01 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 4 | 38 | 8.94e-01 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 5 | 50 | 8.94e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 3 | 25 | 8.94e-01 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 2 | 15 | 8.94e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 11 | 134 | 8.94e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 5 | 52 | 8.94e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 6 | 67 | 8.94e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 11 | 135 | 8.94e-01 |
| KEGG | KEGG:05214 | Glioma | 6 | 67 | 8.94e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 7 | 77 | 8.94e-01 |
| KEGG | KEGG:04530 | Tight junction | 11 | 138 | 8.94e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 7 | 78 | 8.94e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 7 | 76 | 8.94e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 9 | 110 | 9.02e-01 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 7 | 84 | 9.04e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 8 | 98 | 9.04e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 5 | 55 | 9.04e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 9 | 112 | 9.04e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 7 | 84 | 9.04e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 5 | 55 | 9.04e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 7 | 83 | 9.04e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 11 | 144 | 9.06e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 1 | 5 | 9.06e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 4 | 43 | 9.06e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 3 | 30 | 9.06e-01 |
| KEGG | KEGG:03060 | Protein export | 3 | 30 | 9.06e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 8 | 100 | 9.06e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 11 | 145 | 9.07e-01 |
| KEGG | KEGG:05218 | Melanoma | 5 | 58 | 9.07e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 28 | 408 | 9.17e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 2 | 19 | 9.17e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 6 | 75 | 9.17e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 8 | 106 | 9.17e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 11 | 149 | 9.17e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 3 | 33 | 9.17e-01 |
| KEGG | KEGG:00071 | Fatty acid degradation | 3 | 32 | 9.17e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 5 | 61 | 9.17e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 2 | 19 | 9.17e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 10 | 132 | 9.17e-01 |
| KEGG | KEGG:00000 | KEGG root term | 367 | 5802 | 9.17e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 6 | 76 | 9.17e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 6 | 74 | 9.17e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 12 | 163 | 9.17e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 1 | 7 | 9.32e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 4 | 48 | 9.32e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 17 | 246 | 9.32e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 4 | 49 | 9.32e-01 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 4 | 49 | 9.32e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 9 | 123 | 9.32e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 5 | 64 | 9.33e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 7 | 95 | 9.47e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 2 | 21 | 9.47e-01 |
| KEGG | KEGG:04115 | p53 signaling pathway | 5 | 66 | 9.64e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 4 | 51 | 9.64e-01 |
| KEGG | KEGG:05034 | Alcoholism | 8 | 113 | 9.78e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 6 | 84 | 9.78e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 4 | 53 | 9.78e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 5 | 68 | 9.78e-01 |
| KEGG | KEGG:04510 | Focal adhesion | 12 | 177 | 9.78e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 10 | 145 | 9.78e-01 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 20 | 303 | 9.78e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 12 | 176 | 9.78e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 6 | 86 | 9.81e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 4 | 55 | 9.81e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 3 | 39 | 9.81e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 8 | 117 | 9.81e-01 |
| KEGG | KEGG:05224 | Breast cancer | 8 | 117 | 9.81e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 6 | 85 | 9.81e-01 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 1 | 9 | 9.81e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2 | 69 | 1.00e+00 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 6 | 91 | 1.00e+00 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 7 | 131 | 1.00e+00 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 8 | 153 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 2 | 46 | 1.00e+00 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 8 | 165 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 2 | 162 | 1.00e+00 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 2 | 43 | 1.00e+00 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 3 | 104 | 1.00e+00 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 1 | 41 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 3 | 52 | 1.00e+00 |
| KEGG | KEGG:04924 | Renin secretion | 3 | 50 | 1.00e+00 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 9 | 142 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 6 | 185 | 1.00e+00 |
| KEGG | KEGG:05212 | Pancreatic cancer | 4 | 75 | 1.00e+00 |
| KEGG | KEGG:05213 | Endometrial cancer | 4 | 57 | 1.00e+00 |
| KEGG | KEGG:05219 | Bladder cancer | 2 | 37 | 1.00e+00 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 6 | 153 | 1.00e+00 |
| KEGG | KEGG:05222 | Small cell lung cancer | 5 | 87 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 10 | 168 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 11 | 218 | 1.00e+00 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 3 | 41 | 1.00e+00 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 7 | 179 | 1.00e+00 |
| KEGG | KEGG:05030 | Cocaine addiction | 1 | 35 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 10 | 255 | 1.00e+00 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 4 | 74 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 12 | 225 | 1.00e+00 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 4 | 58 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 13 | 314 | 1.00e+00 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 9 | 151 | 1.00e+00 |
| KEGG | KEGG:05131 | Shigellosis | 11 | 210 | 1.00e+00 |
| KEGG | KEGG:05132 | Salmonella infection | 9 | 214 | 1.00e+00 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 2 | 33 | 1.00e+00 |
| KEGG | KEGG:05133 | Pertussis | 1 | 45 | 1.00e+00 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 1 | 14 | 1.00e+00 |
| KEGG | KEGG:05135 | Yersinia infection | 6 | 112 | 1.00e+00 |
| KEGG | KEGG:05140 | Leishmaniasis | 2 | 42 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 7 | 416 | 1.00e+00 |
| KEGG | KEGG:04976 | Bile secretion | 3 | 42 | 1.00e+00 |
| KEGG | KEGG:05143 | African trypanosomiasis | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:05144 | Malaria | 1 | 20 | 1.00e+00 |
| KEGG | KEGG:05145 | Toxoplasmosis | 2 | 81 | 1.00e+00 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 1 | 31 | 1.00e+00 |
| KEGG | KEGG:05146 | Amoebiasis | 1 | 64 | 1.00e+00 |
| KEGG | KEGG:05152 | Tuberculosis | 5 | 106 | 1.00e+00 |
| KEGG | KEGG:05160 | Hepatitis C | 7 | 116 | 1.00e+00 |
| KEGG | KEGG:05161 | Hepatitis B | 5 | 136 | 1.00e+00 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 1 | 20 | 1.00e+00 |
| KEGG | KEGG:05162 | Measles | 2 | 97 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 20 | 384 | 1.00e+00 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 2 | 26 | 1.00e+00 |
| KEGG | KEGG:05164 | Influenza A | 5 | 102 | 1.00e+00 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 13 | 271 | 1.00e+00 |
| KEGG | KEGG:05142 | Chagas disease | 3 | 75 | 1.00e+00 |
| KEGG | KEGG:00340 | Histidine metabolism | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 3 | 86 | 1.00e+00 |
| KEGG | KEGG:04916 | Melanogenesis | 5 | 77 | 1.00e+00 |
| KEGG | KEGG:00790 | Folate biosynthesis | 1 | 18 | 1.00e+00 |
| KEGG | KEGG:00830 | Retinol metabolism | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 1 | 21 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 2 | 44 | 1.00e+00 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 1 | 44 | 1.00e+00 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 1 | 28 | 1.00e+00 |
| KEGG | KEGG:01100 | Metabolic pathways | 66 | 1149 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 2 | 98 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 1 | 44 | 1.00e+00 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 1 | 60 | 1.00e+00 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 1 | 25 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 4 | 115 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 1 | 24 | 1.00e+00 |
| KEGG | KEGG:01524 | Platinum drug resistance | 4 | 65 | 1.00e+00 |
| KEGG | KEGG:02010 | ABC transporters | 1 | 29 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 1 | 75 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 4 | 85 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 1 | 74 | 1.00e+00 |
| KEGG | KEGG:03022 | Basal transcription factors | 2 | 40 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 1 | 132 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 1 | 42 | 1.00e+00 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 4 | 99 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 1 | 35 | 1.00e+00 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 2 | 56 | 1.00e+00 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 2 | 29 | 1.00e+00 |
| KEGG | KEGG:00650 | Butanoate metabolism | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 1 | 23 | 1.00e+00 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 2 | 43 | 1.00e+00 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 1 | 14 | 1.00e+00 |
| KEGG | KEGG:00480 | Glutathione metabolism | 1 | 44 | 1.00e+00 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 1 | 23 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 1 | 51 | 1.00e+00 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 1 | 22 | 1.00e+00 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 2 | 37 | 1.00e+00 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 1 | 19 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 1 | 46 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 2 | 29 | 1.00e+00 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 2 | 45 | 1.00e+00 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 4 | 66 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 1 | 25 | 1.00e+00 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 2 | 28 | 1.00e+00 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 2 | 26 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 4 | 106 | 1.00e+00 |
| KEGG | KEGG:00062 | Fatty acid elongation | 1 | 24 | 1.00e+00 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 1 | 33 | 1.00e+00 |
| KEGG | KEGG:00640 | Propanoate metabolism | 1 | 28 | 1.00e+00 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 1 | 20 | 1.00e+00 |
| KEGG | KEGG:03410 | Base excision repair | 3 | 44 | 1.00e+00 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 2 | 59 | 1.00e+00 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:04611 | Platelet activation | 6 | 89 | 1.00e+00 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 1 | 64 | 1.00e+00 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 4 | 117 | 1.00e+00 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 1 | 49 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 2 | 50 | 1.00e+00 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 5 | 87 | 1.00e+00 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 2 | 30 | 1.00e+00 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 2 | 63 | 1.00e+00 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 3 | 57 | 1.00e+00 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 2 | 53 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 1 | 40 | 1.00e+00 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 2 | 56 | 1.00e+00 |
| KEGG | KEGG:04668 | TNF signaling pathway | 5 | 87 | 1.00e+00 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 5 | 79 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 8 | 195 | 1.00e+00 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 5 | 110 | 1.00e+00 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 7 | 179 | 1.00e+00 |
| KEGG | KEGG:04814 | Motor proteins | 9 | 149 | 1.00e+00 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 8 | 121 | 1.00e+00 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 2 | 28 | 1.00e+00 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 4 | 86 | 1.00e+00 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 3 | 96 | 1.00e+00 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 1 | 46 | 1.00e+00 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 5 | 104 | 1.00e+00 |
| KEGG | KEGG:04540 | Gap junction | 4 | 73 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 3 | 69 | 1.00e+00 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 3 | 48 | 1.00e+00 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 4 | 99 | 1.00e+00 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 1 | 20 | 1.00e+00 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 7 | 113 | 1.00e+00 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 4 | 71 | 1.00e+00 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 7 | 108 | 1.00e+00 |
| KEGG | KEGG:04110 | Cell cycle | 10 | 151 | 1.00e+00 |
| KEGG | KEGG:04114 | Oocyte meiosis | 7 | 108 | 1.00e+00 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 6 | 134 | 1.00e+00 |
| KEGG | KEGG:04136 | Autophagy - other | 2 | 31 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 3 | 100 | 1.00e+00 |
| KEGG | KEGG:04140 | Autophagy - animal | 8 | 157 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 4 | 160 | 1.00e+00 |
| KEGG | KEGG:04144 | Endocytosis | 13 | 230 | 1.00e+00 |
| KEGG | KEGG:04145 | Phagosome | 5 | 99 | 1.00e+00 |
| KEGG | KEGG:04146 | Peroxisome | 1 | 69 | 1.00e+00 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 13 | 256 | 1.00e+00 |
| KEGG | KEGG:04210 | Apoptosis | 4 | 117 | 1.00e+00 |
| KEGG | KEGG:04217 | Necroptosis | 3 | 104 | 1.00e+00 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 6 | 94 | 1.00e+00 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 3 | 49 | 1.00e+00 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 6 | 106 | 1.00e+00 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 5 | 94 | 1.00e+00 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 3 | 56 | 1.00e+00 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 4 | 114 | 1.00e+00 |
ESR hyper/hypo
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0007275 | multicellular organism development | 535 | 3383 | 2.97e-17 |
| GO:BP | GO:0009888 | tissue development | 271 | 1425 | 1.64e-16 |
| GO:BP | GO:0032502 | developmental process | 660 | 4475 | 6.10e-16 |
| GO:BP | GO:0048869 | cellular developmental process | 477 | 2988 | 6.10e-16 |
| GO:BP | GO:0030154 | cell differentiation | 477 | 2987 | 6.10e-16 |
| GO:BP | GO:0048856 | anatomical structure development | 618 | 4130 | 6.35e-16 |
| GO:BP | GO:0032501 | multicellular organismal process | 700 | 4830 | 1.31e-15 |
| GO:BP | GO:0050794 | regulation of cellular process | 1018 | 7651 | 1.63e-15 |
| GO:BP | GO:0048513 | animal organ development | 360 | 2130 | 6.37e-15 |
| GO:BP | GO:0051716 | cellular response to stimulus | 704 | 4933 | 4.45e-14 |
| GO:BP | GO:0048731 | system development | 456 | 2903 | 5.56e-14 |
| GO:BP | GO:0050793 | regulation of developmental process | 310 | 1801 | 1.56e-13 |
| GO:BP | GO:0050789 | regulation of biological process | 1049 | 8037 | 1.59e-13 |
| GO:BP | GO:0072359 | circulatory system development | 181 | 896 | 2.79e-13 |
| GO:BP | GO:0065007 | biological regulation | 1072 | 8275 | 4.23e-13 |
| GO:BP | GO:0007154 | cell communication | 616 | 4248 | 5.54e-13 |
| GO:BP | GO:0050896 | response to stimulus | 790 | 5732 | 5.54e-13 |
| GO:BP | GO:0007165 | signal transduction | 566 | 3846 | 1.02e-12 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 326 | 1951 | 1.07e-12 |
| GO:BP | GO:0023052 | signaling | 605 | 4180 | 1.70e-12 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 606 | 4198 | 2.71e-12 |
| GO:BP | GO:0048518 | positive regulation of biological process | 641 | 4561 | 8.79e-11 |
| GO:BP | GO:0048468 | cell development | 322 | 1999 | 2.24e-10 |
| GO:BP | GO:0010646 | regulation of cell communication | 396 | 2601 | 1.04e-09 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 325 | 2052 | 1.45e-09 |
| GO:BP | GO:0048589 | developmental growth | 113 | 527 | 1.51e-09 |
| GO:BP | GO:0048519 | negative regulation of biological process | 571 | 4037 | 1.57e-09 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 542 | 3804 | 2.26e-09 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 183 | 1011 | 3.62e-09 |
| GO:BP | GO:0023051 | regulation of signaling | 392 | 2597 | 3.96e-09 |
| GO:BP | GO:0009966 | regulation of signal transduction | 355 | 2307 | 4.34e-09 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 163 | 876 | 5.34e-09 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 302 | 1900 | 5.34e-09 |
| GO:BP | GO:0007155 | cell adhesion | 181 | 1004 | 5.78e-09 |
| GO:BP | GO:0014706 | striated muscle tissue development | 59 | 218 | 1.56e-08 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 174 | 967 | 1.64e-08 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 197 | 1134 | 1.87e-08 |
| GO:BP | GO:0060429 | epithelium development | 155 | 836 | 1.98e-08 |
| GO:BP | GO:0035239 | tube morphogenesis | 130 | 668 | 2.81e-08 |
| GO:BP | GO:0035265 | organ growth | 42 | 132 | 3.48e-08 |
| GO:BP | GO:0060537 | muscle tissue development | 81 | 353 | 3.75e-08 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 189 | 1088 | 4.15e-08 |
| GO:BP | GO:0060419 | heart growth | 29 | 72 | 4.15e-08 |
| GO:BP | GO:0035556 | intracellular signal transduction | 320 | 2079 | 4.36e-08 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 423 | 2902 | 5.03e-08 |
| GO:BP | GO:0022008 | neurogenesis | 221 | 1327 | 5.27e-08 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 407 | 2780 | 6.92e-08 |
| GO:BP | GO:0007399 | nervous system development | 296 | 1903 | 7.45e-08 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 140 | 749 | 7.70e-08 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 194 | 1135 | 8.11e-08 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 179 | 1027 | 8.59e-08 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 368 | 2474 | 8.85e-08 |
| GO:BP | GO:0007507 | heart development | 105 | 515 | 9.45e-08 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 377 | 2555 | 1.36e-07 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 209 | 1256 | 1.58e-07 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 179 | 1036 | 1.59e-07 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 126 | 662 | 1.61e-07 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 133 | 710 | 1.61e-07 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 189 | 1111 | 1.74e-07 |
| GO:BP | GO:0048568 | embryonic organ development | 73 | 317 | 1.74e-07 |
| GO:BP | GO:0060322 | head development | 114 | 583 | 1.98e-07 |
| GO:BP | GO:0048729 | tissue morphogenesis | 98 | 478 | 2.27e-07 |
| GO:BP | GO:0048699 | generation of neurons | 193 | 1145 | 2.33e-07 |
| GO:BP | GO:0001944 | vasculature development | 112 | 573 | 2.72e-07 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 26 | 65 | 2.81e-07 |
| GO:BP | GO:0048870 | cell motility | 198 | 1190 | 3.94e-07 |
| GO:BP | GO:0035295 | tube development | 148 | 827 | 3.97e-07 |
| GO:BP | GO:0009790 | embryo development | 153 | 864 | 4.39e-07 |
| GO:BP | GO:0008283 | cell population proliferation | 223 | 1386 | 6.78e-07 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 122 | 653 | 7.90e-07 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 341 | 2311 | 9.27e-07 |
| GO:BP | GO:0016477 | cell migration | 181 | 1078 | 9.48e-07 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 52 | 206 | 1.37e-06 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 268 | 1744 | 1.37e-06 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 266 | 1732 | 1.64e-06 |
| GO:BP | GO:0007420 | brain development | 104 | 539 | 1.80e-06 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 260 | 1694 | 2.57e-06 |
| GO:BP | GO:0040007 | growth | 132 | 739 | 2.91e-06 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 199 | 1233 | 3.55e-06 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 105 | 554 | 3.83e-06 |
| GO:BP | GO:0016043 | cellular component organization | 675 | 5139 | 3.99e-06 |
| GO:BP | GO:0030900 | forebrain development | 65 | 292 | 4.15e-06 |
| GO:BP | GO:0070848 | response to growth factor | 108 | 576 | 4.22e-06 |
| GO:BP | GO:0030182 | neuron differentiation | 178 | 1080 | 4.37e-06 |
| GO:BP | GO:0060485 | mesenchyme development | 59 | 256 | 4.62e-06 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 294 | 1974 | 4.68e-06 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 224 | 1430 | 4.96e-06 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 62 | 276 | 5.56e-06 |
| GO:BP | GO:0061061 | muscle structure development | 105 | 559 | 5.56e-06 |
| GO:BP | GO:0001568 | blood vessel development | 103 | 546 | 5.87e-06 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 220 | 1403 | 5.87e-06 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 102 | 540 | 6.27e-06 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 283 | 1900 | 8.28e-06 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 294 | 1992 | 1.04e-05 |
| GO:BP | GO:0021537 | telencephalon development | 50 | 208 | 1.09e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 58 | 257 | 1.15e-05 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 88 | 452 | 1.20e-05 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 92 | 479 | 1.20e-05 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 86 | 440 | 1.37e-05 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 90 | 467 | 1.37e-05 |
| GO:BP | GO:0007417 | central nervous system development | 130 | 748 | 1.46e-05 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 185 | 1154 | 1.46e-05 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 288 | 1959 | 1.93e-05 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 397 | 2842 | 2.02e-05 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 18 | 43 | 2.29e-05 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 112 | 626 | 2.35e-05 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 27 | 85 | 2.45e-05 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 130 | 756 | 2.54e-05 |
| GO:BP | GO:0098609 | cell-cell adhesion | 109 | 607 | 2.74e-05 |
| GO:BP | GO:0003205 | cardiac chamber development | 39 | 151 | 3.18e-05 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 129 | 752 | 3.18e-05 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 212 | 1376 | 3.38e-05 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 299 | 2061 | 3.41e-05 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 99 | 540 | 3.44e-05 |
| GO:BP | GO:0048666 | neuron development | 148 | 894 | 3.73e-05 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 24 | 72 | 3.73e-05 |
| GO:BP | GO:0046620 | regulation of organ growth | 24 | 72 | 3.73e-05 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 77 | 391 | 3.79e-05 |
| GO:BP | GO:0060284 | regulation of cell development | 108 | 605 | 3.84e-05 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 202 | 1304 | 4.16e-05 |
| GO:BP | GO:0007423 | sensory organ development | 78 | 399 | 4.23e-05 |
| GO:BP | GO:0031175 | neuron projection development | 134 | 794 | 4.33e-05 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 181 | 1146 | 4.64e-05 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 75 | 380 | 4.64e-05 |
| GO:BP | GO:0023056 | positive regulation of signaling | 200 | 1292 | 4.82e-05 |
| GO:BP | GO:0002521 | leukocyte differentiation | 77 | 394 | 4.86e-05 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 201 | 1301 | 5.09e-05 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 21 | 59 | 5.09e-05 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 100 | 553 | 5.14e-05 |
| GO:BP | GO:0060420 | regulation of heart growth | 19 | 50 | 5.26e-05 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 31 | 110 | 5.39e-05 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 199 | 1288 | 5.60e-05 |
| GO:BP | GO:0006915 | apoptotic process | 221 | 1459 | 5.72e-05 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 48 | 209 | 5.72e-05 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 24 | 74 | 5.72e-05 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 320 | 2246 | 5.74e-05 |
| GO:BP | GO:0019222 | regulation of metabolic process | 638 | 4914 | 5.75e-05 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 88 | 472 | 5.99e-05 |
| GO:BP | GO:0034330 | cell junction organization | 105 | 591 | 5.99e-05 |
| GO:BP | GO:0043009 | chordate embryonic development | 96 | 529 | 6.71e-05 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 24 | 75 | 7.18e-05 |
| GO:BP | GO:0033002 | muscle cell proliferation | 39 | 157 | 7.24e-05 |
| GO:BP | GO:0009987 | cellular process | 1349 | 11450 | 7.24e-05 |
| GO:BP | GO:0014896 | muscle hypertrophy | 24 | 76 | 9.19e-05 |
| GO:BP | GO:0045165 | cell fate commitment | 39 | 159 | 9.96e-05 |
| GO:BP | GO:0072089 | stem cell proliferation | 26 | 87 | 1.09e-04 |
| GO:BP | GO:0012501 | programmed cell death | 225 | 1505 | 1.10e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 114 | 664 | 1.10e-04 |
| GO:BP | GO:2000145 | regulation of cell motility | 125 | 745 | 1.17e-04 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 358 | 2576 | 1.20e-04 |
| GO:BP | GO:0030334 | regulation of cell migration | 120 | 710 | 1.29e-04 |
| GO:BP | GO:0008219 | cell death | 225 | 1509 | 1.30e-04 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 97 | 545 | 1.31e-04 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 236 | 1597 | 1.38e-04 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 359 | 2589 | 1.39e-04 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 27 | 94 | 1.53e-04 |
| GO:BP | GO:0030029 | actin filament-based process | 115 | 677 | 1.59e-04 |
| GO:BP | GO:0065009 | regulation of molecular function | 209 | 1389 | 1.61e-04 |
| GO:BP | GO:0042692 | muscle cell differentiation | 66 | 334 | 1.61e-04 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 588 | 4521 | 1.62e-04 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 57 | 275 | 1.62e-04 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 19 | 54 | 1.63e-04 |
| GO:BP | GO:0008150 | biological_process | 1406 | 12051 | 1.63e-04 |
| GO:BP | GO:0040012 | regulation of locomotion | 127 | 766 | 1.64e-04 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 13 | 28 | 1.64e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 54 | 256 | 1.64e-04 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 587 | 4515 | 1.68e-04 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 17 | 45 | 1.69e-04 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 682 | 5340 | 1.81e-04 |
| GO:BP | GO:0002064 | epithelial cell development | 38 | 158 | 1.91e-04 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 148 | 926 | 1.98e-04 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 296 | 2088 | 2.05e-04 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 136 | 837 | 2.07e-04 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 107 | 625 | 2.22e-04 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 557 | 4269 | 2.27e-04 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 14 | 33 | 2.37e-04 |
| GO:BP | GO:0030217 | T cell differentiation | 43 | 190 | 2.37e-04 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 43 | 190 | 2.37e-04 |
| GO:BP | GO:0003007 | heart morphogenesis | 48 | 222 | 2.61e-04 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 544 | 4170 | 3.21e-04 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 45 | 205 | 3.26e-04 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 63 | 322 | 3.26e-04 |
| GO:BP | GO:0034329 | cell junction assembly | 67 | 349 | 3.26e-04 |
| GO:BP | GO:0003231 | cardiac ventricle development | 30 | 115 | 3.26e-04 |
| GO:BP | GO:0000902 | cell morphogenesis | 125 | 764 | 3.42e-04 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 20 | 62 | 3.63e-04 |
| GO:BP | GO:0055001 | muscle cell development | 39 | 169 | 3.75e-04 |
| GO:BP | GO:0009605 | response to external stimulus | 241 | 1664 | 3.95e-04 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 415 | 3089 | 4.13e-04 |
| GO:BP | GO:0003008 | system process | 182 | 1201 | 4.13e-04 |
| GO:BP | GO:0001823 | mesonephros development | 23 | 78 | 4.14e-04 |
| GO:BP | GO:0006351 | DNA-templated transcription | 366 | 2683 | 4.29e-04 |
| GO:BP | GO:0040011 | locomotion | 137 | 858 | 4.30e-04 |
| GO:BP | GO:0048645 | animal organ formation | 18 | 53 | 4.35e-04 |
| GO:BP | GO:0007010 | cytoskeleton organization | 184 | 1218 | 4.35e-04 |
| GO:BP | GO:0010468 | regulation of gene expression | 477 | 3613 | 4.36e-04 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 490 | 3724 | 4.47e-04 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 185 | 1227 | 4.55e-04 |
| GO:BP | GO:0030879 | mammary gland development | 28 | 106 | 4.65e-04 |
| GO:BP | GO:0048839 | inner ear development | 33 | 135 | 4.78e-04 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 14 | 35 | 4.78e-04 |
| GO:BP | GO:0007389 | pattern specification process | 60 | 307 | 5.01e-04 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 13 | 31 | 5.29e-04 |
| GO:BP | GO:0030030 | cell projection organization | 189 | 1262 | 5.34e-04 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 33 | 136 | 5.50e-04 |
| GO:BP | GO:0006468 | protein phosphorylation | 156 | 1008 | 5.62e-04 |
| GO:BP | GO:0061448 | connective tissue development | 46 | 217 | 6.03e-04 |
| GO:BP | GO:0016310 | phosphorylation | 182 | 1211 | 6.25e-04 |
| GO:BP | GO:0042110 | T cell activation | 62 | 323 | 6.26e-04 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 499 | 3815 | 6.57e-04 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 40 | 180 | 6.62e-04 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 502 | 3841 | 6.62e-04 |
| GO:BP | GO:0035270 | endocrine system development | 24 | 86 | 6.69e-04 |
| GO:BP | GO:0051960 | regulation of nervous system development | 67 | 358 | 6.69e-04 |
| GO:BP | GO:0071310 | cellular response to organic substance | 202 | 1370 | 6.79e-04 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 367 | 2709 | 7.08e-04 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 44 | 206 | 7.19e-04 |
| GO:BP | GO:0048732 | gland development | 62 | 325 | 7.31e-04 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 53 | 265 | 7.57e-04 |
| GO:BP | GO:0001657 | ureteric bud development | 22 | 76 | 7.70e-04 |
| GO:BP | GO:0072073 | kidney epithelium development | 29 | 115 | 7.70e-04 |
| GO:BP | GO:0010720 | positive regulation of cell development | 62 | 326 | 7.92e-04 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 24 | 87 | 7.93e-04 |
| GO:BP | GO:0031016 | pancreas development | 17 | 51 | 8.80e-04 |
| GO:BP | GO:0042221 | response to chemical | 333 | 2436 | 9.01e-04 |
| GO:BP | GO:0003176 | aortic valve development | 14 | 37 | 9.01e-04 |
| GO:BP | GO:0001501 | skeletal system development | 68 | 369 | 9.16e-04 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 22 | 77 | 9.29e-04 |
| GO:BP | GO:0072164 | mesonephric tubule development | 22 | 77 | 9.29e-04 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 248 | 1746 | 9.70e-04 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 38 | 171 | 9.78e-04 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 20 | 67 | 1.05e-03 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 24 | 89 | 1.14e-03 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 66 | 358 | 1.15e-03 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 11 | 25 | 1.25e-03 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 40 | 186 | 1.31e-03 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 267 | 1908 | 1.31e-03 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 20 | 68 | 1.31e-03 |
| GO:BP | GO:0043583 | ear development | 35 | 155 | 1.36e-03 |
| GO:BP | GO:0072006 | nephron development | 29 | 119 | 1.41e-03 |
| GO:BP | GO:0010799 | regulation of peptidyl-threonine phosphorylation | 13 | 34 | 1.45e-03 |
| GO:BP | GO:0003279 | cardiac septum development | 26 | 102 | 1.52e-03 |
| GO:BP | GO:0048588 | developmental cell growth | 41 | 194 | 1.58e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 20 | 69 | 1.60e-03 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 30 | 126 | 1.64e-03 |
| GO:BP | GO:1902742 | apoptotic process involved in development | 12 | 30 | 1.66e-03 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 19 | 64 | 1.69e-03 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 228 | 1601 | 1.70e-03 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 15 | 44 | 1.74e-03 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 15 | 44 | 1.74e-03 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 15 | 44 | 1.74e-03 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 15 | 44 | 1.74e-03 |
| GO:BP | GO:0060575 | intestinal epithelial cell differentiation | 9 | 18 | 1.75e-03 |
| GO:BP | GO:0030903 | notochord development | 9 | 18 | 1.75e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 21 | 75 | 1.76e-03 |
| GO:BP | GO:0044057 | regulation of system process | 71 | 399 | 1.76e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 27 | 109 | 1.77e-03 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 119 | 751 | 1.77e-03 |
| GO:BP | GO:0048880 | sensory system development | 53 | 275 | 1.83e-03 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 10 | 22 | 1.83e-03 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 48 | 242 | 1.91e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 22 | 81 | 1.91e-03 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 33 | 146 | 1.99e-03 |
| GO:BP | GO:0043010 | camera-type eye development | 47 | 236 | 2.03e-03 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 29 | 122 | 2.06e-03 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 29 | 122 | 2.06e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 51 | 263 | 2.06e-03 |
| GO:BP | GO:0042471 | ear morphogenesis | 21 | 76 | 2.07e-03 |
| GO:BP | GO:0010033 | response to organic substance | 256 | 1835 | 2.15e-03 |
| GO:BP | GO:0032879 | regulation of localization | 217 | 1521 | 2.18e-03 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 23 | 88 | 2.42e-03 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 74 | 425 | 2.42e-03 |
| GO:BP | GO:0003170 | heart valve development | 19 | 66 | 2.44e-03 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 72 | 411 | 2.45e-03 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 89 | 534 | 2.46e-03 |
| GO:BP | GO:0001525 | angiogenesis | 70 | 397 | 2.48e-03 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 11 | 27 | 2.49e-03 |
| GO:BP | GO:0001654 | eye development | 52 | 272 | 2.49e-03 |
| GO:BP | GO:0031099 | regeneration | 33 | 148 | 2.49e-03 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 75 | 433 | 2.50e-03 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 98 | 601 | 2.52e-03 |
| GO:BP | GO:1905314 | semi-lunar valve development | 14 | 41 | 2.68e-03 |
| GO:BP | GO:0150063 | visual system development | 52 | 273 | 2.68e-03 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 17 | 56 | 2.68e-03 |
| GO:BP | GO:0051179 | localization | 511 | 3978 | 2.75e-03 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 15 | 46 | 2.75e-03 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 257 | 1852 | 2.80e-03 |
| GO:BP | GO:0061026 | cardiac muscle tissue regeneration | 5 | 6 | 2.84e-03 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 94 | 574 | 2.90e-03 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 126 | 815 | 2.92e-03 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 71 | 407 | 2.93e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 53 | 281 | 2.93e-03 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 143 | 946 | 2.93e-03 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 403 | 3066 | 3.09e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 55 | 296 | 3.25e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 55 | 296 | 3.25e-03 |
| GO:BP | GO:0045444 | fat cell differentiation | 39 | 189 | 3.37e-03 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 15 | 47 | 3.48e-03 |
| GO:BP | GO:0048340 | paraxial mesoderm morphogenesis | 6 | 9 | 3.50e-03 |
| GO:BP | GO:0060840 | artery development | 22 | 85 | 3.64e-03 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 79 | 468 | 3.66e-03 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 73 | 425 | 3.76e-03 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 71 | 411 | 3.86e-03 |
| GO:BP | GO:0048339 | paraxial mesoderm development | 8 | 16 | 3.89e-03 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 28 | 121 | 3.93e-03 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 12 | 33 | 3.95e-03 |
| GO:BP | GO:0050863 | regulation of T cell activation | 43 | 217 | 3.95e-03 |
| GO:BP | GO:0046634 | regulation of alpha-beta T cell activation | 17 | 58 | 3.97e-03 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 17 | 58 | 3.97e-03 |
| GO:BP | GO:0061035 | regulation of cartilage development | 16 | 53 | 4.20e-03 |
| GO:BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 13 | 38 | 4.22e-03 |
| GO:BP | GO:0051641 | cellular localization | 369 | 2793 | 4.22e-03 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 13 | 38 | 4.22e-03 |
| GO:BP | GO:0045927 | positive regulation of growth | 40 | 198 | 4.22e-03 |
| GO:BP | GO:0048863 | stem cell differentiation | 40 | 198 | 4.22e-03 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 15 | 48 | 4.27e-03 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 15 | 48 | 4.27e-03 |
| GO:BP | GO:0051216 | cartilage development | 33 | 153 | 4.28e-03 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 14 | 43 | 4.28e-03 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 87 | 530 | 4.34e-03 |
| GO:BP | GO:0055123 | digestive system development | 24 | 98 | 4.36e-03 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 35 | 166 | 4.37e-03 |
| GO:BP | GO:0014032 | neural crest cell development | 19 | 70 | 4.88e-03 |
| GO:BP | GO:0007517 | muscle organ development | 52 | 281 | 5.00e-03 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 23 | 93 | 5.00e-03 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 76 | 452 | 5.12e-03 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 34 | 161 | 5.13e-03 |
| GO:BP | GO:0009214 | cyclic nucleotide catabolic process | 7 | 13 | 5.34e-03 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 273 | 2005 | 5.34e-03 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 33 | 155 | 5.35e-03 |
| GO:BP | GO:0060443 | mammary gland morphogenesis | 13 | 39 | 5.39e-03 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 14 | 44 | 5.41e-03 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 21 | 82 | 5.43e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 327 | 2453 | 5.49e-03 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 153 | 1040 | 5.55e-03 |
| GO:BP | GO:0046649 | lymphocyte activation | 79 | 476 | 5.73e-03 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 9 | 21 | 5.83e-03 |
| GO:BP | GO:0010721 | negative regulation of cell development | 39 | 195 | 5.87e-03 |
| GO:BP | GO:0043949 | regulation of cAMP-mediated signaling | 8 | 17 | 5.87e-03 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 8 | 17 | 5.87e-03 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 33 | 156 | 5.87e-03 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 183 | 1279 | 5.87e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 30 | 137 | 5.87e-03 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 73 | 433 | 5.93e-03 |
| GO:BP | GO:0052652 | cyclic purine nucleotide metabolic process | 11 | 30 | 6.07e-03 |
| GO:BP | GO:0060914 | heart formation | 11 | 30 | 6.07e-03 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 16 | 55 | 6.07e-03 |
| GO:BP | GO:0016358 | dendrite development | 39 | 196 | 6.36e-03 |
| GO:BP | GO:0001775 | cell activation | 104 | 665 | 6.38e-03 |
| GO:BP | GO:0040008 | regulation of growth | 81 | 493 | 6.41e-03 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 83 | 508 | 6.49e-03 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 24 | 101 | 6.50e-03 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 44 | 230 | 6.58e-03 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 55 | 306 | 6.59e-03 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 13 | 40 | 6.66e-03 |
| GO:BP | GO:0002066 | columnar/cuboidal epithelial cell development | 13 | 40 | 6.66e-03 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 17 | 61 | 6.71e-03 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 17 | 61 | 6.71e-03 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 50 | 272 | 7.02e-03 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 55 | 307 | 7.06e-03 |
| GO:BP | GO:0048565 | digestive tract development | 22 | 90 | 7.26e-03 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 16 | 56 | 7.26e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 30 | 139 | 7.26e-03 |
| GO:BP | GO:0042246 | tissue regeneration | 16 | 56 | 7.26e-03 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 18 | 67 | 7.26e-03 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 43 | 225 | 7.57e-03 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 406 | 3131 | 7.61e-03 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 28 | 127 | 7.72e-03 |
| GO:BP | GO:0072132 | mesenchyme morphogenesis | 15 | 51 | 7.72e-03 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 406 | 3132 | 7.76e-03 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 41 | 212 | 7.87e-03 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 126 | 839 | 7.87e-03 |
| GO:BP | GO:0009187 | cyclic nucleotide metabolic process | 11 | 31 | 7.87e-03 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 20 | 79 | 7.94e-03 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 42 | 219 | 7.94e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 56 | 316 | 7.94e-03 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 56 | 316 | 7.94e-03 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 12 | 36 | 8.18e-03 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 12 | 36 | 8.18e-03 |
| GO:BP | GO:0046635 | positive regulation of alpha-beta T cell activation | 12 | 36 | 8.18e-03 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 271 | 2006 | 8.18e-03 |
| GO:BP | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 24 | 103 | 8.18e-03 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 37 | 186 | 8.23e-03 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 7 | 14 | 8.23e-03 |
| GO:BP | GO:0001822 | kidney development | 46 | 247 | 8.32e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 18 | 68 | 8.34e-03 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 418 | 3238 | 8.34e-03 |
| GO:BP | GO:0072001 | renal system development | 47 | 254 | 8.34e-03 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 38 | 193 | 8.43e-03 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 76 | 462 | 8.48e-03 |
| GO:BP | GO:0051049 | regulation of transport | 167 | 1164 | 8.50e-03 |
| GO:BP | GO:0001701 | in utero embryonic development | 60 | 346 | 8.61e-03 |
| GO:BP | GO:0031214 | biomineral tissue development | 26 | 116 | 8.86e-03 |
| GO:BP | GO:0042063 | gliogenesis | 47 | 255 | 9.00e-03 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 83 | 515 | 9.00e-03 |
| GO:BP | GO:0010092 | specification of animal organ identity | 10 | 27 | 9.21e-03 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 10 | 27 | 9.21e-03 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 10 | 27 | 9.21e-03 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 23 | 98 | 9.21e-03 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 22 | 92 | 9.21e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 160 | 1111 | 9.24e-03 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 273 | 2028 | 9.24e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 28 | 129 | 9.24e-03 |
| GO:BP | GO:0051648 | vesicle localization | 39 | 201 | 9.31e-03 |
| GO:BP | GO:0090257 | regulation of muscle system process | 36 | 181 | 9.32e-03 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 11 | 32 | 9.91e-03 |
| GO:BP | GO:0045580 | regulation of T cell differentiation | 25 | 111 | 9.95e-03 |
| GO:BP | GO:0030048 | actin filament-based movement | 25 | 111 | 9.95e-03 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 16 | 58 | 9.95e-03 |
| GO:BP | GO:0006950 | response to stress | 355 | 2715 | 9.95e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 19 | 75 | 9.95e-03 |
| GO:BP | GO:0045582 | positive regulation of T cell differentiation | 19 | 75 | 9.95e-03 |
| GO:BP | GO:0050919 | negative chemotaxis | 13 | 42 | 9.95e-03 |
| GO:BP | GO:0048844 | artery morphogenesis | 16 | 58 | 9.95e-03 |
| GO:BP | GO:0048864 | stem cell development | 19 | 75 | 9.95e-03 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 134 | 909 | 1.02e-02 |
| GO:BP | GO:0045321 | leukocyte activation | 89 | 563 | 1.02e-02 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 21 | 87 | 1.03e-02 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 17 | 64 | 1.06e-02 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 120 | 802 | 1.11e-02 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 159 | 1109 | 1.13e-02 |
| GO:BP | GO:0001503 | ossification | 56 | 322 | 1.14e-02 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 90 | 573 | 1.16e-02 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 30 | 144 | 1.16e-02 |
| GO:BP | GO:0043954 | cellular component maintenance | 16 | 59 | 1.18e-02 |
| GO:BP | GO:0072009 | nephron epithelium development | 21 | 88 | 1.19e-02 |
| GO:BP | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 8 | 19 | 1.19e-02 |
| GO:BP | GO:0060603 | mammary gland duct morphogenesis | 10 | 28 | 1.20e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 62 | 366 | 1.20e-02 |
| GO:BP | GO:0051650 | establishment of vesicle localization | 36 | 184 | 1.21e-02 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 78 | 484 | 1.21e-02 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 78 | 484 | 1.21e-02 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 53 | 302 | 1.23e-02 |
| GO:BP | GO:0030033 | microvillus assembly | 7 | 15 | 1.23e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 42 | 225 | 1.23e-02 |
| GO:BP | GO:0048634 | regulation of muscle organ development | 7 | 15 | 1.23e-02 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 37 | 191 | 1.23e-02 |
| GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 11 | 33 | 1.24e-02 |
| GO:BP | GO:0003002 | regionalization | 49 | 274 | 1.25e-02 |
| GO:BP | GO:0060021 | roof of mouth development | 18 | 71 | 1.29e-02 |
| GO:BP | GO:0022612 | gland morphogenesis | 23 | 101 | 1.31e-02 |
| GO:BP | GO:0051249 | regulation of lymphocyte activation | 52 | 296 | 1.33e-02 |
| GO:BP | GO:0042976 | activation of Janus kinase activity | 4 | 5 | 1.37e-02 |
| GO:BP | GO:0030046 | parallel actin filament bundle assembly | 4 | 5 | 1.37e-02 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 55 | 318 | 1.38e-02 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 32 | 159 | 1.39e-02 |
| GO:BP | GO:0045542 | positive regulation of cholesterol biosynthetic process | 5 | 8 | 1.40e-02 |
| GO:BP | GO:0106120 | positive regulation of sterol biosynthetic process | 5 | 8 | 1.40e-02 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 102 | 669 | 1.41e-02 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 9 | 24 | 1.42e-02 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 49 | 276 | 1.44e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 284 | 2138 | 1.47e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 21 | 90 | 1.53e-02 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 10 | 29 | 1.55e-02 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 10 | 29 | 1.55e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 12 | 39 | 1.55e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 43 | 235 | 1.56e-02 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 33 | 167 | 1.57e-02 |
| GO:BP | GO:0010656 | negative regulation of muscle cell apoptotic process | 11 | 34 | 1.57e-02 |
| GO:BP | GO:0009267 | cellular response to starvation | 31 | 154 | 1.61e-02 |
| GO:BP | GO:0099518 | vesicle cytoskeletal trafficking | 16 | 61 | 1.61e-02 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 52 | 299 | 1.61e-02 |
| GO:BP | GO:0009725 | response to hormone | 97 | 634 | 1.63e-02 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 8 | 20 | 1.64e-02 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 8 | 20 | 1.64e-02 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 8 | 20 | 1.64e-02 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 35 | 181 | 1.64e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 162 | 1145 | 1.65e-02 |
| GO:BP | GO:0050868 | negative regulation of T cell activation | 17 | 67 | 1.67e-02 |
| GO:BP | GO:0006996 | organelle organization | 386 | 3001 | 1.68e-02 |
| GO:BP | GO:0060993 | kidney morphogenesis | 18 | 73 | 1.71e-02 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 21 | 91 | 1.71e-02 |
| GO:BP | GO:0008104 | protein localization | 282 | 2128 | 1.71e-02 |
| GO:BP | GO:0035108 | limb morphogenesis | 25 | 116 | 1.72e-02 |
| GO:BP | GO:0035107 | appendage morphogenesis | 25 | 116 | 1.72e-02 |
| GO:BP | GO:0045651 | positive regulation of macrophage differentiation | 6 | 12 | 1.78e-02 |
| GO:BP | GO:0032740 | positive regulation of interleukin-17 production | 6 | 12 | 1.78e-02 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 6 | 12 | 1.78e-02 |
| GO:BP | GO:0003222 | ventricular trabecula myocardium morphogenesis | 6 | 12 | 1.78e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 24 | 110 | 1.78e-02 |
| GO:BP | GO:0001759 | organ induction | 7 | 16 | 1.79e-02 |
| GO:BP | GO:0007267 | cell-cell signaling | 163 | 1156 | 1.79e-02 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 56 | 330 | 1.83e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 37 | 196 | 1.83e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 16 | 62 | 1.84e-02 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 9 | 25 | 1.84e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 16 | 62 | 1.84e-02 |
| GO:BP | GO:0051591 | response to cAMP | 16 | 62 | 1.84e-02 |
| GO:BP | GO:0072028 | nephron morphogenesis | 16 | 62 | 1.84e-02 |
| GO:BP | GO:0051491 | positive regulation of filopodium assembly | 9 | 25 | 1.84e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 9 | 25 | 1.84e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 42 | 231 | 1.88e-02 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 86 | 554 | 1.89e-02 |
| GO:BP | GO:0043500 | muscle adaptation | 21 | 92 | 1.90e-02 |
| GO:BP | GO:0042594 | response to starvation | 35 | 183 | 1.90e-02 |
| GO:BP | GO:0019933 | cAMP-mediated signaling | 11 | 35 | 1.90e-02 |
| GO:BP | GO:1901861 | regulation of muscle tissue development | 11 | 35 | 1.90e-02 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 29 | 143 | 1.90e-02 |
| GO:BP | GO:0031018 | endocrine pancreas development | 10 | 30 | 1.91e-02 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 36 | 190 | 1.91e-02 |
| GO:BP | GO:0030282 | bone mineralization | 20 | 86 | 1.91e-02 |
| GO:BP | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 18 | 74 | 1.91e-02 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 19 | 80 | 1.91e-02 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 41 | 225 | 2.00e-02 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 43 | 239 | 2.00e-02 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 155 | 1096 | 2.00e-02 |
| GO:BP | GO:0010001 | glial cell differentiation | 36 | 191 | 2.08e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 38 | 205 | 2.13e-02 |
| GO:BP | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 8 | 21 | 2.18e-02 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 17 | 69 | 2.18e-02 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 17 | 69 | 2.18e-02 |
| GO:BP | GO:0060561 | apoptotic process involved in morphogenesis | 8 | 21 | 2.18e-02 |
| GO:BP | GO:0035024 | negative regulation of Rho protein signal transduction | 8 | 21 | 2.18e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 64 | 392 | 2.18e-02 |
| GO:BP | GO:0001764 | neuron migration | 28 | 138 | 2.20e-02 |
| GO:BP | GO:0014009 | glial cell proliferation | 12 | 41 | 2.23e-02 |
| GO:BP | GO:0030917 | midbrain-hindbrain boundary development | 3 | 3 | 2.29e-02 |
| GO:BP | GO:2001260 | regulation of semaphorin-plexin signaling pathway | 3 | 3 | 2.29e-02 |
| GO:BP | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 3 | 3 | 2.29e-02 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 38 | 206 | 2.29e-02 |
| GO:BP | GO:0021780 | glial cell fate specification | 3 | 3 | 2.29e-02 |
| GO:BP | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway | 3 | 3 | 2.29e-02 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 9 | 26 | 2.35e-02 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 9 | 26 | 2.35e-02 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 79 | 506 | 2.35e-02 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 9 | 26 | 2.35e-02 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 11 | 36 | 2.35e-02 |
| GO:BP | GO:0001953 | negative regulation of cell-matrix adhesion | 9 | 26 | 2.35e-02 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 15 | 58 | 2.36e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 15 | 58 | 2.36e-02 |
| GO:BP | GO:0097106 | postsynaptic density organization | 10 | 31 | 2.37e-02 |
| GO:BP | GO:0044819 | mitotic G1/S transition checkpoint signaling | 10 | 31 | 2.37e-02 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 28 | 139 | 2.37e-02 |
| GO:BP | GO:0031571 | mitotic G1 DNA damage checkpoint signaling | 10 | 31 | 2.37e-02 |
| GO:BP | GO:0006198 | cAMP catabolic process | 5 | 9 | 2.38e-02 |
| GO:BP | GO:1900115 | extracellular regulation of signal transduction | 5 | 9 | 2.38e-02 |
| GO:BP | GO:0003162 | atrioventricular node development | 5 | 9 | 2.38e-02 |
| GO:BP | GO:1900116 | extracellular negative regulation of signal transduction | 5 | 9 | 2.38e-02 |
| GO:BP | GO:0007219 | Notch signaling pathway | 29 | 146 | 2.43e-02 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 17 | 70 | 2.43e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 32 | 166 | 2.43e-02 |
| GO:BP | GO:0061564 | axon development | 65 | 402 | 2.43e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 17 | 70 | 2.43e-02 |
| GO:BP | GO:0032814 | regulation of natural killer cell activation | 7 | 17 | 2.43e-02 |
| GO:BP | GO:0021542 | dentate gyrus development | 7 | 17 | 2.43e-02 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 106 | 715 | 2.43e-02 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 62 | 380 | 2.45e-02 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 121 | 833 | 2.47e-02 |
| GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 27 | 133 | 2.47e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 158 | 1128 | 2.49e-02 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 22 | 101 | 2.52e-02 |
| GO:BP | GO:0031331 | positive regulation of cellular catabolic process | 49 | 286 | 2.58e-02 |
| GO:BP | GO:0150118 | negative regulation of cell-substrate junction organization | 6 | 13 | 2.58e-02 |
| GO:BP | GO:0030575 | nuclear body organization | 6 | 13 | 2.58e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 14 | 53 | 2.58e-02 |
| GO:BP | GO:0051895 | negative regulation of focal adhesion assembly | 6 | 13 | 2.58e-02 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 29 | 147 | 2.65e-02 |
| GO:BP | GO:0002376 | immune system process | 205 | 1512 | 2.66e-02 |
| GO:BP | GO:0051250 | negative regulation of lymphocyte activation | 20 | 89 | 2.67e-02 |
| GO:BP | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 8 | 22 | 2.79e-02 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 11 | 37 | 2.79e-02 |
| GO:BP | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 8 | 22 | 2.79e-02 |
| GO:BP | GO:0050808 | synapse organization | 61 | 375 | 2.79e-02 |
| GO:BP | GO:0021988 | olfactory lobe development | 8 | 22 | 2.79e-02 |
| GO:BP | GO:0035883 | enteroendocrine cell differentiation | 8 | 22 | 2.79e-02 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 8 | 22 | 2.79e-02 |
| GO:BP | GO:0008286 | insulin receptor signaling pathway | 22 | 102 | 2.80e-02 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 26 | 128 | 2.84e-02 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 26 | 128 | 2.84e-02 |
| GO:BP | GO:0003407 | neural retina development | 13 | 48 | 2.84e-02 |
| GO:BP | GO:0001649 | osteoblast differentiation | 34 | 182 | 2.88e-02 |
| GO:BP | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 9 | 27 | 2.88e-02 |
| GO:BP | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 9 | 27 | 2.88e-02 |
| GO:BP | GO:0003415 | chondrocyte hypertrophy | 4 | 6 | 2.88e-02 |
| GO:BP | GO:0003012 | muscle system process | 56 | 339 | 2.88e-02 |
| GO:BP | GO:0003278 | apoptotic process involved in heart morphogenesis | 4 | 6 | 2.88e-02 |
| GO:BP | GO:0048341 | paraxial mesoderm formation | 4 | 6 | 2.88e-02 |
| GO:BP | GO:0036438 | maintenance of lens transparency | 4 | 6 | 2.88e-02 |
| GO:BP | GO:0072538 | T-helper 17 type immune response | 9 | 27 | 2.88e-02 |
| GO:BP | GO:0060710 | chorio-allantoic fusion | 4 | 6 | 2.88e-02 |
| GO:BP | GO:0035886 | vascular associated smooth muscle cell differentiation | 9 | 27 | 2.88e-02 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 67 | 421 | 2.92e-02 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 20 | 90 | 2.95e-02 |
| GO:BP | GO:0050866 | negative regulation of cell activation | 25 | 122 | 2.96e-02 |
| GO:BP | GO:0065008 | regulation of biological quality | 268 | 2039 | 3.03e-02 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 15 | 60 | 3.07e-02 |
| GO:BP | GO:0072088 | nephron epithelium morphogenesis | 15 | 60 | 3.07e-02 |
| GO:BP | GO:0031399 | regulation of protein modification process | 136 | 959 | 3.08e-02 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 17 | 72 | 3.12e-02 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 101 | 683 | 3.12e-02 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 37 | 204 | 3.13e-02 |
| GO:BP | GO:0007409 | axonogenesis | 59 | 363 | 3.17e-02 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 21 | 97 | 3.20e-02 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 89 | 591 | 3.27e-02 |
| GO:BP | GO:0072273 | metanephric nephron morphogenesis | 7 | 18 | 3.28e-02 |
| GO:BP | GO:0045649 | regulation of macrophage differentiation | 7 | 18 | 3.28e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 13 | 49 | 3.31e-02 |
| GO:BP | GO:0045747 | positive regulation of Notch signaling pathway | 11 | 38 | 3.33e-02 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 61 | 379 | 3.37e-02 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 24 | 117 | 3.45e-02 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 24 | 117 | 3.45e-02 |
| GO:BP | GO:0048736 | appendage development | 28 | 144 | 3.62e-02 |
| GO:BP | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 8 | 23 | 3.62e-02 |
| GO:BP | GO:0060173 | limb development | 28 | 144 | 3.62e-02 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 45 | 263 | 3.66e-02 |
| GO:BP | GO:0003171 | atrioventricular valve development | 9 | 28 | 3.66e-02 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 9 | 28 | 3.66e-02 |
| GO:BP | GO:0048713 | regulation of oligodendrocyte differentiation | 9 | 28 | 3.66e-02 |
| GO:BP | GO:0072234 | metanephric nephron tubule development | 6 | 14 | 3.71e-02 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 20 | 92 | 3.71e-02 |
| GO:BP | GO:0046579 | positive regulation of Ras protein signal transduction | 6 | 14 | 3.71e-02 |
| GO:BP | GO:0010587 | miRNA catabolic process | 6 | 14 | 3.71e-02 |
| GO:BP | GO:0070102 | interleukin-6-mediated signaling pathway | 6 | 14 | 3.71e-02 |
| GO:BP | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus | 5 | 10 | 3.78e-02 |
| GO:BP | GO:0043951 | negative regulation of cAMP-mediated signaling | 5 | 10 | 3.78e-02 |
| GO:BP | GO:0071872 | cellular response to epinephrine stimulus | 5 | 10 | 3.78e-02 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 22 | 105 | 3.78e-02 |
| GO:BP | GO:0030278 | regulation of ossification | 19 | 86 | 3.82e-02 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 33 | 179 | 3.85e-02 |
| GO:BP | GO:0050807 | regulation of synapse organization | 34 | 186 | 3.87e-02 |
| GO:BP | GO:0035019 | somatic stem cell population maintenance | 13 | 50 | 3.87e-02 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 36 | 200 | 3.87e-02 |
| GO:BP | GO:0016049 | cell growth | 65 | 412 | 3.90e-02 |
| GO:BP | GO:0048041 | focal adhesion assembly | 18 | 80 | 3.91e-02 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 70 | 450 | 3.94e-02 |
| GO:BP | GO:0019827 | stem cell population maintenance | 29 | 152 | 3.97e-02 |
| GO:BP | GO:0034331 | cell junction maintenance | 11 | 39 | 3.98e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 14 | 56 | 3.98e-02 |
| GO:BP | GO:0072080 | nephron tubule development | 17 | 74 | 3.98e-02 |
| GO:BP | GO:1902106 | negative regulation of leukocyte differentiation | 16 | 68 | 4.03e-02 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 15 | 62 | 4.03e-02 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 103 | 706 | 4.06e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 59 | 368 | 4.07e-02 |
| GO:BP | GO:0048771 | tissue remodeling | 24 | 119 | 4.12e-02 |
| GO:BP | GO:1901342 | regulation of vasculature development | 37 | 208 | 4.12e-02 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 35 | 194 | 4.13e-02 |
| GO:BP | GO:0021543 | pallium development | 28 | 146 | 4.22e-02 |
| GO:BP | GO:0034097 | response to cytokine | 92 | 621 | 4.22e-02 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 19 | 87 | 4.24e-02 |
| GO:BP | GO:0090102 | cochlea development | 10 | 34 | 4.27e-02 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 94 | 637 | 4.28e-02 |
| GO:BP | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway | 7 | 19 | 4.33e-02 |
| GO:BP | GO:0032528 | microvillus organization | 7 | 19 | 4.33e-02 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 7 | 19 | 4.33e-02 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 30 | 160 | 4.33e-02 |
| GO:BP | GO:0046058 | cAMP metabolic process | 7 | 19 | 4.33e-02 |
| GO:BP | GO:0021591 | ventricular system development | 9 | 29 | 4.46e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 13 | 51 | 4.46e-02 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 9 | 29 | 4.46e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 17 | 75 | 4.46e-02 |
| GO:BP | GO:0048145 | regulation of fibroblast proliferation | 17 | 75 | 4.46e-02 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 13 | 51 | 4.46e-02 |
| GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 9 | 29 | 4.46e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 24 | 120 | 4.47e-02 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 24 | 120 | 4.47e-02 |
| GO:BP | GO:0030316 | osteoclast differentiation | 16 | 69 | 4.51e-02 |
| GO:BP | GO:0099558 | maintenance of synapse structure | 8 | 24 | 4.51e-02 |
| GO:BP | GO:0002063 | chondrocyte development | 8 | 24 | 4.51e-02 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 14 | 57 | 4.52e-02 |
| GO:BP | GO:0061614 | miRNA transcription | 15 | 63 | 4.54e-02 |
| GO:BP | GO:0098727 | maintenance of cell number | 29 | 154 | 4.58e-02 |
| GO:BP | GO:0008544 | epidermis development | 38 | 217 | 4.62e-02 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 63 | 401 | 4.65e-02 |
| GO:BP | GO:0030858 | positive regulation of epithelial cell differentiation | 11 | 40 | 4.67e-02 |
| GO:BP | GO:0030902 | hindbrain development | 23 | 114 | 4.72e-02 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 45 | 268 | 4.80e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 39 | 225 | 4.91e-02 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 47 | 283 | 4.92e-02 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 12 | 46 | 4.98e-02 |
| GO:BP | GO:1904036 | negative regulation of epithelial cell apoptotic process | 12 | 46 | 4.98e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04390 | Hippo signaling pathway | 32 | 134 | 8.21e-03 |
| KEGG | KEGG:05200 | Pathways in cancer | 71 | 408 | 1.78e-02 |
| KEGG | KEGG:04360 | Axon guidance | 34 | 162 | 2.07e-02 |
| KEGG | KEGG:04115 | p53 signaling pathway | 18 | 66 | 2.07e-02 |
| KEGG | KEGG:05226 | Gastric cancer | 26 | 117 | 3.07e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 27 | 125 | 3.23e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 18 | 74 | 3.68e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 26 | 121 | 3.68e-02 |
| KEGG | KEGG:05224 | Breast cancer | 25 | 117 | 3.68e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 30 | 149 | 3.68e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 32 | 164 | 3.71e-02 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 16 | 64 | 4.15e-02 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 14 | 53 | 4.21e-02 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 29 | 151 | 6.15e-02 |
| KEGG | KEGG:00000 | KEGG root term | 701 | 5802 | 8.18e-02 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 9 | 30 | 8.18e-02 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 30 | 164 | 8.18e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 25 | 128 | 8.18e-02 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 7 | 20 | 8.18e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 20 | 97 | 8.23e-02 |
| KEGG | KEGG:04520 | Adherens junction | 18 | 86 | 1.00e-01 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 12 | 49 | 1.01e-01 |
| KEGG | KEGG:05218 | Melanoma | 13 | 58 | 1.34e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 16 | 77 | 1.34e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 20 | 104 | 1.34e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 21 | 110 | 1.34e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 30 | 172 | 1.34e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 14 | 65 | 1.38e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 12 | 53 | 1.45e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 7 | 25 | 1.87e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 14 | 69 | 1.95e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 25 | 145 | 1.95e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 12 | 56 | 1.95e-01 |
| KEGG | KEGG:04924 | Renin secretion | 11 | 50 | 1.99e-01 |
| KEGG | KEGG:04217 | Necroptosis | 19 | 104 | 2.03e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 12 | 57 | 2.04e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 16 | 84 | 2.06e-01 |
| KEGG | KEGG:04814 | Motor proteins | 25 | 149 | 2.18e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 20 | 113 | 2.18e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 29 | 179 | 2.21e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 6 | 22 | 2.35e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 39 | 256 | 2.35e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 18 | 102 | 2.61e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 22 | 132 | 2.76e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 15 | 82 | 2.76e-01 |
| KEGG | KEGG:04730 | Long-term depression | 9 | 42 | 2.86e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 40 | 271 | 2.99e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 11 | 56 | 3.03e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 22 | 135 | 3.05e-01 |
| KEGG | KEGG:05034 | Alcoholism | 19 | 113 | 3.05e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 14 | 78 | 3.06e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 17 | 99 | 3.06e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 12 | 64 | 3.06e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 16 | 92 | 3.06e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 7 | 31 | 3.09e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 19 | 115 | 3.16e-01 |
| KEGG | KEGG:04144 | Endocytosis | 34 | 230 | 3.28e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 16 | 94 | 3.29e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 10 | 52 | 3.30e-01 |
| KEGG | KEGG:05164 | Influenza A | 17 | 102 | 3.30e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 12 | 66 | 3.30e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 12 | 67 | 3.57e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 10 | 54 | 3.78e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 18 | 112 | 3.78e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 22 | 142 | 3.78e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 14 | 83 | 3.84e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 35 | 246 | 3.86e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 11 | 63 | 3.86e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 6 | 28 | 3.86e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 12 | 69 | 3.86e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 22 | 145 | 3.86e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 9 | 48 | 3.86e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 17 | 106 | 3.86e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 10 | 56 | 3.86e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 3 | 10 | 3.86e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 16 | 98 | 3.86e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 7 | 35 | 3.86e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 7 | 35 | 3.86e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 13 | 78 | 3.86e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 2 | 5 | 4.05e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 17 | 109 | 4.05e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 14 | 87 | 4.18e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 15 | 95 | 4.27e-01 |
| KEGG | KEGG:03260 | Virion - Human immunodeficiency virus | 1 | 1 | 4.27e-01 |
| KEGG | KEGG:04540 | Gap junction | 12 | 73 | 4.27e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 23 | 157 | 4.27e-01 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 12 | 74 | 4.50e-01 |
| KEGG | KEGG:04611 | Platelet activation | 14 | 89 | 4.50e-01 |
| KEGG | KEGG:05214 | Glioma | 11 | 67 | 4.56e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 20 | 136 | 4.56e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 18 | 121 | 4.58e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 12 | 75 | 4.58e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 25 | 176 | 4.58e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 22 | 153 | 4.64e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 3 | 12 | 4.64e-01 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 3 | 12 | 4.64e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 12 | 76 | 4.64e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 14 | 91 | 4.64e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 13 | 84 | 4.64e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 5 | 25 | 4.64e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 12 | 76 | 4.64e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 11 | 69 | 4.67e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 13 | 85 | 4.86e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 4 | 19 | 4.90e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 9 | 55 | 4.91e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 13 | 86 | 5.02e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 14 | 94 | 5.04e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 13 | 87 | 5.04e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 8 | 49 | 5.04e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 21 | 151 | 5.04e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 18 | 127 | 5.04e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 11 | 72 | 5.04e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 9 | 56 | 5.04e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 10 | 64 | 5.04e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 13 | 87 | 5.04e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 7 | 41 | 5.04e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 20 | 144 | 5.18e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 6 | 35 | 5.32e-01 |
| KEGG | KEGG:04530 | Tight junction | 19 | 138 | 5.59e-01 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 24 | 179 | 5.59e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 8 | 51 | 5.60e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 9 | 59 | 5.62e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 11 | 75 | 5.62e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 11 | 75 | 5.62e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 14 | 99 | 5.62e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 12 | 83 | 5.62e-01 |
| KEGG | KEGG:02010 | ABC transporters | 5 | 29 | 5.64e-01 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 12 | 84 | 5.79e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 14 | 100 | 5.79e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 19 | 142 | 5.92e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 9 | 61 | 5.92e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 8 | 53 | 5.92e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 11 | 77 | 5.92e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 18 | 134 | 5.92e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 12 | 86 | 6.10e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 4 | 23 | 6.10e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 22 | 170 | 6.23e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 8 | 55 | 6.23e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 9 | 63 | 6.23e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 11 | 79 | 6.23e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 8 | 55 | 6.23e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 3 | 16 | 6.23e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 7 | 49 | 6.88e-01 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 7 | 49 | 6.88e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 5 | 33 | 6.88e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 9 | 65 | 6.88e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 12 | 91 | 7.09e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 14 | 108 | 7.09e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 8 | 58 | 7.09e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 7 | 50 | 7.09e-01 |
| KEGG | KEGG:04976 | Bile secretion | 6 | 42 | 7.10e-01 |
| KEGG | KEGG:04210 | Apoptosis | 15 | 117 | 7.11e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 10 | 76 | 7.31e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 6 | 43 | 7.31e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 6 | 43 | 7.31e-01 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 14 | 110 | 7.31e-01 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 7 | 52 | 7.33e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 7 | 52 | 7.33e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 26 | 214 | 7.33e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 13 | 102 | 7.33e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 3 | 19 | 7.33e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 19 | 153 | 7.33e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 6 | 45 | 7.38e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 12 | 96 | 7.38e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 2 | 12 | 7.38e-01 |
| KEGG | KEGG:04744 | Phototransduction | 2 | 12 | 7.38e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 3 | 20 | 7.38e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 1 | 4 | 7.38e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 2 | 12 | 7.38e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 1 | 4 | 7.38e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 2 | 12 | 7.38e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 14 | 112 | 7.38e-01 |
| KEGG | KEGG:00340 | Histidine metabolism | 2 | 12 | 7.38e-01 |
| KEGG | KEGG:05144 | Malaria | 3 | 20 | 7.38e-01 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 13 | 106 | 7.55e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 15 | 123 | 7.55e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 13 | 106 | 7.55e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 3 | 21 | 7.72e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 14 | 116 | 7.78e-01 |
| KEGG | KEGG:04110 | Cell cycle | 18 | 151 | 7.78e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 12 | 99 | 7.80e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 10 | 83 | 7.92e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 3 | 22 | 7.92e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 3 | 22 | 7.92e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 1 | 5 | 7.92e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 3 | 22 | 7.92e-01 |
| KEGG | KEGG:04742 | Taste transduction | 3 | 22 | 7.92e-01 |
| KEGG | KEGG:05142 | Chagas disease | 9 | 75 | 8.05e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 9 | 75 | 8.05e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 2 | 14 | 8.08e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 2 | 14 | 8.08e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 7 | 58 | 8.10e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 8 | 67 | 8.12e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 5 | 41 | 8.25e-01 |
| KEGG | KEGG:05131 | Shigellosis | 24 | 210 | 8.26e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 12 | 104 | 8.33e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 10 | 86 | 8.33e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 11 | 97 | 8.74e-01 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 10 | 89 | 8.94e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 7 | 62 | 8.96e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 1 | 7 | 9.05e-01 |
| KEGG | KEGG:04145 | Phagosome | 11 | 99 | 9.05e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 18 | 163 | 9.06e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 3 | 26 | 9.06e-01 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 3 | 27 | 9.43e-01 |
| KEGG | KEGG:04122 | Sulfur relay system | 1 | 8 | 9.50e-01 |
| KEGG | KEGG:05219 | Bladder cancer | 4 | 37 | 9.50e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 6 | 56 | 9.50e-01 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 4 | 37 | 9.50e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 3 | 28 | 9.60e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 5 | 48 | 9.80e-01 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 2 | 19 | 9.83e-01 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 3 | 29 | 9.83e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 5 | 49 | 9.94e-01 |
| KEGG | KEGG:05162 | Measles | 10 | 97 | 9.95e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 3 | 30 | 9.97e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 2 | 20 | 9.97e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 3 | 30 | 9.97e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 8 | 79 | 9.97e-01 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 1 | 25 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 2 | 44 | 1.00e+00 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 4 | 55 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 8 | 162 | 1.00e+00 |
| KEGG | KEGG:00062 | Fatty acid elongation | 1 | 24 | 1.00e+00 |
| KEGG | KEGG:00071 | Fatty acid degradation | 1 | 32 | 1.00e+00 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 1 | 28 | 1.00e+00 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 16 | 165 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 12 | 185 | 1.00e+00 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 11 | 131 | 1.00e+00 |
| KEGG | KEGG:05140 | Leishmaniasis | 4 | 42 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 2 | 38 | 1.00e+00 |
| KEGG | KEGG:05133 | Pertussis | 3 | 45 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 38 | 384 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 16 | 218 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 23 | 255 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 29 | 303 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 25 | 416 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 17 | 225 | 1.00e+00 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 2 | 33 | 1.00e+00 |
| KEGG | KEGG:04978 | Mineral absorption | 3 | 42 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 3 | 106 | 1.00e+00 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 3 | 31 | 1.00e+00 |
| KEGG | KEGG:05145 | Toxoplasmosis | 5 | 81 | 1.00e+00 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 3 | 38 | 1.00e+00 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 1 | 15 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 32 | 314 | 1.00e+00 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 10 | 114 | 1.00e+00 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 1 | 29 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 3 | 75 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 1 | 24 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 3 | 35 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 6 | 115 | 1.00e+00 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 6 | 68 | 1.00e+00 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 3 | 50 | 1.00e+00 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 1 | 28 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 4 | 127 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 3 | 98 | 1.00e+00 |
| KEGG | KEGG:01100 | Metabolic pathways | 116 | 1149 | 1.00e+00 |
| KEGG | KEGG:05332 | Graft-versus-host disease | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 2 | 24 | 1.00e+00 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 4 | 44 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 2 | 44 | 1.00e+00 |
| KEGG | KEGG:00920 | Sulfur metabolism | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 4 | 45 | 1.00e+00 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:04146 | Peroxisome | 5 | 69 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 8 | 85 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 3 | 74 | 1.00e+00 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 7 | 71 | 1.00e+00 |
| KEGG | KEGG:03440 | Homologous recombination | 3 | 39 | 1.00e+00 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 5 | 59 | 1.00e+00 |
| KEGG | KEGG:03410 | Base excision repair | 3 | 44 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 3 | 46 | 1.00e+00 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 9 | 108 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 14 | 168 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 2 | 30 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 3 | 42 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 5 | 132 | 1.00e+00 |
| KEGG | KEGG:03030 | DNA replication | 3 | 35 | 1.00e+00 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 2 | 31 | 1.00e+00 |
| KEGG | KEGG:03022 | Basal transcription factors | 2 | 40 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 9 | 100 | 1.00e+00 |
| KEGG | KEGG:03020 | RNA polymerase | 3 | 34 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 11 | 160 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 9 | 117 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 17 | 177 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 5 | 69 | 1.00e+00 |
| KEGG | KEGG:05330 | Allograft rejection | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:00830 | Retinol metabolism | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 1 | 21 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 3 | 46 | 1.00e+00 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 2 | 46 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 1 | 39 | 1.00e+00 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 2 | 22 | 1.00e+00 |
| KEGG | KEGG:00511 | Other glycan degradation | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 2 | 25 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 15 | 195 | 1.00e+00 |
| KEGG | KEGG:00480 | Glutathione metabolism | 2 | 44 | 1.00e+00 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 7 | 99 | 1.00e+00 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 1 | 11 | 1.00e+00 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 3 | 38 | 1.00e+00 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 7 | 84 | 1.00e+00 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 3 | 39 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 2 | 51 | 1.00e+00 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 4 | 57 | 1.00e+00 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 2 | 43 | 1.00e+00 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 3 | 33 | 1.00e+00 |
| KEGG | KEGG:00650 | Butanoate metabolism | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 1 | 28 | 1.00e+00 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 5 | 64 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 3 | 40 | 1.00e+00 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 1 | 15 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 2 | 41 | 1.00e+00 |
| KEGG | KEGG:00670 | One carbon pool by folate | 1 | 18 | 1.00e+00 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 1 | 49 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 2 | 50 | 1.00e+00 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 1 | 26 | 1.00e+00 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 7 | 117 | 1.00e+00 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 798 | 4830 | 1.71e-24 |
| GO:BP | GO:0048856 | anatomical structure development | 698 | 4130 | 8.31e-23 |
| GO:BP | GO:0007275 | multicellular organism development | 594 | 3383 | 2.73e-22 |
| GO:BP | GO:0048731 | system development | 525 | 2903 | 7.08e-22 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 386 | 1951 | 8.01e-22 |
| GO:BP | GO:0032502 | developmental process | 731 | 4475 | 3.19e-20 |
| GO:BP | GO:0048869 | cellular developmental process | 525 | 2988 | 4.22e-19 |
| GO:BP | GO:0030154 | cell differentiation | 525 | 2987 | 4.22e-19 |
| GO:BP | GO:0007154 | cell communication | 694 | 4248 | 9.35e-19 |
| GO:BP | GO:0023052 | signaling | 684 | 4180 | 1.43e-18 |
| GO:BP | GO:0050896 | response to stimulus | 879 | 5732 | 1.31e-17 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 382 | 2052 | 7.59e-17 |
| GO:BP | GO:0007399 | nervous system development | 359 | 1903 | 1.39e-16 |
| GO:BP | GO:0007165 | signal transduction | 628 | 3846 | 3.80e-16 |
| GO:BP | GO:0048468 | cell development | 369 | 1999 | 1.42e-15 |
| GO:BP | GO:0051716 | cellular response to stimulus | 767 | 4933 | 1.46e-15 |
| GO:BP | GO:0022008 | neurogenesis | 264 | 1327 | 2.27e-14 |
| GO:BP | GO:0050793 | regulation of developmental process | 334 | 1801 | 3.89e-14 |
| GO:BP | GO:0034330 | cell junction organization | 144 | 591 | 3.89e-14 |
| GO:BP | GO:0030029 | actin filament-based process | 158 | 677 | 7.26e-14 |
| GO:BP | GO:0048699 | generation of neurons | 233 | 1145 | 1.24e-13 |
| GO:BP | GO:0050789 | regulation of biological process | 1136 | 8037 | 1.94e-13 |
| GO:BP | GO:0050794 | regulation of cellular process | 1089 | 7651 | 3.49e-13 |
| GO:BP | GO:0044057 | regulation of system process | 107 | 399 | 3.66e-13 |
| GO:BP | GO:0065007 | biological regulation | 1159 | 8275 | 1.45e-12 |
| GO:BP | GO:0030182 | neuron differentiation | 217 | 1080 | 5.18e-12 |
| GO:BP | GO:0048513 | animal organ development | 371 | 2130 | 8.09e-12 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 221 | 1111 | 8.09e-12 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 138 | 601 | 1.85e-11 |
| GO:BP | GO:0003008 | system process | 233 | 1201 | 2.33e-11 |
| GO:BP | GO:0009888 | tissue development | 265 | 1425 | 5.87e-11 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 181 | 876 | 6.38e-11 |
| GO:BP | GO:0010646 | regulation of cell communication | 431 | 2601 | 1.07e-10 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 643 | 4198 | 1.69e-10 |
| GO:BP | GO:0048518 | positive regulation of biological process | 690 | 4561 | 1.69e-10 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 139 | 625 | 1.69e-10 |
| GO:BP | GO:0007267 | cell-cell signaling | 221 | 1156 | 4.23e-10 |
| GO:BP | GO:0031175 | neuron projection development | 165 | 794 | 4.23e-10 |
| GO:BP | GO:0023051 | regulation of signaling | 426 | 2597 | 6.64e-10 |
| GO:BP | GO:0007010 | cytoskeleton organization | 229 | 1218 | 8.71e-10 |
| GO:BP | GO:0048666 | neuron development | 179 | 894 | 1.23e-09 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 214 | 1134 | 3.30e-09 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 148 | 710 | 4.50e-09 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 113 | 501 | 8.52e-09 |
| GO:BP | GO:0003012 | muscle system process | 85 | 339 | 8.93e-09 |
| GO:BP | GO:0000902 | cell morphogenesis | 155 | 764 | 1.19e-08 |
| GO:BP | GO:0099536 | synaptic signaling | 115 | 518 | 1.52e-08 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 334 | 1992 | 2.05e-08 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 111 | 497 | 2.11e-08 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 111 | 497 | 2.11e-08 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 224 | 1227 | 2.26e-08 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 91 | 380 | 2.26e-08 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 185 | 967 | 2.35e-08 |
| GO:BP | GO:0050808 | synapse organization | 90 | 375 | 2.44e-08 |
| GO:BP | GO:0008016 | regulation of heart contraction | 52 | 170 | 2.59e-08 |
| GO:BP | GO:0030030 | cell projection organization | 228 | 1262 | 3.82e-08 |
| GO:BP | GO:0014706 | striated muscle tissue development | 61 | 218 | 3.92e-08 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 117 | 540 | 4.14e-08 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 119 | 553 | 4.44e-08 |
| GO:BP | GO:0065008 | regulation of biological quality | 338 | 2039 | 5.03e-08 |
| GO:BP | GO:0060047 | heart contraction | 57 | 200 | 6.58e-08 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 455 | 2902 | 6.59e-08 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 189 | 1011 | 8.91e-08 |
| GO:BP | GO:0035295 | tube development | 161 | 827 | 9.25e-08 |
| GO:BP | GO:0006936 | muscle contraction | 69 | 267 | 1.06e-07 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 46 | 148 | 1.36e-07 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 82 | 342 | 1.37e-07 |
| GO:BP | GO:0009966 | regulation of signal transduction | 372 | 2307 | 1.54e-07 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 82 | 343 | 1.55e-07 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 57 | 206 | 1.95e-07 |
| GO:BP | GO:0072359 | circulatory system development | 170 | 896 | 2.03e-07 |
| GO:BP | GO:0007155 | cell adhesion | 186 | 1004 | 2.28e-07 |
| GO:BP | GO:0034329 | cell junction assembly | 82 | 349 | 3.49e-07 |
| GO:BP | GO:0016477 | cell migration | 196 | 1078 | 3.76e-07 |
| GO:BP | GO:0003015 | heart process | 57 | 210 | 3.97e-07 |
| GO:BP | GO:0008015 | blood circulation | 86 | 374 | 4.18e-07 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 127 | 626 | 4.23e-07 |
| GO:BP | GO:0003013 | circulatory system process | 98 | 446 | 4.23e-07 |
| GO:BP | GO:1903522 | regulation of blood circulation | 55 | 200 | 4.25e-07 |
| GO:BP | GO:0048870 | cell motility | 212 | 1190 | 4.35e-07 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 112 | 534 | 5.17e-07 |
| GO:BP | GO:0035239 | tube morphogenesis | 133 | 668 | 5.82e-07 |
| GO:BP | GO:0090257 | regulation of muscle system process | 51 | 181 | 6.06e-07 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 312 | 1900 | 6.06e-07 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 111 | 530 | 6.29e-07 |
| GO:BP | GO:0035556 | intracellular signal transduction | 336 | 2079 | 7.98e-07 |
| GO:BP | GO:0048589 | developmental growth | 110 | 527 | 8.77e-07 |
| GO:BP | GO:0007015 | actin filament organization | 86 | 381 | 9.19e-07 |
| GO:BP | GO:0008283 | cell population proliferation | 238 | 1386 | 1.17e-06 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 129 | 653 | 1.48e-06 |
| GO:BP | GO:0061337 | cardiac conduction | 31 | 87 | 1.48e-06 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 107 | 515 | 1.72e-06 |
| GO:BP | GO:0031032 | actomyosin structure organization | 51 | 189 | 2.62e-06 |
| GO:BP | GO:0048519 | negative regulation of biological process | 592 | 4037 | 2.77e-06 |
| GO:BP | GO:0032879 | regulation of localization | 255 | 1521 | 2.86e-06 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 238 | 1403 | 3.22e-06 |
| GO:BP | GO:0048729 | tissue morphogenesis | 100 | 478 | 3.36e-06 |
| GO:BP | GO:0016358 | dendrite development | 52 | 196 | 3.36e-06 |
| GO:BP | GO:0060284 | regulation of cell development | 120 | 605 | 3.48e-06 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 132 | 683 | 3.58e-06 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 39 | 129 | 3.83e-06 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 98 | 468 | 4.19e-06 |
| GO:BP | GO:0050877 | nervous system process | 124 | 634 | 4.54e-06 |
| GO:BP | GO:0099173 | postsynapse organization | 45 | 161 | 4.90e-06 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 200 | 1146 | 5.04e-06 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 559 | 3804 | 6.00e-06 |
| GO:BP | GO:0010720 | positive regulation of cell development | 74 | 326 | 6.45e-06 |
| GO:BP | GO:0006941 | striated muscle contraction | 43 | 153 | 7.79e-06 |
| GO:BP | GO:0051960 | regulation of nervous system development | 79 | 358 | 8.29e-06 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 127 | 662 | 9.18e-06 |
| GO:BP | GO:0021537 | telencephalon development | 53 | 208 | 9.33e-06 |
| GO:BP | GO:0061564 | axon development | 86 | 402 | 9.56e-06 |
| GO:BP | GO:0040011 | locomotion | 156 | 858 | 1.17e-05 |
| GO:BP | GO:0040007 | growth | 138 | 739 | 1.30e-05 |
| GO:BP | GO:0030900 | forebrain development | 67 | 292 | 1.61e-05 |
| GO:BP | GO:0009790 | embryo development | 156 | 864 | 1.79e-05 |
| GO:BP | GO:0060537 | muscle tissue development | 77 | 353 | 1.84e-05 |
| GO:BP | GO:0016043 | cellular component organization | 724 | 5139 | 2.48e-05 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 148 | 815 | 2.55e-05 |
| GO:BP | GO:0007423 | sensory organ development | 84 | 399 | 2.57e-05 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 139 | 756 | 2.81e-05 |
| GO:BP | GO:0061061 | muscle structure development | 109 | 559 | 2.95e-05 |
| GO:BP | GO:0007507 | heart development | 102 | 515 | 3.24e-05 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 211 | 1256 | 3.55e-05 |
| GO:BP | GO:0098609 | cell-cell adhesion | 116 | 607 | 3.58e-05 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 96 | 479 | 3.97e-05 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 57 | 242 | 4.74e-05 |
| GO:BP | GO:0030334 | regulation of cell migration | 131 | 710 | 4.80e-05 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 186 | 1088 | 5.36e-05 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 100 | 508 | 5.36e-05 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 21 | 55 | 5.70e-05 |
| GO:BP | GO:0042221 | response to chemical | 371 | 2436 | 6.26e-05 |
| GO:BP | GO:0060485 | mesenchyme development | 59 | 256 | 6.27e-05 |
| GO:BP | GO:0007417 | central nervous system development | 136 | 748 | 6.44e-05 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 69 | 316 | 6.44e-05 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 136 | 749 | 6.89e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 59 | 257 | 6.97e-05 |
| GO:BP | GO:0048880 | sensory system development | 62 | 275 | 7.16e-05 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 67 | 306 | 7.98e-05 |
| GO:BP | GO:0031644 | regulation of nervous system process | 26 | 79 | 7.98e-05 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 62 | 276 | 7.98e-05 |
| GO:BP | GO:0010721 | negative regulation of cell development | 48 | 195 | 8.38e-05 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 104 | 540 | 8.46e-05 |
| GO:BP | GO:0040012 | regulation of locomotion | 138 | 766 | 8.46e-05 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 47 | 190 | 9.08e-05 |
| GO:BP | GO:0006468 | protein phosphorylation | 173 | 1008 | 9.36e-05 |
| GO:BP | GO:0007409 | axonogenesis | 76 | 363 | 9.38e-05 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 415 | 2780 | 9.38e-05 |
| GO:BP | GO:0001654 | eye development | 61 | 272 | 9.72e-05 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 28 | 90 | 1.06e-04 |
| GO:BP | GO:0150063 | visual system development | 61 | 273 | 1.09e-04 |
| GO:BP | GO:0060322 | head development | 110 | 583 | 1.10e-04 |
| GO:BP | GO:0050807 | regulation of synapse organization | 46 | 186 | 1.12e-04 |
| GO:BP | GO:2000145 | regulation of cell motility | 134 | 745 | 1.24e-04 |
| GO:BP | GO:0042391 | regulation of membrane potential | 65 | 299 | 1.34e-04 |
| GO:BP | GO:0051049 | regulation of transport | 194 | 1164 | 1.48e-04 |
| GO:BP | GO:0030001 | metal ion transport | 105 | 554 | 1.48e-04 |
| GO:BP | GO:0006915 | apoptotic process | 235 | 1459 | 1.63e-04 |
| GO:BP | GO:0099545 | trans-synaptic signaling by trans-synaptic complex | 6 | 6 | 1.85e-04 |
| GO:BP | GO:0043010 | camera-type eye development | 54 | 236 | 1.86e-04 |
| GO:BP | GO:0016310 | phosphorylation | 200 | 1211 | 1.86e-04 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 68 | 322 | 2.20e-04 |
| GO:BP | GO:0002027 | regulation of heart rate | 26 | 84 | 2.51e-04 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 14 | 31 | 3.06e-04 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 33 | 121 | 3.13e-04 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 86 | 440 | 3.31e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 22 | 66 | 3.43e-04 |
| GO:BP | GO:0007420 | brain development | 101 | 539 | 3.58e-04 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 145 | 837 | 3.61e-04 |
| GO:BP | GO:0001568 | blood vessel development | 102 | 546 | 3.66e-04 |
| GO:BP | GO:0042592 | homeostatic process | 197 | 1204 | 3.87e-04 |
| GO:BP | GO:0042692 | muscle cell differentiation | 69 | 334 | 3.90e-04 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 369 | 2474 | 4.19e-04 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 23 | 72 | 4.59e-04 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 31 | 113 | 4.91e-04 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 208 | 1288 | 4.95e-04 |
| GO:BP | GO:0055001 | muscle cell development | 41 | 169 | 5.65e-04 |
| GO:BP | GO:0040008 | regulation of growth | 93 | 493 | 5.80e-04 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 64 | 307 | 5.80e-04 |
| GO:BP | GO:0008219 | cell death | 238 | 1509 | 5.80e-04 |
| GO:BP | GO:0045216 | cell-cell junction organization | 39 | 158 | 5.80e-04 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 95 | 506 | 5.80e-04 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 72 | 358 | 6.20e-04 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 73 | 365 | 6.58e-04 |
| GO:BP | GO:0012501 | programmed cell death | 237 | 1505 | 6.61e-04 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 88 | 462 | 6.61e-04 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 33 | 126 | 7.00e-04 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 45 | 194 | 7.02e-04 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 25 | 84 | 7.06e-04 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 219 | 1376 | 7.07e-04 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 19 | 55 | 7.08e-04 |
| GO:BP | GO:1901698 | response to nitrogen compound | 134 | 774 | 7.41e-04 |
| GO:BP | GO:0030048 | actin filament-based movement | 30 | 111 | 8.47e-04 |
| GO:BP | GO:0055002 | striated muscle cell development | 22 | 70 | 8.55e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 77 | 394 | 8.57e-04 |
| GO:BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 15 | 38 | 8.76e-04 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 40 | 167 | 8.91e-04 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 12 | 26 | 9.06e-04 |
| GO:BP | GO:0001944 | vasculature development | 104 | 573 | 9.13e-04 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 13 | 30 | 9.39e-04 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 47 | 209 | 1.01e-03 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 47 | 209 | 1.01e-03 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 376 | 2555 | 1.02e-03 |
| GO:BP | GO:0060429 | epithelium development | 142 | 836 | 1.05e-03 |
| GO:BP | GO:0070848 | response to growth factor | 104 | 576 | 1.11e-03 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 48 | 216 | 1.12e-03 |
| GO:BP | GO:0006811 | monoatomic ion transport | 132 | 769 | 1.21e-03 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 29 | 108 | 1.23e-03 |
| GO:BP | GO:0030239 | myofibril assembly | 21 | 67 | 1.28e-03 |
| GO:BP | GO:0007416 | synapse assembly | 37 | 153 | 1.35e-03 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 46 | 206 | 1.41e-03 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 78 | 407 | 1.42e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 29 | 109 | 1.45e-03 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 81 | 427 | 1.45e-03 |
| GO:BP | GO:0023056 | positive regulation of signaling | 205 | 1292 | 1.47e-03 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 100 | 554 | 1.50e-03 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 80 | 421 | 1.50e-03 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 100 | 554 | 1.50e-03 |
| GO:BP | GO:0001501 | skeletal system development | 72 | 369 | 1.50e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 24 | 83 | 1.51e-03 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 49 | 225 | 1.51e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 730 | 5340 | 1.53e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 96 | 529 | 1.70e-03 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 151 | 909 | 1.71e-03 |
| GO:BP | GO:0009605 | response to external stimulus | 255 | 1664 | 1.80e-03 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 73 | 378 | 1.81e-03 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 75 | 391 | 1.81e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 16 | 45 | 1.84e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 122 | 708 | 1.86e-03 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 20 | 64 | 1.87e-03 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 22 | 74 | 1.88e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 98 | 545 | 1.96e-03 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 123 | 716 | 1.96e-03 |
| GO:BP | GO:0006816 | calcium ion transport | 56 | 271 | 1.99e-03 |
| GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 72 | 373 | 1.99e-03 |
| GO:BP | GO:0003007 | heart morphogenesis | 48 | 222 | 2.05e-03 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 110 | 628 | 2.13e-03 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 24 | 85 | 2.13e-03 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 9 | 17 | 2.15e-03 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 9 | 17 | 2.15e-03 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 9 | 17 | 2.15e-03 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 48 | 223 | 2.24e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 22 | 75 | 2.24e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 106 | 602 | 2.26e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 86 | 467 | 2.26e-03 |
| GO:BP | GO:0048568 | embryonic organ development | 63 | 317 | 2.26e-03 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 45 | 205 | 2.26e-03 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 53 | 254 | 2.26e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 48 | 224 | 2.45e-03 |
| GO:BP | GO:0140352 | export from cell | 109 | 624 | 2.45e-03 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 139 | 833 | 2.50e-03 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 13 | 33 | 2.50e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 295 | 1974 | 2.57e-03 |
| GO:BP | GO:0010885 | regulation of cholesterol storage | 8 | 14 | 2.62e-03 |
| GO:BP | GO:0001657 | ureteric bud development | 22 | 76 | 2.65e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 57 | 281 | 2.69e-03 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 19 | 61 | 2.70e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 20 | 66 | 2.71e-03 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 25 | 92 | 2.77e-03 |
| GO:BP | GO:0051050 | positive regulation of transport | 106 | 606 | 2.79e-03 |
| GO:BP | GO:0007600 | sensory perception | 54 | 263 | 2.88e-03 |
| GO:BP | GO:0001816 | cytokine production | 88 | 485 | 2.99e-03 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 56 | 276 | 2.99e-03 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 14 | 38 | 2.99e-03 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 92 | 512 | 2.99e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 33 | 137 | 3.00e-03 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 278 | 1852 | 3.00e-03 |
| GO:BP | GO:0055123 | digestive system development | 26 | 98 | 3.01e-03 |
| GO:BP | GO:0072164 | mesonephric tubule development | 22 | 77 | 3.11e-03 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 101 | 574 | 3.11e-03 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 22 | 77 | 3.11e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 59 | 296 | 3.16e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 292 | 1959 | 3.16e-03 |
| GO:BP | GO:0060419 | heart growth | 21 | 72 | 3.16e-03 |
| GO:BP | GO:0051179 | localization | 554 | 3978 | 3.21e-03 |
| GO:BP | GO:0098900 | regulation of action potential | 15 | 43 | 3.34e-03 |
| GO:BP | GO:0045214 | sarcomere organization | 15 | 43 | 3.34e-03 |
| GO:BP | GO:0001764 | neuron migration | 33 | 138 | 3.35e-03 |
| GO:BP | GO:0001817 | regulation of cytokine production | 87 | 481 | 3.45e-03 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 28 | 110 | 3.46e-03 |
| GO:BP | GO:0001823 | mesonephros development | 22 | 78 | 3.69e-03 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 25 | 94 | 3.70e-03 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 25 | 94 | 3.70e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 33 | 139 | 3.78e-03 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 33 | 139 | 3.78e-03 |
| GO:BP | GO:0021915 | neural tube development | 33 | 139 | 3.78e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 20 | 68 | 3.86e-03 |
| GO:BP | GO:0046634 | regulation of alpha-beta T cell activation | 18 | 58 | 3.88e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 62 | 318 | 3.90e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 35 | 151 | 3.94e-03 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 13 | 35 | 4.40e-03 |
| GO:BP | GO:0019725 | cellular homeostasis | 103 | 594 | 4.40e-03 |
| GO:BP | GO:0048588 | developmental cell growth | 42 | 194 | 4.55e-03 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 73 | 392 | 4.60e-03 |
| GO:BP | GO:0048565 | digestive tract development | 24 | 90 | 4.60e-03 |
| GO:BP | GO:0030316 | osteoclast differentiation | 20 | 69 | 4.68e-03 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 17 | 54 | 4.73e-03 |
| GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 23 | 85 | 4.87e-03 |
| GO:BP | GO:0097106 | postsynaptic density organization | 12 | 31 | 4.87e-03 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 36 | 159 | 5.07e-03 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 28 | 113 | 5.24e-03 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 11 | 27 | 5.24e-03 |
| GO:BP | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 11 | 27 | 5.24e-03 |
| GO:BP | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 11 | 27 | 5.24e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 58 | 296 | 5.24e-03 |
| GO:BP | GO:0006812 | monoatomic cation transport | 111 | 653 | 5.28e-03 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 7 | 12 | 5.29e-03 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 24 | 91 | 5.30e-03 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 29 | 119 | 5.42e-03 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 90 | 509 | 5.42e-03 |
| GO:BP | GO:0086027 | AV node cell to bundle of His cell signaling | 6 | 9 | 5.69e-03 |
| GO:BP | GO:0086016 | AV node cell action potential | 6 | 9 | 5.69e-03 |
| GO:BP | GO:0065009 | regulation of molecular function | 213 | 1389 | 5.70e-03 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 198 | 1279 | 5.76e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 22 | 81 | 6.00e-03 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 165 | 1040 | 6.10e-03 |
| GO:BP | GO:0046903 | secretion | 111 | 656 | 6.12e-03 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 36 | 161 | 6.21e-03 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 178 | 1135 | 6.24e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 281 | 1900 | 6.46e-03 |
| GO:BP | GO:0045927 | positive regulation of growth | 42 | 198 | 6.62e-03 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 25 | 98 | 6.62e-03 |
| GO:BP | GO:0048736 | appendage development | 33 | 144 | 6.73e-03 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 335 | 2311 | 6.73e-03 |
| GO:BP | GO:0060173 | limb development | 33 | 144 | 6.73e-03 |
| GO:BP | GO:0003231 | cardiac ventricle development | 28 | 115 | 6.73e-03 |
| GO:BP | GO:0060603 | mammary gland duct morphogenesis | 11 | 28 | 7.11e-03 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 11 | 28 | 7.11e-03 |
| GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 31 | 133 | 7.36e-03 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 27 | 110 | 7.36e-03 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 13 | 37 | 7.37e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 97 | 563 | 7.56e-03 |
| GO:BP | GO:0035107 | appendage morphogenesis | 28 | 116 | 7.61e-03 |
| GO:BP | GO:0035108 | limb morphogenesis | 28 | 116 | 7.61e-03 |
| GO:BP | GO:0060444 | branching involved in mammary gland duct morphogenesis | 9 | 20 | 7.61e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 52 | 263 | 7.96e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 52 | 263 | 7.96e-03 |
| GO:BP | GO:0050919 | negative chemotaxis | 14 | 42 | 7.98e-03 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 30 | 128 | 8.02e-03 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 19 | 67 | 8.02e-03 |
| GO:BP | GO:0001570 | vasculogenesis | 19 | 67 | 8.02e-03 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 73 | 401 | 8.05e-03 |
| GO:BP | GO:0031667 | response to nutrient levels | 68 | 368 | 8.23e-03 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 27 | 111 | 8.24e-03 |
| GO:BP | GO:0045580 | regulation of T cell differentiation | 27 | 111 | 8.24e-03 |
| GO:BP | GO:0007616 | long-term memory | 12 | 33 | 8.35e-03 |
| GO:BP | GO:0009611 | response to wounding | 73 | 402 | 8.56e-03 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 91 | 525 | 8.96e-03 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 163 | 1036 | 9.05e-03 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 62 | 330 | 9.24e-03 |
| GO:BP | GO:1903539 | protein localization to postsynaptic membrane | 13 | 38 | 9.39e-03 |
| GO:BP | GO:0060996 | dendritic spine development | 22 | 84 | 9.40e-03 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 11 | 29 | 9.47e-03 |
| GO:BP | GO:1902106 | negative regulation of leukocyte differentiation | 19 | 68 | 9.50e-03 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 28 | 118 | 9.69e-03 |
| GO:BP | GO:0030217 | T cell differentiation | 40 | 190 | 9.77e-03 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 21 | 79 | 1.00e-02 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 31 | 136 | 1.03e-02 |
| GO:BP | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 10 | 25 | 1.03e-02 |
| GO:BP | GO:0071310 | cellular response to organic substance | 208 | 1370 | 1.03e-02 |
| GO:BP | GO:0097120 | receptor localization to synapse | 16 | 53 | 1.03e-02 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 106 | 632 | 1.03e-02 |
| GO:BP | GO:0045124 | regulation of bone resorption | 10 | 25 | 1.03e-02 |
| GO:BP | GO:0001819 | positive regulation of cytokine production | 55 | 286 | 1.03e-02 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 216 | 1430 | 1.05e-02 |
| GO:BP | GO:0010033 | response to organic substance | 270 | 1835 | 1.06e-02 |
| GO:BP | GO:0048671 | negative regulation of collateral sprouting | 6 | 10 | 1.08e-02 |
| GO:BP | GO:0071872 | cellular response to epinephrine stimulus | 6 | 10 | 1.08e-02 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 29 | 125 | 1.10e-02 |
| GO:BP | GO:0035588 | G protein-coupled purinergic receptor signaling pathway | 5 | 7 | 1.10e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 161 | 1027 | 1.10e-02 |
| GO:BP | GO:0001973 | G protein-coupled adenosine receptor signaling pathway | 5 | 7 | 1.10e-02 |
| GO:BP | GO:0060079 | excitatory postsynaptic potential | 19 | 69 | 1.10e-02 |
| GO:BP | GO:0035148 | tube formation | 30 | 131 | 1.11e-02 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 34 | 155 | 1.13e-02 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 23 | 91 | 1.14e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 177 | 1145 | 1.14e-02 |
| GO:BP | GO:0007517 | muscle organ development | 54 | 281 | 1.14e-02 |
| GO:BP | GO:0061448 | connective tissue development | 44 | 217 | 1.14e-02 |
| GO:BP | GO:0001508 | action potential | 26 | 108 | 1.14e-02 |
| GO:BP | GO:0060443 | mammary gland morphogenesis | 13 | 39 | 1.15e-02 |
| GO:BP | GO:0062237 | protein localization to postsynapse | 13 | 39 | 1.15e-02 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 172 | 1109 | 1.15e-02 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 53 | 275 | 1.17e-02 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 17 | 59 | 1.17e-02 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 38 | 180 | 1.17e-02 |
| GO:BP | GO:0043954 | cellular component maintenance | 17 | 59 | 1.17e-02 |
| GO:BP | GO:0001818 | negative regulation of cytokine production | 37 | 174 | 1.18e-02 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 178 | 1154 | 1.18e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 28 | 120 | 1.18e-02 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 50 | 256 | 1.19e-02 |
| GO:BP | GO:0008366 | axon ensheathment | 29 | 126 | 1.19e-02 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 29 | 126 | 1.19e-02 |
| GO:BP | GO:0007272 | ensheathment of neurons | 29 | 126 | 1.19e-02 |
| GO:BP | GO:0035265 | organ growth | 30 | 132 | 1.20e-02 |
| GO:BP | GO:0023057 | negative regulation of signaling | 172 | 1111 | 1.21e-02 |
| GO:BP | GO:0006813 | potassium ion transport | 32 | 144 | 1.21e-02 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 43 | 212 | 1.24e-02 |
| GO:BP | GO:0014032 | neural crest cell development | 19 | 70 | 1.26e-02 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 38 | 181 | 1.27e-02 |
| GO:BP | GO:0009987 | cellular process | 1450 | 11450 | 1.31e-02 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 41 | 200 | 1.31e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 18 | 65 | 1.32e-02 |
| GO:BP | GO:0043266 | regulation of potassium ion transport | 18 | 65 | 1.32e-02 |
| GO:BP | GO:1904407 | positive regulation of nitric oxide metabolic process | 10 | 26 | 1.32e-02 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 149 | 946 | 1.32e-02 |
| GO:BP | GO:0048679 | regulation of axon regeneration | 10 | 26 | 1.32e-02 |
| GO:BP | GO:0048668 | collateral sprouting | 10 | 26 | 1.32e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 58 | 310 | 1.34e-02 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 82 | 472 | 1.36e-02 |
| GO:BP | GO:0001843 | neural tube closure | 22 | 87 | 1.36e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 53 | 278 | 1.41e-02 |
| GO:BP | GO:0042330 | taxis | 51 | 265 | 1.41e-02 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 146 | 926 | 1.41e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 26 | 110 | 1.41e-02 |
| GO:BP | GO:0006935 | chemotaxis | 51 | 265 | 1.41e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 23 | 93 | 1.43e-02 |
| GO:BP | GO:0060420 | regulation of heart growth | 15 | 50 | 1.43e-02 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 9 | 22 | 1.43e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 28 | 122 | 1.44e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 28 | 122 | 1.44e-02 |
| GO:BP | GO:0072175 | epithelial tube formation | 28 | 122 | 1.44e-02 |
| GO:BP | GO:0060392 | negative regulation of SMAD protein signal transduction | 8 | 18 | 1.45e-02 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 21 | 82 | 1.45e-02 |
| GO:BP | GO:0030903 | notochord development | 8 | 18 | 1.45e-02 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 29 | 128 | 1.45e-02 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 51 | 266 | 1.50e-02 |
| GO:BP | GO:0060606 | tube closure | 22 | 88 | 1.54e-02 |
| GO:BP | GO:0032940 | secretion by cell | 97 | 579 | 1.56e-02 |
| GO:BP | GO:0045165 | cell fate commitment | 34 | 159 | 1.59e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 77 | 441 | 1.61e-02 |
| GO:BP | GO:0031641 | regulation of myelination | 12 | 36 | 1.66e-02 |
| GO:BP | GO:0046635 | positive regulation of alpha-beta T cell activation | 12 | 36 | 1.66e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 16 | 56 | 1.66e-02 |
| GO:BP | GO:0001775 | cell activation | 109 | 665 | 1.66e-02 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 16 | 56 | 1.66e-02 |
| GO:BP | GO:0060341 | regulation of cellular localization | 130 | 815 | 1.66e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 46 | 235 | 1.66e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 19 | 72 | 1.66e-02 |
| GO:BP | GO:0007389 | pattern specification process | 57 | 307 | 1.67e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 15 | 51 | 1.70e-02 |
| GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 15 | 51 | 1.70e-02 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 39 | 191 | 1.72e-02 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 128 | 802 | 1.75e-02 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 22 | 89 | 1.75e-02 |
| GO:BP | GO:0021670 | lateral ventricle development | 6 | 11 | 1.75e-02 |
| GO:BP | GO:0030852 | regulation of granulocyte differentiation | 6 | 11 | 1.75e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 6 | 11 | 1.75e-02 |
| GO:BP | GO:0097061 | dendritic spine organization | 18 | 67 | 1.76e-02 |
| GO:BP | GO:0042552 | myelination | 28 | 124 | 1.77e-02 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 30 | 136 | 1.78e-02 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 56 | 302 | 1.86e-02 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 236 | 1601 | 1.86e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 17 | 62 | 1.86e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 44 | 224 | 1.90e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 25 | 107 | 1.90e-02 |
| GO:BP | GO:1903707 | negative regulation of hemopoiesis | 19 | 73 | 1.90e-02 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 19 | 73 | 1.90e-02 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 19 | 73 | 1.90e-02 |
| GO:BP | GO:2000178 | negative regulation of neural precursor cell proliferation | 9 | 23 | 1.90e-02 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 25 | 107 | 1.90e-02 |
| GO:BP | GO:0099643 | signal release from synapse | 25 | 107 | 1.90e-02 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 11 | 32 | 1.90e-02 |
| GO:BP | GO:0086045 | membrane depolarization during AV node cell action potential | 4 | 5 | 1.90e-02 |
| GO:BP | GO:0010886 | positive regulation of cholesterol storage | 4 | 5 | 1.90e-02 |
| GO:BP | GO:0099562 | maintenance of postsynaptic density structure | 4 | 5 | 1.90e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 30 | 137 | 1.94e-02 |
| GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 29 | 131 | 1.94e-02 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 22 | 90 | 1.94e-02 |
| GO:BP | GO:0001841 | neural tube formation | 23 | 96 | 1.98e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 117 | 727 | 1.98e-02 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 18 | 68 | 1.98e-02 |
| GO:BP | GO:0016082 | synaptic vesicle priming | 7 | 15 | 1.98e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 44 | 225 | 1.98e-02 |
| GO:BP | GO:0010878 | cholesterol storage | 8 | 19 | 1.98e-02 |
| GO:BP | GO:0048670 | regulation of collateral sprouting | 8 | 19 | 1.98e-02 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 15 | 52 | 1.98e-02 |
| GO:BP | GO:0034616 | response to laminar fluid shear stress | 7 | 15 | 1.98e-02 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 20 | 79 | 1.98e-02 |
| GO:BP | GO:0031646 | positive regulation of nervous system process | 8 | 19 | 1.98e-02 |
| GO:BP | GO:0048169 | regulation of long-term neuronal synaptic plasticity | 8 | 19 | 1.98e-02 |
| GO:BP | GO:0032634 | interleukin-5 production | 5 | 8 | 2.02e-02 |
| GO:BP | GO:0021612 | facial nerve structural organization | 5 | 8 | 2.02e-02 |
| GO:BP | GO:0032674 | regulation of interleukin-5 production | 5 | 8 | 2.02e-02 |
| GO:BP | GO:0050714 | positive regulation of protein secretion | 24 | 102 | 2.03e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 33 | 156 | 2.03e-02 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 25 | 108 | 2.07e-02 |
| GO:BP | GO:0032535 | regulation of cellular component size | 57 | 311 | 2.07e-02 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 17 | 63 | 2.10e-02 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 186 | 1233 | 2.12e-02 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 19 | 74 | 2.12e-02 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 19 | 74 | 2.12e-02 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 71 | 406 | 2.12e-02 |
| GO:BP | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 19 | 74 | 2.12e-02 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 10 | 28 | 2.14e-02 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 10 | 28 | 2.14e-02 |
| GO:BP | GO:0014020 | primary neural tube formation | 22 | 91 | 2.14e-02 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 195 | 1301 | 2.17e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 70 | 400 | 2.21e-02 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 20 | 80 | 2.25e-02 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 73 | 421 | 2.27e-02 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 15 | 53 | 2.31e-02 |
| GO:BP | GO:0061035 | regulation of cartilage development | 15 | 53 | 2.31e-02 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 35 | 170 | 2.33e-02 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 288 | 2006 | 2.36e-02 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 45 | 234 | 2.36e-02 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 14 | 48 | 2.38e-02 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 195 | 1304 | 2.38e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 19 | 75 | 2.40e-02 |
| GO:BP | GO:0031103 | axon regeneration | 13 | 43 | 2.40e-02 |
| GO:BP | GO:0045582 | positive regulation of T cell differentiation | 19 | 75 | 2.40e-02 |
| GO:BP | GO:0048864 | stem cell development | 19 | 75 | 2.40e-02 |
| GO:BP | GO:0060348 | bone development | 33 | 158 | 2.40e-02 |
| GO:BP | GO:0051480 | regulation of cytosolic calcium ion concentration | 12 | 38 | 2.40e-02 |
| GO:BP | GO:0043500 | muscle adaptation | 22 | 92 | 2.40e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 19 | 75 | 2.40e-02 |
| GO:BP | GO:0042594 | response to starvation | 37 | 183 | 2.40e-02 |
| GO:BP | GO:0099558 | maintenance of synapse structure | 9 | 24 | 2.41e-02 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 79 | 464 | 2.42e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 39 | 196 | 2.44e-02 |
| GO:BP | GO:0051235 | maintenance of location | 49 | 261 | 2.47e-02 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 35 | 171 | 2.50e-02 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 30 | 140 | 2.50e-02 |
| GO:BP | GO:0051222 | positive regulation of protein transport | 38 | 190 | 2.51e-02 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 27 | 122 | 2.55e-02 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 16 | 59 | 2.55e-02 |
| GO:BP | GO:0023061 | signal release | 60 | 335 | 2.57e-02 |
| GO:BP | GO:0007411 | axon guidance | 37 | 184 | 2.57e-02 |
| GO:BP | GO:0097485 | neuron projection guidance | 37 | 184 | 2.57e-02 |
| GO:BP | GO:0006939 | smooth muscle contraction | 18 | 70 | 2.58e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 152 | 989 | 2.58e-02 |
| GO:BP | GO:0032409 | regulation of transporter activity | 33 | 159 | 2.59e-02 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 21 | 87 | 2.61e-02 |
| GO:BP | GO:0071871 | response to epinephrine | 6 | 12 | 2.61e-02 |
| GO:BP | GO:0098911 | regulation of ventricular cardiac muscle cell action potential | 6 | 12 | 2.61e-02 |
| GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 49 | 262 | 2.61e-02 |
| GO:BP | GO:0009306 | protein secretion | 49 | 262 | 2.61e-02 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 6 | 12 | 2.61e-02 |
| GO:BP | GO:0098792 | xenophagy | 6 | 12 | 2.61e-02 |
| GO:BP | GO:0031281 | positive regulation of cyclase activity | 8 | 20 | 2.62e-02 |
| GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 10 | 29 | 2.66e-02 |
| GO:BP | GO:0048483 | autonomic nervous system development | 10 | 29 | 2.66e-02 |
| GO:BP | GO:0070570 | regulation of neuron projection regeneration | 10 | 29 | 2.66e-02 |
| GO:BP | GO:0106027 | neuron projection organization | 19 | 76 | 2.69e-02 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 48 | 256 | 2.69e-02 |
| GO:BP | GO:0097306 | cellular response to alcohol | 19 | 76 | 2.69e-02 |
| GO:BP | GO:0014896 | muscle hypertrophy | 19 | 76 | 2.69e-02 |
| GO:BP | GO:0021782 | glial cell development | 23 | 99 | 2.70e-02 |
| GO:BP | GO:0050863 | regulation of T cell activation | 42 | 217 | 2.72e-02 |
| GO:BP | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 7 | 16 | 2.72e-02 |
| GO:BP | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane | 7 | 16 | 2.72e-02 |
| GO:BP | GO:1903540 | establishment of protein localization to postsynaptic membrane | 7 | 16 | 2.72e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 28 | 129 | 2.73e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 13 | 44 | 2.79e-02 |
| GO:BP | GO:0098815 | modulation of excitatory postsynaptic potential | 13 | 44 | 2.79e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 13 | 44 | 2.79e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 13 | 44 | 2.79e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 13 | 44 | 2.79e-02 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 13 | 44 | 2.79e-02 |
| GO:BP | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 12 | 39 | 2.82e-02 |
| GO:BP | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway | 3 | 3 | 2.85e-02 |
| GO:BP | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential | 3 | 3 | 2.85e-02 |
| GO:BP | GO:0031099 | regeneration | 31 | 148 | 2.87e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 44 | 231 | 2.90e-02 |
| GO:BP | GO:0007613 | memory | 22 | 94 | 2.95e-02 |
| GO:BP | GO:0001659 | temperature homeostasis | 29 | 136 | 2.96e-02 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 19 | 77 | 3.05e-02 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 9 | 25 | 3.06e-02 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 38 | 193 | 3.09e-02 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 40 | 206 | 3.13e-02 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 49 | 265 | 3.14e-02 |
| GO:BP | GO:0010817 | regulation of hormone levels | 60 | 339 | 3.16e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 20 | 83 | 3.17e-02 |
| GO:BP | GO:0006950 | response to stress | 378 | 2715 | 3.19e-02 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 30 | 143 | 3.21e-02 |
| GO:BP | GO:0031102 | neuron projection regeneration | 14 | 50 | 3.23e-02 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 29 | 137 | 3.27e-02 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 22 | 95 | 3.32e-02 |
| GO:BP | GO:0043149 | stress fiber assembly | 22 | 95 | 3.32e-02 |
| GO:BP | GO:0030851 | granulocyte differentiation | 10 | 30 | 3.33e-02 |
| GO:BP | GO:0032906 | transforming growth factor beta2 production | 5 | 9 | 3.34e-02 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 13 | 45 | 3.34e-02 |
| GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 5 | 9 | 3.34e-02 |
| GO:BP | GO:0008217 | regulation of blood pressure | 25 | 113 | 3.34e-02 |
| GO:BP | GO:0021604 | cranial nerve structural organization | 5 | 9 | 3.34e-02 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 112 | 706 | 3.34e-02 |
| GO:BP | GO:0003073 | regulation of systemic arterial blood pressure | 16 | 61 | 3.34e-02 |
| GO:BP | GO:0021610 | facial nerve morphogenesis | 5 | 9 | 3.34e-02 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 27 | 125 | 3.34e-02 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 32 | 156 | 3.34e-02 |
| GO:BP | GO:0021561 | facial nerve development | 5 | 9 | 3.34e-02 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 5 | 9 | 3.34e-02 |
| GO:BP | GO:0035329 | hippo signaling | 12 | 40 | 3.39e-02 |
| GO:BP | GO:0099637 | neurotransmitter receptor transport | 8 | 21 | 3.43e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 8 | 21 | 3.43e-02 |
| GO:BP | GO:0006836 | neurotransmitter transport | 30 | 144 | 3.46e-02 |
| GO:BP | GO:0001666 | response to hypoxia | 46 | 247 | 3.48e-02 |
| GO:BP | GO:0030097 | hemopoiesis | 106 | 664 | 3.48e-02 |
| GO:BP | GO:0006996 | organelle organization | 414 | 3001 | 3.50e-02 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 61 | 348 | 3.51e-02 |
| GO:BP | GO:0022607 | cellular component assembly | 347 | 2481 | 3.61e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 21 | 90 | 3.61e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 32 | 157 | 3.61e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 118 | 752 | 3.68e-02 |
| GO:BP | GO:0006810 | transport | 436 | 3176 | 3.70e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 154 | 1016 | 3.73e-02 |
| GO:BP | GO:0046639 | negative regulation of alpha-beta T cell differentiation | 7 | 17 | 3.74e-02 |
| GO:BP | GO:0098877 | neurotransmitter receptor transport to plasma membrane | 7 | 17 | 3.74e-02 |
| GO:BP | GO:0021602 | cranial nerve morphogenesis | 7 | 17 | 3.74e-02 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 288 | 2028 | 3.74e-02 |
| GO:BP | GO:0097107 | postsynaptic density assembly | 7 | 17 | 3.74e-02 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 72 | 425 | 3.74e-02 |
| GO:BP | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation | 6 | 13 | 3.80e-02 |
| GO:BP | GO:0042063 | gliogenesis | 47 | 255 | 3.80e-02 |
| GO:BP | GO:1905874 | regulation of postsynaptic density organization | 6 | 13 | 3.80e-02 |
| GO:BP | GO:0048486 | parasympathetic nervous system development | 6 | 13 | 3.80e-02 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 16 | 62 | 3.80e-02 |
| GO:BP | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell communication | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 9 | 26 | 3.80e-02 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 9 | 26 | 3.80e-02 |
| GO:BP | GO:0010616 | negative regulation of cardiac muscle adaptation | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0030853 | negative regulation of granulocyte differentiation | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0050861 | positive regulation of B cell receptor signaling pathway | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling | 4 | 6 | 3.80e-02 |
| GO:BP | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 9 | 26 | 3.80e-02 |
| GO:BP | GO:0032754 | positive regulation of interleukin-5 production | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0021636 | trigeminal nerve morphogenesis | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0021637 | trigeminal nerve structural organization | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0048790 | maintenance of presynaptic active zone structure | 4 | 6 | 3.80e-02 |
| GO:BP | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway | 4 | 6 | 3.80e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 13 | 46 | 3.83e-02 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 13 | 46 | 3.83e-02 |
| GO:BP | GO:0070661 | leukocyte proliferation | 37 | 190 | 3.84e-02 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 41 | 216 | 3.84e-02 |
| GO:BP | GO:1901655 | cellular response to ketone | 20 | 85 | 3.85e-02 |
| GO:BP | GO:0042110 | T cell activation | 57 | 323 | 3.86e-02 |
| GO:BP | GO:0051249 | regulation of lymphocyte activation | 53 | 296 | 3.89e-02 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 58 | 330 | 3.90e-02 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 21 | 91 | 3.91e-02 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 21 | 91 | 3.91e-02 |
| GO:BP | GO:0035418 | protein localization to synapse | 17 | 68 | 3.92e-02 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 47 | 256 | 3.92e-02 |
| GO:BP | GO:0030517 | negative regulation of axon extension | 12 | 41 | 3.92e-02 |
| GO:BP | GO:0034405 | response to fluid shear stress | 10 | 31 | 3.93e-02 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 10 | 31 | 3.93e-02 |
| GO:BP | GO:0010950 | positive regulation of endopeptidase activity | 23 | 103 | 3.94e-02 |
| GO:BP | GO:0046649 | lymphocyte activation | 79 | 476 | 3.96e-02 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 11 | 36 | 3.96e-02 |
| GO:BP | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 11 | 36 | 3.96e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 43 | 230 | 4.04e-02 |
| GO:BP | GO:0043434 | response to peptide hormone | 57 | 324 | 4.05e-02 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 35 | 178 | 4.05e-02 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 68 | 400 | 4.13e-02 |
| GO:BP | GO:0008150 | biological_process | 1512 | 12051 | 4.14e-02 |
| GO:BP | GO:0051216 | cartilage development | 31 | 153 | 4.22e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 14 | 52 | 4.22e-02 |
| GO:BP | GO:0061614 | miRNA transcription | 16 | 63 | 4.24e-02 |
| GO:BP | GO:0048863 | stem cell differentiation | 38 | 198 | 4.25e-02 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 65 | 380 | 4.30e-02 |
| GO:BP | GO:0048499 | synaptic vesicle membrane organization | 8 | 22 | 4.30e-02 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 8 | 22 | 4.30e-02 |
| GO:BP | GO:1990138 | neuron projection extension | 30 | 147 | 4.30e-02 |
| GO:BP | GO:0050890 | cognition | 43 | 231 | 4.30e-02 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 30 | 147 | 4.30e-02 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 33 | 166 | 4.30e-02 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 21 | 92 | 4.32e-02 |
| GO:BP | GO:0050851 | antigen receptor-mediated signaling pathway | 24 | 110 | 4.32e-02 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 22 | 98 | 4.34e-02 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 47 | 258 | 4.40e-02 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 32 | 160 | 4.42e-02 |
| GO:BP | GO:0009880 | embryonic pattern specification | 13 | 47 | 4.43e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 42 | 225 | 4.45e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 42 | 225 | 4.45e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 132 | 861 | 4.45e-02 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 40 | 212 | 4.50e-02 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 15 | 58 | 4.53e-02 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 27 | 129 | 4.57e-02 |
| GO:BP | GO:0048709 | oligodendrocyte differentiation | 18 | 75 | 4.57e-02 |
| GO:BP | GO:0002376 | immune system process | 219 | 1512 | 4.57e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 9 | 27 | 4.67e-02 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 44 | 239 | 4.68e-02 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 25 | 117 | 4.72e-02 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 24 | 111 | 4.77e-02 |
| GO:BP | GO:0033173 | calcineurin-NFAT signaling cascade | 11 | 37 | 4.77e-02 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 29 | 142 | 4.78e-02 |
| GO:BP | GO:0051641 | cellular localization | 385 | 2793 | 4.78e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 10 | 32 | 4.79e-02 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 22 | 99 | 4.80e-02 |
| GO:BP | GO:0099500 | vesicle fusion to plasma membrane | 7 | 18 | 4.82e-02 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 38 | 200 | 4.82e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 38 | 200 | 4.82e-02 |
| GO:BP | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane | 7 | 18 | 4.82e-02 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 7 | 18 | 4.82e-02 |
| GO:BP | GO:0001525 | angiogenesis | 67 | 397 | 4.95e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 24 | 72 | 8.44e-04 |
| KEGG | KEGG:04360 | Axon guidance | 39 | 162 | 3.74e-03 |
| KEGG | KEGG:04911 | Insulin secretion | 20 | 64 | 5.48e-03 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 38 | 164 | 5.78e-03 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 31 | 127 | 6.94e-03 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 23 | 84 | 6.94e-03 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 22 | 79 | 6.94e-03 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 19 | 67 | 9.20e-03 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 34 | 151 | 9.20e-03 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 36 | 164 | 9.20e-03 |
| KEGG | KEGG:04976 | Bile secretion | 14 | 42 | 9.20e-03 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 21 | 77 | 9.20e-03 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 20 | 75 | 1.37e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 30 | 134 | 1.69e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 22 | 91 | 2.34e-02 |
| KEGG | KEGG:04972 | Pancreatic secretion | 16 | 58 | 2.34e-02 |
| KEGG | KEGG:04726 | Serotonergic synapse | 17 | 63 | 2.34e-02 |
| KEGG | KEGG:04971 | Gastric acid secretion | 15 | 52 | 2.34e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 27 | 121 | 2.37e-02 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 30 | 142 | 3.15e-02 |
| KEGG | KEGG:04740 | Olfactory transduction | 9 | 25 | 3.17e-02 |
| KEGG | KEGG:04611 | Platelet activation | 21 | 89 | 3.26e-02 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 28 | 132 | 3.43e-02 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 15 | 56 | 3.43e-02 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 25 | 115 | 3.87e-02 |
| KEGG | KEGG:03430 | Mismatch repair | 8 | 22 | 4.20e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 17 | 69 | 4.20e-02 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 13 | 48 | 4.96e-02 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 9 | 28 | 5.42e-02 |
| KEGG | KEGG:04725 | Cholinergic synapse | 19 | 83 | 5.42e-02 |
| KEGG | KEGG:04924 | Renin secretion | 13 | 50 | 6.53e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 14 | 56 | 6.81e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 17 | 74 | 7.31e-02 |
| KEGG | KEGG:05226 | Gastric cancer | 24 | 117 | 7.32e-02 |
| KEGG | KEGG:04713 | Circadian entrainment | 16 | 69 | 7.58e-02 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 20 | 94 | 7.58e-02 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 32 | 170 | 7.58e-02 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 11 | 41 | 7.58e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 25 | 125 | 7.58e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 11 | 41 | 7.58e-02 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 15 | 64 | 7.58e-02 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 8 | 26 | 8.15e-02 |
| KEGG | KEGG:04730 | Long-term depression | 11 | 42 | 8.18e-02 |
| KEGG | KEGG:04742 | Taste transduction | 7 | 22 | 1.00e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 13 | 55 | 1.01e-01 |
| KEGG | KEGG:04814 | Motor proteins | 28 | 149 | 1.01e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 15 | 67 | 1.01e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 12 | 50 | 1.09e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 42 | 246 | 1.10e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 22 | 112 | 1.10e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 31 | 172 | 1.15e-01 |
| KEGG | KEGG:05218 | Melanoma | 13 | 58 | 1.37e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 20 | 102 | 1.38e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 25 | 135 | 1.39e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 12 | 53 | 1.49e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 7 | 25 | 1.57e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 20 | 104 | 1.57e-01 |
| KEGG | KEGG:04540 | Gap junction | 15 | 73 | 1.71e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 17 | 86 | 1.73e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 12 | 55 | 1.76e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 10 | 43 | 1.76e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 18 | 94 | 1.91e-01 |
| KEGG | KEGG:03410 | Base excision repair | 10 | 44 | 1.94e-01 |
| KEGG | KEGG:05142 | Chagas disease | 15 | 75 | 1.94e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 23 | 128 | 1.95e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 26 | 149 | 2.00e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 15 | 76 | 2.04e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 2.15e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 15 | 77 | 2.20e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 25 | 145 | 2.25e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 25 | 145 | 2.25e-01 |
| KEGG | KEGG:04530 | Tight junction | 24 | 138 | 2.25e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 18 | 98 | 2.32e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 19 | 106 | 2.50e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 8 | 35 | 2.50e-01 |
| KEGG | KEGG:04520 | Adherens junction | 16 | 86 | 2.50e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 61 | 408 | 2.50e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 29 | 176 | 2.53e-01 |
| KEGG | KEGG:05214 | Glioma | 13 | 67 | 2.59e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 11 | 55 | 2.62e-01 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 14 | 74 | 2.62e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 2 | 4 | 2.62e-01 |
| KEGG | KEGG:00000 | KEGG root term | 740 | 5802 | 2.62e-01 |
| KEGG | KEGG:05164 | Influenza A | 18 | 102 | 2.62e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 14 | 76 | 2.62e-01 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 10 | 49 | 2.62e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 14 | 76 | 2.62e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 17 | 95 | 2.62e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 14 | 75 | 2.62e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 40 | 256 | 2.62e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 15 | 82 | 2.62e-01 |
| KEGG | KEGG:04210 | Apoptosis | 20 | 117 | 2.62e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 20 | 116 | 2.62e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 23 | 136 | 2.62e-01 |
| KEGG | KEGG:05224 | Breast cancer | 20 | 117 | 2.62e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 19 | 108 | 2.62e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 19 | 110 | 2.62e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 7 | 31 | 2.62e-01 |
| KEGG | KEGG:00230 | Purine metabolism | 17 | 97 | 2.73e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 4 | 14 | 2.74e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 12 | 64 | 2.86e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 10 | 51 | 2.88e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 16 | 92 | 3.03e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 12 | 65 | 3.05e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 15 | 86 | 3.13e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 20 | 121 | 3.13e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 23 | 142 | 3.13e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 12 | 66 | 3.21e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 15 | 87 | 3.30e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 3 | 10 | 3.45e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 2 | 5 | 3.50e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 10 | 54 | 3.53e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 16 | 96 | 3.54e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 4 | 16 | 3.54e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 13 | 75 | 3.54e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 5 | 22 | 3.54e-01 |
| KEGG | KEGG:03260 | Virion - Human immunodeficiency virus | 1 | 1 | 3.54e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 10 | 55 | 3.58e-01 |
| KEGG | KEGG:03030 | DNA replication | 7 | 35 | 3.58e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 7 | 35 | 3.58e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 7 | 35 | 3.58e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 8 | 42 | 3.70e-01 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 9 | 49 | 3.78e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 14 | 84 | 3.80e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 10 | 56 | 3.80e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 15 | 91 | 3.80e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 18 | 113 | 3.84e-01 |
| KEGG | KEGG:05034 | Alcoholism | 18 | 113 | 3.84e-01 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 16 | 99 | 3.87e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 16 | 99 | 3.87e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 14 | 85 | 3.87e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 13 | 78 | 3.87e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 10 | 57 | 3.87e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 16 | 100 | 3.99e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 39 | 271 | 4.01e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 10 | 58 | 4.05e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 13 | 79 | 4.05e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 17 | 108 | 4.05e-01 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 3 | 12 | 4.18e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 16 | 102 | 4.29e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 9 | 53 | 4.59e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 9 | 53 | 4.59e-01 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 14 | 89 | 4.60e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 16 | 104 | 4.66e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 12 | 75 | 4.68e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 26 | 179 | 4.69e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 10 | 61 | 4.71e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 17 | 112 | 4.71e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 24 | 165 | 4.80e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4 | 20 | 4.88e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 4 | 20 | 4.88e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 22 | 151 | 4.88e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 13 | 84 | 4.88e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 11 | 69 | 4.88e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 10 | 63 | 5.14e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 22 | 153 | 5.14e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 12 | 78 | 5.14e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 3 | 14 | 5.14e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 18 | 123 | 5.15e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 8 | 49 | 5.15e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 11 | 71 | 5.16e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 7 | 42 | 5.16e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 5 | 28 | 5.19e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 16 | 109 | 5.26e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 23 | 163 | 5.40e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 3 | 15 | 5.54e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 4 | 22 | 5.59e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 14 | 97 | 5.93e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 5 | 30 | 5.99e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 20 | 144 | 6.06e-01 |
| KEGG | KEGG:05133 | Pertussis | 7 | 45 | 6.06e-01 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 15 | 106 | 6.11e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 12 | 83 | 6.11e-01 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 6.20e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 4 | 24 | 6.44e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 6 | 39 | 6.48e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 2 | 10 | 6.50e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 2 | 10 | 6.50e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 9 | 62 | 6.50e-01 |
| KEGG | KEGG:05131 | Shigellosis | 28 | 210 | 6.50e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 8 | 56 | 6.88e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 5 | 33 | 6.88e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 8 | 56 | 6.88e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 12 | 87 | 6.88e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 9 | 64 | 6.92e-01 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 2 | 11 | 7.08e-01 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 4 | 26 | 7.08e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 1 | 4 | 7.12e-01 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1 | 4 | 7.12e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 9 | 65 | 7.12e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 3 | 19 | 7.23e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 3 | 19 | 7.23e-01 |
| KEGG | KEGG:04115 | p53 signaling pathway | 9 | 66 | 7.26e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 15 | 114 | 7.33e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 8 | 59 | 7.36e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 2 | 12 | 7.36e-01 |
| KEGG | KEGG:04744 | Phototransduction | 2 | 12 | 7.36e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 2 | 12 | 7.36e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 2 | 12 | 7.36e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 11 | 83 | 7.36e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 11 | 84 | 7.53e-01 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 6 | 44 | 7.53e-01 |
| KEGG | KEGG:04144 | Endocytosis | 29 | 230 | 7.66e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 3 | 21 | 7.76e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 11 | 86 | 7.76e-01 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 2 | 13 | 7.76e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 1 | 5 | 7.76e-01 |
| KEGG | KEGG:05219 | Bladder cancer | 5 | 37 | 7.76e-01 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 5 | 37 | 7.76e-01 |
| KEGG | KEGG:04110 | Cell cycle | 19 | 151 | 7.76e-01 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 6 | 46 | 7.92e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 3 | 22 | 8.07e-01 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 3 | 22 | 8.07e-01 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 1 | 6 | 8.23e-01 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 1 | 6 | 8.23e-01 |
| KEGG | KEGG:05162 | Measles | 12 | 97 | 8.23e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 4 | 31 | 8.23e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 13 | 106 | 8.23e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 5 | 39 | 8.23e-01 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 4 | 31 | 8.23e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 6 | 49 | 8.45e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 19 | 157 | 8.45e-01 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 2 | 15 | 8.45e-01 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 14 | 117 | 8.64e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 2 | 16 | 8.76e-01 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 20 | 168 | 8.76e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 7 | 59 | 8.76e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 2 | 16 | 8.76e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 18 | 153 | 8.89e-01 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 8 | 69 | 8.92e-01 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 21 | 179 | 8.92e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 5 | 43 | 8.92e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 10 | 87 | 9.07e-01 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 5 | 44 | 9.11e-01 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 1 | 8 | 9.17e-01 |
| KEGG | KEGG:00790 | Folate biosynthesis | 2 | 18 | 9.38e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 3 | 28 | 9.56e-01 |
| KEGG | KEGG:04145 | Phagosome | 11 | 99 | 9.56e-01 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 1 | 9 | 9.62e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 2 | 19 | 9.63e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 4 | 38 | 9.67e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 3 | 30 | 9.78e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 2 | 20 | 9.78e-01 |
| KEGG | KEGG:05332 | Graft-versus-host disease | 1 | 10 | 9.78e-01 |
| KEGG | KEGG:05330 | Allograft rejection | 1 | 10 | 9.78e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 3 | 30 | 9.78e-01 |
| KEGG | KEGG:05144 | Malaria | 2 | 20 | 9.78e-01 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 6 | 57 | 9.78e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 5 | 49 | 9.80e-01 |
| KEGG | KEGG:03022 | Basal transcription factors | 4 | 40 | 9.81e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 7 | 68 | 9.81e-01 |
| KEGG | KEGG:04217 | Necroptosis | 11 | 104 | 9.81e-01 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 3 | 31 | 9.86e-01 |
| KEGG | KEGG:05010 | Alzheimer disease | 35 | 314 | 9.87e-01 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 6 | 60 | 9.90e-01 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 1 | 11 | 9.90e-01 |
| KEGG | KEGG:04510 | Focal adhesion | 19 | 177 | 9.91e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 10 | 99 | 9.93e-01 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 3 | 33 | 9.93e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 5 | 52 | 9.93e-01 |
| KEGG | KEGG:05145 | Toxoplasmosis | 8 | 81 | 9.93e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 2 | 23 | 9.93e-01 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 9.93e-01 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 5 | 52 | 9.93e-01 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 1 | 12 | 9.93e-01 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 4 | 49 | 1.00e+00 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 10 | 110 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 3 | 40 | 1.00e+00 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 2 | 25 | 1.00e+00 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 2 | 27 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 17 | 195 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 3 | 50 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 21 | 225 | 1.00e+00 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 13 | 131 | 1.00e+00 |
| KEGG | KEGG:00062 | Fatty acid elongation | 2 | 24 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 25 | 303 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 24 | 255 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 18 | 218 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 41 | 384 | 1.00e+00 |
| KEGG | KEGG:05132 | Salmonella infection | 20 | 214 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 1 | 38 | 1.00e+00 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 1 | 18 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 23 | 416 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 12 | 162 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 13 | 185 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 4 | 46 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 1 | 30 | 1.00e+00 |
| KEGG | KEGG:00071 | Fatty acid degradation | 1 | 32 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 2 | 42 | 1.00e+00 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 1 | 19 | 1.00e+00 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 6 | 99 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 3 | 127 | 1.00e+00 |
| KEGG | KEGG:04146 | Peroxisome | 5 | 69 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 3 | 39 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 2 | 46 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 2 | 75 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 6 | 117 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 2 | 24 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 2 | 35 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 12 | 160 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 2 | 25 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 11 | 115 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 9 | 100 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 4 | 51 | 1.00e+00 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 3 | 50 | 1.00e+00 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 4 | 45 | 1.00e+00 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 1 | 13 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 9 | 98 | 1.00e+00 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 12 | 134 | 1.00e+00 |
| KEGG | KEGG:01100 | Metabolic pathways | 119 | 1149 | 1.00e+00 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 2 | 44 | 1.00e+00 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 1 | 21 | 1.00e+00 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 1 | 22 | 1.00e+00 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 2 | 29 | 1.00e+00 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 1 | 33 | 1.00e+00 |
| KEGG | KEGG:00650 | Butanoate metabolism | 1 | 17 | 1.00e+00 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 1 | 28 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 7 | 85 | 1.00e+00 |
| KEGG | KEGG:02010 | ABC transporters | 2 | 29 | 1.00e+00 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 2 | 25 | 1.00e+00 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 4 | 48 | 1.00e+00 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 3 | 43 | 1.00e+00 |
| KEGG | KEGG:03020 | RNA polymerase | 1 | 34 | 1.00e+00 |
| KEGG | KEGG:00480 | Glutathione metabolism | 2 | 44 | 1.00e+00 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 3 | 38 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 5 | 132 | 1.00e+00 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 1 | 45 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 3 | 106 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 5 | 74 | 1.00e+00 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 2 | 29 | 1.00e+00 |
LR hyper/hypo
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0051716 | cellular response to stimulus | 1370 | 4933 | 1.40e-24 |
| GO:BP | GO:0007154 | cell communication | 1205 | 4248 | 2.65e-24 |
| GO:BP | GO:0050896 | response to stimulus | 1544 | 5732 | 5.64e-23 |
| GO:BP | GO:0023052 | signaling | 1181 | 4180 | 5.64e-23 |
| GO:BP | GO:0007165 | signal transduction | 1098 | 3846 | 1.44e-22 |
| GO:BP | GO:0032501 | multicellular organismal process | 1323 | 4830 | 6.55e-21 |
| GO:BP | GO:0007275 | multicellular organism development | 967 | 3383 | 5.21e-19 |
| GO:BP | GO:0032502 | developmental process | 1227 | 4475 | 9.49e-19 |
| GO:BP | GO:0048856 | anatomical structure development | 1142 | 4130 | 3.21e-18 |
| GO:BP | GO:0050794 | regulation of cellular process | 1942 | 7651 | 1.33e-17 |
| GO:BP | GO:0030154 | cell differentiation | 860 | 2987 | 2.89e-17 |
| GO:BP | GO:0048869 | cellular developmental process | 860 | 2988 | 2.96e-17 |
| GO:BP | GO:0010646 | regulation of cell communication | 763 | 2601 | 4.67e-17 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1234 | 4561 | 1.09e-16 |
| GO:BP | GO:0050789 | regulation of biological process | 2019 | 8037 | 1.55e-16 |
| GO:BP | GO:0048731 | system development | 833 | 2903 | 3.17e-16 |
| GO:BP | GO:0023051 | regulation of signaling | 757 | 2597 | 3.45e-16 |
| GO:BP | GO:0009966 | regulation of signal transduction | 684 | 2307 | 4.03e-16 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 829 | 2902 | 1.33e-15 |
| GO:BP | GO:0065007 | biological regulation | 2064 | 8275 | 1.49e-15 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 590 | 1951 | 2.09e-15 |
| GO:BP | GO:0048513 | animal organ development | 635 | 2130 | 2.50e-15 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1137 | 4198 | 5.21e-15 |
| GO:BP | GO:0035556 | intracellular signal transduction | 620 | 2079 | 6.07e-15 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1042 | 3804 | 8.16e-15 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 611 | 2052 | 1.53e-14 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 571 | 1900 | 2.83e-14 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1093 | 4037 | 3.79e-14 |
| GO:BP | GO:0009888 | tissue development | 445 | 1425 | 1.48e-13 |
| GO:BP | GO:0048468 | cell development | 587 | 1999 | 1.55e-12 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 434 | 1403 | 1.99e-12 |
| GO:BP | GO:0072359 | circulatory system development | 299 | 896 | 2.14e-12 |
| GO:BP | GO:0050793 | regulation of developmental process | 536 | 1801 | 2.14e-12 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 314 | 967 | 2.36e-11 |
| GO:BP | GO:0048589 | developmental growth | 191 | 527 | 5.47e-11 |
| GO:BP | GO:0022008 | neurogenesis | 406 | 1327 | 9.63e-11 |
| GO:BP | GO:0007399 | nervous system development | 551 | 1903 | 1.89e-10 |
| GO:BP | GO:0048699 | generation of neurons | 357 | 1145 | 1.95e-10 |
| GO:BP | GO:0008283 | cell population proliferation | 418 | 1386 | 4.01e-10 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 346 | 1111 | 5.23e-10 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 414 | 1376 | 7.30e-10 |
| GO:BP | GO:0007507 | heart development | 180 | 515 | 8.28e-09 |
| GO:BP | GO:0030900 | forebrain development | 115 | 292 | 9.63e-09 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 244 | 749 | 9.63e-09 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 278 | 876 | 9.63e-09 |
| GO:BP | GO:0003008 | system process | 361 | 1201 | 2.35e-08 |
| GO:BP | GO:0030182 | neuron differentiation | 328 | 1080 | 5.05e-08 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 345 | 1146 | 5.08e-08 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 230 | 710 | 6.00e-08 |
| GO:BP | GO:0007267 | cell-cell signaling | 347 | 1156 | 6.29e-08 |
| GO:BP | GO:0014706 | striated muscle tissue development | 90 | 218 | 6.44e-08 |
| GO:BP | GO:0060537 | muscle tissue development | 130 | 353 | 8.95e-08 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 206 | 626 | 1.13e-07 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 339 | 1134 | 1.62e-07 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 378 | 1288 | 1.85e-07 |
| GO:BP | GO:0016477 | cell migration | 324 | 1078 | 2.02e-07 |
| GO:BP | GO:0035239 | tube morphogenesis | 216 | 668 | 2.22e-07 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 326 | 1088 | 2.47e-07 |
| GO:BP | GO:0001944 | vasculature development | 190 | 573 | 2.47e-07 |
| GO:BP | GO:0035295 | tube development | 258 | 827 | 2.50e-07 |
| GO:BP | GO:0023056 | positive regulation of signaling | 378 | 1292 | 2.52e-07 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 361 | 1227 | 3.01e-07 |
| GO:BP | GO:0009790 | embryo development | 267 | 864 | 3.38e-07 |
| GO:BP | GO:0007417 | central nervous system development | 236 | 748 | 4.06e-07 |
| GO:BP | GO:0030030 | cell projection organization | 369 | 1262 | 4.09e-07 |
| GO:BP | GO:0030029 | actin filament-based process | 217 | 677 | 4.09e-07 |
| GO:BP | GO:0060429 | epithelium development | 259 | 836 | 4.35e-07 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 516 | 1852 | 4.59e-07 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 367 | 1256 | 4.73e-07 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 341 | 1154 | 4.73e-07 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 741 | 2780 | 4.81e-07 |
| GO:BP | GO:0040007 | growth | 233 | 739 | 4.92e-07 |
| GO:BP | GO:0001568 | blood vessel development | 181 | 546 | 5.00e-07 |
| GO:BP | GO:0042221 | response to chemical | 658 | 2436 | 5.00e-07 |
| GO:BP | GO:0060322 | head development | 191 | 583 | 5.14e-07 |
| GO:BP | GO:0021537 | telencephalon development | 84 | 208 | 5.91e-07 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 237 | 756 | 5.91e-07 |
| GO:BP | GO:0048870 | cell motility | 349 | 1190 | 6.88e-07 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 160 | 472 | 6.88e-07 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 169 | 506 | 8.48e-07 |
| GO:BP | GO:0044057 | regulation of system process | 139 | 399 | 9.98e-07 |
| GO:BP | GO:0003013 | circulatory system process | 152 | 446 | 1.07e-06 |
| GO:BP | GO:0007010 | cytoskeleton organization | 354 | 1218 | 1.50e-06 |
| GO:BP | GO:0032879 | regulation of localization | 430 | 1521 | 1.51e-06 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 82 | 206 | 1.76e-06 |
| GO:BP | GO:0040011 | locomotion | 261 | 858 | 1.94e-06 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 449 | 1601 | 1.99e-06 |
| GO:BP | GO:0030334 | regulation of cell migration | 222 | 710 | 2.09e-06 |
| GO:BP | GO:0031175 | neuron projection development | 244 | 794 | 2.16e-06 |
| GO:BP | GO:0048666 | neuron development | 270 | 894 | 2.17e-06 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 254 | 833 | 2.20e-06 |
| GO:BP | GO:2000145 | regulation of cell motility | 231 | 745 | 2.20e-06 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 300 | 1011 | 2.20e-06 |
| GO:BP | GO:0060419 | heart growth | 38 | 72 | 2.20e-06 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 155 | 462 | 2.20e-06 |
| GO:BP | GO:0007420 | brain development | 176 | 539 | 2.20e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 661 | 2474 | 2.40e-06 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 176 | 540 | 2.50e-06 |
| GO:BP | GO:0040012 | regulation of locomotion | 236 | 766 | 2.65e-06 |
| GO:BP | GO:0008150 | biological_process | 2791 | 12051 | 2.87e-06 |
| GO:BP | GO:0008015 | blood circulation | 130 | 374 | 2.87e-06 |
| GO:BP | GO:0033002 | muscle cell proliferation | 66 | 157 | 3.15e-06 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 560 | 2061 | 3.15e-06 |
| GO:BP | GO:0001503 | ossification | 115 | 322 | 3.32e-06 |
| GO:BP | GO:0034330 | cell junction organization | 189 | 591 | 3.46e-06 |
| GO:BP | GO:0016310 | phosphorylation | 349 | 1211 | 4.09e-06 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 178 | 553 | 5.17e-06 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 207 | 662 | 5.28e-06 |
| GO:BP | GO:1901653 | cellular response to peptide | 103 | 284 | 6.80e-06 |
| GO:BP | GO:0006468 | protein phosphorylation | 296 | 1008 | 7.15e-06 |
| GO:BP | GO:0048638 | regulation of developmental growth | 95 | 257 | 7.59e-06 |
| GO:BP | GO:0071310 | cellular response to organic substance | 387 | 1370 | 7.67e-06 |
| GO:BP | GO:0009987 | cellular process | 2665 | 11450 | 8.48e-06 |
| GO:BP | GO:1901652 | response to peptide | 130 | 381 | 8.58e-06 |
| GO:BP | GO:0007423 | sensory organ development | 135 | 399 | 8.58e-06 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 479 | 1744 | 8.59e-06 |
| GO:BP | GO:0007155 | cell adhesion | 294 | 1004 | 9.80e-06 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 32 | 59 | 9.80e-06 |
| GO:BP | GO:0003012 | muscle system process | 118 | 339 | 9.80e-06 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 303 | 1040 | 1.03e-05 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 466 | 1694 | 1.04e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 674 | 2555 | 1.17e-05 |
| GO:BP | GO:0009605 | response to external stimulus | 458 | 1664 | 1.25e-05 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 162 | 501 | 1.29e-05 |
| GO:BP | GO:1901698 | response to nitrogen compound | 234 | 774 | 1.35e-05 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 148 | 450 | 1.40e-05 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 326 | 1135 | 1.45e-05 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 474 | 1732 | 1.49e-05 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 145 | 440 | 1.59e-05 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 560 | 2088 | 1.77e-05 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 540 | 2006 | 1.81e-05 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 598 | 2246 | 1.81e-05 |
| GO:BP | GO:0035265 | organ growth | 56 | 132 | 1.83e-05 |
| GO:BP | GO:0023057 | negative regulation of signaling | 319 | 1111 | 1.96e-05 |
| GO:BP | GO:0010033 | response to organic substance | 498 | 1835 | 2.02e-05 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 536 | 1992 | 2.10e-05 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 318 | 1109 | 2.30e-05 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 327 | 1145 | 2.34e-05 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 544 | 2028 | 2.52e-05 |
| GO:BP | GO:0045165 | cell fate commitment | 64 | 159 | 2.52e-05 |
| GO:BP | GO:0099536 | synaptic signaling | 165 | 518 | 2.58e-05 |
| GO:BP | GO:0048568 | embryonic organ development | 110 | 317 | 2.61e-05 |
| GO:BP | GO:0048729 | tissue morphogenesis | 154 | 478 | 2.92e-05 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 159 | 497 | 3.05e-05 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 159 | 497 | 3.05e-05 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 530 | 1974 | 3.15e-05 |
| GO:BP | GO:0051179 | localization | 1004 | 3978 | 3.46e-05 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 359 | 1279 | 3.70e-05 |
| GO:BP | GO:0001764 | neuron migration | 57 | 138 | 3.75e-05 |
| GO:BP | GO:0061061 | muscle structure development | 175 | 559 | 3.82e-05 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 33 | 65 | 3.82e-05 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 92 | 256 | 3.86e-05 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 99 | 281 | 4.18e-05 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 48 | 110 | 4.18e-05 |
| GO:BP | GO:0045444 | fat cell differentiation | 72 | 189 | 5.38e-05 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 126 | 380 | 5.76e-05 |
| GO:BP | GO:0006950 | response to stress | 705 | 2715 | 5.82e-05 |
| GO:BP | GO:0002376 | immune system process | 415 | 1512 | 5.85e-05 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 97 | 276 | 5.91e-05 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 185 | 601 | 6.02e-05 |
| GO:BP | GO:0002682 | regulation of immune system process | 271 | 936 | 6.73e-05 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 212 | 706 | 7.00e-05 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 363 | 1304 | 7.05e-05 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 523 | 1959 | 7.29e-05 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 149 | 467 | 7.37e-05 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 362 | 1301 | 7.49e-05 |
| GO:BP | GO:0006915 | apoptotic process | 401 | 1459 | 7.49e-05 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 345 | 1233 | 7.76e-05 |
| GO:BP | GO:0003205 | cardiac chamber development | 60 | 151 | 8.01e-05 |
| GO:BP | GO:0002521 | leukocyte differentiation | 129 | 394 | 8.39e-05 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 214 | 716 | 8.51e-05 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 508 | 1900 | 8.53e-05 |
| GO:BP | GO:0035108 | limb morphogenesis | 49 | 116 | 9.03e-05 |
| GO:BP | GO:0035107 | appendage morphogenesis | 49 | 116 | 9.03e-05 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 128 | 391 | 9.03e-05 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 393 | 1430 | 9.33e-05 |
| GO:BP | GO:0065008 | regulation of biological quality | 541 | 2039 | 9.66e-05 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 107 | 316 | 1.13e-04 |
| GO:BP | GO:0001775 | cell activation | 200 | 665 | 1.15e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 166 | 535 | 1.15e-04 |
| GO:BP | GO:0042592 | homeostatic process | 336 | 1204 | 1.30e-04 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 68 | 180 | 1.30e-04 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 124 | 379 | 1.30e-04 |
| GO:BP | GO:0043009 | chordate embryonic development | 164 | 529 | 1.36e-04 |
| GO:BP | GO:0008219 | cell death | 411 | 1509 | 1.36e-04 |
| GO:BP | GO:0012501 | programmed cell death | 410 | 1505 | 1.36e-04 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 124 | 380 | 1.47e-04 |
| GO:BP | GO:0043010 | camera-type eye development | 84 | 236 | 1.49e-04 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 20 | 33 | 1.50e-04 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 604 | 2311 | 1.61e-04 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 158 | 508 | 1.64e-04 |
| GO:BP | GO:0046620 | regulation of organ growth | 34 | 72 | 1.70e-04 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 221 | 751 | 1.72e-04 |
| GO:BP | GO:0031099 | regeneration | 58 | 148 | 1.75e-04 |
| GO:BP | GO:0002683 | negative regulation of immune system process | 105 | 312 | 1.76e-04 |
| GO:BP | GO:0034329 | cell junction assembly | 115 | 349 | 1.92e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 108 | 324 | 2.08e-04 |
| GO:BP | GO:0045017 | glycerolipid biosynthetic process | 78 | 217 | 2.08e-04 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 69 | 186 | 2.12e-04 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 51 | 126 | 2.19e-04 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 51 | 126 | 2.19e-04 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 167 | 545 | 2.19e-04 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 290 | 1027 | 2.21e-04 |
| GO:BP | GO:0070848 | response to growth factor | 175 | 576 | 2.27e-04 |
| GO:BP | GO:0006955 | immune response | 266 | 932 | 2.31e-04 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 292 | 1036 | 2.37e-04 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 84 | 239 | 2.40e-04 |
| GO:BP | GO:0060420 | regulation of heart growth | 26 | 50 | 2.46e-04 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 169 | 554 | 2.49e-04 |
| GO:BP | GO:0048880 | sensory system development | 94 | 275 | 2.54e-04 |
| GO:BP | GO:0001654 | eye development | 93 | 272 | 2.80e-04 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 149 | 479 | 2.80e-04 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 28 | 56 | 2.82e-04 |
| GO:BP | GO:0042246 | tissue regeneration | 28 | 56 | 2.82e-04 |
| GO:BP | GO:0045321 | leukocyte activation | 171 | 563 | 2.83e-04 |
| GO:BP | GO:0090257 | regulation of muscle system process | 67 | 181 | 2.91e-04 |
| GO:BP | GO:0030282 | bone mineralization | 38 | 86 | 2.99e-04 |
| GO:BP | GO:0150063 | visual system development | 93 | 273 | 3.21e-04 |
| GO:BP | GO:0046474 | glycerophospholipid biosynthetic process | 68 | 186 | 4.00e-04 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 1116 | 4521 | 4.00e-04 |
| GO:BP | GO:0007015 | actin filament organization | 122 | 381 | 4.19e-04 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 464 | 1746 | 4.22e-04 |
| GO:BP | GO:0001823 | mesonephros development | 35 | 78 | 4.42e-04 |
| GO:BP | GO:0016043 | cellular component organization | 1257 | 5139 | 4.44e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 31 | 66 | 4.49e-04 |
| GO:BP | GO:0001659 | temperature homeostasis | 53 | 136 | 4.75e-04 |
| GO:BP | GO:0003007 | heart morphogenesis | 78 | 222 | 4.75e-04 |
| GO:BP | GO:0072001 | renal system development | 87 | 254 | 4.75e-04 |
| GO:BP | GO:0042100 | B cell proliferation | 24 | 46 | 4.80e-04 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 63 | 170 | 4.89e-04 |
| GO:BP | GO:0008016 | regulation of heart contraction | 63 | 170 | 4.89e-04 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 21 | 38 | 5.25e-04 |
| GO:BP | GO:0051049 | regulation of transport | 321 | 1164 | 5.25e-04 |
| GO:BP | GO:0001501 | skeletal system development | 118 | 369 | 5.92e-04 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 239 | 837 | 6.05e-04 |
| GO:BP | GO:0001657 | ureteric bud development | 34 | 76 | 6.05e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 195 | 664 | 6.18e-04 |
| GO:BP | GO:0001649 | osteoblast differentiation | 66 | 182 | 6.74e-04 |
| GO:BP | GO:0003015 | heart process | 74 | 210 | 6.74e-04 |
| GO:BP | GO:0051641 | cellular localization | 711 | 2793 | 6.98e-04 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 239 | 839 | 7.10e-04 |
| GO:BP | GO:0030278 | regulation of ossification | 37 | 86 | 7.41e-04 |
| GO:BP | GO:0003279 | cardiac septum development | 42 | 102 | 7.59e-04 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 34 | 77 | 8.19e-04 |
| GO:BP | GO:0072164 | mesonephric tubule development | 34 | 77 | 8.19e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 29 | 62 | 8.71e-04 |
| GO:BP | GO:0021954 | central nervous system neuron development | 29 | 62 | 8.71e-04 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 184 | 625 | 8.79e-04 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 132 | 425 | 8.79e-04 |
| GO:BP | GO:0030879 | mammary gland development | 43 | 106 | 9.14e-04 |
| GO:BP | GO:0002253 | activation of immune response | 103 | 317 | 9.24e-04 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 191 | 653 | 9.28e-04 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 72 | 205 | 9.37e-04 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 195 | 669 | 9.52e-04 |
| GO:BP | GO:0000902 | cell morphogenesis | 219 | 764 | 9.90e-04 |
| GO:BP | GO:0050776 | regulation of immune response | 156 | 518 | 1.00e-03 |
| GO:BP | GO:0002757 | immune response-activating signaling pathway | 93 | 281 | 1.00e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 424 | 1597 | 1.05e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 97 | 296 | 1.05e-03 |
| GO:BP | GO:0006936 | muscle contraction | 89 | 267 | 1.09e-03 |
| GO:BP | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 60 | 164 | 1.09e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 33 | 75 | 1.10e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 38 | 91 | 1.17e-03 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 15 | 24 | 1.17e-03 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 206 | 715 | 1.17e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 29 | 63 | 1.17e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 38 | 91 | 1.17e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 30 | 66 | 1.17e-03 |
| GO:BP | GO:0060173 | limb development | 54 | 144 | 1.19e-03 |
| GO:BP | GO:0048736 | appendage development | 54 | 144 | 1.19e-03 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 12 | 17 | 1.24e-03 |
| GO:BP | GO:0014856 | skeletal muscle cell proliferation | 12 | 17 | 1.24e-03 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 12 | 17 | 1.24e-03 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 12 | 17 | 1.24e-03 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 41 | 101 | 1.25e-03 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 169 | 571 | 1.25e-03 |
| GO:BP | GO:0060047 | heart contraction | 70 | 200 | 1.26e-03 |
| GO:BP | GO:0031347 | regulation of defense response | 148 | 490 | 1.26e-03 |
| GO:BP | GO:0035148 | tube formation | 50 | 131 | 1.30e-03 |
| GO:BP | GO:0009725 | response to hormone | 185 | 634 | 1.31e-03 |
| GO:BP | GO:0006810 | transport | 797 | 3176 | 1.32e-03 |
| GO:BP | GO:0051234 | establishment of localization | 860 | 3447 | 1.36e-03 |
| GO:BP | GO:0070661 | leukocyte proliferation | 67 | 190 | 1.38e-03 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 109 | 343 | 1.38e-03 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 49 | 128 | 1.39e-03 |
| GO:BP | GO:0065009 | regulation of molecular function | 372 | 1389 | 1.43e-03 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 97 | 299 | 1.48e-03 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 125 | 404 | 1.51e-03 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 197 | 683 | 1.51e-03 |
| GO:BP | GO:0008654 | phospholipid biosynthetic process | 78 | 230 | 1.55e-03 |
| GO:BP | GO:0002764 | immune response-regulating signaling pathway | 95 | 292 | 1.55e-03 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 166 | 562 | 1.55e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 26 | 55 | 1.55e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 44 | 112 | 1.59e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 87 | 263 | 1.61e-03 |
| GO:BP | GO:0019222 | regulation of metabolic process | 1197 | 4914 | 1.61e-03 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 85 | 256 | 1.68e-03 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 34 | 80 | 1.77e-03 |
| GO:BP | GO:0042692 | muscle cell differentiation | 106 | 334 | 1.77e-03 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 78 | 231 | 1.77e-03 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 108 | 342 | 1.89e-03 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 37 | 90 | 1.97e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 37 | 90 | 1.97e-03 |
| GO:BP | GO:0061337 | cardiac conduction | 36 | 87 | 2.09e-03 |
| GO:BP | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 62 | 175 | 2.09e-03 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 121 | 392 | 2.10e-03 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 43 | 110 | 2.13e-03 |
| GO:BP | GO:1903522 | regulation of blood circulation | 69 | 200 | 2.16e-03 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 213 | 752 | 2.35e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 101 | 318 | 2.47e-03 |
| GO:BP | GO:0043583 | ear development | 56 | 155 | 2.49e-03 |
| GO:BP | GO:0007389 | pattern specification process | 98 | 307 | 2.52e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 37 | 91 | 2.52e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 298 | 1096 | 2.59e-03 |
| GO:BP | GO:0050808 | synapse organization | 116 | 375 | 2.59e-03 |
| GO:BP | GO:0060443 | mammary gland morphogenesis | 20 | 39 | 2.59e-03 |
| GO:BP | GO:0010720 | positive regulation of cell development | 103 | 326 | 2.59e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 176 | 607 | 2.59e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 256 | 926 | 2.60e-03 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 182 | 631 | 2.67e-03 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 48 | 128 | 2.69e-03 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 136 | 452 | 2.73e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 623 | 2453 | 2.79e-03 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 121 | 395 | 2.84e-03 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 22 | 45 | 2.84e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 22 | 45 | 2.84e-03 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 139 | 464 | 2.84e-03 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 89 | 275 | 2.91e-03 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 17 | 31 | 2.91e-03 |
| GO:BP | GO:0046649 | lymphocyte activation | 142 | 476 | 2.93e-03 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 124 | 407 | 2.98e-03 |
| GO:BP | GO:0060284 | regulation of cell development | 175 | 605 | 2.98e-03 |
| GO:BP | GO:0021543 | pallium development | 53 | 146 | 3.10e-03 |
| GO:BP | GO:0072175 | epithelial tube formation | 46 | 122 | 3.10e-03 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 1101 | 4515 | 3.18e-03 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 40 | 102 | 3.18e-03 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 235 | 845 | 3.26e-03 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 36 | 89 | 3.30e-03 |
| GO:BP | GO:0046651 | lymphocyte proliferation | 58 | 164 | 3.39e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 75 | 225 | 3.46e-03 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 235 | 846 | 3.48e-03 |
| GO:BP | GO:0001822 | kidney development | 81 | 247 | 3.48e-03 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 224 | 802 | 3.52e-03 |
| GO:BP | GO:0042391 | regulation of membrane potential | 95 | 299 | 3.54e-03 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 13 | 21 | 3.58e-03 |
| GO:BP | GO:0031214 | biomineral tissue development | 44 | 116 | 3.58e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 29 | 67 | 3.60e-03 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 227 | 815 | 3.76e-03 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 21 | 43 | 3.86e-03 |
| GO:BP | GO:0061564 | axon development | 122 | 402 | 3.86e-03 |
| GO:BP | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress | 6 | 6 | 3.86e-03 |
| GO:BP | GO:0010616 | negative regulation of cardiac muscle adaptation | 6 | 6 | 3.86e-03 |
| GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 21 | 43 | 3.86e-03 |
| GO:BP | GO:0099545 | trans-synaptic signaling by trans-synaptic complex | 6 | 6 | 3.86e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 304 | 1128 | 3.87e-03 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 26 | 58 | 3.88e-03 |
| GO:BP | GO:0035721 | intraciliary retrograde transport | 10 | 14 | 3.90e-03 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 10 | 14 | 3.90e-03 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 32 | 77 | 4.04e-03 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 166 | 574 | 4.18e-03 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 53 | 148 | 4.29e-03 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 35 | 87 | 4.34e-03 |
| GO:BP | GO:0007548 | sex differentiation | 65 | 191 | 4.63e-03 |
| GO:BP | GO:0002262 | myeloid cell homeostasis | 52 | 145 | 4.69e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 226 | 815 | 4.93e-03 |
| GO:BP | GO:0032880 | regulation of protein localization | 204 | 727 | 5.02e-03 |
| GO:BP | GO:0030048 | actin filament-based movement | 42 | 111 | 5.08e-03 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 27 | 62 | 5.10e-03 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 39 | 101 | 5.18e-03 |
| GO:BP | GO:0003093 | regulation of glomerular filtration | 7 | 8 | 5.31e-03 |
| GO:BP | GO:0001977 | renal system process involved in regulation of blood volume | 7 | 8 | 5.31e-03 |
| GO:BP | GO:1900180 | regulation of protein localization to nucleus | 46 | 125 | 5.41e-03 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 126 | 421 | 5.44e-03 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 134 | 452 | 5.45e-03 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 15 | 27 | 5.47e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 31 | 75 | 5.49e-03 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 23 | 50 | 5.51e-03 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 129 | 433 | 5.61e-03 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 30 | 72 | 5.80e-03 |
| GO:BP | GO:0030031 | cell projection assembly | 141 | 480 | 5.81e-03 |
| GO:BP | GO:0050866 | negative regulation of cell activation | 45 | 122 | 5.81e-03 |
| GO:BP | GO:0007517 | muscle organ development | 89 | 281 | 5.82e-03 |
| GO:BP | GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation | 16 | 30 | 6.14e-03 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 138 | 469 | 6.14e-03 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 544 | 2138 | 6.14e-03 |
| GO:BP | GO:0021872 | forebrain generation of neurons | 16 | 30 | 6.14e-03 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 16 | 30 | 6.14e-03 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 13 | 22 | 6.17e-03 |
| GO:BP | GO:0002252 | immune effector process | 100 | 323 | 6.17e-03 |
| GO:BP | GO:0040018 | positive regulation of multicellular organism growth | 13 | 22 | 6.17e-03 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 123 | 411 | 6.17e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 84 | 263 | 6.18e-03 |
| GO:BP | GO:0021987 | cerebral cortex development | 39 | 102 | 6.18e-03 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 39 | 102 | 6.18e-03 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 56 | 161 | 6.23e-03 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 156 | 540 | 6.32e-03 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 709 | 2842 | 6.43e-03 |
| GO:BP | GO:2000107 | negative regulation of leukocyte apoptotic process | 17 | 33 | 6.62e-03 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 76 | 234 | 6.69e-03 |
| GO:BP | GO:0042471 | ear morphogenesis | 31 | 76 | 6.85e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 31 | 76 | 6.85e-03 |
| GO:BP | GO:0007405 | neuroblast proliferation | 25 | 57 | 7.01e-03 |
| GO:BP | GO:0033043 | regulation of organelle organization | 274 | 1016 | 7.06e-03 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 120 | 401 | 7.10e-03 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 78 | 242 | 7.20e-03 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 913 | 3724 | 7.22e-03 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 23 | 51 | 7.34e-03 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 54 | 155 | 7.38e-03 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 79 | 246 | 7.44e-03 |
| GO:BP | GO:0010171 | body morphogenesis | 21 | 45 | 7.44e-03 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 126 | 425 | 7.53e-03 |
| GO:BP | GO:0010468 | regulation of gene expression | 887 | 3613 | 7.53e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 73 | 224 | 7.53e-03 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 87 | 276 | 7.53e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 33 | 83 | 7.53e-03 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 68 | 206 | 7.92e-03 |
| GO:BP | GO:0008104 | protein localization | 540 | 2128 | 7.92e-03 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 28 | 67 | 7.96e-03 |
| GO:BP | GO:0048634 | regulation of muscle organ development | 10 | 15 | 7.98e-03 |
| GO:BP | GO:0031667 | response to nutrient levels | 111 | 368 | 8.20e-03 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 15 | 28 | 8.28e-03 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 15 | 28 | 8.28e-03 |
| GO:BP | GO:0060603 | mammary gland duct morphogenesis | 15 | 28 | 8.28e-03 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 73 | 225 | 8.55e-03 |
| GO:BP | GO:0046661 | male sex differentiation | 42 | 114 | 8.58e-03 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 122 | 411 | 8.60e-03 |
| GO:BP | GO:0040008 | regulation of growth | 143 | 493 | 8.66e-03 |
| GO:BP | GO:0048839 | inner ear development | 48 | 135 | 8.78e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 30 | 74 | 9.01e-03 |
| GO:BP | GO:0097106 | postsynaptic density organization | 16 | 31 | 9.01e-03 |
| GO:BP | GO:0043403 | skeletal muscle tissue regeneration | 16 | 31 | 9.01e-03 |
| GO:BP | GO:0001701 | in utero embryonic development | 105 | 346 | 9.01e-03 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 25 | 58 | 9.02e-03 |
| GO:BP | GO:0002027 | regulation of heart rate | 33 | 84 | 9.29e-03 |
| GO:BP | GO:0030500 | regulation of bone mineralization | 24 | 55 | 9.34e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1281 | 5340 | 9.34e-03 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 932 | 3815 | 9.34e-03 |
| GO:BP | GO:0021915 | neural tube development | 49 | 139 | 9.42e-03 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 45 | 125 | 9.44e-03 |
| GO:BP | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 29 | 71 | 9.48e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 179 | 637 | 9.53e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 32 | 81 | 9.88e-03 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 74 | 230 | 9.88e-03 |
| GO:BP | GO:0021879 | forebrain neuron differentiation | 13 | 23 | 9.91e-03 |
| GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 19 | 40 | 9.95e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 21 | 46 | 9.95e-03 |
| GO:BP | GO:2001222 | regulation of neuron migration | 19 | 40 | 9.95e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 28 | 68 | 9.95e-03 |
| GO:BP | GO:0098900 | regulation of action potential | 20 | 43 | 9.96e-03 |
| GO:BP | GO:0014841 | skeletal muscle satellite cell proliferation | 9 | 13 | 9.99e-03 |
| GO:BP | GO:0003231 | cardiac ventricle development | 42 | 115 | 1.00e-02 |
| GO:BP | GO:0051050 | positive regulation of transport | 171 | 606 | 1.00e-02 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 46 | 129 | 1.01e-02 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 246 | 909 | 1.04e-02 |
| GO:BP | GO:0009267 | cellular response to starvation | 53 | 154 | 1.05e-02 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 127 | 433 | 1.05e-02 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 937 | 3841 | 1.05e-02 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 70 | 216 | 1.07e-02 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 167 | 591 | 1.07e-02 |
| GO:BP | GO:0042594 | response to starvation | 61 | 183 | 1.07e-02 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 64 | 194 | 1.08e-02 |
| GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 11 | 18 | 1.08e-02 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 49 | 140 | 1.08e-02 |
| GO:BP | GO:0048771 | tissue remodeling | 43 | 119 | 1.09e-02 |
| GO:BP | GO:0022402 | cell cycle process | 287 | 1078 | 1.09e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 30 | 75 | 1.10e-02 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 14 | 26 | 1.11e-02 |
| GO:BP | GO:0048863 | stem cell differentiation | 65 | 198 | 1.12e-02 |
| GO:BP | GO:0043954 | cellular component maintenance | 25 | 59 | 1.14e-02 |
| GO:BP | GO:0097009 | energy homeostasis | 25 | 59 | 1.14e-02 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 98 | 322 | 1.14e-02 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 48 | 137 | 1.17e-02 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 35 | 92 | 1.17e-02 |
| GO:BP | GO:2000106 | regulation of leukocyte apoptotic process | 24 | 56 | 1.19e-02 |
| GO:BP | GO:0061448 | connective tissue development | 70 | 217 | 1.20e-02 |
| GO:BP | GO:0008544 | epidermis development | 70 | 217 | 1.20e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 8 | 11 | 1.22e-02 |
| GO:BP | GO:0086070 | SA node cell to atrial cardiac muscle cell communication | 8 | 11 | 1.22e-02 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 28 | 69 | 1.22e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 28 | 69 | 1.22e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 56 | 166 | 1.22e-02 |
| GO:BP | GO:1990874 | vascular associated smooth muscle cell proliferation | 23 | 53 | 1.22e-02 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 23 | 53 | 1.22e-02 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 39 | 106 | 1.24e-02 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 34 | 89 | 1.25e-02 |
| GO:BP | GO:0071878 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway | 5 | 5 | 1.25e-02 |
| GO:BP | GO:0031644 | regulation of nervous system process | 31 | 79 | 1.26e-02 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 54 | 159 | 1.26e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 152 | 534 | 1.26e-02 |
| GO:BP | GO:0042063 | gliogenesis | 80 | 255 | 1.28e-02 |
| GO:BP | GO:0051960 | regulation of nervous system development | 107 | 358 | 1.28e-02 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 254 | 946 | 1.28e-02 |
| GO:BP | GO:0050877 | nervous system process | 177 | 634 | 1.29e-02 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 60 | 181 | 1.29e-02 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 17 | 35 | 1.29e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 17 | 35 | 1.29e-02 |
| GO:BP | GO:0030888 | regulation of B cell proliferation | 17 | 35 | 1.29e-02 |
| GO:BP | GO:0030501 | positive regulation of bone mineralization | 17 | 35 | 1.29e-02 |
| GO:BP | GO:0001525 | angiogenesis | 117 | 397 | 1.30e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 109 | 366 | 1.30e-02 |
| GO:BP | GO:1902117 | positive regulation of organelle assembly | 30 | 76 | 1.33e-02 |
| GO:BP | GO:0001818 | negative regulation of cytokine production | 58 | 174 | 1.33e-02 |
| GO:BP | GO:0006661 | phosphatidylinositol biosynthetic process | 42 | 117 | 1.34e-02 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 42 | 117 | 1.34e-02 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 42 | 117 | 1.34e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 53 | 156 | 1.34e-02 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 53 | 156 | 1.34e-02 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 135 | 468 | 1.35e-02 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 1033 | 4269 | 1.37e-02 |
| GO:BP | GO:0051481 | negative regulation of cytosolic calcium ion concentration | 7 | 9 | 1.38e-02 |
| GO:BP | GO:0007409 | axonogenesis | 108 | 363 | 1.38e-02 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 7 | 9 | 1.38e-02 |
| GO:BP | GO:0086027 | AV node cell to bundle of His cell signaling | 7 | 9 | 1.38e-02 |
| GO:BP | GO:0031032 | actomyosin structure organization | 62 | 189 | 1.38e-02 |
| GO:BP | GO:0001780 | neutrophil homeostasis | 10 | 16 | 1.38e-02 |
| GO:BP | GO:0086016 | AV node cell action potential | 7 | 9 | 1.38e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 57 | 171 | 1.43e-02 |
| GO:BP | GO:0046903 | secretion | 182 | 656 | 1.43e-02 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 45 | 128 | 1.44e-02 |
| GO:BP | GO:0050778 | positive regulation of immune response | 121 | 414 | 1.44e-02 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 176 | 632 | 1.44e-02 |
| GO:BP | GO:0006941 | striated muscle contraction | 52 | 153 | 1.44e-02 |
| GO:BP | GO:0045761 | regulation of adenylate cyclase activity | 13 | 24 | 1.46e-02 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 13 | 24 | 1.46e-02 |
| GO:BP | GO:0001973 | G protein-coupled adenosine receptor signaling pathway | 6 | 7 | 1.46e-02 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 93 | 306 | 1.46e-02 |
| GO:BP | GO:0035588 | G protein-coupled purinergic receptor signaling pathway | 6 | 7 | 1.46e-02 |
| GO:BP | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization | 6 | 7 | 1.46e-02 |
| GO:BP | GO:0061572 | actin filament bundle organization | 48 | 139 | 1.51e-02 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 760 | 3089 | 1.51e-02 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 23 | 54 | 1.53e-02 |
| GO:BP | GO:0030217 | T cell differentiation | 62 | 190 | 1.55e-02 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 40 | 111 | 1.56e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 22 | 51 | 1.59e-02 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 14 | 27 | 1.59e-02 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 22 | 51 | 1.59e-02 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 66 | 205 | 1.59e-02 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 93 | 307 | 1.61e-02 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 93 | 307 | 1.61e-02 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 150 | 530 | 1.61e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 117 | 400 | 1.62e-02 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 47 | 136 | 1.63e-02 |
| GO:BP | GO:0007049 | cell cycle | 391 | 1520 | 1.63e-02 |
| GO:BP | GO:0014015 | positive regulation of gliogenesis | 21 | 48 | 1.64e-02 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 79 | 254 | 1.64e-02 |
| GO:BP | GO:0030851 | granulocyte differentiation | 15 | 30 | 1.67e-02 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 43 | 122 | 1.67e-02 |
| GO:BP | GO:0072073 | kidney epithelium development | 41 | 115 | 1.67e-02 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 32 | 84 | 1.67e-02 |
| GO:BP | GO:0042110 | T cell activation | 97 | 323 | 1.69e-02 |
| GO:BP | GO:0019934 | cGMP-mediated signaling | 11 | 19 | 1.70e-02 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 146 | 515 | 1.70e-02 |
| GO:BP | GO:0045216 | cell-cell junction organization | 53 | 158 | 1.70e-02 |
| GO:BP | GO:0071378 | cellular response to growth hormone stimulus | 11 | 19 | 1.70e-02 |
| GO:BP | GO:0031646 | positive regulation of nervous system process | 11 | 19 | 1.70e-02 |
| GO:BP | GO:0045778 | positive regulation of ossification | 19 | 42 | 1.70e-02 |
| GO:BP | GO:0060348 | bone development | 53 | 158 | 1.70e-02 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 106 | 358 | 1.71e-02 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 34 | 91 | 1.72e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 56 | 169 | 1.72e-02 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 36 | 98 | 1.77e-02 |
| GO:BP | GO:0055123 | digestive system development | 36 | 98 | 1.77e-02 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 138 | 484 | 1.78e-02 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 138 | 484 | 1.78e-02 |
| GO:BP | GO:0072087 | renal vesicle development | 9 | 14 | 1.78e-02 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 38 | 105 | 1.79e-02 |
| GO:BP | GO:1904892 | regulation of receptor signaling pathway via STAT | 24 | 58 | 1.82e-02 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 71 | 225 | 1.82e-02 |
| GO:BP | GO:0031122 | cytoplasmic microtubule organization | 24 | 58 | 1.82e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 85 | 278 | 1.83e-02 |
| GO:BP | GO:0006952 | defense response | 262 | 987 | 1.87e-02 |
| GO:BP | GO:0009611 | response to wounding | 117 | 402 | 1.87e-02 |
| GO:BP | GO:0031331 | positive regulation of cellular catabolic process | 87 | 286 | 1.90e-02 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 41 | 116 | 1.95e-02 |
| GO:BP | GO:0097150 | neuronal stem cell population maintenance | 12 | 22 | 1.95e-02 |
| GO:BP | GO:1901186 | positive regulation of ERBB signaling pathway | 12 | 22 | 1.95e-02 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 95 | 317 | 1.95e-02 |
| GO:BP | GO:0043588 | skin development | 59 | 181 | 1.95e-02 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 1007 | 4170 | 1.97e-02 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 79 | 256 | 1.99e-02 |
| GO:BP | GO:1904659 | glucose transmembrane transport | 32 | 85 | 2.00e-02 |
| GO:BP | GO:0016358 | dendrite development | 63 | 196 | 2.00e-02 |
| GO:BP | GO:0033554 | cellular response to stress | 394 | 1538 | 2.00e-02 |
| GO:BP | GO:0043409 | negative regulation of MAPK cascade | 46 | 134 | 2.00e-02 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 34 | 92 | 2.06e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 81 | 264 | 2.06e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 81 | 264 | 2.06e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 42 | 120 | 2.07e-02 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 42 | 120 | 2.07e-02 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 167 | 602 | 2.07e-02 |
| GO:BP | GO:0030001 | metal ion transport | 155 | 554 | 2.08e-02 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 638 | 2576 | 2.11e-02 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 641 | 2589 | 2.12e-02 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 13 | 25 | 2.13e-02 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 69 | 219 | 2.13e-02 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 20 | 46 | 2.17e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 28 | 72 | 2.18e-02 |
| GO:BP | GO:0001776 | leukocyte homeostasis | 28 | 72 | 2.18e-02 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 98 | 330 | 2.19e-02 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 98 | 330 | 2.19e-02 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 33 | 89 | 2.20e-02 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 33 | 89 | 2.20e-02 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 154 | 551 | 2.21e-02 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 14 | 28 | 2.24e-02 |
| GO:BP | GO:0048806 | genitalia development | 14 | 28 | 2.24e-02 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 39 | 110 | 2.26e-02 |
| GO:BP | GO:0007416 | synapse assembly | 51 | 153 | 2.26e-02 |
| GO:BP | GO:0001779 | natural killer cell differentiation | 10 | 17 | 2.27e-02 |
| GO:BP | GO:0034143 | regulation of toll-like receptor 4 signaling pathway | 10 | 17 | 2.27e-02 |
| GO:BP | GO:0045859 | regulation of protein kinase activity | 102 | 346 | 2.27e-02 |
| GO:BP | GO:0035329 | hippo signaling | 18 | 40 | 2.27e-02 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 172 | 624 | 2.28e-02 |
| GO:BP | GO:1990776 | response to angiotensin | 15 | 31 | 2.28e-02 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 17 | 37 | 2.28e-02 |
| GO:BP | GO:1900181 | negative regulation of protein localization to nucleus | 15 | 31 | 2.28e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 133 | 468 | 2.28e-02 |
| GO:BP | GO:0140352 | export from cell | 172 | 624 | 2.28e-02 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 15 | 31 | 2.28e-02 |
| GO:BP | GO:0098911 | regulation of ventricular cardiac muscle cell action potential | 8 | 12 | 2.28e-02 |
| GO:BP | GO:0046473 | phosphatidic acid metabolic process | 15 | 31 | 2.28e-02 |
| GO:BP | GO:0003161 | cardiac conduction system development | 16 | 34 | 2.29e-02 |
| GO:BP | GO:0035270 | endocrine system development | 32 | 86 | 2.33e-02 |
| GO:BP | GO:0031399 | regulation of protein modification process | 254 | 959 | 2.33e-02 |
| GO:BP | GO:0002366 | leukocyte activation involved in immune response | 52 | 157 | 2.33e-02 |
| GO:BP | GO:0010827 | regulation of glucose transmembrane transport | 23 | 56 | 2.35e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 42 | 121 | 2.35e-02 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 23 | 56 | 2.35e-02 |
| GO:BP | GO:0120034 | positive regulation of plasma membrane bounded cell projection assembly | 34 | 93 | 2.38e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 126 | 441 | 2.39e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 38 | 107 | 2.40e-02 |
| GO:BP | GO:0045927 | positive regulation of growth | 63 | 198 | 2.44e-02 |
| GO:BP | GO:0036211 | protein modification process | 601 | 2423 | 2.47e-02 |
| GO:BP | GO:0040014 | regulation of multicellular organism growth | 22 | 53 | 2.49e-02 |
| GO:BP | GO:0061458 | reproductive system development | 68 | 217 | 2.52e-02 |
| GO:BP | GO:0003002 | regionalization | 83 | 274 | 2.53e-02 |
| GO:BP | GO:0098727 | maintenance of cell number | 51 | 154 | 2.54e-02 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 33 | 90 | 2.58e-02 |
| GO:BP | GO:0048565 | digestive tract development | 33 | 90 | 2.58e-02 |
| GO:BP | GO:0046660 | female sex differentiation | 33 | 90 | 2.58e-02 |
| GO:BP | GO:0010508 | positive regulation of autophagy | 46 | 136 | 2.58e-02 |
| GO:BP | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 11 | 20 | 2.59e-02 |
| GO:BP | GO:0006954 | inflammatory response | 130 | 458 | 2.59e-02 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 11 | 20 | 2.59e-02 |
| GO:BP | GO:1903707 | negative regulation of hemopoiesis | 28 | 73 | 2.59e-02 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 11 | 20 | 2.59e-02 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 11 | 20 | 2.59e-02 |
| GO:BP | GO:0055001 | muscle cell development | 55 | 169 | 2.62e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 67 | 214 | 2.73e-02 |
| GO:BP | GO:0002285 | lymphocyte activation involved in immune response | 40 | 115 | 2.78e-02 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 24 | 60 | 2.79e-02 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 32 | 87 | 2.79e-02 |
| GO:BP | GO:0001508 | action potential | 38 | 108 | 2.80e-02 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 38 | 108 | 2.80e-02 |
| GO:BP | GO:0071900 | regulation of protein serine/threonine kinase activity | 64 | 203 | 2.80e-02 |
| GO:BP | GO:0060485 | mesenchyme development | 78 | 256 | 2.80e-02 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 34 | 94 | 2.81e-02 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 34 | 94 | 2.81e-02 |
| GO:BP | GO:0002021 | response to dietary excess | 12 | 23 | 2.86e-02 |
| GO:BP | GO:0010612 | regulation of cardiac muscle adaptation | 7 | 10 | 2.89e-02 |
| GO:BP | GO:1903242 | regulation of cardiac muscle hypertrophy in response to stress | 7 | 10 | 2.89e-02 |
| GO:BP | GO:1902855 | regulation of non-motile cilium assembly | 7 | 10 | 2.89e-02 |
| GO:BP | GO:0014857 | regulation of skeletal muscle cell proliferation | 7 | 10 | 2.89e-02 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 23 | 57 | 2.94e-02 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 23 | 57 | 2.94e-02 |
| GO:BP | GO:0043549 | regulation of kinase activity | 108 | 373 | 2.98e-02 |
| GO:BP | GO:0001570 | vasculogenesis | 26 | 67 | 2.99e-02 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 13 | 26 | 3.01e-02 |
| GO:BP | GO:0035590 | purinergic nucleotide receptor signaling pathway | 9 | 15 | 3.01e-02 |
| GO:BP | GO:0030033 | microvillus assembly | 9 | 15 | 3.01e-02 |
| GO:BP | GO:0045724 | positive regulation of cilium assembly | 13 | 26 | 3.01e-02 |
| GO:BP | GO:0072202 | cell differentiation involved in metanephros development | 9 | 15 | 3.01e-02 |
| GO:BP | GO:0006654 | phosphatidic acid biosynthetic process | 14 | 29 | 3.08e-02 |
| GO:BP | GO:1904385 | cellular response to angiotensin | 14 | 29 | 3.08e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 14 | 29 | 3.08e-02 |
| GO:BP | GO:0034097 | response to cytokine | 170 | 621 | 3.08e-02 |
| GO:BP | GO:1901861 | regulation of muscle tissue development | 16 | 35 | 3.08e-02 |
| GO:BP | GO:0072210 | metanephric nephron development | 14 | 29 | 3.08e-02 |
| GO:BP | GO:0019827 | stem cell population maintenance | 50 | 152 | 3.09e-02 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 64 | 204 | 3.09e-02 |
| GO:BP | GO:0001656 | metanephros development | 25 | 64 | 3.19e-02 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 88 | 296 | 3.20e-02 |
| GO:BP | GO:0001817 | regulation of cytokine production | 135 | 481 | 3.20e-02 |
| GO:BP | GO:0001816 | cytokine production | 136 | 485 | 3.20e-02 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 38 | 109 | 3.24e-02 |
| GO:BP | GO:0050890 | cognition | 71 | 231 | 3.27e-02 |
| GO:BP | GO:0008645 | hexose transmembrane transport | 32 | 88 | 3.27e-02 |
| GO:BP | GO:0002695 | negative regulation of leukocyte activation | 36 | 102 | 3.27e-02 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 184 | 679 | 3.28e-02 |
| GO:BP | GO:0042733 | embryonic digit morphogenesis | 21 | 51 | 3.28e-02 |
| GO:BP | GO:0042113 | B cell activation | 55 | 171 | 3.30e-02 |
| GO:BP | GO:0046488 | phosphatidylinositol metabolic process | 46 | 138 | 3.34e-02 |
| GO:BP | GO:0002263 | cell activation involved in immune response | 52 | 160 | 3.34e-02 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 665 | 2709 | 3.47e-02 |
| GO:BP | GO:0042149 | cellular response to glucose starvation | 20 | 48 | 3.48e-02 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 47 | 142 | 3.51e-02 |
| GO:BP | GO:0032868 | response to insulin | 65 | 209 | 3.53e-02 |
| GO:BP | GO:0000278 | mitotic cell cycle | 214 | 803 | 3.54e-02 |
| GO:BP | GO:0060840 | artery development | 31 | 85 | 3.54e-02 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 57 | 179 | 3.54e-02 |
| GO:BP | GO:0007017 | microtubule-based process | 204 | 762 | 3.54e-02 |
| GO:BP | GO:0072273 | metanephric nephron morphogenesis | 10 | 18 | 3.54e-02 |
| GO:BP | GO:0060396 | growth hormone receptor signaling pathway | 10 | 18 | 3.54e-02 |
| GO:BP | GO:0045649 | regulation of macrophage differentiation | 10 | 18 | 3.54e-02 |
| GO:BP | GO:0071476 | cellular hypotonic response | 6 | 8 | 3.54e-02 |
| GO:BP | GO:1902857 | positive regulation of non-motile cilium assembly | 6 | 8 | 3.54e-02 |
| GO:BP | GO:0014842 | regulation of skeletal muscle satellite cell proliferation | 6 | 8 | 3.54e-02 |
| GO:BP | GO:0035264 | multicellular organism growth | 42 | 124 | 3.54e-02 |
| GO:BP | GO:0002758 | innate immune response-activating signaling pathway | 54 | 168 | 3.57e-02 |
| GO:BP | GO:1902106 | negative regulation of leukocyte differentiation | 26 | 68 | 3.58e-02 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 26 | 68 | 3.58e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 51 | 157 | 3.61e-02 |
| GO:BP | GO:0032946 | positive regulation of mononuclear cell proliferation | 28 | 75 | 3.73e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 28 | 75 | 3.73e-02 |
| GO:BP | GO:0050851 | antigen receptor-mediated signaling pathway | 38 | 110 | 3.73e-02 |
| GO:BP | GO:0032237 | activation of store-operated calcium channel activity | 4 | 4 | 3.75e-02 |
| GO:BP | GO:0075732 | viral penetration into host nucleus | 4 | 4 | 3.75e-02 |
| GO:BP | GO:0098910 | regulation of atrial cardiac muscle cell action potential | 4 | 4 | 3.75e-02 |
| GO:BP | GO:0099179 | regulation of synaptic membrane adhesion | 4 | 4 | 3.75e-02 |
| GO:BP | GO:0032898 | neurotrophin production | 4 | 4 | 3.75e-02 |
| GO:BP | GO:1902262 | apoptotic process involved in blood vessel morphogenesis | 4 | 4 | 3.75e-02 |
| GO:BP | GO:0071839 | apoptotic process in bone marrow cell | 4 | 4 | 3.75e-02 |
| GO:BP | GO:0007296 | vitellogenesis | 4 | 4 | 3.75e-02 |
| GO:BP | GO:0048286 | lung alveolus development | 18 | 42 | 3.76e-02 |
| GO:BP | GO:0022412 | cellular process involved in reproduction in multicellular organism | 81 | 271 | 3.77e-02 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 30 | 82 | 3.77e-02 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 89 | 302 | 3.77e-02 |
| GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 22 | 55 | 3.79e-02 |
| GO:BP | GO:0001841 | neural tube formation | 34 | 96 | 3.79e-02 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 82 | 275 | 3.79e-02 |
| GO:BP | GO:0051250 | negative regulation of lymphocyte activation | 32 | 89 | 3.79e-02 |
| GO:BP | GO:0015749 | monosaccharide transmembrane transport | 32 | 89 | 3.79e-02 |
| GO:BP | GO:0001708 | cell fate specification | 22 | 55 | 3.79e-02 |
| GO:BP | GO:0034219 | carbohydrate transmembrane transport | 34 | 96 | 3.79e-02 |
| GO:BP | GO:0001783 | B cell apoptotic process | 11 | 21 | 3.79e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 11 | 21 | 3.79e-02 |
| GO:BP | GO:0035137 | hindlimb morphogenesis | 11 | 21 | 3.79e-02 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 11 | 21 | 3.79e-02 |
| GO:BP | GO:0099560 | synaptic membrane adhesion | 11 | 21 | 3.79e-02 |
| GO:BP | GO:0006351 | DNA-templated transcription | 658 | 2683 | 3.79e-02 |
| GO:BP | GO:0003094 | glomerular filtration | 11 | 21 | 3.79e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 61 | 195 | 3.82e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 17 | 39 | 3.83e-02 |
| GO:BP | GO:2001259 | positive regulation of cation channel activity | 17 | 39 | 3.83e-02 |
| GO:BP | GO:0034331 | cell junction maintenance | 17 | 39 | 3.83e-02 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 47 | 143 | 3.84e-02 |
| GO:BP | GO:0030432 | peristalsis | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0030539 | male genitalia development | 8 | 13 | 3.88e-02 |
| GO:BP | GO:0044419 | biological process involved in interspecies interaction between organisms | 262 | 1004 | 3.88e-02 |
| GO:BP | GO:0043570 | maintenance of DNA repeat elements | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0060592 | mammary gland formation | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0071679 | commissural neuron axon guidance | 8 | 13 | 3.88e-02 |
| GO:BP | GO:0002831 | regulation of response to biotic stimulus | 97 | 334 | 3.88e-02 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 16 | 36 | 3.88e-02 |
| GO:BP | GO:0001696 | gastric acid secretion | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0034163 | regulation of toll-like receptor 9 signaling pathway | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0048790 | maintenance of presynaptic active zone structure | 5 | 6 | 3.88e-02 |
| GO:BP | GO:2000171 | negative regulation of dendrite development | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 54 | 169 | 3.88e-02 |
| GO:BP | GO:0002218 | activation of innate immune response | 58 | 184 | 3.88e-02 |
| GO:BP | GO:0070673 | response to interleukin-18 | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 42 | 125 | 3.88e-02 |
| GO:BP | GO:0072077 | renal vesicle morphogenesis | 8 | 13 | 3.88e-02 |
| GO:BP | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 8 | 13 | 3.88e-02 |
| GO:BP | GO:0014816 | skeletal muscle satellite cell differentiation | 5 | 6 | 3.88e-02 |
| GO:BP | GO:0002064 | epithelial cell development | 51 | 158 | 3.88e-02 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 21 | 52 | 3.90e-02 |
| GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 12 | 24 | 3.90e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 21 | 52 | 3.90e-02 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 12 | 24 | 3.90e-02 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 45 | 136 | 3.90e-02 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 24 | 62 | 3.94e-02 |
| GO:BP | GO:0060323 | head morphogenesis | 15 | 33 | 3.96e-02 |
| GO:BP | GO:0060416 | response to growth hormone | 13 | 27 | 3.99e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 13 | 27 | 3.99e-02 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 43 | 129 | 4.06e-02 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 152 | 554 | 4.09e-02 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 38 | 111 | 4.10e-02 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 26 | 69 | 4.12e-02 |
| GO:BP | GO:0030316 | osteoclast differentiation | 26 | 69 | 4.12e-02 |
| GO:BP | GO:0001892 | embryonic placenta development | 26 | 69 | 4.12e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 227 | 861 | 4.19e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 41 | 122 | 4.20e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 41 | 122 | 4.20e-02 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 62 | 200 | 4.23e-02 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 476 | 1908 | 4.24e-02 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 47 | 144 | 4.24e-02 |
| GO:BP | GO:0006644 | phospholipid metabolic process | 90 | 308 | 4.31e-02 |
| GO:BP | GO:0019058 | viral life cycle | 74 | 246 | 4.32e-02 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 63 | 204 | 4.32e-02 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 39 | 115 | 4.33e-02 |
| GO:BP | GO:0032409 | regulation of transporter activity | 51 | 159 | 4.35e-02 |
| GO:BP | GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 19 | 46 | 4.36e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 92 | 316 | 4.36e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 19 | 46 | 4.36e-02 |
| GO:BP | GO:1901342 | regulation of vasculature development | 64 | 208 | 4.40e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 45 | 137 | 4.42e-02 |
| GO:BP | GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 22 | 56 | 4.53e-02 |
| GO:BP | GO:2000177 | regulation of neural precursor cell proliferation | 27 | 73 | 4.60e-02 |
| GO:BP | GO:0045606 | positive regulation of epidermal cell differentiation | 9 | 16 | 4.61e-02 |
| GO:BP | GO:0098801 | regulation of renal system process | 9 | 16 | 4.61e-02 |
| GO:BP | GO:0051302 | regulation of cell division | 46 | 141 | 4.62e-02 |
| GO:BP | GO:0007613 | memory | 33 | 94 | 4.62e-02 |
| GO:BP | GO:0030522 | intracellular receptor signaling pathway | 81 | 274 | 4.71e-02 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 498 | 2005 | 4.72e-02 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 251 | 963 | 4.74e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 68 | 224 | 4.75e-02 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 58 | 186 | 4.75e-02 |
| GO:BP | GO:0044770 | cell cycle phase transition | 134 | 484 | 4.77e-02 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 156 | 573 | 4.83e-02 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 59 | 190 | 4.86e-02 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 59 | 190 | 4.86e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 64 | 209 | 4.87e-02 |
| GO:BP | GO:0022414 | reproductive process | 245 | 939 | 4.94e-02 |
| GO:BP | GO:0051726 | regulation of cell cycle | 244 | 935 | 4.95e-02 |
| GO:BP | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 26 | 70 | 4.95e-02 |
| GO:BP | GO:0006939 | smooth muscle contraction | 26 | 70 | 4.95e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 26 | 70 | 4.95e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:00000 | KEGG root term | 1404 | 5802 | 6.60e-03 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 32 | 74 | 8.56e-03 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 37 | 91 | 8.56e-03 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 29 | 72 | 2.98e-02 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 40 | 109 | 2.98e-02 |
| KEGG | KEGG:04014 | Ras signaling pathway | 58 | 172 | 2.98e-02 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 38 | 104 | 3.33e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 55 | 164 | 3.33e-02 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 54 | 164 | 4.13e-02 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 29 | 76 | 4.13e-02 |
| KEGG | KEGG:05200 | Pathways in cancer | 117 | 408 | 4.13e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 43 | 125 | 4.13e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 35 | 97 | 4.13e-02 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 34 | 94 | 4.13e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 46 | 134 | 4.13e-02 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 75 | 246 | 4.21e-02 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 48 | 145 | 4.21e-02 |
| KEGG | KEGG:04976 | Bile secretion | 18 | 42 | 4.91e-02 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 20 | 49 | 5.53e-02 |
| KEGG | KEGG:04924 | Renin secretion | 20 | 50 | 6.93e-02 |
| KEGG | KEGG:04360 | Axon guidance | 51 | 162 | 8.12e-02 |
| KEGG | KEGG:04931 | Insulin resistance | 32 | 95 | 9.29e-02 |
| KEGG | KEGG:05226 | Gastric cancer | 38 | 117 | 9.29e-02 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 21 | 56 | 9.29e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 41 | 128 | 9.29e-02 |
| KEGG | KEGG:04210 | Apoptosis | 38 | 117 | 9.29e-02 |
| KEGG | KEGG:05164 | Influenza A | 34 | 102 | 9.29e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 21 | 56 | 9.29e-02 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 34 | 102 | 9.29e-02 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 24 | 66 | 9.29e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 16 | 41 | 1.29e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 26 | 76 | 1.29e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 20 | 55 | 1.29e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 24 | 69 | 1.29e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 29 | 87 | 1.29e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 20 | 55 | 1.29e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 46 | 151 | 1.29e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 42 | 136 | 1.29e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 20 | 56 | 1.47e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 45 | 149 | 1.48e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 43 | 142 | 1.50e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 43 | 142 | 1.50e-01 |
| KEGG | KEGG:04611 | Platelet activation | 29 | 89 | 1.50e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 31 | 97 | 1.52e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 22 | 64 | 1.52e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 20 | 57 | 1.53e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 9 | 20 | 1.56e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 31 | 98 | 1.62e-01 |
| KEGG | KEGG:05224 | Breast cancer | 36 | 117 | 1.62e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 52 | 179 | 1.62e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 23 | 69 | 1.71e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 27 | 84 | 1.74e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 17 | 48 | 1.75e-01 |
| KEGG | KEGG:04115 | p53 signaling pathway | 22 | 66 | 1.75e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 29 | 92 | 1.75e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 46 | 157 | 1.75e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 36 | 121 | 1.81e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 10 | 25 | 1.81e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 25 | 78 | 1.81e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 3 | 4 | 1.81e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 40 | 135 | 1.81e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 25 | 78 | 1.81e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 3 | 4 | 1.81e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 36 | 121 | 1.81e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 13 | 35 | 1.81e-01 |
| KEGG | KEGG:05142 | Chagas disease | 24 | 75 | 1.81e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 7 | 15 | 1.81e-01 |
| KEGG | KEGG:04730 | Long-term depression | 15 | 42 | 1.81e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 18 | 52 | 1.81e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 26 | 82 | 1.81e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 44 | 151 | 1.81e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 70 | 256 | 1.81e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 26 | 83 | 1.86e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 33 | 110 | 1.86e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 32 | 106 | 1.86e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 44 | 153 | 1.86e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 21 | 65 | 1.94e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 30 | 99 | 1.94e-01 |
| KEGG | KEGG:05218 | Melanoma | 19 | 58 | 2.03e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 24 | 77 | 2.03e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 10 | 26 | 2.03e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 37 | 127 | 2.03e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 7 | 16 | 2.03e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 38 | 132 | 2.20e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 49 | 176 | 2.22e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 26 | 86 | 2.35e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 21 | 67 | 2.35e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 46 | 165 | 2.35e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 58 | 214 | 2.44e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 16 | 49 | 2.52e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 20 | 64 | 2.52e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 11 | 31 | 2.59e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 9 | 24 | 2.59e-01 |
| KEGG | KEGG:04110 | Cell cycle | 42 | 151 | 2.64e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 21 | 69 | 2.67e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 20 | 65 | 2.67e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 12 | 35 | 2.67e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 10 | 28 | 2.67e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 16 | 50 | 2.67e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 32 | 112 | 2.67e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 25 | 84 | 2.67e-01 |
| KEGG | KEGG:04540 | Gap junction | 22 | 73 | 2.68e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 13 | 39 | 2.68e-01 |
| KEGG | KEGG:04144 | Endocytosis | 61 | 230 | 2.74e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 18 | 58 | 2.74e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 40 | 145 | 2.80e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 25 | 86 | 3.00e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 18 | 59 | 3.00e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 29 | 102 | 3.00e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 30 | 106 | 3.00e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 19 | 63 | 3.04e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 8 | 22 | 3.05e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 8 | 22 | 3.05e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 22 | 75 | 3.08e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 25 | 87 | 3.11e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 17 | 56 | 3.20e-01 |
| KEGG | KEGG:04744 | Phototransduction | 5 | 12 | 3.25e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 31 | 112 | 3.33e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 32 | 116 | 3.33e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 10 | 30 | 3.35e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 16 | 53 | 3.44e-01 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 32 | 117 | 3.54e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 13 | 42 | 3.66e-01 |
| KEGG | KEGG:04530 | Tight junction | 37 | 138 | 3.67e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 69 | 271 | 3.68e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 24 | 86 | 3.83e-01 |
| KEGG | KEGG:04520 | Adherens junction | 24 | 86 | 3.83e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 7 | 20 | 3.84e-01 |
| KEGG | KEGG:05214 | Glioma | 19 | 67 | 4.07e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 21 | 75 | 4.07e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 20 | 71 | 4.07e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 18 | 63 | 4.07e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 21 | 75 | 4.07e-01 |
| KEGG | KEGG:00650 | Butanoate metabolism | 6 | 17 | 4.17e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 29 | 108 | 4.17e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 44 | 170 | 4.17e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 16 | 56 | 4.36e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 18 | 64 | 4.36e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 30 | 113 | 4.38e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 8 | 25 | 4.47e-01 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 24 | 89 | 4.55e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 30 | 114 | 4.55e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 4.55e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 15 | 53 | 4.55e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 23 | 85 | 4.55e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 5 | 14 | 4.55e-01 |
| KEGG | KEGG:05133 | Pertussis | 13 | 45 | 4.55e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 12 | 41 | 4.55e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 30 | 115 | 4.75e-01 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 20 | 74 | 4.76e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 7 | 22 | 4.76e-01 |
| KEGG | KEGG:04742 | Taste transduction | 7 | 22 | 4.76e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 24 | 91 | 4.80e-01 |
| KEGG | KEGG:04814 | Motor proteins | 38 | 149 | 4.80e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 11 | 38 | 4.80e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 9 | 30 | 4.80e-01 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 45 | 179 | 4.80e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 15 | 54 | 4.80e-01 |
| KEGG | KEGG:03260 | Virion - Human immunodeficiency virus | 1 | 1 | 4.85e-01 |
| KEGG | KEGG:01100 | Metabolic pathways | 269 | 1149 | 4.85e-01 |
| KEGG | KEGG:04217 | Necroptosis | 27 | 104 | 4.85e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 20 | 75 | 4.85e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 21 | 79 | 4.85e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 25 | 96 | 4.93e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 11 | 39 | 5.02e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 6 | 19 | 5.02e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 12 | 43 | 5.02e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 7 | 23 | 5.02e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 15 | 55 | 5.02e-01 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 12 | 43 | 5.02e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 20 | 76 | 5.03e-01 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 28 | 110 | 5.17e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 17 | 64 | 5.17e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 36 | 144 | 5.20e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 14 | 52 | 5.28e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 20 | 77 | 5.29e-01 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 4 | 12 | 5.34e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 24 | 94 | 5.34e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 6 | 20 | 5.47e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 16 | 61 | 5.47e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 13 | 49 | 5.68e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 12 | 45 | 5.74e-01 |
| KEGG | KEGG:04137 | Mitophagy - animal | 25 | 100 | 5.82e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 9 | 33 | 5.89e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 2 | 5 | 5.89e-01 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 7 | 25 | 6.02e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 21 | 84 | 6.05e-01 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 21 | 84 | 6.05e-01 |
| KEGG | KEGG:05162 | Measles | 24 | 97 | 6.06e-01 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 4 | 13 | 6.06e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 13 | 51 | 6.38e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 17 | 68 | 6.38e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 8 | 30 | 6.40e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 26 | 108 | 6.80e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 8 | 31 | 6.81e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 4 | 14 | 6.81e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 4 | 14 | 6.81e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 20 | 83 | 6.81e-01 |
| KEGG | KEGG:03410 | Base excision repair | 11 | 44 | 6.81e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 21 | 87 | 6.81e-01 |
| KEGG | KEGG:03030 | DNA replication | 9 | 35 | 6.81e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 3 | 10 | 6.81e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 20 | 83 | 6.81e-01 |
| KEGG | KEGG:00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 1 | 2 | 6.81e-01 |
| KEGG | KEGG:03267 | Virion - Adenovirus | 1 | 2 | 6.81e-01 |
| KEGG | KEGG:05131 | Shigellosis | 49 | 210 | 6.87e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 19 | 79 | 6.88e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 5 | 19 | 7.15e-01 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 11 | 45 | 7.16e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 16 | 67 | 7.22e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 7 | 28 | 7.25e-01 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 7 | 28 | 7.25e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 7 | 28 | 7.25e-01 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 12 | 50 | 7.32e-01 |
| KEGG | KEGG:05145 | Toxoplasmosis | 19 | 81 | 7.39e-01 |
| KEGG | KEGG:00062 | Fatty acid elongation | 6 | 24 | 7.39e-01 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 8 | 33 | 7.44e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 13 | 55 | 7.44e-01 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 8 | 33 | 7.44e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 10 | 42 | 7.50e-01 |
| KEGG | KEGG:05144 | Malaria | 5 | 20 | 7.50e-01 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 30 | 131 | 7.57e-01 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 7 | 29 | 7.57e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 4 | 16 | 7.73e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 5 | 21 | 7.98e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 3 | 12 | 7.98e-01 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 13 | 57 | 7.98e-01 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 5 | 21 | 7.98e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 3 | 12 | 7.98e-01 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 8.04e-01 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 6 | 26 | 8.09e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 14 | 62 | 8.09e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 8 | 35 | 8.09e-01 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 6 | 26 | 8.09e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 13 | 58 | 8.11e-01 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 9 | 40 | 8.11e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 11 | 49 | 8.11e-01 |
| KEGG | KEGG:03022 | Basal transcription factors | 9 | 40 | 8.11e-01 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 4 | 17 | 8.11e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 23 | 104 | 8.17e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 5 | 22 | 8.17e-01 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 2 | 8 | 8.17e-01 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 5 | 22 | 8.17e-01 |
| KEGG | KEGG:00350 | Tyrosine metabolism | 3 | 13 | 8.32e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 27 | 123 | 8.35e-01 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 4 | 18 | 8.46e-01 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 10 | 46 | 8.48e-01 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 23 | 106 | 8.57e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 29 | 134 | 8.69e-01 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 21 | 99 | 8.75e-01 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 2 | 9 | 8.75e-01 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 6 | 29 | 8.75e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 21 | 99 | 8.75e-01 |
| KEGG | KEGG:04145 | Phagosome | 21 | 99 | 8.75e-01 |
| KEGG | KEGG:05034 | Alcoholism | 24 | 113 | 8.75e-01 |
| KEGG | KEGG:02010 | ABC transporters | 6 | 29 | 8.75e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 4 | 19 | 8.75e-01 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 8 | 38 | 8.75e-01 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1 | 4 | 8.75e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 10 | 48 | 8.75e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 35 | 163 | 8.75e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 33 | 153 | 8.75e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 11 | 53 | 8.82e-01 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 10 | 49 | 8.87e-01 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 9 | 44 | 8.87e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 9 | 44 | 8.87e-01 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 3 | 15 | 8.87e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 2 | 10 | 8.87e-01 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 10 | 49 | 8.87e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 2 | 10 | 8.87e-01 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 5 | 25 | 8.87e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 12 | 59 | 8.93e-01 |
| KEGG | KEGG:00360 | Phenylalanine metabolism | 1 | 5 | 9.09e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 1 | 5 | 9.09e-01 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 6 | 31 | 9.16e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 3 | 16 | 9.18e-01 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 7 | 37 | 9.43e-01 |
| KEGG | KEGG:00071 | Fatty acid degradation | 6 | 32 | 9.43e-01 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 4 | 22 | 9.46e-01 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 2 | 12 | 9.51e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 2 | 12 | 9.51e-01 |
| KEGG | KEGG:00340 | Histidine metabolism | 2 | 12 | 9.51e-01 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 5 | 28 | 9.51e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 8 | 43 | 9.51e-01 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 1 | 6 | 9.51e-01 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 1 | 6 | 9.51e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 2 | 12 | 9.51e-01 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 4 | 23 | 9.54e-01 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 8 | 44 | 9.55e-01 |
| KEGG | KEGG:04146 | Peroxisome | 13 | 69 | 9.55e-01 |
| KEGG | KEGG:00670 | One carbon pool by folate | 3 | 18 | 9.55e-01 |
| KEGG | KEGG:00790 | Folate biosynthesis | 3 | 18 | 9.55e-01 |
| KEGG | KEGG:01523 | Antifolate resistance | 4 | 24 | 9.70e-01 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 3 | 19 | 9.82e-01 |
| KEGG | KEGG:03060 | Protein export | 5 | 30 | 9.82e-01 |
| KEGG | KEGG:05416 | Viral myocarditis | 8 | 46 | 9.85e-01 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 60 | 303 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 4 | 35 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 60 | 416 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 20 | 115 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 34 | 225 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 32 | 218 | 1.00e+00 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 3 | 21 | 1.00e+00 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 1 | 13 | 1.00e+00 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 3 | 25 | 1.00e+00 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 10 | 60 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 46 | 255 | 1.00e+00 |
| KEGG | KEGG:00920 | Sulfur metabolism | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 6 | 44 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 73 | 384 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 18 | 98 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 4 | 38 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 55 | 314 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 11 | 127 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 3 | 52 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 32 | 177 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 9 | 69 | 1.00e+00 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 2 | 27 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 4 | 41 | 1.00e+00 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 17 | 100 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 4 | 31 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 8 | 50 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 11 | 106 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 6 | 75 | 1.00e+00 |
| KEGG | KEGG:05219 | Bladder cancer | 5 | 37 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 20 | 117 | 1.00e+00 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 1 | 11 | 1.00e+00 |
| KEGG | KEGG:04122 | Sulfur relay system | 1 | 8 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 32 | 195 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 6 | 51 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 4 | 39 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 24 | 162 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 12 | 85 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 12 | 74 | 1.00e+00 |
| KEGG | KEGG:03020 | RNA polymerase | 2 | 34 | 1.00e+00 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 3 | 23 | 1.00e+00 |
| KEGG | KEGG:00511 | Other glycan degradation | 2 | 16 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 33 | 185 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 27 | 168 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 11 | 132 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 3 | 42 | 1.00e+00 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 17 | 99 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 6 | 46 | 1.00e+00 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 2 | 17 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 19 | 160 | 1.00e+00 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 995 | 4830 | 8.12e-15 |
| GO:BP | GO:0048731 | system development | 646 | 2903 | 1.05e-14 |
| GO:BP | GO:0007275 | multicellular organism development | 732 | 3383 | 2.04e-14 |
| GO:BP | GO:0032502 | developmental process | 927 | 4475 | 2.11e-14 |
| GO:BP | GO:0048856 | anatomical structure development | 865 | 4130 | 2.41e-14 |
| GO:BP | GO:0007154 | cell communication | 872 | 4248 | 5.20e-12 |
| GO:BP | GO:0023052 | signaling | 858 | 4180 | 8.47e-12 |
| GO:BP | GO:0065007 | biological regulation | 1549 | 8275 | 8.47e-12 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 449 | 1951 | 8.47e-12 |
| GO:BP | GO:0072359 | circulatory system development | 238 | 896 | 1.13e-11 |
| GO:BP | GO:0050789 | regulation of biological process | 1507 | 8037 | 2.54e-11 |
| GO:BP | GO:0050794 | regulation of cellular process | 1443 | 7651 | 3.46e-11 |
| GO:BP | GO:0048869 | cellular developmental process | 633 | 2988 | 3.32e-10 |
| GO:BP | GO:0030154 | cell differentiation | 632 | 2987 | 4.23e-10 |
| GO:BP | GO:0051716 | cellular response to stimulus | 977 | 4933 | 4.36e-10 |
| GO:BP | GO:0007165 | signal transduction | 786 | 3846 | 4.51e-10 |
| GO:BP | GO:0050896 | response to stimulus | 1113 | 5732 | 5.90e-10 |
| GO:BP | GO:0048513 | animal organ development | 472 | 2130 | 5.90e-10 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 455 | 2052 | 1.50e-09 |
| GO:BP | GO:0044057 | regulation of system process | 122 | 399 | 1.56e-09 |
| GO:BP | GO:0009888 | tissue development | 334 | 1425 | 2.03e-09 |
| GO:BP | GO:0050793 | regulation of developmental process | 405 | 1801 | 3.74e-09 |
| GO:BP | GO:0048518 | positive regulation of biological process | 904 | 4561 | 4.54e-09 |
| GO:BP | GO:0007507 | heart development | 146 | 515 | 5.81e-09 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 221 | 876 | 1.11e-08 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 837 | 4198 | 1.25e-08 |
| GO:BP | GO:0003008 | system process | 285 | 1201 | 1.81e-08 |
| GO:BP | GO:0014706 | striated muscle tissue development | 76 | 218 | 1.81e-08 |
| GO:BP | GO:0090257 | regulation of muscle system process | 65 | 181 | 1.04e-07 |
| GO:BP | GO:0048468 | cell development | 433 | 1999 | 1.27e-07 |
| GO:BP | GO:0007399 | nervous system development | 414 | 1903 | 1.84e-07 |
| GO:BP | GO:0010646 | regulation of cell communication | 542 | 2601 | 2.44e-07 |
| GO:BP | GO:0048519 | negative regulation of biological process | 798 | 4037 | 2.82e-07 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 70 | 206 | 3.03e-07 |
| GO:BP | GO:0060537 | muscle tissue development | 104 | 353 | 3.72e-07 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 753 | 3804 | 8.63e-07 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 315 | 1403 | 9.12e-07 |
| GO:BP | GO:0035556 | intracellular signal transduction | 441 | 2079 | 1.29e-06 |
| GO:BP | GO:0003013 | circulatory system process | 122 | 446 | 1.87e-06 |
| GO:BP | GO:0023051 | regulation of signaling | 534 | 2597 | 2.24e-06 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 255 | 1111 | 4.10e-06 |
| GO:BP | GO:0008015 | blood circulation | 105 | 374 | 4.52e-06 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 174 | 710 | 8.96e-06 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 225 | 967 | 9.05e-06 |
| GO:BP | GO:0055001 | muscle cell development | 57 | 169 | 1.07e-05 |
| GO:BP | GO:0008016 | regulation of heart contraction | 57 | 170 | 1.32e-05 |
| GO:BP | GO:0009966 | regulation of signal transduction | 475 | 2307 | 1.46e-05 |
| GO:BP | GO:0003012 | muscle system process | 95 | 339 | 2.05e-05 |
| GO:BP | GO:0022008 | neurogenesis | 291 | 1327 | 3.20e-05 |
| GO:BP | GO:0008283 | cell population proliferation | 302 | 1386 | 3.33e-05 |
| GO:BP | GO:0042692 | muscle cell differentiation | 93 | 334 | 3.63e-05 |
| GO:BP | GO:0061061 | muscle structure development | 140 | 559 | 4.26e-05 |
| GO:BP | GO:0003015 | heart process | 65 | 210 | 4.26e-05 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 578 | 2902 | 4.47e-05 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 253 | 1134 | 4.66e-05 |
| GO:BP | GO:0035239 | tube morphogenesis | 161 | 668 | 7.01e-05 |
| GO:BP | GO:1903522 | regulation of blood circulation | 62 | 200 | 7.02e-05 |
| GO:BP | GO:0007267 | cell-cell signaling | 256 | 1156 | 7.14e-05 |
| GO:BP | GO:0065008 | regulation of biological quality | 420 | 2039 | 7.93e-05 |
| GO:BP | GO:0060419 | heart growth | 30 | 72 | 7.93e-05 |
| GO:BP | GO:0035295 | tube development | 192 | 827 | 8.14e-05 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 394 | 1900 | 9.15e-05 |
| GO:BP | GO:0016477 | cell migration | 240 | 1078 | 1.01e-04 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 29 | 70 | 1.32e-04 |
| GO:BP | GO:0048589 | developmental growth | 131 | 527 | 1.32e-04 |
| GO:BP | GO:0048699 | generation of neurons | 252 | 1145 | 1.32e-04 |
| GO:BP | GO:0060047 | heart contraction | 61 | 200 | 1.37e-04 |
| GO:BP | GO:0030029 | actin filament-based process | 161 | 677 | 1.38e-04 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 158 | 662 | 1.38e-04 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 229 | 1027 | 1.47e-04 |
| GO:BP | GO:0060322 | head development | 142 | 583 | 1.47e-04 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 70 | 242 | 1.84e-04 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 30 | 75 | 1.84e-04 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 230 | 1036 | 1.88e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 73 | 256 | 1.92e-04 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 225 | 1011 | 2.00e-04 |
| GO:BP | GO:0021537 | telencephalon development | 62 | 208 | 2.30e-04 |
| GO:BP | GO:0014896 | muscle hypertrophy | 30 | 76 | 2.39e-04 |
| GO:BP | GO:0035265 | organ growth | 44 | 132 | 2.82e-04 |
| GO:BP | GO:0001568 | blood vessel development | 133 | 546 | 2.82e-04 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 149 | 626 | 2.83e-04 |
| GO:BP | GO:0007417 | central nervous system development | 173 | 748 | 2.92e-04 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 24 | 55 | 2.93e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 27 | 66 | 3.19e-04 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 247 | 1135 | 3.26e-04 |
| GO:BP | GO:0001944 | vasculature development | 138 | 573 | 3.26e-04 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 249 | 1146 | 3.32e-04 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 29 | 74 | 3.72e-04 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 265 | 1233 | 3.74e-04 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 123 | 501 | 3.99e-04 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 122 | 497 | 4.30e-04 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 122 | 497 | 4.30e-04 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 33 | 90 | 4.31e-04 |
| GO:BP | GO:0032879 | regulation of localization | 318 | 1521 | 4.42e-04 |
| GO:BP | GO:0007155 | cell adhesion | 221 | 1004 | 4.51e-04 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 17 | 33 | 4.69e-04 |
| GO:BP | GO:0048870 | cell motility | 256 | 1190 | 4.76e-04 |
| GO:BP | GO:0030048 | actin filament-based movement | 38 | 111 | 5.36e-04 |
| GO:BP | GO:0016043 | cellular component organization | 955 | 5139 | 5.39e-04 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 147 | 625 | 5.39e-04 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 205 | 926 | 6.51e-04 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 26 | 65 | 6.54e-04 |
| GO:BP | GO:0009790 | embryo development | 193 | 864 | 6.64e-04 |
| GO:BP | GO:0009987 | cellular process | 1987 | 11450 | 6.64e-04 |
| GO:BP | GO:0099536 | synaptic signaling | 125 | 518 | 7.07e-04 |
| GO:BP | GO:0007420 | brain development | 129 | 539 | 7.76e-04 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 26 | 66 | 8.66e-04 |
| GO:BP | GO:0030900 | forebrain development | 78 | 292 | 8.82e-04 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 401 | 1992 | 9.52e-04 |
| GO:BP | GO:0030182 | neuron differentiation | 233 | 1080 | 9.52e-04 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 113 | 462 | 9.57e-04 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 18 | 38 | 9.67e-04 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 288 | 1376 | 1.02e-03 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 260 | 1227 | 1.11e-03 |
| GO:BP | GO:0048638 | regulation of developmental growth | 70 | 257 | 1.15e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 28 | 75 | 1.22e-03 |
| GO:BP | GO:0061337 | cardiac conduction | 31 | 87 | 1.29e-03 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 13 | 23 | 1.38e-03 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 41 | 129 | 1.51e-03 |
| GO:BP | GO:0002027 | regulation of heart rate | 30 | 84 | 1.63e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 21 | 50 | 1.72e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 36 | 109 | 1.85e-03 |
| GO:BP | GO:0008150 | biological_process | 2075 | 12051 | 1.91e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 47 | 157 | 2.14e-03 |
| GO:BP | GO:0030097 | hemopoiesis | 151 | 664 | 2.16e-03 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 100 | 407 | 2.19e-03 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 24 | 62 | 2.24e-03 |
| GO:BP | GO:0030030 | cell projection organization | 264 | 1262 | 2.25e-03 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 13 | 24 | 2.32e-03 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 13 | 24 | 2.32e-03 |
| GO:BP | GO:0048729 | tissue morphogenesis | 114 | 478 | 2.44e-03 |
| GO:BP | GO:0040007 | growth | 165 | 739 | 2.52e-03 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 20 | 48 | 2.82e-03 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 103 | 425 | 2.86e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 24 | 63 | 2.87e-03 |
| GO:BP | GO:0031175 | neuron projection development | 175 | 794 | 3.02e-03 |
| GO:BP | GO:0048880 | sensory system development | 72 | 275 | 3.08e-03 |
| GO:BP | GO:0042592 | homeostatic process | 252 | 1204 | 3.10e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 45 | 151 | 3.16e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 111 | 467 | 3.36e-03 |
| GO:BP | GO:0001654 | eye development | 71 | 272 | 3.74e-03 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 13 | 25 | 3.75e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 25 | 68 | 3.78e-03 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 29 | 84 | 3.82e-03 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 113 | 479 | 3.90e-03 |
| GO:BP | GO:0019933 | cAMP-mediated signaling | 16 | 35 | 3.93e-03 |
| GO:BP | GO:0150063 | visual system development | 71 | 273 | 4.06e-03 |
| GO:BP | GO:0031032 | actomyosin structure organization | 53 | 189 | 4.15e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 41 | 136 | 4.73e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 28 | 81 | 4.76e-03 |
| GO:BP | GO:0042391 | regulation of membrane potential | 76 | 299 | 5.04e-03 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 166 | 756 | 5.23e-03 |
| GO:BP | GO:0048666 | neuron development | 192 | 894 | 5.51e-03 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 13 | 26 | 5.85e-03 |
| GO:BP | GO:0040011 | locomotion | 185 | 858 | 5.85e-03 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 7 | 9 | 5.87e-03 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 181 | 837 | 5.87e-03 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 19 | 47 | 6.02e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 348 | 1746 | 6.17e-03 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 117 | 506 | 6.17e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 267 | 1301 | 6.17e-03 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 11 | 20 | 6.17e-03 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 164 | 749 | 6.17e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 35 | 112 | 6.17e-03 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 11 | 20 | 6.17e-03 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 11 | 20 | 6.17e-03 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 10 | 17 | 6.17e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 389 | 1974 | 6.17e-03 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 10 | 17 | 6.17e-03 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 10 | 17 | 6.17e-03 |
| GO:BP | GO:0001508 | action potential | 34 | 108 | 6.49e-03 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 96 | 401 | 6.55e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 267 | 1304 | 7.06e-03 |
| GO:BP | GO:0061448 | connective tissue development | 58 | 217 | 7.06e-03 |
| GO:BP | GO:0030334 | regulation of cell migration | 156 | 710 | 7.07e-03 |
| GO:BP | GO:0043010 | camera-type eye development | 62 | 236 | 7.07e-03 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 38 | 126 | 7.07e-03 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 14 | 30 | 7.07e-03 |
| GO:BP | GO:0034330 | cell junction organization | 133 | 591 | 7.37e-03 |
| GO:BP | GO:0043500 | muscle adaptation | 30 | 92 | 7.54e-03 |
| GO:BP | GO:0051899 | membrane depolarization | 22 | 60 | 8.56e-03 |
| GO:BP | GO:0040012 | regulation of locomotion | 166 | 766 | 8.77e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 289 | 1430 | 8.94e-03 |
| GO:BP | GO:0006936 | muscle contraction | 68 | 267 | 8.96e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 18 | 45 | 8.96e-03 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 18 | 45 | 8.96e-03 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 34 | 110 | 8.96e-03 |
| GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 12 | 24 | 8.96e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 476 | 2474 | 8.96e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 78 | 316 | 9.06e-03 |
| GO:BP | GO:0007010 | cytoskeleton organization | 250 | 1218 | 9.07e-03 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 226 | 1088 | 9.08e-03 |
| GO:BP | GO:0042221 | response to chemical | 469 | 2436 | 9.25e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 384 | 1959 | 9.42e-03 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 11 | 21 | 9.42e-03 |
| GO:BP | GO:0006271 | DNA strand elongation involved in DNA replication | 9 | 15 | 9.42e-03 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 11 | 21 | 9.42e-03 |
| GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 10 | 18 | 9.76e-03 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 14 | 31 | 9.76e-03 |
| GO:BP | GO:0000902 | cell morphogenesis | 165 | 764 | 9.96e-03 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 529 | 2780 | 1.02e-02 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 373 | 1900 | 1.02e-02 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 78 | 318 | 1.05e-02 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 38 | 129 | 1.06e-02 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 364 | 1852 | 1.10e-02 |
| GO:BP | GO:2000145 | regulation of cell motility | 161 | 745 | 1.11e-02 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 256 | 1256 | 1.11e-02 |
| GO:BP | GO:0051049 | regulation of transport | 239 | 1164 | 1.14e-02 |
| GO:BP | GO:0007423 | sensory organ development | 94 | 399 | 1.16e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 36 | 121 | 1.20e-02 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 102 | 440 | 1.20e-02 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 42 | 148 | 1.20e-02 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 25 | 74 | 1.20e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 162 | 752 | 1.20e-02 |
| GO:BP | GO:0014032 | neural crest cell development | 24 | 70 | 1.21e-02 |
| GO:BP | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration | 7 | 10 | 1.21e-02 |
| GO:BP | GO:0071872 | cellular response to epinephrine stimulus | 7 | 10 | 1.21e-02 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 90 | 380 | 1.23e-02 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 29 | 91 | 1.24e-02 |
| GO:BP | GO:0006941 | striated muscle contraction | 43 | 153 | 1.24e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 124 | 554 | 1.24e-02 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 143 | 653 | 1.24e-02 |
| GO:BP | GO:0030001 | metal ion transport | 124 | 554 | 1.24e-02 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 177 | 833 | 1.25e-02 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 133 | 601 | 1.26e-02 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 49 | 181 | 1.26e-02 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 108 | 472 | 1.26e-02 |
| GO:BP | GO:0071310 | cellular response to organic substance | 276 | 1370 | 1.26e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 14 | 32 | 1.28e-02 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 45 | 163 | 1.35e-02 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 115 | 509 | 1.35e-02 |
| GO:BP | GO:0007389 | pattern specification process | 75 | 307 | 1.37e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 19 | 51 | 1.44e-02 |
| GO:BP | GO:0071679 | commissural neuron axon guidance | 8 | 13 | 1.44e-02 |
| GO:BP | GO:0045165 | cell fate commitment | 44 | 159 | 1.44e-02 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 21 | 59 | 1.47e-02 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 13 | 29 | 1.50e-02 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 13 | 29 | 1.50e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 13 | 29 | 1.50e-02 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 967 | 5340 | 1.61e-02 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 12 | 26 | 1.76e-02 |
| GO:BP | GO:1904738 | vascular associated smooth muscle cell migration | 12 | 26 | 1.76e-02 |
| GO:BP | GO:0003418 | growth plate cartilage chondrocyte differentiation | 6 | 8 | 1.76e-02 |
| GO:BP | GO:0060509 | type I pneumocyte differentiation | 6 | 8 | 1.76e-02 |
| GO:BP | GO:0003007 | heart morphogenesis | 57 | 222 | 1.76e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 119 | 534 | 1.77e-02 |
| GO:BP | GO:0001656 | metanephros development | 22 | 64 | 1.80e-02 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 371 | 1908 | 1.85e-02 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 32 | 107 | 1.94e-02 |
| GO:BP | GO:0099643 | signal release from synapse | 32 | 107 | 1.94e-02 |
| GO:BP | GO:0030010 | establishment of cell polarity | 38 | 134 | 1.97e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 11 | 23 | 2.02e-02 |
| GO:BP | GO:0070528 | protein kinase C signaling | 11 | 23 | 2.02e-02 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 54 | 209 | 2.02e-02 |
| GO:BP | GO:0048568 | embryonic organ development | 76 | 317 | 2.07e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 28 | 90 | 2.07e-02 |
| GO:BP | GO:0031018 | endocrine pancreas development | 13 | 30 | 2.08e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 57 | 224 | 2.12e-02 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 153 | 716 | 2.13e-02 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 138 | 637 | 2.18e-02 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 825 | 4521 | 2.21e-02 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 213 | 1040 | 2.28e-02 |
| GO:BP | GO:0043697 | cell dedifferentiation | 5 | 6 | 2.42e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 92 | 400 | 2.42e-02 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 258 | 1288 | 2.42e-02 |
| GO:BP | GO:0043949 | regulation of cAMP-mediated signaling | 9 | 17 | 2.42e-02 |
| GO:BP | GO:0061026 | cardiac muscle tissue regeneration | 5 | 6 | 2.42e-02 |
| GO:BP | GO:0048790 | maintenance of presynaptic active zone structure | 5 | 6 | 2.42e-02 |
| GO:BP | GO:0043434 | response to peptide hormone | 77 | 324 | 2.42e-02 |
| GO:BP | GO:0043696 | dedifferentiation | 5 | 6 | 2.42e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 12 | 27 | 2.44e-02 |
| GO:BP | GO:0086069 | bundle of His cell to Purkinje myocyte communication | 8 | 14 | 2.48e-02 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 119 | 540 | 2.50e-02 |
| GO:BP | GO:0055002 | striated muscle cell development | 23 | 70 | 2.52e-02 |
| GO:BP | GO:0019222 | regulation of metabolic process | 891 | 4914 | 2.52e-02 |
| GO:BP | GO:0050890 | cognition | 58 | 231 | 2.54e-02 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 116 | 525 | 2.58e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 26 | 83 | 2.64e-02 |
| GO:BP | GO:0098910 | regulation of atrial cardiac muscle cell action potential | 4 | 4 | 2.68e-02 |
| GO:BP | GO:0071242 | cellular response to ammonium ion | 4 | 4 | 2.68e-02 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 25 | 79 | 2.77e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 313 | 1597 | 2.79e-02 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 104 | 464 | 2.79e-02 |
| GO:BP | GO:0098868 | bone growth | 11 | 24 | 2.83e-02 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 24 | 75 | 2.86e-02 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 121 | 553 | 2.86e-02 |
| GO:BP | GO:0048864 | stem cell development | 24 | 75 | 2.86e-02 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 80 | 342 | 2.92e-02 |
| GO:BP | GO:0048588 | developmental cell growth | 50 | 194 | 2.94e-02 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 56 | 223 | 2.95e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 14 | 35 | 3.01e-02 |
| GO:BP | GO:0060429 | epithelium development | 174 | 836 | 3.01e-02 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 47 | 180 | 3.02e-02 |
| GO:BP | GO:0098609 | cell-cell adhesion | 131 | 607 | 3.06e-02 |
| GO:BP | GO:0030239 | myofibril assembly | 22 | 67 | 3.06e-02 |
| GO:BP | GO:0045055 | regulated exocytosis | 41 | 152 | 3.11e-02 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 80 | 343 | 3.11e-02 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 255 | 1279 | 3.11e-02 |
| GO:BP | GO:0002521 | leukocyte differentiation | 90 | 394 | 3.11e-02 |
| GO:BP | GO:0050877 | nervous system process | 136 | 634 | 3.11e-02 |
| GO:BP | GO:0006950 | response to stress | 510 | 2715 | 3.11e-02 |
| GO:BP | GO:0003254 | regulation of membrane depolarization | 15 | 39 | 3.11e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 36 | 129 | 3.12e-02 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 439 | 2311 | 3.13e-02 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 10 | 21 | 3.15e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 16 | 43 | 3.18e-02 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 12 | 28 | 3.18e-02 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 51 | 200 | 3.18e-02 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 12 | 28 | 3.18e-02 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 62 | 254 | 3.27e-02 |
| GO:BP | GO:1901698 | response to nitrogen compound | 162 | 774 | 3.27e-02 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 116 | 530 | 3.29e-02 |
| GO:BP | GO:0035107 | appendage morphogenesis | 33 | 116 | 3.35e-02 |
| GO:BP | GO:0035108 | limb morphogenesis | 33 | 116 | 3.35e-02 |
| GO:BP | GO:0046620 | regulation of organ growth | 23 | 72 | 3.38e-02 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 23 | 72 | 3.38e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 104 | 468 | 3.38e-02 |
| GO:BP | GO:0060173 | limb development | 39 | 144 | 3.39e-02 |
| GO:BP | GO:1990709 | presynaptic active zone organization | 6 | 9 | 3.39e-02 |
| GO:BP | GO:0006468 | protein phosphorylation | 205 | 1008 | 3.39e-02 |
| GO:BP | GO:0030903 | notochord development | 9 | 18 | 3.39e-02 |
| GO:BP | GO:0048736 | appendage development | 39 | 144 | 3.39e-02 |
| GO:BP | GO:0006836 | neurotransmitter transport | 39 | 144 | 3.39e-02 |
| GO:BP | GO:0086016 | AV node cell action potential | 6 | 9 | 3.39e-02 |
| GO:BP | GO:0051481 | negative regulation of cytosolic calcium ion concentration | 6 | 9 | 3.39e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 230 | 1145 | 3.39e-02 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 96 | 427 | 3.39e-02 |
| GO:BP | GO:0086027 | AV node cell to bundle of His cell signaling | 6 | 9 | 3.39e-02 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 113 | 515 | 3.39e-02 |
| GO:BP | GO:1901652 | response to peptide | 87 | 381 | 3.43e-02 |
| GO:BP | GO:0031641 | regulation of myelination | 14 | 36 | 3.66e-02 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 11 | 25 | 3.66e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 11 | 25 | 3.66e-02 |
| GO:BP | GO:0003417 | growth plate cartilage development | 8 | 15 | 3.69e-02 |
| GO:BP | GO:0072202 | cell differentiation involved in metanephros development | 8 | 15 | 3.69e-02 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 31 | 108 | 3.72e-02 |
| GO:BP | GO:0010889 | regulation of sequestering of triglyceride | 7 | 12 | 3.74e-02 |
| GO:BP | GO:0031643 | positive regulation of myelination | 7 | 12 | 3.74e-02 |
| GO:BP | GO:0071871 | response to epinephrine | 7 | 12 | 3.74e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 15 | 40 | 3.75e-02 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 129 | 602 | 3.81e-02 |
| GO:BP | GO:0023056 | positive regulation of signaling | 256 | 1292 | 3.81e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 17 | 48 | 3.82e-02 |
| GO:BP | GO:0035270 | endocrine system development | 26 | 86 | 3.82e-02 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 480 | 2555 | 3.96e-02 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 387 | 2028 | 4.16e-02 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 33 | 118 | 4.16e-02 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 27 | 91 | 4.19e-02 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 27 | 91 | 4.19e-02 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 383 | 2006 | 4.21e-02 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 63 | 263 | 4.37e-02 |
| GO:BP | GO:0019725 | cellular homeostasis | 127 | 594 | 4.38e-02 |
| GO:BP | GO:0060284 | regulation of cell development | 129 | 605 | 4.48e-02 |
| GO:BP | GO:0006812 | monoatomic cation transport | 138 | 653 | 4.49e-02 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 83 | 365 | 4.63e-02 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 168 | 815 | 4.67e-02 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 88 | 391 | 4.71e-02 |
| GO:BP | GO:0072001 | renal system development | 61 | 254 | 4.71e-02 |
| GO:BP | GO:0003002 | regionalization | 65 | 274 | 4.71e-02 |
| GO:BP | GO:0060042 | retina morphogenesis in camera-type eye | 15 | 41 | 4.72e-02 |
| GO:BP | GO:0001775 | cell activation | 140 | 665 | 4.77e-02 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 27 | 92 | 4.81e-02 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 27 | 92 | 4.81e-02 |
| GO:BP | GO:0001764 | neuron migration | 37 | 138 | 4.90e-02 |
| GO:BP | GO:1904407 | positive regulation of nitric oxide metabolic process | 11 | 26 | 4.92e-02 |
| GO:BP | GO:0031646 | positive regulation of nervous system process | 9 | 19 | 4.93e-02 |
| GO:BP | GO:0016310 | phosphorylation | 240 | 1211 | 4.96e-02 |
| GO:BP | GO:0003014 | renal system process | 24 | 79 | 4.97e-02 |
| GO:BP | GO:0008654 | phospholipid biosynthetic process | 56 | 230 | 4.97e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 43 | 127 | 6.44e-04 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 47 | 151 | 1.52e-03 |
| KEGG | KEGG:04911 | Insulin secretion | 25 | 64 | 1.92e-03 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 27 | 82 | 1.89e-02 |
| KEGG | KEGG:04360 | Axon guidance | 45 | 162 | 1.89e-02 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 38 | 132 | 1.92e-02 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 31 | 102 | 1.92e-02 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 18 | 48 | 1.92e-02 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 25 | 77 | 2.00e-02 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 29 | 98 | 3.37e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 35 | 125 | 3.37e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 19 | 56 | 3.56e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 43 | 164 | 3.56e-02 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 23 | 75 | 4.64e-02 |
| KEGG | KEGG:05142 | Chagas disease | 23 | 75 | 4.64e-02 |
| KEGG | KEGG:04611 | Platelet activation | 26 | 89 | 4.70e-02 |
| KEGG | KEGG:04730 | Long-term depression | 15 | 42 | 4.70e-02 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 22 | 72 | 5.04e-02 |
| KEGG | KEGG:05030 | Cocaine addiction | 13 | 35 | 5.40e-02 |
| KEGG | KEGG:04713 | Circadian entrainment | 21 | 69 | 5.90e-02 |
| KEGG | KEGG:03410 | Base excision repair | 15 | 44 | 6.05e-02 |
| KEGG | KEGG:04725 | Cholinergic synapse | 24 | 83 | 6.05e-02 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 41 | 164 | 6.44e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 32 | 121 | 6.44e-02 |
| KEGG | KEGG:04740 | Olfactory transduction | 10 | 25 | 6.61e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 14 | 41 | 6.72e-02 |
| KEGG | KEGG:04814 | Motor proteins | 37 | 149 | 9.28e-02 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 17 | 56 | 9.75e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 26 | 97 | 9.75e-02 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 23 | 84 | 1.08e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 19 | 67 | 1.25e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 25 | 95 | 1.25e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 10 | 28 | 1.25e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 24 | 91 | 1.32e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 23 | 87 | 1.42e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 19 | 69 | 1.55e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 34 | 142 | 1.57e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 18 | 66 | 1.79e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 9 | 26 | 1.79e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 15 | 52 | 1.79e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 28 | 115 | 1.90e-01 |
| KEGG | KEGG:03030 | DNA replication | 11 | 35 | 1.90e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 40 | 176 | 1.90e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 39 | 172 | 2.00e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 20 | 77 | 2.00e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 17 | 63 | 2.00e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 6 | 15 | 2.01e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 25 | 102 | 2.01e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 19 | 74 | 2.26e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 15 | 55 | 2.26e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 20 | 79 | 2.26e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 26 | 110 | 2.52e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 54 | 256 | 2.52e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 21 | 86 | 2.59e-01 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 25 | 106 | 2.59e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 31 | 136 | 2.59e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 25 | 106 | 2.59e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 14 | 53 | 2.78e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 14 | 53 | 2.78e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 26 | 112 | 2.78e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 21 | 87 | 2.78e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 15 | 58 | 2.81e-01 |
| KEGG | KEGG:04540 | Gap junction | 18 | 73 | 2.89e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 13 | 49 | 2.93e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 24 | 104 | 2.93e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 51 | 246 | 2.93e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 32 | 145 | 2.93e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 16 | 64 | 2.93e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 16 | 64 | 2.93e-01 |
| KEGG | KEGG:05133 | Pertussis | 12 | 45 | 3.02e-01 |
| KEGG | KEGG:04924 | Renin secretion | 13 | 50 | 3.07e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 14 | 55 | 3.09e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 26 | 116 | 3.10e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 4 | 10 | 3.10e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 4 | 10 | 3.10e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 11 | 41 | 3.10e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 5 | 14 | 3.10e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 22 | 96 | 3.15e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 20 | 86 | 3.18e-01 |
| KEGG | KEGG:04976 | Bile secretion | 11 | 42 | 3.43e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 9 | 33 | 3.63e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 79 | 408 | 3.63e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 54 | 271 | 3.74e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 23 | 104 | 3.74e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 7 | 24 | 3.74e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 3.74e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 21 | 94 | 3.74e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 37 | 179 | 3.74e-01 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 20 | 89 | 3.75e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 19 | 84 | 3.77e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 14 | 59 | 3.95e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 28 | 134 | 4.21e-01 |
| KEGG | KEGG:05164 | Influenza A | 22 | 102 | 4.21e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 8 | 30 | 4.21e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 13 | 55 | 4.21e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 9 | 35 | 4.21e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 12 | 50 | 4.21e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 5 | 16 | 4.21e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 17 | 76 | 4.26e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 4 | 12 | 4.28e-01 |
| KEGG | KEGG:04110 | Cell cycle | 31 | 151 | 4.30e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 2 | 4 | 4.32e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 14 | 61 | 4.32e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 13 | 56 | 4.32e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 8 | 31 | 4.33e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 23 | 109 | 4.41e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 17 | 78 | 4.43e-01 |
| KEGG | KEGG:04742 | Taste transduction | 6 | 22 | 4.43e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 17 | 78 | 4.43e-01 |
| KEGG | KEGG:00650 | Butanoate metabolism | 5 | 17 | 4.43e-01 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 21 | 99 | 4.43e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 20 | 94 | 4.43e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 6 | 22 | 4.43e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 15 | 67 | 4.43e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 25 | 121 | 4.43e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 10 | 42 | 4.47e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 30 | 149 | 4.58e-01 |
| KEGG | KEGG:00232 | Caffeine metabolism | 1 | 1 | 4.75e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 12 | 53 | 4.75e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 18 | 85 | 4.75e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 15 | 69 | 4.75e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 10 | 43 | 4.76e-01 |
| KEGG | KEGG:05034 | Alcoholism | 23 | 113 | 4.92e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 27 | 135 | 4.92e-01 |
| KEGG | KEGG:04520 | Adherens junction | 18 | 86 | 4.92e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 31 | 157 | 4.92e-01 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 11 | 49 | 4.93e-01 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 11 | 49 | 4.93e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 14 | 65 | 4.97e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 16 | 76 | 5.05e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 4 | 14 | 5.05e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 30 | 153 | 5.07e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 12 | 55 | 5.08e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 5 | 19 | 5.08e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 12 | 56 | 5.43e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 17 | 83 | 5.43e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 11 | 51 | 5.56e-01 |
| KEGG | KEGG:00000 | KEGG root term | 989 | 5802 | 5.58e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 17 | 84 | 5.68e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 12 | 57 | 5.73e-01 |
| KEGG | KEGG:01100 | Metabolic pathways | 201 | 1149 | 6.10e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 18 | 91 | 6.11e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 21 | 108 | 6.15e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 17 | 86 | 6.15e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 15 | 75 | 6.15e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 13 | 64 | 6.15e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 19 | 97 | 6.15e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 4 | 16 | 6.16e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 18 | 92 | 6.16e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 4 | 16 | 6.16e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 9 | 43 | 6.25e-01 |
| KEGG | KEGG:04530 | Tight junction | 26 | 138 | 6.25e-01 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 9 | 43 | 6.25e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 13 | 65 | 6.25e-01 |
| KEGG | KEGG:04217 | Necroptosis | 20 | 104 | 6.25e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 10 | 49 | 6.48e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 5 | 22 | 6.52e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 22 | 117 | 6.65e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 20 | 106 | 6.73e-01 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 3 | 12 | 6.78e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 8 | 39 | 6.78e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 3 | 12 | 6.78e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 9 | 45 | 6.97e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 15 | 79 | 7.02e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 21 | 114 | 7.23e-01 |
| KEGG | KEGG:05218 | Melanoma | 11 | 58 | 7.59e-01 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3 | 13 | 7.59e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 11 | 58 | 7.59e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 27 | 151 | 7.75e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 14 | 76 | 7.83e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 4 | 19 | 7.83e-01 |
| KEGG | KEGG:05224 | Breast cancer | 21 | 117 | 7.89e-01 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 7.89e-01 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 11 | 60 | 7.89e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 29 | 165 | 7.89e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 25 | 142 | 7.89e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 6 | 31 | 7.89e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 10 | 54 | 7.89e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 5 | 25 | 7.89e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 30 | 170 | 7.89e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 15 | 83 | 7.89e-01 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 7 | 37 | 7.89e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 18 | 100 | 7.89e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 9 | 49 | 7.92e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 4 | 20 | 7.92e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 15 | 84 | 7.92e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 20 | 113 | 7.92e-01 |
| KEGG | KEGG:05214 | Glioma | 12 | 67 | 8.08e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 25 | 144 | 8.12e-01 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 7 | 38 | 8.12e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 8 | 44 | 8.15e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 10 | 56 | 8.21e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 4 | 21 | 8.30e-01 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 4 | 21 | 8.30e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 7 | 39 | 8.42e-01 |
| KEGG | KEGG:04146 | Peroxisome | 12 | 69 | 8.50e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 17 | 99 | 8.52e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 5 | 28 | 8.55e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 5 | 28 | 8.55e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 1 | 4 | 8.55e-01 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 8 | 46 | 8.55e-01 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 4 | 22 | 8.55e-01 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 5 | 28 | 8.55e-01 |
| KEGG | KEGG:00920 | Sulfur metabolism | 2 | 10 | 8.55e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 2 | 10 | 8.55e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 12 | 71 | 8.78e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 18 | 108 | 8.89e-01 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 4 | 23 | 8.89e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 4 | 23 | 8.89e-01 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 5 | 29 | 8.89e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 24 | 145 | 8.93e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 27 | 163 | 8.93e-01 |
| KEGG | KEGG:05162 | Measles | 16 | 97 | 8.99e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 7 | 42 | 8.99e-01 |
| KEGG | KEGG:00062 | Fatty acid elongation | 4 | 24 | 9.24e-01 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 29 | 179 | 9.26e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 2 | 12 | 9.26e-01 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 8 | 50 | 9.26e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 12 | 75 | 9.26e-01 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 4 | 25 | 9.26e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 16 | 99 | 9.26e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 12 | 75 | 9.26e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 11 | 68 | 9.26e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 1 | 5 | 9.26e-01 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 5 | 31 | 9.26e-01 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 7 | 44 | 9.26e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 2 | 12 | 9.26e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 6 | 38 | 9.33e-01 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 2 | 13 | 9.57e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 3 | 20 | 9.57e-01 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 1 | 6 | 9.57e-01 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 1 | 6 | 9.57e-01 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 4 | 26 | 9.57e-01 |
| KEGG | KEGG:04714 | Thermogenesis | 31 | 195 | 9.57e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 20 | 128 | 9.57e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 3 | 20 | 9.57e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 8 | 52 | 9.57e-01 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 5 | 33 | 9.57e-01 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 13 | 85 | 9.67e-01 |
| KEGG | KEGG:04210 | Apoptosis | 18 | 117 | 9.69e-01 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 18 | 117 | 9.69e-01 |
| KEGG | KEGG:03020 | RNA polymerase | 5 | 34 | 9.69e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 2 | 14 | 9.76e-01 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 26 | 168 | 9.76e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 17 | 112 | 9.76e-01 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 20 | 131 | 9.76e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 7 | 48 | 9.76e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 5 | 35 | 9.80e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 3 | 22 | 9.96e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 3 | 22 | 9.96e-01 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 17 | 115 | 9.98e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 20 | 134 | 9.98e-01 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 2 | 15 | 9.98e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 9 | 63 | 9.98e-01 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 4 | 39 | 1.00e+00 |
| KEGG | KEGG:02010 | ABC transporters | 3 | 29 | 1.00e+00 |
| KEGG | KEGG:00340 | Histidine metabolism | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 1 | 24 | 1.00e+00 |
| KEGG | KEGG:05145 | Toxoplasmosis | 11 | 81 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 5 | 46 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 6 | 51 | 1.00e+00 |
| KEGG | KEGG:05144 | Malaria | 2 | 20 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 3 | 31 | 1.00e+00 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 5 | 45 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 9 | 106 | 1.00e+00 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 1 | 19 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 5 | 38 | 1.00e+00 |
| KEGG | KEGG:05132 | Salmonella infection | 30 | 214 | 1.00e+00 |
| KEGG | KEGG:05131 | Shigellosis | 31 | 210 | 1.00e+00 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 2 | 17 | 1.00e+00 |
| KEGG | KEGG:00071 | Fatty acid degradation | 4 | 32 | 1.00e+00 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 9 | 74 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 6 | 46 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 3 | 25 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 3 | 52 | 1.00e+00 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 14 | 99 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 10 | 98 | 1.00e+00 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 7 | 62 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 10 | 74 | 1.00e+00 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 1 | 21 | 1.00e+00 |
| KEGG | KEGG:05222 | Small cell lung cancer | 12 | 87 | 1.00e+00 |
| KEGG | KEGG:03022 | Basal transcription factors | 3 | 40 | 1.00e+00 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 2 | 26 | 1.00e+00 |
| KEGG | KEGG:05219 | Bladder cancer | 4 | 37 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 6 | 132 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 3 | 42 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 3 | 30 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 4 | 44 | 1.00e+00 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 2 | 22 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 21 | 185 | 1.00e+00 |
| KEGG | KEGG:00790 | Folate biosynthesis | 2 | 18 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 8 | 127 | 1.00e+00 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 2 | 17 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 5 | 75 | 1.00e+00 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 2 | 23 | 1.00e+00 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 1 | 29 | 1.00e+00 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 2 | 27 | 1.00e+00 |
| KEGG | KEGG:00670 | One carbon pool by folate | 2 | 18 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 19 | 162 | 1.00e+00 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 20 | 153 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 35 | 416 | 1.00e+00 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 7 | 59 | 1.00e+00 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:04710 | Circadian rhythm | 4 | 30 | 1.00e+00 |
| KEGG | KEGG:04144 | Endocytosis | 35 | 230 | 1.00e+00 |
| KEGG | KEGG:04145 | Phagosome | 13 | 99 | 1.00e+00 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 3 | 30 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 22 | 177 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 6 | 69 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 10 | 117 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 3 | 40 | 1.00e+00 |
| KEGG | KEGG:04744 | Phototransduction | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 4 | 35 | 1.00e+00 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 6 | 49 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 5 | 50 | 1.00e+00 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 8 | 57 | 1.00e+00 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 16 | 110 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 2 | 41 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 18 | 160 | 1.00e+00 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 3 | 25 | 1.00e+00 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 18 | 123 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 14 | 100 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 30 | 225 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 37 | 303 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 4 | 44 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 36 | 255 | 1.00e+00 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 4 | 33 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 31 | 218 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 51 | 384 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 38 | 314 | 1.00e+00 |
| KEGG | KEGG:04122 | Sulfur relay system | 1 | 8 | 1.00e+00 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 1 | 19 | 1.00e+00 |
| KEGG | KEGG:04115 | p53 signaling pathway | 6 | 66 | 1.00e+00 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 3 | 28 | 1.00e+00 |
NR hyper/hypo
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0051716 | cellular response to stimulus | 1706 | 4933 | 1.36e-18 |
| GO:BP | GO:0050794 | regulation of cellular process | 2511 | 7651 | 1.58e-18 |
| GO:BP | GO:0050789 | regulation of biological process | 2612 | 8037 | 4.64e-17 |
| GO:BP | GO:0050896 | response to stimulus | 1933 | 5732 | 7.02e-17 |
| GO:BP | GO:0065007 | biological regulation | 2675 | 8275 | 1.86e-16 |
| GO:BP | GO:0007165 | signal transduction | 1346 | 3846 | 2.63e-15 |
| GO:BP | GO:0007154 | cell communication | 1470 | 4248 | 2.63e-15 |
| GO:BP | GO:0023052 | signaling | 1445 | 4180 | 9.47e-15 |
| GO:BP | GO:0007275 | multicellular organism development | 1187 | 3383 | 3.26e-13 |
| GO:BP | GO:0048856 | anatomical structure development | 1410 | 4130 | 5.14e-12 |
| GO:BP | GO:0032501 | multicellular organismal process | 1623 | 4830 | 5.24e-12 |
| GO:BP | GO:0048869 | cellular developmental process | 1054 | 2988 | 5.24e-12 |
| GO:BP | GO:0030154 | cell differentiation | 1054 | 2987 | 5.24e-12 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1307 | 3804 | 8.14e-12 |
| GO:BP | GO:0048468 | cell development | 734 | 1999 | 2.32e-11 |
| GO:BP | GO:0032502 | developmental process | 1508 | 4475 | 3.41e-11 |
| GO:BP | GO:0048731 | system development | 1018 | 2903 | 9.38e-11 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 714 | 1951 | 1.10e-10 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1368 | 4037 | 1.69e-10 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1526 | 4561 | 3.01e-10 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1415 | 4198 | 3.06e-10 |
| GO:BP | GO:0048513 | animal organ development | 765 | 2130 | 1.04e-09 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 739 | 2052 | 1.41e-09 |
| GO:BP | GO:0035556 | intracellular signal transduction | 747 | 2079 | 1.72e-09 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1005 | 2902 | 3.76e-09 |
| GO:BP | GO:0022008 | neurogenesis | 500 | 1327 | 4.34e-09 |
| GO:BP | GO:0072359 | circulatory system development | 355 | 896 | 5.59e-09 |
| GO:BP | GO:0050793 | regulation of developmental process | 653 | 1801 | 7.39e-09 |
| GO:BP | GO:0009966 | regulation of signal transduction | 815 | 2307 | 7.39e-09 |
| GO:BP | GO:0009888 | tissue development | 530 | 1425 | 9.41e-09 |
| GO:BP | GO:0048699 | generation of neurons | 435 | 1145 | 2.65e-08 |
| GO:BP | GO:0010646 | regulation of cell communication | 903 | 2601 | 3.02e-08 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 431 | 1135 | 3.32e-08 |
| GO:BP | GO:0048589 | developmental growth | 223 | 527 | 4.10e-08 |
| GO:BP | GO:0007399 | nervous system development | 680 | 1903 | 4.69e-08 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 461 | 1233 | 8.28e-08 |
| GO:BP | GO:0008283 | cell population proliferation | 511 | 1386 | 8.66e-08 |
| GO:BP | GO:0023051 | regulation of signaling | 897 | 2597 | 1.06e-07 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 384 | 1011 | 3.24e-07 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 369 | 967 | 3.56e-07 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 389 | 1027 | 3.56e-07 |
| GO:BP | GO:0040007 | growth | 292 | 739 | 3.76e-07 |
| GO:BP | GO:0030900 | forebrain development | 134 | 292 | 4.39e-07 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 391 | 1036 | 4.84e-07 |
| GO:BP | GO:0021537 | telencephalon development | 102 | 208 | 4.84e-07 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 427 | 1146 | 5.43e-07 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 699 | 1992 | 7.35e-07 |
| GO:BP | GO:0030182 | neuron differentiation | 403 | 1080 | 1.27e-06 |
| GO:BP | GO:0060322 | head development | 235 | 583 | 1.88e-06 |
| GO:BP | GO:0035239 | tube morphogenesis | 264 | 668 | 1.98e-06 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 507 | 1403 | 2.02e-06 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 292 | 752 | 2.39e-06 |
| GO:BP | GO:0007417 | central nervous system development | 290 | 748 | 3.15e-06 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 417 | 1134 | 4.69e-06 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 495 | 1376 | 5.75e-06 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 456 | 1256 | 5.93e-06 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 713 | 2061 | 6.25e-06 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 331 | 876 | 6.35e-06 |
| GO:BP | GO:0007507 | heart development | 208 | 515 | 9.59e-06 |
| GO:BP | GO:0007049 | cell cycle | 539 | 1520 | 1.12e-05 |
| GO:BP | GO:0035295 | tube development | 313 | 827 | 1.22e-05 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 659 | 1900 | 1.42e-05 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 398 | 1088 | 1.69e-05 |
| GO:BP | GO:0007420 | brain development | 215 | 539 | 1.69e-05 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 592 | 1694 | 2.21e-05 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 244 | 626 | 2.21e-05 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 442 | 1227 | 2.42e-05 |
| GO:BP | GO:0007010 | cytoskeleton organization | 439 | 1218 | 2.42e-05 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 272 | 710 | 2.42e-05 |
| GO:BP | GO:0007423 | sensory organ development | 165 | 399 | 3.33e-05 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 606 | 1744 | 3.52e-05 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 121 | 276 | 3.69e-05 |
| GO:BP | GO:0003008 | system process | 432 | 1201 | 3.69e-05 |
| GO:BP | GO:0006915 | apoptotic process | 515 | 1459 | 3.69e-05 |
| GO:BP | GO:0009790 | embryo development | 322 | 864 | 3.69e-05 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 601 | 1732 | 4.63e-05 |
| GO:BP | GO:0016477 | cell migration | 391 | 1078 | 5.26e-05 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 638 | 1852 | 5.83e-05 |
| GO:BP | GO:0032879 | regulation of localization | 533 | 1521 | 5.93e-05 |
| GO:BP | GO:0030030 | cell projection organization | 450 | 1262 | 5.93e-05 |
| GO:BP | GO:0003013 | circulatory system process | 180 | 446 | 5.93e-05 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 1458 | 4521 | 6.14e-05 |
| GO:BP | GO:0060429 | epithelium development | 311 | 836 | 6.40e-05 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 212 | 540 | 6.40e-05 |
| GO:BP | GO:0001568 | blood vessel development | 214 | 546 | 6.40e-05 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 282 | 749 | 6.77e-05 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 185 | 462 | 7.03e-05 |
| GO:BP | GO:0007267 | cell-cell signaling | 415 | 1156 | 7.03e-05 |
| GO:BP | GO:0048870 | cell motility | 426 | 1190 | 7.03e-05 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 216 | 553 | 7.13e-05 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 200 | 506 | 7.13e-05 |
| GO:BP | GO:0044057 | regulation of system process | 163 | 399 | 7.52e-05 |
| GO:BP | GO:0043010 | camera-type eye development | 105 | 236 | 7.57e-05 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 400 | 1111 | 7.71e-05 |
| GO:BP | GO:0001654 | eye development | 118 | 272 | 7.71e-05 |
| GO:BP | GO:0048568 | embryonic organ development | 134 | 317 | 7.96e-05 |
| GO:BP | GO:0048880 | sensory system development | 119 | 275 | 7.96e-05 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 309 | 833 | 8.08e-05 |
| GO:BP | GO:0022402 | cell cycle process | 389 | 1078 | 8.11e-05 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 602 | 1746 | 9.11e-05 |
| GO:BP | GO:0150063 | visual system development | 118 | 273 | 9.11e-05 |
| GO:BP | GO:0012501 | programmed cell death | 525 | 1505 | 1.08e-04 |
| GO:BP | GO:0090257 | regulation of muscle system process | 84 | 181 | 1.09e-04 |
| GO:BP | GO:0045444 | fat cell differentiation | 87 | 189 | 1.09e-04 |
| GO:BP | GO:0048666 | neuron development | 328 | 894 | 1.11e-04 |
| GO:BP | GO:0008219 | cell death | 526 | 1509 | 1.12e-04 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 176 | 440 | 1.18e-04 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 923 | 2780 | 1.18e-04 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 708 | 2088 | 1.22e-04 |
| GO:BP | GO:0008015 | blood circulation | 153 | 374 | 1.26e-04 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 757 | 2246 | 1.29e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 111 | 256 | 1.43e-04 |
| GO:BP | GO:0031175 | neuron projection development | 294 | 794 | 1.58e-04 |
| GO:BP | GO:0009987 | cellular process | 3468 | 11450 | 1.58e-04 |
| GO:BP | GO:0042221 | response to chemical | 815 | 2436 | 1.59e-04 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 451 | 1279 | 1.67e-04 |
| GO:BP | GO:0001944 | vasculature development | 220 | 573 | 1.89e-04 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 373 | 1040 | 2.32e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 58 | 116 | 2.45e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 58 | 116 | 2.45e-04 |
| GO:BP | GO:0060284 | regulation of cell development | 230 | 605 | 2.46e-04 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 249 | 662 | 2.46e-04 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 824 | 2474 | 2.82e-04 |
| GO:BP | GO:0048638 | regulation of developmental growth | 110 | 257 | 3.03e-04 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 187 | 479 | 3.09e-04 |
| GO:BP | GO:0033043 | regulation of organelle organization | 364 | 1016 | 3.26e-04 |
| GO:BP | GO:1901698 | response to nitrogen compound | 285 | 774 | 3.45e-04 |
| GO:BP | GO:0071310 | cellular response to organic substance | 477 | 1370 | 3.67e-04 |
| GO:BP | GO:0060537 | muscle tissue development | 143 | 353 | 4.45e-04 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 935 | 2842 | 4.55e-04 |
| GO:BP | GO:0019222 | regulation of metabolic process | 1563 | 4914 | 4.70e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 157 | 394 | 4.70e-04 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 111 | 263 | 5.58e-04 |
| GO:BP | GO:0048729 | tissue morphogenesis | 185 | 478 | 6.09e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 494 | 1430 | 6.14e-04 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 264 | 716 | 6.56e-04 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 277 | 756 | 6.82e-04 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 155 | 391 | 7.17e-04 |
| GO:BP | GO:0003012 | muscle system process | 137 | 339 | 7.48e-04 |
| GO:BP | GO:0033002 | muscle cell proliferation | 72 | 157 | 7.85e-04 |
| GO:BP | GO:0060419 | heart growth | 39 | 72 | 8.15e-04 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 61 | 128 | 8.33e-04 |
| GO:BP | GO:0014706 | striated muscle tissue development | 94 | 218 | 9.20e-04 |
| GO:BP | GO:0051960 | regulation of nervous system development | 143 | 358 | 9.56e-04 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 60 | 126 | 9.90e-04 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 452 | 1304 | 9.93e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 131 | 324 | 1.07e-03 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 174 | 450 | 1.09e-03 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 32 | 56 | 1.11e-03 |
| GO:BP | GO:0007389 | pattern specification process | 125 | 307 | 1.11e-03 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 852 | 2589 | 1.15e-03 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 848 | 2576 | 1.15e-03 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 101 | 239 | 1.16e-03 |
| GO:BP | GO:0030097 | hemopoiesis | 245 | 664 | 1.16e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 121 | 296 | 1.17e-03 |
| GO:BP | GO:0045165 | cell fate commitment | 72 | 159 | 1.20e-03 |
| GO:BP | GO:0051179 | localization | 1275 | 3978 | 1.20e-03 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 181 | 472 | 1.21e-03 |
| GO:BP | GO:0010033 | response to organic substance | 618 | 1835 | 1.21e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 450 | 1301 | 1.21e-03 |
| GO:BP | GO:0040008 | regulation of growth | 188 | 493 | 1.23e-03 |
| GO:BP | GO:1901652 | response to peptide | 150 | 381 | 1.30e-03 |
| GO:BP | GO:0072001 | renal system development | 106 | 254 | 1.30e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 46 | 91 | 1.31e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 46 | 91 | 1.31e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 179 | 467 | 1.34e-03 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 33 | 59 | 1.35e-03 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 640 | 1908 | 1.36e-03 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 149 | 379 | 1.45e-03 |
| GO:BP | GO:0006950 | response to stress | 889 | 2715 | 1.46e-03 |
| GO:BP | GO:0060173 | limb development | 66 | 144 | 1.51e-03 |
| GO:BP | GO:0048736 | appendage development | 66 | 144 | 1.51e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 329 | 926 | 1.57e-03 |
| GO:BP | GO:1901653 | cellular response to peptide | 116 | 284 | 1.62e-03 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 399 | 1145 | 1.63e-03 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 149 | 380 | 1.63e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 199 | 529 | 1.69e-03 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1002 | 3089 | 1.85e-03 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 206 | 551 | 1.89e-03 |
| GO:BP | GO:0031099 | regeneration | 67 | 148 | 2.03e-03 |
| GO:BP | GO:0007017 | microtubule-based process | 275 | 762 | 2.03e-03 |
| GO:BP | GO:0010720 | positive regulation of cell development | 130 | 326 | 2.03e-03 |
| GO:BP | GO:0035265 | organ growth | 61 | 132 | 2.09e-03 |
| GO:BP | GO:0006351 | DNA-templated transcription | 877 | 2683 | 2.09e-03 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 994 | 3066 | 2.13e-03 |
| GO:BP | GO:0033554 | cellular response to stress | 522 | 1538 | 2.13e-03 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 386 | 1109 | 2.34e-03 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 148 | 380 | 2.42e-03 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 667 | 2005 | 2.44e-03 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 884 | 2709 | 2.44e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 114 | 281 | 2.45e-03 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 155 | 401 | 2.47e-03 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 49 | 101 | 2.47e-03 |
| GO:BP | GO:2000177 | regulation of neural precursor cell proliferation | 38 | 73 | 2.48e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 126 | 316 | 2.48e-03 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 1013 | 3132 | 2.48e-03 |
| GO:BP | GO:0051726 | regulation of cell cycle | 330 | 935 | 2.48e-03 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 247 | 679 | 2.56e-03 |
| GO:BP | GO:0099536 | synaptic signaling | 194 | 518 | 2.56e-03 |
| GO:BP | GO:0007059 | chromosome segregation | 145 | 372 | 2.59e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 386 | 1111 | 2.60e-03 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 761 | 2311 | 2.61e-03 |
| GO:BP | GO:0034330 | cell junction organization | 218 | 591 | 2.64e-03 |
| GO:BP | GO:0006468 | protein phosphorylation | 353 | 1008 | 2.67e-03 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 21 | 33 | 2.72e-03 |
| GO:BP | GO:0000278 | mitotic cell cycle | 287 | 803 | 2.72e-03 |
| GO:BP | GO:0030029 | actin filament-based process | 246 | 677 | 2.76e-03 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 188 | 501 | 2.82e-03 |
| GO:BP | GO:0016043 | cellular component organization | 1617 | 5139 | 2.82e-03 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 1430 | 4515 | 2.86e-03 |
| GO:BP | GO:0035148 | tube formation | 60 | 131 | 2.91e-03 |
| GO:BP | GO:0032880 | regulation of protein localization | 262 | 727 | 2.96e-03 |
| GO:BP | GO:0000902 | cell morphogenesis | 274 | 764 | 2.96e-03 |
| GO:BP | GO:0016310 | phosphorylation | 417 | 1211 | 2.99e-03 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 122 | 306 | 3.00e-03 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 835 | 2555 | 3.02e-03 |
| GO:BP | GO:0007100 | mitotic centrosome separation | 11 | 13 | 3.16e-03 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 87 | 206 | 3.16e-03 |
| GO:BP | GO:0040011 | locomotion | 304 | 858 | 3.23e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 202 | 545 | 3.32e-03 |
| GO:BP | GO:0008016 | regulation of heart contraction | 74 | 170 | 3.34e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 290 | 815 | 3.34e-03 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 217 | 591 | 3.45e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 67 | 151 | 3.53e-03 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 1010 | 3131 | 3.53e-03 |
| GO:BP | GO:0030217 | T cell differentiation | 81 | 190 | 3.66e-03 |
| GO:BP | GO:0046620 | regulation of organ growth | 37 | 72 | 3.85e-03 |
| GO:BP | GO:0003015 | heart process | 88 | 210 | 3.85e-03 |
| GO:BP | GO:0008150 | biological_process | 3619 | 12051 | 3.94e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 28 | 50 | 4.00e-03 |
| GO:BP | GO:0001764 | neuron migration | 62 | 138 | 4.05e-03 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 289 | 815 | 4.33e-03 |
| GO:BP | GO:0030334 | regulation of cell migration | 255 | 710 | 4.39e-03 |
| GO:BP | GO:0120034 | positive regulation of plasma membrane bounded cell projection assembly | 45 | 93 | 4.44e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 34 | 65 | 4.56e-03 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 77 | 180 | 4.56e-03 |
| GO:BP | GO:1900180 | regulation of protein localization to nucleus | 57 | 125 | 4.57e-03 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 185 | 497 | 4.69e-03 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 185 | 497 | 4.69e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 536 | 1597 | 4.70e-03 |
| GO:BP | GO:0070848 | response to growth factor | 211 | 576 | 4.70e-03 |
| GO:BP | GO:0061448 | connective tissue development | 90 | 217 | 4.73e-03 |
| GO:BP | GO:0060047 | heart contraction | 84 | 200 | 4.73e-03 |
| GO:BP | GO:0021915 | neural tube development | 62 | 139 | 4.95e-03 |
| GO:BP | GO:0007051 | spindle organization | 80 | 189 | 4.98e-03 |
| GO:BP | GO:1900744 | regulation of p38MAPK cascade | 20 | 32 | 4.98e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 378 | 1096 | 5.08e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 33 | 63 | 5.26e-03 |
| GO:BP | GO:1902742 | apoptotic process involved in development | 19 | 30 | 5.66e-03 |
| GO:BP | GO:0040012 | regulation of locomotion | 272 | 766 | 5.82e-03 |
| GO:BP | GO:0001822 | kidney development | 100 | 247 | 5.88e-03 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 203 | 554 | 5.93e-03 |
| GO:BP | GO:0001657 | ureteric bud development | 38 | 76 | 5.94e-03 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 58 | 129 | 5.98e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 58 | 129 | 5.98e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 34 | 66 | 6.20e-03 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 18 | 28 | 6.27e-03 |
| GO:BP | GO:0002027 | regulation of heart rate | 41 | 84 | 6.39e-03 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 149 | 392 | 6.59e-03 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 160 | 425 | 6.61e-03 |
| GO:BP | GO:0003007 | heart morphogenesis | 91 | 222 | 6.62e-03 |
| GO:BP | GO:0003002 | regionalization | 109 | 274 | 6.62e-03 |
| GO:BP | GO:0021543 | pallium development | 64 | 146 | 6.66e-03 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 92 | 225 | 6.73e-03 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 1185 | 3724 | 6.76e-03 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 1349 | 4269 | 6.95e-03 |
| GO:BP | GO:0061337 | cardiac conduction | 42 | 87 | 7.03e-03 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 81 | 194 | 7.14e-03 |
| GO:BP | GO:0001501 | skeletal system development | 141 | 369 | 7.15e-03 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 51 | 111 | 7.24e-03 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 120 | 307 | 7.25e-03 |
| GO:BP | GO:0000165 | MAPK cascade | 196 | 535 | 7.25e-03 |
| GO:BP | GO:1900182 | positive regulation of protein localization to nucleus | 40 | 82 | 7.35e-03 |
| GO:BP | GO:0072175 | epithelial tube formation | 55 | 122 | 7.49e-03 |
| GO:BP | GO:0001503 | ossification | 125 | 322 | 7.49e-03 |
| GO:BP | GO:2000145 | regulation of cell motility | 264 | 745 | 7.61e-03 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 38 | 77 | 7.61e-03 |
| GO:BP | GO:0072164 | mesonephric tubule development | 38 | 77 | 7.61e-03 |
| GO:BP | GO:0046474 | glycerophospholipid biosynthetic process | 78 | 186 | 7.61e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 43 | 90 | 7.61e-03 |
| GO:BP | GO:0042592 | homeostatic process | 410 | 1204 | 7.70e-03 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 137 | 358 | 7.74e-03 |
| GO:BP | GO:0009725 | response to hormone | 228 | 634 | 7.74e-03 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 158 | 421 | 7.87e-03 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 1318 | 4170 | 7.87e-03 |
| GO:BP | GO:0010468 | regulation of gene expression | 1150 | 3613 | 7.91e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 34 | 67 | 8.07e-03 |
| GO:BP | GO:0051299 | centrosome separation | 11 | 14 | 8.13e-03 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 32 | 62 | 8.17e-03 |
| GO:BP | GO:0031023 | microtubule organizing center organization | 61 | 139 | 8.20e-03 |
| GO:BP | GO:0006996 | organelle organization | 964 | 3001 | 8.35e-03 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 172 | 464 | 8.46e-03 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 102 | 256 | 8.77e-03 |
| GO:BP | GO:0060485 | mesenchyme development | 102 | 256 | 8.77e-03 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 67 | 156 | 8.77e-03 |
| GO:BP | GO:0038066 | p38MAPK cascade | 25 | 45 | 8.79e-03 |
| GO:BP | GO:0061061 | muscle structure development | 203 | 559 | 8.92e-03 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 22 | 38 | 9.28e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 40 | 83 | 9.28e-03 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 27 | 50 | 9.28e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 385 | 1128 | 9.28e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 43 | 91 | 9.53e-03 |
| GO:BP | GO:0001823 | mesonephros development | 38 | 78 | 9.84e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 228 | 637 | 9.86e-03 |
| GO:BP | GO:0001775 | cell activation | 237 | 665 | 1.00e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 50 | 110 | 1.01e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 50 | 110 | 1.01e-02 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 1209 | 3815 | 1.01e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 93 | 231 | 1.02e-02 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 233 | 653 | 1.02e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 47 | 102 | 1.02e-02 |
| GO:BP | GO:0051641 | cellular localization | 899 | 2793 | 1.03e-02 |
| GO:BP | GO:0000280 | nuclear division | 133 | 349 | 1.06e-02 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 1034 | 3238 | 1.07e-02 |
| GO:BP | GO:0045017 | glycerolipid biosynthetic process | 88 | 217 | 1.08e-02 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 30 | 58 | 1.11e-02 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 206 | 571 | 1.14e-02 |
| GO:BP | GO:1902117 | positive regulation of organelle assembly | 37 | 76 | 1.14e-02 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 167 | 452 | 1.14e-02 |
| GO:BP | GO:0007098 | centrosome cycle | 56 | 127 | 1.14e-02 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 84 | 206 | 1.16e-02 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 49 | 108 | 1.17e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 80 | 195 | 1.26e-02 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 16 | 25 | 1.27e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 27 | 51 | 1.31e-02 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 223 | 625 | 1.31e-02 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 36 | 74 | 1.36e-02 |
| GO:BP | GO:0030879 | mammary gland development | 48 | 106 | 1.38e-02 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 656 | 2006 | 1.39e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 22 | 39 | 1.39e-02 |
| GO:BP | GO:0031331 | positive regulation of cellular catabolic process | 111 | 286 | 1.40e-02 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 15 | 23 | 1.41e-02 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 646 | 1974 | 1.41e-02 |
| GO:BP | GO:0021761 | limbic system development | 42 | 90 | 1.41e-02 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 1214 | 3841 | 1.42e-02 |
| GO:BP | GO:0010506 | regulation of autophagy | 122 | 319 | 1.46e-02 |
| GO:BP | GO:0048732 | gland development | 124 | 325 | 1.47e-02 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 53 | 120 | 1.47e-02 |
| GO:BP | GO:0042692 | muscle cell differentiation | 127 | 334 | 1.47e-02 |
| GO:BP | GO:0048592 | eye morphogenesis | 50 | 112 | 1.54e-02 |
| GO:BP | GO:0035137 | hindlimb morphogenesis | 14 | 21 | 1.54e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 108 | 278 | 1.54e-02 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 662 | 2028 | 1.54e-02 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 35 | 72 | 1.57e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 55 | 126 | 1.62e-02 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 38 | 80 | 1.62e-02 |
| GO:BP | GO:0009267 | cellular response to starvation | 65 | 154 | 1.62e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 71 | 171 | 1.62e-02 |
| GO:BP | GO:0043584 | nose development | 9 | 11 | 1.62e-02 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 171 | 468 | 1.64e-02 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 33 | 67 | 1.64e-02 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 184 | 508 | 1.68e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 162 | 441 | 1.71e-02 |
| GO:BP | GO:1903522 | regulation of blood circulation | 81 | 200 | 1.71e-02 |
| GO:BP | GO:0010638 | positive regulation of organelle organization | 159 | 432 | 1.72e-02 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 36 | 75 | 1.72e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 36 | 75 | 1.72e-02 |
| GO:BP | GO:0014020 | primary neural tube formation | 42 | 91 | 1.75e-02 |
| GO:BP | GO:0042594 | response to starvation | 75 | 183 | 1.76e-02 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 53 | 121 | 1.76e-02 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 49 | 110 | 1.76e-02 |
| GO:BP | GO:0060602 | branch elongation of an epithelium | 11 | 15 | 1.78e-02 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 20 | 35 | 1.84e-02 |
| GO:BP | GO:0055001 | muscle cell development | 70 | 169 | 1.84e-02 |
| GO:BP | GO:0065009 | regulation of molecular function | 463 | 1389 | 1.84e-02 |
| GO:BP | GO:1903046 | meiotic cell cycle process | 59 | 138 | 1.86e-02 |
| GO:BP | GO:0030278 | regulation of ossification | 40 | 86 | 1.89e-02 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 214 | 602 | 1.89e-02 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 621 | 1900 | 1.92e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 91 | 230 | 1.94e-02 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 221 | 624 | 1.94e-02 |
| GO:BP | GO:0045216 | cell-cell junction organization | 66 | 158 | 1.94e-02 |
| GO:BP | GO:0007155 | cell adhesion | 342 | 1004 | 1.95e-02 |
| GO:BP | GO:0003166 | bundle of His development | 6 | 6 | 1.95e-02 |
| GO:BP | GO:0035329 | hippo signaling | 22 | 40 | 1.95e-02 |
| GO:BP | GO:0060677 | ureteric bud elongation | 6 | 6 | 1.95e-02 |
| GO:BP | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress | 6 | 6 | 1.95e-02 |
| GO:BP | GO:0010616 | negative regulation of cardiac muscle adaptation | 6 | 6 | 1.95e-02 |
| GO:BP | GO:0014816 | skeletal muscle satellite cell differentiation | 6 | 6 | 1.95e-02 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 639 | 1959 | 1.95e-02 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 41 | 89 | 2.00e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 38 | 81 | 2.00e-02 |
| GO:BP | GO:0045724 | positive regulation of cilium assembly | 16 | 26 | 2.02e-02 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 24 | 45 | 2.02e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 89 | 225 | 2.14e-02 |
| GO:BP | GO:0007517 | muscle organ development | 108 | 281 | 2.15e-02 |
| GO:BP | GO:0014896 | muscle hypertrophy | 36 | 76 | 2.16e-02 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 65 | 156 | 2.20e-02 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 120 | 317 | 2.20e-02 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 15 | 24 | 2.32e-02 |
| GO:BP | GO:0001843 | neural tube closure | 40 | 87 | 2.35e-02 |
| GO:BP | GO:0072089 | stem cell proliferation | 40 | 87 | 2.35e-02 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 40 | 87 | 2.35e-02 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 311 | 909 | 2.36e-02 |
| GO:BP | GO:0006936 | muscle contraction | 103 | 267 | 2.37e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 27 | 53 | 2.38e-02 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 388 | 1154 | 2.40e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 25 | 48 | 2.40e-02 |
| GO:BP | GO:0007548 | sex differentiation | 77 | 191 | 2.40e-02 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 18 | 31 | 2.41e-02 |
| GO:BP | GO:0046473 | phosphatidic acid metabolic process | 18 | 31 | 2.41e-02 |
| GO:BP | GO:0002683 | negative regulation of immune system process | 118 | 312 | 2.44e-02 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 32 | 66 | 2.44e-02 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 41 | 90 | 2.49e-02 |
| GO:BP | GO:0035136 | forelimb morphogenesis | 14 | 22 | 2.57e-02 |
| GO:BP | GO:1901186 | positive regulation of ERBB signaling pathway | 14 | 22 | 2.57e-02 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 14 | 22 | 2.57e-02 |
| GO:BP | GO:0021988 | olfactory lobe development | 14 | 22 | 2.57e-02 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 14 | 22 | 2.57e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 83 | 209 | 2.59e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 50 | 115 | 2.66e-02 |
| GO:BP | GO:0034329 | cell junction assembly | 130 | 349 | 2.69e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 33 | 69 | 2.69e-02 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 116 | 307 | 2.71e-02 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 88 | 224 | 2.72e-02 |
| GO:BP | GO:0098609 | cell-cell adhesion | 214 | 607 | 2.73e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 288 | 839 | 2.75e-02 |
| GO:BP | GO:0006654 | phosphatidic acid biosynthetic process | 17 | 29 | 2.75e-02 |
| GO:BP | GO:0021591 | ventricular system development | 17 | 29 | 2.75e-02 |
| GO:BP | GO:0048483 | autonomic nervous system development | 17 | 29 | 2.75e-02 |
| GO:BP | GO:0046605 | regulation of centrosome cycle | 26 | 51 | 2.75e-02 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 212 | 601 | 2.75e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 69 | 169 | 2.75e-02 |
| GO:BP | GO:0001841 | neural tube formation | 43 | 96 | 2.75e-02 |
| GO:BP | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 13 | 20 | 2.83e-02 |
| GO:BP | GO:0060606 | tube closure | 40 | 88 | 2.86e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 136 | 368 | 2.89e-02 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 105 | 275 | 2.94e-02 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 287 | 837 | 2.94e-02 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 105 | 275 | 2.94e-02 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 73 | 181 | 2.94e-02 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 192 | 540 | 2.96e-02 |
| GO:BP | GO:0000003 | reproduction | 322 | 948 | 2.96e-02 |
| GO:BP | GO:0072033 | renal vesicle formation | 7 | 8 | 2.98e-02 |
| GO:BP | GO:0021612 | facial nerve structural organization | 7 | 8 | 2.98e-02 |
| GO:BP | GO:0046602 | regulation of mitotic centrosome separation | 7 | 8 | 2.98e-02 |
| GO:BP | GO:0003161 | cardiac conduction system development | 19 | 34 | 3.01e-02 |
| GO:BP | GO:0061564 | axon development | 147 | 402 | 3.01e-02 |
| GO:BP | GO:0051150 | regulation of smooth muscle cell differentiation | 19 | 34 | 3.01e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 45 | 102 | 3.03e-02 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 60 | 144 | 3.03e-02 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 76 | 190 | 3.03e-02 |
| GO:BP | GO:0035115 | embryonic forelimb morphogenesis | 12 | 18 | 3.06e-02 |
| GO:BP | GO:0001570 | vasculogenesis | 32 | 67 | 3.06e-02 |
| GO:BP | GO:0030903 | notochord development | 12 | 18 | 3.06e-02 |
| GO:BP | GO:0007015 | actin filament organization | 140 | 381 | 3.07e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 35 | 75 | 3.08e-02 |
| GO:BP | GO:0060443 | mammary gland morphogenesis | 21 | 39 | 3.13e-02 |
| GO:BP | GO:0045604 | regulation of epidermal cell differentiation | 21 | 39 | 3.13e-02 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 104 | 273 | 3.23e-02 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 105 | 276 | 3.23e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 30 | 62 | 3.24e-02 |
| GO:BP | GO:0006974 | DNA damage response | 275 | 801 | 3.24e-02 |
| GO:BP | GO:0030282 | bone mineralization | 39 | 86 | 3.24e-02 |
| GO:BP | GO:0035270 | endocrine system development | 39 | 86 | 3.24e-02 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 163 | 452 | 3.26e-02 |
| GO:BP | GO:0001649 | osteoblast differentiation | 73 | 182 | 3.29e-02 |
| GO:BP | GO:0140013 | meiotic nuclear division | 52 | 122 | 3.29e-02 |
| GO:BP | GO:0045606 | positive regulation of epidermal cell differentiation | 11 | 16 | 3.29e-02 |
| GO:BP | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 33 | 70 | 3.29e-02 |
| GO:BP | GO:0050866 | negative regulation of cell activation | 52 | 122 | 3.29e-02 |
| GO:BP | GO:0030031 | cell projection assembly | 172 | 480 | 3.33e-02 |
| GO:BP | GO:0000012 | single strand break repair | 8 | 10 | 3.40e-02 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 59 | 142 | 3.40e-02 |
| GO:BP | GO:0072189 | ureter development | 8 | 10 | 3.40e-02 |
| GO:BP | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration | 8 | 10 | 3.40e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 18 | 32 | 3.43e-02 |
| GO:BP | GO:0048588 | developmental cell growth | 77 | 194 | 3.44e-02 |
| GO:BP | GO:0033599 | regulation of mammary gland epithelial cell proliferation | 10 | 14 | 3.44e-02 |
| GO:BP | GO:1902170 | cellular response to reactive nitrogen species | 10 | 14 | 3.44e-02 |
| GO:BP | GO:0070102 | interleukin-6-mediated signaling pathway | 10 | 14 | 3.44e-02 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 10 | 14 | 3.44e-02 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 9 | 12 | 3.46e-02 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 15 | 25 | 3.46e-02 |
| GO:BP | GO:0065008 | regulation of biological quality | 659 | 2039 | 3.46e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 26 | 52 | 3.46e-02 |
| GO:BP | GO:0003401 | axis elongation | 15 | 25 | 3.46e-02 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 15 | 25 | 3.46e-02 |
| GO:BP | GO:0010225 | response to UV-C | 9 | 12 | 3.46e-02 |
| GO:BP | GO:0071732 | cellular response to nitric oxide | 9 | 12 | 3.46e-02 |
| GO:BP | GO:0097531 | mast cell migration | 9 | 12 | 3.46e-02 |
| GO:BP | GO:0045618 | positive regulation of keratinocyte differentiation | 9 | 12 | 3.46e-02 |
| GO:BP | GO:0022412 | cellular process involved in reproduction in multicellular organism | 103 | 271 | 3.46e-02 |
| GO:BP | GO:0022414 | reproductive process | 318 | 939 | 3.50e-02 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 81 | 206 | 3.50e-02 |
| GO:BP | GO:0000731 | DNA synthesis involved in DNA repair | 20 | 37 | 3.53e-02 |
| GO:BP | GO:0060612 | adipose tissue development | 24 | 47 | 3.55e-02 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 168 | 469 | 3.62e-02 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 38 | 84 | 3.65e-02 |
| GO:BP | GO:0008654 | phospholipid biosynthetic process | 89 | 230 | 3.72e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 32 | 68 | 3.76e-02 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 66 | 163 | 3.85e-02 |
| GO:BP | GO:0021872 | forebrain generation of neurons | 17 | 30 | 3.91e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 67 | 166 | 3.91e-02 |
| GO:BP | GO:0045927 | positive regulation of growth | 78 | 198 | 3.91e-02 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 27 | 55 | 3.91e-02 |
| GO:BP | GO:0031018 | endocrine pancreas development | 17 | 30 | 3.91e-02 |
| GO:BP | GO:0033598 | mammary gland epithelial cell proliferation | 14 | 23 | 3.92e-02 |
| GO:BP | GO:0021879 | forebrain neuron differentiation | 14 | 23 | 3.92e-02 |
| GO:BP | GO:0070925 | organelle assembly | 289 | 849 | 3.93e-02 |
| GO:BP | GO:0045321 | leukocyte activation | 198 | 563 | 3.93e-02 |
| GO:BP | GO:0021675 | nerve development | 30 | 63 | 4.03e-02 |
| GO:BP | GO:0033036 | macromolecule localization | 784 | 2453 | 4.09e-02 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 85 | 219 | 4.09e-02 |
| GO:BP | GO:0072073 | kidney epithelium development | 49 | 115 | 4.09e-02 |
| GO:BP | GO:0043523 | regulation of neuron apoptotic process | 71 | 178 | 4.11e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 145 | 400 | 4.17e-02 |
| GO:BP | GO:0001525 | angiogenesis | 144 | 397 | 4.19e-02 |
| GO:BP | GO:0043583 | ear development | 63 | 155 | 4.20e-02 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 230 | 664 | 4.20e-02 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 45 | 104 | 4.20e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 21 | 40 | 4.20e-02 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 94 | 246 | 4.23e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 28 | 58 | 4.27e-02 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 34 | 74 | 4.33e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 65 | 161 | 4.33e-02 |
| GO:BP | GO:0061919 | process utilizing autophagic mechanism | 184 | 521 | 4.39e-02 |
| GO:BP | GO:0006914 | autophagy | 184 | 521 | 4.39e-02 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 13 | 21 | 4.44e-02 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 13 | 21 | 4.44e-02 |
| GO:BP | GO:0060561 | apoptotic process involved in morphogenesis | 13 | 21 | 4.44e-02 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 80 | 205 | 4.44e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 38 | 85 | 4.44e-02 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 146 | 404 | 4.48e-02 |
| GO:BP | GO:0060603 | mammary gland duct morphogenesis | 16 | 28 | 4.48e-02 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 126 | 343 | 4.50e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 83 | 214 | 4.51e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 188 | 534 | 4.55e-02 |
| GO:BP | GO:0030216 | keratinocyte differentiation | 35 | 77 | 4.58e-02 |
| GO:BP | GO:0006941 | striated muscle contraction | 62 | 153 | 4.70e-02 |
| GO:BP | GO:1904747 | positive regulation of apoptotic process involved in development | 5 | 5 | 4.70e-02 |
| GO:BP | GO:1902339 | positive regulation of apoptotic process involved in morphogenesis | 5 | 5 | 4.70e-02 |
| GO:BP | GO:0010886 | positive regulation of cholesterol storage | 5 | 5 | 4.70e-02 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1650 | 5340 | 4.70e-02 |
| GO:BP | GO:0010891 | negative regulation of sequestering of triglyceride | 5 | 5 | 4.70e-02 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 231 | 669 | 4.70e-02 |
| GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 55 | 133 | 4.76e-02 |
| GO:BP | GO:0071539 | protein localization to centrosome | 18 | 33 | 4.76e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 63 | 156 | 4.76e-02 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 22 | 43 | 4.81e-02 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 425 | 1288 | 4.82e-02 |
| GO:BP | GO:0010508 | positive regulation of autophagy | 56 | 136 | 4.84e-02 |
| GO:BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 20 | 38 | 4.84e-02 |
| GO:BP | GO:0051276 | chromosome organization | 188 | 535 | 4.85e-02 |
| GO:BP | GO:0032388 | positive regulation of intracellular transport | 50 | 119 | 4.89e-02 |
| GO:BP | GO:0042246 | tissue regeneration | 27 | 56 | 4.91e-02 |
| GO:BP | GO:2000106 | regulation of leukocyte apoptotic process | 27 | 56 | 4.91e-02 |
| GO:BP | GO:0048285 | organelle fission | 142 | 393 | 4.92e-02 |
| GO:BP | GO:0019934 | cGMP-mediated signaling | 12 | 19 | 4.93e-02 |
| GO:BP | GO:0090068 | positive regulation of cell cycle process | 81 | 209 | 4.95e-02 |
| GO:BP | GO:0032868 | response to insulin | 81 | 209 | 4.95e-02 |
| GO:BP | GO:0023056 | positive regulation of signaling | 426 | 1292 | 4.95e-02 |
| GO:BP | GO:0001656 | metanephros development | 30 | 64 | 4.96e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:05217 | Basal cell carcinoma | 28 | 49 | 8.69e-03 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 45 | 91 | 8.69e-03 |
| KEGG | KEGG:05200 | Pathways in cancer | 154 | 408 | 1.47e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 57 | 128 | 1.47e-02 |
| KEGG | KEGG:05224 | Breast cancer | 53 | 117 | 1.47e-02 |
| KEGG | KEGG:05226 | Gastric cancer | 52 | 117 | 2.40e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 22 | 41 | 3.49e-02 |
| KEGG | KEGG:04115 | p53 signaling pathway | 32 | 66 | 3.49e-02 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 34 | 72 | 3.49e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 35 | 74 | 3.49e-02 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 28 | 56 | 3.49e-02 |
| KEGG | KEGG:00000 | KEGG root term | 1791 | 5802 | 3.78e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 43 | 97 | 3.78e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 61 | 149 | 4.50e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 51 | 121 | 4.61e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 27 | 56 | 5.18e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 52 | 125 | 5.18e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 55 | 134 | 5.34e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 65 | 164 | 5.83e-02 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 42 | 98 | 5.83e-02 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 30 | 66 | 7.17e-02 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 37 | 86 | 8.18e-02 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 30 | 67 | 8.55e-02 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 43 | 104 | 8.80e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 36 | 84 | 8.80e-02 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 45 | 110 | 8.80e-02 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 33 | 76 | 8.80e-02 |
| KEGG | KEGG:05213 | Endometrial cancer | 26 | 57 | 8.94e-02 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 44 | 109 | 1.17e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 56 | 145 | 1.30e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 22 | 48 | 1.35e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 28 | 65 | 1.48e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 52 | 135 | 1.58e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 54 | 142 | 1.75e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 57 | 151 | 1.75e-01 |
| KEGG | KEGG:04924 | Renin secretion | 22 | 50 | 1.99e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 23 | 53 | 2.05e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 37 | 94 | 2.34e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 43 | 112 | 2.34e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 51 | 136 | 2.34e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 44 | 116 | 2.52e-01 |
| KEGG | KEGG:04611 | Platelet activation | 35 | 89 | 2.52e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 16 | 35 | 2.52e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 30 | 75 | 2.54e-01 |
| KEGG | KEGG:05218 | Melanoma | 24 | 58 | 2.54e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 23 | 55 | 2.54e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 11 | 22 | 2.54e-01 |
| KEGG | KEGG:04360 | Axon guidance | 59 | 162 | 2.54e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 86 | 246 | 2.54e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 12 | 25 | 2.57e-01 |
| KEGG | KEGG:03410 | Base excision repair | 19 | 44 | 2.57e-01 |
| KEGG | KEGG:04110 | Cell cycle | 55 | 151 | 2.57e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 57 | 157 | 2.57e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 33 | 85 | 2.63e-01 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 59 | 164 | 2.65e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 23 | 56 | 2.65e-01 |
| KEGG | KEGG:04730 | Long-term depression | 18 | 42 | 2.71e-01 |
| KEGG | KEGG:04976 | Bile secretion | 18 | 42 | 2.71e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 32 | 83 | 2.82e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 21 | 51 | 2.89e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 29 | 75 | 2.96e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 33 | 87 | 2.96e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 61 | 172 | 2.96e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 27 | 69 | 2.96e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 27 | 69 | 2.96e-01 |
| KEGG | KEGG:05142 | Chagas disease | 29 | 75 | 2.96e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 20 | 49 | 3.07e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 20 | 49 | 3.07e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 39 | 106 | 3.20e-01 |
| KEGG | KEGG:04540 | Gap junction | 28 | 73 | 3.24e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 9 | 19 | 3.46e-01 |
| KEGG | KEGG:04217 | Necroptosis | 38 | 104 | 3.46e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 9 | 19 | 3.46e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 32 | 86 | 3.46e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 31 | 83 | 3.46e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 29 | 77 | 3.46e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 34 | 92 | 3.46e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 62 | 179 | 3.46e-01 |
| KEGG | KEGG:04210 | Apoptosis | 42 | 117 | 3.51e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 45 | 127 | 3.58e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 18 | 45 | 3.58e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 29 | 78 | 3.58e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 17 | 42 | 3.58e-01 |
| KEGG | KEGG:04742 | Taste transduction | 10 | 22 | 3.58e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 32 | 87 | 3.58e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 11 | 25 | 3.58e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 12 | 28 | 3.70e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 13 | 31 | 3.79e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 30 | 82 | 3.88e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 28 | 76 | 3.88e-01 |
| KEGG | KEGG:05034 | Alcoholism | 40 | 113 | 3.88e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 50 | 144 | 3.88e-01 |
| KEGG | KEGG:05214 | Glioma | 25 | 67 | 3.89e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 50 | 145 | 4.06e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 34 | 95 | 4.06e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 11 | 26 | 4.13e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 42 | 121 | 4.23e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 19 | 50 | 4.23e-01 |
| KEGG | KEGG:04814 | Motor proteins | 51 | 149 | 4.23e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 14 | 35 | 4.23e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 7 | 15 | 4.23e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 21 | 56 | 4.23e-01 |
| KEGG | KEGG:05222 | Small cell lung cancer | 31 | 87 | 4.34e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 27 | 75 | 4.43e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 28 | 78 | 4.43e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 55 | 163 | 4.43e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 34 | 97 | 4.51e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 23 | 63 | 4.52e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 5 | 10 | 4.54e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 13 | 33 | 4.54e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 12 | 30 | 4.54e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 12 | 30 | 4.54e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 23 | 64 | 4.86e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 23 | 64 | 4.86e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 23 | 64 | 4.86e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 7 | 16 | 4.89e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 21 | 58 | 4.89e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 20 | 55 | 4.90e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 19 | 52 | 4.91e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 9 | 22 | 5.02e-01 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 29 | 84 | 5.27e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 29 | 84 | 5.27e-01 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 34 | 100 | 5.27e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 87 | 271 | 5.27e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 50 | 151 | 5.27e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 44 | 132 | 5.27e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 19 | 53 | 5.29e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 31 | 91 | 5.42e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 54 | 165 | 5.49e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 6 | 14 | 5.56e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 36 | 108 | 5.75e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 19 | 54 | 5.75e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 26 | 76 | 5.75e-01 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 33 | 99 | 6.02e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 26 | 77 | 6.21e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 20 | 58 | 6.22e-01 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 25 | 74 | 6.24e-01 |
| KEGG | KEGG:05162 | Measles | 32 | 97 | 6.46e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 9 | 24 | 6.46e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 22 | 65 | 6.48e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 5 | 12 | 6.52e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 15 | 43 | 6.57e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 49 | 153 | 6.64e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 18 | 53 | 6.85e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 26 | 79 | 6.94e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 11 | 31 | 6.94e-01 |
| KEGG | KEGG:04144 | Endocytosis | 72 | 230 | 6.95e-01 |
| KEGG | KEGG:00232 | Caffeine metabolism | 1 | 1 | 6.95e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 10 | 28 | 6.95e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 32 | 99 | 7.04e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 14 | 41 | 7.12e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 8 | 22 | 7.12e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 55 | 176 | 7.27e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 36 | 113 | 7.27e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 16 | 48 | 7.27e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 7.27e-01 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 10 | 29 | 7.27e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 4 | 10 | 7.27e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 6 | 16 | 7.27e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 23 | 71 | 7.27e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 4 | 10 | 7.27e-01 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 2 | 4 | 7.27e-01 |
| KEGG | KEGG:02010 | ABC transporters | 10 | 29 | 7.27e-01 |
| KEGG | KEGG:03030 | DNA replication | 12 | 35 | 7.27e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 22 | 68 | 7.28e-01 |
| KEGG | KEGG:05131 | Shigellosis | 65 | 210 | 7.28e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 34 | 108 | 7.39e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 24 | 75 | 7.39e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 13 | 39 | 7.39e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 66 | 214 | 7.39e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 32 | 102 | 7.53e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 22 | 69 | 7.53e-01 |
| KEGG | KEGG:05164 | Influenza A | 32 | 102 | 7.53e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 19 | 59 | 7.53e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 44 | 142 | 7.56e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 30 | 96 | 7.61e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 78 | 256 | 7.61e-01 |
| KEGG | KEGG:00650 | Butanoate metabolism | 6 | 17 | 7.61e-01 |
| KEGG | KEGG:04520 | Adherens junction | 27 | 86 | 7.61e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 5 | 14 | 7.68e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 5 | 14 | 7.68e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 38 | 123 | 7.68e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 52 | 170 | 7.74e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 41 | 134 | 7.99e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 14 | 44 | 7.99e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 20 | 64 | 7.99e-01 |
| KEGG | KEGG:04530 | Tight junction | 42 | 138 | 8.11e-01 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 3 | 8 | 8.11e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 35 | 115 | 8.27e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 17 | 55 | 8.43e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 2 | 5 | 8.43e-01 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 8 | 25 | 8.48e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 24 | 79 | 8.58e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 12 | 39 | 8.84e-01 |
| KEGG | KEGG:03267 | Virion - Adenovirus | 1 | 2 | 8.96e-01 |
| KEGG | KEGG:00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 1 | 2 | 8.96e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 6 | 19 | 8.98e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 28 | 94 | 9.05e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 13 | 43 | 9.05e-01 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 10 | 33 | 9.17e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 5 | 16 | 9.25e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 7 | 23 | 9.29e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 30 | 102 | 9.29e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 45 | 153 | 9.29e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 9 | 30 | 9.29e-01 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 4 | 13 | 9.43e-01 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 6 | 20 | 9.43e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 31 | 106 | 9.43e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 6 | 20 | 9.43e-01 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 2 | 6 | 9.46e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 25 | 86 | 9.46e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 16 | 55 | 9.46e-01 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 32 | 110 | 9.46e-01 |
| KEGG | KEGG:04146 | Peroxisome | 20 | 69 | 9.51e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 11 | 38 | 9.59e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 15 | 52 | 9.59e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 6 | 21 | 9.95e-01 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 12 | 46 | 1.00e+00 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 43 | 195 | 1.00e+00 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 13 | 56 | 1.00e+00 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 27 | 99 | 1.00e+00 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 16 | 57 | 1.00e+00 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 17 | 63 | 1.00e+00 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 48 | 179 | 1.00e+00 |
| KEGG | KEGG:04744 | Phototransduction | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 3 | 23 | 1.00e+00 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 28 | 104 | 1.00e+00 |
| KEGG | KEGG:05145 | Toxoplasmosis | 22 | 81 | 1.00e+00 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 2 | 18 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 100 | 416 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 26 | 162 | 1.00e+00 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 4 | 23 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 37 | 185 | 1.00e+00 |
| KEGG | KEGG:05219 | Bladder cancer | 7 | 37 | 1.00e+00 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 15 | 62 | 1.00e+00 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 1 | 11 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 14 | 52 | 1.00e+00 |
| KEGG | KEGG:05330 | Allograft rejection | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:05332 | Graft-versus-host disease | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 38 | 168 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 10 | 46 | 1.00e+00 |
| KEGG | KEGG:05144 | Malaria | 4 | 20 | 1.00e+00 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 20 | 84 | 1.00e+00 |
| KEGG | KEGG:05140 | Leishmaniasis | 10 | 42 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 5 | 38 | 1.00e+00 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 33 | 131 | 1.00e+00 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 4 | 15 | 1.00e+00 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 1 | 4 | 1.00e+00 |
| KEGG | KEGG:00360 | Phenylalanine metabolism | 1 | 5 | 1.00e+00 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 17 | 61 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 81 | 314 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 49 | 225 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 82 | 303 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 64 | 255 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 46 | 218 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 108 | 384 | 1.00e+00 |
| KEGG | KEGG:05030 | Cocaine addiction | 9 | 35 | 1.00e+00 |
| KEGG | KEGG:05031 | Amphetamine addiction | 12 | 49 | 1.00e+00 |
| KEGG | KEGG:05033 | Nicotine addiction | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:05133 | Pertussis | 12 | 45 | 1.00e+00 |
| KEGG | KEGG:05135 | Yersinia infection | 31 | 112 | 1.00e+00 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 8 | 49 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 11 | 50 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 17 | 85 | 1.00e+00 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 3 | 27 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 1 | 12 | 1.00e+00 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 3 | 17 | 1.00e+00 |
| KEGG | KEGG:00790 | Folate biosynthesis | 4 | 18 | 1.00e+00 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 5 | 28 | 1.00e+00 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 2 | 22 | 1.00e+00 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 3 | 21 | 1.00e+00 |
| KEGG | KEGG:00920 | Sulfur metabolism | 2 | 10 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 9 | 44 | 1.00e+00 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 6 | 26 | 1.00e+00 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 4 | 21 | 1.00e+00 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 11 | 44 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 8 | 44 | 1.00e+00 |
| KEGG | KEGG:01100 | Metabolic pathways | 329 | 1149 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 19 | 98 | 1.00e+00 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 5 | 28 | 1.00e+00 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 13 | 50 | 1.00e+00 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 12 | 60 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 27 | 115 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 7 | 35 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 6 | 24 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 18 | 75 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 15 | 127 | 1.00e+00 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 25 | 99 | 1.00e+00 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 32 | 117 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 16 | 74 | 1.00e+00 |
| KEGG | KEGG:03020 | RNA polymerase | 8 | 34 | 1.00e+00 |
| KEGG | KEGG:03022 | Basal transcription factors | 11 | 40 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 21 | 132 | 1.00e+00 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 1 | 5 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 6 | 42 | 1.00e+00 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 1 | 6 | 1.00e+00 |
| KEGG | KEGG:00670 | One carbon pool by folate | 4 | 18 | 1.00e+00 |
| KEGG | KEGG:00350 | Tyrosine metabolism | 3 | 13 | 1.00e+00 |
| KEGG | KEGG:00340 | Histidine metabolism | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 8 | 38 | 1.00e+00 |
| KEGG | KEGG:00310 | Lysine degradation | 14 | 59 | 1.00e+00 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 11 | 43 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 4 | 31 | 1.00e+00 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 8 | 29 | 1.00e+00 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 12 | 45 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 8 | 51 | 1.00e+00 |
| KEGG | KEGG:00511 | Other glycan degradation | 2 | 16 | 1.00e+00 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 4 | 22 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 5 | 39 | 1.00e+00 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 7 | 37 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 10 | 46 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 17 | 106 | 1.00e+00 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 2 | 19 | 1.00e+00 |
| KEGG | KEGG:00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 2 | 11 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 5 | 25 | 1.00e+00 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 3 | 17 | 1.00e+00 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 5 | 26 | 1.00e+00 |
| KEGG | KEGG:00071 | Fatty acid degradation | 7 | 32 | 1.00e+00 |
| KEGG | KEGG:00062 | Fatty acid elongation | 6 | 24 | 1.00e+00 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 1 | 13 | 1.00e+00 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 9 | 33 | 1.00e+00 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 4 | 25 | 1.00e+00 |
| KEGG | KEGG:00640 | Propanoate metabolism | 7 | 28 | 1.00e+00 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 2 | 9 | 1.00e+00 |
| KEGG | KEGG:00052 | Galactose metabolism | 4 | 22 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 4 | 30 | 1.00e+00 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 32 | 114 | 1.00e+00 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 4 | 20 | 1.00e+00 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 8 | 31 | 1.00e+00 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 21 | 89 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 26 | 100 | 1.00e+00 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 13 | 49 | 1.00e+00 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 30 | 106 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 36 | 160 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 24 | 117 | 1.00e+00 |
| KEGG | KEGG:04122 | Sulfur relay system | 2 | 8 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 12 | 69 | 1.00e+00 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 20 | 83 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 44 | 177 | 1.00e+00 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 19 | 67 | 1.00e+00 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 4 | 41 | 1.00e+00 |
| KEGG | KEGG:04145 | Phagosome | 26 | 99 | 1.00e+00 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 1 | 6 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 8 | 40 | 1.00e+00 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0050794 | regulation of cellular process | 2939 | 7651 | 4.95e-11 |
| GO:BP | GO:0065007 | biological regulation | 3143 | 8275 | 1.39e-09 |
| GO:BP | GO:0051716 | cellular response to stimulus | 1949 | 4933 | 1.39e-09 |
| GO:BP | GO:0050789 | regulation of biological process | 3058 | 8037 | 1.39e-09 |
| GO:BP | GO:0007049 | cell cycle | 663 | 1520 | 1.11e-08 |
| GO:BP | GO:0022402 | cell cycle process | 487 | 1078 | 1.90e-08 |
| GO:BP | GO:0050896 | response to stimulus | 2215 | 5732 | 2.63e-07 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1510 | 3804 | 5.27e-07 |
| GO:BP | GO:0007059 | chromosome segregation | 188 | 372 | 2.10e-06 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1776 | 4561 | 5.74e-06 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1582 | 4037 | 9.57e-06 |
| GO:BP | GO:0000278 | mitotic cell cycle | 361 | 803 | 1.04e-05 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1640 | 4198 | 1.04e-05 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 310 | 679 | 1.72e-05 |
| GO:BP | GO:0000280 | nuclear division | 174 | 349 | 1.80e-05 |
| GO:BP | GO:0007154 | cell communication | 1654 | 4248 | 1.91e-05 |
| GO:BP | GO:0007165 | signal transduction | 1507 | 3846 | 1.91e-05 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 287 | 624 | 1.94e-05 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1227 | 3089 | 2.19e-05 |
| GO:BP | GO:0051301 | cell division | 263 | 566 | 2.19e-05 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 525 | 1233 | 3.68e-05 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 1747 | 4521 | 5.65e-05 |
| GO:BP | GO:0023052 | signaling | 1622 | 4180 | 6.43e-05 |
| GO:BP | GO:0007010 | cytoskeleton organization | 516 | 1218 | 9.23e-05 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 1127 | 2842 | 1.19e-04 |
| GO:BP | GO:0006974 | DNA damage response | 352 | 801 | 1.44e-04 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 1739 | 4515 | 1.46e-04 |
| GO:BP | GO:0000070 | mitotic sister chromatid segregation | 97 | 180 | 1.46e-04 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 481 | 1135 | 1.82e-04 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 1564 | 4039 | 1.82e-04 |
| GO:BP | GO:0033043 | regulation of organelle organization | 435 | 1016 | 1.82e-04 |
| GO:BP | GO:0048285 | organelle fission | 187 | 393 | 1.82e-04 |
| GO:BP | GO:0019222 | regulation of metabolic process | 1881 | 4914 | 1.90e-04 |
| GO:BP | GO:0051726 | regulation of cell cycle | 403 | 935 | 1.90e-04 |
| GO:BP | GO:0000819 | sister chromatid segregation | 113 | 218 | 1.90e-04 |
| GO:BP | GO:0051276 | chromosome organization | 244 | 535 | 2.38e-04 |
| GO:BP | GO:0072359 | circulatory system development | 387 | 896 | 2.38e-04 |
| GO:BP | GO:0140014 | mitotic nuclear division | 127 | 252 | 2.57e-04 |
| GO:BP | GO:0040007 | growth | 325 | 739 | 2.57e-04 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 250 | 551 | 2.67e-04 |
| GO:BP | GO:0098813 | nuclear chromosome segregation | 134 | 269 | 2.82e-04 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 437 | 1027 | 2.83e-04 |
| GO:BP | GO:0007275 | multicellular organism development | 1320 | 3383 | 2.83e-04 |
| GO:BP | GO:0048589 | developmental growth | 240 | 527 | 2.84e-04 |
| GO:BP | GO:0007507 | heart development | 235 | 515 | 2.99e-04 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 1021 | 2576 | 3.36e-04 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 770 | 1908 | 4.84e-04 |
| GO:BP | GO:0035556 | intracellular signal transduction | 834 | 2079 | 4.85e-04 |
| GO:BP | GO:0008283 | cell population proliferation | 572 | 1386 | 5.59e-04 |
| GO:BP | GO:0051983 | regulation of chromosome segregation | 68 | 121 | 6.49e-04 |
| GO:BP | GO:0006351 | DNA-templated transcription | 1057 | 2683 | 6.67e-04 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 1022 | 2589 | 6.81e-04 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 437 | 1036 | 6.84e-04 |
| GO:BP | GO:0006260 | DNA replication | 126 | 255 | 7.57e-04 |
| GO:BP | GO:0010468 | regulation of gene expression | 1398 | 3613 | 7.58e-04 |
| GO:BP | GO:0009888 | tissue development | 585 | 1425 | 8.05e-04 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 1600 | 4170 | 8.93e-04 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 798 | 1992 | 9.01e-04 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 83 | 156 | 9.27e-04 |
| GO:BP | GO:0033554 | cellular response to stress | 627 | 1538 | 9.31e-04 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 820 | 2052 | 9.32e-04 |
| GO:BP | GO:0050793 | regulation of developmental process | 726 | 1801 | 9.32e-04 |
| GO:BP | GO:0048513 | animal organ development | 849 | 2130 | 9.42e-04 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 1635 | 4269 | 9.47e-04 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 325 | 752 | 9.98e-04 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 1063 | 2709 | 1.09e-03 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1089 | 2780 | 1.12e-03 |
| GO:BP | GO:0048468 | cell development | 799 | 1999 | 1.12e-03 |
| GO:BP | GO:0021537 | telencephalon development | 105 | 208 | 1.13e-03 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 801 | 2005 | 1.13e-03 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 1435 | 3724 | 1.13e-03 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 684 | 1694 | 1.23e-03 |
| GO:BP | GO:0090068 | positive regulation of cell cycle process | 105 | 209 | 1.42e-03 |
| GO:BP | GO:0140013 | meiotic nuclear division | 67 | 122 | 1.50e-03 |
| GO:BP | GO:1903046 | meiotic cell cycle process | 74 | 138 | 1.63e-03 |
| GO:BP | GO:0007017 | microtubule-based process | 327 | 762 | 1.65e-03 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 1475 | 3841 | 1.69e-03 |
| GO:BP | GO:0061982 | meiosis I cell cycle process | 48 | 81 | 1.74e-03 |
| GO:BP | GO:0009966 | regulation of signal transduction | 911 | 2307 | 1.74e-03 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 1464 | 3815 | 2.11e-03 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 700 | 1744 | 2.11e-03 |
| GO:BP | GO:0048731 | system development | 1130 | 2903 | 2.14e-03 |
| GO:BP | GO:0006259 | DNA metabolic process | 374 | 886 | 2.16e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 971 | 2474 | 2.41e-03 |
| GO:BP | GO:0006261 | DNA-templated DNA replication | 79 | 151 | 2.43e-03 |
| GO:BP | GO:0048869 | cellular developmental process | 1160 | 2988 | 2.58e-03 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 776 | 1951 | 2.71e-03 |
| GO:BP | GO:0009987 | cellular process | 4160 | 11450 | 2.73e-03 |
| GO:BP | GO:0010646 | regulation of cell communication | 1017 | 2601 | 2.73e-03 |
| GO:BP | GO:0030154 | cell differentiation | 1159 | 2987 | 2.77e-03 |
| GO:BP | GO:0006996 | organelle organization | 1164 | 3001 | 2.81e-03 |
| GO:BP | GO:0006281 | DNA repair | 239 | 543 | 2.85e-03 |
| GO:BP | GO:0007051 | spindle organization | 95 | 189 | 2.85e-03 |
| GO:BP | GO:0030900 | forebrain development | 138 | 292 | 2.88e-03 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 147 | 314 | 2.89e-03 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 693 | 1732 | 3.16e-03 |
| GO:BP | GO:0014706 | striated muscle tissue development | 107 | 218 | 3.21e-03 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 1186 | 3066 | 3.63e-03 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 815 | 2061 | 3.63e-03 |
| GO:BP | GO:0048856 | anatomical structure development | 1574 | 4130 | 3.65e-03 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 1701 | 4481 | 3.74e-03 |
| GO:BP | GO:1901653 | cellular response to peptide | 134 | 284 | 3.82e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 641 | 1597 | 4.00e-03 |
| GO:BP | GO:0060429 | epithelium development | 352 | 836 | 4.00e-03 |
| GO:BP | GO:0043010 | camera-type eye development | 114 | 236 | 4.01e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 824 | 2088 | 4.20e-03 |
| GO:BP | GO:0023051 | regulation of signaling | 1012 | 2597 | 4.46e-03 |
| GO:BP | GO:0044770 | cell cycle phase transition | 214 | 484 | 4.64e-03 |
| GO:BP | GO:0008150 | biological_process | 4360 | 12051 | 4.71e-03 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 350 | 833 | 4.85e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 577 | 1430 | 4.98e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 132 | 281 | 5.14e-03 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 401 | 967 | 5.35e-03 |
| GO:BP | GO:0051984 | positive regulation of chromosome segregation | 20 | 27 | 5.35e-03 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 469 | 1146 | 5.61e-03 |
| GO:BP | GO:0001654 | eye development | 128 | 272 | 5.80e-03 |
| GO:BP | GO:0055123 | digestive system development | 54 | 98 | 5.95e-03 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 1206 | 3131 | 5.95e-03 |
| GO:BP | GO:0022008 | neurogenesis | 537 | 1327 | 6.15e-03 |
| GO:BP | GO:0048880 | sensory system development | 129 | 275 | 6.29e-03 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 994 | 2555 | 6.31e-03 |
| GO:BP | GO:0060419 | heart growth | 42 | 72 | 6.41e-03 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 1739 | 4599 | 6.41e-03 |
| GO:BP | GO:1901987 | regulation of cell cycle phase transition | 175 | 389 | 6.45e-03 |
| GO:BP | GO:0032502 | developmental process | 1694 | 4475 | 6.45e-03 |
| GO:BP | GO:0150063 | visual system development | 128 | 273 | 6.50e-03 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 204 | 462 | 6.50e-03 |
| GO:BP | GO:0032501 | multicellular organismal process | 1822 | 4830 | 6.50e-03 |
| GO:BP | GO:0009262 | deoxyribonucleotide metabolic process | 24 | 35 | 6.52e-03 |
| GO:BP | GO:0019692 | deoxyribose phosphate metabolic process | 24 | 35 | 6.52e-03 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 1205 | 3132 | 6.77e-03 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 903 | 2311 | 6.91e-03 |
| GO:BP | GO:0021988 | olfactory lobe development | 17 | 22 | 7.04e-03 |
| GO:BP | GO:0048565 | digestive tract development | 50 | 90 | 7.27e-03 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 9 | 9 | 7.92e-03 |
| GO:BP | GO:1901652 | response to peptide | 171 | 381 | 8.26e-03 |
| GO:BP | GO:0007127 | meiosis I | 43 | 75 | 8.28e-03 |
| GO:BP | GO:0016043 | cellular component organization | 1931 | 5139 | 8.49e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 79 | 157 | 8.57e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 877 | 2246 | 9.39e-03 |
| GO:BP | GO:0040008 | regulation of growth | 215 | 493 | 9.39e-03 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 220 | 506 | 9.69e-03 |
| GO:BP | GO:0033047 | regulation of mitotic sister chromatid segregation | 32 | 52 | 9.79e-03 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 1241 | 3238 | 9.79e-03 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1118 | 2902 | 9.79e-03 |
| GO:BP | GO:2001251 | negative regulation of chromosome organization | 49 | 89 | 1.06e-02 |
| GO:BP | GO:0051321 | meiotic cell cycle | 92 | 189 | 1.10e-02 |
| GO:BP | GO:0009394 | 2’-deoxyribonucleotide metabolic process | 23 | 34 | 1.12e-02 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 99 | 206 | 1.14e-02 |
| GO:BP | GO:0051304 | chromosome separation | 43 | 76 | 1.15e-02 |
| GO:BP | GO:0007423 | sensory organ development | 177 | 399 | 1.20e-02 |
| GO:BP | GO:0050000 | chromosome localization | 58 | 110 | 1.28e-02 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 12 | 14 | 1.28e-02 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 523 | 1301 | 1.28e-02 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 35 | 59 | 1.28e-02 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 41 | 72 | 1.28e-02 |
| GO:BP | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 16 | 21 | 1.28e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 464 | 1145 | 1.28e-02 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 524 | 1304 | 1.28e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 109 | 231 | 1.28e-02 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 551 | 1376 | 1.28e-02 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 1740 | 4620 | 1.29e-02 |
| GO:BP | GO:0045786 | negative regulation of cell cycle | 153 | 340 | 1.32e-02 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 126 | 273 | 1.32e-02 |
| GO:BP | GO:1905818 | regulation of chromosome separation | 40 | 70 | 1.32e-02 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 689 | 1746 | 1.32e-02 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 1796 | 4776 | 1.32e-02 |
| GO:BP | GO:0000075 | cell cycle checkpoint signaling | 91 | 188 | 1.34e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 176 | 398 | 1.36e-02 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 112 | 239 | 1.37e-02 |
| GO:BP | GO:0060537 | muscle tissue development | 158 | 353 | 1.39e-02 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 17 | 23 | 1.39e-02 |
| GO:BP | GO:0008608 | attachment of spindle microtubules to kinetochore | 31 | 51 | 1.44e-02 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 139 | 306 | 1.47e-02 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 18 | 25 | 1.53e-02 |
| GO:BP | GO:0044057 | regulation of system process | 176 | 399 | 1.53e-02 |
| GO:BP | GO:0048638 | regulation of developmental growth | 119 | 257 | 1.56e-02 |
| GO:BP | GO:0051303 | establishment of chromosome localization | 54 | 102 | 1.59e-02 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 312 | 749 | 1.60e-02 |
| GO:BP | GO:0035886 | vascular associated smooth muscle cell differentiation | 19 | 27 | 1.60e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 173 | 392 | 1.62e-02 |
| GO:BP | GO:0007389 | pattern specification process | 139 | 307 | 1.67e-02 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 255 | 602 | 1.72e-02 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 121 | 263 | 1.85e-02 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 264 | 626 | 1.87e-02 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 48 | 89 | 1.87e-02 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 33 | 56 | 1.91e-02 |
| GO:BP | GO:0051310 | metaphase chromosome alignment | 51 | 96 | 1.96e-02 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 440 | 1088 | 1.96e-02 |
| GO:BP | GO:0007052 | mitotic spindle organization | 64 | 126 | 1.96e-02 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 47 | 87 | 1.98e-02 |
| GO:BP | GO:0045839 | negative regulation of mitotic nuclear division | 32 | 54 | 1.98e-02 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 126 | 276 | 1.98e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 37 | 65 | 2.09e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 121 | 264 | 2.09e-02 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 457 | 1134 | 2.09e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 121 | 264 | 2.09e-02 |
| GO:BP | GO:0010948 | negative regulation of cell cycle process | 125 | 274 | 2.09e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 46 | 85 | 2.09e-02 |
| GO:BP | GO:0006950 | response to stress | 1043 | 2715 | 2.09e-02 |
| GO:BP | GO:0042692 | muscle cell differentiation | 149 | 334 | 2.13e-02 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 359 | 876 | 2.16e-02 |
| GO:BP | GO:0021772 | olfactory bulb development | 15 | 20 | 2.19e-02 |
| GO:BP | GO:0007548 | sex differentiation | 91 | 191 | 2.19e-02 |
| GO:BP | GO:0033046 | negative regulation of sister chromatid segregation | 28 | 46 | 2.30e-02 |
| GO:BP | GO:2000816 | negative regulation of mitotic sister chromatid separation | 28 | 46 | 2.30e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 191 | 441 | 2.30e-02 |
| GO:BP | GO:0035295 | tube development | 340 | 827 | 2.30e-02 |
| GO:BP | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 28 | 46 | 2.30e-02 |
| GO:BP | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 28 | 46 | 2.30e-02 |
| GO:BP | GO:0009790 | embryo development | 354 | 864 | 2.32e-02 |
| GO:BP | GO:0071174 | mitotic spindle checkpoint signaling | 27 | 44 | 2.35e-02 |
| GO:BP | GO:0071173 | spindle assembly checkpoint signaling | 27 | 44 | 2.35e-02 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 203 | 472 | 2.35e-02 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 724 | 1852 | 2.35e-02 |
| GO:BP | GO:0007094 | mitotic spindle assembly checkpoint signaling | 27 | 44 | 2.35e-02 |
| GO:BP | GO:0048699 | generation of neurons | 460 | 1145 | 2.43e-02 |
| GO:BP | GO:0051784 | negative regulation of nuclear division | 33 | 57 | 2.57e-02 |
| GO:BP | GO:0051150 | regulation of smooth muscle cell differentiation | 22 | 34 | 2.74e-02 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 141 | 316 | 2.74e-02 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 501 | 1256 | 2.78e-02 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 37 | 66 | 2.79e-02 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 768 | 1974 | 2.79e-02 |
| GO:BP | GO:0045017 | glycerolipid biosynthetic process | 101 | 217 | 2.81e-02 |
| GO:BP | GO:0007088 | regulation of mitotic nuclear division | 52 | 100 | 2.86e-02 |
| GO:BP | GO:0043434 | response to peptide hormone | 144 | 324 | 2.87e-02 |
| GO:BP | GO:0048634 | regulation of muscle organ development | 12 | 15 | 2.93e-02 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 190 | 441 | 2.99e-02 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 446 | 1111 | 3.03e-02 |
| GO:BP | GO:0030029 | actin filament-based process | 281 | 677 | 3.26e-02 |
| GO:BP | GO:1905819 | negative regulation of chromosome separation | 28 | 47 | 3.38e-02 |
| GO:BP | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 28 | 47 | 3.38e-02 |
| GO:BP | GO:0007417 | central nervous system development | 308 | 748 | 3.38e-02 |
| GO:BP | GO:0051985 | negative regulation of chromosome segregation | 28 | 47 | 3.38e-02 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 13 | 17 | 3.48e-02 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 13 | 17 | 3.48e-02 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 13 | 17 | 3.48e-02 |
| GO:BP | GO:0031577 | spindle checkpoint signaling | 27 | 45 | 3.53e-02 |
| GO:BP | GO:0009155 | purine deoxyribonucleotide catabolic process | 7 | 7 | 3.53e-02 |
| GO:BP | GO:0007080 | mitotic metaphase chromosome alignment | 33 | 58 | 3.58e-02 |
| GO:BP | GO:0007093 | mitotic cell cycle checkpoint signaling | 69 | 141 | 3.61e-02 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 293 | 710 | 3.69e-02 |
| GO:BP | GO:0016070 | RNA metabolic process | 1356 | 3588 | 3.76e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 342 | 839 | 3.79e-02 |
| GO:BP | GO:0060322 | head development | 244 | 583 | 3.90e-02 |
| GO:BP | GO:0003205 | cardiac chamber development | 73 | 151 | 3.90e-02 |
| GO:BP | GO:0033045 | regulation of sister chromatid segregation | 51 | 99 | 3.90e-02 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 295 | 716 | 3.90e-02 |
| GO:BP | GO:0016477 | cell migration | 432 | 1078 | 3.97e-02 |
| GO:BP | GO:1901698 | response to nitrogen compound | 317 | 774 | 3.99e-02 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 31 | 54 | 4.01e-02 |
| GO:BP | GO:0042221 | response to chemical | 935 | 2436 | 4.11e-02 |
| GO:BP | GO:0048568 | embryonic organ development | 140 | 317 | 4.16e-02 |
| GO:BP | GO:1901988 | negative regulation of cell cycle phase transition | 108 | 237 | 4.17e-02 |
| GO:BP | GO:0071310 | cellular response to organic substance | 541 | 1370 | 4.17e-02 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 173 | 401 | 4.25e-02 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 21 | 33 | 4.33e-02 |
| GO:BP | GO:0010638 | positive regulation of organelle organization | 185 | 432 | 4.39e-02 |
| GO:BP | GO:0009151 | purine deoxyribonucleotide metabolic process | 10 | 12 | 4.41e-02 |
| GO:BP | GO:0051783 | regulation of nuclear division | 58 | 116 | 4.41e-02 |
| GO:BP | GO:0098792 | xenophagy | 10 | 12 | 4.41e-02 |
| GO:BP | GO:0060420 | regulation of heart growth | 29 | 50 | 4.44e-02 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 29 | 50 | 4.44e-02 |
| GO:BP | GO:0046474 | glycerophospholipid biosynthetic process | 87 | 186 | 4.62e-02 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 62 | 126 | 4.98e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04115 | p53 signaling pathway | 38 | 66 | 2.96e-02 |
| KEGG | KEGG:04110 | Cell cycle | 75 | 151 | 2.96e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 52 | 97 | 2.96e-02 |
| KEGG | KEGG:03410 | Base excision repair | 26 | 44 | 1.08e-01 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 27 | 49 | 2.83e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 44 | 91 | 3.72e-01 |
| KEGG | KEGG:01524 | Platinum drug resistance | 33 | 65 | 3.72e-01 |
| KEGG | KEGG:03430 | Mismatch repair | 14 | 22 | 3.72e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 37 | 76 | 4.29e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 22 | 41 | 4.29e-01 |
| KEGG | KEGG:05224 | Breast cancer | 54 | 117 | 4.29e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 35 | 72 | 4.55e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 75 | 179 | 5.30e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 65 | 149 | 5.30e-01 |
| KEGG | KEGG:03440 | Homologous recombination | 20 | 39 | 5.30e-01 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 38 | 83 | 5.30e-01 |
| KEGG | KEGG:05216 | Thyroid cancer | 18 | 35 | 5.30e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 35 | 74 | 5.30e-01 |
| KEGG | KEGG:05218 | Melanoma | 28 | 58 | 5.30e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 9 | 15 | 5.30e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 27 | 56 | 5.30e-01 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 32 | 67 | 5.30e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 51 | 117 | 5.30e-01 |
| KEGG | KEGG:03030 | DNA replication | 18 | 35 | 5.30e-01 |
| KEGG | KEGG:04148 | Efferocytosis | 55 | 125 | 5.30e-01 |
| KEGG | KEGG:04814 | Motor proteins | 65 | 149 | 5.30e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 39 | 86 | 5.30e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 17 | 33 | 5.30e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 46 | 104 | 5.30e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 44 | 95 | 5.30e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 58 | 134 | 5.30e-01 |
| KEGG | KEGG:00000 | KEGG root term | 2112 | 5802 | 5.35e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 23 | 48 | 5.47e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 23 | 48 | 5.47e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 26 | 56 | 5.86e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 26 | 56 | 5.86e-01 |
| KEGG | KEGG:04217 | Necroptosis | 45 | 104 | 5.86e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 30 | 66 | 5.86e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 13 | 25 | 5.92e-01 |
| KEGG | KEGG:05210 | Colorectal cancer | 37 | 84 | 5.92e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 44 | 102 | 5.92e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 54 | 128 | 5.92e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 38 | 87 | 5.92e-01 |
| KEGG | KEGG:05212 | Pancreatic cancer | 33 | 75 | 6.05e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 42 | 98 | 6.05e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 51 | 121 | 6.05e-01 |
| KEGG | KEGG:05213 | Endometrial cancer | 26 | 57 | 6.05e-01 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 21 | 45 | 6.05e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 55 | 132 | 6.16e-01 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 67 | 164 | 6.20e-01 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 30 | 68 | 6.20e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 62 | 151 | 6.20e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 46 | 109 | 6.20e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 10 | 19 | 6.27e-01 |
| KEGG | KEGG:04611 | Platelet activation | 38 | 89 | 6.33e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 46 | 110 | 6.36e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 56 | 136 | 6.36e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 33 | 78 | 6.87e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 35 | 83 | 6.87e-01 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 32 | 75 | 6.87e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 32 | 75 | 6.87e-01 |
| KEGG | KEGG:04210 | Apoptosis | 48 | 117 | 6.87e-01 |
| KEGG | KEGG:00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 2 | 2 | 6.87e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 20 | 44 | 6.87e-01 |
| KEGG | KEGG:04976 | Bile secretion | 19 | 42 | 6.87e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 33 | 78 | 6.87e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 19 | 42 | 6.87e-01 |
| KEGG | KEGG:04540 | Gap junction | 31 | 73 | 6.89e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 156 | 408 | 6.89e-01 |
| KEGG | KEGG:04924 | Renin secretion | 22 | 50 | 6.89e-01 |
| KEGG | KEGG:05164 | Influenza A | 42 | 102 | 6.89e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 16 | 35 | 6.89e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 40 | 97 | 6.98e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 49 | 121 | 7.13e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 58 | 145 | 7.14e-01 |
| KEGG | KEGG:04146 | Peroxisome | 29 | 69 | 7.21e-01 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 65 | 164 | 7.21e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 34 | 82 | 7.21e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 27 | 64 | 7.33e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 8 | 16 | 7.45e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 8 | 16 | 7.45e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 21 | 49 | 7.50e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 12 | 26 | 7.50e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 95 | 246 | 7.50e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 40 | 99 | 7.61e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 56 | 142 | 7.61e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 17 | 39 | 7.61e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 35 | 86 | 7.61e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 57 | 145 | 7.74e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 67 | 172 | 7.74e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 43 | 108 | 7.85e-01 |
| KEGG | KEGG:04730 | Long-term depression | 18 | 42 | 7.85e-01 |
| KEGG | KEGG:04360 | Axon guidance | 63 | 162 | 7.94e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 35 | 87 | 7.94e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 10 | 22 | 8.33e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 23 | 56 | 8.47e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 44 | 112 | 8.47e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 26 | 64 | 8.47e-01 |
| KEGG | KEGG:03265 | Virion - Ebolavirus and Lyssavirus | 3 | 5 | 8.48e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 13 | 30 | 8.48e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 3 | 5 | 8.48e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 37 | 94 | 8.73e-01 |
| KEGG | KEGG:05034 | Alcoholism | 44 | 113 | 8.76e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 5 | 10 | 8.81e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 45 | 116 | 8.83e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 12 | 28 | 8.88e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 30 | 76 | 9.04e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 27 | 69 | 9.43e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 54 | 142 | 9.43e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 20 | 50 | 9.43e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 27 | 69 | 9.43e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 27 | 69 | 9.43e-01 |
| KEGG | KEGG:00350 | Tyrosine metabolism | 6 | 13 | 9.43e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 22 | 55 | 9.43e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 30 | 77 | 9.43e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 21 | 53 | 9.48e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 35 | 91 | 9.48e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 18 | 45 | 9.48e-01 |
| KEGG | KEGG:05214 | Glioma | 26 | 67 | 9.65e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 59 | 157 | 9.65e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 48 | 127 | 9.65e-01 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 23 | 59 | 9.70e-01 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 13 | 49 | 1.00e+00 |
| KEGG | KEGG:04520 | Adherens junction | 29 | 86 | 1.00e+00 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 35 | 117 | 1.00e+00 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 24 | 83 | 1.00e+00 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 23 | 63 | 1.00e+00 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 15 | 50 | 1.00e+00 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 33 | 100 | 1.00e+00 |
| KEGG | KEGG:04530 | Tight junction | 48 | 138 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 8 | 40 | 1.00e+00 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 5 | 41 | 1.00e+00 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 20 | 53 | 1.00e+00 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 19 | 57 | 1.00e+00 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 22 | 64 | 1.00e+00 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 3 | 6 | 1.00e+00 |
| KEGG | KEGG:04510 | Focal adhesion | 45 | 177 | 1.00e+00 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 5 | 12 | 1.00e+00 |
| KEGG | KEGG:03267 | Virion - Adenovirus | 1 | 2 | 1.00e+00 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 1 | 6 | 1.00e+00 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 37 | 99 | 1.00e+00 |
| KEGG | KEGG:03060 | Protein export | 7 | 30 | 1.00e+00 |
| KEGG | KEGG:03050 | Proteasome | 10 | 42 | 1.00e+00 |
| KEGG | KEGG:03040 | Spliceosome | 35 | 132 | 1.00e+00 |
| KEGG | KEGG:03022 | Basal transcription factors | 13 | 40 | 1.00e+00 |
| KEGG | KEGG:03020 | RNA polymerase | 8 | 34 | 1.00e+00 |
| KEGG | KEGG:03018 | RNA degradation | 23 | 74 | 1.00e+00 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 35 | 99 | 1.00e+00 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 23 | 85 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 21 | 75 | 1.00e+00 |
| KEGG | KEGG:02010 | ABC transporters | 9 | 29 | 1.00e+00 |
| KEGG | KEGG:01523 | Antifolate resistance | 7 | 24 | 1.00e+00 |
| KEGG | KEGG:01522 | Endocrine resistance | 32 | 85 | 1.00e+00 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 8 | 35 | 1.00e+00 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 41 | 115 | 1.00e+00 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 19 | 60 | 1.00e+00 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 12 | 50 | 1.00e+00 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 10 | 28 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 23 | 98 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 22 | 127 | 1.00e+00 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 6 | 20 | 1.00e+00 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 39 | 113 | 1.00e+00 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 25 | 71 | 1.00e+00 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 35 | 106 | 1.00e+00 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 16 | 49 | 1.00e+00 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 34 | 92 | 1.00e+00 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 18 | 49 | 1.00e+00 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 30 | 94 | 1.00e+00 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 18 | 67 | 1.00e+00 |
| KEGG | KEGG:04218 | Cellular senescence | 51 | 144 | 1.00e+00 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 12 | 30 | 1.00e+00 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 20 | 54 | 1.00e+00 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 88 | 256 | 1.00e+00 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 49 | 135 | 1.00e+00 |
| KEGG | KEGG:04145 | Phagosome | 28 | 99 | 1.00e+00 |
| KEGG | KEGG:04144 | Endocytosis | 82 | 230 | 1.00e+00 |
| KEGG | KEGG:04142 | Lysosome | 27 | 117 | 1.00e+00 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 37 | 160 | 1.00e+00 |
| KEGG | KEGG:04137 | Mitophagy - animal | 33 | 100 | 1.00e+00 |
| KEGG | KEGG:04136 | Autophagy - other | 11 | 31 | 1.00e+00 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 12 | 31 | 1.00e+00 |
| KEGG | KEGG:04122 | Sulfur relay system | 3 | 8 | 1.00e+00 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 47 | 134 | 1.00e+00 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 36 | 108 | 1.00e+00 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 39 | 106 | 1.00e+00 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 27 | 89 | 1.00e+00 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 12 | 69 | 1.00e+00 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 29 | 86 | 1.00e+00 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 27 | 84 | 1.00e+00 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 13 | 46 | 1.00e+00 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 89 | 271 | 1.00e+00 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 63 | 176 | 1.00e+00 |
| KEGG | KEGG:05162 | Measles | 34 | 97 | 1.00e+00 |
| KEGG | KEGG:05152 | Tuberculosis | 39 | 106 | 1.00e+00 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 3 | 18 | 1.00e+00 |
| KEGG | KEGG:05146 | Amoebiasis | 21 | 64 | 1.00e+00 |
| KEGG | KEGG:05145 | Toxoplasmosis | 21 | 81 | 1.00e+00 |
| KEGG | KEGG:05144 | Malaria | 6 | 20 | 1.00e+00 |
| KEGG | KEGG:05143 | African trypanosomiasis | 5 | 16 | 1.00e+00 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 148 | 416 | 1.00e+00 |
| KEGG | KEGG:05142 | Chagas disease | 28 | 75 | 1.00e+00 |
| KEGG | KEGG:05135 | Yersinia infection | 36 | 112 | 1.00e+00 |
| KEGG | KEGG:05134 | Legionellosis | 7 | 38 | 1.00e+00 |
| KEGG | KEGG:05133 | Pertussis | 13 | 45 | 1.00e+00 |
| KEGG | KEGG:05132 | Salmonella infection | 74 | 214 | 1.00e+00 |
| KEGG | KEGG:05131 | Shigellosis | 71 | 210 | 1.00e+00 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 54 | 151 | 1.00e+00 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 18 | 58 | 1.00e+00 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 14 | 43 | 1.00e+00 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 22 | 74 | 1.00e+00 |
| KEGG | KEGG:05140 | Leishmaniasis | 11 | 42 | 1.00e+00 |
| KEGG | KEGG:05033 | Nicotine addiction | 4 | 12 | 1.00e+00 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 50 | 153 | 1.00e+00 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 30 | 162 | 1.00e+00 |
| KEGG | KEGG:05416 | Viral myocarditis | 10 | 46 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 44 | 168 | 1.00e+00 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 26 | 84 | 1.00e+00 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 26 | 79 | 1.00e+00 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:05332 | Graft-versus-host disease | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:05330 | Allograft rejection | 1 | 10 | 1.00e+00 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 15 | 43 | 1.00e+00 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 16 | 52 | 1.00e+00 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 59 | 165 | 1.00e+00 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 7 | 22 | 1.00e+00 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 31 | 84 | 1.00e+00 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 18 | 62 | 1.00e+00 |
| KEGG | KEGG:05222 | Small cell lung cancer | 31 | 87 | 1.00e+00 |
| KEGG | KEGG:05219 | Bladder cancer | 8 | 37 | 1.00e+00 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 25 | 65 | 1.00e+00 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 40 | 185 | 1.00e+00 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 57 | 170 | 1.00e+00 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 5 | 23 | 1.00e+00 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 57 | 163 | 1.00e+00 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 1 | 11 | 1.00e+00 |
| KEGG | KEGG:05031 | Amphetamine addiction | 18 | 49 | 1.00e+00 |
| KEGG | KEGG:05030 | Cocaine addiction | 14 | 35 | 1.00e+00 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 115 | 384 | 1.00e+00 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 19 | 52 | 1.00e+00 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 21 | 55 | 1.00e+00 |
| KEGG | KEGG:04916 | Melanogenesis | 28 | 77 | 1.00e+00 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 34 | 96 | 1.00e+00 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 26 | 76 | 1.00e+00 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 54 | 179 | 1.00e+00 |
| KEGG | KEGG:04744 | Phototransduction | 5 | 12 | 1.00e+00 |
| KEGG | KEGG:04742 | Taste transduction | 8 | 22 | 1.00e+00 |
| KEGG | KEGG:04740 | Olfactory transduction | 10 | 25 | 1.00e+00 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 42 | 115 | 1.00e+00 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 32 | 102 | 1.00e+00 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 28 | 99 | 1.00e+00 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 33 | 110 | 1.00e+00 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 17 | 51 | 1.00e+00 |
| KEGG | KEGG:04720 | Long-term potentiation | 20 | 55 | 1.00e+00 |
| KEGG | KEGG:04714 | Thermogenesis | 48 | 195 | 1.00e+00 |
| KEGG | KEGG:04710 | Circadian rhythm | 12 | 30 | 1.00e+00 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 24 | 79 | 1.00e+00 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 28 | 75 | 1.00e+00 |
| KEGG | KEGG:04726 | Serotonergic synapse | 24 | 63 | 1.00e+00 |
| KEGG | KEGG:01100 | Metabolic pathways | 394 | 1149 | 1.00e+00 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 33 | 104 | 1.00e+00 |
| KEGG | KEGG:04929 | GnRH secretion | 19 | 53 | 1.00e+00 |
| KEGG | KEGG:05020 | Prion disease | 57 | 218 | 1.00e+00 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 41 | 123 | 1.00e+00 |
| KEGG | KEGG:05016 | Huntington disease | 71 | 255 | 1.00e+00 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 100 | 303 | 1.00e+00 |
| KEGG | KEGG:05012 | Parkinson disease | 53 | 225 | 1.00e+00 |
| KEGG | KEGG:05010 | Alzheimer disease | 90 | 314 | 1.00e+00 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 9 | 33 | 1.00e+00 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 5 | 14 | 1.00e+00 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 6 | 19 | 1.00e+00 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 18 | 61 | 1.00e+00 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 10 | 31 | 1.00e+00 |
| KEGG | KEGG:04972 | Pancreatic secretion | 22 | 58 | 1.00e+00 |
| KEGG | KEGG:04971 | Gastric acid secretion | 18 | 52 | 1.00e+00 |
| KEGG | KEGG:04970 | Salivary secretion | 21 | 55 | 1.00e+00 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 8 | 19 | 1.00e+00 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 7 | 20 | 1.00e+00 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 12 | 38 | 1.00e+00 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 12 | 41 | 1.00e+00 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 2 | 4 | 1.00e+00 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 5 | 15 | 1.00e+00 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 33 | 131 | 1.00e+00 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 19 | 56 | 1.00e+00 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 9 | 24 | 1.00e+00 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 39 | 114 | 1.00e+00 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 5 | 21 | 1.00e+00 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 14 | 38 | 1.00e+00 |
| KEGG | KEGG:00340 | Histidine metabolism | 4 | 12 | 1.00e+00 |
| KEGG | KEGG:00360 | Phenylalanine metabolism | 2 | 5 | 1.00e+00 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 3 | 23 | 1.00e+00 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 3 | 8 | 1.00e+00 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 1 | 6 | 1.00e+00 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 5 | 14 | 1.00e+00 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 14 | 44 | 1.00e+00 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 2 | 4 | 1.00e+00 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 10 | 51 | 1.00e+00 |
| KEGG | KEGG:00511 | Other glycan degradation | 1 | 16 | 1.00e+00 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 4 | 22 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 6 | 39 | 1.00e+00 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 8 | 37 | 1.00e+00 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 11 | 46 | 1.00e+00 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1 | 4 | 1.00e+00 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 55 | 153 | 1.00e+00 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 5 | 21 | 1.00e+00 |
| KEGG | KEGG:00310 | Lysine degradation | 19 | 59 | 1.00e+00 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 14 | 43 | 1.00e+00 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 10 | 44 | 1.00e+00 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 6 | 28 | 1.00e+00 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 8 | 25 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 2 | 12 | 1.00e+00 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 6 | 27 | 1.00e+00 |
| KEGG | KEGG:00052 | Galactose metabolism | 7 | 22 | 1.00e+00 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 2 | 9 | 1.00e+00 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 1.00e+00 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 3 | 12 | 1.00e+00 |
| KEGG | KEGG:00071 | Fatty acid degradation | 7 | 32 | 1.00e+00 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 6 | 17 | 1.00e+00 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 4 | 11 | 1.00e+00 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 5 | 19 | 1.00e+00 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 17 | 106 | 1.00e+00 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 10 | 29 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 6 | 31 | 1.00e+00 |
| KEGG | KEGG:00062 | Fatty acid elongation | 5 | 24 | 1.00e+00 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 4 | 13 | 1.00e+00 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 8 | 23 | 1.00e+00 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 5 | 25 | 1.00e+00 |
| KEGG | KEGG:00650 | Butanoate metabolism | 7 | 17 | 1.00e+00 |
| KEGG | KEGG:00670 | One carbon pool by folate | 5 | 18 | 1.00e+00 |
| KEGG | KEGG:00640 | Propanoate metabolism | 8 | 28 | 1.00e+00 |
| KEGG | KEGG:00730 | Thiamine metabolism | 4 | 10 | 1.00e+00 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 8 | 33 | 1.00e+00 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 2 | 13 | 1.00e+00 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 1 | 9 | 1.00e+00 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 5 | 14 | 1.00e+00 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 8 | 29 | 1.00e+00 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 4 | 10 | 1.00e+00 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 6 | 17 | 1.00e+00 |
| KEGG | KEGG:00790 | Folate biosynthesis | 4 | 18 | 1.00e+00 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 3 | 7 | 1.00e+00 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 8 | 26 | 1.00e+00 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 8 | 28 | 1.00e+00 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 9 | 22 | 1.00e+00 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 6 | 21 | 1.00e+00 |
| KEGG | KEGG:00920 | Sulfur metabolism | 3 | 10 | 1.00e+00 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 9 | 25 | 1.00e+00 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 16 | 44 | 1.00e+00 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 6 | 26 | 1.00e+00 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 8 | 20 | 1.00e+00 |
sessionInfo()R version 4.3.1 (2023-06-16 ucrt)
Platform: x86_64-w64-mingw32/x64 (64-bit)
Running under: Windows 10 x64 (build 19045)
Matrix products: default
locale:
[1] LC_COLLATE=English_United States.utf8
[2] LC_CTYPE=English_United States.utf8
[3] LC_MONETARY=English_United States.utf8
[4] LC_NUMERIC=C
[5] LC_TIME=English_United States.utf8
time zone: America/Chicago
tzcode source: internal
attached base packages:
[1] grid stats4 stats graphics grDevices utils datasets
[8] methods base
other attached packages:
[1] biomaRt_2.58.2
[2] ggpubr_0.6.0
[3] BiocParallel_1.36.0
[4] ggVennDiagram_1.5.2
[5] scales_1.3.0
[6] VennDiagram_1.7.3
[7] futile.logger_1.4.3
[8] gridExtra_2.3
[9] ggfortify_0.4.17
[10] edgeR_4.0.16
[11] limma_3.58.1
[12] rtracklayer_1.62.0
[13] org.Hs.eg.db_3.18.0
[14] TxDb.Hsapiens.UCSC.hg38.knownGene_3.18.0
[15] GenomicFeatures_1.54.4
[16] AnnotationDbi_1.64.1
[17] Biobase_2.62.0
[18] GenomicRanges_1.54.1
[19] GenomeInfoDb_1.38.8
[20] IRanges_2.36.0
[21] S4Vectors_0.40.2
[22] BiocGenerics_0.48.1
[23] ChIPseeker_1.38.0
[24] gprofiler2_0.2.3
[25] RColorBrewer_1.1-3
[26] broom_1.0.6
[27] kableExtra_1.4.0
[28] lubridate_1.9.3
[29] forcats_1.0.0
[30] stringr_1.5.1
[31] dplyr_1.1.4
[32] purrr_1.0.2
[33] readr_2.1.5
[34] tidyr_1.3.1
[35] tibble_3.2.1
[36] ggplot2_3.5.1
[37] tidyverse_2.0.0
[38] workflowr_1.7.1
loaded via a namespace (and not attached):
[1] fs_1.6.4
[2] matrixStats_1.3.0
[3] bitops_1.0-7
[4] enrichplot_1.22.0
[5] HDO.db_0.99.1
[6] httr_1.4.7
[7] tools_4.3.1
[8] backports_1.5.0
[9] utf8_1.2.4
[10] R6_2.5.1
[11] lazyeval_0.2.2
[12] withr_3.0.0
[13] prettyunits_1.2.0
[14] cli_3.6.2
[15] formatR_1.14
[16] scatterpie_0.2.2
[17] labeling_0.4.3
[18] sass_0.4.9
[19] Rsamtools_2.18.0
[20] systemfonts_1.1.0
[21] yulab.utils_0.1.4
[22] DOSE_3.28.2
[23] svglite_2.1.3
[24] plotrix_3.8-4
[25] rstudioapi_0.16.0
[26] RSQLite_2.3.7
[27] generics_0.1.3
[28] gridGraphics_0.5-1
[29] TxDb.Hsapiens.UCSC.hg19.knownGene_3.2.2
[30] BiocIO_1.12.0
[31] vroom_1.6.5
[32] gtools_3.9.5
[33] car_3.1-2
[34] GO.db_3.18.0
[35] Matrix_1.6-5
[36] fansi_1.0.6
[37] abind_1.4-5
[38] lifecycle_1.0.4
[39] whisker_0.4.1
[40] yaml_2.3.8
[41] carData_3.0-5
[42] SummarizedExperiment_1.32.0
[43] gplots_3.1.3.1
[44] qvalue_2.34.0
[45] SparseArray_1.2.4
[46] BiocFileCache_2.10.2
[47] blob_1.2.4
[48] promises_1.3.0
[49] crayon_1.5.2
[50] lattice_0.22-6
[51] cowplot_1.1.3
[52] KEGGREST_1.42.0
[53] pillar_1.9.0
[54] knitr_1.47
[55] fgsea_1.28.0
[56] rjson_0.2.21
[57] boot_1.3-30
[58] codetools_0.2-20
[59] fastmatch_1.1-4
[60] glue_1.7.0
[61] getPass_0.2-4
[62] ggfun_0.1.5
[63] data.table_1.15.4
[64] vctrs_0.6.5
[65] png_0.1-8
[66] treeio_1.26.0
[67] gtable_0.3.5
[68] cachem_1.1.0
[69] xfun_0.44
[70] S4Arrays_1.2.1
[71] mime_0.12
[72] tidygraph_1.3.1
[73] statmod_1.5.0
[74] interactiveDisplayBase_1.40.0
[75] nlme_3.1-164
[76] ggtree_3.10.1
[77] bit64_4.0.5
[78] progress_1.2.3
[79] filelock_1.0.3
[80] rprojroot_2.0.4
[81] bslib_0.7.0
[82] KernSmooth_2.23-24
[83] colorspace_2.1-0
[84] DBI_1.2.3
[85] tidyselect_1.2.1
[86] processx_3.8.4
[87] bit_4.0.5
[88] compiler_4.3.1
[89] curl_5.2.1
[90] git2r_0.33.0
[91] xml2_1.3.6
[92] DelayedArray_0.28.0
[93] plotly_4.10.4
[94] shadowtext_0.1.3
[95] caTools_1.18.2
[96] callr_3.7.6
[97] rappdirs_0.3.3
[98] digest_0.6.35
[99] rmarkdown_2.27
[100] XVector_0.42.0
[101] htmltools_0.5.8.1
[102] pkgconfig_2.0.3
[103] MatrixGenerics_1.14.0
[104] highr_0.11
[105] dbplyr_2.5.0
[106] fastmap_1.2.0
[107] rlang_1.1.3
[108] htmlwidgets_1.6.4
[109] shiny_1.8.1.1
[110] farver_2.1.2
[111] jquerylib_0.1.4
[112] jsonlite_1.8.8
[113] GOSemSim_2.28.1
[114] RCurl_1.98-1.14
[115] magrittr_2.0.3
[116] GenomeInfoDbData_1.2.11
[117] ggplotify_0.1.2
[118] patchwork_1.2.0
[119] munsell_0.5.1
[120] Rcpp_1.0.12
[121] ape_5.8
[122] viridis_0.6.5
[123] stringi_1.8.4
[124] ggraph_2.2.1
[125] zlibbioc_1.48.2
[126] MASS_7.3-60.0.1
[127] AnnotationHub_3.10.1
[128] plyr_1.8.9
[129] parallel_4.3.1
[130] ggrepel_0.9.5
[131] Biostrings_2.70.3
[132] graphlayouts_1.1.1
[133] splines_4.3.1
[134] hms_1.1.3
[135] locfit_1.5-9.9
[136] ps_1.7.6
[137] igraph_2.0.3
[138] ggsignif_0.6.4
[139] reshape2_1.4.4
[140] futile.options_1.0.1
[141] BiocVersion_3.18.1
[142] XML_3.99-0.16.1
[143] evaluate_0.23
[144] lambda.r_1.2.4
[145] BiocManager_1.30.23
[146] tzdb_0.4.0
[147] tweenr_2.0.3
[148] httpuv_1.6.15
[149] polyclip_1.10-6
[150] ggforce_0.4.2
[151] xtable_1.8-4
[152] restfulr_0.0.15
[153] tidytree_0.4.6
[154] rstatix_0.7.2
[155] later_1.3.2
[156] viridisLite_0.4.2
[157] aplot_0.2.2
[158] memoise_2.0.1
[159] GenomicAlignments_1.38.2
[160] timechange_0.3.0